Citrus Sinensis ID: 037563
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWZ5 | 821 | G-type lectin S-receptor- | yes | no | 0.711 | 0.524 | 0.585 | 1e-142 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.767 | 0.533 | 0.385 | 1e-86 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.546 | 0.379 | 0.470 | 8e-83 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.541 | 0.395 | 0.482 | 1e-78 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.650 | 0.475 | 0.4 | 3e-74 | |
| Q94C25 | 452 | Probable receptor-like pr | no | no | 0.445 | 0.597 | 0.478 | 1e-67 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.702 | 0.521 | 0.334 | 3e-67 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.344 | 0.262 | 0.584 | 5e-67 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.638 | 0.465 | 0.345 | 3e-60 | |
| Q9SY95 | 802 | G-type lectin S-receptor- | no | no | 0.892 | 0.674 | 0.292 | 6e-58 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 504 bits (1298), Expect = e-142, Method: Compositional matrix adjust.
Identities = 257/439 (58%), Positives = 323/439 (73%), Gaps = 8/439 (1%)
Query: 173 NGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLG-SQFNCRP 231
NG I+FSNL +G +A KIP + C PEPC PY+VC C C L ++ +C+
Sbjct: 258 NGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGLSRARSDCKT 317
Query: 232 PVASTCNESMNSA----KLFYLGERLDYFALGFVSPFPK-YDINTCKEACLHNCSCSVLF 286
+ S C ++ ++A +L G+ +DYFALG+ PF K D+++CKE C +NCSC LF
Sbjct: 318 GITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLF 377
Query: 287 FENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVVIV 346
F+NS+ NCFLFD IGS + S G +G+VSY+KI+ + D GK +V+IV
Sbjct: 378 FQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIA--STGSGGGDNGEDDGKHFPYVVIIV 435
Query: 347 VATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNF 406
V T+ +IA L++ H ++K + + QE+ EED FLE+ SGMP RF+Y DL AT NF
Sbjct: 436 VVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNF 495
Query: 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
S KLGQGGFGSVY G LPDG ++AVKKLE IGQGKKEF AEV+IIG++HH+HLV+L+GFC
Sbjct: 496 SVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFC 555
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
EGAHRLLAYE+L GSL++WIF + L W+TRFNIALGTAKGLAYLHE+C+ +IV
Sbjct: 556 AEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIV 615
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
HCDIKPEN+LLDDNF AKVSDFGLAKLM RE+S V+TT+RGTRGYLAPEWITN ISEKS
Sbjct: 616 HCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKS 675
Query: 587 DVYSYGMVLLEIIGGRKSF 605
DVYSYGMVLLE+IGGRK++
Sbjct: 676 DVYSYGMVLLELIGGRKNY 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 197/511 (38%), Positives = 289/511 (56%), Gaps = 46/511 (9%)
Query: 125 VECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFMEGMRLKSSNGEITFSNLRNG 184
VE + + SG L L+ NG+++ + P P F + S+G+ S +G
Sbjct: 223 VEYLTVTTSG-LALMARNGTVVVVRVALP-----PSSDFR--VAKMDSSGKFIVSRF-SG 273
Query: 185 RAATSEVIKIPQNSCSVPEPCNPYFVCYFDN-----RCQCPPSL---GSQFNCRPPVAS- 235
+ +E P +SC +P C +C DN C CP + + C P S
Sbjct: 274 KNLVTE-FSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPDEMRMDAGKGVCVPVSQSL 332
Query: 236 ----TCNESMNSAKLFYLGERLDYFALGFVSPFPK-YDINTCKEACLHNCSCSVLFFENS 290
+C E+ N + L LG + YF+ F P + C + C NCSC +F+EN+
Sbjct: 333 SLPVSC-EARNISYL-ELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENT 390
Query: 291 TKNCFLF-DQIGSLQRSQQGSTGY--VSYMKISRGNEVLNSKIRESDGGKTVVLIVVIVV 347
+++C+L D GSL + + + Y+K+S + GG + +I ++++
Sbjct: 391 SRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLL 450
Query: 348 AT----ILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLES-------FSGMPTRFSY 396
+L+ LL+ W R + ++ + ES G+P +F +
Sbjct: 451 PCSGFFLLIALGLLW---WRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEF 507
Query: 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVH 455
++L +AT+NF ++G GGFGSVY G LPD +AVKK+ + G G++EF E+ IIGN+
Sbjct: 508 EELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIR 567
Query: 456 HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
H +LVKL+GFC G LL YEY+ +GSL+K +F+ L W RF+IALGTA+GLA
Sbjct: 568 HTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGN--GPVLEWQERFDIALGTARGLA 625
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
YLH C+ KI+HCD+KPEN+LL D+F K+SDFGL+KL+N+EES ++TT+RGTRGYLAPE
Sbjct: 626 YLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPE 685
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
WITN ISEK+DVYSYGMVLLE++ GRK+ S
Sbjct: 686 WITNAAISEKADVYSYGMVLLELVSGRKNCS 716
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 162/344 (47%), Positives = 224/344 (65%), Gaps = 13/344 (3%)
Query: 268 DINTCKEACLHNCSC--SVLFFENSTKNCFLFDQIGSLQRSQQGSTGYV---SYMKISRG 322
++ C E CL +C C SV ++ C++ + GST +V +
Sbjct: 396 NVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSN 455
Query: 323 NEVLNSKIRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDY 382
+ +SK R+S G + VL++ IVV +LV+ +LL L+++ RKR K + +N
Sbjct: 456 SNNNDSKSRKSHGLRQKVLVIPIVVG-MLVLVALLGMLLYYNLDRKRTLKRAAKNSL--- 511
Query: 383 FLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLE-SIGQGK 441
P F+Y DL T NFS LG GGFG+VY G + VAVK+L+ ++ G+
Sbjct: 512 ---ILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGE 568
Query: 442 KEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWN 501
+EF EV IG++HH++LV+L G+C E +HRLL YEY++NGSLDKWIF+S + + L W
Sbjct: 569 REFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWR 628
Query: 502 TRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561
TRF IA+ TA+G+AY HE+C +I+HCDIKPEN+LLDDNF KVSDFGLAK+M RE S V
Sbjct: 629 TRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV 688
Query: 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
T +RGTRGYLAPEW++N PI+ K+DVYSYGM+LLEI+GGR++
Sbjct: 689 VTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNL 732
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 165/342 (48%), Positives = 221/342 (64%), Gaps = 14/342 (4%)
Query: 272 CKEACLHNCSC-SVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKI 330
C+ CL + C + + + + NC+ Q S SY+K+ G V N+
Sbjct: 350 CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVC-GPVVANTLE 408
Query: 331 RESDGGKTVVLIVVIVVATILVIASLL-----YAGLWHHNKRKRLTKFSQENLEEDY-FL 384
R + G + + +VA + VIA LL GLW RK +F L Y L
Sbjct: 409 RATKGDDNNSKVHLWIVA-VAVIAGLLGLVAVEIGLWWCCCRKN-PRFG--TLSSHYTLL 464
Query: 385 ESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF 444
E SG P +F+Y +L + TK+F KLG GGFG+VY G+L + VAVK+LE I QG+K+F
Sbjct: 465 EYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQF 524
Query: 445 SAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF 504
EV I + HH++LV+L GFC +G HRLL YE++ NGSLD ++F +T+ ++FL W RF
Sbjct: 525 RMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLF-TTDSAKFLTWEYRF 583
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN-REESLVYT 563
NIALGTAKG+ YLHEEC IVHCDIKPEN+L+DDNF AKVSDFGLAKL+N ++ +
Sbjct: 584 NIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMS 643
Query: 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
++RGTRGYLAPEW+ N PI+ KSDVYSYGMVLLE++ G+++F
Sbjct: 644 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNF 685
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (715), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 170/425 (40%), Positives = 239/425 (56%), Gaps = 31/425 (7%)
Query: 195 PQNSCSVPEPCNPYFVCYFDNR--CQCP----PSLGSQFNCRPPVASTCNE-----SMNS 243
P+ C V C + +C + C+CP P ++ + A + S
Sbjct: 286 PRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGD 345
Query: 244 AKLFYLGERLDYFALGFVSP-FPKYDINTCKEACLHNCSCSVLFFENSTKNCFLF--DQI 300
F+ RL L S + ++ C AC +CSC ++ + C ++ D +
Sbjct: 346 INQFF---RLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVL 402
Query: 301 GSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVVIVVATILVIASLLYAG 360
Q + S G + Y++++ ++V N + S LI V+ ++ VI +L
Sbjct: 403 NLQQLEDENSEGNIFYLRLA-ASDVPN--VGASGKSNNKGLIFGAVLGSLGVIVLVLLVV 459
Query: 361 LWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYL 420
+ R+R ++ G + FSY +L ATKNFS KLG GGFGSV+
Sbjct: 460 ILILRYRRRKRMRGEKG----------DGTLSAFSYRELQNATKNFSDKLGGGGFGSVFK 509
Query: 421 GMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480
G LPD +AVK+LE I QG+K+F EV IG + HV+LV+L+GFC EG+ +LL Y+Y+
Sbjct: 510 GALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMP 569
Query: 481 NGSLDKWIF-NSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539
NGSLD +F N EE L W RF IALGTA+GLAYLH+EC I+HCDIKPEN+LLD
Sbjct: 570 NGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDS 629
Query: 540 NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
F KV+DFGLAKL+ R+ S V TT+RGTRGYLAPEWI+ I+ K+DVYSYGM+L E++
Sbjct: 630 QFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELV 689
Query: 600 GGRKS 604
GR++
Sbjct: 690 SGRRN 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 135/282 (47%), Positives = 186/282 (65%), Gaps = 12/282 (4%)
Query: 337 KTVVLIVVIVVATILVIASLLYAGLWHHNKRKRL-TKFSQENLE---EDYFLESFSGMPT 392
KT LI + ++ IL + L ++ +RK L ++F+ E E E FL +G+PT
Sbjct: 32 KTFYLIAGVDISLILAVICFLIIRSRYNKERKLLVSRFASEGRELRIEYSFLRKVAGVPT 91
Query: 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIG 452
+F +DL +AT F + +G+GG GSV+ G+L DG QVAVK++E +G++EF +EV I
Sbjct: 92 KFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEEKGEREFRSEVAAIA 151
Query: 453 NVHHVHLVKLKGFCIEGAH---RLLAYEYLVNGSLDKWIFNSTEESRF-----LCWNTRF 504
+V H +LV+L G+ + R L Y+Y+VN SLD WIF L W R+
Sbjct: 152 SVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNRGRSGGGCLSWEQRY 211
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564
+A+ AK LAYLH +C KI+H D+KPEN+LLD+NF A V+DFGL+KL+ R+ES V T
Sbjct: 212 QVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARDESRVLTD 271
Query: 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+RGTRGYLAPEW+ + ISEKSDVYSYG+VLLE+IGGR+S S
Sbjct: 272 IRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSIS 313
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 256 bits (654), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 157/469 (33%), Positives = 243/469 (51%), Gaps = 43/469 (9%)
Query: 173 NGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNR--CQCPPSLGSQ---- 226
+G + ++ + + S + C++ C P +C++ C CPP ++
Sbjct: 270 DGNLRLYSMNDSDGSWSVSMVAMTQPCNIHGLCGPNGICHYSPTPTCSCPPGYATRNPGN 329
Query: 227 --FNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSV 284
C V +TC+ + F D++ + TC++ C+ +C+C
Sbjct: 330 WTEGCMAIVNTTCDRYDKRSMRFVRLPNTDFWG-SDQQHLLSVSLRTCRDICISDCTCKG 388
Query: 285 LFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESD---------- 334
++ T +C+ + S R+ S Y+K+ G V N+ I SD
Sbjct: 389 FQYQEGTGSCYPKAYLFS-GRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLD 447
Query: 335 -------------------GGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQ 375
GG++ +A V+ + W ++ L
Sbjct: 448 CDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSEL 507
Query: 376 ENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLE 435
E+ Y ++ + R+SY +L KAT+ F +LG+G G+VY G+L D VAVKKLE
Sbjct: 508 WASEKGY--KAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLE 565
Query: 436 SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEES 495
++ QGK+ F AE+++IG ++H++LV++ GFC EG+HRLL EY+ NGSL +F S +
Sbjct: 566 NVRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILF-SEGGN 624
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555
L W RFNIALG AKGLAYLH EC ++HCD+KPEN+LLD F K++DFGL KL+N
Sbjct: 625 ILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLN 684
Query: 556 REESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603
R S + +RGT GY+APEW+++ PI+ K DVYSYG+VLLE++ G +
Sbjct: 685 RGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTR 733
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (653), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 124/212 (58%), Positives = 156/212 (73%), Gaps = 3/212 (1%)
Query: 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQ-VAVKKLESIGQGKKEFSAEVTIIG 452
FS+ +L AT FS K+G GGFG+V+ G LP VAVK+LE G G+ EF AEV IG
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIG 510
Query: 453 NVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK 512
N+ HV+LV+L+GFC E HRLL Y+Y+ GSL ++ S + L W TRF IALGTAK
Sbjct: 511 NIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGTAK 568
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+AYLHE C I+HCDIKPEN+LLD ++ AKVSDFGLAKL+ R+ S V T+RGT GY+
Sbjct: 569 GIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYV 628
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604
APEWI+ PI+ K+DVYS+GM LLE+IGGR++
Sbjct: 629 APEWISGLPITTKADVYSFGMTLLELIGGRRN 660
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 146/422 (34%), Positives = 227/422 (53%), Gaps = 35/422 (8%)
Query: 199 CSVPE------PCNPYFVCYFDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGER 252
C PE P N Y C D Q CRP T N +N + L E+
Sbjct: 330 CECPERFVLKDPSNEYGDCLPDFEMQ---------TCRPE-NQTANSDVNLYEFITL-EK 378
Query: 253 LDYFALGFVSPFPKYDINTCKEACLHNCSCS-VLFFENSTKNCFLFD-QIGSLQRSQQGS 310
++ G + YD CK +CL +C C+ V+F N C+ + +RS +G
Sbjct: 379 TNW-PFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGD 437
Query: 311 TGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVV--IVVATILVIASLLYAGLWHHNKRK 368
+ +++K+ R + + + + K LI+ +++ T + K K
Sbjct: 438 SD--TFIKV-RNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAFVIFDTSCSYRKTKKSK 494
Query: 369 RLTKFSQENLEEDYFLESFSGMPTR-FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP--- 424
+ K ++ + + + R F+Y +L +AT++F+ +LG+G FG VY G L
Sbjct: 495 NMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAG 554
Query: 425 -DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482
+ VAVKKL+ + +KEF EV +IG +HH +LV+L GFC EG +++ YE+L G
Sbjct: 555 GSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQG 614
Query: 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 542
+L ++F S W R NIA+ A+G+ YLHEEC +I+HCDIKP+N+LLD+ +T
Sbjct: 615 TLANFLFRRPRPS----WEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYT 670
Query: 543 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602
++SDFGLAKL+ ++ T +RGT+GY+APEW N+PI+ K DVYSYG++LLEI+ +
Sbjct: 671 PRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCK 730
Query: 603 KS 604
K+
Sbjct: 731 KA 732
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY95|Y1155_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 OS=Arabidopsis thaliana GN=At1g61550 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 198/676 (29%), Positives = 305/676 (45%), Gaps = 135/676 (19%)
Query: 47 GLFLISNNSVFGFGFYTALDVQ--FFSLVVIHISSAKVVWTANRGLLIRDSD-KFVFEKS 103
G L S N +F GF++ + + + + I VVW ANR + D+ +
Sbjct: 30 GQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGIIPRTVVWVANRENSVTDATADLAISSN 89
Query: 104 GNAYLQRG-NGEAWS-ANTSGQKVECMELQDSGNLVLLG-VNGSIL-------------- 146
G+ L G + WS T EL DSGNL+++ V+G L
Sbjct: 90 GSLLLFDGKHSTVWSTGETFASNGSSAELSDSGNLLVIDKVSGITLWQSFEHLGDTMLPY 149
Query: 147 -----------------WQSFSHP--------TDTLLPGQQF-MEGMR------------ 168
W+S++ P T +P Q F M G +
Sbjct: 150 SSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYITTQVPPQGFIMRGSKPYWRSGPWAKTR 209
Query: 169 -----------------LKSSNGEITFSNL-RNGRAA----TSE---------------V 191
+ +NG + FS+L RN + + TSE
Sbjct: 210 FTGVPLTDESYTHPFSVQQDANGSVYFSHLQRNFKRSLLVLTSEGSLKVTHHNGTDWVLN 269
Query: 192 IKIPQNSCSVPEPCNPYFVCYFD--NRCQCPPSLGSQFNCRPPVASTCNESMNSAKLF-- 247
I +P N+C C P+ +C +C+C QF+ + + +L
Sbjct: 270 IDVPANTCDFYGVCGPFGLCVMSIPPKCKCFKGFVPQFSEEWKRGNWTGGCVRRTELLCQ 329
Query: 248 --YLGERLDYF-ALGFVSPFPKYDI------NTCKEACLHNCSCSVLFFENSTKNCFLFD 298
G ++ F + + P Y+ C ++CLHNCSC + N C +++
Sbjct: 330 GNSTGRHVNVFHPVANIKPPDFYEFVSSGSAEECYQSCLHNCSCLAFAYINGI-GCLIWN 388
Query: 299 QIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGG----KTVVLIVVIVVATILVIA 354
Q + M+ S G E+L+ ++ S+ G K ++ ++ ++ + +A
Sbjct: 389 Q------------ELMDVMQFSVGGELLSIRLASSEMGGNQRKKTIIASIVSISLFVTLA 436
Query: 355 SLLYAGLWHHNKRKR--LTKFS-QENLEEDYFLESFSGMPTRFSYDDLCKATKNFS--TK 409
S + G W + + ++K S Q D E SG+ F + AT NFS K
Sbjct: 437 SAAF-GFWRYRLKHNAIVSKVSLQGAWRNDLKSEDVSGL-YFFEMKTIEIATNNFSLVNK 494
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
LGQGGFG VY G L DG ++AVK+L S GQGK+EF E+ +I + H++LV++ G CIE
Sbjct: 495 LGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIE 554
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
G RLL YE++VN SLD +IF+S + + W RF+I G A+GL YLH + ++I+H
Sbjct: 555 GEERLLVYEFMVNKSLDTFIFDSRKRVE-IDWPKRFSIIQGIARGLLYLHRDSRLRIIHR 613
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNPISEKSD 587
D+K N+LLDD K+SDFGLA++ + T + GT GY++PE+ SEKSD
Sbjct: 614 DVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKSD 673
Query: 588 VYSYGMVLLEIIGGRK 603
YS+G++LLE+I G K
Sbjct: 674 TYSFGVLLLEVISGEK 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| 255553179 | 774 | s-receptor kinase, putative [Ricinus com | 0.808 | 0.633 | 0.658 | 0.0 | |
| 225442967 | 828 | PREDICTED: G-type lectin S-receptor-like | 0.996 | 0.729 | 0.497 | 0.0 | |
| 297743455 | 896 | unnamed protein product [Vitis vinifera] | 0.929 | 0.628 | 0.461 | 1e-161 | |
| 357455241 | 815 | S-locus-specific glycoprotein S6 [Medica | 0.747 | 0.555 | 0.589 | 1e-160 | |
| 356557243 | 814 | PREDICTED: G-type lectin S-receptor-like | 0.782 | 0.582 | 0.569 | 1e-151 | |
| 224092482 | 816 | predicted protein [Populus trichocarpa] | 0.709 | 0.526 | 0.602 | 1e-151 | |
| 449437142 | 776 | PREDICTED: G-type lectin S-receptor-like | 0.707 | 0.552 | 0.600 | 1e-150 | |
| 449441906 | 823 | PREDICTED: G-type lectin S-receptor-like | 0.991 | 0.730 | 0.465 | 1e-150 | |
| 449499240 | 823 | PREDICTED: LOW QUALITY PROTEIN: G-type l | 0.991 | 0.730 | 0.465 | 1e-149 | |
| 356550614 | 813 | PREDICTED: G-type lectin S-receptor-like | 0.782 | 0.583 | 0.560 | 1e-149 |
| >gi|255553179|ref|XP_002517632.1| s-receptor kinase, putative [Ricinus communis] gi|223543264|gb|EEF44796.1| s-receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/501 (65%), Positives = 386/501 (77%), Gaps = 11/501 (2%)
Query: 106 AYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQ-SFSHPTDTLLPGQQFM 164
Y N + N+ KV + L S + VN +LWQ F +D P +
Sbjct: 161 VYWSLANDSRKTNNSVNGKVHSLSLV-SNSWNFYDVNRVLLWQFIFFESSD---PNATWA 216
Query: 165 EGMRLKSSNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLG 224
+ S+G I F NL+ GR+ E KIPQNSC +PEPC+ Y+VCYFDN CQCPP L
Sbjct: 217 VKL---GSDGAIEFYNLQKGRSVAPEATKIPQNSCGIPEPCDRYYVCYFDNWCQCPPPLK 273
Query: 225 SQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSV 284
S+F+C+PPVASTCN S NS +LFY+GE+LDYFA+GFV P K ++N+CKEACL NCSC V
Sbjct: 274 SEFDCKPPVASTCNGSKNSVELFYVGEKLDYFAVGFVKPLLKSNLNSCKEACLDNCSCIV 333
Query: 285 LFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVV 344
LFFE ST CFLFDQ+GS R Q GS GYVSYMK+S + NSK S+GG+ +LI V
Sbjct: 334 LFFEESTGRCFLFDQLGSFTRIQAGSPGYVSYMKVSTSKQ--NSK-SGSNGGREALLIAV 390
Query: 345 IVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATK 404
I++AT+ VIA +Y G+W++ ++ R +F Q+NLEED F +S SGMP R+S+ DLC ATK
Sbjct: 391 IIIATVFVIAGFIYLGVWYNRRKHRFLEFPQDNLEEDNFWDSLSGMPARYSFSDLCTATK 450
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
NFS K+GQGGFGSVYLGMLPDG Q+AVKKLE IGQGKKEF AEV+IIG+VHHVHLVKLKG
Sbjct: 451 NFSMKVGQGGFGSVYLGMLPDGAQLAVKKLEGIGQGKKEFRAEVSIIGSVHHVHLVKLKG 510
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
FC EGAHRLL YE++ GSLDKWIF + EES L WNTRFNIA+G AKGLAYLHEECEVK
Sbjct: 511 FCAEGAHRLLVYEFMEKGSLDKWIFKNNEESSSLDWNTRFNIAIGMAKGLAYLHEECEVK 570
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE+SLVYTT+RGTRGYLAPEWITNNPISE
Sbjct: 571 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREDSLVYTTVRGTRGYLAPEWITNNPISE 630
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSDVYSYGMVLLEIIGGRK++
Sbjct: 631 KSDVYSYGMVLLEIIGGRKNY 651
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442967|ref|XP_002265931.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/697 (49%), Positives = 444/697 (63%), Gaps = 93/697 (13%)
Query: 1 MGLFRYTGALCFCVLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG FR+ C C++LV K C+A +Q+ G++YPGF+ +QMEW +N G+FL+SN+S F G
Sbjct: 8 MGWFRFLRTFCLCLILVLKICMASTQNTGQIYPGFQGSQMEWKDNKGMFLLSNSSTFALG 67
Query: 61 FYTALDVQFFSLVVIHIS----------------SAKVVWTANRGLLIRDSDKFVF---- 100
F L+ F LVVIH++ S K V+ N ++ DK ++
Sbjct: 68 FLNTLE-GLFVLVVIHVASSKAVWTANRSFLIQNSDKFVFEKNGNAYLKGGDKIIWSTDT 126
Query: 101 ----------EKSGNAYLQRGNG----EAWSANT----SGQK-VECMELQ---------- 131
+ +GN + NG +++S T SGQ+ VE M+L+
Sbjct: 127 AGQGVTAMELQDTGNLVVLGENGRILWQSFSHPTDTLLSGQEFVEGMKLKGFSNRDNLFN 186
Query: 132 ----DSGNLVLLG--VNGSILWQSFSHPTDTLLPGQQFMEGMRLKS-------------- 171
SG+L+L W + T+ G + + S
Sbjct: 187 YLEMKSGDLILYAGFQTPQTYWSMSNESRKTIYKGHGKVHSASMMSNSWNFYDQNQALVW 246
Query: 172 -------------------SNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCY 212
S G I+F +L+ G A +E KIPQNSCSVPEPC PY+VC
Sbjct: 247 QFNFSENLDPNVTWAGVLDSEGSISFYDLQKGNLAPAESTKIPQNSCSVPEPCEPYYVCS 306
Query: 213 FDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTC 272
DNRCQCP +L S NC+P + S CN S NS +L ++G+ L+YFALGFV+P K D+N C
Sbjct: 307 VDNRCQCPSALNSSVNCKPQITSVCNVSKNSVELLHVGDSLNYFALGFVAPSLKSDLNGC 366
Query: 273 KEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEV---LNSK 329
+EAC NCSC VLFFENS+ NCFLFDQIGS QRS S+G++SY+K+S ++ N
Sbjct: 367 REACFGNCSCLVLFFENSSGNCFLFDQIGSFQRSNWYSSGFISYVKVSNNGDLDGGQNRS 426
Query: 330 IRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSG 389
E GGK +++IV+I VAT+LVI ++Y G + + + K + + S +NLEED FL+S SG
Sbjct: 427 REERKGGKIILVIVLIAVATVLVIFGVVYLG-FRYRREKEIQECSPDNLEEDDFLDSISG 485
Query: 390 MPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVT 449
MP RF Y +L AT NFS KLGQGGFGSVY G+LPDG Q+AVKKLE +GQGKKEF AEV
Sbjct: 486 MPIRFRYKELQNATSNFSEKLGQGGFGSVYKGVLPDGTQLAVKKLEGVGQGKKEFRAEVC 545
Query: 450 IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALG 509
IG++HHVHLVKLKGFC EGAHRLL YE+L GSLDK IF + + L W TRF+IALG
Sbjct: 546 TIGSIHHVHLVKLKGFCNEGAHRLLVYEFLGKGSLDKLIFKNNRKDLLLDWETRFSIALG 605
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 569
TAKGLAYLHEEC+ KI+HCDIKPENVLLDDN+ AKVSDFGLAKLMNR++S V+TT+RGTR
Sbjct: 606 TAKGLAYLHEECDPKIIHCDIKPENVLLDDNYLAKVSDFGLAKLMNRDQSHVFTTVRGTR 665
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
GYLAPEWI N+ ISEKSDV+S+GMVLLEIIGGRK++
Sbjct: 666 GYLAPEWIANHAISEKSDVFSFGMVLLEIIGGRKNYD 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743455|emb|CBI36322.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1485), Expect = e-161, Method: Compositional matrix adjust.
Identities = 321/696 (46%), Positives = 413/696 (59%), Gaps = 133/696 (19%)
Query: 1 MGLFRYTGALCFCVLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG FR+ C C++LV K C+A +Q+ G++YPGF+ +QMEW +N G+FL+SN+S F G
Sbjct: 93 MGWFRFLRTFCLCLILVLKICMASTQNTGQIYPGFQGSQMEWKDNKGMFLLSNSSTFALG 152
Query: 61 FYTALDVQFFSLVVIHISSA----------------KVVWTANRGLLIRDSDKFVF---- 100
F L+ F LVVIH++S+ K V+ N ++ DK ++
Sbjct: 153 FLNTLE-GLFVLVVIHVASSKAVWTANRSFLIQNSDKFVFEKNGNAYLKGGDKIIWSTDT 211
Query: 101 ----------EKSGNAYLQRGNG----EAWSANT----SGQK-VECMELQ---------- 131
+ +GN + NG +++S T SGQ+ VE M+L+
Sbjct: 212 AGQGVTAMELQDTGNLVVLGENGRILWQSFSHPTDTLLSGQEFVEGMKLKGFSNRDNLFN 271
Query: 132 ----DSGNLVLLG--VNGSILWQSFSHPTDTLLPGQQFMEGMRLKS-------------- 171
SG+L+L W + T+ G + + S
Sbjct: 272 YLEMKSGDLILYAGFQTPQTYWSMSNESRKTIYKGHGKVHSASMMSNSWNFYDQNQALVW 331
Query: 172 -------------------SNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCY 212
S G I+F +L+ G A +E KIPQNSCSVPEPC PY+VC
Sbjct: 332 QFNFSENLDPNVTWAGVLDSEGSISFYDLQKGNLAPAESTKIPQNSCSVPEPCEPYYVCS 391
Query: 213 FDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTC 272
DNRCQCP +L S NC+P + S CN S NS +L +
Sbjct: 392 VDNRCQCPSALNSSVNCKPQITSVCNVSKNSVELLH------------------------ 427
Query: 273 KEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEV---LNSK 329
NS+ NCFLFDQIGS QRS S+G++SY+K+S ++ N
Sbjct: 428 ----------------NSSGNCFLFDQIGSFQRSNWYSSGFISYVKVSNNGDLDGGQNRS 471
Query: 330 IRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSG 389
E GGK +++IV+I VAT+LVI ++Y G + + + K + + S +NLEED FL+S SG
Sbjct: 472 REERKGGKIILVIVLIAVATVLVIFGVVYLG-FRYRREKEIQECSPDNLEEDDFLDSISG 530
Query: 390 MPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVT 449
MP RF Y +L AT NFS KLGQGGFGSVY G+LPDG Q+AVKKLE +GQGKKEF AEV
Sbjct: 531 MPIRFRYKELQNATSNFSEKLGQGGFGSVYKGVLPDGTQLAVKKLEGVGQGKKEFRAEVC 590
Query: 450 IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALG 509
IG++HHVHLVKLKGFC EGAHRLL YE+L GSLDK IF + + L W TRF+IALG
Sbjct: 591 TIGSIHHVHLVKLKGFCNEGAHRLLVYEFLGKGSLDKLIFKNNRKDLLLDWETRFSIALG 650
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 569
TAKGLAYLHEEC+ KI+HCDIKPENVLLDDN+ AKVSDFGLAKLMNR++S V+TT+RGTR
Sbjct: 651 TAKGLAYLHEECDPKIIHCDIKPENVLLDDNYLAKVSDFGLAKLMNRDQSHVFTTVRGTR 710
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
GYLAPEWI N+ ISEKSDV+S+GMVLLEIIGGRK++
Sbjct: 711 GYLAPEWIANHAISEKSDVFSFGMVLLEIIGGRKNY 746
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455241|ref|XP_003597901.1| S-locus-specific glycoprotein S6 [Medicago truncatula] gi|355486949|gb|AES68152.1| S-locus-specific glycoprotein S6 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 274/465 (58%), Positives = 348/465 (74%), Gaps = 12/465 (2%)
Query: 142 NGSILWQS-FSHPTDTLLPGQQFMEGMRLKSSNGEITFSNLRNGRAATSEVIKIPQNSCS 200
NG ++W++ FS +D + F + NG I+F +L G++ EV K+PQ+ C
Sbjct: 241 NGILVWKTVFSDHSDP----KSFYAAIL--DPNGAISFYDLNKGKSTNPEVFKLPQDPCG 294
Query: 201 VPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGF 260
VPEPC+PY+VC+F N C+CP L S+FNC+PP S C+ +S +L Y+GE LDYFAL +
Sbjct: 295 VPEPCDPYYVCFFANWCECPSLLRSRFNCKPPNISACSPR-SSTELLYVGEHLDYFALKY 353
Query: 261 VSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKIS 320
+P K +N+CK+AC+ NCSC VLF+ENST CF FDQ GS QR + + GYVSYMK+S
Sbjct: 354 DAPVLKSTLNSCKDACVKNCSCLVLFYENSTGRCFHFDQTGSFQRFKGSTGGYVSYMKVS 413
Query: 321 RGNEVLNSKIRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEE 380
+ + K ++L+ VIV+ T+LVIA L+ G W + K+K ++ QE LEE
Sbjct: 414 TDSGGNDGSSSGK---KNMLLVFVIVILTVLVIAGLI-TGFWCYKKKKSFDEYPQETLEE 469
Query: 381 DYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG 440
D F + S MP RF+Y L +ATK+FSTK+G+GGFGSVYLG+L D Q+AVKKLE +GQG
Sbjct: 470 DDFFDGLSNMPARFTYSALARATKDFSTKIGEGGFGSVYLGLLEDDTQLAVKKLEGVGQG 529
Query: 441 KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCW 500
KEF AEV+IIG++HHVHLVKLKGFC EG HRLL YEY+ GSLDKWIF ++E + L W
Sbjct: 530 AKEFKAEVSIIGSIHHVHLVKLKGFCAEGPHRLLVYEYMARGSLDKWIFKNSENTLLLTW 589
Query: 501 NTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560
TR+NIA+GTAKGLAYLHEECEV+I+HCDIKP+NVLLDDNF AKVSDFGLAKLM+RE+S
Sbjct: 590 ETRYNIAIGTAKGLAYLHEECEVRIIHCDIKPQNVLLDDNFMAKVSDFGLAKLMSREQSH 649
Query: 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
V+TTLRGTRGYLAPEWITN ISEKSDV+SYGM+LLEI+GGRK++
Sbjct: 650 VFTTLRGTRGYLAPEWITNYAISEKSDVFSYGMLLLEIVGGRKNY 694
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557243|ref|XP_003546927.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-151, Method: Compositional matrix adjust.
Identities = 283/497 (56%), Positives = 365/497 (73%), Gaps = 23/497 (4%)
Query: 117 SANTSGQKVECMELQDSGNLVLLGVNGSILWQS-FSHPTDTLLPGQQFMEGMRLKSSNGE 175
S N +G KV L S +L +N ++LW+ FS +D P + + G
Sbjct: 212 SRNNTG-KVHSASLV-SNSLSFYDINRALLWKVVFSEHSD---PKSLWAATL---DPTGA 263
Query: 176 ITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPPVAS 235
ITF +L GRA E +K+PQ+ C +P+PC+PY+VC+F+N C CP L ++FNC+PP S
Sbjct: 264 ITFYDLNKGRAPNPEAVKVPQDPCGIPQPCDPYYVCFFENWCICPKLLRTRFNCKPPNIS 323
Query: 236 TCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCF 295
TC+ S S +L Y+GE LDYFAL + +P K ++N CKE CL NCSC VLFFENST CF
Sbjct: 324 TCSRS--STELLYVGEELDYFALKYTAPVSKSNLNACKETCLGNCSCLVLFFENSTGRCF 381
Query: 296 LFDQIGSLQRSQQGST--GYVSYMKIS---RGNEVLNSKIRESDGGKTVVLIVVIVVATI 350
FDQ GS QR ++G+ GYVS+MK+S ++ +K R +D VV++V+ V+ +
Sbjct: 382 HFDQTGSFQRYKRGAGAGGYVSFMKVSISSASDDGHGNKNRRNDAVLVVVIVVLTVLVIV 441
Query: 351 LVIASLLYAGLWHHNKRKR-LTKFSQENLEEDYFLESF-SGMPTRFSYDDLCKATKNFST 408
+I G W+ KRK+ + K+ Q++L+ED SGMP RF++ LC+ATK+FST
Sbjct: 442 GLIM-----GFWYFYKRKKNVAKYPQDDLDEDDDFLDSLSGMPARFTFAALCRATKDFST 496
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
K+G+GGFGSVYLG+L DGIQ+AVKKLE +GQG KEF AEV+IIG++HHVHLVKLKGFC E
Sbjct: 497 KIGEGGFGSVYLGVLEDGIQLAVKKLEGVGQGAKEFKAEVSIIGSIHHVHLVKLKGFCAE 556
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
G HRLL YEY+ GSLDKWIF +++ + L W+TR+NIA+GTAKGLAYLHEECEV+I+HC
Sbjct: 557 GPHRLLVYEYMARGSLDKWIFKNSDNTFLLNWDTRYNIAIGTAKGLAYLHEECEVRIIHC 616
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 588
DIKP+NVLLDDNFTAKVSDFGLAKLM+RE+S V+TTLRGTRGYLAPEWITN ISEKSDV
Sbjct: 617 DIKPQNVLLDDNFTAKVSDFGLAKLMSREQSHVFTTLRGTRGYLAPEWITNYAISEKSDV 676
Query: 589 YSYGMVLLEIIGGRKSF 605
+SYGM+LLEI+GGRK++
Sbjct: 677 FSYGMLLLEIVGGRKNY 693
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092482|ref|XP_002309629.1| predicted protein [Populus trichocarpa] gi|222855605|gb|EEE93152.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1394), Expect = e-151, Method: Compositional matrix adjust.
Identities = 261/433 (60%), Positives = 320/433 (73%), Gaps = 3/433 (0%)
Query: 173 NGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPP 232
+G I+F NL +G + KIP + CS PEPC+ ++VC +N CQCP L ++ NC+
Sbjct: 264 DGFISFYNLDDG--GSDSQTKIPSDPCSRPEPCDAHYVCSGNNVCQCPSGLSNRLNCQTE 321
Query: 233 VASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTK 292
V S+C+ S S +L G+RL+YFALGFV P D+ CK AC NCSC FF NS+
Sbjct: 322 VVSSCDGSNGSTELVSAGDRLNYFALGFVPPSSITDLEGCKSACHGNCSCLAFFFHNSSG 381
Query: 293 NCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVVIVVATILV 352
NCFLF IGS Q S GS+ +V+Y+K+S ++ + G K+ ++V+IV+ T++V
Sbjct: 382 NCFLFSDIGSFQNSNAGSS-FVAYIKVSSDGGSGSNAGGDGSGEKSFPIVVIIVIGTLIV 440
Query: 353 IASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQ 412
I LLY +H K+K++ + E+D FLE+ SGMP RFSY DL AT NFS KLGQ
Sbjct: 441 ICGLLYMAFRYHRKKKKMLESPPNTSEDDNFLETLSGMPIRFSYRDLQTATNNFSVKLGQ 500
Query: 413 GGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472
GGFGSVY G LPDG Q+AVKKLE +GQGKKEF AEV+IIG++HH HLV++KGFC EG HR
Sbjct: 501 GGFGSVYQGALPDGTQLAVKKLEGMGQGKKEFRAEVSIIGSIHHHHLVRIKGFCAEGTHR 560
Query: 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532
LLAYE++ NGSLDKWIF +E L W TRFNIA+GTAKGLAYLHE+C+VKI+HCDIKP
Sbjct: 561 LLAYEFMANGSLDKWIFKRNKEEFLLDWETRFNIAVGTAKGLAYLHEDCDVKIIHCDIKP 620
Query: 533 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592
ENVLLD F AKVSDFGLAKLMNRE+S V+TTLRGTRGYLAPEWITN ISEKSDVYSYG
Sbjct: 621 ENVLLDGQFLAKVSDFGLAKLMNREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYG 680
Query: 593 MVLLEIIGGRKSF 605
M+LLEIIGGRK+F
Sbjct: 681 MLLLEIIGGRKNF 693
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437142|ref|XP_004136351.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/433 (60%), Positives = 323/433 (74%), Gaps = 4/433 (0%)
Query: 173 NGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPP 232
+G ++F NL++ AA++ +IP++SCS PEPC PYF+CY N+CQCP L + +C+P
Sbjct: 225 DGFVSFYNLQDSGAAST--TRIPEDSCSTPEPCGPYFICYSGNKCQCPSVLSTNPSCQPG 282
Query: 233 VASTCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTK 292
+ S C++S S KL Y + YFAL F+ D+N CK AC+ NCSC LFFEN T
Sbjct: 283 IVSPCHQSNGSIKLAY-ATGVKYFALEFLPSTSTTDLNGCKNACMSNCSCRALFFENLTG 341
Query: 293 NCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESDGGKTVVLIVVIVVATILV 352
NCFL D +GS Q S + S +VSY+K+S ++ +GG ++ +I+V T V
Sbjct: 342 NCFLLDDVGSFQNSNEDSN-FVSYIKVSNNGGSGDNNGGSRNGGMNSHIVAIIIVFTGFV 400
Query: 353 IASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQ 412
I LLY ++ ++K+L E E+D FL+ +G P R+SYD+L AT NFS KLGQ
Sbjct: 401 ICGLLYLAFCYYKRKKKLPGTPHETSEDDNFLDGLTGAPIRYSYDNLQTATNNFSMKLGQ 460
Query: 413 GGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472
GGFGSVY G+LPDG +VAVKKLE++GQGKKEF AEV+IIG++HHVHLV+LKG+C EG+H+
Sbjct: 461 GGFGSVYQGLLPDGTRVAVKKLEAVGQGKKEFRAEVSIIGSIHHVHLVRLKGYCAEGSHK 520
Query: 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532
LLAYEY+ NGSLDKWIF +E L WNTRFNIALGTAKGLAYLHE+C+VKI+HCDIKP
Sbjct: 521 LLAYEYMGNGSLDKWIFRKNKEDFLLDWNTRFNIALGTAKGLAYLHEDCDVKIIHCDIKP 580
Query: 533 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592
ENVLLDD F AKVSDFGLAKLM RE+S V+TTLRGTRGYLAPEWITN ISEKSDVYSYG
Sbjct: 581 ENVLLDDKFLAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSYG 640
Query: 593 MVLLEIIGGRKSF 605
MVLLEIIGGRK+F
Sbjct: 641 MVLLEIIGGRKNF 653
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441906|ref|XP_004138723.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 327/703 (46%), Positives = 414/703 (58%), Gaps = 102/703 (14%)
Query: 1 MGLFRYTGALCFCV-------LLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISN 53
MG R+ G L + LL F+ C AG Q +G++ PG + TQM W++++G+FL SN
Sbjct: 1 MGTSRFRGYLLLIIWVSLILLLLRFRPCAAGFQSVGQISPGLQGTQMNWVDHDGVFLRSN 60
Query: 54 NSVFGFGFYTALDVQFFSLVVIHISSAKVVWT---------------------------- 85
NS FGFGF +V + L +IH+SS +VWT
Sbjct: 61 NSEFGFGFNNQQNVTQYYLAIIHLSSRSIVWTANQASPVTTSDKFLFDENGNVVLYHESI 120
Query: 86 -------ANRG---LLIRDSDKFVFEKSGNAYLQRGNGEAWSANTSGQK-VECMEL---Q 131
AN+G L +RDS V S NA + G S Q VE M L
Sbjct: 121 VVWSTNTANKGVSALALRDSGNLVLFGSDNAVIWESFGHPTDTLLSNQGFVEGMRLVSKP 180
Query: 132 DSGNLVL---LGVNGSILWQSFSHP----------------------------------- 153
DS NL+ L +L+ F P
Sbjct: 181 DSNNLMYFLELKSGDMVLYSGFKSPQPYWSMSRENRKTINKDGGSVISATLTANSWNFHG 240
Query: 154 -TDTLLPGQQFMEGMRLKS---------SNGEITFSNLRNGRAATSEVIKIPQNSCSVPE 203
D LL QF + S S+G I+F L++G + + I+IP + C PE
Sbjct: 241 ENDVLL--WQFSFSTNIDSNATWTAVLGSDGFISFYKLQDGGSGDASSIRIPDDPCGTPE 298
Query: 204 PCNPYFVCYFDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSP 263
PC F+CY + +C CP LGS+ NC+ + S C++S +L +++ YFAL F+ P
Sbjct: 299 PCEANFICYSEKKCICPSILGSRPNCQTGITSPCDQSSGPVELVESQDKIGYFALQFMQP 358
Query: 264 FPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKI-SRG 322
K D+ CK +C NCSC LFF+ ST CFLFD+IG S+ S+ +VSY+K+ G
Sbjct: 359 SLKTDLENCKSSCSSNCSCIALFFQVSTGGCFLFDEIGGFLNSK--SSEFVSYIKLLKNG 416
Query: 323 NEVLNSKIRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDY 382
N+ S G ++ I+ I +T++VI L+Y G+ K+K+ + SQE+ EE+
Sbjct: 417 ENGENNGGNGSGGKNSIPAILGIAFSTMIVICVLIYVGVRFLRKKKKPPEPSQESSEEEN 476
Query: 383 FLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK 442
FLE SG P R+SY+DL AT NFS KLGQGGFGSVY G LPDG ++AVKKLE IGQGKK
Sbjct: 477 FLEGLSGAPIRYSYNDLQTATDNFSVKLGQGGFGSVYKGFLPDGTRLAVKKLEGIGQGKK 536
Query: 443 EFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNT 502
EF AEV IIG++HH+HLV+LKGFC EG HRLLAYE++ NGSLDKWIF + L W+T
Sbjct: 537 EFRAEVGIIGSIHHIHLVRLKGFCAEGTHRLLAYEFMANGSLDKWIFKKNKADLSLDWDT 596
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
RFNIA+GTAKGLAYLHE+C+ KIVHCDIKPENVLLDDNF AKVSDFGLAKLMNRE+S V+
Sbjct: 597 RFNIAVGTAKGLAYLHEDCDAKIVHCDIKPENVLLDDNFQAKVSDFGLAKLMNREQSHVF 656
Query: 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
TTLRGTRGYLAPEWITN ISEKSDVYSYGMVLLEIIGGRK++
Sbjct: 657 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNY 699
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449499240|ref|XP_004160765.1| PREDICTED: LOW QUALITY PROTEIN: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-149, Method: Compositional matrix adjust.
Identities = 327/703 (46%), Positives = 413/703 (58%), Gaps = 102/703 (14%)
Query: 1 MGLFRYTGALCFCV-------LLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISN 53
MG R+ G L + LL F+ C AG Q +G++ PG + TQM W++++G+FL SN
Sbjct: 1 MGTSRFRGYLLLIIWVSLILLLLRFRPCAAGFQSVGQISPGLQGTQMNWVDHDGVFLRSN 60
Query: 54 NSVFGFGFYTALDVQFFSLVVIHISSAKVVWT---------------------------- 85
NS FGFGF +V + L +IH+SS +VWT
Sbjct: 61 NSEFGFGFNNQQNVTQYYLAIIHLSSRSIVWTANQASPVTTSDKFFVDENGNVVLYHESI 120
Query: 86 -------ANRG---LLIRDSDKFVFEKSGNAYLQRGNGEAWSANTSGQK-VECMEL---Q 131
AN+G L +RDS V S NA + G S Q VE M L
Sbjct: 121 VVWSTNTANKGVSALALRDSGNLVLFGSDNAVIWESFGHPTDTLLSNQGFVEGMRLVSKP 180
Query: 132 DSGNLVL---LGVNGSILWQSFSHP----------------------------------- 153
DS NL+ L +L+ F P
Sbjct: 181 DSNNLMYFLELKSGDMVLYSGFKSPQPYWSMSRENRKTINKDGGSVISATLTANSWNFHG 240
Query: 154 -TDTLLPGQQFMEGMRLKS---------SNGEITFSNLRNGRAATSEVIKIPQNSCSVPE 203
D LL QF + S S+G I+F L++G + + I+IP + C PE
Sbjct: 241 ENDVLL--WQFSFSTNIDSNATWTAVLGSDGFISFYKLQDGGSGDASSIRIPDDPCGTPE 298
Query: 204 PCNPYFVCYFDNRCQCPPSLGSQFNCRPPVASTCNESMNSAKLFYLGERLDYFALGFVSP 263
PC F+CY + C CP LGS+ NC+ + S C++S +L +++ YFAL F+ P
Sbjct: 299 PCEANFICYSEKXCICPSILGSRPNCQTGITSPCDQSSGPVELVESQDKIGYFALQFMQP 358
Query: 264 FPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKI-SRG 322
K D+ CK +C NCSC LFF+ ST CFLFD+IG S+ S+ +VSY+K+ G
Sbjct: 359 SLKTDLENCKSSCSSNCSCIALFFQVSTGGCFLFDEIGGFLNSK--SSEFVSYIKLLKNG 416
Query: 323 NEVLNSKIRESDGGKTVVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDY 382
N+ S G ++ I+ I +T++VI L+Y G+ K+K+ + SQE+ EE+
Sbjct: 417 ENGENNGGNGSGGKNSIPAILGIAFSTMIVICVLIYVGVRFLRKKKKPPEPSQESSEEEN 476
Query: 383 FLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK 442
FLE SG P R+SY+DL AT NFS KLGQGGFGSVY G LPDG ++AVKKLE IGQGKK
Sbjct: 477 FLEGLSGAPIRYSYNDLQTATDNFSVKLGQGGFGSVYKGFLPDGTRLAVKKLEGIGQGKK 536
Query: 443 EFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNT 502
EF AEV IIG++HH+HLV+LKGFC EG HRLLAYE++ NGSLDKWIF + L W+T
Sbjct: 537 EFRAEVGIIGSIHHIHLVRLKGFCAEGTHRLLAYEFMANGSLDKWIFKXNKADLSLDWDT 596
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
RFNIA+GTAKGLAYLHE+C+ KIVHCDIKPENVLLDDNF AKVSDFGLAKLMNRE+S V+
Sbjct: 597 RFNIAVGTAKGLAYLHEDCDAKIVHCDIKPENVLLDDNFQAKVSDFGLAKLMNREQSHVF 656
Query: 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
TTLRGTRGYLAPEWITN ISEKSDVYSYGMVLLEIIGGRK++
Sbjct: 657 TTLRGTRGYLAPEWITNYAISEKSDVYSYGMVLLEIIGGRKNY 699
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550614|ref|XP_003543680.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-149, Method: Compositional matrix adjust.
Identities = 278/496 (56%), Positives = 363/496 (73%), Gaps = 22/496 (4%)
Query: 117 SANTSGQKVECMELQDSGNLVLLGVNGSILWQS-FSHPTDTLLPGQQFMEGMRLKSSNGE 175
S N +G KV L S +L ++ ++LW+ FS +D P + + G
Sbjct: 212 SKNNTG-KVHSASLV-SNSLSFYDISRALLWKVVFSEDSD---PKSLWAATL---DPTGA 263
Query: 176 ITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPPVAS 235
ITF +L GRA E +K+PQ+ C +P+PC+PY+VC+F+N C CP L +++NC+PP S
Sbjct: 264 ITFYDLNKGRAPNPEAVKVPQDPCGIPQPCDPYYVCFFENWCICPKLLRTRYNCKPPNIS 323
Query: 236 TCNESMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCF 295
TC+ S S +L Y+GE LDYFAL + +P K ++N CKE CL NCSC VLFFENST CF
Sbjct: 324 TCSRS--STELLYVGEELDYFALKYTAPVSKSNLNACKETCLGNCSCLVLFFENSTGRCF 381
Query: 296 LFDQIGSLQRSQQGST--GYVSYMKISRGNEVLNSKIRESDGGKTVV--LIVVIVVATIL 351
FDQ GS QR ++G+ GYVS+MK+S ++S + G K +++V+V+ +
Sbjct: 382 HFDQTGSFQRYKRGAGAGGYVSFMKVS-----ISSASDDGHGNKNGRNDMVLVVVIVLTV 436
Query: 352 VIASLLYAGLWHHNKRKR-LTKFSQENLEEDYFLESF-SGMPTRFSYDDLCKATKNFSTK 409
++ L G W+ KRK+ + K+ Q++L+ED SGMP RF++ LC+ATK+FS+K
Sbjct: 437 LVIVGLITGFWYLFKRKKNVAKYPQDDLDEDDDFLDSLSGMPARFTFAALCRATKDFSSK 496
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469
+G+GGFGSVYLG+L DG Q+AVKKLE +GQG KEF AEV+IIG++HHVHLVKLKGFC EG
Sbjct: 497 IGEGGFGSVYLGVLEDGTQLAVKKLEGVGQGAKEFKAEVSIIGSIHHVHLVKLKGFCAEG 556
Query: 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529
HRLL YEY+ GSLDKWIF ++E + L W+TR+NIA+GTAKGLAYLHEEC+V+I+HCD
Sbjct: 557 PHRLLVYEYMARGSLDKWIFKNSENTFLLNWDTRYNIAIGTAKGLAYLHEECDVRIIHCD 616
Query: 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 589
IKP+NVLLDDNFTAKVSDFGLAKLM+RE+S V+TTLRGTRGYLAPEWITN ISEKSDV+
Sbjct: 617 IKPQNVLLDDNFTAKVSDFGLAKLMSREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVF 676
Query: 590 SYGMVLLEIIGGRKSF 605
SYGM+LLEIIGGRK++
Sbjct: 677 SYGMLLLEIIGGRKNY 692
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.711 | 0.524 | 0.571 | 1.2e-173 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.603 | 0.419 | 0.436 | 9.7e-99 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.801 | 0.586 | 0.356 | 1.9e-74 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.892 | 0.652 | 0.361 | 5.1e-74 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.531 | 0.387 | 0.383 | 8.8e-74 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.702 | 0.531 | 0.326 | 2e-69 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.641 | 0.480 | 0.348 | 1.4e-68 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.641 | 0.482 | 0.329 | 1.6e-65 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.655 | 0.483 | 0.338 | 6e-65 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.643 | 0.485 | 0.331 | 8.9e-65 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1299 (462.3 bits), Expect = 1.2e-173, Sum P(2) = 1.2e-173
Identities = 252/441 (57%), Positives = 314/441 (71%)
Query: 172 SNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLG-SQFNCR 230
+NG I+FSNL +G +A KIP + C PEPC PY+VC C C L ++ +C+
Sbjct: 257 NNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGLSRARSDCK 316
Query: 231 PPVASTCNESMNSA----KLFYLGERLDYFALGFVSPFPKY-DINTCKEACLHNCSCSVL 285
+ S C ++ ++A +L G+ +DYFALG+ PF K D+++CKE C +NCSC L
Sbjct: 317 TGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGL 376
Query: 286 FFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKI-SRGNEVLNSKIRESDGGKXXXXXXX 344
FF+NS+ NCFLFD IGS + S G +G+VSY+KI S G+ D GK
Sbjct: 377 FFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGS---GGGDNGEDDGKHFPYVVI 433
Query: 345 XXXXXXXXXXSLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATK 404
L++ H ++K + + QE+ EED FLE+ SGMP RF+Y DL AT
Sbjct: 434 IVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATN 493
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
NFS KLGQGGFGSVY G LPDG ++AVKKLE IGQGKKEF AEV+IIG++HH+HLV+L+G
Sbjct: 494 NFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRG 553
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
FC EGAHRLLAYE+L GSL++WIF + L W+TRFNIALGTAKGLAYLHE+C+ +
Sbjct: 554 FCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDAR 613
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
IVHCDIKPEN+LLDDNF AKVSDFGLAKLM RE+S V+TT+RGTRGYLAPEWITN ISE
Sbjct: 614 IVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISE 673
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSDVYSYGMVLLE+IGGRK++
Sbjct: 674 KSDVYSYGMVLLELIGGRKNY 694
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 9.7e-99, Sum P(2) = 9.7e-99
Identities = 168/385 (43%), Positives = 234/385 (60%)
Query: 236 TCNESMNSAKLFYLGERLDYFALGFVSPFPK-YDINTCKEACLHNCSCSVLFFENSTKNC 294
+C E+ N + L LG + YF+ F P + C + C NCSC +F+EN++++C
Sbjct: 337 SC-EARNISYL-ELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSC 394
Query: 295 FLF-DQIGSLQRSQQGSTGY--VSYMKISRGNEVLNSKIRESDGGKXXXXXXXXXXXXXX 351
+L D GSL + + + Y+K+S + GG
Sbjct: 395 YLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSG 454
Query: 352 XXXSLLYAGL--WHHNKRKRLTKFSQENLE-----EDYFLESFS--GMPTRFSYDDLCKA 402
L+ GL W R + ++ + E L SF G+P +F +++L +A
Sbjct: 455 FFL-LIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQA 513
Query: 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVK 461
T+NF ++G GGFGSVY G LPD +AVKK+ + G G++EF E+ IIGN+ H +LVK
Sbjct: 514 TENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVK 573
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L+GFC G LL YEY+ +GSL+K +F+ L W RF+IALGTA+GLAYLH C
Sbjct: 574 LRGFCARGRQLLLVYEYMNHGSLEKTLFSGN--GPVLEWQERFDIALGTARGLAYLHSGC 631
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+ KI+HCD+KPEN+LL D+F K+SDFGL+KL+N+EES ++TT+RGTRGYLAPEWITN
Sbjct: 632 DQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAA 691
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSFS 606
ISEK+DVYSYGMVLLE++ GRK+ S
Sbjct: 692 ISEKADVYSYGMVLLELVSGRKNCS 716
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 185/519 (35%), Positives = 265/519 (51%)
Query: 101 EKSGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPG 160
E + L G+ E WS SG + DS + + +N + FS+ TD+
Sbjct: 194 ESTAYKILWNGSNEYWS---SGPWNPQSRIFDS--VPEMRLNYIYNFSFFSNTTDSYFTY 248
Query: 161 Q---QFMEGMRLKSSNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNR- 216
Q + +G+I G A + P+ C V C + +C +
Sbjct: 249 SIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEP 308
Query: 217 -CQCP----PSLGSQFNCRPPVASTCNESMNSAKLFYLGE--RLDYFALGFVSP-FPKYD 268
C+CP P ++ + A ++ + + RL L S +
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTS 368
Query: 269 INTCKEACLHNCSCSVLFFENSTKNCFLF--DQIGSLQRSQQGSTGYVSYMKISRGNEVL 326
++ C AC +CSC ++ + C ++ D + Q + S G + Y++++ ++V
Sbjct: 369 LSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLA-ASDVP 427
Query: 327 NSKIRESDGGKXXXXXXXXXXXXXXXXXSLLYAGLWHHNKRKRLTKFSQENLEEDYFLES 386
N K L+ + + +RKR+ E
Sbjct: 428 NVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYRRRKRMRG------------EK 475
Query: 387 FSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA 446
G + FSY +L ATKNFS KLG GGFGSV+ G LPD +AVK+LE I QG+K+F
Sbjct: 476 GDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRT 535
Query: 447 EVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIF-NSTEESRFLCWNTRFN 505
EV IG + HV+LV+L+GFC EG+ +LL Y+Y+ NGSLD +F N EE L W RF
Sbjct: 536 EVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQ 595
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
IALGTA+GLAYLH+EC I+HCDIKPEN+LLD F KV+DFGLAKL+ R+ S V TT+
Sbjct: 596 IALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTM 655
Query: 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604
RGTRGYLAPEWI+ I+ K+DVYSYGM+L E++ GR++
Sbjct: 656 RGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRN 694
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
Identities = 213/589 (36%), Positives = 308/589 (52%)
Query: 43 INNNGLFLISNNSVFGFGFYTALDVQFFSLVVI-HISSAKVVWTANRGLLIRDSDKFVFE 101
I + G F++ NN +++ D ++V + ++ K++ + + S
Sbjct: 119 IEDTGEFILLNNR--SVPVWSSFDNPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLR 176
Query: 102 KSGNA-YLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVN---GS-ILWQSFSHPTDT 156
+ +A Y G ++S+N S + + LQ +G + + N G+ I++ ++T
Sbjct: 177 WNTSAIYWNHGLNSSFSSNLSSPR---LSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNT 233
Query: 157 LLPGQQFMEGMRLKSSNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVC-YFDN 215
+F++ N I S RN + + Q C V C + +C Y D
Sbjct: 234 F----RFLK--LDDDGNLRIYSSASRNSGPVNAHWSAVDQ--CLVYGYCGNFGICSYNDT 285
Query: 216 R--CQCPPSLGSQF--------NCRPPVA-STCNESMNSAKLFYLGERLDYFALGFVSPF 264
C CP S F C+ V S C S N+ L + RL + S
Sbjct: 286 NPICSCP-SRNFDFVDVNDRRKGCKRKVELSDC--SGNTTMLDLVHTRLFTYEDDPNSES 342
Query: 265 PKYDINTCKEACLHNCSC-SVLFFENSTKNCFLFDQIGSLQRSQQG-STGYVSYMKISRG 322
+ C+ CL + C + + + + NC+ GS Q S SY+K+ G
Sbjct: 343 FFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQ-KHPGSFFTGYQWPSVPSTSYVKVC-G 400
Query: 323 NEVLNSKIRESDGGKXXXXXXXXXXXXXXXXXSL-LYA---GLWHHNKRKRLTKFSQENL 378
V N+ R + G L L A GLW RK +F L
Sbjct: 401 PVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKN-PRFG--TL 457
Query: 379 EEDY-FLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI 437
Y LE SG P +F+Y +L + TK+F KLG GGFG+VY G+L + VAVK+LE I
Sbjct: 458 SSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI 517
Query: 438 GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRF 497
QG+K+F EV I + HH++LV+L GFC +G HRLL YE++ NGSLD ++F +T+ ++F
Sbjct: 518 EQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLF-TTDSAKF 576
Query: 498 LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557
L W RFNIALGTAKG+ YLHEEC IVHCDIKPEN+L+DDNF AKVSDFGLAKL+N +
Sbjct: 577 LTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPK 636
Query: 558 ESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
++ +++RGTRGYLAPEW+ N PI+ KSDVYSYGMVLLE++ G+++F
Sbjct: 637 DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNF 685
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 8.8e-74, Sum P(3) = 8.8e-74
Identities = 135/352 (38%), Positives = 196/352 (55%)
Query: 272 CKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGS-TGYVSYMKISRGNEVLNSKI 330
C E+CL NCSC+ F+ C L+ G+L Q+ S TG V Y++++ +S+
Sbjct: 377 CPESCLKNCSCTAYSFDRGI-GCLLWS--GNLMDMQEFSGTGVVFYIRLA------DSEF 427
Query: 331 RESDGGKXXXXXXXXXXXXXXXXXSLLYAGLWH---HNKRKRLTKFSQENLE----EDY- 382
++ +L LW H ++ R T+ E +E D
Sbjct: 428 KKRTNRSIVITVTLLVGAFLFAGTVVL--ALWKIAKHREKNRNTRLLNERMEALSSNDVG 485
Query: 383 --FLESFS--GMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLE- 435
+ + +P F + L AT NFS KLGQGGFG+VY G L +G+ +AVK+L
Sbjct: 486 AILVNQYKLKELPL-FEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSR 544
Query: 436 SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEES 495
+ GQG +EF EV +I + H +LV+L GFCIEG R+L YE++ LD ++F+ ++
Sbjct: 545 TSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQ- 603
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555
R L W TRFNI G +GL YLH + +KI+H D+K N+LLD+N K+SDFGLA++
Sbjct: 604 RLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQ 663
Query: 556 REESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
E V T + GT GY+APE+ SEKSDV+S G++LLEI+ GR++ S
Sbjct: 664 GNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSS 715
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 2.0e-69, Sum P(2) = 2.0e-69
Identities = 152/466 (32%), Positives = 232/466 (49%)
Query: 161 QQFMEGMRLKSSNGEITFSNLRNGRAATSEVIKIPQNSCSVPEPCNPYFVCYFD--NRCQ 218
+ F + + +S G + ++ NG I +P N+C C P+ +C +C+
Sbjct: 241 RNFKRSLLVLTSEGSLKVTH-HNGTDWVLN-IDVPANTCDFYGVCGPFGLCVMSIPPKCK 298
Query: 219 CPPSLGSQFNCRPPVASTCNESMNSAKLFY----LGERLDYF-ALGFVSPFPKYDI---- 269
C QF+ + + +L G ++ F + + P Y+
Sbjct: 299 CFKGFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFYEFVSSG 358
Query: 270 --NTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISRGNEVLN 327
C ++CLHNCSC + N C +++Q + M+ S G E+L+
Sbjct: 359 SAEECYQSCLHNCSCLAFAYINGI-GCLIWNQ------------ELMDVMQFSVGGELLS 405
Query: 328 SKIRESD-GGKXXXXXXXXXXXXXXXXXSLLYA--GLWHHNKRKR--LTKFSQENL-EED 381
++ S+ GG +L A G W + + ++K S + D
Sbjct: 406 IRLASSEMGGNQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRND 465
Query: 382 YFLESFSGMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-G 438
E SG+ F + AT NFS KLGQGGFG VY G L DG ++AVK+L S G
Sbjct: 466 LKSEDVSGLYF-FEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSG 524
Query: 439 QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFL 498
QGK+EF E+ +I + H++LV++ G CIEG RLL YE++VN SLD +IF+S + +
Sbjct: 525 QGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVE-I 583
Query: 499 CWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558
W RF+I G A+GL YLH + ++I+H D+K N+LLDD K+SDFGLA++ +
Sbjct: 584 DWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTK 643
Query: 559 SLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603
T + GT GY++PE+ SEKSD YS+G++LLE+I G K
Sbjct: 644 YQDNTRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEK 689
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 1.4e-68, Sum P(2) = 1.4e-68
Identities = 153/439 (34%), Positives = 225/439 (51%)
Query: 195 PQNSCSVPEPCNPYFVCYFD--NRCQC-----PPSL-----GSQFN-CRPPVASTCNESM 241
P+NSC + C P+ +C +C+C P S+ G+ + C C +
Sbjct: 278 PENSCDIYGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNT 337
Query: 242 NSAKL--FYLGERL---DYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFL 296
N + FY + D++ F S F D C + CLHNCSC + N C +
Sbjct: 338 NGKTVNGFYHVANIKPPDFYE--FAS-F--VDAEGCYQICLHNCSCLAFAYINGI-GCLM 391
Query: 297 FDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESD-GGKXXXXXXXXXXXXXXXXXS 355
++Q + ++ S G E+L+ ++ S+ GG
Sbjct: 392 WNQ------------DLMDAVQFSAGGEILSIRLASSELGGNKRNKIIVASIVSLSLFVI 439
Query: 356 LLYAGLWH------HNKRKRLTKF-SQENLEEDYFLESFSGMPTRFSYDDLCKATKNFS- 407
L +A H +++K S+E D + SG+ F + + AT NFS
Sbjct: 440 LAFAAFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKF-FEMNTIQTATDNFSL 498
Query: 408 -TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLGQGGFGSVY G L DG ++AVK+L S GQGK+EF E+ +I + H +LV++ G
Sbjct: 499 SNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGC 558
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
CIEG RLL YE+L+N SLD ++F+S + + W RFNI G A+GL YLH + +++
Sbjct: 559 CIEGEERLLVYEFLLNKSLDTFLFDSRKRLE-IDWPKRFNIIEGIARGLHYLHRDSCLRV 617
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISE 584
+H D+K N+LLD+ K+SDFGLA++ E T + GT GY+APE+ SE
Sbjct: 618 IHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSE 677
Query: 585 KSDVYSYGMVLLEIIGGRK 603
KSD+YS+G++LLEII G K
Sbjct: 678 KSDIYSFGVILLEIITGEK 696
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 1.6e-65, Sum P(2) = 1.6e-65
Identities = 144/437 (32%), Positives = 220/437 (50%)
Query: 195 PQNSCSVPEPCNPYFVCY--FDNRCQC----PPSLGSQFN-------CRPPVASTC--NE 239
P++SC C P+ +C +C C P L ++ C C N
Sbjct: 278 PEHSCDYYGVCGPFGLCVKSVPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTELYCQGNS 337
Query: 240 SMNSAKLFYLGERL---DYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFL 296
+ A +F+ R+ D++ F S F ++ C+++CLHNCSC +
Sbjct: 338 TGKYANVFHPVARIKPPDFYE--FAS-F--VNVEECQKSCLHNCSCLAFAY--------- 383
Query: 297 FDQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESD-GGKXXXXXXXXXXXXXXXXXS 355
D IG L +Q + ++ S G E+L+ ++ S+ GG
Sbjct: 384 IDGIGCLMWNQD----LMDAVQFSEGGELLSIRLARSELGGNKRKKAITASIVSLSLVVI 439
Query: 356 LLYAGL--WHHNKRKRL---TKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFS--T 408
+ + W + + T SQ + D + G+ F + AT NFS
Sbjct: 440 IAFVAFCFWRYRVKHNADITTDASQVSWRNDLKPQDVPGLDF-FDMHTIQTATNNFSISN 498
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
KLGQGGFG VY G L DG ++AVK+L S GQGK+EF E+ +I + H +LV++ G CI
Sbjct: 499 KLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCI 558
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
EG +LL YE+++N SLD ++F+S + + W R +I G A+G+ YLH + +K++H
Sbjct: 559 EGEEKLLIYEFMLNNSLDTFLFDSRKRLE-IDWPKRLDIIQGIARGIHYLHRDSHLKVIH 617
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKS 586
D+K N+LLD+ K+SDFGLA++ E T + GT GY+APE+ SEKS
Sbjct: 618 RDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKS 677
Query: 587 DVYSYGMVLLEIIGGRK 603
D+YS+G+++LEII G K
Sbjct: 678 DIYSFGVLMLEIISGEK 694
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 6.0e-65, Sum P(2) = 6.0e-65
Identities = 150/443 (33%), Positives = 230/443 (51%)
Query: 195 PQNSCSVPEPCNPYFVCYFDNR--CQC----PPSLGSQFNC----RPPVASTCNESMNSA 244
P SC + C P+ +C CQC P ++ R V T ++
Sbjct: 276 PLTSCDLYGRCGPFGLCVRSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNS 335
Query: 245 KLFYLGERLD-YFALGFVSPFPKYDINT------CKEACLHNCSCSVLFFENSTKNCFLF 297
+ G+ D ++ + + P Y++ + C + CL NCSC+ + +
Sbjct: 336 SVETQGKDRDVFYHVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSG------- 388
Query: 298 DQIGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESD--GGKXXXXXXXXXXXXXXXXXS 355
IG L +Q+ + +K G E L+ ++ S+ G K
Sbjct: 389 --IGCLVWNQE----LLDTVKFIGGGETLSLRLAHSELTGRKRIKIITVATLSLSVCLIL 442
Query: 356 LLYA-GLWHHN-KRKRLTKFSQENLE----EDYFLESFSGMPTRFSYDDLCKATKNFST- 408
+L A G W + K+ + S++N+E D + SG+ F DL AT NFS
Sbjct: 443 VLVACGCWRYRVKQNGSSLVSKDNVEGAWKSDLQSQDVSGL-NFFEIHDLQTATNNFSVL 501
Query: 409 -KLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
KLGQGGFG+VY G L DG ++AVK+L S QG +EF E+ +I + H +L++L G C
Sbjct: 502 NKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCC 561
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
I+G +LL YEY+VN SLD +IF+ ++ + W TRFNI G A+GL YLH + +++V
Sbjct: 562 IDGEEKLLVYEYMVNKSLDIFIFDLKKKLE-IDWATRFNIIQGIARGLLYLHRDSFLRVV 620
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNPISEK 585
H D+K N+LLD+ K+SDFGLA+L + + T ++ GT GY++PE+ SEK
Sbjct: 621 HRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEK 680
Query: 586 SDVYSYGMVLLEIIGGRK--SFS 606
SD+YS+G+++LEII G++ SFS
Sbjct: 681 SDIYSFGVLMLEIITGKEISSFS 703
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 8.9e-65, Sum P(2) = 8.9e-65
Identities = 143/432 (33%), Positives = 217/432 (50%)
Query: 195 PQNSCSVPEPCNPYFVCYFDN--RCQC-----PPSL-----GSQFN-CRPPVASTC--NE 239
P NSC + C P+ +C +C+C P S G+ C C N
Sbjct: 278 PANSCDIYGVCGPFGLCIVSVPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQGNS 337
Query: 240 SMNSAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQ 299
+ +F+ + F D C ++CLHNCSC + + C +++Q
Sbjct: 338 TGKDVNIFHPVTNVKL--PDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGI-GCLIWNQ 394
Query: 300 IGSLQRSQQGSTGYVSYMKISRGNEVLNSKIRESD-GGKXXXXXXXXXXXXXXXXXSLLY 358
+ ++ S G E+L+ ++ S+ GG L
Sbjct: 395 ------------NLMDAVQFSAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLFVILTS 442
Query: 359 A--GLWHHN-KRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFS--TKLGQG 413
A G W + K K T ++ D + G+ F + + AT NFS KLGQG
Sbjct: 443 AAFGFWRYRVKHKAYTL--KDAWRNDLKSKEVPGLEF-FEMNTIQTATNNFSLSNKLGQG 499
Query: 414 GFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472
GFGSVY G L DG ++AVK+L S GQGK+EF E+ +I + H +LV++ G CIEG +
Sbjct: 500 GFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEK 559
Query: 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532
LL YE+++N SLD ++F++ ++ + W RF+I G A+GL YLH + +K++H D+K
Sbjct: 560 LLIYEFMLNKSLDTFVFDARKKLE-VDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKV 618
Query: 533 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSY 591
N+LLD+ K+SDFGLA++ + T + GT GY++PE+ SEKSD+YS+
Sbjct: 619 SNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSF 678
Query: 592 GMVLLEIIGGRK 603
G++LLEII G K
Sbjct: 679 GVLLLEIIIGEK 690
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 606 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-24 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd01100 | 73 | cd01100, APPLE_Factor_XI_like, Subfamily of PAN/AP | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-51
Identities = 73/203 (35%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTIIGNVHHVHLVKLKG 464
KLG G FG+VY G VAVK L+ + K+ E+ I+ + H ++V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ H L EY G L ++ L + IAL +GL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TNNPIS 583
I+H D+KPEN+LLD+N K++DFGLAK + + S TT GT Y+APE + N
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 584 EKSDVYSYGMVLLEIIGGRKSFS 606
K DV+S G++L E++ G+ FS
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFS 200
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 75/194 (38%), Positives = 108/194 (55%), Gaps = 12/194 (6%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
LG+GGFG+VYL G +VA+K + E +E E+ I+ ++H ++VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ H L EY GSL + E L + I L +GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 527 HCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPISE 584
H D+KPEN+LLD DN K++DFGL+KL+ ++SL T+ GT Y+APE + SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 585 KSDVYSYGMVLLEI 598
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-46
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 406 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVH 458
KLG+G FG VY G L ++VAVK L ++ Q +EF E I+ + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+VKL G C E ++ EY+ G L + + L + + AL A+G+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 575
+ +H D+ N L+ +N K+SDFGL++ + ++ Y ++G + ++APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAPE 174
Query: 576 WITNNPISEKSDVYSYGMVLLEI 598
+ + KSDV+S+G++L EI
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-46
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 406 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVH 458
KLG+G FG VY G L ++VAVK L ++ Q +EF E I+ + H +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+VKL G C E + EY+ G L ++ + + L + + AL A+G+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 575
+ +H D+ N L+ +N K+SDFGL++ + ++ Y RG + ++APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPE 173
Query: 576 WITNNPISEKSDVYSYGMVLLEI 598
+ + KSDV+S+G++L EI
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLG+G FG VYL G VA+K + + I + ++ E+ I+ + H ++V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLC-WNTRFNIALGTAKGLAYLHEECEVK 524
+ L EY G L + ++ L RF L YLH +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARF-YLRQILSALEYLHSK---G 117
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
IVH D+KPEN+LLD++ K++DFGLA+ ++ E TT GT Y+APE + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGK 175
Query: 585 KSDVYSYGMVLLEIIGGR 602
D++S G++L E++ G+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-44
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 406 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVH 458
KLG+G FG VY G L +VAVK L + + ++EF E +I+ + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+V+L G C +G + EY+ G L ++ + L +AL AKG+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 575
VH D+ N L+ +N K+SDFGL++ + ++ Y G + ++APE
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKLPIKWMAPE 174
Query: 576 WITNNPISEKSDVYSYGMVLLEII-GGRKSFS 606
+ + + KSDV+S+G++L EI G + +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
KLG+G FG VY G L +VAVK L ++ + +K+F E ++ + H ++V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDK-----WIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
G C E L EY+ G L + E L + A+ AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAP 574
K VH D+ N L+ ++ K+SDFGL++ + ++ Y G + ++AP
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD--YYRKKTGGKLPIRWMAP 176
Query: 575 EWITNNPISEKSDVYSYGMVLLEI 598
E + + + KSDV+S+G++L EI
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKG 464
LG+G FGSVYL + D G +AVK +E G ++E A E+ I+ ++ H ++V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 465 FCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN---IALGTA---KGLAY 516
E + EY+ GSL S L + I T +GLAY
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSL----------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPE 575
LH IVH DIK N+L+D + K++DFG AK + E+ T ++RGT ++APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
I +D++S G ++E+ G+ +S
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFS-AEVTIIGNVHHVHLVKLKG 464
++G+G FG VYL DG +K+ L ++ + ++E + EV I+ ++H +++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLC----WNTRFNIALGTAKGLAYLHEE 520
E + EY G L + I +E + + + L L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHSR 122
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
KI+H DIKP+N+ L N K+ DFG++K+++ + T+ GT YL+PE N
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPELCQNK 178
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
P + KSD++S G VL E+ + F
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPF 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
K+G+GGFG VY G +VA+K + + K++ E+ I+ H ++VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHEE 520
++ + E+ GSL + ST N + KGL YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKST--------NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
I+H DIK N+LL + K+ DFGL+ ++ ++ T+ GT ++APE I
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGK 172
Query: 581 PISEKSDVYSYGMVLLEIIGGR 602
P K+D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 3e-30
Identities = 74/211 (35%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKL----ESIGQGKKEFSAEVTIIGNV-HHVHLVKLK 463
KLG+G FG VYL D VA+K L ES + + F E+ I+ ++ H ++VKL
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
F + L EY+ GSL+ + L + I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL-KKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 524 KIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPEWI 577
I+H DIKPEN+LLD D K+ DFGLAKL+ S +T GT GY+APE +
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 578 T---NNPISEKSDVYSYGMVLLEIIGGRKSF 605
S SD++S G+ L E++ G F
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 406 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVK 461
+G+G FG VY G+ L G VA+K++ + K E+ ++ N+ H ++VK
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWI-----FNSTEESRFLCWNTRFNIALGTAKGLAY 516
G + EY NGSL + I F + + ++ + + +GLAY
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-----YQVL----QGLAY 114
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
LHE+ ++H DIK N+L + K++DFG+A +N + + GT ++APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEV 170
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGR 602
I + S SD++S G ++E++ G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLG G FG V++G +VAVK L+ + F E I+ + H LV+L C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ GSL F + E + L ++A A+G+AYL +H
Sbjct: 73 EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D+ N+L+ +N K++DFGLA+L+ +E YT G + + APE + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G++L EI+
Sbjct: 185 SDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G FG V LG G +VAVK L+ + F AE +++ + H +LV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
++G + EY+ GSL ++ + + + AL +G+ YL E+
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
VH D+ NVL+ ++ AKVSDFGLAK E S + + + APE + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 586 SDVYSYGMVLLEI 598
SDV+S+G++L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 406 FSTKLGQGGFGSVYLGMLP-----DGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVH 458
F +LG+G FG V L G QVAVK L Q + +F E+ I+ + H +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 459 LVKLKGFCIEGAHR---LLAYEYLVNGSLDKWI-FNSTEESRFLCWNTRFNIALGTAKGL 514
+VK KG C E L EYL +GSL ++ + + + + KG+
Sbjct: 68 IVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL----KRLLLFSSQICKGM 122
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---- 570
YL + + +H D+ N+L++ K+SDFGLAK++ E Y ++
Sbjct: 123 DYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP--EDKDYYYVKEPGESPIF 177
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606
+ APE + + S SDV+S+G+ L E+ G S S
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 410 LGQGGFGSVYLGML----PDGIQVAVKKLESIGQGKK--EFSAEVTIIGNVHHVHLVKLK 463
+G G FG V G L I VA+K L++ K+ +F E +I+G H ++++L+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G + ++ EY+ NGSLDK++ + + + G A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNN 580
VH D+ N+L++ N KVSDFGL++ + E+ YTT +G + + APE I
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTT-KGGKIPIRWTAPEAIAYR 183
Query: 581 PISEKSDVYSYGMVLLEII 599
+ SDV+S+G+V+ E++
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 64/193 (33%), Positives = 104/193 (53%), Gaps = 11/193 (5%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-KEFSAEVTIIGNVHHVHLVKLKGFCI 467
KLG G FG V+ G+ + ++VA+K L+S K ++F EV + + H HL+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
G + E + GSL F + E + L + ++A A+G+AYL E+ +H
Sbjct: 73 VGEPVYIITELMEKGSLL--AFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY--LAPEWITNNPISEK 585
D+ N+L+ ++ KV+DFGLA+L+ + VY + Y APE ++ S K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKED---VYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 586 SDVYSYGMVLLEI 598
SDV+S+G++L E+
Sbjct: 185 SDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLG G FG V+ G+ + VAVK L+ K+F AE I+ + H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ E + GSL +++ R L ++A A G+AYL + +H
Sbjct: 73 EEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D+ NVL+ +N KV+DFGLA+++ + Y G + + APE N S K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G++L EI+
Sbjct: 185 SDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 66/202 (32%), Positives = 111/202 (54%), Gaps = 23/202 (11%)
Query: 410 LGQGGFGSVYLGM-LPDG----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG G FG+VY G+ +P+G I VA+K L E+ + KE E ++ +V H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE--SRFLCWNTRFNIALGTAKGLAYLHEE 520
G C+ +L+ + + G L ++ N + S++L N + AKG++YL E
Sbjct: 75 LGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKGMSYLEE- 127
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 577
++VH D+ NVL+ K++DFGLAKL++ +E + G + ++A E I
Sbjct: 128 --KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVPIKWMALESI 183
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
+ + KSDV+SYG+ + E++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
K+G G FG VY + L G +AVK++ ++ + KE + E+ ++ + H +LVK G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 465 FCIEGAHR---LLAYEYLVNGSLDKWIFNSTEESRFLCWNT--RFNIALGTAKGLAYLHE 519
+E HR + EY G+L E R L + + + L +GLAYLH
Sbjct: 67 --VE-VHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQL--LEGLAYLHS 117
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT---TLRGTRGYLAPEW 576
IVH DIKP N+ LD N K+ DFG A + + + +L GT Y+APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 577 ITNNPISEK---SDVYSYGMVLLEIIGGRKSFS 606
IT +D++S G V+LE+ G++ +S
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 409 KLGQGGFGSVYL-GMLPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
KLG+G +GSVY L D A+K+ L S+ Q ++E + E+ I+ +V+H +++ K
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
++G + EY G L K I ++ + + + I + +GL LHE+ K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
I+H D+K N+LL N K+ D G++K++ ++++ T + GT Y+APE P S
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWKGRPYSY 180
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSD++S G +L E+ F
Sbjct: 181 KSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 408 TKLGQGGFGSVYLGMLPD------GIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVH 458
+LGQG FG VY G+ +VA+K + S+ + + EF E +++ + H
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHH 70
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLC------WNTRFNIALGTAK 512
+V+L G G L+ E + G L ++ + E+ +A A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+AYL + K VH D+ N ++ ++ T K+ DFG+ + + E+ Y +G +G L
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYR--KGGKGLL 183
Query: 573 -----APEWITNNPISEKSDVYSYGMVLLEI 598
APE + + + KSDV+S+G+VL E+
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLG G FG V++G +VA+K L+ + F AE ++ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
++ EY+ NGSL F T E L N ++A A+G+A++ + +H
Sbjct: 73 EPIYIIT-EYMENGSLVD--FLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D++ N+L+ + K++DFGLA+L+ E YT G + + APE I + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G++L EI+
Sbjct: 184 SDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 36/215 (16%)
Query: 410 LGQGGFGSVYLG----MLPDG--IQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG+G FG V+LG + P+ VAVK L+ + +K+F E ++ N H ++VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWN----TRFN------IALGTA 511
G C EG ++ +EY+ +G L+K++ + ++ FL IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT----LRG 567
G+ YL + VH D+ N L+ + K+ DFG M+R+ VYTT + G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG----MSRD---VYTTDYYRVGG 182
Query: 568 TR----GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
++ PE I + +SDV+S+G+VL EI
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 71/199 (35%), Positives = 96/199 (48%), Gaps = 22/199 (11%)
Query: 410 LGQGGFGSVYLG--MLPDG--IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG G FGSV G ++ G ++VAVK L E I GKKEF E +++ + H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTE--ESRFLCWNTRFNIALGTAKGLAYLHEEC 521
G C +G +L E G L K++ E S A A G+AYL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 578
VH D+ NVLL + AK+SDFG+++ + Y R + APE I
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECIN 171
Query: 579 NNPISEKSDVYSYGMVLLE 597
S KSDV+SYG+ L E
Sbjct: 172 YGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
F +LG G FG V+LG I VA+K + + +F E ++ + H +LV+L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C + + EY+ NG L ++ E L ++ + + YL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
+H D+ N L+ ++ KVSDFGLA+ + ++ YT+ +GT+ + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 583 SEKSDVYSYGMVLLEIIGGRK 603
S KSDV+S+G+++ E+ K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-23
Identities = 45/83 (54%), Positives = 52/83 (62%), Gaps = 3/83 (3%)
Query: 82 VVWTANRGLLIRDSD-KFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGNLVL 138
VVW ANR + DS + + GN L GNG WS+NTSG+ C LQD GNLVL
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLVL 63
Query: 139 LGVNGSILWQSFSHPTDTLLPGQ 161
+G +LWQSF HPTDTLLPGQ
Sbjct: 64 YDNSGKVLWQSFDHPTDTLLPGQ 86
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGF 465
+LG+G GSV L + + K + +K+ E+ I + ++VK G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 466 CIEGAHRLL--AYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYL 517
++ + + A EY GSLD I+ + R IA KGL+YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDS-IYK-----KVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEW 576
H KI+H DIKP N+LL K+ DFG++ +L+N T GT Y+APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG----TFTGTSFYMAPER 174
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
I P S SDV+S G+ LLE+ R F
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
KLG+G +GSVY + G VA+K + + + +E E++I+ ++VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 468 EGAHRLLAYEYLVNGS-LDKWIFNSTE----ESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ + EY GS D I T E I T KGL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA------ILYQTLKGLEYLHS--- 117
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPEWI 577
K +H DIK N+LL++ AK++DFG++ L T T+ GT ++APE I
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 578 TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ K+D++S G+ +E+ G+ +S
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTIIGNVHHVHLVKLKG 464
+G+G FG+V DG + K+++ +KE +EV I+ + H ++V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 465 -FCIEGAHRLLAY-EYLVNGSLDKWIFNSTEESRFL----CWNTRFNIALGTAKGLAYLH 518
L EY G L + I +E +++ W + L L H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYECH 122
Query: 519 --EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
+ ++H D+KP N+ LD N K+ DFGLAK++ + S T GT Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYVGTPYYMSPEQ 181
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + EKSD++S G ++ E+ F+
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 8e-23
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHH 456
++ + KLG G +G VY G+ + VAVK L+ +EF E ++ + H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
+LV+L G C + E++ G+L ++ + + +A + + Y
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEY 119
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLA 573
L ++ +H D+ N L+ +N KV+DFGL++LM + YT G + + A
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTA 173
Query: 574 PEWITNNPISEKSDVYSYGMVLLEI 598
PE + N S KSDV+++G++L EI
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 404 KNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
KN K+G+G G VY G +VA+KK+ Q K+ E+ I+ + H ++V
Sbjct: 22 KNLE-KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAY 516
+ G + EY+ GSL I + R N + +GL Y
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEY 131
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
LH + ++H DIK +N+LL + + K++DFG A + +E+S ++ GT ++APE
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEV 187
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGG 601
I K D++S G++ +E+ G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 59/198 (29%), Positives = 106/198 (53%), Gaps = 14/198 (7%)
Query: 410 LGQGGFGSVYLGMLP----DGIQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLK 463
+G G FG V+ G+L + VA+K L+ + +++F +E +I+G H ++++L+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G + ++ EY+ NG+LDK++ + E + G A G+ YL ++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL---SDM 126
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG--YLAPEWITNNP 581
VH D+ N+L++ N KVSDFGL++++ + YTT G + APE I
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 582 ISEKSDVYSYGMVLLEII 599
+ SDV+S+G+V+ E++
Sbjct: 187 FTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 408 TKLGQGGFGSVYLGML-PDGIQVAVKK--LESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
LGQG G VY P G A+KK ++ + +K+ E+ + + ++VK G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 465 -FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA---KGLAYLHEE 520
F EG + EY+ GSL + + +A KGL YLH +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPV-LAYIARQILKGLDYLHTK 118
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITN 579
I+H DIKP N+L++ K++DFG++K++ E +L T GT Y++PE I
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQG 174
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
S +D++S G+ LLE G+ F
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFL 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
K+G+G FG VY G+L +VAVK + K++F E I+ H ++VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
++ + E + GSL F +++R L ++L A G+ YL + +
Sbjct: 62 VQKQPIYIVMELVPGGSL--LTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTR----GYLAPEWITNNP 581
H D+ N L+ +N K+SDFG M+REE +YT G + + APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 582 ISEKSDVYSYGMVLLEI 598
+ +SDV+SYG++L E
Sbjct: 172 YTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G G FG V+LG + +VA+K + +++F E ++ + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C E + L +E++ +G L ++ + +F T + L +G+AYL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGKF-SQETLLGMCLDVCEGMAYLESSN---V 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
+H D+ N L+ +N KVSDFG+ + + ++ YT+ GT+ + +PE + +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 583 SEKSDVYSYGMVLLEI 598
S KSDV+S+G+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 410 LGQGGFGSVYLGMLP----DGIQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLK 463
+G G FG V G L I VA+K L++ + +++F +E +I+G H +++ L+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G + ++ EY+ NGSLD F + +F + G A G+ YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQL-VGMLRGIASGMKYL---SDM 125
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNN 580
VH D+ N+L++ N KVSDFGL++++ + YTT RG + + APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYR 184
Query: 581 PISEKSDVYSYGMVLLEII 599
+ SDV+SYG+V+ E++
Sbjct: 185 KFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 31/216 (14%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLE--SIG-QGKKEFSA-------EVTIIGNVHHVH 458
+G G FGSVYLGM G +AVK++E S+ K + E+ ++ + H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAY 516
+V+ G ++ H + EY+ GS+ + + + EE+ N KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR------NFVRQILKGLNY 121
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG------ 570
LH I+H DIK N+L+D+ K+SDFG++K + E + + T G R
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSV 176
Query: 571 -YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
++APE + + K+D++S G +++E++ G+ F
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 409 KLGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKG 464
K+G+G FG V+ + +V A+K+++ ++E E ++ + ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
++ + EY NG L K + + R L + + + GLA+LH + K
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
I+H DIK N+ LD K+ D G+AKL++ + + T+ GT YL+PE + P +E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSDV++ G+VL E G+ F
Sbjct: 181 KSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLE--SIGQGKKE--FSAEVTIIGNVHHVHLVKLKG 464
LG+G FG V L D ++ A+K L+ I + K+ E I+ ++H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEECE 522
+ + +L L EY G L + ++E RF RF A + A L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLA--LEYLHSL-- 112
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I++ D+KPEN+LLD + K++DFGLAK ++ E S T GT YLAPE +
Sbjct: 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEVLLGKGY 170
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
+ D +S G++L E++ G+ F
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 409 KLGQGGFGSVYLGML--PDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+LG G G V +L P G +AVK +LE +K+ E+ I+ + ++V G
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF--NIALGTAKGLAYLHEECE 522
+ EY+ GSLDK + R R IA+ KGL YLHE+
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK--ILKEVQGRI---PERILGKIAVAVLKGLTYLHEK-- 119
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNP 581
KI+H D+KP N+L++ K+ DFG++ +L+N + T GT Y+APE I N
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGND 175
Query: 582 ISEKSDVYSYGMVLLEIIGGR 602
S KSD++S G+ L+E+ GR
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 406 FSTKLGQGGFGSVYL---GMLPD--GIQVAVKKLE-SIGQGKKEFSAEVTIIGNVHHVHL 459
F +LG+G FGSV L L D G VAVKKL+ S + ++F E+ I+ ++ H ++
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 460 VKLKGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEE---SRFLCWNTRFNIALGTAKGL 514
VK KG C R L EYL GSL ++ E + L + ++ KG+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGM 121
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYL 572
YL + + VH D+ N+L++ K+ DFGL K++ ++E V +
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 573 APEWITNNPISEKSDVYSYGMVLLEI 598
APE +T + S SDV+S+G+VL E+
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 409 KLGQGGFGSVYLG----MLP--DGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
+LG+G FG V+L + P D I VAVK L ++ +K+F E ++ N+ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRF---------LCWNTRFNIALGTAK 512
G C+EG ++ +EY+ +G L+K++ ++ L + +IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG-- 570
G+ YL + VH D+ N L+ +N K+ DFG M+R+ VY+T G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG----MSRD---VYSTDYYRVGGH 181
Query: 571 ------YLAPEWITNNPISEKSDVYSYGMVLLEI 598
++ PE I + +SDV+S G+VL EI
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 12/194 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLG G FG V++G +VAVK L+ + F E I+ + H LV+L E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
++ EY+ GSL F E R L ++A A G+AY+ + +H
Sbjct: 73 EPIYIVT-EYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D++ N+L+ D K++DFGLA+L+ E YT +G + + APE + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G++L E++
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLG G FG V++G + +VAVK L+ + F E ++ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ GSL ++ S E + L + + A+G+AY+ + +H
Sbjct: 73 EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKL-IDFSAQIAEGMAYIERK---NYIHR 127
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D++ NVL+ ++ K++DFGLA+++ E YT G + + APE I + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G++L EI+
Sbjct: 185 SDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 410 LGQGGFGSVYLGML-PDG---IQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLK 463
+G G FG V G L G I VA+K L+S + +++F +E +I+G H +++ L+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G + ++ E++ NG+LD F + +F + G A G+ YL E+
Sbjct: 72 GVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQL-VGMLRGIAAGMKYL---SEM 125
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTR---GYLAPEWITN 579
VH D+ N+L++ N KVSDFGL++ + + S YT+ G + + APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 580 NPISEKSDVYSYGMVLLEII 599
+ SDV+SYG+V+ E++
Sbjct: 186 RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 409 KLGQGGFGSVYL-GMLPDGIQVAVKKLES-IGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
++G+G G V+ G VA+KK+ +G A E+ + H ++VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNS----TEES-----RFLCWNTRFNIALGTAKGLA 515
G+ +L EY + L + + + E R L KG+A
Sbjct: 67 VFPHGSGFVLVMEY-MPSDLSEVLRDEERPLPEAQVKSYMRMLL------------KGVA 113
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
Y+H I+H D+KP N+L+ + K++DFGLA+L + EE +Y+ TR Y APE
Sbjct: 114 YMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 576 WITNNP-ISEKSDVYSYGMVLLEIIGGRKSFS 606
+ D+++ G + E++ G F
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 410 LGQGGFGSVY----LGMLPDGIQ--VAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
+GQG FG V+ G+LP VAVK L E+ + +F E ++ H ++VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLD--------KWIFNSTEESRF----------LCWNTR 503
L G C G L +EY+ G L+ + + + + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 504 FNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563
IA A G+AYL E K VH D+ N L+ +N K++DFGL++ + + Y
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YY 186
Query: 564 TLRGTRG----YLAPEWITNNPISEKSDVYSYGMVLLEI 598
++ PE I N + +SDV++YG+VL EI
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLGQG FG V++G +VA+K L+ + F E ++ + H LV+L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
E ++ EY+ GSL F E ++L ++A A G+AY+ +
Sbjct: 70 VSEEPIYIVT-EYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 583 SEKSDVYSYGMVLLEI 598
+ KSDV+S+G++L E+
Sbjct: 181 TIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 410 LGQGGFGSVYLGMLPDGIQ--VAVKKLE----SIGQGKKEFS-------AEVTIIG-NVH 455
LG G FG VY + Q +A+K++ + G+ K+E +EVTII +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 456 HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEES--RFL---CWNTRFNIALGT 510
H ++V+ +E RL L+ G+ FNS +E RF WN + L
Sbjct: 68 HPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
L YLH+E +IVH D+ P N++L ++ ++DFGLAK E L T++ GT
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTIL 178
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEI 598
Y PE + N P EK+DV+++G +L ++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-20
Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
K+G+G FG +YL D +K+ L + +KE S EV ++ + H ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNST----EESRFLCWNTRFNIALGTAKGLAYLHEE 520
E + EY G L K I E + L W + I+LG L ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG----LKHIHDR 120
Query: 521 CEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
KI+H DIK +N+ L N AK+ DFG+A+ +N L YT + GT YL+PE N
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQN 176
Query: 580 NPISEKSDVYSYGMVLLEI 598
P + K+D++S G VL E+
Sbjct: 177 RPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKG 464
+ +G +G V+L G A+K K + I + + + E I+ ++VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ +G L L EYL G L + S +E R IA L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS-- 111
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNREESLVYTTLR-----GTRGYLAP 574
I+H D+KP+N+L+D N K++DFGL+K L+ R+ +L GT Y+AP
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGG 601
E I S+ D +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLE----SIGQGKKEFSA---EVTIIGNVHHVHLVKL 462
LG+G +G+VY G+ G +AVK++E ++ +KE+ EV ++ ++ HV++V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
G C++ + E++ GS+ + F E F C T+ G+AYLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-CKYTK-----QILDGVAYLHNN 121
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-----NREESLVYTTLRGTRGYLAPE 575
C +VH DIK NV+L N K+ DFG A+ + + S + ++ GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
I + KSD++S G + E+ G+ +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
+G+G FG+V G G +VAVK K + Q F E ++ +HH +LV+L G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 467 I-EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF-NIALGTAKGLAYLHEECEVK 524
+ G + + E + G+L ++ R L + +L A+G+ YL + K
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---K 120
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+VH D+ N+L+ ++ AKVSDFGLA++ S+ + + APE + + S
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSS 176
Query: 585 KSDVYSYGMVLLEIIG-GRKSF 605
KSDV+SYG++L E+ GR +
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 21/201 (10%)
Query: 410 LGQGGFGSVYLGM-LPDG----IQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG G FG+V+ G+ +P+G I VA+K ++ S Q +E + + +G++ H ++V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIF---NSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
G C GA L + GSL + +S + R L W + AKG+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLEE 127
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWIT 578
+VH ++ N+LL + +++DFG+A L+ ++ Y+ + ++A E I
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 579 NNPISEKSDVYSYGMVLLEII 599
+ +SDV+SYG+ + E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK------KEFSAEVTIIGNVHHVHLVKL 462
LG G FGSVY G+ L DG AVK++ G+ K+ E+ ++ + H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTA---KGLAYL 517
G E + + E + GSL K + + S E I L T GL YL
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---------IRLYTRQILLGLEYL 118
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
H+ VH DIK N+L+D N K++DFG+AK + E + +G+ ++APE I
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVI 173
Query: 578 -TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+D++S G +LE+ G+ +S
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 409 KLGQGGFGSVYLG----MLP--DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVK 461
+LG+G FG V+L + P D + VAVK L+ +K+F E ++ N+ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLC------------WNTRFNIALG 509
G C +G ++ +EY+ +G L+K++ ++ L + +IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 569
A G+ YL + VH D+ N L+ N K+ DFG M+R+ VY+T
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFG----MSRD---VYSTDYYRV 181
Query: 570 G--------YLAPEWITNNPISEKSDVYSYGMVLLEI 598
G ++ PE I + +SDV+S+G++L EI
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 406 FSTKLGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSAEVTIIGNV-----HHV 457
F +G+G F +V L + A+K L+ + + KK V I V H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRLNGHP 62
Query: 458 HLVKLKGFCIEGAHRL-LAYEYLVNGSLDKWI-----FNSTEESRFLCWNTRFNIALGTA 511
++KL + + L EY NG L ++I + C TRF A
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD------EKC--TRFYAAE-IL 112
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR----- 566
L YLH I+H D+KPEN+LLD + K++DFG AK+++ S
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 567 --------------GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
GT Y++PE + P + SD+++ G ++ +++ G+ F
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 23/206 (11%)
Query: 410 LGQGGFGSVYLGM-LPDG----IQVAVKKL-ESIG-QGKKEFSAEVTIIGNVHHVHLVKL 462
LG G FG+VY G+ +P+G I VA+K L E+ G + EF E I+ ++ H HLV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE--SRFLCWNTRFNIALGTAKGLAYLHEE 520
G C+ +L+ + + +G L ++ + S+ L N + AKG+ YL E
Sbjct: 75 LGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER 128
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--GYLAPEWIT 578
++VH D+ NVL+ K++DFGLA+L+ +E Y G ++A E I
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-EYNADGGKMPIKWMALECIH 184
Query: 579 NNPISEKSDVYSYGMVLLEII--GGR 602
+ +SDV+SYG+ + E++ GG+
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGK 210
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 64/192 (33%), Positives = 96/192 (50%), Gaps = 16/192 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
+G+G FG V LG G +VAVK K ++ Q F AE +++ + H +LV+L G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 468 EGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
E L + EY+ GSL ++ + L + +L + + YL V
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H D+ NVL+ ++ AKVSDFGL K E S T + + APE + S KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 587 DVYSYGMVLLEI 598
DV+S+G++L EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 410 LGQGGFGSVYLGML--PDG--IQVAVKKLESIGQGKK--EFSAEVTIIGNVHHVHLVKLK 463
+G+G FG VY G L DG I AVK L I ++ +F E I+ + H +++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 464 GFCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
G C+ EG+ L+ Y+ +G L +I + E+ L AKG+ YL +
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG------YLAPE 575
K VH D+ N +LD++FT KV+DFGLA+ + +E Y ++ G ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE---YYSVHNHTGAKLPVKWMALE 172
Query: 576 WITNNPISEKSDVYSYGMVLLEII 599
+ + KSDV+S+G++L E++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 410 LGQGGFGSVYLGM-LPDG----IQVAVKKLESIGQGK--KEFSAEVTIIGNVHHVHLVKL 462
LG G FG+VY G+ +P+G I VA+K+L K KE E ++ +V + H+ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C+ +L+ + + G L ++ E + N + AKG+ YL E
Sbjct: 75 LGICLTSTVQLIT-QLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEER-- 128
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
++VH D+ NVL+ K++DFGLAKL+ +E + G + ++A E I +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIKWMALESILH 185
Query: 580 NPISEKSDVYSYGMVLLEII 599
+ +SDV+SYG+ + E++
Sbjct: 186 RIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 22/212 (10%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGK-------KEFSAEVTIIGNVHHV 457
+G+G +G VYL + + G +AVK++E G+ K +E+ + ++ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
++V+ GF + + EY+ GS+ + RF RF +GLAYL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRF-FTEQVLEGLAYL 124
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-NREESLVYTTLRGTRGYLAPEW 576
H + I+H D+K +N+L+D + K+SDFG++K + ++ +++G+ ++APE
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 577 ITNNP--ISEKSDVYSYGMVLLEIIGGRKSFS 606
I + S K D++S G V+LE+ GR+ +S
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
F +LG G FG V G VA+K ++ + EF E ++ + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C + + EY+ NG L ++ E + + + +G+AYL + +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
+H D+ N L+DD KVSDFGL++ + +E YT+ G++ + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 583 SEKSDVYSYGMVLLEI 598
S KSDV+++G+++ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
K+G+G F VY + L DG VA+KK++ + +++ E+ ++ + H +++K
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
IE + E G L + I + ++ R + T + + L ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+I+H DIKP NV + K+ D GL + + + + + +L GT Y++PE I N +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERIHENGYN 184
Query: 584 EKSDVYSYGMVLLEI 598
KSD++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 34/214 (15%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE--FSAEVTIIGNVHHVHLVK 461
NF K+G+G G V + G QVAVKK++ Q ++E F+ EV I+ + H ++V+
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVE 80
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLA 515
+ + G + E+L G+L + + TR N + L K L+
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALS 129
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGY 571
+LH + ++H DIK +++LL + K+SDFG ++K + R +SLV GT +
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYW 181
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+APE I+ P + D++S G++++E++ G +
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLGQG FG V++G +VA+K L+ + F E I+ + H LV L
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
E ++ E++ GSL F + ++L ++A A G+AY+ +
Sbjct: 70 VSEEPIYIVT-EFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
+H D++ N+L+ DN K++DFGLA+L+ E YT +G + + APE
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 583 SEKSDVYSYGMVLLEII 599
+ KSDV+S+G++L E++
Sbjct: 181 TIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-18
Identities = 42/112 (37%), Positives = 62/112 (55%), Gaps = 2/112 (1%)
Query: 43 INNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEK 102
++G L+S NS+F GF+T + ++L++ SS VVW ANR + DS +
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQS 62
Query: 103 SGNAYLQRGNG-EAWSANTSGQK-VECMELQDSGNLVLLGVNGSILWQSFSH 152
GN L G+G WS+NT+G + L D GNLV+ +G+ LWQSF +
Sbjct: 63 DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 409 KLGQGGFGSVYLG----MLP--DGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVK 461
+LG+G FG V+L +LP D + VAVK L+ + +++F E ++ + H H+V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRF-----------LCWNTRFNIALGT 510
G C EG L+ +EY+ +G L++++ + +++ L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRG 567
A G+ YL + VH D+ N L+ K+ DFG M+R+ +Y+T G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFG----MSRD---IYSTDYYRVG 181
Query: 568 TRG-----YLAPEWITNNPISEKSDVYSYGMVLLEI 598
R ++ PE I + +SD++S+G+VL EI
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-18
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 3/114 (2%)
Query: 43 INNNGLFLISNNSVFGFGFYT-ALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFE 101
++G L+S+ S+F GF+ + + ++L++ SS VVW ANR S +
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQ 62
Query: 102 KSGNAYLQRGNG-EAWSANTSGQK-VECMELQDSGNLVLLGVNGSILWQSFSHP 153
GN + G+G WS+NT+ + L D GNLVL +G+ LWQSF +P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLK 463
++G+G +G VY G VA+KK+ + K+ F E+ ++ + H ++V+LK
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 464 GFCIEGAHR--LLAYEYL---VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+ +EY+ + G LD + E +F + +GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKC-YMKQLLEGLQYLH 117
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI- 577
I+H DIK N+L++++ K++DFGLA+ + S YT T Y PE +
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 578 --TNNPISEKSDVYSYGMVLLEIIGGR 602
T + D++S G +L E+ G+
Sbjct: 175 GATR--YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 391 PTRFSYDDLCKATKN---FSTKLGQGGFGSVY------LGMLPDGIQVAVKKLESIGQG- 440
PT+ YD + +N F LG G FG V L ++VAVK L+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 441 -KKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFL 498
++ +E+ I+ ++ +H ++V L G C G L+ EY G L ++ E FL
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFL 138
Query: 499 CWNTRFNIALGTAKGLAYL-HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNR 556
+ + AKG+A+L + C +H D+ NVLL K+ DFGLA+ +MN
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND 194
Query: 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
+V R ++APE I N + +SDV+SYG++L EI
Sbjct: 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+G+G +G V G VA+KK E KK EV ++ + H ++V LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGLAYLHEE 520
L +EY+ L+ + + R W + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHSH 119
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
I+H DIKPEN+L+ ++ K+ DFG A+ + + T TR Y APE + +
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 581 PISEKS-DVYSYGMVLLEIIGGRKSF 605
K DV++ G ++ E++ G F
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA--------EVTIIGNV-HHVH 458
+LG G FGSVYL G VA+KK+ KK+F + EV + + H +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+VKLK E +EY+ G+L + + + + + +I +GLA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
+ H D+KPEN+L+ K++DFGLA+ + YT TR Y APE +
Sbjct: 117 K---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILL 171
Query: 579 -----NNPISEKSDVYSYGMVLLEIIGGRKSF 605
++P+ D+++ G ++ E+ R F
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 42/228 (18%)
Query: 401 KATKNFSTKLGQGGFGSVYLG--MLPDG----IQVAVKKL--ESIGQGKKEFSAEVTIIG 452
+ F +LG+G FG VY G P+ VA+K L + + ++EF E ++
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 453 NVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL------------------DKWIFNSTEE 494
++ H ++V L G C + + +EYL +G L D+ + +S +
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 495 SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554
S FL +IA+ A G+ YL VH D+ N L+ + T K+SDFGL++ +
Sbjct: 124 SDFL------HIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 555 NREESLVYTTLRGTR----GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
S Y ++ ++ PE I + +SD++S+G+VL EI
Sbjct: 175 ---YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 409 KLGQGGFGSVYL-GMLPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKG 464
K+G+G FG L DG Q +K++ KE EV ++ N+ H ++V+ +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNST----EESRFLCWNTRFNIALGTAKGLAYLHEE 520
E + + +Y G L K I E + L W + +AL ++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDR 120
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
KI+H DIK +N+ L + T K+ DFG+A+++N L T + GT YL+PE N
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
P + KSD+++ G VL E+ + +F
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 71/231 (30%), Positives = 111/231 (48%), Gaps = 46/231 (19%)
Query: 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGML--PDGIQVAVKKLESIGQGK--KEFSAEV- 448
F+ +DL + +G+G FG+V ML P G +AVK++ S K K ++
Sbjct: 1 FTAEDLKDLGE-----IGRGAFGTVN-KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 449 TIIGNVHHVHLVKLKG---------FCIEGAHRLLAYEYLVNGSLDKW--IFNSTEESRF 497
++ + ++VK G C+E L++ SLDK+ +S
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSVI 104
Query: 498 LCWNTRF--NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLM 554
IA+ T K L YL EE +KI+H D+KP N+LLD N K+ DFG++ +L+
Sbjct: 105 ---PEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
Query: 555 NREESLVYTTLRGTRGYLAPEWITNN---PISEKSDVYSYGMVLLEIIGGR 602
+ S+ T G R Y+APE I + +SDV+S G+ L E+ G+
Sbjct: 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 410 LGQGGFGSVYLGMLPD-------GIQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLV 460
LG G FG VY G D I+VAVK L + Q KKEF E ++ N +H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESR---FLCWNTRFNIALGTAKGLAYL 517
KL G C+ + + E + G L ++ ++ E L +I L AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 518 HEECEVKIVHCDIKPENVLL-----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--- 569
++ +H D+ N L+ D + K+ DFGLA+ + + + Y G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD---YYRKEGEGLLP 176
Query: 570 -GYLAPEWITNNPISEKSDVYSYGMVLLEII 599
++APE + + + +SDV+S+G+++ EI+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 409 KLGQGGFGSVYLGML----PDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G+G FG VY G+ + I VAVK K + +++F E I+ H H+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G E ++ E G L ++ L + + + LAYL
Sbjct: 73 IGVITENPVWIV-MELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--GYLAPEWITNN 580
+ VH DI NVL+ K+ DFGL++ + E+ Y +G ++APE I
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFR 183
Query: 581 PISEKSDVYSYGMVLLEIIG-GRKSF 605
+ SDV+ +G+ + EI+ G K F
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 410 LGQGGFGSVYLGML-PDGI----QVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG+G FG V L P+G QVAVK L ES G + E+ I+ N++H ++VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 463 KGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
KG C E L E+L +GSL +++ + + + A+ KG+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL---KQQLKYAVQICKGMDYLGSR 128
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWIT 578
+ VH D+ NVL++ K+ DFGL K + ++E V L + APE +
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 579 NNPISEKSDVYSYGMVLLEII 599
+ SDV+S+G+ L E++
Sbjct: 186 QSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 71/203 (34%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 410 LGQGGFGSVYLGMLP-DGIQVAVKKL--ESIGQGK--KEFSAEVTI-IGNVHHVHLVKLK 463
+G+G FG V L DG AVK L ++I + K K AE + + NV H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ + A +L +Y+ G L F+ E F RF A A L YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+ I++ D+KPEN+LLD ++DFGL K E S +T GT YLAPE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D + G VL E++ G F
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 31/209 (14%)
Query: 409 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEF-SAEVTIIGNVHHVHLVKLKGFC 466
K+G+G G V + G QVAVKK++ Q ++E EV I+ + HH ++V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHEE 520
+ G + E+L G+L + +TR N + L + L+YLH +
Sbjct: 89 LVGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLSVLRALSYLHNQ 137
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE----ESLVYTTLRGTRGYLAPEW 576
++H DIK +++LL + K+SDFG +++E +SLV GT ++APE
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEV 189
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
I+ P + D++S G++++E+I G +
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-------AVKKLESI----GQGKKEFSAEVTIIGNVHHVH 458
LG+GGFG V +QV A KKL+ G+K E I+ V+
Sbjct: 1 LGKGGFGEVC------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGL 514
+V L H L + G L I+N E R + ++ + G+
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------TCGI 108
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 574
+LH + IV+ D+KPENVLLDD ++SD GLA + +++ T GT GY+AP
Sbjct: 109 LHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAP 163
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
E + P S D ++ G + E++ GR F
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 410 LGQGGFGSVYLG--MLPDG--IQVAVKKLESIGQGKKE--FSAEVTIIGNVHHVHLVKLK 463
LG G FG + G LP + VA+ L + K+ F AE +G H ++V+L+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G G ++ EY+ NG+LD F E + L + G A G+ YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL--APEWITNNP 581
VH + VL++ + K+S F +L + +YTT+ G L APE I +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 582 ISEKSDVYSYGMVLLEII 599
S SDV+S+G+V+ E++
Sbjct: 185 FSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 410 LGQGGFGSVYLGML--PDGIQ--VAVK--KLESIGQGK-KEFSAEVTIIGNVHHVHLVKL 462
LG+G FGSV G L DG Q VAVK KL+ + +EF +E + + H +++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 463 KGFCIEGAHR------LLAYEYLVNGSLDKWIFNS--TEESRFLCWNTRFNIALGTAKGL 514
G C E + ++ ++ +G L ++ S L T + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GY 571
YL +H D+ N +L ++ T V+DFGL+K + + Y R + +
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD--YYRQGRIAKMPVKW 181
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
+A E + + + KSDV+++G+ + EI
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 410 LGQGGFGSVYLGML------PDGIQVAVKKLESIGQGKKE--FSAEVTIIGNVHHVHLVK 461
LG G FG VY G+ +QVAVK L + E F E I+ +H ++V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWI---FNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
L G E R + E + G L ++ E L A AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 519 EECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL--- 572
E +H DI N LL AK++DFG+A+ + R Y +G R L
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS--YYR--KGGRAMLPIK 186
Query: 573 --APEWITNNPISEKSDVYSYGMVLLEI 598
PE + + K+DV+S+G++L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 42/226 (18%)
Query: 408 TKLGQGGFGSV------YLGMLPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVH 458
LG+G FG V L VAVK L+ E E ++ V+H H
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPH 64
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS--------------------TEESRFL 498
++KL G C + LL EY GSL ++ S + R L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 499 CWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558
+ A ++G+ YL E+K+VH D+ NVL+ + K+SDFGL++ + E+
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 559 SLVYTTLRGTRG-----YLAPEWITNNPISEKSDVYSYGMVLLEII 599
S V + ++G ++A E + ++ + +SDV+S+G++L EI+
Sbjct: 182 SYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGF 465
LG G GSV +P G +A KK+ IG +K+ E+ I+ ++V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+ + + E++ GSLD+ + IA+ +GL YL+ +I
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK----IAVAVVEGLTYLYNV--HRI 125
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+H DIKP N+L++ K+ DFG++ +L+N + T GT Y++PE I +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTV 181
Query: 585 KSDVYSYGMVLLEIIGGRKSFS 606
KSDV+S G+ ++E+ G+ F+
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 410 LGQGGFGSVYLGMLP-----DGIQVAVKKLES-IGQGKKE-FSAEVTIIGNVHHVHLVKL 462
LG+G FG V L G VAVK L+ GQ + E+ I+ ++H ++VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 463 KGFCIEGAHR--LLAYEYLVNGSLDKWI-FNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
KG C E + L EY+ GSL ++ + ++ L + A +G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLHS 125
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG--YLAPEWI 577
+ +H D+ NVLLD++ K+ DFGLAK + G + A E +
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
N S SDV+S+G+ L E++
Sbjct: 183 KENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV 457
++ + + KLG G FG V++ +VAVK ++ + F AE ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
LVKL + ++ E++ GSL F ++E + + A+G+A++
Sbjct: 62 KLVKLHAVVTKEPIYIIT-EFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAP 574
+ +H D++ N+L+ + K++DFGLA+++ E YT G + + AP
Sbjct: 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAP 172
Query: 575 EWITNNPISEKSDVYSYGMVLLEII 599
E I + KSDV+S+G++L+EI+
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKL-ESIGQGKK-EFSAEVTIIGNVHHVHLVKLKGFCI 467
LG+G FG V+ G L D VAVK E + Q K +F +E I+ H ++VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
+ + E + G ++ +E L AL A G+AYL + +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK---NCIH 116
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR----GYLAPEWITNNPIS 583
D+ N L+ +N K+SDFG+++ +E+ +Y++ G + + APE + S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSS-SGLKQIPIKWTAPEALNYGRYS 172
Query: 584 EKSDVYSYGMVLLE 597
+SDV+SYG++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
F +LG G FG V+LG I+VA+K + +++F E ++ + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C + + E++ NG L ++ + L + ++ +G+ YL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
+H D+ N L+ KVSDFG+ + + +E YT+ G + + PE +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 583 SEKSDVYSYGMVLLEI 598
S KSDV+S+G+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKGF 465
+G+G FG V+L D V +K++ K E A E ++ + H ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNST----EESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+E ++ EY G+L ++I +E L + + +AL ++H +
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK- 120
Query: 522 EVKIVHCDIKPENVLLDDNFTA-KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
I+H D+K +N+LLD + K+ DFG++K+++ +S YT + GT Y++PE
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
P ++KSD+++ G VL E+ +++F
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 405 NFSTKLGQGGFGSVYL----------------GMLPDG-IQVAVKKL--ESIGQGKKEFS 445
NF KLG+G FG V+L D + VAVK L ++ +++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 446 AEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF- 504
EV I+ + ++ +L G C + EY+ NG L++++ E+ L N++
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 505 ------NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE- 557
+A A G+ YL + VH D+ N L+ N+T K++DFG M+R
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG----MSRNL 180
Query: 558 ESLVYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSYGMVLLEI 598
S Y ++G R L W+ + + KSDV+++G+ L EI
Sbjct: 181 YSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
LG+G +G VY L +++A+K++ E + + E+ + + H ++V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 468 EGAHRLLAYEYLVNGSLD-----KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
E + E + GSL KW E + + + +GL YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHDN-- 127
Query: 523 VKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+IVH DIK +NVL++ + K+SDFG +K + T GT Y+APE I P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGP 185
Query: 582 --ISEKSDVYSYGMVLLEIIGGRKSF 605
+D++S G ++E+ G+ F
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 23/202 (11%)
Query: 410 LGQGGFGSVYLGM-LPDG----IQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG G FG+VY G+ +PDG I VA+K L + + KE E ++ V ++ +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE--SRFLCWNTRFNIALGTAKGLAYLHEE 520
G C+ +L+ + + G L ++ + + S+ L N + AKG++YL E
Sbjct: 75 LGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGMSYLEE- 127
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 577
V++VH D+ NVL+ K++DFGLA+L++ +E+ + G + ++A E I
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD--GGKVPIKWMALESI 183
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
+ + +SDV+SYG+ + E++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEF-SAEVTIIGNVHHVHLVKLKGFC 466
K+G+G G V + + G VAVKK++ Q ++E EV I+ + H ++V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHEE 520
+ G + E+L G+L + +TR N + L K L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE----ESLVYTTLRGTRGYLAPEW 576
++H DIK +++LL + K+SDFG +++E +SLV GT ++APE
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEL 187
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
I+ P + D++S G++++E++ G +
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGK-KEFSAEVTIIGNVHHVHLVKLKG- 464
+LG+G +GSVY + P G+ +A+K++ + + K + E+ I+ ++V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
F IEGA + EY+ GSLDK ++ + + + I KGL +L EE
Sbjct: 68 FFIEGA-VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-----TN 579
I+H D+KP NVL++ N K+ DFG++ N SL T + G + Y+APE I
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 580 NPI-SEKSDVYSYGMVLLEIIGGR 602
NP + +SDV+S G+ +LE+ GR
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G FG VY + VA+K LE ++ E+ + ++ K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA---LGTAKGLAYLHEECE 522
++G+ + EY GS + + + IA GL YLHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGS----CLDLLKPGKL----DETYIAFILREVLLGLEYLHEE-- 117
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+H DIK N+LL + K++DFG++ + S T + GT ++APE I +
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175
Query: 583 SEKSDVYSYGMVLLEIIGG 601
EK+D++S G+ +E+ G
Sbjct: 176 DEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 410 LGQGGFGSVY-LGMLPDGIQVAVKKLES----IGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
LG+GGFG V + G A KKL+ +G++ E I+ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ E L L+NG K+ + E F F A GL +LH+ +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQR---R 115
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
IV+ D+KPENVLLDD+ ++SD GLA + + + GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPEVLQGEVYDF 173
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
D ++ G L E+I GR F
Sbjct: 174 SVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTIIGNVHHVHLVKLKGF 465
++G+G FG VY G+ +V K+ + + + E E+T++ ++ + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 466 CIEGAHRLLAYEYLVNGS-LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
++G + EYL GS LD EE+ I KGL YLH E +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA------TILREILKGLDYLHSE---R 121
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+H DIK NVLL + K++DFG+A + + + T GT ++APE I +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 585 KSDVYSYGMVLLEIIGGRKSFS 606
K+D++S G+ +E+ G S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTIIGNVHHVHLVKL 462
LGQG FG VYL D G ++AVK++ + KKE +A E+ ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWI-----FNSTEESRFLCWNTRFNIALGTAKGLAYL 517
G + + EY+ GS+ + T ++ TR +G+ YL
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY----TR-----QILEGVEYL 120
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN--REESLVYTTLRGTRGYLAPE 575
H IVH DIK N+L D K+ DFG +K + ++ GT +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 576 WITNNPISEKSDVYSYGMVLLEII 599
I+ K+DV+S G ++E++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 37/213 (17%)
Query: 410 LGQGGFGSVY-LGMLPDGIQVAVKKLESI--GQGKKEFSAEVTI-IGNVHHVHLVKLKG- 464
LG+G +G V + +P G +AVK++ + Q +K ++ I + +V + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 465 --------FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
C+E +++ SLDK+ ++ + + IA+ K L Y
Sbjct: 69 LFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPE 575
LH + + ++H D+KP NVL++ N K+ DFG++ L++ S+ T G + Y+APE
Sbjct: 119 LHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPE 173
Query: 576 WITNNPISE------KSDVYSYGMVLLEIIGGR 602
I NP KSDV+S G+ ++E+ GR
Sbjct: 174 RI--NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLK 463
K+G+G F VY L DG+ VA+KK++ + + + E+ ++ ++H +++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
IE + E G L + I + ++ R + T + + L ++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--- 125
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+++H DIKP NV + K+ D GL + + + + ++ L GT Y++PE I N +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYN 184
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
KSD++S G +L E+ + F
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTIIGNVHHVHLVKLKGFC 466
K+GQG G+VY + + G +VA+K++ Q KKE E+ ++ H ++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ G + EYL GSL + + + + R + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QVI 137
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 587 DVYSYGMVLLEIIGG 601
D++S G++ +E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 39/212 (18%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLK 463
KLG+G +G VY G VA+KK+ + ++ + E++++ + H ++VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK--------GLA 515
L +EY + ++L ++ K GLA
Sbjct: 65 DVIHTERKLYLVFEYC-----------DMDLKKYLD-KRPGPLSPNLIKSIMYQLLRGLA 112
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL----MNREESLVYTTLRGTRGY 571
Y H +I+H D+KP+N+L++ + K++DFGLA+ + YT T Y
Sbjct: 113 YCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-----YTHEVVTLWY 164
Query: 572 LAPEWITNNPISEKS-DVYSYGMVLLEIIGGR 602
APE + + + D++S G + E+I G+
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 59/216 (27%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 406 FSTKLGQGGFGSVYLGML-PDGIQV--AVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHL 459
F +G+G FG V + DG+++ A+K+++ ++F+ E+ ++ + HH ++
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA-------- 511
+ L G C + LA EY +G+L ++ +SR L + F IA TA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 512 --------KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563
+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL++ +E + T
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 181
Query: 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
R ++A E + + + SDV+SYG++L EI+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTIIGNVHHVHLVKLKGF 465
++G+G FG V+ G+ QV K+ + + + E E+T++ ++ K G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 466 CIEGAHRLLAYEYLVNGS-LDKWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLHEEC 521
++G + EYL GS LD +E F IA KGL YLH E
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYLHSE- 120
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
K +H DIK NVLL + K++DFG+A + + + T GT ++APE I +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 582 ISEKSDVYSYGMVLLEIIGG 601
K+D++S G+ +E+ G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 70/203 (34%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKE---FSAEVTIIGNVHHVHLVKLK 463
+G+G FG V L + AVK L+ +I + K+E S ++ NV H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
F + A +L +Y+ G L ++ E FL RF A A L YLH
Sbjct: 63 -FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS--- 114
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+ IV+ D+KPEN+LLD ++DFGL K N E + +T GT YLAPE + P
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D + G VL E++ G F
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 23/199 (11%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG-F 465
LG G G+VY L +AVK L+ + +K+ +E+ I+ +++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 466 CIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+E +R+ + E++ GSLD ++ E + IA+ KGL YL +K
Sbjct: 69 FVE--NRISICTEFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYL---WSLK 115
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
I+H D+KP N+L++ K+ DFG++ +L+N + T GT Y+APE I+
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYG 171
Query: 584 EKSDVYSYGMVLLEIIGGR 602
SDV+S G+ +E+ GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 69/202 (34%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 410 LGQGGFGSVYLGMLP-DG----IQVAVKKLESIGQGKKEFSAEVTII-GNVHHVHLVKLK 463
+G+G FG V L DG ++V KK+ + +K AE ++ NV H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + +L VNG + F+ E F RF A A L YLH +
Sbjct: 63 -YSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---I 115
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
IV+ D+KPEN+LLD ++DFGL K +S TT GT YLAPE I P
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G VL E++ G F
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 66/202 (32%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 410 LGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEV-----TIIGNVHHVHLVKLK 463
+G+G FG V L DG AVK L+ KK+ + ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + A +L VNG + F+ E FL RF A A + YLH +
Sbjct: 63 -YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---L 115
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
I++ D+KPEN+LLD ++DFGL K E +T GT YLAPE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G VL E++ G F
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTIIGNVHHVHLVKLKGFC 466
K+GQG G+VY + + G +VA+K++ Q KKE E+ ++ + ++V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ G + EYL GSL + + + + R + + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 587 DVYSYGMVLLEIIGGRKSF 605
D++S G++ +E++ G +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 408 TKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHL 459
T LG+G FG V+L V VK L+ + EF E+ + + H ++
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS-----TEESRFLCWNTRFNIALGTAKGL 514
V+L G C E + EY G L +++ + + L + + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLA 573
+L + VH D+ N L+ KVS L+K + N E + L R +LA
Sbjct: 131 DHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLA 186
Query: 574 PEWITNNPISEKSDVYSYGMVLLEI 598
PE + + S KSDV+S+G+++ E+
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 409 KLGQGGFGSVYLG---MLPDGIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLK 463
+LG G FG V G M I VA+K L++ + + E E I+ + + ++V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLHEE 520
G C E +L E G L+K++ +E T N+ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEI------TVSNVVELMHQVSMGMKYLEGK 114
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG-----YLAPE 575
VH D+ NVLL + AK+SDFGL+K + ++S Y R + G + APE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKAR-SAGKWPLKWYAPE 168
Query: 576 WITNNPISEKSDVYSYGMVLLE 597
I S +SDV+SYG+ + E
Sbjct: 169 CINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
L YLH + I+H DIKP+N+LLD+ ++DF +A + + T+ GT GY+
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYM 166
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE + S D +S G+ E + G++ +
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 406 FSTKLGQGGFGSVYL----GMLP-------------DGIQVAVKKLESIG--QGKKEFSA 446
F KLG+G FG V+L GM + VAVK L + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 447 EVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN-------STEESRFLC 499
E+ I+ + ++++L CI + EY+ NG L++++ + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 500 WNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559
++T +A A G+ YL + VH D+ N L+ N+T K++DFG+++ + +
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD- 184
Query: 560 LVYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSYGMVLLEII 599
Y ++G R L W++ I + SDV+++G+ L EI+
Sbjct: 185 --YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 406 FSTKLGQGGFGSV----------YLGMLPDG-----IQVAVKKLES--IGQGKKEFSAEV 448
KLG+G FG V +LG + VAVK L + + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 449 TIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWN-----TR 503
I+ + + ++++L G C+ + EY+ NG L++++ ES F N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 504 FNI---ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560
N+ A+ A G+ YL + VH D+ N L+ +++T K++DFG+++ + +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-- 183
Query: 561 VYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSYGMVLLEI 598
Y ++G R L W+ I + SDV+++G+ L E+
Sbjct: 184 -YYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 410 LGQGGFGSVYLG---MLPDGIQV-AVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKL 462
LGQG FG V+L PD Q+ A+K L+ + + E I+ V+H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 463 K-GFCIEGAHRLLAYEYLVNGSLDKWIFNS-TEESRFLCWNTRFNIALGTAKGLAYLHEE 520
F EG L+ ++L G L F ++E F + +F +A A L +LH
Sbjct: 64 HYAFQTEGKLYLI-LDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLHS- 116
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
+ I++ D+KPEN+LLD+ K++DFGL+K E Y + GT Y+APE +
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRR 173
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
++ +D +S+G+++ E++ G F
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-14
Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTIIGNVHHVHLVKLKGFC 466
K+GQG G+V+ + + G +VA+K++ Q KKE E+ ++ + + ++V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ G + EYL GSL + + + + R + + L +LH +++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H DIK +NVLL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 587 DVYSYGMVLLEIIGGRKSF 605
D++S G++ +E++ G +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G+G FG V+ G L D VAVK K +F E I+ H ++V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C + + E LV G D F TE R L + A G+ YL +
Sbjct: 62 CTQKQPIYIVME-LVQGG-DFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---C 115
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR----GYLAPEWITNNP 581
+H D+ N L+ + K+SDFG+++ EE VY + G + + APE +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 582 ISEKSDVYSYGMVLLE 597
S +SDV+S+G++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 406 FSTKLGQGGFGSVYLGMLP-DGIQV--AVKKLESIG--QGKKEFSAEVTIIGNV-HHVHL 459
F +G+G FG V M+ DG+++ A+K L+ ++F+ E+ ++ + HH ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK------- 512
+ L G C + +A EY G+L ++ +SR L + F GTA
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 513 ---------GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563
G+ YL E+ + +H D+ NVL+ +N +K++DFGL++ EE V
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 564 TL-RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
T+ R ++A E + + + KSDV+S+G++L EI+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 409 KLGQGGFGSVYLGMLPDGIQ------VAVKKL-ESIGQGKK-EFSAEVTIIGNVHHVHLV 460
+LGQG FG VY G D I+ VAVK + ES ++ EF E +++ H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESR------FLCWNTRFNIALGTAKGL 514
+L G +G L+ E + +G L ++ + E+ +A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRGTRG- 570
AYL+ + K VH D+ N ++ +FT K+ DFG M R+ +Y T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG----MTRD---IYETDYYRKGGKGL 182
Query: 571 ----YLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE + + + SD++S+G+VL EI
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 406 FSTKLGQGGFGSVYLG--MLP--DGIQ-VAVKKLESIGQGKK--EFSAEVTIIGNVHHVH 458
F +LG+ FG +Y G LP D Q VA+K L+ I ++ EF E +++ +HH +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTR-------------FN 505
+V L G + + +EYL G L +++ + S C + +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--SLVYT 563
IA+ A G+ YL VH D+ N+L+ + K+SD GL++ + + +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
+L R ++ PE I S SD++S+G+VL EI
Sbjct: 186 SLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTIIGNVHHVHLVKLKGFC 466
K+GQG G+VY M + G +VA++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ G + EYL GSL + + + + R + + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 587 DVYSYGMVLLEIIGGRKSF 605
D++S G++ +E+I G +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 409 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEF-SAEVTIIGNVHHVHLVKLKGFC 466
K+G+G G V + G QVAVK ++ Q ++E EV I+ + H ++V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLHEECEV 523
+ G + E+L G+L + ++R IA + L YLH +
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRL----NEEQIATVCESVLQALCYLHSQ--- 136
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEWITN 579
++H DIK +++LL + K+SDFG ++K + + +SLV GT ++APE I+
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISR 191
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
P + D++S G++++E++ G +
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 59/213 (27%), Positives = 112/213 (52%), Gaps = 33/213 (15%)
Query: 410 LGQGGFGSVYLGMLP-DGIQV--AVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLK 463
+G+G FG V + DG+++ A+K+++ ++F+ E+ ++ + HH +++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA------------ 511
G C + LA EY +G+L ++ +SR L + F IA TA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 512 ----KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL-R 566
+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL++ +E V T+ R
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 172
Query: 567 GTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
++A E + + + SDV+SYG++L EI+
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 409 KLGQGGFGSVYLG--MLPDG--IQVAVKKLESIGQGK--KEFSAEVTIIGNVHHVHLVKL 462
KLG G FG V G G I VAVK L+S +F E I+ ++ H +L++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
G + H L + E GSL + + +T + A+ A G+ YL +
Sbjct: 62 YGVVL--THPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGL--AKLMNREESLVYTTLRGTRGYLAPEWITN 579
+ +H D+ N+LL + K+ DFGL A N + ++ L+ + APE +
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 580 NPISEKSDVYSYGMVLLEI 598
S SDV+ +G+ L E+
Sbjct: 175 RTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
K+G+G +G VY G VA+KK+ ES G K E+ ++ ++H +++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLL 64
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF-NIALGTAKGLAYLHEECE 522
L +E++ D ++ ++ + + + +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I+H D+KPEN+L++ K++DFGLA+ YT TR Y APE + +
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 583 -SEKSDVYSYGMVLLEIIGGRKSF 605
S D++S G + E++ R F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTIIGNVHHVHLVKLKGF 465
K+G+G FG V+ G+ +V K+ + + + E E+T++ ++ K G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 466 CIEGAHRLLAYEYLVNGS-LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
++ + EYL GS LD +E++ I KGL YLH E K
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLHSE---K 121
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+H DIK NVLL ++ K++DFG+A + + + T GT ++APE I +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 585 KSDVYSYGMVLLEIIGGRKSFS 606
K+D++S G+ +E+ G S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 407 STKLGQGGFGSVYLGMLPDGIQ------VAVKKLESIGQGKK--EFSAEVTIIGNVHHVH 458
S +LGQG FG VY G+ ++ VA+K + ++ EF E +++ + H
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFL----CWNTRFNIALGTAK 512
+V+L G +G L+ E + G L ++ E+ + +A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRGTR 569
G+AYL+ K VH D+ N ++ ++FT K+ DFG M R+ +Y T +G +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRD---IYETDYYRKGGK 180
Query: 570 G-----YLAPEWITNNPISEKSDVYSYGMVLLEI 598
G +++PE + + + SDV+S+G+VL EI
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 408 TKLGQGGFGSV---YLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVK 461
+LG G FG+V M VAVK L++ K E E ++ + + ++V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ G C E +L E G L+K++ ++++ + + + G+ YL E
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT--RGYLAPEWITN 579
VH D+ NVLL AK+SDFGL+K + +E+ G + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 580 NPISEKSDVYSYGMVLLE 597
S KSDV+S+G+++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 62/226 (27%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-----EVTIIGNVHHVHLVKLK 463
+G G +G V + G +VA+KK+ ++ A E+ ++ ++ H +++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGL- 64
Query: 464 GFCIEGAHRLLAYE--------YLV----NGSLDKWIFNS---TEE--SRFLCWNTRFNI 506
+L Y+V L K I + T++ FL R
Sbjct: 65 -------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR--- 114
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV----- 561
GL YLH ++H D+KP N+L++ N K+ DFGLA+ ++ +E
Sbjct: 115 ------GLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 562 YTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGR 602
Y TR Y APE + + I D++S G + E++ +
Sbjct: 166 YVV---TRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 69/201 (34%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 410 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V + G A KKLE I + K E A E I+ V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ E L L+NG K+ E+ F F A GL LH+E +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE---R 122
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
IV+ D+KPEN+LLDD+ ++SD GLA ++ E GT GY+APE + N +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
D ++ G +L E+I G+ F
Sbjct: 181 SPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK--EFSAEVTIIGNVHHVHLVKL-KGFC 466
LG G FG VY + A K+ I ++ +F E+ I+ H ++V L + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTE------ESRFLCWNTRFNIALGTAKGLAYLHEE 520
E +L E+ G+LD I E + R++C + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDS-IMLELERGLTEPQIRYVCRQM--------LEALNFLHSH 122
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI--- 577
K++H D+K N+LL + K++DFG++ N+ T GT ++APE +
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 578 --TNNPISEKSDVYSYGMVLLEIIGGR 602
+NP K+D++S G+ L+E+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LG+G FG L D V K++ + +++ E+ I+ + H +++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECE 522
++ L+ EY G+L I E + W ++Y+H+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA-- 120
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I+H DIK N+ L K+ DFG++K++ E S+ T + GT Y++PE
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
+ KSD+++ G VL E++ +++F
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 408 TKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKL 462
++G G FG+VY + VA+KK+ G+ E EV + + H + ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 463 KGFCIEGAHRLLAYEYLVNGSLD-----KWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
KG + L EY + + D K E + I G +GLAYL
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYL 131
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
H + H DIK N+LL + T K++DFG A L++ S V GT ++APE I
Sbjct: 132 HSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 578 ---TNNPISEKSDVYSYGMVLLEI 598
K DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 41/225 (18%)
Query: 402 ATKNFS-----TKLGQGGFGSVYLGM-LPDGIQVAVKKL-----ESIGQGKKEFSAEVTI 450
A K+ S ++G G G+VY + P G A+K + +++ +++ E+ I
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREIEI 125
Query: 451 IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT 510
+ +V+H ++VK + E++ GSL+ +FL ++A
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLA-----DVARQI 177
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLR 566
G+AYLH IVH DIKP N+L++ K++DFG LA+ M+ S V
Sbjct: 178 LSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----- 229
Query: 567 GTRGYLAPEWITNNPISE------KSDVYSYGMVLLEIIGGRKSF 605
GT Y++PE I N ++ D++S G+ +LE GR F
Sbjct: 230 GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G G VY + LP+ +VA+K+ LE E EV + +H ++VK
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 466 CIEGAHRLLAYEYLVNGS-LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ G L YL GS LD I S+ L + KGL YLH ++
Sbjct: 68 FVVGDELWLVMPYLSGGSLLD--IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI- 124
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEWITN- 579
H DIK N+LL ++ + K++DFG LA +R V T GT ++APE +
Sbjct: 125 --HRDIKAGNILLGEDGSVKIADFGVSASLADGGDR-TRKVRKTFVGTPCWMAPEVMEQV 181
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ K+D++S+G+ +E+ G +S
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLK 463
K+G+G F VY L D VA+KK++ + +++ E+ ++ ++H +++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
IE + E G L + I ++ R + T + + + ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+++H DIKP NV + K+ D GL + + + + ++ L GT Y++PE I N +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYN 184
Query: 584 EKSDVYSYGMVLLEI 598
KSD++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 410 LGQGGFGSVYLGML-PDGIQVAVKKL--ESIGQGKKE---FSAEVTIIGNVHHVHLVKLK 463
LG GGFG V L + A+K + I + ++ FS E I+ +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + + EY + G L + + F + RF IA YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIA-CVVLAFEYLHNR--- 112
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I++ D+KPEN+LLD N K+ DFG AK L + +++ T GT Y+APE I N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGY 169
Query: 583 SEKSDVYSYGMVLLEIIGGRKSFS 606
D +S G++L E++ GR F
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDG--IQVAVKKLES---IGQGKKE--FS 445
+ Y+D NF LG G FG V L + VA+K+ E I Q + + FS
Sbjct: 26 KMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 446 AEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN 505
E I+ ++H V L G + ++ L E+++ G E FL N RF
Sbjct: 81 -ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG----------EFFTFLRRNKRFP 129
Query: 506 IALGT--AKGLAYLHEECE-VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+G A + + E + + IV+ D+KPEN+LLD + K++DFG AK++ ++ Y
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTY 186
Query: 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
TL GT Y+APE + N + +D ++ G+ + EI+ G F
Sbjct: 187 -TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKGF 465
+G+G +G V L DG Q +KKL ++E A E ++ + H ++V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE- 66
Query: 466 CIEGAHRLLAYEYLVNGSL---DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
EG LL Y+V G D + ++ + L N + A L YLHE+
Sbjct: 67 SWEGEDGLL---YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I+H D+K +NV L KV D G+A+++ + + +TL GT Y++PE +N P
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA-STLIGTPYYMSPELFSNKPY 179
Query: 583 SEKSDVYSYGMVLLEIIGGRKSFS 606
+ KSDV++ G + E+ + +F+
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 410 LGQGGFGSVY-LGMLPDGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKG 464
LG+GGFG V M G A KKL +G + E I+ VH +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 465 FCIEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + L ++NG L I+N EE+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+I++ D+KPENVLLD++ ++SD GLA +L + + GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAGTPGFMAPELLQGEEY 174
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D ++ G+ L E+I R F
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 40/127 (31%), Positives = 75/127 (59%), Gaps = 11/127 (8%)
Query: 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536
E++ GSLD+ + +++ + N I++ +GL YL E+ KI+H D+KP N+L
Sbjct: 79 EHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNIL 132
Query: 537 LDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVL 595
++ K+ DFG++ +L++ S+ + GTR Y++PE + + +SD++S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLID---SMA-NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 596 LEIIGGR 602
+E+ GR
Sbjct: 189 VEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 410 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V + G A K+LE I + K E A E I+ V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKW-IFN----STEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ E L ++NG K+ I+N EE R L + A GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCGLEDLHR 120
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
E V+ D+KPEN+LLDD ++SD GLA + ES+ GT GY+APE + N
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNN 175
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
+ D + G ++ E+I G+ F
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKG-F 465
+LG G FG VY + G A K +E+ + + E + E+ I+ +H ++VKL G F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+G ++ E+ G++D + E R L I + L YLH KI
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEWI---- 577
+H D+K NVLL + K++DFG++ K + R +S + GT ++APE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 578 -TNNPISEKSDVYSYGMVLLEI 598
+ P K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 43/188 (22%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKK--EFSA--EVTIIGNVHHVHLVK 461
KLG+G + VY G VA+KK L + K F+A E+ ++ + H +++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 462 L-----KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF------NIALGT 510
L I L +E++ L+K I + + + L T
Sbjct: 67 LLDVFGHKSNIN-----LVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMT 111
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM---NREESLVYTTLRG 567
+GL YLH I+H D+KP N+L+ + K++DFGLA+ NR+ T
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVV 164
Query: 568 TRGYLAPE 575
TR Y APE
Sbjct: 165 TRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 71/209 (33%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 410 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V + G A KKLE I + K E A E I+ V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKW-IFN----STEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ E L L+NG K+ I+N +E R + + A GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEITCGLEDLHR 120
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR---GTRGYLAPEW 576
E +IV+ D+KPEN+LLDD ++SD GLA + E T+R GT GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIRGRVGTVGYMAPEV 172
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ N + D + G ++ E+I G+ F
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-------FSAEVTIIGNVHHVHLVK 461
LG G F S Y + G +AVK++ + E E+ ++ ++H H+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ G E +H L E++ GS+ + + + +E N +GL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE------AVIINYTEQLLRGLSYLHE 121
Query: 520 ECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNRE---ESLVYTTLRGTRGYLAPE 575
+I+H D+K N+L+D +++DFG A + + L GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGR 602
+ DV+S G V++E+ +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 53/199 (26%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 408 TKLGQGGFGSVY-LGMLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
++LG G G V + P G+ +A K LE + + E+ ++ + ++V G
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ E++ GSLD+ + +E++ + +++ +GLAYL E+ +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKHQ-- 124
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
I+H D+KP N+L++ K+ DFG++ +L++ + + GTR Y++PE + S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 180
Query: 584 EKSDVYSYGMVLLEIIGGR 602
+SD++S G+ L+E+ GR
Sbjct: 181 VQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 41/223 (18%)
Query: 410 LGQGGFGSVYLGML------PDGIQVAVKKLESIGQGKKEFSAEVT------IIGNVHHV 457
LG+G FG V + VAVK L+ +K+ S V+ +IG H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK--HK 76
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNI------- 506
+++ L G C + + EY +G+L ++ S +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 507 -ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
A A+G+ +L + K +H D+ NVL+ ++ K++DFGLA+ ++ + T
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 566 RGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII--GG 601
T G L APE + + + +SDV+S+G++L EI GG
Sbjct: 192 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 54/233 (23%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSA--EVTIIGNVHHVH 458
KLG+G FG VY + G VA+KK+ + +K+ +A E+ I+ + H +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLKHPN 68
Query: 459 LVKLKGFCIE---GAHRLLAYEYLV--------NGSLDKWIFNSTEESRFLCWNTRFNIA 507
+V L +E + R Y+V +G L+ ES+ C
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-LTESQIKC------YM 121
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL-------------M 554
L +G+ YLHE I+H DIK N+L+D+ K++DFGLA+
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKS-----DVYSYGMVLLEIIGGR 602
+ YT L TR Y PE + + E+ D++ G V E+ R
Sbjct: 179 GTRK---YTNLVVTRWYRPPELL----LGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNREESLVYTTLRGTRG 570
G+ LH+ I+H DIKPEN+L+D K++DFGL++ L N++ GT
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPD 158
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
YLAPE I + SD +S G V+ E + G F
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 410 LGQGGFGSVYLG-MLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+ +G G+ Y G + +G+Q VK++ + A+ +G + H ++VKL G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS 754
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
L +EY+ +L +E R L W R IA+G AK L +LH C +V
Sbjct: 755 EKGAYLIHEYIEGKNL-------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 588
++ PE +++D + L L+ + T + Y+APE I+EKSD+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDI 861
Query: 589 YSYGMVLLEIIGGRKS 604
Y +G++L+E++ G+
Sbjct: 862 YGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLES---IGQGKKE-FSAEVTIIGNVHHVHLVKLKG 464
LG G FG V L + A+K L + + E E I+ ++ H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLHEEC 521
+ ++ L EY+ G L + S RF RF + L L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLA----LEYLHSL- 120
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
IV+ D+KPEN+LLD + K++DFG AK R + Y TL GT YLAPE I +
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTY-TLCGTPEYLAPEIILSKG 174
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D ++ G+++ E++ G F
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTIIGNVHHVHLVKL 462
LGQG FG VYL D G ++AVK+++ + KE +A E+ ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 463 KGFCIEGAHRLLA--YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
G + R L+ E++ GS I + + L N +G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPE 575
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGR 602
I+ K+D++S G ++E++ +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTIIGNVHHVHLVKL 462
LGQG FG VYL D G ++A K+++ + KE SA E+ ++ N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 463 KGFCIEGAHRLLA--YEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
G + A + L EY+ GS+ + + + ES + + +G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLA 573
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMS 177
Query: 574 PEWITNNPISEKSDVYSYGMVLLEII 599
PE I+ K+DV+S G ++E++
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHV---HLVKLK 463
+G+G +G+VY G +P G VA+K L++ + EV ++ + ++ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G ++G + EY GS+ + +++ R L Y+H+ V
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHK---V 120
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
++H DIK N+L+ + K+ DFG+A L+N + S +T GT ++APE IT
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 584 E-KSDVYSYGMVLLEIIGG 601
+ K+D++S G+ + E+ G
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKLE-SIGQGKKEFSAEVT---IIGNVHHVHLVKLKG 464
LG+G FG V L G A+K L+ + K E + +T ++ N H L LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + RL EY+ G L F+ + E F TRF A L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
KIV+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKL-KGF 465
+LG G FG VY + G+ A K +++ + + E + E+ I+ + H ++VKL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
E +L E+ G++D + E R L + T + L YLHE KI
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEWI---- 577
+H D+K N+L + K++DFG++ + + R +S + GT ++APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCET 179
Query: 578 -TNNPISEKSDVYSYGMVLLEI 598
+ P K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKL-ESIGQGKKEFSAEVT---IIGNVHHVHLVKLKG 464
LG+G FG V L G A+K L + + K E + VT ++ N H L LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + RL EY G L F+ + E F RF A L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSR--- 114
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+V+ DIK EN++LD + K++DFGL K + + + T GT YLAPE + +N
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYG 173
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-12
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 29/177 (16%)
Query: 442 KEFSAEVTIIGNVHHVHLVKL--KGFCIEGAHRLLA-YEYLVNGSLDKWIFN----STEE 494
F E + ++H ++V L G G L A +EY+ +L + + E
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPGRTLREVLAADGALPAGE 80
Query: 495 SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLA 551
+ L L LA H + IVH D+KP+N+++ AKV DFG+
Sbjct: 81 TGRL--------MLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 552 KLM-NREESLVYTTLR-----GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602
L+ ++ V T R GT Y APE + P++ SD+Y++G++ LE + G+
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKE--FSAEVTIIGNVHHVHLVKLK 463
++G G FG V LG G+ +V VK+L + ++ F EV ++H ++++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCW-NTRFNIALGTAKGLAYLHEECE 522
G CIE LL E+ G L ++ ++ + + +A A GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPEWI 577
+H D+ N L + + K+ D+GLA E+ + LR +LAPE +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELV 174
Query: 578 TN-------NPISEKSDVYSYGMVLLEI 598
++KS+++S G+ + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 70/209 (33%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 410 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V + G A KKLE I + K E A E I+ V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKW-IFN----STEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ E L ++NG K+ I+N +E R + + A GL L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDLQR 120
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR---GTRGYLAPEW 576
E +IV+ D+KPEN+LLDD ++SD GLA + E T+R GT GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-----TVRGRVGTVGYMAPEV 172
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
I N + D + G ++ E+I G+ F
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467
+G G +G VY G + G A+K ++ G ++E E+ ++ HH ++ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 468 EGA------HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ L E+ GS+ I N+ + W I +GL++LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--N 579
K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE I
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 187
Query: 580 NPISE---KSDVYSYGMVLLEIIGG 601
NP + KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF----------SAEVTIIGNVHHVHL 459
LG+G FG V L + A K ++ KKE E ++ N H L
Sbjct: 3 LGKGTFGKVILVR-----EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 460 VKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
LK + + RL EY G L F+ + E F RF A L YLH
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGTRGYLAP 574
+V+ D+K EN++LD + K++DFGL K E + T GT YLAP
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 164
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
E + +N D + G+V+ E++ GR F
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 34/205 (16%)
Query: 409 KLGQGGFGSVYLG-MLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G G +G VY + G VA+K KLE G + E++++ H ++V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEES------RFLCWNTRFNIALGTAKGLAYLHE 519
+ + EY GSL I+ T ++C T KGLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRET--------LKGLAYLHE 119
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPE 575
+H DIK N+LL ++ K++DFG++ + + +S + GT ++APE
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPE 171
Query: 576 WITNNPIS---EKSDVYSYGMVLLE 597
K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467
+G+G +G VY G VA+K ++ I ++E E I+ +H ++ G I
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 468 E-----GAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ +L L E GS+ + ++ + L I T +GLAYLHE
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN- 132
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--N 579
K++H DIK +N+LL N K+ DFG++ ++ T + GT ++APE I
Sbjct: 133 --KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACDE 189
Query: 580 NP---ISEKSDVYSYGMVLLE 597
P +SDV+S G+ +E
Sbjct: 190 QPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL YLH I+H DIKP N+L++ N K+ DFGLA++ +ES T T+ Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 572 LAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSF 605
APE + + + D++S G + E++G R F
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKK---LESIGQGKKEFSAEVTIIGNVHHVHLVKLK-GF 465
+G+G FG L + Q K L ++ E ++ + H ++V K F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNST----EESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+G H + EY G L + I E L W + + G+ ++HE+
Sbjct: 68 EADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+++H DIK +N+ L N K+ DFG A+L+ + T + GT Y+ PE N P
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ KSD++S G +L E+ + F
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 35/221 (15%)
Query: 410 LGQGGFGSVYL----GM---LPDGI-QVAVKKLESIGQGKKEFSAEVT------IIGNVH 455
LG+G FG V + G+ P+ + +VAVK L+S +K+ S ++ +IG
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGK-- 82
Query: 456 HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN---------- 505
H +++ L G C + + EY G+L +++ C+N
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 506 --IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563
A A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + T
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 564 TL-RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI--IGG 601
T R ++APE + + + +SDV+S+G++L EI +GG
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 410 LGQGGFGSVYL-GMLPDGIQVAVKKLE-SIGQGKKEFSAEVT---IIGNVHHVHLVKLKG 464
LG+G FG V L G A+K L+ + K E + +T ++ N H L LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + RL EY G L F+ + E F RF A L YLH E V
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV 117
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
V+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 27/225 (12%)
Query: 398 DLCKATKNFSTKLGQGGFGSVYL----GMLPD----GIQVAVKKLESIGQGK--KEFSAE 447
+L + LG+G FG V + G+ D + VAVK L+ K + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 448 VTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWI-----------FNSTE-E 494
+ ++ + H +++ L G C + + EY G+L +++ F++ +
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 495 SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-L 553
L + + A A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
N + T R ++APE + + + +SDV+S+G++L EI
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF-----SAEVTIIGN------VHHV 457
LG+G FG V L L + A+K L KK+ E T++ H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL------KKDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 458 HLVKLKGFCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L L FC H EYL G L +F+ RF RF A GL
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARF-YAAEIICGLQ 110
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL-MNREESLVYTTLRGTRGYLAP 574
+LH++ I++ D+K +NVLLD + K++DFG+ K MN E +T GT Y+AP
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAP 165
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
E + +E D +S+G++L E++ G+ F
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKL-ESIGQGKKE---FSAEVTIIGNVHHVHLVKL 462
T++GQGG+G V+L D G VA+K++ +S+ E E I+ LVKL
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ + LA EY+ G + N +E+ RF +A + LHE
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYMAEMFE-AVDALHE 119
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWIT 578
+ +H D+KPEN L+D + K++DFGL+K ++ S+V G+ Y+APE +
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLR 171
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSFS 606
D +S G +L E + G FS
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 410 LGQGGFGSVYLGML---PDG--------IQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH 458
LGQG F ++Y G+L D + V +K L S + F +++ + H H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
LVKL G C+ + ++ EY+ G LD ++ + + + L W + ++A A L YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 519 EECEVKIVHCDIKPENVLL---DDNFT----AKVSDFGLAKLMNREESLVYTTLRGTRGY 571
++ K+VH ++ +N+L+ N K+SD G+ + E V R +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERIP--W 170
Query: 572 LAPEWITN--NPISEKSDVYSYGMVLLEI 598
+APE I N ++ +D +S+G LLEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 410 LGQGGFGSVYLGMLPDGIQV----AVKKLESIGQGKKEFS-AEVTIIGNVHHVHLVKLKG 464
+G+G FG V D ++ ++K + + + + AE T++ V+ +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEECEV 523
F + +L +NG + + E RF RF A L A L LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCA--LENLHK---F 112
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+++ D+KPEN+LLD + DFGL KL N ++ T GT YLAPE + + +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
+ D ++ G++L E++ G F
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGI-QVAVKKLESIGQGK------KEFSAEVTIIGNVHHVHLVK 461
+LG+G FG+VYL + + +K L+ I G+ + + E ++ + H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+E + EY LD + + L N + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+I+H D+K +N+ L +N K+ DFG+++L+ L TT GT Y++PE + +
Sbjct: 126 --RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPEALKHQG 181
Query: 582 ISEKSDVYSYGMVLLEI 598
KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 410 LGQGGFGSVYLGMLPDG------IQVAVKKLESIGQGKKEFS---AEVTIIGNVHHVHLV 460
LG+GG+G V+ G + V K +I + +K+ + AE I+ V H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTE-ESRFLCWNTRFNIALGTAKGLAYLHE 519
L G L EYL G L F E E F+ F ++ + L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLS-EISLALEHLHQ 118
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
+ I++ D+KPEN+LLD K++DFGL K + E V T GT Y+APE +
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + D +S G ++ +++ G F+
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 53/199 (26%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 408 TKLGQGGFGSVY-LGMLPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
++LG G G V+ + P G+ +A K LE + + E+ ++ + ++V G
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ E++ GSLD+ + + + +++ KGL YL E+ K
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----VSIAVIKGLTYLREKH--K 124
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
I+H D+KP N+L++ K+ DFG++ +L++ + + GTR Y++PE + S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 180
Query: 584 EKSDVYSYGMVLLEIIGGR 602
+SD++S G+ L+E+ GR
Sbjct: 181 VQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
K+G+G +G VY G G VA+KK LES +G + E++++ + H ++V L+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 465 FCIEGAHRLLAYEYLVNGSLD-KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
++ + L +E+L S+D K +S + +++ + +G+ + H
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTRGYLAPEWITNN 580
+++H D+KP+N+L+D+ K++DFGLA+ R VYT T Y APE + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGS 176
Query: 581 P-ISEKSDVYSYGMVLLEIIGGRKSF 605
P S D++S G + E+ + F
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 61/235 (25%), Positives = 109/235 (46%), Gaps = 36/235 (15%)
Query: 394 FSYDDLCKATKNFSTKLGQGGFGSVY----LGMLPD----GIQVAVKKLESIGQGK--KE 443
FS D L LG+G FG V LG+ D + VAVK L+ K +
Sbjct: 12 FSRDKL-----TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD 66
Query: 444 FSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWI-------------F 489
+E+ ++ + H +++ L G C + + EY G+L +++
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126
Query: 490 NSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549
+ + + + + A+G+ YL + K +H D+ NVL+ +N K++DFG
Sbjct: 127 ARVPDEQ-MTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 182
Query: 550 LAKLMNREESLVYTTL-RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI--IGG 601
LA+ +N + TT R ++APE + + + +SDV+S+G+++ EI +GG
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 410 LGQGGFGSVYLGMLPDG---IQVAVKKLESIGQGKKE---FSAEVTIIGNVHHVHLVKLK 463
LG+G FGSV G L ++VAVK ++ + E F +E + H ++++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 464 GFCIEGAHR------LLAYEYLVNGSLDKWIFNST--EESRFLCWNTRFNIALGTAKGLA 515
G C++ ++ ++ +G L ++ S + ++L A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYL 572
YL + +H D+ N +L++N V+DFGL+K + + Y R + ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKWI 181
Query: 573 APEWITNNPISEKSDVYSYGMVLLEI 598
A E + + + KSDV+S+G+ + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 402 ATKNFSTKLGQGGFGSVYLGML---PDGIQ---VAVKKLESIGQG--KKEFSAEVTIIGN 453
+T F +LG+ FG VY G L G Q VA+K L+ +G ++EF E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 454 VHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIF--------NSTEESRFLCWNTR-- 503
+ H ++V L G + + + Y + L +++ ST++ + +
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 504 --FNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--S 559
+I A G+ +L +VH D+ NVL+ D K+SD GL + + +
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
L+ +L R +++PE I S SD++SYG+VL E+
Sbjct: 182 LMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467
+G G +G VY G + G A+K ++ ++E E+ ++ HH ++ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 468 EGA------HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ + L E+ GS+ + N+ + W I +GLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--N 579
K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE I
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 197
Query: 580 NPISE---KSDVYSYGMVLLEIIGG 601
NP + +SD++S G+ +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLK 463
++G G FG V LG + G QV VK+L Q + +F E ++ H +L++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN-IALGTAKGLAYLHEECE 522
G C E LL E+ G L ++ + + T +A A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPEWI 577
+H D+ N LL + T K+ D+GL+ +E+ V + LR ++APE +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELV 174
Query: 578 T---NNPI----SEKSDVYSYGMVLLEI 598
N + +++S+V+S G+ + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 46/233 (19%)
Query: 406 FSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKL--ESIGQGKKEFSA 446
F KLG+G FG V+L + + + VAVK L ++ + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 447 EVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWI-----FNSTEESR----- 496
EV I+ + ++++L G C++ + EY+ NG L++++ + E
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 497 -----FLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551
+ +++ ++AL A G+ YL + VH D+ N L+ +N T K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 552 KLMNREESLVYTTLRGTRGYLAPEW-----ITNNPISEKSDVYSYGMVLLEII 599
+ + + Y ++G R L W I + SDV+++G+ L EI+
Sbjct: 186 RNLYAGD---YYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 409 KLGQGGFGSVYLGMLPDGIQ-VAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLK 463
++G G FG+VY + VAVKK+ G+ E EV + + H + ++ K
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 464 GFCIEGAHRLLAYEYLVNGSLD-----KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
G ++ L EY + + D K E + I G +GLAYLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLH 138
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI- 577
++H DIK N+LL + K++DFG A + S V GT ++APE I
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 578 --TNNPISEKSDVYSYGMVLLEI 598
K DV+S G+ +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 410 LGQGGFGSVYLGMLP-DGIQVAVK--KLESIGQGKK--EFSAEVTIIGNVHHVHLVK-LK 463
LG G FG V + G A+K K I + K+ + E +I+ + H +V +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEES-RFLCWNTRFNIALGTAKGLAYLHEEC 521
F E +R+ E++V G L F ++ RF +F A YLH +
Sbjct: 86 SFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHA-ELVLAFEYLHSK- 137
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
I++ D+KPEN+LLD+ KV+DFG AK + + + TL GT YLAPE I +
Sbjct: 138 --DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF---TLCGTPEYLAPEVIQSKG 191
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D ++ G++L E I G F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKL-ESIGQG---KKEFSAEVTIIGNVHHVHLVKLK 463
+G+GG G VYL P +VA+KK+ E + + KK F E I ++ H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT--------AKGLA 515
C +G Y+ +L K + S + L ++G +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-----------SLVYTT 564
Y+H + ++H D+KP+N+LL + D+G A EE ++ Y++
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 565 LR------GTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
+ GT Y+APE + P SE +D+Y+ G++L +++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL-----------ESIGQGKKEFSAEVTIIGNVHHV 457
LG+G FG V L L ++ AVK L E K+ + + G H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAGK--HP 56
Query: 458 HLVKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
L +L C + RL EY+ G L +F+ RF RF A GL +
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARF-YAAEIVLGLQF 111
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGTRGYL 572
LHE I++ D+K +NVLLD K++DFG+ K E ++ +T GT Y+
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDYI 163
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE ++ P D ++ G++L E++ G+ F
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 410 LGQGGFGSVY----LGMLPD----GIQVAVKKLESIGQGK--KEFSAEVTIIGNV-HHVH 458
LG+G FG V G+ + VAVK L+ K + +E+ ++ + H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWI-----------FNSTEESR-FLCWNTRFNI 506
++ L G C + + EY G+L +++ F+ T+ L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL- 565
A A+G+ YL + +H D+ NVL+ ++ K++DFGLA+ ++ + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI--IGG 601
R ++APE + + + +SDV+S+G+++ EI +GG
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 8/101 (7%)
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
+ + K L YL E+ V +H D+KP N+LLD + K+ DFG++ + +S T
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174
Query: 566 RGTRGYLAPEWIT-NNPISE---KSDVYSYGMVLLEIIGGR 602
G Y+APE I +P + ++DV+S G+ L+E+ G+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 409 KLGQGGFGSVYLGMLPDGIQ-VAVKK-LESIGQG--KKEFSAEVTIIGNVHHVHLVKLKG 464
+G+G +G V + Q VA+KK LES KK E+ ++ + H +LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 465 FCIEGAHRLLAYEYLVNGSLDKW--IFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
L +E++ + LD N +ESR F I +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR--KYLFQIL----RGIEFCHSH-- 119
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I+H DIKPEN+L+ + K+ DFG A+ + VYT TR Y APE + +
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTK 177
Query: 583 SEKS-DVYSYGMVLLEIIGGRKSF 605
++ D+++ G ++ E++ G F
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLK 463
++G G FG+VY + + VA+KK+ G+ E EV + + H + ++ +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 464 GFCIEGAHRLLAYEYLVNGSLD-----KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
G + L EY + + D K E + + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------VTHGALQGLAYLH 132
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI- 577
++H D+K N+LL + K+ DFG A +M V GT ++APE I
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 578 --TNNPISEKSDVYSYGMVLLEIIGGRK 603
K DV+S G+ +E + RK
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF-----SAEVTII-------- 451
NF LG+G FG V L + +L +I KK+ E T++
Sbjct: 3 NFLMVLGKGSFGKVMLAE-----RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 452 GNVHHVHLVKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT 510
G L +L C + RL EY+ G L +++ + +F + F A
Sbjct: 58 GKPPF--LTQLHS-CFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVF-YAAEI 110
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
A GL +LH + I++ D+K +NV+LD K++DFG+ K N T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPD 166
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
Y+APE I P + D +++G++L E++ G+ F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 408 TKLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+ +G G +GSV G++VAVKKL +SI K+ + E+ ++ ++ H +++ L
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 81
Query: 463 KG-FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
F + YLV + + N + + + +F I +GL Y+H
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS-- 138
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE----WI 577
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE W+
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWM 193
Query: 578 TNNPISEKSDVYSYGMVLLEIIGGRKSF 605
N + D++S G ++ E++ GR F
Sbjct: 194 HYN---QTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
+ GL +LH I++ D+K +NV+LD K++DFG+ K + + + T GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPD 166
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
Y+APE I P + D ++YG++L E++ G+ F
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469
L G G V++ P V K IGQ K E ++ NV+H ++++K + G
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLK---IGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVSG 129
Query: 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529
A + L + S D + + T+ SR L + I +GL YLH + +I+H D
Sbjct: 130 AITCMV---LPHYSSDLYTY-LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD 182
Query: 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 589
+K EN+ ++D + D G A+ + + L GT APE + + + K+D++
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPA--FLGLAGTVETNAPEVLARDKYNSKADIW 240
Query: 590 SYGMVLLEII 599
S G+VL E++
Sbjct: 241 SAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQ-VAVKKL---ESIGQGKKE-FSAEVTIIGNVHHVHLVKLKG 464
+G G FG V+L A+K + E I +++ E ++ V H +++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 465 FCIEGAHRLL--AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
F E R L EY+ G L ++ NS RF F A L YLH +
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLF-YASEIVCALEYLHSK-- 120
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWITNNP 581
+IV+ D+KPEN+LLD K++DFG AK L +R TL GT YLAPE I +
Sbjct: 121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKG 174
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
++ D ++ G+++ E++ G F
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 400 CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGN 453
C++ F ++G+G +G VY G VA+KK +++ G S E+T++ N
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 454 VHHVHLVKLKGFCIEGAHR---LLAYEYLVN--GSLDKWIFNSTEESRFLCWNTRFNIAL 508
+ H ++V+LK + G H L EY SL + ES+ C + L
Sbjct: 63 LRHPNIVELKE-VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------LML 115
Query: 509 GTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV---YTTL 565
+GL YLHE I+H D+K N+LL D K++DFGLA R L T
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA----RTYGLPAKPMTPK 168
Query: 566 RGTRGYLAPEWITNNPISEKS-DVYSYGMVLLEIIGGR 602
T Y APE + + D+++ G +L E++ +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLK 463
++G G FG+VY + VA+KK+ G+ E EV + + H + ++ K
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 464 GFCIEGAHRLLAYEYLVNGSLD-----KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
G + L EY + + D K E + I G +GLAYLH
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLH 142
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI- 577
++H DIK N+LL + K++DFG A + + S V GT ++APE I
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 578 --TNNPISEKSDVYSYGMVLLEI 598
K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+G G FG VY + D +VA+KK+ Q K E+ I+ N++H++++ LK +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYT 130
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIAL----------GTAKGLAYLH 518
+ +N ++ F +++ R N AL + LAY+H
Sbjct: 131 ECFKKNEKNIFLNVVME---FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 519 EECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEW 576
+ I H D+KP+N+L+D N T K+ DFG AK L+ + S+ Y +R Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPEL 241
Query: 577 I---TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ TN + D++S G ++ E+I G FS
Sbjct: 242 MLGATN--YTTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
K + + H+ IVH DIKPEN+L+ N K+ DFG A+ ++ + YT TR Y
Sbjct: 111 KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+PE + P + D++S G +L E+ G+ F
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR---EESLVYTTLRGT 568
+GL Y+H ++H D+KP N+L++++ ++ DFG+A+ ++ E T T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 569 RGYLAPEWI-TNNPISEKSDVYSYGMVLLEIIGGRKSF 605
R Y APE + + + D++S G + E++G R+ F
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 184
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE I E D++S G ++ E+I G F
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL Y+H +VH D+KP N+L+++N K+ DFGLA++ + + T TR Y
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYY 171
Query: 572 LAPE-WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE +T + D++S G + E++ G+ F
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTIIGNVHHVHLVKL 462
LG+G FG VYL D G ++AVK++ + KE +A E+ ++ N+ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 463 KGFCIEGAHRLLA--YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
G + + L+ EY+ GS I + + L N +G++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPE 575
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 576 WITNNPISEKSDVYSYGMVLLEII 599
I+ K+DV+S ++E++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKGF 465
KLG+G + +VY G G VA+K++ + +A E++++ + H ++V+L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+L +EY+ + L K++ ++ L NT + KG+A+ HE ++
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKL----MNREESLVYT-------TLRGTRGYLAP 574
+H D+KP+N+L++ K++DFGLA+ +N + V T L G+R Y
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--- 178
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
S D++S G ++ E+I GR F
Sbjct: 179 --------STSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 410 LGQGGFGSVYLGMLP----DGIQVAVKKLES---IGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG+G FGSV L +VAVK L++ +EF E + H +++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 463 KGFCIEGAHR------LLAYEYLVNGSLDKWIFNST--EESRFLCWNTRFNIALGTAKGL 514
G + + ++ ++ +G L ++ S EE L T + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-----NREESLVYTTLRGTR 569
YL + +H D+ N +L++N T V+DFGL+K + R+ ++
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEII 599
+LA E + +N + SDV+++G+ + EI+
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
+H ++ VH DIKPENVL+D K++DFG A + + + GT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 577 ITNNPISEKS------DVYSYGMVLLEIIGGRKSFS 606
+T K D +S G++ E+I GR F
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 25/166 (15%)
Query: 444 FSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRF-LCWNT 502
F +++ V H+HL + G C+ G+ ++ E++ +G LD + E+ R + W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW-- 118
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVL-----LDDNFTA--KVSDFGLA-KLM 554
+ +A A L+YL ++ +VH ++ +N+L L + + K+SD G++ +
Sbjct: 119 KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 555 NREESLVYTTLRGTR-GYLAPEWITN-NPISEKSDVYSYGMVLLEI 598
+REE R R ++APE + N +S +D +S+G LLEI
Sbjct: 176 SREE-------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK----LMNREESLVYTTLRG 567
K L Y+H ++H D+KP N+LL+ + K++DFGLA+ L E+ V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 568 TRGYLAPE-WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
TR Y APE + + ++ D++S G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
+K+G+G +G V+ + G VA+KK E KK E+ ++ + H +LV L
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL- 65
Query: 464 GFCIEGAHRL----LAYEYL---VNGSLDKWIFNSTEES-RFLCWNTRFNIALGTAKGLA 515
IE R L +EY V L+K E + + W T + +
Sbjct: 66 ---IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVN 114
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+ H+ +H D+KPEN+L+ K+ DFG A+++ YT TR Y APE
Sbjct: 115 FCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPE 170
Query: 576 WIT-----NNPISEKSDVYSYGMVLLEIIGG 601
+ P+ DV++ G V E++ G
Sbjct: 171 LLVGDTQYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
K+G+G +G VY G VA+KK LE+ +G + E++++ ++H ++V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA----------KGL 514
L +E+L + L K++ ++ L +G+
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYM------------DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTRGY 571
AY H +++H D+KP+N+L+D K++DFGLA+ R YT T Y
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR----TYTHEVVTLWY 165
Query: 572 LAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSFS 606
APE + + S D++S G + E++ R F
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
NF LG+G FG V L ++ K+ ++ E T++ ++ L G
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK----RVLALSG 58
Query: 465 ---------FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGL 514
C + RL EY+ G L ++ + RF + F A A GL
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVF-YAAEIAIGL 114
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 574
+LH + I++ D+K +NV+LD K++DFG+ K N + + T GT Y+AP
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
E I P + D +++G++L E++ G+ F
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 14/98 (14%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL Y+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 181
Query: 572 LAPE----WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE W+ N + D++S G ++ E++ G+ F
Sbjct: 182 RAPEIMLNWMHYN---QTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 64/241 (26%), Positives = 97/241 (40%), Gaps = 62/241 (25%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKE----------FSAEVTIIGNVHHVH 458
+G+G FG V+L D QV A+K L +K AE I+ +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVL------RKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 459 LVKLKGFC-IEGAHRL-LAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKG 513
+VKL + + L L EY+ G L + EE+ RF IA
Sbjct: 63 IVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIAELVL-A 113
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR------- 566
L +H+ + +H DIKP+N+L+D + K++DFGL K MN+ + Y
Sbjct: 114 LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 567 ---------------------GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
GT Y+APE + P + D +S G++L E++ G F
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 606 S 606
Sbjct: 231 Y 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 6/96 (6%)
Query: 511 AKGLAYL-HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGT 568
A+G+ +L + C +H D+ NVLL D AK+ DFGLA+ +MN +V R
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 569 RGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604
++APE I + + +SDV+SYG++L EI KS
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 409 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
KLG+G + +V+ G L + + VA+K++ + +A EV+++ N+ H ++V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
L +EYL + L +++ N + + +GL+Y H+ K
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLAPE-WITNN 580
I+H D+KP+N+L+++ K++DFGLA R +S+ Y+ T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
S D++ G +L E+ GR F
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 31/87 (35%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL +LH C IVH D+KPEN+L+ K++DFGLA++ + + +L T + T Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWY 173
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
APE + + + D++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTR 569
GL Y+H ++H D+KP N+L++ + K+ DFGLA+ + E + T TR
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 570 GYLAPE-WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
Y APE ++ ++ DV+S G +L E++G + F
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLKG 464
+G+G +G VY D G VA+KK+ + K+ F E+ I+ ++H ++V LK
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 465 FCIEGAHRL----------LAYEYL---VNGSLDKWIFNSTEESRFLCWNTRFNIALGTA 511
+ L L +EY+ + G L+ + + +E+ F L
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-----IKSFMKQL--L 126
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL Y H++ +H DIK N+LL++ K++DFGLA+L N EES YT T Y
Sbjct: 127 EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 572 LAPEWITNNPISEKS-DVYSYGMVLLEIIGGRKSF 605
PE + + DV+S G +L E+ + F
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL Y+H ++H D+KP N+LL+ N K+ DFGLA+ + + + T TR Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTRWY 174
Query: 572 LAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605
APE + N + + DV+S G + E++G + F
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 407 STKLGQGGFGSV-YLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKL 462
S LG G G+V + DG AVK ++ G K AEV + N +VK
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 463 KGFCIEGAHRLLAY----------------EYLVNGSLDKWIFNSTEESRFLCWNTRFNI 506
C H A +Y G L + I + + +R
Sbjct: 96 ---C----HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEA 145
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTL 565
L + L +H ++H DIK N+LL N K+ DFG +K+ S V T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
GT Y+APE P S+K+D++S G++L E++ ++ F
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--SLVYTTLRGTR 569
+GL Y+H ++H D+KP N+LL+ N K+ DFGLA++ + E + T TR
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 570 GYLAPEWITNNPISEKS-DVYSYGMVLLEIIGGRKSF 605
Y APE + N+ K+ D++S G +L E++ R F
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 410 LGQGGFGSVY-LGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467
+G+G +G VY + DG AVK L+ I +E AE I+ ++ +H ++VK G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 468 E-----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ G L E GS+ + + + L I G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT---- 578
+I+H D+K N+LL K+ DFG++ + L T GT ++APE I
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQ 205
Query: 579 -NNPISEKSDVYSYGMVLLEIIGG 601
+ + DV+S G+ +E+ G
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 408 TKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLK 463
++G G +GSV + G +VA+KKL Q + K E+T++ ++ H +++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 464 G-FCIEGAHRLLAYEYLV----NGSLDKWIFN--STEESRFLCWNTRFNIALGTAKGLAY 516
F + YLV L K + + S ++ ++L + GL Y
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKY 132
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 185
Query: 577 ITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605
I N ++ D++S G ++ E++ G+ F
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 30/210 (14%)
Query: 409 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
KLG+G + +VY G L D + VA+K++ + +A EV+++ ++ H ++V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNT--RFNIAL---GTAKGLAYLHE 519
L +EYL + L +++ + C N+ N+ L +GL Y H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDD--------CGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLAPE- 575
K++H D+KP+N+L+++ K++DFGLA R +S+ Y+ T Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLA----RAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ + S + D++ G + E+ GR F
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLES--IGQGKKEFSAEVTI----IGNVHHVH--LV 460
LG+G FG V L L + ++ AVK L+ I Q + E T+ I ++ H L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ---DDDVECTMTEKRILSLARNHPFLT 59
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+L C + RL VNG +F+ + RF RF A T+ L +LH++
Sbjct: 60 QLY-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDK 115
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
I++ D+K +NVLLD K++DFG+ K +T GT Y+APE +
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-STFCGTPDYIAPEILQEM 171
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
D ++ G++L E++ G F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL-ESIGQGKKEFS---AEVTIIGNVHHVH---LVK 461
+G+G FG VY D ++ A+K L + KKE + E I+ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 462 LKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
LK F + L L +Y+ G L ++ +E RF +F IA L +LH+
Sbjct: 61 LK-FSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY 115
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
IV+ D+KPEN+LLD + DFGL+K N ++ T GT YLAPE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 581 P-ISEKSDVYSYGMVLLEIIGGRKSF 605
++ D +S G+++ E+ G F
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 409 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
KLG+G + +V+ G L + + VA+K++ + +A EV+++ ++ H ++V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWN--TRFNIAL---GTAKGLAYLHE 519
L +EYL DK + ++ C N + N+ + +GLAY H
Sbjct: 72 IVHTDKSLTLVFEYL-----DKDLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WIT 578
K++H D+KP+N+L+++ K++DFGLA+ + Y+ T Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSF 605
++ S + D++ G + E+ GR F
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 40/135 (29%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI 530
H E+L G L +F+ ++ RF + F A GL +LH + I++ D+
Sbjct: 70 HLFFVMEFLNGGDL---MFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSK---GIIYRDL 122
Query: 531 KPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 590
K +NV+LD + K++DFG+ K ++ +T GT Y+APE + + D +S
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYIAPEILQGLKYTFSVDWWS 181
Query: 591 YGMVLLEIIGGRKSF 605
+G++L E++ G+ F
Sbjct: 182 FGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKGFC 466
LG G G V+ + D +VAVKK+ + + A E+ II + H ++VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 467 IEGAHRL---------LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
L L Y+V ++ + N E+ + R +GL Y+
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYI 130
Query: 518 HEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNRE--------ESLVYTTLRGT 568
H ++H D+KP NV ++ ++ K+ DFGLA++++ E LV R
Sbjct: 131 HS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 569 RGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
R L+P N ++ D+++ G + E++ G+ F+
Sbjct: 188 RLLLSP-----NNYTKAIDMWAAGCIFAEMLTGKPLFA 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 33/159 (20%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
K+G+G +G+V+ VA+K+ L+ +G + E+ ++ + H ++V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 465 FCIEGAHRL-LAYEYL----------VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKG 513
+ +L L +EY NG +D I S F L KG
Sbjct: 67 -VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS------------FMFQL--LKG 111
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552
LA+ H ++H D+KP+N+L++ N K++DFGLA+
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 5/87 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+G+ +LH IVH D+KP+N+L+ + K++DFGLA++ + E +L T++ T Y
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWY 172
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
APE + + + D++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 70/245 (28%), Positives = 105/245 (42%), Gaps = 63/245 (25%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLKG 464
+G+G FG V L D G A+KKL +KE AE I+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY- 67
Query: 465 FCIEGAHRL-LAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+ + + L L EYL G + K F TEE TRF IA T + +H
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--TEEE------TRFYIA-ETILAIDSIH 118
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGL---------------------------- 550
+ + +H DIKP+N+LLD K+SDFGL
Sbjct: 119 K---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 551 AKLMNREE----------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG 600
+K M+ + +L Y+T+ GT Y+APE +++ D +S G+++ E++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 601 GRKSF 605
G F
Sbjct: 235 GYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 57/230 (24%), Positives = 87/230 (37%), Gaps = 38/230 (16%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLE--SIGQGKK--EFSAEVTIIGNVHHVHLVKLK 463
LG+G G V+L L G A+K L+ + + K E I+ + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ L +Y G L + + RF A L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLL--- 122
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKL------------------MNREESLVYT-- 563
IV+ D+KPEN+LL ++ +SDF L+K + T
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 564 ---TLR-----GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ R GT Y+APE I+ + D ++ G++L E++ G F
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 410 LGQGGFGSVYLGM---LPDGIQ-----VAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLV 460
LGQG F ++ G+ + D + V +K L+ + E F +++ + H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY-LHE 519
G C+ G ++ EY+ GSLD ++ + N + L AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-----KKNKNLINISWK--LEVAKQLAWALHF 115
Query: 520 ECEVKIVHCDIKPENVLL---DDNFTA-----KVSDFGLAKLMNREESLVYTTLRGTRGY 571
+ + H ++ +NVLL +D T K+SD G++ + +E L+ +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI-----PW 170
Query: 572 LAPEWITN-NPISEKSDVYSYGMVLLEIIGG 601
+ PE I N +S +D +S+G L EI G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTR 569
A+G+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V R
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE I + + +SDV+S+G++L EI
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 63/218 (28%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 405 NFSTKLGQGGFGSVYLGML-PDGIQVAVKKL-----------ESIGQGKKEFSAEVTIIG 452
LG+G FG V L G A+K L ES+ K+ F
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----AN 57
Query: 453 NVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK 512
+ H LV L H EY G L I F F A
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAAC-VVL 112
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGT 568
GL YLHE KIV+ D+K +N+LLD K++DFGL K E + + +T GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGT 164
Query: 569 RGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+LAPE +T + D + G+++ E++ G F
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 426 GIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLKGF-----CIEGAHRLLAYE 477
GI VAVKKL Q + K E+ ++ V+H +++ L +E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 478 YLVNGSLDKWIFNSTEESRF-------LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI 530
L++ +L + I + R LC G+ +LH I+H D+
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC-------------GIKHLHS---AGIIHRDL 149
Query: 531 KPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 590
KP N+++ + T K+ DFGLA+ + + T TR Y APE I E D++S
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 591 YGMVLLEIIGGRKSF 605
G ++ E++ G F
Sbjct: 208 VGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
KGL Y+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWY 181
Query: 572 LAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605
APE I N ++ D++S G ++ E++ G+ F
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVK--KLESIGQGKKEFSAEVTIIGN------VHHVHLV 460
LG+G FG V L L +V A+K K + I Q + + T+ H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLT 59
Query: 461 KLKGFCIEGAHRLL-AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
L C + RL EY+ G L +F +F +RF A T L +LH
Sbjct: 60 ALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHR 114
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
+++ D+K +N+LLD K++DFG+ K + TT GT Y+APE +
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
D ++ G+++ E++ G+ F
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 405 NFSTKLGQGGFGSVYLGML---PDGIQVAVKKLESIGQGKKEFSA----EVTIIGNVHHV 457
+G+G +G VY DG + A+KK + + S E+ ++ + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 458 HLVKLKGFCIEGAHRL--LAYEYLVNGSLDKW--I-FNSTEESRFLCWNTRFNIALGTAK 512
++V L +E A + L ++Y D W I F+ + + + ++
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY---AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 513 GLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMN 555
G+ YLH ++H D+KP N+L+ + K+ D GLA+L N
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 44/229 (19%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKL-------------ESIGQGKKEFSA--EVTIIGN 453
LG+G +G V G VA+KK+ + +G F+ E+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 454 VHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNST---EESRFLCWNTRFNIALGT 510
+ H +++ L +EG L + + L K + + ES+ C I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKC------ILLQI 128
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-------------KLMNRE 557
GL LH+ +H D+ P N+ ++ K++DFGLA K +
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 558 ESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605
T+ T Y APE + D++S G + E++ G+ F
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 19/174 (10%)
Query: 438 GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY--LVNGSLDKW---IFNST 492
G K E+ I+ + H ++ L + AY + V + K+ +F
Sbjct: 127 VTGGKTPGREIDILKTISHRAIINL----------IHAYRWKSTVCMVMPKYKCDLFTYV 176
Query: 493 EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA- 551
+ S L I + LAYLH I+H D+K EN+ LD+ A + DFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233
Query: 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
KL ++ GT +PE + +P K+D++S G+VL E+ +
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 408 TKLGQGGFGSVYLGMLPDGIQ-VAVKKL----ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
T +G G +GSV Q VAVKKL +S+ ++ + E+ ++ ++ H +++ L
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79
Query: 463 -----KGFCIEGAHRLLAYEYLVNGSLD---KWIFNSTEESRFLCWNTRFNIALGTAKGL 514
IE + + L+ L+ K S E +FL + +GL
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LRGL 131
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 574
Y+H I+H D+KP NV ++++ ++ DFGLA+ + E T TR Y AP
Sbjct: 132 KYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAP 184
Query: 575 E----WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
E W+ N + D++S G ++ E++ G+ F
Sbjct: 185 EIMLNWMHYN---QTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
K L ++H I H DIKPEN+L+ D+ K++DFG + + + YT TR Y
Sbjct: 111 KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWY 164
Query: 572 LAPEWI-TNNPISEKSDVYSYGMVLLEII 599
APE + T+ K D+++ G V EI+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
L +LH+ + I++ DIK EN+LLD ++DFGL+K EE + GT Y+A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 574 PEWITNNPISEKS--DVYSYGMVLLEIIGGRKSFS 606
PE I D +S G++ E++ G F+
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 466 CIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
C + RL L EY+ G L +F+ + + + RF A L +LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
I++ D+K +NVLLD + K++D+G+ K +T GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYIAPEILRGEEYGF 175
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
D ++ G+++ E++ GR F
Sbjct: 176 SVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLKG 464
+G+G FG V L QV A+K L K+ SA E I+ + + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 465 FCIEGAHRLLAYEYLVNGSL----------DKWIFNSTEESRFLCWNTRFNIALGTAKGL 514
+ + + EY+ G L +KW RF A L
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW--------------ARFYTA-EVVLAL 155
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 574
+H + +H D+KP+N+LLD + K++DFG M+ + T GT Y++P
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 575 EWITN----NPISEKSDVYSYGMVLLEIIGGRKSF 605
E + + + D +S G+ L E++ G F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF-----SAEVTIIGNV------HHV 457
LG+G FG V+L L Q A+K L KK+ E T++ H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL------KKDVVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 458 HLVKLKGFCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L L +C + EYL G L +F+ +F F A GL
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATF-YAAEIICGLQ 110
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV----YTTLRGTRGY 571
+LH + IV+ D+K +N+LLD + K++DFG+ K E+++ T GT Y
Sbjct: 111 FLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDY 162
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+APE + + D +S+G++L E++ G+ F
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFS-AEVTIIGNVHH-VHLVKLK 463
K+G+G +G VY G VA+KK LE +G + E++++ + +++V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 464 GFCIE------GAHRL-LAYEYLVNGSLDKWI-FNSTEESRFLCWNTRFNIALGTAKGLA 515
+E G L L +EYL + L K++ N R L T + KG+A
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTA-KVSDFGLAKLMNREESL---VYTTLRGTRGY 571
+ H+ ++H D+KP+N+L+D K++D GL R S+ YT T Y
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG----RAFSIPVKSYTHEIVTLWY 177
Query: 572 LAPE-WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE + + S D++S G + E+ + F
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 409 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKGF 465
KLG+G + +VY G +G VA+K + + F+A E +++ + H ++V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 466 CIEGAHRLLAYEYLVNGSLDKWI------FNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
L +EY V+ L +++ + FL F + +GL+Y+H+
Sbjct: 72 IHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFL-----FQLL----RGLSYIHQ 121
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WIT 578
I+H D+KP+N+L+ D K++DFGLA+ S Y+ T Y P+ +
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ S D++ G + +E+I G +F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 192
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE I E D++S G ++ E+I G F
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/154 (22%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 458 HLVKLKGFCIEGAHRL----LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKG 513
+++K+ GF I+ L L EY G L + + + L + T+ ++A+ KG
Sbjct: 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKG 134
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
L L++ + ++ + L+ +N+ K+ GL K+++ + Y +
Sbjct: 135 LYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFS 188
Query: 574 PEWITN--NPISEKSDVYSYGMVLLEIIGGRKSF 605
+ + + + + K D+YS G+VL EI G+ F
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222
|
Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGIQ---VAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKL 462
K+G+G +G VY D + +A+KK LE +G + E++++ + H ++V+L
Sbjct: 9 KIGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF--NIALGTAKGLAYLHEE 520
+ L +EYL + L K + +S + ++ N R +G+AY H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAK----NPRLIKTYLYQILRGIAYCHSH 121
Query: 521 CEVKIVHCDIKPENVLLDDNFTA-KVSDFGLAKLMN---REESLVYTTLRGTRGYLAPE- 575
+++H D+KP+N+L+D A K++DFGLA+ R +T T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR----TFTHEVVTLWYRAPEI 174
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ + S D++S G + E++ + F
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTIIGNVHHVHLVKLKG 464
K+G+G +G VY G VA+KK L++ +G + E++++ ++H ++VKL
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKW--IFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
L +E+L + L K+ + L + F + +GLA+ H
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLAFCHSH-- 119
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+++H D+KP+N+L++ K++DFGLA+ YT T Y APE +
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKY 177
Query: 583 -SEKSDVYSYGMVLLEIIGGRKSF 605
S D++S G + E++ R F
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 455 HHVHLVKLKGFCIEGAHRLL-AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKG 513
+H LV L C + RL EY+ G L +F+ + + + RF A +
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLA 108
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
L YLHE I++ D+K +NVLLD K++D+G+ K R +T GT Y+A
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIA 164
Query: 574 PEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
PE + D ++ G+++ E++ GR F
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 409 KLGQGGFGSVYLGML---PDGIQVAVKKLESIGQGKK--EFSAEVTIIGNVHHVHLVKLK 463
++G G FG V L + +V VK+L++ K+ EF + + H ++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G C+E LL +EY G L ++ R +A A G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-----VYTTLRGTRGYLAPEWIT 578
+H D+ N L + T KV D+G+ +E+ + LR +LAPE +
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVG 174
Query: 579 N-------NPISEKSDVYSYGMVLLEI 598
++ S+V++ G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTR 569
AKG+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE I + + +SDV+S+G++L EI
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 33/205 (16%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFS---AEVTIIGNVHHVHLVKLKGF 465
++G G +G VY ++A K+ + G +FS E+ ++ H ++V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTE-----ESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ + EY GSL I++ T + ++C T +GLAYLH +
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRET--------LQGLAYLHSK 125
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEW 576
++ H DIK N+LL DN K++DFG+A + + +S + GT ++APE
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEV 177
Query: 577 IT---NNPISEKSDVYSYGMVLLEI 598
N ++ D+++ G+ +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 4/89 (4%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTR 569
A+G+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V + R
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE I + + +SDV+S+G++L EI
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 185
Query: 573 APEWITNNPISEKSDVYSYGMVLLEII 599
APE I E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-07
Identities = 16/49 (32%), Positives = 28/49 (57%), Gaps = 1/49 (2%)
Query: 272 CKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKIS 320
C+EACL NCSC+ + N + C L++ + + RS G Y++++
Sbjct: 37 CREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSG-GGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 29/94 (30%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL +LH ++VH D+KP+N+L+ + K++DFGLA++ + + +L T++ T Y
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 175
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE + + + D++S G + E+ + F
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
GL ++H +V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 573 APEWITNNPISEKS-DVYSYGMVLLEIIGGRKSF 605
APE + + S D +S G +L +++ G F
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
L +LH+ + IV+ DIK EN+LLD ++DFGL+K EE + GT Y+A
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 574 PEWITNNPISEKS-DVYSYGMVLLEIIGGRKSFS 606
PE I K+ D +S G+++ E++ G F+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 412 QGGFGSVYLGMLPDGI-----QVAVKKLESIGQGKKE-----FSAEVTIIGNVHHVHLVK 461
+G FG ++ G+L D +V VK ++ E E ++ + H +++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK---TVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 462 LKGFCIE-GAHRLLAYEYLVNGSLDKWIFNS--TEESRFLCWNTRFNIALGT--AKGLAY 516
+ CIE G + Y Y+ G+L ++ E + +T+ + + A G++Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 574
LH+ ++H DI N ++D+ K++D L++ + L R + ++A
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WMAL 188
Query: 575 EWITNNPISEKSDVYSYGMVLLEII 599
E + N S SDV+S+G++L E++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 36/115 (31%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 494 ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553
ES L + + A G+ +L + VH D+ NVL+ + K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 554 MNREESLV-----YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI--IGG 601
+ R+ + + + L+ ++APE I NN + SDV+S+G++L EI +GG
Sbjct: 289 IMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
GL ++H +V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 573 APEWITNNPISEKS-DVYSYGMVLLEIIGGRKSF 605
APE + + S D +S G +L +++ G F
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 38/161 (23%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 447 EVTIIGNVHHVHLVKLK--------GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFL 498
E+ +G ++H +++K++ + I + Y ++ + + D W + R L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W------KDRPL 265
Query: 499 CWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558
TR I + Y+H++ K++H DIK EN+ L+ + + DFG A +E
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
GT +PE + + E +D++S G++LL+++
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 11/171 (6%)
Query: 437 IGQGKKEFSA-EVTIIGNVHHVHLVKLKG-FCIEGAHRLLAYEYLVNGSLDKWIFNSTEE 494
I G++ +A E I+ ++H +++LKG F L+ Y D + + + +
Sbjct: 122 IKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY----KTDLYCYLAAKR 177
Query: 495 SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554
+ +C I + + YLHE +I+H DIK EN+ ++ + DFG A
Sbjct: 178 NIAIC--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ Y GT APE + +P D++S G+VL E+ S
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTR 569
AKG+++L + +H D+ N+LL K+ DFGLA+ + N +V R
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE I N + +SDV+SYG++L EI
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTR 569
+ L Y+H + H D+KP+N+L + + K+ DFGLA++ + ++ +T TR
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 570 GYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSF 605
Y APE + + + D++S G + E++ G+ F
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNREESL------- 560
T L YLH IVH D+KP+N+L+ K++DFGL+K LM+ +L
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 561 -----VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG 601
+ + GT Y+APE I + D ++ G++L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 407 STKLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLV 460
K+GQG FG V+ I VA+KK+ + K+ F E+ I+ + H ++V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQI-VALKKVL-MENEKEGFPITALREIKILQLLKHENVV 74
Query: 461 KLKGFC---IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK----- 512
L C +R YLV + F + + L N L K
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLV---FE---FCEHDLAGLLS-NKNVKFTLSEIKKVMKM 127
Query: 513 ---GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK---LMNREESLVYTTLR 566
GL Y+H KI+H D+K N+L+ + K++DFGLA+ L + YT
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 567 GTRGYLAPE 575
T Y PE
Sbjct: 185 VTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 456 HVHLVKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTA 511
H LV L C + RL E++ G L +F+ + + + RF I+L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
L +LHE I++ D+K +NVLLD K++D+G+ K R +T GT Y
Sbjct: 109 --LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-STFCGTPNY 162
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+APE + D ++ G+++ E++ GR F
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 409 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLKGF 465
KLG+G + +VY G+ +G VA+K + + F+A E +++ + H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+EY+ D + +N R +GLAY+H + I
Sbjct: 72 IHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLAPE-WITNNP 581
+H D+KP+N+L+ K++DFGLA R +S+ Y++ T Y P+ +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
S D++ G + +E++ G+ +F
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 410 LGQGGFGSVY-LGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGF-- 465
+G+G +G V+ + +G + AVK L+ I +E AE I+ + H ++VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 466 ---CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAY 516
G L E GS+ + FL R I GL +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLV------KGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPE 575
LH K +H D+K N+LL K+ DFG+ A+L + L T GT ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPE 194
Query: 576 WIT-----NNPISEKSDVYSYGMVLLEIIGG 601
I ++ + DV+S G+ +E+ G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI 530
+ L +Y V G L + S E R RF IA + + +H ++ VH DI
Sbjct: 75 YLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYIA----EMVLAIHSIHQLHYVHRDI 128
Query: 531 KPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-----NPISEK 585
KP+NVLLD N +++DFG MN++ ++ + GT Y++PE + +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 586 SDVYSYGMVLLEIIGGRKSF 605
D +S G+ + E++ G F
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY--TTLRGT 568
A+G+ +L + VH D+ NVLL K+ DFGLA+ + + + V +T
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 569 RGYLAPEWITNNPISEKSDVYSYGMVLLEI--IGG 601
+ ++APE I +N + SDV+SYG++L EI +GG
Sbjct: 304 K-WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 54/239 (22%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLKG 464
+G+G FG V L D V A+K L +KE AE I+ + +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ + L E+L G + + TEE T+F IA T + +H+
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE------TQFYIA-ETVLAIDSIHQ-- 119
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLA---KLMNREE-------------------- 558
+ +H DIKP+N+LLD K+SDFGL K +R E
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 559 ------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
L ++T+ GT Y+APE ++ D +S G+++ E++ G F
Sbjct: 179 KRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLKG 464
+G+G FG V L +V A+K L K+ SA E I+ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 465 FCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
FC + + + EY+ G L + N + W + TA+ + L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFY-----TAEVVLALDAIHS 160
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP- 581
+ ++H D+KP+N+LLD + K++DFG M+ + T GT Y++PE + +
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 582 ---ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D +S G+ L E++ G F
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVKLKG 464
+G+G FG V L +V A+K L K+ SA E I+ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ + + EY+ G L + N ++ RF TA+ + L +
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFY----TAEVVLALDAIHSMG 162
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP--- 581
+H D+KP+N+LLD + K++DFG MN+E + T GT Y++PE + +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 582 -ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D +S G+ L E++ G F
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
L +LH+ + I++ DIK EN+LLD N ++DFGL+K + +E + GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 573 APEWITNNPISEKS--DVYSYGMVLLEIIGGRKSFS 606
AP+ + D +S G+++ E++ G F+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 4/134 (2%)
Query: 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532
LL EY G L+K I +E + + L + + L E K++H D+K
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 533 ENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 591
N+ L K+ DFG +K + SL V ++ GT YLAPE S+K+D++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 592 GMVLLEIIGGRKSF 605
G++L E++ + F
Sbjct: 258 GVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 5e-06
Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 9/102 (8%)
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYT 563
I + L LH+ I+H DIK ENVL D + D+GL K++ +
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----S 164
Query: 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
GT Y +PE I + D ++ G++ E++ G+ F
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G G +G VY + G A+K KLE G+ E+ ++ + H ++V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNST---EESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ + E+ GSL I++ T ES+ ++ T +GL YLH + +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIA------YVSRETLQGLYYLHSKGK 127
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN----REESLVYTTLRGTRGYLAPEWIT 578
+ H DIK N+LL DN K++DFG++ + + +S + GT ++APE
Sbjct: 128 M---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPEVAA 179
Query: 579 ---NNPISEKSDVYSYGMVLLEI 598
++ D+++ G+ +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 21/164 (12%)
Query: 444 FSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTR 503
F +++ V H H+V L G C+ ++ E++ G LD ++ ++ L +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWK 107
Query: 504 FNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL-----DDNFTA--KVSDFGLA-KLMN 555
F +A A L+YL ++ +VH ++ +N+LL D K+SD G+ +++
Sbjct: 108 FKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 556 REESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEI 598
R+E + ++APE + ++ +S +D +S+G L EI
Sbjct: 165 RQECVERIP------WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 54/239 (22%)
Query: 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLKG 464
+G+G FG V L D G A+K L +KE AE I+ +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ + L E+L G + + +EE+ T+F IA T + +H+
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEA------TQFYIA-ETVLAIDAIHQ-- 119
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLA---KLMNREE-------------------- 558
+ +H DIKP+N+LLD K+SDFGL K +R E
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 559 ------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
L Y+T+ GT Y+APE ++ D +S G+++ E++ G F
Sbjct: 179 KRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 34/169 (20%)
Query: 395 SYDDLCKATKNFSTKLGQGGFGSVYLGM--LPDGIQVAVKKLESIGQGKKEFSA--EVTI 450
+Y L K LG+G + +VY G L + VA+K++ + F+A E ++
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASL 56
Query: 451 IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF----NI 506
+ ++ H ++V L L +EYL T+ +++ N+
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLD-----------TDLKQYMDDCGGGLSMHNV 105
Query: 507 ALGT---AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552
L +GLAY H+ +++H D+KP+N+L+ + K++DFGLA+
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 35/163 (21%)
Query: 412 QGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH-------LVKLKG 464
+G FG VYLG + KL ++ KK A++ VH V L K
Sbjct: 14 RGAFGKVYLGR-----KKNNSKLYAVKVVKK---ADMINKNMVHQVQAERDALALSK-SP 64
Query: 465 FCIEGAHRL-------LAYEYLVNGSLDKW--IFNSTEESRFLCWNTRFNIALGTAKGLA 515
F + + L L EYL+ G + I+ +E I+ A L
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM-----AVKYIS-EVALALD 118
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL-MNRE 557
YLH I+H D+KP+N+L+ + K++DFGL+K+ +NRE
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAP 574
Y+H E I+H DIK ENVL++ + DFG A S + + GT AP
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 575 EWITNNPISEKSDVYSYGMVLLE 597
E + +P + D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 20/50 (40%), Positives = 30/50 (60%)
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
VH DIKP+NVLLD N +++DFG + + ++ GT Y++PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
G+A+LH+ I+H D+K N+LL++ K+ DFGLA+ YT L T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYR 173
Query: 573 APEWITNNPI-SEKSDVYSYGMVLLEII 599
APE + S D++S G + E++
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 47/253 (18%)
Query: 390 MPTRFSYDDLCKATKNFST--KLGQGGFGSVYLGMLPDGIQVAV-KKLESIGQGKKEFSA 446
MP + YDD + K+G G FG V+L + K + G ++E S
Sbjct: 1 MPGK--YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ 58
Query: 447 ---EVTIIGNVHHVHLVK-LKGFCIEGAHRL-LAYEYLVNGSLDKWI------FNSTEES 495
EV ++ + H ++V+ + F + +L + E+ G L + I F EE
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECE----VKIVHCDIKPENVLLDDNF---------- 541
+ +I LAY H + +++H D+KP+N+ L
Sbjct: 119 AIV------DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 542 -------TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS--EKSDVYSYG 592
AK+ DFGL+K + ES+ ++ + GT Y +PE + + S +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 593 MVLLEIIGGRKSF 605
++ E+ G+ F
Sbjct: 231 CIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 30/163 (18%)
Query: 410 LGQGGFGSVYLGMLPDGIQV---AVKKLESIGQGKKEFSAEVTI---------------I 451
+G GGFG VY + AV K+E++ + E + I
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLEN--ETIVMETLVYNNIYDIDKIALWKNI 77
Query: 452 GNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE-SRFLCWNTRF--NIAL 508
N+ H+ + K G C + Y +++ L+K + N+ E R C N + NI
Sbjct: 78 HNIDHLGIPKYYG-CGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 509 GTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551
L Y+HE I H DIKPEN+++D N + D+G+A
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLKG 464
+G+G FG V + L + +V A+K L K+ F E ++ N + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ + L +Y V G L + S E R RF +A + +H+ +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT-----N 579
VH DIKP+N+L+D N +++DFG + + ++ + GT Y++PE +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
+ D +S G+ + E++ G F
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|238533 cd01100, APPLE_Factor_XI_like, Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 3e-04
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 1/69 (1%)
Query: 247 FYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRS 306
F G +D+ + F C+ AC + C + +K CFL G+L +S
Sbjct: 6 FRQGSNVDFRGGDLSTVFAS-SAEQCQAACTADPGCLAFTYNTKSKKCFLKSSEGTLTKS 64
Query: 307 QQGSTGYVS 315
+G
Sbjct: 65 TGAVSGPRL 73
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 73 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 46/145 (31%)
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL------------ 550
RF IA T + +H+ + +H DIKP+N+L+D + K++DFGL
Sbjct: 104 RFYIAELTC-AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 551 ------------------AKLMNRE------------ESLVYTTLRGTRGYLAPEWITNN 580
+++ + + +L GT Y+APE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
++ D +S G++L E++ G+ F
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 59/259 (22%), Positives = 96/259 (37%), Gaps = 70/259 (27%)
Query: 405 NFST--KLGQGGFGSVYL-GMLPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHV 457
+F T +G+G FG V L G A+K L KK+ AE ++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLD----KWIFNSTEESRFLCWNTRFNIALGTAKG 513
+V L + + L E+L G L K+ S + +RF + +A+
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF--YMAECVLAIEAVHK 119
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-------------KLMNREES- 559
L ++H DIKP+N+L+D K+SDFGL+ KL+ + +
Sbjct: 120 LGFIHR---------DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 560 ---------------------------------LVYTTLRGTRGYLAPEWITNNPISEKS 586
+ Y+T+ GT Y+APE ++
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV-GTPDYIAPEIFLQQGYGQEC 229
Query: 587 DVYSYGMVLLEIIGGRKSF 605
D +S G ++ E + G F
Sbjct: 230 DWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 17/97 (17%)
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
+ L L LH + K N+LL + + G E+S
Sbjct: 22 VCLQCLGALRELHRQ---------AKSGNILLTWD--GLLKLDGSVAFKTPEQS------ 64
Query: 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602
R ++APE I +EK+D+YS G+ L E +
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE 101
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 46/126 (36%)
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMN--------------REESLVYT-------- 563
+H DIKP+N+L+D + K++DFGL R++S+ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 564 ------------------------TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
+L GT Y+APE + ++ D +S G++L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 600 GGRKSF 605
G+ F
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 98.82 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.22 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.02 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.36 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.27 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.69 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.61 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.34 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.31 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.76 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=396.84 Aligned_cols=214 Identities=55% Similarity=0.911 Sum_probs=193.2
Q ss_pred CCCccChHHHHHHhhccc--cccCCcCceeEEEEEeCCCcEEEEEEecccCCC-hHHHHHHHHHHHhcccCCcceeecce
Q 037563 390 MPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-KKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 390 ~~~~~~~~el~~~~~~~~--~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
....|++.|+..||.+|+ +.||+|+||.||+|.+++++.||||++...... .++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 689999999999999999999999999766554 77899999999999999999999999
Q ss_pred eccc-cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEE
Q 037563 467 IEGA-HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 545 (606)
Q Consensus 467 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl 545 (606)
.+.. +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||..+.++|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9999 599999999999999999875543 7899999999999999999999998889999999999999999999999
Q ss_pred eeccCCcccCc-CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 546 SDFGLAKLMNR-EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 546 ~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|||+++.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 99999976654 33221111 89999999999999999999999999999999999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.15 Aligned_cols=194 Identities=29% Similarity=0.486 Sum_probs=174.4
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.++++||+|+|+.||+|++++ +.+||||.+.... ...+-...|+++|+.++|||||+|++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 4556779999999999999875 8899999996553 23456789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC------CcEEEeeccCCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN------FTAKVSDFGLAKL 553 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~------~~~kl~Dfgla~~ 553 (606)
.+|+|.+|++... .+++..+..++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999997643 589999999999999999999999 99999999999999864 4689999999998
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.+.. ...+.+|++-|||||+++.+.|+.|+|+||.|+|+||+++|+.||.
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 87543 2356899999999999999999999999999999999999999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.84 Aligned_cols=199 Identities=35% Similarity=0.580 Sum_probs=174.5
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccc-cceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-HRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-~~~lV~E 477 (606)
....+.+.||+|+||+||+|.+.....||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 334455669999999999999955555999999754322 568999999999999999999999999988 7899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc-eeecCCCCCCeEEcCCC-cEEEeeccCCcccC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK-IVHCDIKPENVLLDDNF-TAKVSDFGLAKLMN 555 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~-iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~ 555 (606)
||++|+|.++++.. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999875 235799999999999999999999998 6 99999999999999998 99999999998765
Q ss_pred cCcceeeeecccccCcccccccc--CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWIT--NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ...+...||..|||||++. ...++.|+|||||||++|||+||+.||.
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 432 2334478999999999999 6699999999999999999999999994
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.01 Aligned_cols=206 Identities=31% Similarity=0.517 Sum_probs=186.0
Q ss_pred ChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 395 ~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
...++.+....+.++||+|.||.||.|.++....||+|.++......++|.+|+++|++++|+|||+++|+|..+..++|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 34566777778889999999999999999777799999998877778899999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|||||+.|+|.+||+. ..+..++..+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+||||++..
T Consensus 279 VtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999976 2345688999999999999999999998 9999999999999999999999999999965
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
..+.........-++.|.|||.+....|+.|||||||||+||||+| |+.||
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 5554444445566889999999999999999999999999999999 88886
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=323.31 Aligned_cols=198 Identities=28% Similarity=0.389 Sum_probs=177.4
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
...+++.+.||+|+||+||.++.++ ++.+|+|++++.. .+.+...+|..+|.+++||.||+++-.|++...+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3456778999999999999999766 7889999997642 3467889999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+.||.|..+|++. ..+++..+.-++..|+.||.|||+. +|+||||||+|||||++|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999643 4588888888999999999999998 99999999999999999999999999999654
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ...+.+||+.|||||++.+..++..+|.||+|+++|||++|.+||.
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 4322 3355899999999999999999999999999999999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=321.47 Aligned_cols=193 Identities=31% Similarity=0.430 Sum_probs=173.2
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecc--cCCChHHHHHHHHHHHhcccCCcceeecceecccc-ceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH-RLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-~~lV~E~~~ 480 (606)
+....||+|..|+|||++++. ++.+|+|++.. .....+++.+|++++++.+||+||+++|.|..... ..|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 445679999999999999975 78899999832 23456889999999999999999999999999884 999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|++++... +.+++...-.|+.++++||.|||+. .+||||||||+|||++..|++||+|||.++.+...
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999654 4589999999999999999999974 39999999999999999999999999999987654
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 3456899999999999999999999999999999999999999983
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.63 Aligned_cols=197 Identities=28% Similarity=0.413 Sum_probs=179.9
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecc----cCCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLES----IGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+|...+.||+|||+.+|.++. ..|+.||+|++.+ .....+.+.+||++.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566678899999999999998 6799999999976 3445678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
|+|++++|.+++.+ .+.+++.++..++.||+.||.|||+. +|+|||||..|++|+++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999863 35699999999999999999999999 999999999999999999999999999998876
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+... ..+.+|||.|+|||++....++..+||||+|||||-||.|++||-
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 5443 345899999999999999999999999999999999999999993
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=349.33 Aligned_cols=209 Identities=28% Similarity=0.515 Sum_probs=182.5
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecc
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGF 465 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~ 465 (606)
....++......+.++||+|+||+||+|+..+ ...||||.+++... ..++|++|+++++.++|||||+|+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 44566777788899999999999999999543 46799999986543 56899999999999999999999999
Q ss_pred eeccccceeeeeeccCCChhhhhhhcccc----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEE----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
|.+++.+++|+|||..|||.+||...... ..+++..+.+.||.|||.||+||-++ .++||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence 99999999999999999999999754321 22388899999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCcceeee-ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
||.++..+||+||||++.....+..... ...-+++||+||.|.++.||.+||||||||+|||++| |+.|+
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence 9999999999999999987655443322 3345789999999999999999999999999999999 88886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=308.56 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=181.0
Q ss_pred HHHhhccccccCCcCceeEEEEE-eCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeec-ceecccc-ce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKG-FCIEGAH-RL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~-~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g-~~~~~~~-~~ 473 (606)
..+.+.+.++||+|.||+|||+. +.+|..+|.|.+.-. .+.+++...|+.+|++++|||||+.++ -+.++.+ ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34556777899999999999998 457999999998632 345678899999999999999999999 5566555 88
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV-KIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
|||||+..|+|...++....+.+.++++.+++++.|+++||..+|+..+. -|.||||||.||+|+.+|.+|+.|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999988877788999999999999999999999994321 39999999999999999999999999999
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
++.+.... ....+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||
T Consensus 177 ~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 177 FLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred HhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 98766543 34579999999999999999999999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.95 Aligned_cols=198 Identities=31% Similarity=0.493 Sum_probs=171.3
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--------ChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
....+-+.+.||+|+||.|-+|..+ .|+.||||++.+... ......+|+++|++++|||||++++++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4455677889999999999999975 489999999964321 2234679999999999999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---CcEEEee
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSD 547 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~---~~~kl~D 547 (606)
..|+|||||+||+|.+++-.. +.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ -.+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999654 3466777788999999999999999 99999999999999766 7799999
Q ss_pred ccCCcccCcCcceeeeecccccCccccccccCCCC---CCccchHHHHHHHHHHHhCCCCCC
Q 037563 548 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI---SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 548 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
||+|+..+. ...+.+.+||+.|.|||++.+... ..++|+||+|||||-+++|.+|||
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 999998763 334677899999999999976543 348899999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.47 Aligned_cols=207 Identities=32% Similarity=0.602 Sum_probs=182.0
Q ss_pred ccChHHHHHHhhccc-----------cccCCcCceeEEEEEeCC----CcEEEEEEeccc--CCChHHHHHHHHHHHhcc
Q 037563 393 RFSYDDLCKATKNFS-----------TKLGQGGFGSVYLGMLPD----GIQVAVKKLESI--GQGKKEFSAEVTIIGNVH 455 (606)
Q Consensus 393 ~~~~~el~~~~~~~~-----------~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~ 455 (606)
.++|+|..++-.+|. +.||.|.||+|++|+++. ...||||.|+.. +..+++|+.|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 467777776666554 458999999999999863 357999999864 455689999999999999
Q ss_pred cCCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 456 HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 456 h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
||||++|.|+.......+||.|||+||+|+.||+.... .+.+.++..++.+||.||.||-+. +++||||.++||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence 99999999999999999999999999999999976553 488899999999999999999987 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCcceeeeeccc--ccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREESLVYTTLRG--TRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|++.+..+||+|||+++.+..+....+++..| +++|.|||.|..+.+|..+|||||||+|||.++ |.+||
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 99999999999999999887665444444433 779999999999999999999999999999888 99997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.50 Aligned_cols=192 Identities=31% Similarity=0.414 Sum_probs=174.5
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||.|+||+|.+.+.+. |..+|+|++++.. ...+...+|..+|+.+.||+++++++.+.+...+++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 4667889999999999999864 7889999997542 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
++||.|.++|++.+ .++++.+.-++.||+.||+|||+. .|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 126 v~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred cCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999997544 488899999999999999999998 9999999999999999999999999999976543
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.-+.+|||.|+|||.+...++...+|.|||||++|||+.|.+||.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 346899999999999999999999999999999999999999994
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.88 Aligned_cols=207 Identities=26% Similarity=0.441 Sum_probs=181.2
Q ss_pred ChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 395 ~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...|+.+....|.++||+|-||+|..+....+..||||+++... ..+.+|..||++|.+++||||++|+|+|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 36677888888999999999999999999888999999997653 4468999999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++++|||++|+|.+||...... .+.-.....|+.||+.||+||.+. +++||||.++|+|+|.++++||+|||+++
T Consensus 611 cmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999765432 245556677999999999999998 99999999999999999999999999999
Q ss_pred ccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh--CCCCCC
Q 037563 553 LMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG--GRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt--G~~pfs 606 (606)
.+...+... ....+-+++|||||.+..+.+|.++|||+||+.+||+++ ..+||+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 766554432 334556889999999999999999999999999999765 777774
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.10 Aligned_cols=192 Identities=33% Similarity=0.508 Sum_probs=174.6
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+.||+|.||.||||+-+. .+.||+|.+.+... +.+.+.+|++++++++|||||.++..|....+.++|.||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 345679999999999999865 78899999876543 34568899999999999999999999999999999999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
| +|..+|... ..+++..+..|+.++..||.|||+. +|.|||+||+|||++..+.+|++|||+|+.+.....
T Consensus 85 g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 85 G-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred h-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 8 999999543 4589999999999999999999999 999999999999999999999999999998876544
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..+...|||-|||||...+++|+..+|.||+|||+||+.+|++||
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 356789999999999999999999999999999999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.75 Aligned_cols=199 Identities=26% Similarity=0.343 Sum_probs=174.5
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc--ccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~ 473 (606)
....++-.++||+|.||.|||++.. .|+.||+|+++... ....-..+||++|++++||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3445566688999999999999964 58999999997543 2345678899999999999999999998876 6899
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
||+|||++ +|.-++.... -.+++.++.-++.|++.||+|+|++ +|.|||||.+|||||.+|.+||+|||||++
T Consensus 195 lVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999987 7777765433 3588999999999999999999999 999999999999999999999999999999
Q ss_pred cCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+.......++..+-|..|.|||.+.+. .|+..+|+||.||||.||+.|++.|
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 887777777888999999999988875 7899999999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.14 Aligned_cols=198 Identities=28% Similarity=0.429 Sum_probs=175.2
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+.|.+.||+|+|++|++++..+ ++++|||++.+. +...+-+..|-..|.+| .||.|++|+..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 345788899999999999999765 889999999654 23445677788888899 899999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||.++|+|.++|... ..+++.....++.||+.||+|||++ |||||||||+|||||.|+++||+|||.|+.+.
T Consensus 153 Le~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999654 4588899999999999999999999 99999999999999999999999999999876
Q ss_pred cCcce----------e--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESL----------V--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... . ....+||..|.+||++.....+..+|+|+||||||+|+.|++||.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 43221 1 134789999999999999999999999999999999999999993
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=290.35 Aligned_cols=194 Identities=26% Similarity=0.366 Sum_probs=169.0
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
++...++|+|+||.|||++.++ |+.||||++..++++ .+-.++||++|++++|+|+|.|+.+|......+||+||+
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 3445689999999999999986 899999999766543 245689999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+..-|.+.= .. ...++.....+++.|+++|+.|+|++ +++||||||+||||..++.+||+|||.|+.+.. .+
T Consensus 84 dhTvL~eLe-~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 84 DHTVLHELE-RY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred chHHHHHHH-hc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 885554432 22 23478889999999999999999999 999999999999999999999999999998874 23
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..++..+.|..|.|||.+.+ .+|...+||||+||++.||++|.+-|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 34567889999999999988 68999999999999999999998865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=338.55 Aligned_cols=208 Identities=30% Similarity=0.531 Sum_probs=180.5
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEEeCC--Cc----EEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeeccee
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLPD--GI----QVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~--~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~ 467 (606)
+.++......+.+.||+|+||.||.|...+ +. .||||.++.. .++..+|..|..+|++++|||||+++|+|.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 445667777888899999999999999754 33 4999999765 456679999999999999999999999999
Q ss_pred ccccceeeeeeccCCChhhhhhhccc---cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
+....+|++|||++|+|..||++.+. +...++....+.++.|||+|+.||+++ ++|||||.++|+||++...+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 99999999999999999999987632 235688999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcceeeeec-ccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 545 VSDFGLAKLMNREESLVYTTL-RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+|||||+.+...+....... .-...|||||.+..+.||.|+|||||||++||++| |..||.
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999996655444332222 44679999999999999999999999999999999 888873
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.87 Aligned_cols=203 Identities=29% Similarity=0.496 Sum_probs=174.9
Q ss_pred ChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecccc
Q 037563 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 395 ~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~ 471 (606)
.++|+......+.+.||+|.||+||+|++.. .||||+++... +..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4666767777788999999999999999854 59999997543 345789999999999999999999999999887
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.||+-+++|.+|+.+|+... ..+...+.++|+.||++||.|||.+ +|||||||..||+|++++++||.|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999997654 3588889999999999999999999 9999999999999999999999999998
Q ss_pred cccCcCc-ceeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREE-SLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..-..-. ........|...|||||+++. .+|+..+||||||+|+|||++|..||+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 6533211 111233567889999999875 478999999999999999999999996
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.64 Aligned_cols=196 Identities=27% Similarity=0.357 Sum_probs=172.2
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
++....||+|+||+||+++-++ |..+|+|+++++. ...+.+++|-.+|...++|.||+|+..|++..++||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 3556789999999999999765 8999999998753 4567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc--
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-- 556 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~-- 556 (606)
+|||++..+|... ..|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 223 lPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 223 LPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred cCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999643 4689999999999999999999998 999999999999999999999999999863311
Q ss_pred --------------------Ccce-----e-------------------eeecccccCccccccccCCCCCCccchHHHH
Q 037563 557 --------------------EESL-----V-------------------YTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592 (606)
Q Consensus 557 --------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~G 592 (606)
.+.. . ....+|||.|||||++.+..++...|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0 0124799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCC
Q 037563 593 MVLLEIIGGRKSFS 606 (606)
Q Consensus 593 vvl~elltG~~pfs 606 (606)
||+||||.|.+||+
T Consensus 376 ~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFC 389 (550)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.79 Aligned_cols=190 Identities=33% Similarity=0.507 Sum_probs=160.2
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHH--hcccCCcceeecceeccc----cceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIG--NVHHVHLVKLKGFCIEGA----HRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~--~l~h~nIv~l~g~~~~~~----~~~lV~E 477 (606)
.++.+.+|+|.||.||||.+ +++.||||+++.. +.+.|.+|-.+.+ .++|+||+++++.-.... +.+||+|
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 35567799999999999999 5589999999753 4566766665555 568999999999977655 7899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC------CCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC------EVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
|.+.|+|.+||.. ..++|....+|+..+++||+|||+.. +++|+|||||++||||.+|+++.|+|||+|
T Consensus 289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999954 46899999999999999999999864 568999999999999999999999999999
Q ss_pred cccCcCcc-eeeeecccccCccccccccCCC-CC-----CccchHHHHHHHHHHHhC
Q 037563 552 KLMNREES-LVYTTLRGTRGYLAPEWITNNP-IS-----EKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 552 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~t-----~~~Dv~s~Gvvl~elltG 601 (606)
..+..... ......+||.+|||||++.+.. +. .+.||||+|.|||||++.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 88765433 2223479999999999998753 22 368999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.01 Aligned_cols=198 Identities=30% Similarity=0.457 Sum_probs=173.4
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----C--CChHHHHHHHHHHHhcc-cCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----G--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~ 472 (606)
...+.+.+.||+|+||+|+.+... .++.||+|.+... . ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 345677788999999999999865 4799999976543 1 23456778999999999 99999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCC
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLA 551 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla 551 (606)
++||||+.+|+|.+++.+. ..+.+..+..++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999652 4578899999999999999999998 99999999999999999 99999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCC-CC-CccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNP-IS-EKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......+..||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 9874 2222346689999999999999987 75 78999999999999999999995
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.62 Aligned_cols=183 Identities=32% Similarity=0.561 Sum_probs=164.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhhh
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKW 487 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 487 (606)
+-||.|+.|-||+|++ .++.||||+++..+ ..+|+-|++|+|+||+.+.|+|......+|||||++.|-|...
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 4599999999999999 56889999875432 4688999999999999999999999999999999999999999
Q ss_pred hhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeeccc
Q 037563 488 IFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567 (606)
Q Consensus 488 l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 567 (606)
|+.. ..+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++..... .......|
T Consensus 203 Lka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 203 LKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred Hhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 9543 4577888899999999999999999 9999999999999999999999999999876543 22345789
Q ss_pred ccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 568 TRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 568 t~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|..|||||+|...+.++|+|||||||||||||||..||.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 999999999999999999999999999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.12 Aligned_cols=196 Identities=29% Similarity=0.390 Sum_probs=173.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcc-cCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV 475 (606)
..++|.+.||+|+||+|+++.++. ++.+|||++++. .++.+..+.|-.++.... ||.+++|+..++.+++++.|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 445778999999999999999875 778999999865 345677888888887775 99999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||..||++..+. ....+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|.+||+||||++...
T Consensus 448 mey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999954443 224588899999999999999999999 99999999999999999999999999999754
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ...++.+||+.|||||++.+..|+..+|.|||||+|||||.|+.||.
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred CCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 332 24567999999999999999999999999999999999999999994
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.83 Aligned_cols=189 Identities=30% Similarity=0.508 Sum_probs=173.0
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCCChH-HHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKK-EFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~-~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.+||+|+-|.||.++.. .++.||||++....+..+ -+.+|+.+|+..+|+|||+++..+..+++++.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 67999999999999954 588999999987766554 4789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeec
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
+.+.. ..+++.+...|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ...+.
T Consensus 359 DvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~Tm 429 (550)
T KOG0578|consen 359 DVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTM 429 (550)
T ss_pred hhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccc
Confidence 98843 3488999999999999999999999 999999999999999999999999999998876554 34568
Q ss_pred ccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+||+.|||||++....|++|+||||||++++||+.|++||
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY 469 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY 469 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence 9999999999999999999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.92 Aligned_cols=197 Identities=35% Similarity=0.499 Sum_probs=167.7
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccc--cceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA--HRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~E~~ 479 (606)
....+.||+|+||.||++...+ |+..|||...... ...+.+.+|+.+|.+++|||||+.+|...... ..++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3445779999999999999876 8999999886542 22567899999999999999999999855544 578999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCc--
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNR-- 556 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~-- 556 (606)
++|+|.+++.+... .+++..+..++.||++||+|||++ +|+||||||.|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999976442 489999999999999999999998 9999999999999999 79999999999987663
Q ss_pred CcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........||+.|||||++..+ ....++|||||||++.||+||++||+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 111223457899999999999853 33459999999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.29 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=174.9
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEEeCC--C--cE-EEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecce
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLPD--G--IQ-VAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~--~--~~-vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
-+|+......+.++||+|+||.||+|++.. + .. ||||..+.. .....+|.+|+++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 455666666777999999999999999754 2 23 899988742 34568999999999999999999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEe
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 546 (606)
....++++|||+++||+|++||..... .++..+++.++.+.|.||+|||+. +++||||.++|+|+..++.+||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999976543 588999999999999999999998 99999999999999999999999
Q ss_pred eccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 547 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|||+++...... .......-+..|+|||.+....++.++|||||||++||+.+ |..||.
T Consensus 305 DFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 305 DFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred ccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence 999998654111 11112245789999999999999999999999999999999 888873
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=272.10 Aligned_cols=194 Identities=27% Similarity=0.415 Sum_probs=168.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--C-hHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--G-KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~-~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
|.-.++||+|.||.||+|++. .|+.||||+++..+. + .....+||+.|+.++|+||+.++++|-..+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 344578999999999999975 489999999975432 2 356789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+. +|+..+++.. ..++..+...++.++++||+|||++ .|.||||||.|+||+++|.+||+|||+++.+.....
T Consensus 84 ~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 65 8999986544 4688889999999999999999999 999999999999999999999999999998876543
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. .+..+.|.-|.|||.+.+. .|+..+||||.|||+.||+-|.+-|
T Consensus 157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 2 2334789999999988764 6899999999999999999987654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.50 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=174.9
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecc--cCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
..|++.+.||.|.-++||+|+. +.+..||||++.- .....+++..|+..|..++||||++.+..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4567778899999999999995 4579999999953 344568899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
|.+|++.+.++..-.. .+++..+..|+.++++||.|||.+ |.||||||+.||||+++|.+||+|||.+..+-.+.
T Consensus 106 Ma~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999776553 488999999999999999999999 99999999999999999999999999876554322
Q ss_pred c---eeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 S---LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~---~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......+||+.|||||+++. ..|+.|+||||||+...||.+|+.||+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 2 11255789999999999654 468899999999999999999999995
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=305.29 Aligned_cols=196 Identities=26% Similarity=0.348 Sum_probs=170.0
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||+||+++... ++.+|+|+++... .....+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 4567889999999999998764 7899999996432 2345788899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999643 3588999999999999999999998 99999999999999999999999999987543211
Q ss_pred c----------------------------------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCC
Q 037563 559 S----------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 559 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234789999999999999999999999999999999999999
Q ss_pred CC
Q 037563 605 FS 606 (606)
Q Consensus 605 fs 606 (606)
|.
T Consensus 236 f~ 237 (363)
T cd05628 236 FC 237 (363)
T ss_pred CC
Confidence 94
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.93 Aligned_cols=196 Identities=31% Similarity=0.388 Sum_probs=170.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+...+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.+++|+||+++++.+.+....++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 445678999999999999974 58999999986432 2334678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988864322 3588899999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 2234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.22 Aligned_cols=205 Identities=26% Similarity=0.441 Sum_probs=169.4
Q ss_pred HHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+++.++||+|+||.||++.+ ..++.||+|+++... ...+.+.+|+.++.++ +||||++++++|.+.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4456678889999999999999974 135689999986432 2345789999999999 899999999988764
Q ss_pred c-cceeeeeeccCCChhhhhhhcccc------------------------------------------------------
Q 037563 470 A-HRLLAYEYLVNGSLDKWIFNSTEE------------------------------------------------------ 494 (606)
Q Consensus 470 ~-~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------ 494 (606)
. ..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 578999999999999998653210
Q ss_pred ----ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce-eeeeccccc
Q 037563 495 ----SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTR 569 (606)
Q Consensus 495 ----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~ 569 (606)
...+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++........ ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13477888899999999999999998 9999999999999999999999999999865433221 122345578
Q ss_pred CccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 570 GYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 570 ~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 8999999999999999999999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.08 Aligned_cols=192 Identities=29% Similarity=0.377 Sum_probs=170.1
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456788999999999999986 48899999986432 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++.....++.||+.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 83 VPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999998643 3478889999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 23568999999999999889999999999999999999999984
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=294.23 Aligned_cols=196 Identities=30% Similarity=0.437 Sum_probs=172.7
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHH--HHHHHHHHhcc-cCCcceeecceeccc-cceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEF--SAEVTIIGNVH-HVHLVKLKGFCIEGA-HRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~--~~Ei~~l~~l~-h~nIv~l~g~~~~~~-~~~lV 475 (606)
..+|...++||.|.||.||+|+-. .+..||||++++.-...++. .+|++.|++++ ||||++|.+++.+.. .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456777899999999999999965 48899999998765445553 67999999999 999999999999988 99999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
||||+. +|++.+... ...+++..+..|+.||++||+|+|++ |++|||+||+|||+..+..+||+|||+||...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999955 899998765 36799999999999999999999999 99999999999999988999999999999876
Q ss_pred cCcceeeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... .++..+.|..|+|||++. ...|+.+.|+||+|+|++|+.+-++-|
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 543 356788999999999765 567899999999999999999988876
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.12 Aligned_cols=196 Identities=24% Similarity=0.330 Sum_probs=168.4
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||+||+++..+ ++.+|+|+++... ...+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 4567889999999999999754 7899999996432 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998643 3478888899999999999999998 99999999999999999999999999976432100
Q ss_pred c----------------------------------------------eeeeecccccCccccccccCCCCCCccchHHHH
Q 037563 559 S----------------------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592 (606)
Q Consensus 559 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~G 592 (606)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCC
Q 037563 593 MVLLEIIGGRKSFS 606 (606)
Q Consensus 593 vvl~elltG~~pfs 606 (606)
|++|||++|+.||.
T Consensus 236 ~il~elltG~~Pf~ 249 (381)
T cd05626 236 VILFEMLVGQPPFL 249 (381)
T ss_pred hHHHHHHhCCCCCc
Confidence 99999999999993
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.50 Aligned_cols=194 Identities=28% Similarity=0.394 Sum_probs=171.9
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++... ++.||+|++.... ...+.+.+|+.++.+++||||+++++.+.++...++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 346778899999999999999864 7899999986432 33467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998643 3477888899999999999999998 999999999999999999999999999986543
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 22 23568999999999999999999999999999999999999983
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.56 Aligned_cols=196 Identities=29% Similarity=0.406 Sum_probs=172.2
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC--CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
....+++.+.||+|+||.||++++++ +..||+|++... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 33457788999999999999998654 368999998643 233567889999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999998643 3478899999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 54322 24578999999999998889999999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.06 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=171.0
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
...+++.+.||+|+||.||+++... ++.+|+|++... ....+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3556777899999999999999864 788999998642 22345688999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999853 2367888999999999999999998 99999999999999999999999999998765
Q ss_pred cCcceeeeecccccCccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...........||+.|||||.+.+.. ++.++||||+|+++|||++|+.||.
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 43322234567999999999987643 7789999999999999999999983
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.81 Aligned_cols=190 Identities=29% Similarity=0.365 Sum_probs=166.5
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||.||+++.. +++.+|+|+++.. .....++.+|+.++++++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999975 5889999998643 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 999998543 3578899999999999999999998 99999999999999999999999999987533221 122
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCC
Confidence 3457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.22 Aligned_cols=189 Identities=26% Similarity=0.340 Sum_probs=166.5
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||.||+++..+ ++.||+|+++.. ......+..|+.++.+++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999864 788999998643 23446788899999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 9998643 3478899999999999999999998 999999999999999999999999999986433222 2234
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.31 Aligned_cols=192 Identities=29% Similarity=0.395 Sum_probs=171.0
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||.||+++..+ ++.||+|+++.. ....+++.+|++++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 4567889999999999999864 789999999643 23346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999543 3578889999999999999999998 999999999999999999999999999986543
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 1234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.80 Aligned_cols=191 Identities=29% Similarity=0.365 Sum_probs=166.7
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||.||+++.. +++.||+|+++.. ......+.+|++++++++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 35899999999999975 5889999999643 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 999888543 3578999999999999999999998 99999999999999999999999999987543222 122
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 34578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.22 Aligned_cols=198 Identities=26% Similarity=0.453 Sum_probs=177.9
Q ss_pred HHHhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
.+-+++|.+.||+|.||.|-+++. ..|+.||||.+++.. ++.-.+++||++|..++||||+.++.+|...+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345677888999999999999996 569999999997553 334468899999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||..+|.|++|+... ..+++..+..++.||..|+.|+|++ +++|||||.+|||||+++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999644 4599999999999999999999999 9999999999999999999999999999887
Q ss_pred CcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ..++.+|++-|.+||.+.+.+| .+.+|-|||||+||-|+.|..||+
T Consensus 204 ~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 204 ADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred cccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 6543 2456899999999999999988 589999999999999999999995
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=267.53 Aligned_cols=195 Identities=28% Similarity=0.393 Sum_probs=174.6
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|-||.||.|+.+. +..||+|++.+.. +..+++.+|+++-..++||||+++++++.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 35788999999999999999765 6789999997542 445789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|.++|+|...|..... ..+++.....++.|+|.||.|+|.. +++||||||.|+|++.++..||+|||-+.....
T Consensus 103 ya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred ecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 9999999999975433 4578888889999999999999998 999999999999999999999999998865432
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....+.+||..|++||...+..++..+|+|++|++.||++.|.+||
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF 222 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF 222 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence 2235688999999999999999999999999999999999999999
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.13 Aligned_cols=196 Identities=26% Similarity=0.348 Sum_probs=169.7
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||.||+++.. +++.||||+++.. ......+.+|+.++..++||||+++++.+.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456688999999999999986 4889999999643 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999998643 3488999999999999999999998 99999999999999999999999999987543211
Q ss_pred ce-------------------------------------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhC
Q 037563 559 SL-------------------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 559 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG 601 (606)
.. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 00124689999999999999999999999999999999999
Q ss_pred CCCCC
Q 037563 602 RKSFS 606 (606)
Q Consensus 602 ~~pfs 606 (606)
+.||.
T Consensus 236 ~~Pf~ 240 (364)
T cd05599 236 YPPFC 240 (364)
T ss_pred CCCCC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.95 Aligned_cols=196 Identities=23% Similarity=0.325 Sum_probs=168.0
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.++||+|+||.||+++.. +++.+|+|++.... ...+.+.+|++++++++|+||+++++.+.++...++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456688999999999999975 47889999986432 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998643 3478888899999999999999998 99999999999999999999999999975321100
Q ss_pred ----------------------------------------------ceeeeecccccCccccccccCCCCCCccchHHHH
Q 037563 559 ----------------------------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592 (606)
Q Consensus 559 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~G 592 (606)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCC
Q 037563 593 MVLLEIIGGRKSFS 606 (606)
Q Consensus 593 vvl~elltG~~pfs 606 (606)
|++|||++|+.||.
T Consensus 236 vil~elltG~~Pf~ 249 (382)
T cd05625 236 VILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.96 Aligned_cols=207 Identities=27% Similarity=0.445 Sum_probs=184.2
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
..-+|+.+.......+||.|-||.||.|+++. .-.||||.++...-..++|+.|+.+|+.++|||+|+|+|+|..+...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 35567777777778899999999999999976 56899999998877889999999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
|||.|||.+|+|.+||+.... ..++...++.++.||+.||+||..+ ++|||||.++|+|+.++-.+||+|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999986544 3467778899999999999999998 99999999999999999999999999999
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
++..+....-....-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 987765332223344789999999999999999999999999999998 76665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.00 Aligned_cols=190 Identities=30% Similarity=0.384 Sum_probs=166.9
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||.||+++.. +++.||+|++... .....++.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999975 4889999999643 233467888999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 999888543 3588999999999999999999998 99999999999999999999999999987543222 122
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCC
Confidence 3457899999999999888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=284.13 Aligned_cols=197 Identities=27% Similarity=0.377 Sum_probs=161.8
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc----ccce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG----AHRL 473 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~----~~~~ 473 (606)
-....+..+.+.||+|.||+||+|.+ .|+.||||++...++....-+.||..-..++|+||+.+++.-..+ .+++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 33445556778999999999999999 678999999976544444445566666678999999999876543 3678
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEEcCCCcEEEeec
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFTAKVSDF 548 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Df 548 (606)
||.+|.++|+|.|||.. ..++....++++..+|.||++||.+. ++.|.|||||++|||+..++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999954 46888999999999999999999763 678999999999999999999999999
Q ss_pred cCCcccCcCcc---eeeeecccccCccccccccCCCC------CCccchHHHHHHHHHHHh
Q 037563 549 GLAKLMNREES---LVYTTLRGTRGYLAPEWITNNPI------SEKSDVYSYGMVLLEIIG 600 (606)
Q Consensus 549 gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------t~~~Dv~s~Gvvl~ellt 600 (606)
|+|-......+ ...+..+||.+|||||++...-. -..+||||||+|+||+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99987665533 23456789999999999865422 246899999999999863
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.12 Aligned_cols=196 Identities=23% Similarity=0.319 Sum_probs=167.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.++||+|+||.||+++.. +++.||||++... ....+++.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456688999999999999875 5889999998643 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999998643 3578888899999999999999998 99999999999999999999999999986332100
Q ss_pred c-------------e---------------------------------eeeecccccCccccccccCCCCCCccchHHHH
Q 037563 559 S-------------L---------------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592 (606)
Q Consensus 559 ~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~G 592 (606)
. . ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCC
Q 037563 593 MVLLEIIGGRKSFS 606 (606)
Q Consensus 593 vvl~elltG~~pfs 606 (606)
|++|||++|+.||.
T Consensus 236 vil~elltG~~Pf~ 249 (377)
T cd05629 236 AIMFECLIGWPPFC 249 (377)
T ss_pred hhhhhhhcCCCCCC
Confidence 99999999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.17 Aligned_cols=198 Identities=24% Similarity=0.310 Sum_probs=170.2
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
...+++.+.||+|+||.||+++... ++.+|+|+++.. ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 4566778899999999999999764 789999998643 22345678899999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998853 2367788889999999999999998 99999999999999999999999999998764
Q ss_pred cCcceeeeecccccCccccccccCC----CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNN----PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 4322222346799999999988653 37889999999999999999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=299.96 Aligned_cols=200 Identities=25% Similarity=0.306 Sum_probs=171.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+....+++.+.||+|+||.||+++... ++.+|+|++... ....+.+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 334667778999999999999999864 788999998642 123456788999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999853 2367888889999999999999998 999999999999999999999999999987
Q ss_pred cCcCcceeeeecccccCccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.............||+.|||||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 6543322233567999999999987543 7889999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.52 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=168.4
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.++||+|+||.||+++... ++.||+|++... ....+.+.+|+.++++++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 5667899999999999999754 789999998643 23356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999643 3477888889999999999999998 99999999999999999999999999975321000
Q ss_pred ------------------------------------------ceeeeecccccCccccccccCCCCCCccchHHHHHHHH
Q 037563 559 ------------------------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLL 596 (606)
Q Consensus 559 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ 596 (606)
........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCC
Q 037563 597 EIIGGRKSFS 606 (606)
Q Consensus 597 elltG~~pfs 606 (606)
||++|+.||.
T Consensus 236 ell~G~~Pf~ 245 (376)
T cd05598 236 EMLVGQPPFL 245 (376)
T ss_pred ehhhCCCCCC
Confidence 9999999983
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.85 Aligned_cols=193 Identities=31% Similarity=0.430 Sum_probs=168.3
Q ss_pred cCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||+||++... +++.+|+|++.... ...+.+..|++++++++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 58899999986432 2235678899999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
..++.........+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988865444445689999999999999999999998 9999999999999999999999999999765443221 233
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.42 Aligned_cols=192 Identities=27% Similarity=0.416 Sum_probs=172.8
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEecc--cCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLES--IGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
.+.||+|.||.||||.+.. ++.||+|++.- .+...+++.+|+.++.+++++||.+.+|.+..+..++++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 3679999999999999764 78899999864 35567899999999999999999999999999999999999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeee
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 563 (606)
+.+.|... ..+.+....-|+.++..||.|||.+ +.+|||||+.|||+..+|.+|++|||++..+....... .
T Consensus 98 v~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 98 VLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred hhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 99998533 3346667777889999999999999 99999999999999999999999999999887665544 6
Q ss_pred ecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.+||+.|||||++....|+.|+||||||++.+||.+|.+|++
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 7899999999999998899999999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.32 Aligned_cols=194 Identities=28% Similarity=0.442 Sum_probs=173.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+-|.|-.|++. .|+..|||++.+. ......+..||-+|+-+.|||++++++++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 345677999999999999975 4999999999654 22346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|.|.++|... +.++++++.+++.||+.|+.|+|.. +|+|||+||+|+|||.++++||+|||||.+-.++.
T Consensus 94 v~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999999543 4588999999999999999999998 99999999999999999999999999998754432
Q ss_pred ceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...+.+|++.|.|||++++.+| +.++||||.||||+.||||+.||+
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 3466799999999999999988 579999999999999999999995
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=280.09 Aligned_cols=199 Identities=26% Similarity=0.464 Sum_probs=174.1
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+.+.+.||+|+||.||++.++++..+|+|.++......+++.+|+.++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 44677789999999999999998888999999876656678899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999986432 2478999999999999999999998 99999999999999999999999999998654333222
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 222345678999999988889999999999999999999 899984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.60 Aligned_cols=191 Identities=30% Similarity=0.413 Sum_probs=165.5
Q ss_pred cccCCcCceeEEEEEeC----CCcEEEEEEeccc-----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.||+|+||.||+++.. .++.||+|+++.. ......+.+|+.++++++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 4788999998643 12345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+.+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998543 3467788888999999999999998 99999999999999999999999999987543222
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence 1 1233578999999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.83 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=169.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCC-cceeecceeccc------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVH-LVKLKGFCIEGA------ 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~------ 470 (606)
..+...++||+|.||.||+|+.. +|+.||+|+++-... ......+|+.++++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34455578999999999999975 488999999975433 2345689999999999999 999999998877
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..++|+||+ ..+|..|+.........++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 788999999 4599999976654323466688999999999999999999 999999999999999999999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+...-+. ...+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 99665332 235667889999999999887 7899999999999999999998877
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=280.65 Aligned_cols=204 Identities=31% Similarity=0.484 Sum_probs=177.2
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
|+....+++.+.||+|++|.||++.+.+++.||+|.++......+++.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34556678889999999999999998788899999997665567889999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999996543 24588999999999999999999998 9999999999999999999999999999876532
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..........+..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 2111111223468999999998899999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.16 Aligned_cols=196 Identities=26% Similarity=0.358 Sum_probs=169.5
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||+++.++ ++.+|+|+++... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 5667889999999999999864 7889999986542 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++.+..+... ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99877655422 23588889999999999999999998 999999999999999999999999999987654333
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......+++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 22334578999999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.07 Aligned_cols=197 Identities=23% Similarity=0.317 Sum_probs=169.4
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||+++... ++.||+|++... ....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 5677889999999999999764 889999998642 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999998542 23578889999999999999999998 99999999999999999999999999987654433
Q ss_pred ceeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........||+.|||||++.. ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 222233468999999999863 457889999999999999999999983
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=294.22 Aligned_cols=197 Identities=24% Similarity=0.310 Sum_probs=170.2
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||.||+++... ++.||+|++... ....+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 5667889999999999999764 788999998642 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999996532 3578888999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 333334579999999998875 457889999999999999999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=280.96 Aligned_cols=203 Identities=27% Similarity=0.484 Sum_probs=176.6
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+....+.+.++||+|+||.||+|...++..|++|.+.......+.+.+|+.++++++|+||+++++.+.+....+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34556778899999999999999988888999999876555677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999986542 24578889999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........++..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 222223345678999999988889999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.49 Aligned_cols=201 Identities=26% Similarity=0.447 Sum_probs=170.4
Q ss_pred HHHhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
....+++.+.||+|+||.||+|.++ .+..||+|+++... ...+.+.+|+..+.+++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4456778899999999999999864 35689999987543 22457899999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999986532 3588999999999999999999998 999999999999999999999999998765
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.............++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 43222111122345678999999999999999999999999999875 999983
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.94 Aligned_cols=196 Identities=28% Similarity=0.396 Sum_probs=173.0
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|++++..++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556788999999999999986 5889999999643 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999654 3588899999999999999999998 99999999999999999999999999998665432
Q ss_pred ----------------------------ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 ----------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 111234568999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.32 Aligned_cols=188 Identities=21% Similarity=0.372 Sum_probs=163.4
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCC----hHHHHHHHHHHHhcccCCcceeecceec----cccceeeeeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG----KKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLAYEYL 479 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~E~~ 479 (606)
..||+|++|.||+|.+ +|+.||||+++..... .+.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999999 7899999999765333 3677899999999999999999999876 34678999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++|+|.+++... ..+++....+++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999643 3588999999999999999999974 277899999999999999999999999998654322
Q ss_pred eeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 23467899999999876 678999999999999999999999984
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.17 Aligned_cols=197 Identities=22% Similarity=0.312 Sum_probs=169.2
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.++||+|+||.||+++.+. ++.+|+|++... ....+.+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 4667889999999999999865 678999998642 22345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999996532 3578888999999999999999998 99999999999999999999999999997654433
Q ss_pred ceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 32233457899999999886 3457889999999999999999999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.08 Aligned_cols=202 Identities=26% Similarity=0.462 Sum_probs=168.4
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-----------------CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVK 461 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-----------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~ 461 (606)
+..+.+.++||+|+||.||++.+++ +..||+|.+.... ....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4456777899999999999998532 3469999986532 23467999999999999999999
Q ss_pred eecceeccccceeeeeeccCCChhhhhhhccc---------------cccccChhhHHHHHHHHHHHHHHHHhcCCCcee
Q 037563 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTE---------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526 (606)
Q Consensus 462 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ii 526 (606)
+++++.+....++||||+++++|.+++..... ....+++.....++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999854321 113477888999999999999999998 999
Q ss_pred ecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh--CCC
Q 037563 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG--GRK 603 (606)
Q Consensus 527 H~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt--G~~ 603 (606)
||||||+||++++++.+||+|||+++......... .....++..|||||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654433211 123445789999999988889999999999999999987 556
Q ss_pred CC
Q 037563 604 SF 605 (606)
Q Consensus 604 pf 605 (606)
||
T Consensus 241 p~ 242 (304)
T cd05096 241 PY 242 (304)
T ss_pred CC
Confidence 66
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.76 Aligned_cols=191 Identities=30% Similarity=0.379 Sum_probs=163.2
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHh-cccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGN-VHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~-l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++..+ ++.||+|+++.. ....+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999764 788999998643 2234455667766665 4899999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999988543 3478889999999999999999998 99999999999999999999999999998643322 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 234578999999999999899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.65 Aligned_cols=196 Identities=27% Similarity=0.345 Sum_probs=168.1
Q ss_pred hccccccCCcCceeEEEEEeC----CCcEEEEEEeccc-----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~ 473 (606)
+++.+.||+|+||.||+++.. .++.||+|++... ....+.+..|+.+++++ +|+||+++++++.+....+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456788999999999998853 4789999998642 12345688899999999 5999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998643 3478899999999999999999998 999999999999999999999999999986
Q ss_pred cCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.............||+.|||||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 544333223345789999999998765 47889999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=280.05 Aligned_cols=190 Identities=31% Similarity=0.426 Sum_probs=159.0
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccc-----cceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-----HRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~E~~~~ 481 (606)
+.+|.|+||.||+|++.. ++.||||+.-.... .--.|+++|++++|||||+|+-++.... ...+||||||.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 679999999999999765 68999998854322 2356889999999999999999886432 34599999976
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccCcCcce
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|.+++.........++...+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+...+..
T Consensus 107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 89999876444445677777888999999999999997 99999999999999976 89999999999988765543
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.
T Consensus 183 --iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 183 --ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred --eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 234567899999988874 78999999999999999999998773
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.14 Aligned_cols=194 Identities=25% Similarity=0.336 Sum_probs=166.0
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCCh---HHHHHHHHHHHhcccCCcceeecceec--cccceeeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLLAYEY 478 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~E~ 478 (606)
+..++|++|.||.||+|+++. ++.||+|+++-..... ---.+||.+|.+++|||||.+..+..- -+..|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 445789999999999999865 7889999997543211 245889999999999999999988753 4568999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++ +|...+..-. +.+...++.-+..|+++|++|||++ .|+|||||++|+|+...|.+||+|||+|+.++...
T Consensus 159 ~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 159 VEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 987 8888886533 4677888888999999999999999 99999999999999999999999999999887653
Q ss_pred ceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..++..+.|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 345678889999999988775 68999999999999999999998773
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=295.27 Aligned_cols=197 Identities=25% Similarity=0.296 Sum_probs=171.7
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 566788999999999999976 48899999997532 2446788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999999996542 3588899999999999999999998 99999999999999999999999999998765444
Q ss_pred ceeeeecccccCcccccccc------CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWIT------NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~------~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........+|+.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 33334457899999999886 4567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.80 Aligned_cols=191 Identities=27% Similarity=0.346 Sum_probs=165.3
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+|+..+ ++.||+|+++.. ....+.+..|.+++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999864 789999998643 23345677888888866 799999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 9999888543 3478889999999999999999998 999999999999999999999999999875432221 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence 234568999999999999899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=288.82 Aligned_cols=195 Identities=27% Similarity=0.354 Sum_probs=167.5
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccC-Ccceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHV-HLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~-nIv~l~g~~~~~~~~~lV~E 477 (606)
+++.+.||+|+||.||+++..+ ++.||+|+++.. ....+.+..|+.++..++|+ +|+++++++.+....++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 4567889999999999999765 678999998643 23456788899999999765 58889999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998543 3478889999999999999999998 9999999999999999999999999998753222
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 11 2234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.83 Aligned_cols=190 Identities=29% Similarity=0.377 Sum_probs=165.6
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||.||+++.. +++.||+|+++.. .....++..|++++..++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999975 5889999999643 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
+|..++... ..+++..+..++.||+.||.|||+ . +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 999888543 358899999999999999999997 5 999999999999999999999999999875432221 1
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf 196 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCC
Confidence 23456899999999999989999999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.65 Aligned_cols=205 Identities=28% Similarity=0.486 Sum_probs=171.3
Q ss_pred HHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||+++. ..+..||||+++... ...+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3445677889999999999999973 235689999996443 2346788999999999 899999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccc--------------------------------------------------------
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTE-------------------------------------------------------- 493 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 493 (606)
...++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ---------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 494 ---------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 494 ---------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
....+++..+..++.||++||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 012478889999999999999999998 99999999999999999999999999998664433
Q ss_pred cee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 211 122345678999999999999999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=289.92 Aligned_cols=191 Identities=25% Similarity=0.349 Sum_probs=166.1
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++.. +++.||+|+++.. ....+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999976 4789999999743 22345688899999988 699999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 9999888543 3588999999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||++.+..++.++|+||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 234578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.02 Aligned_cols=196 Identities=26% Similarity=0.344 Sum_probs=169.6
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||+++..+ ++.||+|+++.. ....+.+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 4566889999999999999764 889999998643 23346788899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999998543 3578899999999999999999998 99999999999999999999999999987543211
Q ss_pred c----------------------------------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCC
Q 037563 559 S----------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 559 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001134689999999999999999999999999999999999999
Q ss_pred CC
Q 037563 605 FS 606 (606)
Q Consensus 605 fs 606 (606)
|.
T Consensus 236 f~ 237 (360)
T cd05627 236 FC 237 (360)
T ss_pred CC
Confidence 84
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.03 Aligned_cols=190 Identities=26% Similarity=0.367 Sum_probs=164.8
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++... ++.+|+|+++.. ....+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 368999999999999764 789999998753 12345678888888877 799999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 9999888543 3588899999999999999999998 999999999999999999999999999875432211 1
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence 23457899999999999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.88 Aligned_cols=195 Identities=27% Similarity=0.362 Sum_probs=167.0
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+++.+.||+|+||.||+++... ++.||+|+++... ...+.+..|..++..+ +|++|+++++++.+....++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4567889999999999999764 6799999986432 2334567788888777 58999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988543 3478899999999999999999998 9999999999999999999999999999754322
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 2 12234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=287.96 Aligned_cols=191 Identities=28% Similarity=0.364 Sum_probs=165.5
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++.+. ++.||+|+++.. ....+.+..|+.++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999864 789999998643 23446677888888876 699999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 9999988543 3478899999999999999999998 99999999999999999999999999987543222 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 234578999999999999899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.12 Aligned_cols=196 Identities=27% Similarity=0.384 Sum_probs=162.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---------------ChHHHHHHHHHHHhcccCCcceeecce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------------GKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---------------~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
.+++.+.||+|.||.|-+++.. +++.||||++.+.+. ..+...+||.+|++++|||||+|+.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 3566688999999999999975 589999999964321 125789999999999999999999998
Q ss_pred ec--cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 467 IE--GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 467 ~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
.+ ...+|||+||+..|.+...= .....+++.++.+++.++..||+|||.+ +||||||||+|+||+++|++|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 76 45789999999988875432 1222389999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccCcC----cceeeeecccccCccccccccCCC----CCCccchHHHHHHHHHHHhCCCCC
Q 037563 545 VSDFGLAKLMNRE----ESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 545 l~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+|||.+...... .........|||.|||||...++. .+.+.||||+||.||-|+.|+.||
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999865221 111123368999999999887632 256789999999999999999999
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=277.52 Aligned_cols=199 Identities=27% Similarity=0.461 Sum_probs=173.6
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+.+.+.||+|+||.||++...++..+|+|.++......+++.+|+.++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 44677889999999999999987777899999876555567899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999986532 2578999999999999999999998 99999999999999999999999999988654433222
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|++||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 222345678999999988889999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=278.22 Aligned_cols=203 Identities=27% Similarity=0.467 Sum_probs=174.7
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+....+.+.++||+|+||.||++...+ ++.|++|+++......+++.+|++++++++|+||+++++++......+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 334556777899999999999999764 7889999987665566789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999865332 4578999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..........+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 2211112234668999999998899999999999999999998 999873
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=288.06 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=171.2
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+++.+.||+|+||.||+++... +..+|+|.+.... ...+++.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3456677889999999999999864 7889999886432 234679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999998643 3478889999999999999999985 26999999999999999999999999998765432
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2 233568999999999999899999999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=285.77 Aligned_cols=191 Identities=28% Similarity=0.384 Sum_probs=164.3
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++..+ ++.||+|+++.. ....+.+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 368999999999999865 788999998653 23345567777787764 899999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||++++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 9999998542 3478889999999999999999998 999999999999999999999999999875322221 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 234578999999999999899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.88 Aligned_cols=205 Identities=30% Similarity=0.500 Sum_probs=171.1
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+++.+.||+|+||.||+++.. ++..||+|+++... ...+.+.+|+.+++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45566788899999999999998842 24579999996532 2245688999999999 899999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccc--------------------------------------------------------
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTE-------------------------------------------------------- 493 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 493 (606)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864221
Q ss_pred ----------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee-e
Q 037563 494 ----------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-Y 562 (606)
Q Consensus 494 ----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 562 (606)
....+++..+.+++.||+.||+|||++ +++||||||+||++++++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 012477888999999999999999998 99999999999999999999999999998654432211 1
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....++..|||||++.+..++.++||||||+++|||++ |+.||.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 22345678999999998899999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=288.22 Aligned_cols=193 Identities=30% Similarity=0.397 Sum_probs=165.2
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHH---HhcccCCcceeecceeccccceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTII---GNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l---~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
++.+.||+|+||.||++... +++.||||+++.. ....+.+..|+.++ ++++||||+++++++.+....++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999975 4889999999643 22345667776655 4567999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|..++.. ..+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988742 3588999999999999999999998 999999999999999999999999999875432
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......|++.|||||.+.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~ 202 (324)
T cd05589 154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202 (324)
T ss_pred CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 221 2234678999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=282.75 Aligned_cols=196 Identities=27% Similarity=0.413 Sum_probs=167.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+.+.++||+|+||.||+++.. +++.||+|+++... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3566788999999999999976 47899999986432 33457789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 DS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred Cc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 75 8998885432 3478889999999999999999998 999999999999999999999999999976433221
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1233567899999998865 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=287.26 Aligned_cols=195 Identities=27% Similarity=0.368 Sum_probs=167.4
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+++.+.||+|+||.||+++.. +++.||+|+++.. ....+.+..|+.++..+. |++|+++++++.+....++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 567789999999999999975 4889999998643 233456788888888886 5778889999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998543 3488999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 21 1233568999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.55 Aligned_cols=200 Identities=24% Similarity=0.262 Sum_probs=172.1
Q ss_pred hccccccCCcCceeEEEEEeCC--CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+.+.+.||+|+||.||++.... ++.||+|.+.... .....+..|+.+++.++||||+++++++.+....++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 6677899999999999998643 5678888764332 233567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES- 559 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~- 559 (606)
+|+|.+++.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999865433345688899999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 12234568999999999999999999999999999999999999984
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=276.05 Aligned_cols=203 Identities=29% Similarity=0.506 Sum_probs=177.0
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++...++++.++||+|+||.||++..++++.+|+|.+.......+++.+|+.++++++|+||+++++++. ....+++||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4567788899999999999999999988999999999876666788999999999999999999999864 456899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.... +..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999986533 24588899999999999999999998 9999999999999999999999999999876533
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........++..|+|||.+....++.++|+||||++++||++ |+.||.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 2222223345778999999988889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=285.27 Aligned_cols=191 Identities=28% Similarity=0.363 Sum_probs=164.5
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++... ++.||+|+++.. ....+.+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999864 789999999653 23345667788787754 899999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 9999988543 3478889999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 344678999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.39 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=165.7
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
..+.+.++||+|+||.||+++... ++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 346777899999999999999754 7899999653 3457889999999999999999999999999999999985
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 6888887543 3478899999999999999999998 9999999999999999999999999999754332222
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 233467999999999999999999999999999999999999876
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=287.50 Aligned_cols=191 Identities=31% Similarity=0.422 Sum_probs=162.2
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHH-HHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVT-IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++.. +++.||+|++.... ....++..|+. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999986 47899999986431 22344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 9999888542 3477888889999999999999998 999999999999999999999999999875432221 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence 234568999999999998899999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=287.76 Aligned_cols=191 Identities=32% Similarity=0.417 Sum_probs=162.9
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHH-HHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVT-IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||+||+++.. +++.||+|++.... ...+++..|.. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35899999999999986 58999999986431 22344555554 56789999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 9999998643 3578888999999999999999998 99999999999999999999999999987543222 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 234578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=287.15 Aligned_cols=190 Identities=25% Similarity=0.334 Sum_probs=165.6
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++... ++.+|+|+++... ...+.+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 7889999997532 2345688899999888 699999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 9999888543 3588999999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence 23467899999999999999999999999999999999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=275.80 Aligned_cols=198 Identities=26% Similarity=0.462 Sum_probs=171.7
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
.+.+.+.||+|+||.||++..+++..+|+|.+........++.+|++++++++|+||+++++++.+....++|+||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45677889999999999999877778999998765556678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999986533 2588999999999999999999998 999999999999999999999999999986543322111
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 12234567999999998889999999999999999999 898884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=280.25 Aligned_cols=196 Identities=31% Similarity=0.396 Sum_probs=170.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
++..+.||+|+||+||++... +++.||+|+++... .....+.+|+.++++++||||+++++.+.++...++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456678999999999999975 58899999986432 2234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998864322 3588999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||.
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 1 233568999999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.49 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=172.0
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
+....+++.++||+|+||.||++... ++..+|+|.+.... ....++.+|++++++++|+||+++++++.++...++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34456778889999999999999986 47889999876432 2346789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++... ..+++.....++.|++.||.|||+. .+++|+||||+||++++++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999998643 3478888999999999999999974 269999999999999999999999999987653
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 321 123568999999999998889999999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=275.38 Aligned_cols=201 Identities=29% Similarity=0.490 Sum_probs=172.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
....+.+.++||+|+||.||+|++++...||+|+++......+++.+|++++++++|+||+++++.+.+ ...++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 345678889999999999999998777789999998655566789999999999999999999998754 5679999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999996532 23578899999999999999999998 999999999999999999999999999986654332
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 22223446678999999988889999999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=286.23 Aligned_cols=191 Identities=31% Similarity=0.406 Sum_probs=161.7
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHH-HHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEV-TIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei-~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++... ++.+|+|++.... ....++..|. .+++.++|+||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 6789999986432 2233444454 456788999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++.....++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 9999998643 3467788888999999999999998 999999999999999999999999999975432221 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=287.65 Aligned_cols=191 Identities=33% Similarity=0.417 Sum_probs=162.9
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHH-HHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVT-IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||+||+++.. +++.+|+|++... .....++..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999975 5889999998643 123345556654 46778999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 9999888543 3578899999999999999999998 999999999999999999999999999875432221 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 234578999999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=324.13 Aligned_cols=196 Identities=28% Similarity=0.526 Sum_probs=164.8
Q ss_pred ccChHHHHHHhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecccc
Q 037563 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 393 ~~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~ 471 (606)
.++++++..+ ....+.||+|+||.||+|+. .+++.||||+++..... ...|++.+++++|||||+++|+|.+...
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3455555443 34456799999999999997 46899999998654322 2356889999999999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++|+|.++++ .++|..+.+|+.||++||+|||..+..+++||||||+||+++.++.+++. ++..
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999994 37899999999999999999997666699999999999999999988886 6655
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... ....+++.|||||++.+..++.++|||||||++|||+||+.||
T Consensus 830 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 830 GLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred cccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 433221 1236789999999999999999999999999999999999997
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.25 Aligned_cols=196 Identities=25% Similarity=0.377 Sum_probs=166.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.++||+|+||.||+++.. +++.||+|+++... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4567789999999999999986 58899999986442 23356788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 86 H-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred C-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 5 67888775432 3478888999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12234567899999998765 457889999999999999999999983
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=273.94 Aligned_cols=202 Identities=29% Similarity=0.484 Sum_probs=173.7
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+....+++.++||+|+||.||++..+++..+|+|.++......+++.+|+.++++++|+|++++++++. ....+++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 344567788899999999999999888889999999866556778999999999999999999999875 4568999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999986532 23578999999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........++..|+|||.+.+..++.++|+||||+++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 222222345678999999988889999999999999999999 899984
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.50 Aligned_cols=191 Identities=29% Similarity=0.383 Sum_probs=165.5
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++... ++.||+|+++.. ......+..|++++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999864 789999999743 23345677888888888 699999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++... ..+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 9999888543 3588999999999999999999998 999999999999999999999999999875322221 1
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 233568999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=287.47 Aligned_cols=191 Identities=29% Similarity=0.401 Sum_probs=167.0
Q ss_pred cccCCcCceeEEEEEe----CCCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 408 TKLGQGGFGSVYLGML----PDGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~----~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+.||+|+||.||+++. ..++.+|+|+++... .....+..|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999875 257899999997532 234567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999998542 3588999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence 2234578999999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.79 Aligned_cols=194 Identities=30% Similarity=0.501 Sum_probs=170.1
Q ss_pred cccccCCcCceeEEEEEe-CCC----cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 406 FSTKLGQGGFGSVYLGML-PDG----IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~-~~~----~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
-.++||+|+||+||||.+ ++| -+||+|++.... +...++.+|+..|.+++|||+++|+|+|..+. ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 346799999999999996 333 468999986543 44689999999999999999999999999877 8899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
|+.|+|.+|++..+ ..+..+..+.|..|||+||.|||.+ +++||||.++|||+..-..+||.|||+++.+..+.
T Consensus 779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999997644 4578889999999999999999998 99999999999999999999999999999987665
Q ss_pred c-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 S-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
. .......-.+.|||-|.+....++.++|||||||.+||++| |..|+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 4 22233445788999999999999999999999999999999 998873
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.01 Aligned_cols=191 Identities=27% Similarity=0.420 Sum_probs=161.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.++||+|+||.||+++.. +++.||||++..... ..+++.+|++++++++|+||+++++++.+....++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 345678999999999999975 589999999864322 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986543 245667788999999999999998 999999999999999999999999999987643321
Q ss_pred eeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 1234578999999998743 223568999999999999999999984
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.48 Aligned_cols=203 Identities=30% Similarity=0.533 Sum_probs=173.2
Q ss_pred HHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
..++.+.+.||+|+||.||+|+..+ ++.||+|.++.... ..+++.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567778899999999999998743 47899999875533 357899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccc----------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTE----------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 542 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~ 542 (606)
++||||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 224578899999999999999999998 9999999999999999999
Q ss_pred EEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 543 AKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999999765332211 1122345778999999999999999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=275.27 Aligned_cols=190 Identities=34% Similarity=0.481 Sum_probs=165.1
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||.||+++.+. ++.+|+|++.... ...+.+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999764 8999999986421 2234566799999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988864332 3478889999999999999999998 99999999999999999999999999988664432 2234
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 568999999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=278.35 Aligned_cols=197 Identities=37% Similarity=0.634 Sum_probs=165.6
Q ss_pred ccccccCCcCceeEEEEEeC-----CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++.+.||+|.||.||+|.+. .+..|+||.++.... ..++|.+|++.+++++||||++++|++.+....++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999986 257899999965432 35789999999999999999999999998888999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.++|.... ...+++..+..|+.||++||.|||++ +++|++|+++||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999997652 24588999999999999999999998 9999999999999999999999999999877332
Q ss_pred cce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... ..........|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 221 1223456789999999998889999999999999999999 778873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.89 Aligned_cols=202 Identities=28% Similarity=0.354 Sum_probs=171.9
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc-------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------- 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------- 470 (606)
..+.+.+.||+|+||.||+++.. +++.||||++.... .....+.+|+..+..++|+||++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 35677789999999999999864 58999999986532 23456888999999999999999988775432
Q ss_pred -cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 471 -HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 471 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 35799999999999999976554446788999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9986543221 22234678999999999999999999999999999999999999984
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.73 Aligned_cols=195 Identities=23% Similarity=0.428 Sum_probs=163.8
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccc-----ccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-----HRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~l 474 (606)
+++.+.||+|+||.||+|+.. +++.||||++... .....++.+|++++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456788999999999999975 5899999998643 223456889999999999999999999875432 4799
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+. ++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 6898888532 3488999999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcc--eeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES--LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 32221 11234578999999998865 578999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=273.21 Aligned_cols=203 Identities=30% Similarity=0.510 Sum_probs=177.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+....+.+.++||+|+||.||++.+++++.++||.+.......+++.+|+.++++++|+||+++++++......++||||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45566778899999999999999988888999999987666778899999999999999999999999998999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... +..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999996533 24588999999999999999999998 99999999999999999999999999998765322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........+..|+|||.+.+..++.++|+||||++++||++ |+.||+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 211122334678999999998889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=277.24 Aligned_cols=196 Identities=24% Similarity=0.389 Sum_probs=163.0
Q ss_pred hhccccccCCcCceeEEEEEeC--CCcEEEEEEecccC---CChHHHHHHHHHHHhc---ccCCcceeeccee-----cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIG---QGKKEFSAEVTIIGNV---HHVHLVKLKGFCI-----EG 469 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~--~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~-----~~ 469 (606)
.+++.++||+|+||.||+++.. +++.||+|+++... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3566788999999999999863 46889999886432 2234567787777766 6999999999885 24
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46789999996 589998865332 3478899999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++...... ......+++.|+|||.+.+..++.++||||||+++|||++|++||.
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 998654332 2234568999999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.16 Aligned_cols=204 Identities=28% Similarity=0.444 Sum_probs=170.1
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||+|+... +..||||+++... ...+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 334566777899999999999998532 3469999996542 23467899999999996 99999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccc--------------------------------------------------------
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTE-------------------------------------------------------- 493 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 493 (606)
...++||||+++|+|.++|.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999999865321
Q ss_pred ------------------------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 494 ------------------------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 494 ------------------------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
....+++..+..++.||++||.|||+. +++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 012477888899999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999865433221 1122346788999999998889999999999999999997 98887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=271.96 Aligned_cols=201 Identities=28% Similarity=0.477 Sum_probs=172.3
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
....+++.++||+|++|.||++.++++..+++|++.......+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34557778899999999999999877778999998765556678999999999999999999999875 45679999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999996532 23578999999999999999999998 999999999999999999999999999986643322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22223345678999999988889999999999999999999 899984
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=269.78 Aligned_cols=203 Identities=26% Similarity=0.322 Sum_probs=173.4
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+.-...++.+.||+|.-|+||++++.+ +...|+|++.+.. ....+.+.|-++|+.++||.+++|+..++.+...+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 333445667889999999999999976 4789999997543 23456778899999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|||||+||+|...++.+.. +.+++..+.-++..++-||+|||.. |||+|||||+||||.++|++-|+||.++..
T Consensus 154 l~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999998876543 6799999999999999999999998 999999999999999999999999988753
Q ss_pred cCc---------------------------------C-c---------------------ceeeeecccccCcccccccc
Q 037563 554 MNR---------------------------------E-E---------------------SLVYTTLRGTRGYLAPEWIT 578 (606)
Q Consensus 554 ~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~ 578 (606)
... . . .......+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 0 00112347899999999999
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 579 NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 579 ~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+...+..+|.|+|||++|||+.|+.||.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 9999999999999999999999999993
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=281.03 Aligned_cols=200 Identities=29% Similarity=0.466 Sum_probs=167.6
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC-Cc----EEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
....++..+.||+|+||.||+|++.+ ++ .||+|+++... ...+++.+|+.+++.++||||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 34456667889999999999998643 33 48999986432 2356889999999999999999999999764 56
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++++||+++|+|.+++.... ..+++...+.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 89999999999999986532 3478889999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 553 LMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
......... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 765443321 122334678999999999999999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=304.25 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=169.8
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.++||+|+||.||+|+... ++.||+|+++... ...+++.+|++++++++||||+++++++.++...++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 5567889999999999999764 8899999986432 1245789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccc-------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 479 LVNGSLDKWIFNSTE-------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
+++++|.+++..... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999864321 123456778899999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcc-----------------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREES-----------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+....... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 86521110 00112468999999999999999999999999999999999999983
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=271.55 Aligned_cols=203 Identities=26% Similarity=0.473 Sum_probs=174.9
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++..+++.+.++||+|+||.||++.+.++..+++|.+.......+.+.+|++++++++|+||+++.+.+.+ ...+++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45566778889999999999999998788889999887655556789999999999999999999999887 77899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999996532 24578889999999999999999998 9999999999999999999999999999765433
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........++..|+|||++....++.++|+||||++++|+++ |+.||.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 2222223345678999999998889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=274.87 Aligned_cols=201 Identities=28% Similarity=0.494 Sum_probs=169.7
Q ss_pred HhhccccccCCcCceeEEEEEe-----CCCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+++.++||+|+||.||+|.+ ..++.+++|.++.... ...++.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999984 2467899999874332 23578999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccc-------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC
Q 037563 475 AYEYLVNGSLDKWIFNSTE-------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 541 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~ 541 (606)
||||+++++|.+++..... ....+++.+...++.|++.||+|||++ +++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853321 123478889999999999999999998 999999999999999999
Q ss_pred cEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 542 TAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 542 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 999999999986543322 11223345678999999988889999999999999999999 99887
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=274.39 Aligned_cols=196 Identities=31% Similarity=0.401 Sum_probs=169.4
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
++..+.||+|+||.||++... .++.+|+|.++... ...+.+.+|+.++++++|+|++++++.+.++...++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345578999999999999976 47899999986432 1234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999864332 3588899999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 2 123468999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-34 Score=260.93 Aligned_cols=195 Identities=28% Similarity=0.471 Sum_probs=170.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.+.||+|.|+.||+.... .|+.+|+|++... ..+.+++.+|+.+.+.++|||||+|+....+...+|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3455677999999999999865 4888898887532 34678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMN 555 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~~~ 555 (606)
|.|++|..-+-.. ...++..+-..+.||+.+|.|+|.+ +|+|||+||.|+++.. ..-+|++|||++..+.
T Consensus 92 m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 92 VTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999997766332 4578888899999999999999999 9999999999999953 3458999999999887
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.........|||+|||||++...+++..+|||+-||||+-|+.|.+||.
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 3333456789999999999999999999999999999999999999995
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=273.60 Aligned_cols=204 Identities=26% Similarity=0.469 Sum_probs=170.0
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
+....+++.++||+|+||.||+|... .+..||+|++.... ....++.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34556778899999999999999853 24679999885432 23457889999999999999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhcccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEE------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653321 23467888999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 545 VSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999987654332211 112345778999999998889999999999999999999 78887
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=273.75 Aligned_cols=202 Identities=29% Similarity=0.543 Sum_probs=170.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+.+.+.||+|+||.||+|.... ...|++|.+..... ..+++.+|+..+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 345777899999999999998643 25799998864332 3467899999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC
Q 037563 474 LAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 541 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~ 541 (606)
++|||+++++|.+++...... ...+++.....++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999654221 13578889999999999999999998 999999999999999999
Q ss_pred cEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 542 TAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 542 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999986543322 11223456788999999988889999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=287.17 Aligned_cols=193 Identities=30% Similarity=0.468 Sum_probs=168.4
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccc------cceeeee
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HRLLAYE 477 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~~lV~E 477 (606)
.+.||+|+||.||+|+.+ .|+.||||.++... ...+....|++++++++|+|||++.+.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 356999999999999965 49999999997643 34567889999999999999999999866544 5689999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC--CC--cEEEeeccCCcc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD--NF--TAKVSDFGLAKL 553 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~--~~--~~kl~Dfgla~~ 553 (606)
|+.+|+|...|.+..+. ..+++...+.++..+..||.|||.+ +|+||||||.||++-. +| --||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999765543 5699999999999999999999998 9999999999999953 33 369999999998
Q ss_pred cCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+..+. ..+...||..|++||.... ..++..+|.|||||++||.+||..||
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence 76554 4677899999999999884 78999999999999999999999999
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=279.52 Aligned_cols=198 Identities=30% Similarity=0.452 Sum_probs=177.8
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcc-cCCcceeecceeccccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~ 472 (606)
-....+++.++||+|.||.||+++.+. |+.+|+|.+.+.. .....+.+|+.+|+++. |||||.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 344557777899999999999999876 9999999996543 24468999999999998 99999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC----CcEEEeec
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDF 548 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Df 548 (606)
++|||++.||.|.+.+... .+++..+..++.||+.++.|||+. +++||||||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999765 288999999999999999999998 99999999999999643 47999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|++..... .......+||+.|+|||++...+++..+||||+||++|.|++|..||-
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 99998776 334567899999999999999999999999999999999999999993
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=273.22 Aligned_cols=195 Identities=31% Similarity=0.394 Sum_probs=169.0
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
...+.||+|+||+||++... +++.+|+|.++... .....+.+|++++++++|+||+++.+.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 44577999999999999975 48899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 83 NGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred cCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999988864322 3589999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 233568999999999998899999999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=281.48 Aligned_cols=198 Identities=28% Similarity=0.442 Sum_probs=177.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceecccc-ceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH-RLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-~~lV~E 477 (606)
.+...+.+|+|+||.++..+.+ ++..+++|.+.-. ...++...+|+.++++++|||||...+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4566788999999999998876 4678999998643 3345578999999999999999999999999888 899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|++||+|.+.+.... +..++++....++.||+.|+.|||++ .|.|||||+.||++..+..+||.|||+|+.+.++
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999997654 45688999999999999999999988 9999999999999999999999999999998877
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ..+..||+.||.||.+.+.+|..|+|+|||||++|||.+-+++|.
T Consensus 160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC
Confidence 643 345789999999999999999999999999999999999999985
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=273.59 Aligned_cols=204 Identities=30% Similarity=0.541 Sum_probs=171.4
Q ss_pred HHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
.+..+.+.+.||+|+||+||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3445667788999999999999852 24568999886543 3356799999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccc---------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 473 LLAYEYLVNGSLDKWIFNSTE---------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999865331 123489999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 544 KVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999865433221 1122345778999999998889999999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=270.26 Aligned_cols=200 Identities=30% Similarity=0.530 Sum_probs=175.3
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC-ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+..+.+.++||+|+||.||+|...+++.+++|.+..... ...++..|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 455677789999999999999998899999999976543 4678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... +..+++..+..++.||+.||.|||++ +++|+||+|+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997543 24578999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
......++..|+|||.+.+..++.++||||||++++||++ |+.||.
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1223456778999999988889999999999999999998 899984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=270.02 Aligned_cols=198 Identities=30% Similarity=0.528 Sum_probs=170.2
Q ss_pred HhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+.+.+.||+|+||.||+|+++. ...|++|.++... ....+|.+|+.++++++||||+++++.+.+....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456677899999999999999753 4579999886543 2346789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999986533 3588999999999999999999998 99999999999999999999999999998775
Q ss_pred cCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 556 REES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 556 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence 3222 22222345678999999998899999999999999999998 99997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=281.19 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=169.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceec-
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE- 468 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~- 468 (606)
+....+++.+.||+|+||.||++...+ ++.||+|+++... ...+.+..|+.++.++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 345667888999999999999997432 4789999986432 2235678899999999 79999999998865
Q ss_pred cccceeeeeeccCCChhhhhhhcccc------------------------------------------------------
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTEE------------------------------------------------------ 494 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------ 494 (606)
+...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45678999999999999998643210
Q ss_pred ---ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccC
Q 037563 495 ---SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRG 570 (606)
Q Consensus 495 ---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~ 570 (606)
...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+..... .......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999998 999999999999999999999999999987643322 11223456778
Q ss_pred ccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 571 y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=290.77 Aligned_cols=195 Identities=27% Similarity=0.404 Sum_probs=160.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc--------ccce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--------AHRL 473 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--------~~~~ 473 (606)
.+.+.+.||+|+||.||+|+.. .++.||||++... .....+|+.++++++||||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 4667789999999999999975 4789999988543 23345799999999999999998876432 2356
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAK 552 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~ 552 (606)
+||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999985 77777754433445688999999999999999999998 999999999999999665 79999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||.
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6643322 2235679999999988654 68999999999999999999999984
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=285.61 Aligned_cols=194 Identities=28% Similarity=0.401 Sum_probs=164.9
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc-----cceee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-----HRLLA 475 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV 475 (606)
+..++||+|+||.||++... +++.||+|++.... ...+++.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45678999999999999975 58999999986432 23467889999999999999999999998776 78999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 83 ~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 83 TELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99996 578777743 23588999999999999999999998 99999999999999999999999999998654
Q ss_pred cCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 4333333345678999999998774 47899999999999999999999983
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=267.09 Aligned_cols=197 Identities=29% Similarity=0.457 Sum_probs=172.4
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|++|.||+++.. +++.|++|.++.. ....+++.+|++++++++||||+++++++.+....++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 356678999999999999976 4889999998643 234567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999997542 24688899999999999999999998 999999999999999999999999999886654322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....+++.|+|||++.+..++.++|+||||++++||++|+.||+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 1 233467889999999999989999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=284.00 Aligned_cols=193 Identities=30% Similarity=0.428 Sum_probs=170.5
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcc-c-----CCcceeecceeccccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVH-H-----VHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h-----~nIv~l~g~~~~~~~~~lV 475 (606)
+|++.+.||+|.||+|.|+.+.. ++.||||++++...-.++-..|+++|..++ | -|+|+++++|...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 67778899999999999999765 899999999987777778889999999997 3 4999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC--CcEEEeeccCCcc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSDFGLAKL 553 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfgla~~ 553 (606)
+|.+ ..+|+++|+...- ..++...+..|+.||+.+|.+||+. +|||+||||+||||.+- ..+||+|||++..
T Consensus 267 fELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9998 5599999987655 3588999999999999999999998 99999999999999754 3799999999986
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....- . ...-+..|.|||++.+.+|+.+.||||||||+.||.+|.+-|
T Consensus 341 ~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 341 ESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred cCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 54321 1 456688999999999999999999999999999999998766
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=280.08 Aligned_cols=202 Identities=29% Similarity=0.495 Sum_probs=176.9
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC---C--cEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD---G--IQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~---~--~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
++.++.....+.||+|-||.||+|++.+ | -.||||.-+.. ....+.|.+|..+|++++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 4555566677889999999999999643 3 45899988753 3457889999999999999999999999986 4
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..+||||..+-|.|.+||+... ..++......++.||..+|+|||+. .++||||.++|||+....-+|++|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 5799999999999999997654 3588889999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++.+..+.....+...-++.|||||.+.-+.||..+|||-|||.+||+++ |.+||-
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 99887766555555566889999999999999999999999999999988 999983
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=265.63 Aligned_cols=196 Identities=30% Similarity=0.434 Sum_probs=177.0
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
-+++.++||+|+||.|||+.++. |+.+|||.++. +.+.+++..||.++.+.+.+++|+.+|.+-....+++|||||--
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 35667899999999999999875 89999999864 45689999999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+..+.++... ++++++....++...++||+|||.. .-+|||||+.|||++-+|.+|++|||.+..+..... .
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 99999987544 4799999999999999999999998 889999999999999999999999999987654322 2
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+..||+.|||||++..-.|..++||||||+...||..|++||+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence 345789999999999999999999999999999999999999986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=264.80 Aligned_cols=193 Identities=29% Similarity=0.427 Sum_probs=165.5
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
+.||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999998865432 2356889999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeec
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
+++.... ..+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9985432 3478999999999999999999998 999999999999999999999999999875433221111122
Q ss_pred ccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.++..|+|||++.+..++.++||||||+++||+++ |+.||.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 34678999999988889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=272.45 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=169.7
Q ss_pred HhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCCC--hHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
.++.+.++||+|+||.||+|...+ ++.||+|+++..... .+++.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 456777889999999999998643 478999999754322 356889999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhcc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC
Q 037563 474 LAYEYLVNGSLDKWIFNST------------EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 541 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~ 541 (606)
+++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||.||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123478888999999999999999998 999999999999999999
Q ss_pred cEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 542 TAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 542 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999998865433221 1223456789999999988889999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=274.78 Aligned_cols=193 Identities=31% Similarity=0.402 Sum_probs=173.9
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
-+.||+||||.||-++.++ |+-+|.|++.+. .++..-..+|-.+|.+++.+.||.+-..+...+.+++|+..|+|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 3689999999999999765 888999988643 34556678899999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|.-+|.+... +.++++.+.-++.+|+.||++||.+ .|++||+||.|||||++|+++|+|+|+|..+......
T Consensus 270 GDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 270 GDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred CceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 999999987654 5689999999999999999999999 9999999999999999999999999999887655432
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...+||.+|||||++.+..|+...|.||+||++|||+.|+.||.
T Consensus 344 -~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred -ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 34589999999999999999999999999999999999999993
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=282.75 Aligned_cols=189 Identities=27% Similarity=0.332 Sum_probs=159.5
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhc---ccCCcceeecceeccccceeeeeeccC
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNV---HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
||+|+||+||+++... ++.||+|++.... .....+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999764 8899999986431 2233455666666655 699999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 9999988542 3588899999999999999999998 999999999999999999999999999875432221 1
Q ss_pred eeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 2345789999999998764 47899999999999999999999983
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.06 Aligned_cols=207 Identities=29% Similarity=0.466 Sum_probs=172.6
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeeccee
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCI 467 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~ 467 (606)
.++....+.+.++||+|+||.||++++. .++.||+|+++... ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4566667777899999999999999863 24689999997542 22357889999999997 999999999999
Q ss_pred ccccceeeeeeccCCChhhhhhhccc------------------------------------------------------
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTE------------------------------------------------------ 493 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 493 (606)
.....++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 037563 494 ----------------------------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPE 533 (606)
Q Consensus 494 ----------------------------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~ 533 (606)
....+++.....++.||+.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778889999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 534 NVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 534 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999986543222 11122356788999999998889999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=268.44 Aligned_cols=198 Identities=29% Similarity=0.447 Sum_probs=168.4
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceecc------cccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG------AHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~------~~~~l 474 (606)
.+++.+.||+|+||.||+|...+ ++.+|+|++........++.+|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 34556789999999999999764 78899999976666677899999999998 699999999998753 35789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999986532 24588999999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......|+..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 162 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred ccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 43221 123456889999999886 3457889999999999999999999983
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=266.33 Aligned_cols=198 Identities=26% Similarity=0.511 Sum_probs=172.4
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
.+.+.+.||+|+||.||++.+.+++.+++|.+........++.+|++++++++|||++++++++......++|+||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45677899999999999999877889999998766666778999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++.... ..+++..+..++.|++.+|+|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999986432 3478899999999999999999998 999999999999999999999999999876543322211
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 22334678999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.44 Aligned_cols=196 Identities=25% Similarity=0.411 Sum_probs=165.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
++.+.++||+|+||.||+++.+ .++.||+|+++... .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3566788999999999999976 47889999986432 23456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 75 8888875432 3478888999999999999999998 999999999999999999999999999976443222
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1223467899999998865 467899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.69 Aligned_cols=194 Identities=23% Similarity=0.378 Sum_probs=159.0
Q ss_pred ccccCCcCceeEEEEEeC---CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec--cccceeeeeeccC
Q 037563 407 STKLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLLAYEYLVN 481 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~E~~~~ 481 (606)
.++||+|+||.||+++.. .++.+|+|.++... ....+.+|+.++++++||||+++++.+.+ +...++++||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999965 35789999986543 34567889999999999999999998854 4457899999864
Q ss_pred CChhhhhhhccc-----cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE----cCCCcEEEeeccCCc
Q 037563 482 GSLDKWIFNSTE-----ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAK 552 (606)
Q Consensus 482 gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgla~ 552 (606)
+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 78887753221 123588889999999999999999998 99999999999999 466789999999998
Q ss_pred ccCcCcc--eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 553 LMNREES--LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 553 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....... .......+|+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 7643321 122345789999999998764 5789999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=265.86 Aligned_cols=196 Identities=27% Similarity=0.389 Sum_probs=168.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC------CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
++..+.||+|++|.||++... +++.+++|.+.... ...+.+.+|++++++++||||+++++++.++...++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 445678999999999999975 48899999886432 12357889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 84 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999998543 3478888999999999999999998 999999999999999999999999999976543
Q ss_pred Ccceee--eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVY--TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 221111 23457789999999999889999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=266.70 Aligned_cols=196 Identities=28% Similarity=0.422 Sum_probs=161.7
Q ss_pred cccCCcCceeEEEEEeCC---CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||.||+|+..+ +..+++|.++.... ...++.+|+.++++++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998865432 3357889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc-cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 483 SLDKWIFNSTE-ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 483 sL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
+|.+++..... .....++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965432 123456778889999999999999998 99999999999999999999999999997543322211
Q ss_pred -eeecccccCccccccccCC-------CCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 -YTTLRGTRGYLAPEWITNN-------PISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 -~~~~~gt~~y~aPE~~~~~-------~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|+|||++.+. .++.++|+||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 1234567889999988642 35789999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=270.23 Aligned_cols=204 Identities=26% Similarity=0.458 Sum_probs=172.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
+....+.+.+.||+|+||.||+|...+ +..|++|.+.... ....++.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445566778899999999999999753 3689999986443 23457889999999999999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhcccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEE------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
..++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +++|+||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999999654322 23478889999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 545 VSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC
Confidence 9999999865443221 1223456789999999988889999999999999999998 99887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.13 Aligned_cols=197 Identities=27% Similarity=0.443 Sum_probs=164.1
Q ss_pred hhccccccCCcCceeEEEEEeCC-Cc----EEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.+++.+.||+|+||.||+|++.. ++ .+++|.+.... ...+++..|+..+++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 34566889999999999999743 43 47778775332 223578888889999999999999998754 557899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 87 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999996533 3588999999999999999999998 99999999999999999999999999998654
Q ss_pred cCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 3322 22233456789999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=284.32 Aligned_cols=193 Identities=25% Similarity=0.472 Sum_probs=164.9
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEec-----ccCCChHHHHHHHHHHHhcccCCcceeecceecccc--ceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE-----SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH--RLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~-----~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~--~~lV~ 476 (606)
.|..+||+|+|=+||||.+.. |.+||---++ ......+.|..|+.+|+.|+||||++++..+.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 455679999999999999864 6677644332 223345789999999999999999999999987665 66889
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~ 555 (606)
|.|..|+|..|+.+.. .++.+....|+.||++||.|||++ .++|||||||..||+|+ ..|.+||.|+|+|..+.
T Consensus 123 EL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999996543 478889999999999999999997 45999999999999997 46899999999999876
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ....|||.|||||+.. ..|.+.+||||||++++||+|+..|||
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 5542 2368999999999877 669999999999999999999999996
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.39 Aligned_cols=200 Identities=26% Similarity=0.442 Sum_probs=173.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||.||+++.. +++.++||.+.... ...+++.+|+.+++.++|+||+++++++.++...+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 3456678999999999999964 68999999886432 234578899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.........+++..+..++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999875444445688999999999999999999998 9999999999999999999999999998866443
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....++..|+|||++.+..++.++|+||||+++|||++|+.||.
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 221 233568899999999988889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=267.72 Aligned_cols=196 Identities=25% Similarity=0.413 Sum_probs=160.0
Q ss_pred cccCCcCceeEEEEEeCC---CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
++||+|+||.||+|...+ ...+++|.+.... ....++.+|+..++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998644 3568888775432 23457889999999999999999999999999999999999999
Q ss_pred Chhhhhhhcccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce-
Q 037563 483 SLDKWIFNSTEE-SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 560 (606)
Q Consensus 483 sL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 560 (606)
+|.+++...... ....++.....++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764332 23356778889999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeecccccCccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITN-------NPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
......+++.|+|||++.. ..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 1122345678999998642 356789999999999999999 788874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=267.78 Aligned_cols=195 Identities=33% Similarity=0.549 Sum_probs=169.7
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChH---HHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKK---EFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~---~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||+||+++... ++.+|+|++........ ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3567889999999999999876 56899999976643332 3355999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++. ....+++..+..++.||++||.+||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999996 234578999999999999999999998 999999999999999999999999999976422 12
Q ss_pred eeeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......++..|+|||++. +...+.++|+||+|++++||++|+.||.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334567899999999998 7889999999999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.27 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=171.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+|+.. +++.||||.++... ....++.+|++++++++||||+++++++.+....++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3566788999999999999975 58899999875422 223568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.........+++..+..++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999865444445678899999999999999999998 9999999999999999999999999998876433
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~ 206 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 22 112356788999999998888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=283.68 Aligned_cols=197 Identities=24% Similarity=0.301 Sum_probs=168.8
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeCC---CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPD---GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+....+++.+.||+|+||.||++...+ ++.|++|.+... +...+|++++++++||||+++++.+......+
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34445567888999999999999998543 578999987542 34568999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|||++. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 163 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9999985 688888832 24589999999999999999999998 999999999999999999999999999976
Q ss_pred cCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 554322 1123457899999999999999999999999999999999999998
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=301.02 Aligned_cols=211 Identities=23% Similarity=0.377 Sum_probs=171.7
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec-
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE- 468 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~- 468 (606)
+...+.....+.+.++||+|+||.||+++... +..+|+|.+.... .....+..|+.++++++|||||++++++.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 33445555667888999999999999999865 6788999886432 234678999999999999999999998854
Q ss_pred -cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCC----CceeecCCCCCCeEEcC----
Q 037563 469 -GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE----VKIVHCDIKPENVLLDD---- 539 (606)
Q Consensus 469 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~----~~iiH~dlkp~NIll~~---- 539 (606)
....+|||||+++++|.++|.........+++..++.|+.||+.||.|||+... .+|+|+||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346789999999999999997544333568999999999999999999998521 25999999999999964
Q ss_pred -------------CCcEEEeeccCCcccCcCcceeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCC
Q 037563 540 -------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 540 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 23489999999986643321 233578999999998854 4578999999999999999999999
Q ss_pred CC
Q 037563 605 FS 606 (606)
Q Consensus 605 fs 606 (606)
|.
T Consensus 243 F~ 244 (1021)
T PTZ00266 243 FH 244 (1021)
T ss_pred CC
Confidence 94
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.41 Aligned_cols=192 Identities=26% Similarity=0.418 Sum_probs=163.4
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
++||+|+||.||++++. +++.+|+|...... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 58899999876432 2346799999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee-e
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-T 563 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 563 (606)
.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++.......... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986432 3578999999999999999999998 999999999999999999999999999876443211110 1
Q ss_pred ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
....+..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~ 197 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 1123457999999988889999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=270.57 Aligned_cols=202 Identities=29% Similarity=0.520 Sum_probs=170.2
Q ss_pred HhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCC-ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.+.||+|+||.||+++.. ++..+++|.++.... ..+.+.+|+..+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34566788999999999999843 345689998865432 34679999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc
Q 037563 475 AYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 542 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~ 542 (606)
||||+++++|.+++..... ....+++..+..++.||+.||+|||++ +++|+||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999965321 123478999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 543 AKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999765433221 1123446788999999998889999999999999999999 999973
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=263.11 Aligned_cols=190 Identities=31% Similarity=0.493 Sum_probs=161.6
Q ss_pred ccCCcCceeEEEEEeC---CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 409 KLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+||+|+||.||+|.++ ++..+|+|+++.... ..+++.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 478899999864432 2467899999999999999999999875 45678999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee-
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV- 561 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 561 (606)
+|.+++... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999998543 3578899999999999999999998 99999999999999999999999999998765443221
Q ss_pred -eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 -YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 -~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|+|||.+....++.++|+||||+++|||++ |+.||.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 112234578999999988888999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=263.37 Aligned_cols=191 Identities=29% Similarity=0.502 Sum_probs=161.0
Q ss_pred ccCCcCceeEEEEEeC---CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 409 KLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
.||+|+||.||+|++. ++..||+|++..... ..+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 356799999865432 3467999999999999999999999885 456799999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee--
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-- 561 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 561 (606)
|.+++.... ..+++..+.+++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999986432 3588999999999999999999998 99999999999999999999999999998654433211
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|+|||.+....++.++||||||+++||+++ |+.||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 112233578999999988889999999999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=268.59 Aligned_cols=204 Identities=24% Similarity=0.423 Sum_probs=172.3
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC-----CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceec-ccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAH 471 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~ 471 (606)
...++.+.+.||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45567778899999999999999866 6889999886442 234678899999999999999999998766 567
Q ss_pred ceeeeeeccCCChhhhhhhcccc----ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEee
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEE----SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 547 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 547 (606)
.++++||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998654322 14588999999999999999999998 999999999999999999999999
Q ss_pred ccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 548 FGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 548 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 9999865443321 1122345678999999998889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=264.46 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=173.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||++... +++.+++|.++.. ....+.+.+|++++++++|+||+++++.+.+....++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3567788999999999999987 6899999988632 1235678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.........+++.++..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999876544445688999999999999999999998 9999999999999999999999999998865443
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 206 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCc
Confidence 221 22346788999999998888999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=278.77 Aligned_cols=193 Identities=27% Similarity=0.336 Sum_probs=162.9
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccc------c
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------H 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~ 471 (606)
..+.+.+.||+|+||.||+++.. .++.||+|++... .....++.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667789999999999999975 4889999998643 223467889999999999999999999886443 4
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 6899999976 5655552 2367788889999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 7643322 1234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=267.25 Aligned_cols=189 Identities=28% Similarity=0.398 Sum_probs=165.3
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.+.||+|+||.||+++.. +++.+|+|++.... ...+++.+|++++.+++||||+++++.+......++|+||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 356678999999999999964 57889999986432 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99997653 356788889999999999999998 99999999999999999999999999997654322
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 233578999999999998889999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=263.22 Aligned_cols=196 Identities=33% Similarity=0.568 Sum_probs=172.1
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
...+++.+.||+|+||.||++.. .++.|++|.++......+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 34567788999999999999998 47889999997665556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999865432 3588999999999999999999998 999999999999999999999999999987633221
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....+..|+|||.+....++.++||||||++++||++ |+.||.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 2344678999999988889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=268.65 Aligned_cols=204 Identities=27% Similarity=0.464 Sum_probs=168.9
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
+....+.+.++||+|+||.||+|..++ +..||+|.+..... ...++.+|+..+++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 445667788999999999999997542 45799998864432 2346888999999999999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhcccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEE------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
..++||||+++|+|.+++...... ...+++..+.+++.|++.||.|||++ +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999653211 13356778889999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 545 VSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 99999998654322211 112344678999999998889999999999999999999 78887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.32 Aligned_cols=206 Identities=26% Similarity=0.444 Sum_probs=171.1
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~ 466 (606)
++....+.+.++||+|+||.||+++.. +...+|+|.++... ....++..|+.++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344567788899999999999999853 23569999987532 2345788899999999 799999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
......++||||+++++|.+++..... ....+++.+++.++.||+.||+|||+. +++|+||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999975432 123588999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|++++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999987654322111 112234568999999988889999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=270.55 Aligned_cols=203 Identities=24% Similarity=0.414 Sum_probs=167.9
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC---------------CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCccee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD---------------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKL 462 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~---------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l 462 (606)
.+..+++.++||+|+||.||+++..+ ...||+|.+.... ....++.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 44567788899999999999988643 2348999886532 234578999999999999999999
Q ss_pred ecceeccccceeeeeeccCCChhhhhhhccc--------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTE--------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
++++......++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864321 112367889999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh--CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG--GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt--G~~pf 605 (606)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999997654332211 122345678999999988889999999999999999998 56676
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=272.35 Aligned_cols=199 Identities=27% Similarity=0.512 Sum_probs=165.8
Q ss_pred HhhccccccCCcCceeEEEEEeCC-Cc--EEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GI--QVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+.+.+.||+|+||.||++.+.+ +. .+++|.++.. ....+++.+|++++.++ +|+||+++++++.++...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 445777899999999999999753 43 4677777543 22346788999999999 899999999999999999999
Q ss_pred eeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 476 YEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
+||+++++|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975431 123578999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 544 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
||+|||+++...... .......+..|+|||++.+..++.++||||||++++||+| |..||
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 224 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence 999999986432111 1111234668999999988889999999999999999998 99998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=264.38 Aligned_cols=197 Identities=25% Similarity=0.349 Sum_probs=168.7
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
...+++.++||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.+++||||+++++.+......++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 345677789999999999999974 57899999986442 3446788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998542 3578899999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ......++..|+|||.+. ...++.++||||||+++|||++|+.||
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~ 209 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 1 112346788999999874 345788999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=283.88 Aligned_cols=191 Identities=25% Similarity=0.281 Sum_probs=163.7
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+.+.+.||+|+||.||++++.. ++.||||... ...+.+|++++++++|+|||++++++..+...++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 45667889999999999999865 7889999642 2346789999999999999999999999999999999995
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce-
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 560 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 560 (606)
++|.+++.... ..+++..+..|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 244 ~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 68888885432 3589999999999999999999998 9999999999999999999999999999865433221
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122356899999999999999999999999999999999987653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=269.99 Aligned_cols=203 Identities=31% Similarity=0.501 Sum_probs=171.6
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||++... .+..||+|+++... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34456778899999999999999742 24579999887543 2245789999999999 799999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||+++++|.+++..... ..+++.+...++.||+.||+|||++ +++|+||||+||+++.++.+|++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999865332 3478999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 550 LAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 99866543321 1122345778999999998889999999999999999998 999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=265.96 Aligned_cols=199 Identities=29% Similarity=0.472 Sum_probs=166.4
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCc----EEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGI----QVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
...+++.++||+|+||.||+|++. +++ .||+|+++... ...+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 445677789999999999999853 343 48999986432 235678899999999999999999999875 4568
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+++||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999986432 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 65433211 112334678999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=269.21 Aligned_cols=194 Identities=25% Similarity=0.364 Sum_probs=167.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.++||+|+||.||++.... +..+++|.+.... ....++.+|++++.+++||||+++++.+.++...++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 4567889999999999999764 7788988876432 223568899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++... ..+++..+..++.|+++||.|||+. .+++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999643 3478889999999999999999973 289999999999999999999999999987653321
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 133568899999999988889999999999999999999999983
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=271.78 Aligned_cols=194 Identities=23% Similarity=0.381 Sum_probs=158.5
Q ss_pred cccCCcCceeEEEEEeCC---CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec--cccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~E~~~~g 482 (606)
.+||+|+||.||+++..+ +..+|+|.++... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999753 4789999886543 34567899999999999999999998854 4567899999875
Q ss_pred Chhhhhhhcc-----ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE----cCCCcEEEeeccCCcc
Q 037563 483 SLDKWIFNST-----EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKL 553 (606)
Q Consensus 483 sL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgla~~ 553 (606)
+|.+++.... .....+++..+..++.||+.||.|||+. +++||||||+||++ ++++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777764321 1123578889999999999999999998 99999999999999 5678999999999987
Q ss_pred cCcCcc--eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREES--LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 644322 11234567999999998876 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=263.49 Aligned_cols=198 Identities=26% Similarity=0.468 Sum_probs=165.3
Q ss_pred ccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecccc------
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH------ 471 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~------ 471 (606)
.+.+.||+|+||.||+|.+.. +..||+|+++.... ...++.+|++.++.++||||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456789999999999999753 36799999875422 24578999999999999999999998876554
Q ss_pred ceeeeeeccCCChhhhhhhccc--cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTE--ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
.++++||+++++|..++..... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 6899999999999999865432 224588999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 550 LAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 550 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~ 216 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 998664432211 112234678999999988889999999999999999999 88887
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.25 Aligned_cols=205 Identities=25% Similarity=0.467 Sum_probs=172.1
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~ 466 (606)
++....+.+.+.||+|+||.||+++.. ++..||+|.+... ....+++.+|+.++..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 355667788899999999999999741 2457999988643 23456789999999999 899999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
......++||||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975422 123578889999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999876443221 1222345678999999988889999999999999999998 78877
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=269.36 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=169.8
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
++.+.+.||+|+||.||+|+.. +++.+++|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 4566678999999999999964 58899999886543 345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999843 2478889999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 223468889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=265.03 Aligned_cols=198 Identities=25% Similarity=0.480 Sum_probs=163.5
Q ss_pred cccccCCcCceeEEEEEeCCC---cEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------ccce
Q 037563 406 FSTKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AHRL 473 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~~---~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~~ 473 (606)
+.+.||+|+||.||+|++.+. ..+|+|.++... ...+++..|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999997653 258999886532 2346788999999999999999999987532 2468
Q ss_pred eeeeeccCCChhhhhhhcc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 474 LAYEYLVNGSLDKWIFNST--EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
+++||+++++|.+++.... .....+++.....++.||+.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999885332 2234588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 552 KLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 8765432211 122345678999999999899999999999999999999 888884
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=268.95 Aligned_cols=205 Identities=25% Similarity=0.444 Sum_probs=171.6
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+++.+.||+|+||.||++...+ ...+|+|++.... ....++.+|+.++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 334456677889999999999998642 3679999886532 2345688999999999 799999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhcc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNST------------EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
...+++|||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999996532 2234688999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999998765432211 122345678999999988889999999999999999998 988873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=261.45 Aligned_cols=196 Identities=32% Similarity=0.549 Sum_probs=171.0
Q ss_pred cccCCcCceeEEEEEeCC----CcEEEEEEecccCCC--hHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||++...+ +..+++|.++..... .+++.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999864 788999999765433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccc-----ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 482 GSLDKWIFNSTEE-----SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 482 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765221 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred Ccc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 557 EES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 557 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... .......++..|+|||.+....++.++||||+|++++||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 432 11233457889999999988889999999999999999999 699984
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=267.13 Aligned_cols=192 Identities=32% Similarity=0.419 Sum_probs=170.1
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.+.+.||+|+||.||++... +++.+|+|+++... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456788999999999999976 47899999986432 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999998653 3588899999999999999999998 9999999999999999999999999999876443
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....+++.|+|||.+.+...+.++|+||||+++|||++|+.||.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 123468899999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=261.56 Aligned_cols=196 Identities=30% Similarity=0.452 Sum_probs=172.9
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+++.+.||+|+||.||+++..+ ++.+++|.++.... .+++.+|++++++++|+||+++++.+.+....++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 35566789999999999999875 78999999875433 77899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 83 ~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 83 GSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999985432 4588999999999999999999998 999999999999999999999999999987654321 1
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 223457889999999998889999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.17 Aligned_cols=201 Identities=27% Similarity=0.519 Sum_probs=168.8
Q ss_pred HhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.++||+|+||.||++... ++..+++|.++... ...+++.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34566788999999999999742 35678999886443 345689999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhcccc-----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 475 AYEYLVNGSLDKWIFNSTEE-----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
++||+++++|.+++...... ...+++..++.++.||+.||+|||+. +++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998654321 13478899999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 544 KVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999997654322211 122335678999999998889999999999999999998 99998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=274.57 Aligned_cols=205 Identities=26% Similarity=0.453 Sum_probs=168.0
Q ss_pred HHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+++.+.||+|+||.||++.. ..++.||||+++... ...+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456778889999999999999973 246889999997532 2345788999999999 689999999988654
Q ss_pred -ccceeeeeeccCCChhhhhhhccc-------------------------------------------------------
Q 037563 470 -AHRLLAYEYLVNGSLDKWIFNSTE------------------------------------------------------- 493 (606)
Q Consensus 470 -~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 493 (606)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864321
Q ss_pred --------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-eeeee
Q 037563 494 --------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTT 564 (606)
Q Consensus 494 --------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~ 564 (606)
....+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012367888899999999999999998 999999999999999999999999999986533222 11122
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 283 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 345678999999988889999999999999999997 888873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=267.46 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=161.8
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhc---ccCCcceeecceecc-----cc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNV---HHVHLVKLKGFCIEG-----AH 471 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~-----~~ 471 (606)
+++.+.||+|+||.||+++.. +++.||+|.++... .....+.+|+.+++++ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456688999999999999976 48899999886432 2234566777777665 699999999987642 35
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++++||+++ +|.+++..... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7899999985 88888865332 3488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+....... .....++..|+|||.+.+..++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 86643321 233567899999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=287.26 Aligned_cols=194 Identities=22% Similarity=0.366 Sum_probs=160.9
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccC------Ccceeecceecc-ccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV------HLVKLKGFCIEG-AHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~------nIv~l~g~~~~~-~~~~ 473 (606)
..+.+.++||+|+||+||++++.. ++.||||+++......+++..|++++++++|. +++++++++... .+.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 456677899999999999999754 78899999976544456677888888887654 588888888754 4678
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC------------
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF------------ 541 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~------------ 541 (606)
+|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 999987 77888888543 3588899999999999999999973 2899999999999998765
Q ss_pred ----cEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 542 ----TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 542 ----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987643221 234678999999999999999999999999999999999999994
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=269.14 Aligned_cols=198 Identities=28% Similarity=0.512 Sum_probs=164.6
Q ss_pred hccccccCCcCceeEEEEEeCC-C--cEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-G--IQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+.+.+.||+|+||.||+|++++ + ..+++|.++... ...+++.+|++++.++ +||||+++++++.+....++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567889999999999999754 3 347888886432 2346789999999999 79999999999999999999999
Q ss_pred eccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEE
Q 037563 478 YLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 545 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl 545 (606)
|+++++|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999965321 113588899999999999999999998 9999999999999999999999
Q ss_pred eeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 546 SDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 546 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus 161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999998643211 11111233567999999988889999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=264.09 Aligned_cols=198 Identities=30% Similarity=0.545 Sum_probs=168.4
Q ss_pred HhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.+.||+|+||.||+|+.. .+..+|+|.++... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667789999999999999864 23479999886532 2346789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+|++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999996432 3578899999999999999999998 99999999999999999999999999998765
Q ss_pred cCcceeee--ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 556 REESLVYT--TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 556 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
........ ...++..|+|||++.+..++.++|+||||+++||+++ |+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 43322111 1223568999999998889999999999999999887 99998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=264.58 Aligned_cols=198 Identities=29% Similarity=0.550 Sum_probs=167.7
Q ss_pred HhhccccccCCcCceeEEEEEeCC-C---cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..++..+.||+|+||.||+++++. + ..+++|.++... ...+++.+|++++++++|+||+++.+++.+....++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345667889999999999999753 3 379999886542 2346789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999986432 3578999999999999999999998 99999999999999999999999999998664
Q ss_pred cCcceeee--ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 556 REESLVYT--TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 556 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
........ ....+..|+|||++....++.++||||||+++|||++ |+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 33221111 1223457999999988889999999999999999998 99998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=263.40 Aligned_cols=196 Identities=27% Similarity=0.392 Sum_probs=164.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC------CChHHHHHHHHHHHhcccCCcceeecceecc--cccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l 474 (606)
+...+.||+|+||.||+++..+ ++.|++|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 3456789999999999999754 8899999885321 1235788899999999999999999988764 45779
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+|||+++++|.+++... ..+++....+++.|++.+|+|||+. +++|+||+|+||++++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999998643 2477888899999999999999998 9999999999999999999999999998865
Q ss_pred CcCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 42211 11223458889999999988889999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=266.24 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=167.8
Q ss_pred HhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+.+.+.||+|+||.||++.+.+ +..|++|.++.... ...++..|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 445667889999999999999854 46789998864432 3457899999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccc---cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cEEEee
Q 037563 474 LAYEYLVNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSD 547 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~kl~D 547 (606)
+||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +++|+||||+||++++++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999965432 123588999999999999999999998 999999999999998765 599999
Q ss_pred ccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 548 FGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 548 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99998763322111 112233568999999998889999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=261.26 Aligned_cols=194 Identities=31% Similarity=0.513 Sum_probs=166.6
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeeccee-ccccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI-EGAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-~~~~~~lV~E~~~ 480 (606)
..+.+.+.||+|+||.||++.. .+..+++|.++.. ...+.+.+|+.++++++|+|++++++++. ++...++++||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4567778999999999999987 4778999988643 34567999999999999999999999764 4567899999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999865332 3578899999999999999999998 99999999999999999999999999987654322
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 12344678999999998889999999999999999998 999873
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=266.26 Aligned_cols=200 Identities=27% Similarity=0.367 Sum_probs=167.9
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeeccee-----cccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI-----EGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~-----~~~~~~l 474 (606)
.++++.+.||+|+||.||+++... ++.+|+|+++.......++.+|+.++.++ +|+||+++++++. .+...++
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 345566889999999999999754 78999998876554557788999999999 6999999999874 3456899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999998865433345688889999999999999999998 9999999999999999999999999998765
Q ss_pred CcCcceeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... ......+++.|+|||++.. ..++.++||||||+++|||++|+.||
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 43221 1233468999999998753 44788999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=266.75 Aligned_cols=199 Identities=31% Similarity=0.481 Sum_probs=166.5
Q ss_pred ccccccCCcCceeEEEEEeC------CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+.+.||+|+||.||+|+.. ....+++|.+..... ..+++.+|+.++++++||||+++++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999863 235788888864432 2467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccc--------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 037563 477 EYLVNGSLDKWIFNSTE--------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIl 536 (606)
||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 99999999999864321 123578899999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 537 LDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 537 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999865433221 1122345678999999988889999999999999999999 999884
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=269.81 Aligned_cols=205 Identities=24% Similarity=0.439 Sum_probs=169.9
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeeccee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~ 467 (606)
+....+.+.++||+|+||.||+++.. ....+|+|.++... ....++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456678899999999999999742 24578999887532 2345788999999999 6999999999999
Q ss_pred ccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
+....++++||+++++|.+++..... ....+++..+..++.||+.||.|||++ +++|+||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 99999999999999999999965321 124588999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++++++.+||+|||+++........ ......++..|||||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999865432211 1112234567999999988889999999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.16 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=158.2
Q ss_pred cccCCcCceeEEEEEeCCC---cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
++||+|+||.||++...++ ..+++|.++... ...+++.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986443 346677665432 23568999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-ee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LV 561 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 561 (606)
+|.+++..........++.....++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976433334466777889999999999999998 999999999999999999999999999864322111 11
Q ss_pred eeecccccCccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITN-------NPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 123467889999998743 245789999999999999997 566773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=264.30 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=169.9
Q ss_pred HhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCCC--hHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+...+.||+|+||.||+++.+ +.+.+++|.+...... .+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 44556678999999999999964 2467999988654332 468999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccc-----cccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeec
Q 037563 474 LAYEYLVNGSLDKWIFNSTEES-----RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 548 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 548 (606)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544221 2589999999999999999999998 9999999999999999999999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|+++..............++..|+|||.+.+...+.++||||||++++||++ |..||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9987543332222233456778999999988888999999999999999999 78887
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=250.77 Aligned_cols=190 Identities=31% Similarity=0.484 Sum_probs=166.0
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEecccC-----CCh----HHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-----QGK----KEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-----~~~----~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
.+.||+|..+.|-+...+. |.+.|+|++.... ... +.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4569999999999988764 7899999986432 112 3456799999998 599999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+|.|+.|.|.+||.. .-.++++....|+.|+..|++|||.+ .|+||||||+|||+|++.++||+|||.+..+.
T Consensus 102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999943 34699999999999999999999999 99999999999999999999999999999877
Q ss_pred cCcceeeeecccccCccccccccC------CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+.+. ....+|||+|+|||.+.- ..|+..+|+||.|||+|-|+.|-+||
T Consensus 175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 6554 356899999999998742 34788999999999999999999998
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=268.10 Aligned_cols=202 Identities=25% Similarity=0.444 Sum_probs=168.1
Q ss_pred HHhhccccccCCcCceeEEEEEeC-----------------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-----------------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVK 461 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-----------------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~ 461 (606)
...+.+.++||+|+||.||++... +...+|+|++.... ...+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 445678889999999999998642 23468999986532 23468999999999999999999
Q ss_pred eecceeccccceeeeeeccCCChhhhhhhcccc-------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE-------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 462 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
+++++......++||||+++++|.+++...... ...+++.++..++.||+.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999754321 13477889999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh--CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG--GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt--G~~pf 605 (606)
|++++++.+||+|||+++.+....... .....++..|++||......++.++||||||+++|||++ |..||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 999999999999999998654332211 112334678999998888889999999999999999998 77787
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.21 Aligned_cols=191 Identities=35% Similarity=0.529 Sum_probs=162.4
Q ss_pred cccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
++||+|+||.||+|++.. +..+|+|.+..... ..+++.+|++++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998643 26899999875543 4568999999999999999999999876 4567999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... .+++..+..++.|++.+|+|||.. +++|+||||+||++++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999996533 578999999999999999999998 99999999999999999999999999998664433211
Q ss_pred e--eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 Y--TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~--~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 1 11233568999999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=261.31 Aligned_cols=192 Identities=29% Similarity=0.462 Sum_probs=165.9
Q ss_pred cccCCcCceeEEEEEeCC--C--cEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD--G--IQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--~--~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|++|.||++.+.+ + ..||+|.++.... ..+++.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 2 3699999875533 45689999999999999999999999988 888999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce-
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 560 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 560 (606)
++|.+++..... ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4588999999999999999999998 9999999999999999999999999999876543221
Q ss_pred -eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 561 -VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 561 -~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 1122456789999999998889999999999999999999 99998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=276.68 Aligned_cols=193 Identities=26% Similarity=0.294 Sum_probs=163.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------cc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~ 471 (606)
..+.+.+.||+|+||.||+++.. .++.||||++.... ...+++.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45667788999999999999975 47889999996532 2346788899999999999999999987543 34
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 6899999975 6766663 2367888899999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 8654322 2234578999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=263.00 Aligned_cols=193 Identities=27% Similarity=0.518 Sum_probs=161.5
Q ss_pred cccCCcCceeEEEEEeCC-Cc--EEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GI--QVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+|++.+ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999864 33 5788888643 23346789999999999 799999999999999999999999999
Q ss_pred CChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 482 GSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 482 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999965431 123478899999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
+++...... .......+..|+|||++....++.++||||||++++||++ |+.||
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 986322111 1111234567999999988889999999999999999997 99998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=261.38 Aligned_cols=186 Identities=28% Similarity=0.472 Sum_probs=160.1
Q ss_pred cccCCcCceeEEEEEeCCCc-----------EEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 408 TKLGQGGFGSVYLGMLPDGI-----------QVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
+.||+|+||.||+|.+.+.. .+++|.+.........+.+|+.++++++||||+++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999986533 57888776554447889999999999999999999999988 7789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-------cEEEeecc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-------TAKVSDFG 549 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-------~~kl~Dfg 549 (606)
||+++++|.+++..... .+++..+..++.||+.||+|||++ +|+|+||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999965432 588899999999999999999998 999999999999999888 79999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCC--CCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
++...... ....++..|+|||++... .++.++||||||+++|||++ |..||
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 99865431 223466789999998876 78999999999999999999 57776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=267.33 Aligned_cols=202 Identities=29% Similarity=0.484 Sum_probs=170.1
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-----------------CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVK 461 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-----------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~ 461 (606)
...+++.++||+|+||.||++++.+ +..||+|++.... ...+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778899999999999998653 2458999986543 23568899999999999999999
Q ss_pred eecceeccccceeeeeeccCCChhhhhhhcccc-------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE-------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 462 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
+++++..+...++++||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999999999999764321 12588999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh--CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG--GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt--G~~pf 605 (606)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999986543322 11223456778999999988889999999999999999998 66776
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=262.55 Aligned_cols=196 Identities=22% Similarity=0.341 Sum_probs=168.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.++||+|+||.||+++.. +++.+|+|.++... .....+.+|+.+++.++||||+++++.+......++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 34566788999999999999975 48899999986543 33456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++... ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998543 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......|+..|+|||++. ...++.++|+|||||++|||++|+.||
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~ 209 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence 123456899999999874 456788999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.25 Aligned_cols=188 Identities=26% Similarity=0.440 Sum_probs=158.2
Q ss_pred cccCCcCceeEEEEEeCC-------------CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 408 TKLGQGGFGSVYLGMLPD-------------GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-------------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+.||+|+||.||+|++.+ ...|++|.+.... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889876543 23457888999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc-------EEEe
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-------AKVS 546 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~-------~kl~ 546 (606)
+||||+++++|..++.... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999885432 3588899999999999999999998 9999999999999987664 8999
Q ss_pred eccCCcccCcCcceeeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHH-hCCCCCC
Q 037563 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEII-GGRKSFS 606 (606)
Q Consensus 547 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~ell-tG~~pfs 606 (606)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||.
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99998765332 2245788999999886 466889999999999999998 5888873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.40 Aligned_cols=196 Identities=27% Similarity=0.418 Sum_probs=167.3
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+++.++||+|+||.||++.... +..+++|.+.... ...+.+.+|+++++.++||||+++++.+......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999999865 6788999886432 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|..++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 99998875422 3588999999999999999999998 999999999999999999999999999876533221 1
Q ss_pred eeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 23356889999999874 3457789999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=264.16 Aligned_cols=198 Identities=31% Similarity=0.559 Sum_probs=167.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC-C---cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.+.||+|+||.||+|.+.. + ..|++|.+.... ...++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778899999999999999753 2 369999986532 2346899999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999986532 3578899999999999999999998 99999999999999999999999999988654
Q ss_pred cCcce-eeee-cc--cccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 556 REESL-VYTT-LR--GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 556 ~~~~~-~~~~-~~--gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
..... .... .. .+..|+|||.+.+..++.++||||||+++||+++ |+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 33221 1111 11 2457999999998899999999999999999987 99998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.72 Aligned_cols=193 Identities=33% Similarity=0.445 Sum_probs=163.3
Q ss_pred ccccccCCcCceeEEEEEe-----CCCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecc--ccceee
Q 037563 405 NFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLA 475 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV 475 (606)
.+.+.||+|+||+||++.. .+++.||+|.++... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678899999999988653 357789999987543 2456789999999999999999999988654 357899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999853 2488999999999999999999998 99999999999999999999999999998664
Q ss_pred cCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... ......++..|+|||.+.+..++.++||||||++++||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 33221 111234566799999998888999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=272.12 Aligned_cols=206 Identities=26% Similarity=0.463 Sum_probs=171.7
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC--------CcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~ 466 (606)
++...++++.+.||+|+||.||+++... ...||+|.++... ...+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 4555678888999999999999997421 2468999886432 2346899999999999 799999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
.+....++++||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999975321 223578899999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999865432211 1122334567999999999889999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.49 Aligned_cols=195 Identities=29% Similarity=0.455 Sum_probs=167.9
Q ss_pred ccccccCCcCceeEEEEEeCCCcEEEEEEecccCC-------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+.||+|+||+||+|...+++.+|+|.++.... ..+.+.+|+.++++++|+||+++++++.+....++++|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 34577999999999999988899999998864321 12568889999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 83 FVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999543 2477888999999999999999998 9999999999999999999999999998764321
Q ss_pred c-----ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 E-----SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ........++..|+|||++.+..++.++||||||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 1 111223467899999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.91 Aligned_cols=204 Identities=27% Similarity=0.353 Sum_probs=174.6
Q ss_pred HhhccccccCCcCceeEEEEE-eCCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccc-----ccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-----HRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~-~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~l 474 (606)
.++.+.++||+|||.-||.++ +.+++.+|+|++.-.. ++.+..++|++..++++|||+++++.+...+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 456778899999999999999 4568889999997554 66788999999999999999999999986544 4899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+++|...|+|.+.+.....++..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.+++.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999999888777789999999999999999999999973 36999999999999999999999999998764
Q ss_pred CcC-----cc---eeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NRE-----ES---LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~-----~~---~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.-. +. +.......|..|.|||.+. +...++++|||||||+||+|+.|..||.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 311 00 1112345689999999764 5678999999999999999999999994
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.78 Aligned_cols=196 Identities=26% Similarity=0.411 Sum_probs=166.3
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|++|.||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 455678999999999999975 58899999986432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++..... ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 689888854332 24588999999999999999999998 999999999999999999999999999976543321
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~ 202 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCC
Confidence 12234568899999987654 5788999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=263.05 Aligned_cols=200 Identities=28% Similarity=0.418 Sum_probs=167.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
.+.++.+.+.||+|+||.||+|...+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 44556778899999999999999644 2468999886543 234679999999999999999999998875 5578
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999996432 3478999999999999999999998 999999999999999999999999999986
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........+...++..|+|||.+....++.++||||||++++||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 65432222222344568999999988889999999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=275.55 Aligned_cols=193 Identities=25% Similarity=0.291 Sum_probs=162.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------cc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~ 471 (606)
..+.+.+.||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 35666788999999999999975 47899999986532 2345778899999999999999999988643 34
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 97 ~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 6899999975 5666653 2377888899999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 8654322 2234578999999999999899999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=270.79 Aligned_cols=196 Identities=20% Similarity=0.258 Sum_probs=162.6
Q ss_pred cccccCCc--CceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 406 FSTKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 406 ~~~~lG~G--~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.++||+| +|++||+++.. +++.||+|+++... ...+.+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 78999999975 58999999986532 22356778999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999864322 3478899999999999999999998 999999999999999999999999986543321111
Q ss_pred -e-----eeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 -L-----VYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 -~-----~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0 0111345678999999876 458899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=264.71 Aligned_cols=195 Identities=28% Similarity=0.400 Sum_probs=168.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+...+.||+|+||.||+|.+. +++.||+|.++... ...+++.+|++++++++||||+++++.+..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3445577999999999999875 47889999886432 33467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+|++|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998843 3478889999999999999999998 999999999999999999999999999976543321
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 1223467889999999998889999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=260.84 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=170.8
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.++||+|+||.||++... +++.+++|.++.. ....+++.+|+.++++++|+||+++++.+.++...+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456788999999999999976 4789999988543 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++.... ...+++.....++.||+.||.|||+. +++|+||||+||++++++.++++|||++........
T Consensus 82 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999886432 24578889999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||++.+..++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 1233568889999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=265.89 Aligned_cols=194 Identities=26% Similarity=0.441 Sum_probs=170.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.+.+.||.|++|.||+++.. +++.|++|.+.... ...+.+.+|+.+++.++||||+++++.+......++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 456678999999999999964 58999999986443 3456788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 101 ~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 101 GSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999998843 3478999999999999999999998 9999999999999999999999999998865443221
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 123467889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.29 Aligned_cols=196 Identities=26% Similarity=0.424 Sum_probs=171.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 45566788999999999999964 58999999986543 34467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999843 3478889999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 223467889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.77 Aligned_cols=196 Identities=25% Similarity=0.392 Sum_probs=166.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+.+.++||+|+||.||+++.+ .++.||+|.++.. ......+.+|+.++++++||||+++++++......++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566788999999999999976 4788999998643 233456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++.... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 58988886432 3478889999999999999999998 999999999999999999999999999976443221
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 1223456889999998765 357889999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.02 Aligned_cols=192 Identities=26% Similarity=0.375 Sum_probs=162.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------cc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~ 471 (606)
..+...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 34566688999999999999975 47899999986532 2345678899999999999999999987643 34
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 68999987 7889887742 3488899999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 166 RQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred eecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 8654322 33568999999999876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=262.47 Aligned_cols=194 Identities=27% Similarity=0.388 Sum_probs=170.7
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.+.||.|++|.||+++.. +++.+++|.+.... ....++.+|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999976 48899999986432 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999998542 578999999999999999999998 999999999999999999999999999987654321
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 1233567889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.18 Aligned_cols=199 Identities=25% Similarity=0.291 Sum_probs=178.1
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
....+++.+.||+|+||.|..++++. ++.+|+|++.+- ..+..-|..|-.+|..-+.+=|++++-.|++..++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 34556778899999999999999875 778999999762 3455779999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|||||+||+|-..+.+.. .+++..+.-++..|.-||.-||+. |+|||||||+|||||..|++||+|||.+-.+
T Consensus 153 VMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999985432 588999999999999999999998 9999999999999999999999999999888
Q ss_pred CcCcceeeeecccccCcccccccc----C-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWIT----N-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..+........+|||.|++||++. + +.|++..|.||+||++|||+.|..||
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 777667777889999999999885 2 56889999999999999999999999
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=259.32 Aligned_cols=193 Identities=30% Similarity=0.430 Sum_probs=168.3
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC------CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+.||+|+||+||+|... +++.|++|.+.... +..+.+.+|+.++++++|+||+++++++.+....++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 44577999999999999986 68999999886432 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 83 LVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred ecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999998643 3478889999999999999999998 9999999999999999999999999998865443
Q ss_pred cceeeeecccccCccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......++..|++||.+.... ++.++|+||||+++|||++|+.||.
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~ 203 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 2 123456788999999987766 8899999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=264.05 Aligned_cols=199 Identities=28% Similarity=0.381 Sum_probs=167.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceecc-----ccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG-----AHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~-----~~~~lV~ 476 (606)
+.+.+.||+|+||.||++... +++.+|+|++........++.+|+.++.++ +|||++++++++... ...++|+
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 455678999999999999975 488999999876555567788999999999 799999999998754 3578999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999999865443445688999999999999999999998 999999999999999999999999999886543
Q ss_pred CcceeeeecccccCccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNN-----PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......++..|+|||.+... .++.++||||||+++|||++|+.||.
T Consensus 181 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 181 TRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred ccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 221 11234678899999987643 36889999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.46 Aligned_cols=195 Identities=27% Similarity=0.382 Sum_probs=167.7
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||+++.+ +++.||+|++.... ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 566788999999999999986 48899999986432 23456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|..++... ..+++..+..++.|++.+|+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999888876432 3488999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 1223457889999998876 457899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.28 Aligned_cols=202 Identities=30% Similarity=0.528 Sum_probs=168.7
Q ss_pred HHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+++.++||+|+||.||++..+ ++..+|+|++.... ...+++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345667789999999999999864 36789999986432 2346799999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccc------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 473 LLAYEYLVNGSLDKWIFNSTE------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
++|+||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999964321 112477888999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|++++++.+||+|||+++........ .......++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999998765433211 1122334678999999988889999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.69 Aligned_cols=197 Identities=27% Similarity=0.367 Sum_probs=170.6
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+++.++||+|+||+||++... +++.+|+|++... ....+++.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 455677789999999999999975 4888999987543 2335688999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++.....++.|++.+|.|||+. .+++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999988542 3578999999999999999999973 28999999999999999999999999998754322
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||+
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~ 203 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 1 123568999999999988889999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=262.83 Aligned_cols=199 Identities=32% Similarity=0.503 Sum_probs=168.0
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-C----cEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-G----IQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~----~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
...+++.+.||+|+||.||+|..++ + ..+++|.++.... ...++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456777899999999999999753 3 3589998865432 34678899999999999999999999987 7889
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+++++|.+++.... ..+++..+.+++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999986533 2488999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........ .....++..|+|||.+....++.++|+||||+++||+++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 65433211 112233568999999988889999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=260.51 Aligned_cols=195 Identities=30% Similarity=0.491 Sum_probs=167.1
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----------ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
.+.+.||+|++|.||+|... +++.+|+|.+..... ..+.+..|+.++++++||||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999975 478999998854321 1246888999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999543 3478888999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcc-----eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREES-----LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 652211 11122457889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.45 Aligned_cols=198 Identities=30% Similarity=0.470 Sum_probs=166.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecc--ccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~ 472 (606)
.++...++||+|+||.||+++.. ++..||+|.++... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 44566788999999999999842 47889999986442 2346789999999999999999999998775 567
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999985432 3578999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 553 LMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 553 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
........ ......++..|+|||++.+..++.++||||||+++|||++++.|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 76543321 112345677899999998888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=263.13 Aligned_cols=195 Identities=31% Similarity=0.529 Sum_probs=164.7
Q ss_pred ccCCcCceeEEEEEeCC-------CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 409 KLGQGGFGSVYLGMLPD-------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~-------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.||+|+||.||+|+..+ ++.+++|.+.... ....++.+|+.++++++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999999753 2579999886432 34568899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccc---cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-----cEEEeeccCC
Q 037563 480 VNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-----TAKVSDFGLA 551 (606)
Q Consensus 480 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-----~~kl~Dfgla 551 (606)
++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++++. .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975432 123478899999999999999999998 999999999999999887 8999999999
Q ss_pred cccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 552 KLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 765432211 1112345678999999998899999999999999999998 999983
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=258.91 Aligned_cols=191 Identities=26% Similarity=0.418 Sum_probs=163.5
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceec-----cccceeeee
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-----GAHRLLAYE 477 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-----~~~~~lV~E 477 (606)
.+.||+|+||.|.+++.. +|+.||||++.+. ....++-.+|+++|+.++|+||+.+...+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 467999999999999976 4899999999632 2345778899999999999999999998765 346799999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+| ..+|...++. ++.++......++.||++||.|+|+. +++|||+||+|++++.+-..||+|||+|+.....
T Consensus 107 lM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 6688888843 33488888999999999999999998 9999999999999999999999999999987543
Q ss_pred c-ceeeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 E-SLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~-~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ...++..+.|..|.|||.+. ...||...||||.|||+.||++|++-|
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 1 12346678899999999765 467999999999999999999999877
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=261.61 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=163.6
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
...||+|+||.||+|++. +++.|++|.+.... ...+.+.+|++++++++|+||+++++++..+...++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 357999999999999965 47789999886543 3456899999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCcCcceeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYT 563 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~ 563 (606)
.+++...... ...++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ...
T Consensus 93 ~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 167 (268)
T cd06624 93 SALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTE 167 (268)
T ss_pred HHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccc
Confidence 9999653211 1126778888999999999999998 9999999999999986 67999999999876543221 122
Q ss_pred ecccccCccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 564 TLRGTRGYLAPEWITNNP--ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~~--~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...+++.|+|||++.... ++.++||||||+++|||++|+.||.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 345789999999986543 7889999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.26 Aligned_cols=197 Identities=31% Similarity=0.484 Sum_probs=164.2
Q ss_pred hhccccccCCcCceeEEEEEeC-----CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceec--ccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~l 474 (606)
.+.+.+.||+|+||.||++..+ +++.|++|++.... ...+++.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4566788999999999999853 47889999986543 335688999999999999999999998754 346789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999986432 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcceee--eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREESLVY--TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
........ ....++..|+|||.+.+..++.++|+||||++++||++|..|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 44332111 1122345699999998888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=263.61 Aligned_cols=198 Identities=29% Similarity=0.429 Sum_probs=167.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.+.||+|+||.||++..+ .++.+|+|.++... ....++.+|+.++.+++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567788999999999999986 58899999886432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|..++..... ...+++..+..++.||+.||.|||++ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999998865321 23688999999999999999999974 289999999999999999999999999987653321
Q ss_pred eeeeecccccCccccccccCCC------CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNP------ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 12345788999999885543 4789999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.05 Aligned_cols=190 Identities=24% Similarity=0.363 Sum_probs=162.1
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
..+.+.+.||+|+||.||+++... ++.||+|..... ....|+.++++++|+||+++++++.+....++|+||+.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 346777899999999999999864 678999975332 23568999999999999999999999999999999995
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++.... ..+++..+..|+.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 141 -~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 141 -SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred -CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 68888885432 4588999999999999999999998 99999999999999999999999999997543222
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456899999999999999999999999999999999865543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=254.47 Aligned_cols=196 Identities=30% Similarity=0.360 Sum_probs=172.0
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.++|.+.||+|.||+|-+++-+. ++-+|+|++++.. .+...-..|-.+|...+||.+..|...++....++.|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 34677889999999999999754 8899999997542 233455678889999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|..||.|.-+|.+. +.+++....-+...|..||.|||++ +|++||+|.+|.|+|.+|++||+|||+++.--.
T Consensus 249 yanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 249 YANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999998653 4577788888999999999999998 999999999999999999999999999986432
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....+.+.+|||.|+|||++....|...+|.|.+||++|||++|+.||.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 2344567899999999999999999999999999999999999999994
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=263.48 Aligned_cols=198 Identities=27% Similarity=0.390 Sum_probs=168.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+++.++||+|+||.||+|+... ++.+++|.+.... ...+++.+|++++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 346677889999999999999865 7899999986543 33567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|..++.... ..+++..+..++.|++.+|+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999988875432 3588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 1123346788999999884 3456789999999999999999999983
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=257.82 Aligned_cols=197 Identities=24% Similarity=0.381 Sum_probs=171.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||.++.. +++.+++|++... ....+++.+|+.++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456788999999999998865 4888999988643 234567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999986543 24578999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 2234568899999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=259.99 Aligned_cols=195 Identities=27% Similarity=0.404 Sum_probs=164.6
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccC------CChHHHHHHHHHHHhcccCCcceeecceecc--ccceee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLA 475 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV 475 (606)
...+.||+|+||.||++...+ ++.+++|+++... ...+.+.+|+.++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 445789999999999999754 8899999885431 1235688899999999999999999988753 567899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+++++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 85 MEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999998543 2478888999999999999999998 99999999999999999999999999987654
Q ss_pred cCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 3211 11123457889999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=258.98 Aligned_cols=198 Identities=25% Similarity=0.358 Sum_probs=171.5
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+++.+.||+|+||.||++.... ++.+++|.+... ....+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 345677889999999999999754 778999998654 335678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999986532 3588899999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecccccCccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN---PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+... .++.++|+||||+++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 12335678899999998776 78999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=257.78 Aligned_cols=197 Identities=27% Similarity=0.421 Sum_probs=169.0
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec-cccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV~E~ 478 (606)
+++.+.||+|++|.||+++.+. ++.+++|++.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 4677889999999999999764 7889999986432 334678999999999999999999998764 4457899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999996532 24588999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......+++.|+|||++.+..++.++|+||||++++||++|+.||.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 2 2234567899999999999989999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=255.94 Aligned_cols=193 Identities=30% Similarity=0.485 Sum_probs=165.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
++||+|+||.||++.+.+++.|++|.++.... ...++.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998865433 3568999999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee-ee
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-TT 564 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 564 (606)
+++.... ..+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986532 2478889999999999999999998 999999999999999999999999999986542221111 11
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...+..|+|||.+.+..++.++|+||||++++||+| |..||.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 233567999999988889999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=258.70 Aligned_cols=196 Identities=33% Similarity=0.509 Sum_probs=169.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
++..+.||+|+||.||++... +++.+++|.++.... ..+++.+|+.++++++|+||+++++.+.+....++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 445678999999999999975 588999999875533 4578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998642 3478889999999999999999998 999999999999999999999999999987654332
Q ss_pred ee---eeecccccCccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LV---YTTLRGTRGYLAPEWITNNP---ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~---~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....+++.|+|||++.... .+.++||||||++++|+++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 11 11346788999999988766 8899999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=275.18 Aligned_cols=196 Identities=28% Similarity=0.471 Sum_probs=170.8
Q ss_pred hccccccCCcCceeEEEEEeCC--C--cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD--G--IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~--~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
....++||+|.||.|++|.+.. | ..||||.++... ....+|.+|+..|-+|+|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3455789999999999999863 3 468999997654 356899999999999999999999999988 77899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
..+.|+|.+.|++. ....+-......++.|||.||.||.++ ++|||||.++|+||-..-.+||+|||+.+-+...
T Consensus 191 LaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999872 335677888899999999999999998 9999999999999999999999999999988766
Q ss_pred cc-eeeee-cccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 558 ES-LVYTT-LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 558 ~~-~~~~~-~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
+. ..+.. ..-...|+|||.+....|+.++|||+|||.+|||+| |..||
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 55 33333 234678999999999999999999999999999999 77776
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=261.01 Aligned_cols=201 Identities=27% Similarity=0.365 Sum_probs=170.5
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhc-ccCCcceeecceecccc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~ 471 (606)
-+..+.++|...||+|+||.|.++..+. .+.+|||++++.. .+.+--+.|-++|+.- +-|.+++++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4555678999999999999999999765 4568999997542 2233334555566555 46789999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
+|.||||+.||+|-.+++.... +.+..+.-+|..||-||-+||++ +|++||||..|||||.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999998865443 66778888999999999999999 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.---+ .....+..||+.|+|||.+.+++|+..+|.|||||+||||+.|++||.
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 854322 344567899999999999999999999999999999999999999995
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=264.93 Aligned_cols=189 Identities=27% Similarity=0.463 Sum_probs=166.0
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.+||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++||||+++++.+..+...++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999975 5889999998643 234567889999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeec
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ .....
T Consensus 107 ~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 107 DIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 88743 3478899999999999999999998 999999999999999999999999999876543221 12335
Q ss_pred ccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.++..|+|||++.+..++.++||||||++++||++|+.||
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 6889999999999888999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=265.31 Aligned_cols=196 Identities=25% Similarity=0.327 Sum_probs=167.3
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||++.... ++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 4566889999999999999864 7889999886442 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999543 3578899999999999999999998 99999999999999999999999999987421110
Q ss_pred c--------------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 S--------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~--------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0 01112457889999999988889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=261.92 Aligned_cols=197 Identities=25% Similarity=0.389 Sum_probs=169.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.++||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.++...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4667788999999999999975 47899999986442 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 86 GGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999986432 3588999999999999999999998 999999999999999999999999999876533221
Q ss_pred eeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+. ...++.++|+||||+++|||++|+.||.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 223356889999999874 3456789999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.83 Aligned_cols=195 Identities=26% Similarity=0.385 Sum_probs=166.9
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
++++.++||+|+||.||++..++ ++.+|+|++..... ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 35567889999999999999864 88999998864322 345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.++.... ..+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999998876432 2478999999999999999999998 99999999999999999999999999988654432
Q ss_pred ceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++||
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence 2 2233457889999998875 44688999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=259.79 Aligned_cols=194 Identities=25% Similarity=0.377 Sum_probs=171.4
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|+||.||++.... ++.+++|.+.... ...+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 4567889999999999999864 8899999986432 3457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998543 3578899999999999999999998 99999999999999999999999999988765432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 200 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCC
Confidence 1234567889999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=265.60 Aligned_cols=198 Identities=28% Similarity=0.354 Sum_probs=170.1
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+++.+.||+|++|.||++...+ ++.+|+|.+.... ...+.+..|++++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4566789999999999999865 8899999986542 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... ...+++.....++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999986432 24588899999999999999999998 99999999999999999999999999987543221
Q ss_pred ce----------------------------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SL----------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 10 0112357889999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.44 Aligned_cols=199 Identities=28% Similarity=0.449 Sum_probs=168.7
Q ss_pred hccccccCCcCceeEEEEEeCC--CcEEEEEEeccc-----------CCChHHHHHHHHHHHh-cccCCcceeecceecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESI-----------GQGKKEFSAEVTIIGN-VHHVHLVKLKGFCIEG 469 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~-----------~~~~~~~~~Ei~~l~~-l~h~nIv~l~g~~~~~ 469 (606)
+.+.+.||+|+||.||++.+.. ++.+|+|.+... .....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999999865 678999987532 1123457778888865 7999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...+++|||+++++|.+++.........+++..+.+++.|++.+|.|||+. .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999999865433445688999999999999999999963 289999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++....... ......++..|++||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 998755433 2334568899999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.68 Aligned_cols=187 Identities=26% Similarity=0.431 Sum_probs=155.7
Q ss_pred ccCCcCceeEEEEEeCC-------------------------CcEEEEEEecccCC-ChHHHHHHHHHHHhcccCCccee
Q 037563 409 KLGQGGFGSVYLGMLPD-------------------------GIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKL 462 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l 462 (606)
.||+|+||.||+|.+.. ...|++|++..... ...++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 23588998865432 24578889999999999999999
Q ss_pred ecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-
Q 037563 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF- 541 (606)
Q Consensus 463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~- 541 (606)
++++.+....++||||+++++|..++.... ..+++..+..++.||++||+|||++ +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986432 3578899999999999999999998 999999999999998654
Q ss_pred ------cEEEeeccCCcccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHH-HhCCCCCC
Q 037563 542 ------TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEI-IGGRKSFS 606 (606)
Q Consensus 542 ------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~el-ltG~~pfs 606 (606)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3799999988643322 12356788999998865 5678999999999999998 47999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=257.56 Aligned_cols=196 Identities=26% Similarity=0.396 Sum_probs=165.7
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc------CCChHHHHHHHHHHHhcccCCcceeecceecc--cccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l 474 (606)
+.+.+.||+|+||.||+++.. +++.+++|.+... ....+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456788999999999999975 4889999987432 12335788999999999999999999998764 45789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
++||+++++|.+++... ..+++....+++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999998543 2477888999999999999999998 9999999999999999999999999999865
Q ss_pred CcCc--ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREE--SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ........++..|+|||.+.+..++.++|+||||++++||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 3211 111223468899999999998889999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=259.47 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=170.9
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccc------cce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGA------HRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~------~~~ 473 (606)
..+++.+.||+|++|.||++..+ +++.+++|+++......+++.+|+.+++++ +|+||+++++++.+.. ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 44566788999999999999986 478899999877666667899999999999 6999999999997654 479
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999999876443345688999999999999999999998 999999999999999999999999999876
Q ss_pred cCcCcceeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......++..|+|||.+.. ..++.++||||||++++||++|+.||.
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 543222 1233567889999998753 346789999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=260.87 Aligned_cols=195 Identities=28% Similarity=0.409 Sum_probs=169.4
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|+||.||+++.. +++.|++|++.... ...+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999975 58899999986542 23467999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++|.+++.... ..+++.++..++.||+++|+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999986543 4588999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.......++..|+|||.+.+. .++.++||||+|++++||++|++||
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 223345788999999988654 4689999999999999999998877
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=260.26 Aligned_cols=190 Identities=32% Similarity=0.425 Sum_probs=165.1
Q ss_pred cCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||+||++... +++.+++|.+... ....+.+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 5889999998643 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999865432 3588999999999999999999998 99999999999999999999999999987654322 1233
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..++..|+|||.+.+..++.++|+||||++++||++|+.||.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 467889999999988889999999999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=259.67 Aligned_cols=195 Identities=28% Similarity=0.396 Sum_probs=169.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+...++||+|+||.||+|... .++.||+|.++... ...+++.+|++++++++|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3445578999999999999975 47899999886432 33467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999853 2477888999999999999999998 999999999999999999999999999976644322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 1223467889999999988889999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=260.65 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=164.1
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHH-HHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTI-IGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~-l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|+||.||+++.. +++.||+|+++... ....++..|+.. ++..+||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999986 48999999987543 233456666665 56678999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++.........+++..+..++.||+.||+|||++ .+++||||||+||++++++.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 688888865444445689999999999999999999985 389999999999999999999999999998654322
Q ss_pred eeeeecccccCccccccccC----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 1223467889999998764 456889999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=248.37 Aligned_cols=201 Identities=24% Similarity=0.410 Sum_probs=167.7
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEE-eCCCcEEEEEEecccC-CChHHHHHHHHHHHhcc-cCCcceeecceeccccc
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~-~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~ 472 (606)
++|+-+-|. +.||+|+++.|--++ +..+.++|||++.+.. ..+.++.+|++++.+.+ |+||++|+.+|.++...
T Consensus 75 F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 455544444 459999999999887 4579999999998764 45678899999999885 99999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EEEeecc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFG 549 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg 549 (606)
|||||-|.||.|..+|+. ...+++..+.++...|+.||.|||.+ +|.|||+||+|||-..-.. +||+||.
T Consensus 152 YLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999954 34588999999999999999999998 9999999999999975443 7999998
Q ss_pred CCcccCcCcc------eeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREES------LVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+..-+..... ....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 8765432211 2234578899999999753 2347889999999999999999999994
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=261.04 Aligned_cols=197 Identities=33% Similarity=0.425 Sum_probs=168.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecc--ccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~E~ 478 (606)
+++.++||.|++|.||++.+.+ ++.+|+|.+..... ...++.+|++++++++||||+++++++.+. ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 4566889999999999999854 78899999864432 356789999999999999999999998653 367899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.........+++.....++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999998865443445688899999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 23456889999999998899999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=263.30 Aligned_cols=190 Identities=29% Similarity=0.493 Sum_probs=165.8
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
..||+|+||.||++... ++..||||++.... ...+.+.+|+..++.++|+||+++++.+......++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999975 47899999986432 33467889999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeec
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
+++.. ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++........ .....
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 98843 2478889999999999999999998 999999999999999999999999999876543222 12234
Q ss_pred ccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 67899999999988889999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=255.16 Aligned_cols=197 Identities=31% Similarity=0.570 Sum_probs=170.0
Q ss_pred ccccccCCcCceeEEEEEeCC-----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.||+|+||.||+++..+ +..||+|++..... ..+.+.+|+.++.+++|+||+++++++.+....+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999999864 37899999975543 46789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999865332 1288999999999999999999998 9999999999999999999999999999876544
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........++..|+|||.+.+..++.++|+||+|++++||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 3222222346789999999988889999999999999999998 888873
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=255.81 Aligned_cols=193 Identities=30% Similarity=0.518 Sum_probs=165.3
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+.+.+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4467788999999999999986 6778999988643 2456789999999999999999999998764 47999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999965432 3578899999999999999999998 99999999999999999999999999987543221
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 12234568999999988889999999999999999998 999983
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=256.43 Aligned_cols=188 Identities=30% Similarity=0.403 Sum_probs=166.0
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|++|.||+++... ++.+++|++.... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 8899999986432 2346799999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++... ..+++..+..++.||+.||.|||++ +++|+||+|+||++++++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999643 3478899999999999999999998 99999999999999999999999999998765432 1123
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..++..|++||.+....++.++|+||||+++|||++|+.||.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 193 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence 467889999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=285.22 Aligned_cols=202 Identities=19% Similarity=0.306 Sum_probs=159.9
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC--CcEEEEE------------------EecccCCChHHHHHHHHHHHhcccCC
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD--GIQVAVK------------------KLESIGQGKKEFSAEVTIIGNVHHVH 458 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK------------------~l~~~~~~~~~~~~Ei~~l~~l~h~n 458 (606)
.....+++.++||+|+||+||++.++. +...++| .+.........+.+|+.++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 344668888999999999999987643 2122222 22222223456889999999999999
Q ss_pred cceeecceeccccceeeeeeccCCChhhhhhhcccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE-SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 459 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
|+++++++.+....++|+|++. ++|.+++...... ...........|+.||+.||.|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 5777777543221 12233556778999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987654333222345789999999999999999999999999999999998754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=260.54 Aligned_cols=195 Identities=25% Similarity=0.328 Sum_probs=166.0
Q ss_pred hccccccCCcCceeEEEEEe----CCCcEEEEEEecccC-----CChHHHHHHHHHHHhc-ccCCcceeecceeccccce
Q 037563 404 KNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESIG-----QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~ 473 (606)
+++.+.||+|+||.||+++. .+|+.||+|+++... ...+++.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34567899999999999986 368899999986431 2346788999999999 5999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998643 3477888899999999999999998 999999999999999999999999999986
Q ss_pred cCcCcceeeeecccccCccccccccCC--CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.............++..|+|||.+... .++.++||||||+++|||++|+.||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 208 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence 544332222335688999999998753 4678999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.44 Aligned_cols=200 Identities=27% Similarity=0.337 Sum_probs=165.1
Q ss_pred hccccccCCcCceeEEEEEeCCC-cEEEEEEecc-cCCChHHHHHHHHHHHhcc-cCCcceeecce-ec------cccce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDG-IQVAVKKLES-IGQGKKEFSAEVTIIGNVH-HVHLVKLKGFC-IE------GAHRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~-~~vavK~l~~-~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~-~~------~~~~~ 473 (606)
..+.+.|.+|||+.||.+.+..+ .++|+|++-. .+...+.+.+||.+|++|. |+|||.+++.. .. .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34557799999999999998776 9999998853 3455688999999999997 99999999932 21 13567
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
|+||||.+|.|-+++..... ..+++.++++|+.++++|+++||.. +++|||||||.+||||..+++.||||||.+.-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred eehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 99999999999999965433 2399999999999999999999995 66899999999999999999999999999864
Q ss_pred cCcCccee------e--eecccccCccccccc---cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLV------Y--TTLRGTRGYLAPEWI---TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~------~--~~~~gt~~y~aPE~~---~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........ . -...-|+-|+|||++ .+.++++|+|||||||+||-|.-...||.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 32221100 0 012458999999976 57889999999999999999999999993
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=261.23 Aligned_cols=196 Identities=27% Similarity=0.382 Sum_probs=169.3
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||+++.++ ++.|++|+++.. ....+.+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 5677889999999999999864 789999988643 233467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++.+..++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 98777665532 23478899999999999999999998 999999999999999999999999999987655433
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 223345678899999999887 78999999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=259.73 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=167.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceec------cccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE------GAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~------~~~~~ 473 (606)
..+.+.+.||+|+||.||+|+.. .++.+|+|.+........++..|+.++.++ +|+||+++++++.. ....+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 34556678999999999999985 478999999876655567889999999998 69999999999853 45678
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
++|||+++++|.+++..... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 99999999999999865332 3477888899999999999999998 999999999999999999999999999876
Q ss_pred cCcCcceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......++..|+|||.+. ...++.++|+||||+++|||++|+.||.
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 532221 122356888999999875 3457889999999999999999999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=261.45 Aligned_cols=194 Identities=23% Similarity=0.333 Sum_probs=164.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||+++.. +|+.+++|+++... .....+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456688999999999999986 48899999986432 22356788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++.... ..+++..+..++.||++||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 7 57888775432 3588999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 12334678899999988764 4689999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=260.03 Aligned_cols=199 Identities=30% Similarity=0.498 Sum_probs=170.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-----CCcEEEEEEecccCCC--hHHHHHHHHHHHhcccCCcceeecceec--cccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-----~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~ 472 (606)
..+.+.+.||+|+||.||++++. .+..+|||+++..... .+++.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566788999999999999964 3678999999765543 6789999999999999999999999877 5578
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999996533 2588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcce-e-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESL-V-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~-~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........ . .....++..|++||.+.+..++.++||||||++++||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 76533221 1 112344567999999988889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=261.14 Aligned_cols=194 Identities=26% Similarity=0.365 Sum_probs=171.8
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
|++.+.||+|.|..|-++++- .|..||||++.+.+- ....+.+|+.-|+.++|||||+|+.+......+|||.|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 344466999999999998853 699999999976643 3467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~ 558 (606)
.+|+|.+||.... ..+++..+.+++.||..|+.|+|+. .++||||||+||++- .-|.+|+.|||++..+.+..
T Consensus 100 D~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred CCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999997654 4589999999999999999999998 999999999999886 56889999999998776654
Q ss_pred ceeeeecccccCccccccccCCCCC-CccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t-~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. .++.+|+..|-|||.+.+..|+ +.+||||||||||.|++|+.||
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 3 4667899999999999999886 6789999999999999999999
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=261.26 Aligned_cols=196 Identities=26% Similarity=0.408 Sum_probs=165.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.+.||+|++|.||+++.+ +++.||+|.+.... .....+.+|++++++++|+||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3566788999999999999976 57899999986432 22356778999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++ +|.+++.... ..+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 DT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 85 8999886433 2578899999999999999999998 999999999999999999999999999875432211
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1122346789999998865 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=273.54 Aligned_cols=190 Identities=30% Similarity=0.450 Sum_probs=166.4
Q ss_pred ccCCcCceeEEEEEeCC-CcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhh
Q 037563 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
.||+|.||+||.|++.+ ...+|||-++.. .+..+.+..||.+.++++|.|||+.+|.|.+++...|.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 49999999999999876 567999988643 5566789999999999999999999999999999999999999999999
Q ss_pred hhhhcccccccc--ChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeeccCCcccCcCcceeee
Q 037563 487 WIFNSTEESRFL--CWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYT 563 (606)
Q Consensus 487 ~l~~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~ 563 (606)
.|...-. ++ ++.+.--+..||++||.|||++ .|+|||||-+|||++ -.|.+||+|||-++.+..-. ....
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE 734 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE 734 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence 9975432 34 6777788999999999999999 999999999999996 68999999999998764332 2345
Q ss_pred ecccccCccccccccCC--CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 564 TLRGTRGYLAPEWITNN--PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+..||.-|||||++..+ .|...+|||||||.+.||.||++||
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 67899999999999765 4788999999999999999999998
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=255.65 Aligned_cols=192 Identities=32% Similarity=0.542 Sum_probs=157.7
Q ss_pred cccCCcCceeEEEEEeCC----CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeeccee-ccccceeeeeecc
Q 037563 408 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCI-EGAHRLLAYEYLV 480 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-~~~~~~lV~E~~~ 480 (606)
+.||+|+||.||+|.+.+ ...+|+|++.... ...+.+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 4579999885432 23467889999999999999999999876 4556789999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++.... ..+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999986432 2356777889999999999999998 9999999999999999999999999999765432211
Q ss_pred e---eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhC-CCCC
Q 037563 561 V---YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG-RKSF 605 (606)
Q Consensus 561 ~---~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG-~~pf 605 (606)
. .....++..|+|||.+.+..++.++||||||+++|||++| .+||
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 1 1123456789999999888899999999999999999995 5555
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=269.04 Aligned_cols=186 Identities=29% Similarity=0.456 Sum_probs=162.4
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.||+|+||-||-+++. +.+.||||++.-+.. .-+++..|+..|.+++|||++...|++.....-+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 67999999999999975 478899999975432 235789999999999999999999999999999999999965
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+-.+.+.- ..+++-+..+..|..+.+.||+|||+. +.||||||+.||||.+.|.+|++|||.+.+..+.
T Consensus 111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 55555532 225688888999999999999999998 9999999999999999999999999999887654
Q ss_pred eecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 563 TTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...+|||.|||||+|. .+.|+-|+||||||+.-.||...++|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 3478999999999874 578999999999999999999999985
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=258.79 Aligned_cols=194 Identities=31% Similarity=0.446 Sum_probs=170.0
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.+.||+|++|.||++.+. +++.+++|++.... ...+++.+|++++++++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 455678999999999999986 48899999986542 344678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++|.+++.... ..+++....+++.|++.+|+|||+ . +++|+||+|+||++++++.+||+|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999986542 457888999999999999999999 7 999999999999999999999999999876543221
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ...++..|+|||.+.+..++.++||||||++++||++|+.||.
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1567889999999998899999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=262.61 Aligned_cols=197 Identities=30% Similarity=0.511 Sum_probs=163.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCc----EEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGI----QVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.++..+.||+|+||.||++.+. +++ .+|+|.+..... ...++.+|+.++++++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 3445678999999999999864 343 578888865432 234788999999999999999999998754 46799
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++...
T Consensus 87 ~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999986432 3478889999999999999999998 99999999999999999999999999998764
Q ss_pred cCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33221 1122345678999999998899999999999999999998 899983
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=258.77 Aligned_cols=196 Identities=28% Similarity=0.442 Sum_probs=171.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+++.+.||+|++|.||++.++ +++.+++|+++......+++.+|++++++++|+|++++++.+......++++||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445577999999999999987 5889999999765445678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 101 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 173 (286)
T cd06614 101 SLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KR 173 (286)
T ss_pred cHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hh
Confidence 9999996543 3688999999999999999999998 999999999999999999999999998875543321 11
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..|++||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 23457889999999988889999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=255.99 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=171.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.+.||.|+||+||++... ++..+++|++... ....+.+.+|++.++.++|+||+++++.+......++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566788999999999999965 5788999998643 2345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+......
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999965432 13578899999999999999999998 9999999999999999999999999998766543221
Q ss_pred ---eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 ---VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ---~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+... .++.++|+||||+++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 11234678899999998776 78999999999999999999999983
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=256.28 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=170.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec--cccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~E 477 (606)
+++.+.||+|+||.||++... +++.+++|++.... ...+++.+|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456678999999999999965 47889999986432 234568889999999999999999998754 445789999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH-----hcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH-----EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
|+++++|.+++.........+++..+..++.||+.||.||| +. +++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999765444567899999999999999999999 65 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........ .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 159 ILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred cccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 76544321 233568999999999998889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=254.83 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=170.0
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.++||+|+||.+|+++.. +++.+++|++... ....+++.+|+.++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456788999999999999975 4789999998643 233467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++..... ..+++.++.+++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998864322 3478889999999999999999998 999999999999999999999999999986543221
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||++.+...+.++|+||||++++||++|+.||.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 1123457889999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=257.64 Aligned_cols=188 Identities=25% Similarity=0.358 Sum_probs=156.4
Q ss_pred ccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHh---cccCCcceeecceeccccceeeeeecc
Q 037563 409 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGN---VHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~---l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.||+|+||.||++... +++.+|+|.+.... .....+.+|..++.. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999975 48899999886432 112334455444433 479999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999988543 3589999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+. +..++.++|+||||++++||++|+.||.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 12346899999999886 4567899999999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=256.88 Aligned_cols=195 Identities=29% Similarity=0.401 Sum_probs=169.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+.+.++||+|+||.||+|... +++.+|+|.+.... ...+++.+|+..+++++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4556678999999999999874 57899999876432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999843 3478999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 1223467889999999988888999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=260.86 Aligned_cols=194 Identities=26% Similarity=0.349 Sum_probs=165.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC------ChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
+++.+.||+|+||.||+|... +++.|++|+++.... ....+..|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999975 588999999965432 2345778999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+ +++|.+++.... ..+++..+..++.||++||.|||+. +++|+||+|+||+++.++.+||+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 999999996432 2588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... ......+++.|+|||.+.+ ..++.++|+||||++++||++|.+||
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 322 1223456788999998754 46789999999999999999998776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=255.05 Aligned_cols=195 Identities=30% Similarity=0.413 Sum_probs=172.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.+.||+|++|.||+++..+ ++.+++|++.... ...+++.+|+..+.+++|+||+++++++......++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4566889999999999999875 8999999987553 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++|.+++... ..+++..+..++.|++++|+|||+ . +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999643 458899999999999999999999 8 999999999999999999999999999987654332
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||.+....++.++|+||||+++|||++|+.||.
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 2 123467889999999998889999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=257.11 Aligned_cols=194 Identities=27% Similarity=0.427 Sum_probs=167.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcc---cCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+++.+.||+|+||.||+|+.. +++.+++|.+... ....+++.+|+.++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345678999999999999974 5889999988643 334567889999999997 9999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999843 2588999999999999999999998 9999999999999999999999999999876544
Q ss_pred cceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 32 1233568889999998765 456899999999999999999999984
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=259.03 Aligned_cols=195 Identities=24% Similarity=0.382 Sum_probs=162.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+.+.+.||+|+||.||+|... +++.+++|++.... .....+.+|+.++++++|+||+++++++..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 455688999999999999875 58899999986432 233567899999999999999999999999999999999996
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++.... ..+.+..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 67777764332 3467788889999999999999998 999999999999999999999999999876433211
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12234568899999998764 47889999999999999999999983
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=259.53 Aligned_cols=196 Identities=26% Similarity=0.435 Sum_probs=170.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.++.+.+.||+|+||.||++... +++.+++|.+... ....+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667788999999999999864 5788999998643 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 2467888999999999999999998 999999999999999999999999999876544322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+....++.++|+||||+++||+++|+.||.
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1233468889999999988889999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=256.13 Aligned_cols=194 Identities=29% Similarity=0.449 Sum_probs=164.8
Q ss_pred cccccCCcCceeEEEEEeC-CCcEEEEEEecccC----C-------ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 406 FSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----Q-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+.||+|+||.||+|... +++.+|+|.++... . ..+.+.+|++++++++|+|++++++++......+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3467999999999999865 58899999875321 1 1246788999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+|++|||+++.
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999998653 3578889999999999999999998 999999999999999999999999999976
Q ss_pred cCcCcc-eeeeecccccCccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREES-LVYTTLRGTRGYLAPEWITNNP--ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......++..|+|||.+.... ++.++|+||||+++||+++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 543221 1123356788999999887654 7899999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=252.70 Aligned_cols=196 Identities=25% Similarity=0.428 Sum_probs=169.0
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.+.||+|+||.||++... +++.+++|++.... ...+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999975 47889999986432 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 558 (606)
++++|.+++.... ...+++..+.+++.|++.+|.|||++ +++|+||+|+||+++++ +.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999996533 24578899999999999999999998 99999999999999865 468999999998765432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 2 123467889999999998889999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=255.35 Aligned_cols=195 Identities=26% Similarity=0.435 Sum_probs=166.8
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-------ChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
...+.||+|++|.||++... +++.+|+|.+..... ..+++.+|++++++++|+||+++++++.+....++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 34567999999999999964 588999999864321 2367899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~ 555 (606)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 83 EWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred eccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999998643 3578899999999999999999998 999999999999998776 59999999987765
Q ss_pred cCcc---eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES---LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......++..|+|||.+.+..++.++|+||+|++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 3311 11123467889999999988889999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=257.87 Aligned_cols=195 Identities=27% Similarity=0.378 Sum_probs=165.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
++..+.||+|++|.||+++.. +++.|+||+++... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345678999999999999975 48899999886432 23357899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 6 689888865332 4588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecccccCccccccccCCC-CCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 201 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 122345688999999886644 588999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=257.51 Aligned_cols=187 Identities=27% Similarity=0.448 Sum_probs=157.7
Q ss_pred cccCCcCceeEEEEEeCC--------CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.||+|+||.||+|.... ..++++|.+.... ...+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 2348888875443 3346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc--------EEEeeccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--------AKVSDFGL 550 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~Dfgl 550 (606)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999996543 2578899999999999999999998 9999999999999987765 69999998
Q ss_pred CcccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCC-CCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGR-KSF 605 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~-~pf 605 (606)
+...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .||
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 8754432 22457889999999876 45789999999999999999984 555
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=253.93 Aligned_cols=190 Identities=28% Similarity=0.383 Sum_probs=166.0
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||.||+++..+ ++.+++|.+.... ...+.+.+|++++.+++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 8999999986543 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-----
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES----- 559 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~----- 559 (606)
.+++.+.. .+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99986532 588999999999999999999998 999999999999999999999999999876433211
Q ss_pred --eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 --LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 --~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......++..|++||.......+.++||||||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 12233467889999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=258.37 Aligned_cols=197 Identities=26% Similarity=0.322 Sum_probs=163.6
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcc-cCCcceeecceecccc-----ce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAH-----RL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~-----~~ 473 (606)
+++.+.||+|+||.||++... +++.||+|+++... .....+.+|+.++++++ |+||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 456678999999999999976 58899999886432 23467888999999995 6999999999887665 79
Q ss_pred eeeeeccCCChhhhhhhcccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCC
Q 037563 474 LAYEYLVNGSLDKWIFNSTEE-SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLA 551 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla 551 (606)
+||||+++ +|.+++...... ...+++..+..++.||+.||.|||+. +++|+||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 898888654332 34689999999999999999999998 9999999999999998 899999999998
Q ss_pred cccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+....... ......+++.|+|||++.+ ..++.++|+||||+++|||++|+.||
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 212 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence 86533221 1122356788999998765 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=266.31 Aligned_cols=194 Identities=27% Similarity=0.445 Sum_probs=171.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+...||+|.|++|..+++.. +.+||||.+.++.. ..+.+.+|+++|..++|||||+++.+......+|+||||.
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 4556789999999999999764 89999999976532 2356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
.+|.+.+||.+... +.+..+..+..|+.++++|||++ .|+|||||++||||+.+.++||+|||++..+....
T Consensus 138 ~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 138 SGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred cCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc-
Confidence 99999999976543 55578888999999999999999 99999999999999999999999999999876432
Q ss_pred eeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...+..|++.|.|||+..+..+ ++++|+||+|++||-|+.|..||.
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 3456789999999999988776 689999999999999999999995
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=252.74 Aligned_cols=197 Identities=29% Similarity=0.460 Sum_probs=169.7
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|+||.||++..+. +..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+....++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 4566789999999999999864 788999998643 234567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 558 (606)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++ .+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999865332 3578999999999999999999998 999999999999999885 46999999998765432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....+++.|+|||++.+..++.++|+||||++++||++|+.||.
T Consensus 157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred cc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 223468889999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=254.54 Aligned_cols=188 Identities=26% Similarity=0.377 Sum_probs=156.7
Q ss_pred ccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHH---HHhcccCCcceeecceeccccceeeeeecc
Q 037563 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTI---IGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~---l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.||+|+||.||+++..+ ++.||+|.+.... .....+..|..+ +...+||||+++++.+.+....++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999999754 7899999886432 112234444433 444579999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988532 3589999999999999999999998 999999999999999999999999999875543221
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....|+..|+|||.+.+. .++.++|+||+|+++|||++|+.||.
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 234689999999998754 68899999999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=255.83 Aligned_cols=197 Identities=27% Similarity=0.424 Sum_probs=167.1
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+++.++||+|++|.||+|+.. +++.||+|+++... ...+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456788999999999999986 48899999986542 234677889999999999999999999999999999999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+ +|.+++..... ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 82 ~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 5 88888865432 23589999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|++||.+.+. .++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12234568899999987654 56889999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=255.20 Aligned_cols=191 Identities=28% Similarity=0.473 Sum_probs=166.7
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
.+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.++++++||||+++++++......++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 367999999999999964 57899999886433 3345688999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.+......... ...
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccc
Confidence 999854 3478889999999999999999998 9999999999999999999999999988765433221 223
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 468899999999988889999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=256.39 Aligned_cols=195 Identities=26% Similarity=0.377 Sum_probs=166.6
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc--ccceeeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAYEY 478 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~E~ 478 (606)
++.++||+|++|.||+++..+ ++.+++|++.... ...+.+.+|++++++++|+|++++++++.+. ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 456789999999999999764 7899999997542 2346788999999999999999999999888 789999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++ +|.+++.... ..+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 975 8888885432 3588999999999999999999998 99999999999999999999999999998765543
Q ss_pred ceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 222233456788999997764 457899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=258.68 Aligned_cols=191 Identities=29% Similarity=0.436 Sum_probs=163.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||.||+|+.. +++.||+|.+.... ...+++.+|+++++.++||||+++++++.+....++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3566688999999999999975 48899999886432 123568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|++ ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 57777664322 3588999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ...++..|+|||.+. ...++.++||||||+++|||++|+.||
T Consensus 169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~ 214 (307)
T cd06607 169 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (307)
T ss_pred C-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 2 245788999999874 456889999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=263.10 Aligned_cols=191 Identities=31% Similarity=0.498 Sum_probs=166.6
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
+.||+|-||+||-|+++ .|+.||||++.+. .....++++|+.+|.+++||.||.+.--|...+..+.|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 67999999999999986 4999999998654 34567899999999999999999999999999999999999955 5
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---CcEEEeeccCCcccCcCcce
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 560 (606)
..+.+..... ..+++..-.-++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||.|+++++..-
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 5555544332 4688888888999999999999998 99999999999999654 3699999999999876543
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....+||+.|+|||++..+.|...-|+||.|||+|--++|..||.
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 245789999999999999999999999999999999999999994
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=248.35 Aligned_cols=194 Identities=30% Similarity=0.509 Sum_probs=171.9
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
...+.||+|++|.||++... +++.+++|++..... ..+++.+|+.++++++|+|++++++.+......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 44578999999999999986 588999999976543 5678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++.... ..+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||.+........ .
T Consensus 83 ~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 83 SLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred cHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999986532 3588999999999999999999997 999999999999999999999999999987655432 2
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..|++||.+.....+.++|+||||++++||++|+.||+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 33567889999999988889999999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=247.71 Aligned_cols=199 Identities=23% Similarity=0.360 Sum_probs=165.7
Q ss_pred hhccccccCCcCceeEEEEEeCC-----CcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceec-cccce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRL 473 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~ 473 (606)
.++...+||+|.||.|||++-.+ ...+|+|+++..... .....+|+.+++.++|||++.|..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 45667889999999999997543 237899999765322 3567889999999999999999999987 77889
Q ss_pred eeeeeccCCChhhhhhhc-cccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC----CcEEEeec
Q 037563 474 LAYEYLVNGSLDKWIFNS-TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDF 548 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Df 548 (606)
+++||.+. +|.+.++.. ......++...+..|+.||+.|+.|||++ .|+||||||.|||+..+ |.+||+|+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999987 777777533 23345788999999999999999999999 99999999999999877 99999999
Q ss_pred cCCcccCcCcce--eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 549 GLAKLMNREESL--VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 549 gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+++++...-.. .....+.|+-|.|||.+.+. .||...||||.|||+.||+|-++-|
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 999987654321 22345679999999998875 6889999999999999999988766
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=254.26 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=162.9
Q ss_pred ccccccCCcCceeEEEEEeC----CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc------c
Q 037563 405 NFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------H 471 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~ 471 (606)
.+.+.||+|+||.||+|.+. .++.||||++.... ...+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34578999999999999864 36889999986542 23457889999999999999999999886532 2
Q ss_pred ceeeeeeccCCChhhhhhhccc--cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTE--ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
.++++||+++++|.+++..... ....+++....+++.||+.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 3688999999999998754322 123478889999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 550 LAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.++......... .....++..|++||.+....++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 998664332211 122345678999999988889999999999999999999 888873
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=252.11 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=172.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.++||+|+||.||+++.. +++.+++|.+.... ....++.+|++++++++|+||+++++.+.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456688999999999999865 57899999986532 33457888999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|.||++++++.+|++|||+++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999876544445688999999999999999999998 99999999999999999999999999998765431
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|++||.+.+..++.++|+||||+++|||++|+.||+
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 223457889999999999889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=260.08 Aligned_cols=199 Identities=22% Similarity=0.332 Sum_probs=165.1
Q ss_pred hccccccCCcCceeEEEEEeCC---CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceecc--cccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l 474 (606)
+++.++||+|+||.||+|+... ++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999999754 7899999997532 2346778899999999999999999999988 78899
Q ss_pred eeeeccCCChhhhhhhcccc-ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC----CCcEEEeecc
Q 037563 475 AYEYLVNGSLDKWIFNSTEE-SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD----NFTAKVSDFG 549 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfg 549 (606)
||||+++ +|.+++...... ...+++..+..++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 676666433322 23688899999999999999999998 9999999999999999 9999999999
Q ss_pred CCcccCcCcc--eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREES--LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9986543322 11223457889999998766 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=254.27 Aligned_cols=195 Identities=27% Similarity=0.383 Sum_probs=165.5
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
++.++||+|++|.||+|... +++.|++|++.... ...+.+.+|++.+++++|||++++++++.++...+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999975 58999999986432 233678899999999999999999999999999999999995
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++..... ..+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 82 -~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 82 -LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 689999865432 3588999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||++.+. .++.++|+||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12233568899999987654 56889999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=255.67 Aligned_cols=196 Identities=26% Similarity=0.340 Sum_probs=165.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc--ccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~ 476 (606)
.+.+.+.||+|+||.||+|..+ +++.+++|.++.... ....+.+|+.++++++||||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4566688999999999999986 478999999864322 234577899999999999999999998877 8899999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 86 e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99975 9988886432 2588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 321 12334578899999988754 46899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=256.19 Aligned_cols=190 Identities=27% Similarity=0.472 Sum_probs=165.7
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.+||+|+||.||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+......++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999975 58899999885433 33457899999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeec
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
+++.. ..+++.....++.|++.+|+|||+. +++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98743 2478889999999999999999998 999999999999999999999999999876543321 12335
Q ss_pred ccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 67899999999988888999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=251.44 Aligned_cols=187 Identities=30% Similarity=0.345 Sum_probs=158.8
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHH-HHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTI-IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~-l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||++... +++.||+|+++.... ....+..|..+ ....+|+|++++++.+.++...++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999975 478999999865321 12334445444 3455899999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 9999998543 3478899999999999999999998 9999999999999999999999999998764331
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 23467889999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=256.40 Aligned_cols=200 Identities=29% Similarity=0.393 Sum_probs=165.9
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc-----
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA----- 470 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----- 470 (606)
....+.+.+.||+|+||.||+|+.+. ++.|++|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 34556778899999999999999864 7899999986432 23356788999999999999999999987655
Q ss_pred -----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEE
Q 037563 471 -----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 545 (606)
Q Consensus 471 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl 545 (606)
..++|+||+++ ++..++... ...+++..+..++.||+.||+|||+. +|+|+||+|+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999986 676766432 23588999999999999999999998 9999999999999999999999
Q ss_pred eeccCCcccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 546 SDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 546 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999998765433222223356788999998765 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=280.58 Aligned_cols=207 Identities=27% Similarity=0.432 Sum_probs=176.9
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEEeCC--------CcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeec
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKG 464 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g 464 (606)
..|+......+.+.||+|.||.|++|.... ...||||.++... .+.+.+..|+++|+.+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 556666767778899999999999998541 4579999997553 34678999999999995 999999999
Q ss_pred ceeccccceeeeeeccCCChhhhhhhcc---c-------cc--cccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 037563 465 FCIEGAHRLLAYEYLVNGSLDKWIFNST---E-------ES--RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532 (606)
Q Consensus 465 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp 532 (606)
+|.++...++|.||++.|+|.+||+..+ . .. ..++....+.++.|||.||+||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 01 2388999999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeccCCcccCcCcceeeeecc--cccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 533 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR--GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 533 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
+|||+.++..+||+|||+++.............. -+..|||||.+....|+.|+|||||||+||||+| |..||
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999976655544322222 3567999999999999999999999999999999 77776
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=255.30 Aligned_cols=195 Identities=25% Similarity=0.367 Sum_probs=162.3
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+++.++||+|++|.||+|+.. +++.|++|++.... ...+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556788999999999999976 58899999886432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~ 558 (606)
+ ++|.+++..... ..+++..+..++.||+.||+|||++ +++|+||+|+||++++ ++.+||+|||++.......
T Consensus 84 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 578887754322 2357788889999999999999998 9999999999999985 5679999999997654322
Q ss_pred ceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ......+++.|+|||++.+ ..++.++||||||+++|||+||+.||
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf 204 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 1 1223456889999998866 45789999999999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=232.04 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=168.5
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
......-...||+|++|.|-+-++. +|+..|+|+++.. .+..++...|+.+..+. ..|.+|.++|...+....++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3333444578999999999888864 5899999999754 34456778888776655 699999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
||.|. .+|+.+-...-..+..+++...-+|+..+.+||.|||++ ..++|||+||+||||+.+|++|++|||++-.+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99994 588888766656677899999999999999999999998 699999999999999999999999999998765
Q ss_pred cCcceeeeecccccCccccccccC----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITN----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..- ..+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||.
T Consensus 201 dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 201 DSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 432 2233567788999998753 368899999999999999999999984
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=254.95 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=166.2
Q ss_pred hccccccCCcCceeEEEEEeC----CCcEEEEEEeccc-----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~ 473 (606)
+.+.+.||+|++|.||+++.. +++.+|||+++.. ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 356678999999999999853 4688999998643 12345788999999999 5999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++... ..+++..+..++.|++++|.|||+. +++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998542 3478889999999999999999998 999999999999999999999999999887
Q ss_pred cCcCcceeeeecccccCccccccccCCC--CCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNP--ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.............++..|+|||.+.+.. .+.++|+||||+++|||++|+.||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 208 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence 6544322223346789999999987655 788999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=247.01 Aligned_cols=199 Identities=30% Similarity=0.459 Sum_probs=174.3
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|+||.||++... +++.+++|++.... ...+++.+|++.+++++|+|++++++.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999986 48899999997543 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999976543346789999999999999999999998 99999999999999999999999999998765433
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......+++.|+|||.+....++.++|+||+|++++||++|+.||.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 204 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCC
Confidence 12233567889999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=249.02 Aligned_cols=186 Identities=24% Similarity=0.306 Sum_probs=156.2
Q ss_pred ccccc--cCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTK--LGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~--lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+. ||+|+||.||+++.+ +++.+|+|.+........ |+.....+ +||||+++++.+......++||||++
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~ 92 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence 44455 499999999999975 478899998864322211 22222222 79999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCcCcc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREES 559 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 559 (606)
+++|.+++... ..+++..+..++.||++||.|||+. +++|+||+|+||+++.++ .++|+|||+++......
T Consensus 93 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 93 DGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999998543 2689999999999999999999998 999999999999999998 99999999987654332
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...++..|+|||++.+..++.++||||||++++||++|+.||.
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2467899999999999889999999999999999999999984
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=256.15 Aligned_cols=192 Identities=28% Similarity=0.422 Sum_probs=163.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+...+.||+|+||.||+++.. ++..+|+|++.... ....++.+|++++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 33555678999999999999975 47899999986432 22357889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 7777765332 3588999999999999999999998 999999999999999999999999999875433
Q ss_pred CcceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ....+++.|+|||++. ...++.++||||||+++|||++|+.||
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 224 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 2 2346788999999873 456889999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=260.45 Aligned_cols=193 Identities=27% Similarity=0.309 Sum_probs=163.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------cc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~ 471 (606)
..+...+.||+|+||.||+++.. +++.||+|++.... ....++.+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666788999999999999975 58899999986432 2345677899999999999999999987643 34
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+.+ +|.+++.. .++...+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 6899999964 88877742 277888899999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+....... .....++..|+|||.+.+..++.++||||||++++||++|+.||.
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 87543321 233467889999999999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=256.05 Aligned_cols=196 Identities=27% Similarity=0.352 Sum_probs=163.4
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc--ccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~ 476 (606)
.+++.+.||+|+||.||+++... ++.||+|+++... .....+.+|+.++++++|+||+++++++.+. ...++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 45667889999999999999864 8899999986432 1234567899999999999999999998754 4579999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 88 e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 88 EYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred ecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99975 8888886432 4588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 321 1223345788999998865 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=252.24 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=170.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+.+.+.||+|+||.||+++.. +++.+++|++... ....+.+..|++++.+++ |+||+++++.+..+...++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456678999999999999986 5899999998652 233467889999999998 9999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++++|||++......
T Consensus 83 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999643 2589999999999999999999998 9999999999999999999999999998865433
Q ss_pred cc-------------------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES-------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......++..|+|||.......+.++|+||||++++|+++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 21 11223457889999999988889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=253.96 Aligned_cols=197 Identities=30% Similarity=0.423 Sum_probs=161.6
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.++||+|+||.||+++... ++.+|+|.+.... ....++.+|+.++.++. |+||+++++++..+...+++|||++
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 445679999999999999764 7899999986432 33467889999999996 9999999999999889999999986
Q ss_pred CCChhhhhhhc-cccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 481 NGSLDKWIFNS-TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 481 ~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
. ++.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 555543211 11224588999999999999999999974 2899999999999999999999999999976543221
Q ss_pred eeeeecccccCccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN---PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~---~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 1234678899999998766 68899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=246.72 Aligned_cols=195 Identities=31% Similarity=0.453 Sum_probs=171.4
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc--ccceeeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAYEY 478 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~E~ 478 (606)
...+.||+|++|.||+|+.. +++.|++|++.... ...+.+.+|+..+++++|+||+++++.+.+. ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34577999999999999987 58899999986554 3467899999999999999999999999988 888999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++.... .+++..+..++.|++++|+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 83 VSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 99999999986533 688999999999999999999998 99999999999999999999999999998765543
Q ss_pred ce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......++..|++||.+.....+.++||||||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 1233567889999999988889999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=265.03 Aligned_cols=196 Identities=23% Similarity=0.389 Sum_probs=167.9
Q ss_pred hhccccccCCcCceeEEEEEeCCC-cEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDG-IQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~-~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
-.++...||.|+||.|||++.++. .--|.|++... ....++|.-||.+|+..+||+||+|++.+...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 346667899999999999998763 33466777643 4556889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
||-.+..+... +..+.+.++.-++.|++.||.|||++ .|||||||+.|||+.-+|.++|+|||.+...... ..
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 99998887543 35689999999999999999999999 9999999999999999999999999998654322 12
Q ss_pred eeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......|||.|||||+.. ..+|+.++||||||+.|.||.-+.+|-
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 234578999999999764 578999999999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=250.19 Aligned_cols=192 Identities=26% Similarity=0.331 Sum_probs=160.5
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeecceecc--ccceeeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEG--AHRLLAYEY 478 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~--~~~~lV~E~ 478 (606)
.+.++||+|+||.||+++.. +++.+|+|+++... ........|+..+.++. |+|++++++++.+. ...++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999975 48899999986542 22334567888888885 99999999999887 889999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
++ ++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||+|+||+++. +.+||+|||+++......
T Consensus 82 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 97 58888875432 3588999999999999999999998 9999999999999999 999999999998764332
Q ss_pred ceeeeecccccCcccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~-~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||.
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 2 12345788999999764 4557889999999999999999999983
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=245.70 Aligned_cols=195 Identities=29% Similarity=0.423 Sum_probs=171.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+.+.||+|++|.||+++.. +++.+++|.+..... ..+++.+|++++++++|+|++++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 455678999999999999876 478999999976542 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++... ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998643 3588999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||...+...+.++||||+|++++||++|+.||.
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 1 233567889999999888888999999999999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=254.89 Aligned_cols=200 Identities=24% Similarity=0.257 Sum_probs=148.9
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCC----cEEEEEEecccCCCh------------HHHHHHHHHHHhcccCCccee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDG----IQVAVKKLESIGQGK------------KEFSAEVTIIGNVHHVHLVKL 462 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~----~~vavK~l~~~~~~~------------~~~~~Ei~~l~~l~h~nIv~l 462 (606)
+....+.+.+.||+|+||.||+|...+. ..+++|+........ .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3344567788999999999999997653 455666432211110 112223344556689999999
Q ss_pred ecceeccc----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 463 KGFCIEGA----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 463 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
++++.... ..++++|+... ++.+.+... ...++..+..|+.|++.||+|||+. +++||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99765543 33567776543 555555322 2246777889999999999999998 999999999999999
Q ss_pred CCCcEEEeeccCCcccCcCcc------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 539 DNFTAKVSDFGLAKLMNREES------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||++++||++|+.||.
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999986543211 11123468999999999999999999999999999999999999994
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=258.17 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=163.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhc-ccCCcceeecceecc--ccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG--AHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~--~~~~ 473 (606)
...+.+.+.||+|+||.||+|... +++.+|+|++... ......+..|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345667788999999999999976 4789999988532 22345677899999999 999999999998653 4679
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||+|+||++++++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5998887432 578888999999999999999998 999999999999999999999999999986
Q ss_pred cCcCcc----eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES----LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf 213 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence 543321 12223467889999998755 45788999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=259.43 Aligned_cols=194 Identities=26% Similarity=0.424 Sum_probs=161.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceecc-----cccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~l 474 (606)
.+.+.++||+|+||.||+|+.. +++.||+|++... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4566788999999999999965 5889999998643 23346788899999999999999999987644 35789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|+||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 9999975 77777632 3588899999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcce--eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f 210 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 432211 1123467899999998654 56889999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=250.18 Aligned_cols=193 Identities=30% Similarity=0.454 Sum_probs=164.8
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC--ChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+.||+|++|.||+|+..+ ++.|++|++..... ......+|+..+++++ |+||+++++++.++...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 456789999999999999864 78899999865432 2334567999999999 999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999886543 24589999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.||
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 123457889999998754 45789999999999999999999988
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.88 Aligned_cols=197 Identities=24% Similarity=0.319 Sum_probs=162.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecccc-------
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH------- 471 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~------- 471 (606)
.+++.++||+|+||.||+++.. +++.||||++.... .....+.+|++++++++||||+++++++.....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667788999999999999976 48899999885432 223456789999999999999999999876543
Q ss_pred -ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 472 -RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 472 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
.++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+||++++++.+||+|||+
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999965 7887775422 3588999999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCcc---eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREES---LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 986543221 111234568889999987664 46889999999999999999999883
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=236.42 Aligned_cols=194 Identities=25% Similarity=0.407 Sum_probs=161.5
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC--ChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
++...||.|..|.|++.+... |..+|||.+..... +.+++...+.++..-+ .|.||+.+|+|..+....+-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 455779999999999999865 78999999976643 3356666777666655 8999999999999999999999984
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
..++..|.+.. .++++..+-++...+.+||.||..+ .+|+|||+||+|||+|+.|++|++|||++..+....
T Consensus 175 -~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 175 -TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred -HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 35555554432 3588888999999999999999986 599999999999999999999999999998765433
Q ss_pred eeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+...|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 2345678899999998864 457889999999999999999999983
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=285.76 Aligned_cols=192 Identities=32% Similarity=0.446 Sum_probs=164.3
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
..||.|.||.||-+...+ |.-.|+|-++-. ....+...+|.++++.++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 569999999999999655 788899977532 3345678999999999999999999999999999999999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc---e
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES---L 560 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---~ 560 (606)
|.+.+...+ ..++....-+..|++.|+.|||+. +|+||||||.||+|+.+|.+|..|||.|..+..+.. .
T Consensus 1321 La~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999995443 355556666889999999999999 999999999999999999999999999988765531 1
Q ss_pred eeeecccccCccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNP---ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+-|||||++.+.. .....||||+|||++||+||++||+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 123468999999999997643 4568899999999999999999985
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.20 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=162.4
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+.+.+.||+|+||.||+++.++ ++.||||+++... ....++..|+.++.+.. |+||+++++++.++...+++|||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 35677899999999999999875 8899999997543 23456777887777775 99999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++ +|.+++.... ..+++..+..++.||+.||+|||+. .+++|+||+|+||++++++.+||+|||++..+....
T Consensus 96 ~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 96 MST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred cCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 854 7777664422 3688999999999999999999973 289999999999999999999999999987654322
Q ss_pred ceeeeecccccCccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||.
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 2 12345788999999987553 7889999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.26 Aligned_cols=194 Identities=18% Similarity=0.181 Sum_probs=161.5
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
.+.+|.|+++.||+++. +++.||+|++... ....+.+.+|++++++++|+||+++++++.+....+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34466667777777766 6889999998643 2345689999999999999999999999999999999999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc----
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES---- 559 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---- 559 (606)
|.+++..... ..+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+||+.+........
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999975432 3478888999999999999999998 999999999999999999999999998875432111
Q ss_pred --eeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 --LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 --~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......++..|+|||++.. ..++.++|+||||+++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 11123456788999999876 357889999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=248.98 Aligned_cols=194 Identities=29% Similarity=0.400 Sum_probs=167.1
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
++.+.||+|++|.||+++.. +++.+++|++..... ....+..|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34577999999999999975 588999999865432 34678899999999999999999999999999999999997
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||.+....... .
T Consensus 82 ~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 82 T-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred C-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 5 8888875532 3588999999999999999999998 99999999999999999999999999998765543 1
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+. .++.++|+||||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 22334578889999998776 78999999999999999999999983
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=247.94 Aligned_cols=194 Identities=26% Similarity=0.396 Sum_probs=163.4
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhc---ccCCcceeecceecccc-----c
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNV---HHVHLVKLKGFCIEGAH-----R 472 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~~~-----~ 472 (606)
++.+.||+|+||.||+++.+. ++.+|+|+++.... ....+.+|+.++.++ +|+|++++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456789999999999999875 89999999964321 234567788777666 59999999999988776 8
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
+++|||+++ +|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999975 89888865332 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 7644322 123357889999999998889999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=243.05 Aligned_cols=189 Identities=32% Similarity=0.419 Sum_probs=166.3
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
||+|+||.||++...+ ++.+++|.++.... ...++..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999864 88999999865422 346889999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 9999643 2478999999999999999999998 999999999999999999999999999987644321 1234
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..++..|++||.+.+...+.++|+||||+++|||++|+.||+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 567889999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=246.65 Aligned_cols=198 Identities=26% Similarity=0.404 Sum_probs=165.5
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc------CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI------GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
+.+.++||+|+||.||+++... +..+++|.++.. .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567889999999999998754 344556655432 123346778999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||.++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999999876444446789999999999999999999998 9999999999999976 5699999999887644
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 322 1233567889999999988888999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=256.44 Aligned_cols=196 Identities=22% Similarity=0.392 Sum_probs=163.7
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec----cccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~ 473 (606)
..+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34556678999999999999976 48899999986532 334677889999999999999999998763 34678
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 5898888532 3488999999999999999999998 999999999999999999999999999976
Q ss_pred cCcCcc---eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES---LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf 212 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence 543221 11123568889999998765 45789999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=253.82 Aligned_cols=194 Identities=23% Similarity=0.320 Sum_probs=159.1
Q ss_pred cccCCc--CceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G--~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+||+| +||+||+++.. .++.||+|++..... ..+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999975 589999999864332 236788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce-
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 560 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 560 (606)
++|.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999865432 3478889999999999999999998 9999999999999999999999999765432211110
Q ss_pred --e---eeecccccCccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 --V---YTTLRGTRGYLAPEWITNN--PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 --~---~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0 0112345679999998763 46899999999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=247.04 Aligned_cols=194 Identities=30% Similarity=0.410 Sum_probs=166.9
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+.||+|++|.||+|+..+ ++.+++|++... ....+.+..|+.++++++|+||+++++++.+....++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 345679999999999999875 899999998754 2334678899999999999999999999999999999999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||.++.......
T Consensus 82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 58999986542 3588999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......++..|+|||.+.+. .++.++||||||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 12234457789999988766 78999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=254.97 Aligned_cols=192 Identities=26% Similarity=0.350 Sum_probs=160.9
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---------------hHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---------------KKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---------------~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
.+.||+|+||.||+++.. .++.||+|+++..... ...+.+|++++++++|+||+++++++....
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 456999999999999975 5889999988643221 125788999999999999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..++||||++ ++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccc
Confidence 9999999997 5899888542 3478899999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCc-------------ceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREE-------------SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++...... ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 98654110 1111223467889999988764 46889999999999999999999984
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=254.52 Aligned_cols=195 Identities=25% Similarity=0.411 Sum_probs=167.5
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc-----ccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-----HRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~l 474 (606)
+.+.+.||+|++|.||+++..+ ++.+++|++.... ...+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 4567889999999999999865 8899999986542 34567899999999999999999999998775 7899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+|||+++ +|.+++... ..+++..+..++.||+.||+|||+. +++|+||||.||++++++.++|+|||++...
T Consensus 82 v~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999984 888888532 3688999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcc--eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES--LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .......++..|+|||.+.+. .++.++|+||||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 54321 112334678899999999887 78999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=253.52 Aligned_cols=189 Identities=28% Similarity=0.409 Sum_probs=157.9
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccc------cce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~~ 473 (606)
+...+.||+|+||.||+|+.. +++.||+|++... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 445578999999999999975 5899999998643 223456889999999999999999999987543 458
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99999864 6766541 2478889999999999999999998 999999999999999999999999999876
Q ss_pred cCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 43321 23456788999999876 467899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=254.55 Aligned_cols=192 Identities=27% Similarity=0.388 Sum_probs=162.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc------c
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------H 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~ 471 (606)
.++.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34556788999999999999865 58899999985432 22356889999999999999999999987654 3
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 48999998 7799888742 3578999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... ....+++.|+|||.+.+ ..++.++|+||||++++||++|+.||.
T Consensus 166 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 166 RQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 8654321 23457889999998876 457899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=253.58 Aligned_cols=194 Identities=26% Similarity=0.407 Sum_probs=162.4
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceecc-----cccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~l 474 (606)
+...+.||+|+||+||+++.. +++.||||.+... .....++.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 455678999999999999975 4889999998643 23345678899999999999999999988654 34799
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999996 6888887532 3588999999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......++..|+|||.+.. ..++.++|+||||+++|||++|+.||.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 4332 11233467889999998765 468899999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=250.17 Aligned_cols=193 Identities=27% Similarity=0.429 Sum_probs=162.8
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..++...+.||+|+||.||+|+.. +++.+++|.+.... ...+++.+|+++++.++|+|++++++++.+....++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344555678999999999999975 47889999886421 2235688899999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 57877765322 3478899999999999999999998 99999999999999999999999999987654
Q ss_pred cCcceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. ....+++.|+|||.+. ...++.++||||||+++|||++|+.||
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 214 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 32 2345788999999874 345788999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=247.38 Aligned_cols=189 Identities=29% Similarity=0.441 Sum_probs=160.7
Q ss_pred cccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 406 FSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
..++||+|+||+||+|+.. .++.|++|++.... ...+++.+|++++++++|||++++++++.+....++||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 3467999999999999975 47899999986432 223568889999999999999999999999999999999996
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++.... ..+++..+..++.||+.+|.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 105 -~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 105 -GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred -CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 57777765422 3588999999999999999999998 9999999999999999999999999998653322
Q ss_pred eeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2356788999999874 4568889999999999999999999983
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=252.64 Aligned_cols=190 Identities=27% Similarity=0.420 Sum_probs=158.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc------ccc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AHR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~ 472 (606)
++.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3455678999999999999864 58899999986432 2245688899999999999999999987643 345
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++++|++ +++|.+++.. ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||+++
T Consensus 98 ~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred EEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence 7888876 7899887742 3478899999999999999999998 99999999999999999999999999987
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 169 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 169 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred ccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 64332 123467889999998766 56788999999999999999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=249.52 Aligned_cols=198 Identities=29% Similarity=0.389 Sum_probs=161.2
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc-------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------- 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------- 470 (606)
..+.+.++||+|+||.||+++.. +++.+++|++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34566788999999999999975 47899999886432 22346788999999999999999999875443
Q ss_pred -cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 471 -HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 471 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
..++|+||+++ +|...+... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999875 676666432 23589999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcce----------eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESL----------VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++........ ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 99865432211 1122356788999998765 457899999999999999999999983
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=253.92 Aligned_cols=194 Identities=27% Similarity=0.335 Sum_probs=171.2
Q ss_pred hccccccCCcCceeEEEEEeCCCc-EEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGI-QVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~-~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+....||-||||.|=+...+... ..|+|.+++.+ ...+.+..|-.+|...+.|.||+++-.+.++...|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344567999999999999986543 37888886542 3456788899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
|-||.|...|.+.. .++..+..-++.-+..|++|||+. +||+|||||+|.+||.+|-+||.|||.|+.+....
T Consensus 502 ClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999996543 467777788999999999999998 99999999999999999999999999999887654
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..-+.+||+.|.|||.+.+..++..+|.||||++++||++|++|||
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 3456899999999999999999999999999999999999999997
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=255.42 Aligned_cols=192 Identities=23% Similarity=0.368 Sum_probs=165.3
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
++.||-|+||+|-++.-.| ...+|.|.|++. ......+++|-.+|+..+.+=||+|+-.|++++.+|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3669999999999998555 556899999754 24456789999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC------
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN------ 555 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~------ 555 (606)
|++-.+|.+. ..+.+..+.-++..+..|+++.|+. |+|||||||+|||||.+|++||+|||++.-+.
T Consensus 714 GDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 714 GDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999998654 3477788888889999999999997 99999999999999999999999999986431
Q ss_pred ---cC--------------------------------cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh
Q 037563 556 ---RE--------------------------------ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG 600 (606)
Q Consensus 556 ---~~--------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt 600 (606)
.. ........+||+.|+|||++....++...|.||.||||+||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 00 0011123579999999999999999999999999999999999
Q ss_pred CCCCC
Q 037563 601 GRKSF 605 (606)
Q Consensus 601 G~~pf 605 (606)
|+.||
T Consensus 867 g~~pf 871 (1034)
T KOG0608|consen 867 GQPPF 871 (1034)
T ss_pred CCCCc
Confidence 99999
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=237.93 Aligned_cols=178 Identities=24% Similarity=0.205 Sum_probs=152.8
Q ss_pred cCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhhhhhhc
Q 037563 413 GGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS 491 (606)
Q Consensus 413 G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~ 491 (606)
|.+|.||+++.. +++.+|+|++.... ++..|...+....||||+++++++.+....++||||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999986 47899999986542 3344555556667999999999999999999999999999999998543
Q ss_pred cccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCc
Q 037563 492 TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571 (606)
Q Consensus 492 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 571 (606)
..+++.....++.|++.||.|||+. +++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 2488999999999999999999998 99999999999999999999999999886554321 223456789
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 572 ~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+|||.+.+..++.++|+||+|++++||++|+.||
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchh
Confidence 9999998888999999999999999999999876
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=248.89 Aligned_cols=191 Identities=27% Similarity=0.398 Sum_probs=160.8
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceec-cccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||++... +++.||+|++... ....+.+..|++++++++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3455688999999999999965 5889999988542 2234678899999999999999999999865 557889999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+ +++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 91 LL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred hh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 98 5688888742 3467778888999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ....++..|+|||.+.+ ..++.++||||||++++||++|+.||.
T Consensus 162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 23456889999998766 568999999999999999999999983
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=245.01 Aligned_cols=200 Identities=30% Similarity=0.412 Sum_probs=163.9
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--------ChHHHHHHHHHHHhcccCCcceeeccee-cccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--------GKKEFSAEVTIIGNVHHVHLVKLKGFCI-EGAH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-~~~~ 471 (606)
.++-+...||+|||+.|||+.+- ..+-||||+-..... -.+...+|..+.+.++||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 34445567999999999999953 467899997632221 1245677999999999999999999986 5567
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeec
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDF 548 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Df 548 (606)
.+-|.||++|.+|+-||.. .+.++++.+..|+.||+.||.||... +++|||-||||.||||.+ -|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999954 45689999999999999999999985 669999999999999954 578999999
Q ss_pred cCCcccCcCcc------eeeeecccccCccccccccC----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREES------LVYTTLRGTRGYLAPEWITN----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++++..+.. ...+...||..|++||.+.- ..++.|+||||.|||+|..+-|++||.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 99998865432 12334678999999996542 346889999999999999999999993
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=249.61 Aligned_cols=195 Identities=26% Similarity=0.361 Sum_probs=159.7
Q ss_pred hccccccCCcCceeEEEEEeCC---CcEEEEEEecccC---CChHHHHHHHHHHHhc-ccCCcceeecceecc----ccc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG---QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG----AHR 472 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~----~~~ 472 (606)
+.+.+.||+|+||.||+++... +..+|+|++.... ...+.+.+|+.++.++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 4566789999999999999753 6789999986432 2246788899999999 599999999875432 356
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78888886 689888853 24588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcc---eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREES---LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .......++..|+|||++.+ ..++.++|+||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 6543221 11123468899999998765 568899999999999999999999983
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=248.10 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=168.3
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcc-cCCcceeecceecccccee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~l 474 (606)
+....+++.++||+||-+.||++...+.+.+|+|++... .+...-|.+|+..|.+++ |.+|++|++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 334456677889999999999999988889999987543 344578999999999996 9999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||= .-+|..+|..... ....| .+..+-.||+.++.++|.. +|||.||||.|+|+-. |.+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99985 5599999965443 22334 6777899999999999998 9999999999999954 69999999999998
Q ss_pred CcCcc-eeeeecccccCccccccccCCC-----------CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES-LVYTTLRGTRGYLAPEWITNNP-----------ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-----------~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+.. ......+||+.||+||.+.... .+.++||||+|||||+|+-|++||.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 87765 3445689999999999874322 4679999999999999999999983
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=233.63 Aligned_cols=195 Identities=24% Similarity=0.329 Sum_probs=169.1
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+.+.+.||+|+|.+|..++++. .+.+|+|++++. ..+.+-.+.|-.+..+. +||.+|.|+.+++.+..+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 3556889999999999999876 577899988643 33445566677777666 69999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|.+||+|--++++. ..+++..+.-+...|..||.|||++ +||+||||..|+|||..|.+|++|+|+++.--.+
T Consensus 332 yv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999998777543 3488888888999999999999999 9999999999999999999999999999864333
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....++..||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+
T Consensus 405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 234567899999999999999999999999999999999999999995
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=250.55 Aligned_cols=196 Identities=25% Similarity=0.369 Sum_probs=160.1
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceecc----------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG---------- 469 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~---------- 469 (606)
.++.+.+.||+|+||.||+|+... ++.||+|++.... ...+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 345667889999999999999754 8899999986543 3456788999999999999999999876543
Q ss_pred ----ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEE
Q 037563 470 ----AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAK 544 (606)
Q Consensus 470 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~k 544 (606)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 34689999997 588887742 3478899999999999999999998 999999999999997 556799
Q ss_pred EeeccCCcccCcCcce--eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 545 VSDFGLAKLMNREESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999765432111 1122357889999997654 567889999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-30 Score=238.08 Aligned_cols=194 Identities=30% Similarity=0.426 Sum_probs=159.4
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccCCC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
..||.|+||+|+|-.++. |+..|||+++... .+.++++.|.+...+- +.||||+++|.+-.++.-++-||.|. .+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 569999999999999864 8999999997553 4556788888766554 68999999999999999999999994 46
Q ss_pred hhhhhhh-ccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 484 LDKWIFN-STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 484 L~~~l~~-~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
|+.+... ...+...+++...-.|..-+.+||.||... ..|||||+||+|||||..|.+|++|||++..+... ...
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAk 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAK 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HHh
Confidence 6554322 122335688888888999999999999987 68999999999999999999999999999866433 233
Q ss_pred eecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.-.|-..|||||.+.. ..++.++||||||+.|+|+.||+.|+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 44578889999998864 348899999999999999999999973
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.05 Aligned_cols=201 Identities=21% Similarity=0.260 Sum_probs=151.6
Q ss_pred HhhccccccCCcCceeEEEEEe-----------------CCCcEEEEEEecccCCC-h--------------HHHHHHHH
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-----------------PDGIQVAVKKLESIGQG-K--------------KEFSAEVT 449 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~Ei~ 449 (606)
..+.+.++||+|+||.||+|.+ .+++.||||++....+. . +....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3456678999999999999974 23568999998643221 1 23345777
Q ss_pred HHHhcccCCc-----ceeecceec--------cccceeeeeeccCCChhhhhhhccc--------------------ccc
Q 037563 450 IIGNVHHVHL-----VKLKGFCIE--------GAHRLLAYEYLVNGSLDKWIFNSTE--------------------ESR 496 (606)
Q Consensus 450 ~l~~l~h~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~ 496 (606)
++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 8888877655 677887753 3567999999999999999864321 012
Q ss_pred ccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCcccccc
Q 037563 497 FLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576 (606)
Q Consensus 497 ~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 576 (606)
.+++..+..++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||+++.+............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 346778889999999999999998 99999999999999999999999999997654332222122344789999998
Q ss_pred ccCCCC----------------------CCccchHHHHHHHHHHHhCCC-CC
Q 037563 577 ITNNPI----------------------SEKSDVYSYGMVLLEIIGGRK-SF 605 (606)
Q Consensus 577 ~~~~~~----------------------t~~~Dv~s~Gvvl~elltG~~-pf 605 (606)
+..... ..+.||||+||+++||++|.. ||
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 754321 134799999999999999875 65
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=213.19 Aligned_cols=190 Identities=23% Similarity=0.355 Sum_probs=162.2
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
.++||+|.||+|||++..+ ++.||+|+++-... ......+||-+++.++|.|||++++....+..+.+|+||+ ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 3679999999999999766 67899999864432 2356889999999999999999999999999999999999 45
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|..|..... ..++......++.|+++||.++|++ ++.|||+||.|.+|+.+|+.|++|||+++-++-.- ...
T Consensus 86 dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 86 DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 8888875443 3578888999999999999999998 99999999999999999999999999999776443 234
Q ss_pred eecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCC
Q 037563 563 TTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
+..+.|..|.+|+++.+. -|+...|+||-|||+.|+....+|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 556779999999998775 578899999999999999874443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.41 Aligned_cols=191 Identities=25% Similarity=0.403 Sum_probs=162.0
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecccc------c
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH------R 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~------~ 472 (606)
.+.+.+.||+|++|.||+|+... ++.||+|++.... ...+++.+|+.++++++|+||+++++++..... .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 34566889999999999999864 7899999986432 233567789999999999999999998876554 7
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 9999998 6699988853 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 65432 223467889999998765 367899999999999999999999983
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=237.12 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=168.0
Q ss_pred HHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCCC--hHHHHHHHHHHHhcccCCcceeecceecc-c
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQG--KKEFSAEVTIIGNVHHVHLVKLKGFCIEG-A 470 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~ 470 (606)
.+.+...+..+-+|.||+||+|.+. +.+.|.+|.++..... ...+..|-.++..+.|||+..+.+++.+. .
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3444455567899999999999654 4567888888765433 45788999999999999999999999764 5
Q ss_pred cceeeeeeccCCChhhhhhhcc----ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEe
Q 037563 471 HRLLAYEYLVNGSLDKWIFNST----EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 546 (606)
..+.+|.++.-|+|+.||...+ ...+.++..+...++.|++.|++|||+. +++|.||.++|.+||+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 6788899999999999997322 2234577888899999999999999998 99999999999999999999999
Q ss_pred eccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 547 DFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 547 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|=.+++.+-+.+... ......+..||+||.+.+..|+..+|||||||+||||+| |+.|+.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 999998765443321 123456789999999999999999999999999999999 888874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=266.51 Aligned_cols=188 Identities=30% Similarity=0.459 Sum_probs=150.7
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceecc--------------
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-------------- 469 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-------------- 469 (606)
.+.||+||||.|||++.+ ||+.+|||+++.. ......+.+|++.+++++|||||+.+..+.+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 367999999999999976 7999999999755 33346788999999999999999986211100
Q ss_pred --------------------------------------------------------------------------------
Q 037563 470 -------------------------------------------------------------------------------- 469 (606)
Q Consensus 470 -------------------------------------------------------------------------------- 469 (606)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc
Q 037563 470 -------------------------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524 (606)
Q Consensus 470 -------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 524 (606)
..+||-||||+..+|.+++....-.. ......+++.+|+.||.|+|++ +
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---G 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---c
Confidence 12367788888888888775433211 3456788999999999999998 9
Q ss_pred eeecCCCCCCeEEcCCCcEEEeeccCCcccC-----------------cCcceeeeecccccCccccccccCCC---CCC
Q 037563 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMN-----------------REESLVYTTLRGTRGYLAPEWITNNP---ISE 584 (606)
Q Consensus 525 iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ 584 (606)
||||||||.||+||++..+||.|||++.... .......+..+||.-|+|||.+.+.. |+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 01112345678999999999987654 999
Q ss_pred ccchHHHHHHHHHHHh
Q 037563 585 KSDVYSYGMVLLEIIG 600 (606)
Q Consensus 585 ~~Dv~s~Gvvl~ellt 600 (606)
|+|+||+|||++||+-
T Consensus 798 KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY 813 (1351)
T ss_pred hhhhHHHHHHHHHHhc
Confidence 9999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=230.59 Aligned_cols=187 Identities=26% Similarity=0.302 Sum_probs=160.4
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceec----cccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE----GAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~----~~~~~lV~E~~~~ 481 (606)
++||-|--|.|-.+..+. ++.+|+|++... +..++|+++.-.. .|||||.+++++.. ...+++|||+|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 579999999999999864 788999998654 3446677765555 59999999998764 3467899999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcccCcCc
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~ 558 (606)
|.|.+.++.... ..++++++.+|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||.|+.-...
T Consensus 144 GeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~- 217 (400)
T KOG0604|consen 144 GELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP- 217 (400)
T ss_pred hHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC-
Confidence 999999976554 4689999999999999999999998 9999999999999964 557999999999965432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....+..-|+.|.|||++....++...|+||+||++|-|++|.+||
T Consensus 218 -~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 218 -GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred -ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 3345678899999999999999999999999999999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=227.74 Aligned_cols=196 Identities=35% Similarity=0.522 Sum_probs=170.2
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999999876 88999999976543 467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++..... .+++.....++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999865332 178889999999999999999998 99999999999999999999999999998765543112
Q ss_pred eeecccccCccccccc-cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWI-TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....++..|++||.. ....++.++|+|+||++++||++|+.||+
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334677889999988 66778889999999999999999999994
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=264.84 Aligned_cols=143 Identities=26% Similarity=0.380 Sum_probs=127.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.++||+|+||.||++++. .++.||||+++... ...+.+..|+.++..++|+||+++++.+......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3566788999999999999986 48899999986432 123678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
|+++++|.+++... ..+++..+..|+.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998543 3477888999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=252.39 Aligned_cols=199 Identities=28% Similarity=0.421 Sum_probs=175.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceec-----ccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE-----GAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~-----~~~~~l 474 (606)
.+.+|.+.||.|.+|.||+++.. +++-.|+|++.......++.+.|.++++.. +|||++.++|++.. +++++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 45677889999999999999964 588999999988888888999999999988 59999999999864 467899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|||||.+|+.-+.+.+.. +..+.|.....|+..++.||.+||.+ .++|||||=.|||++.++.+|+.|||++..+
T Consensus 99 VMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999997765 56799999999999999999999999 9999999999999999999999999999877
Q ss_pred CcCcceeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ..+..||+.|||||++.- ..|+..+|+||||++..||--|.+|+.
T Consensus 174 dsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 174 DSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred eccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 654333 345789999999999864 246778999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=245.71 Aligned_cols=190 Identities=29% Similarity=0.420 Sum_probs=161.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+++...+|.|+|+.|-.+.... ++..++|++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++|||.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 345666779999999999999754 788999999765 33345666555555 6999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE-cCCCcEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL-DDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~ 558 (606)
.++-|.+.+..... .. ..+.+|+.+|+.++.|||++ +++||||||.|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99988887754332 22 67778999999999999998 99999999999999 58999999999999977654
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....+-|..|.|||++....+++.+|+||||++|||||+|+.||.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 233566889999999999999999999999999999999999983
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=242.34 Aligned_cols=191 Identities=25% Similarity=0.349 Sum_probs=164.3
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---------ChHHHHHHHHHHHhcc---cCCcceeecceecccc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---------GKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAH 471 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~ 471 (606)
...+.+|+|+||.|+.+.++. ..+|+||.+.+.+- ..-.+-.||++|..++ |+||++++.+|.+++.
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 345789999999999999875 57899998865321 1123566999999998 9999999999999999
Q ss_pred ceeeeeec-cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 472 RLLAYEYL-VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 472 ~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
.||+||-. ++-+|.+++... +.+++..+..|+.|++.|+++||++ +|+|||||-+|+.++.+|-+||+|||.
T Consensus 644 yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 99999975 567999998543 4589999999999999999999999 999999999999999999999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+....... ....+||.+|.|||++.+.+| ...-|||++|++||-++-...||
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 98765443 445789999999999999887 45569999999999999988887
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=227.16 Aligned_cols=190 Identities=28% Similarity=0.425 Sum_probs=163.4
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc-----ccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~lV~E~ 478 (606)
+.||-|+||.||..+++ +|+.|+.|++.+.-+ ..+.+.+|++++.-.+|.|++..++..+-. .++|.++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 56999999999999976 599999999976432 357788999999999999999999887643 356888998
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
|. .+|.+.+- ....++...+.-++.||++||.|||+. +|.||||||.|.|++.+-..||+|||+++....++
T Consensus 139 mQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 139 MQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 84 47777663 334688888888999999999999998 99999999999999999999999999999887777
Q ss_pred ceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...++..+.|..|.|||.+++. .|+...||||.|||+.||+-.+.-|
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 7777777889999999999875 6789999999999999999877655
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=233.34 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=173.1
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccC------Ccceeecce
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV------HLVKLKGFC 466 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~------nIv~l~g~~ 466 (606)
+...|....++.+...+|+|.||.|-+..+.. +..||||+++....-.+..+-|++++.++.+. -+|.+.+++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 45556667777888899999999999999765 68899999988777677788899999999422 467888899
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-------
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD------- 539 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~------- 539 (606)
.-.++.+||+|.+ |-++.++|..+.. .+++...+..|+.|++++++|||+. +++|.||||+|||+-+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 9999999999987 6699999966443 4677889999999999999999998 9999999999999932
Q ss_pred -------------CCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 540 -------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 540 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+..+||+|||.|.....+. +..+.|..|.|||++.+-.++.+.||||+||||.|+.||..-|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3468999999999766554 4467899999999999999999999999999999999998766
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=223.70 Aligned_cols=184 Identities=31% Similarity=0.493 Sum_probs=163.0
Q ss_pred CceeEEEEEeCC-CcEEEEEEecccCC-C-hHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhhhhhh
Q 037563 414 GFGSVYLGMLPD-GIQVAVKKLESIGQ-G-KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN 490 (606)
Q Consensus 414 ~fG~Vy~g~~~~-~~~vavK~l~~~~~-~-~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 490 (606)
+||.||+++..+ ++.+++|++..... . .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 89999999975432 2 68899999999999999999999999999999999999999999999864
Q ss_pred ccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccC
Q 037563 491 STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570 (606)
Q Consensus 491 ~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 570 (606)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 32 278899999999999999999998 99999999999999999999999999998765432 2234567889
Q ss_pred ccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 571 y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|++||.+....++.++|+||||++++||++|+.||.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999988889999999999999999999999984
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=251.96 Aligned_cols=198 Identities=20% Similarity=0.218 Sum_probs=140.2
Q ss_pred HhhccccccCCcCceeEEEEEeCC-----CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecc------eeccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF------CIEGA 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~------~~~~~ 470 (606)
..+.+.++||+|+||.||+|++.+ +..||+|++..... .+....| .+....+.++..++.. +....
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 345677899999999999999864 58899998864322 1111111 1122222333332222 24566
Q ss_pred cceeeeeeccCCChhhhhhhcccc----------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEE----------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
..++|+||+++++|.+++...... ........+..++.||+.||+|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 789999999999999998643210 00112334567999999999999998 99999999999
Q ss_pred eEEcC-CCcEEEeeccCCcccCcCcceeeeecccccCccccccccCC----------------------CCCCccchHHH
Q 037563 535 VLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN----------------------PISEKSDVYSY 591 (606)
Q Consensus 535 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~~Dv~s~ 591 (606)
||+++ ++.+||+|||+++.+............+++.|||||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57999999999986654433333456789999999965322 23456799999
Q ss_pred HHHHHHHHhCCCCC
Q 037563 592 GMVLLEIIGGRKSF 605 (606)
Q Consensus 592 Gvvl~elltG~~pf 605 (606)
||++|||+++..|+
T Consensus 366 GviL~el~~~~~~~ 379 (566)
T PLN03225 366 GLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHhCcCCC
Confidence 99999999987664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-27 Score=221.55 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=159.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEec--ccCCC-hHHHHHHHHHHHhcccCCcceeecceecc--------cc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE--SIGQG-KKEFSAEVTIIGNVHHVHLVKLKGFCIEG--------AH 471 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~--~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--------~~ 471 (606)
++-..++|+|.||+||+++.++ ++.||+|+.- ....+ ...-.+|+++|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3444689999999999999865 6778888652 22222 24567899999999999999999998743 34
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++|+++++. +|.-.|.+.. ..++...+.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 6899999977 6777774432 3478888999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcc---eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 552 KLMNREES---LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 552 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+.+...+. ..++..+.|..|.+||.+.+ ..++++.|+|+-|||+.||.|+.+-|
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 87654433 33455677999999998776 57899999999999999999998755
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=210.96 Aligned_cols=190 Identities=24% Similarity=0.403 Sum_probs=162.9
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccc--cceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGA--HRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~--~~~lV~E 477 (606)
..+++.+++|+|-+++||.|.. .+.+.++||+++.. ..+.+.+|+++|..+. ||||++|++...+.. ...|++|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4567778999999999999994 46788999999865 3567899999999997 999999999998754 4569999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~ 556 (606)
|+++.+..... +.++...+..++.++++||.|+|+. ||.|||+||.|++||.. -.++|+|+|+|.+..+
T Consensus 116 ~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99998887665 4577788888999999999999998 99999999999999964 5799999999998876
Q ss_pred CcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... ....+.+..|-.||.+.. +.++.+-|+|||||++.+|+..+.||
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 554 334566788999998765 56788999999999999999999998
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=194.28 Aligned_cols=107 Identities=35% Similarity=0.591 Sum_probs=96.7
Q ss_pred CCcEEEeCCCeeEEEEEecCC-C-cEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEEEcCCc-eeEeeccCC
Q 037563 46 NGLFLISNNSVFGFGFYTALD-V-QFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNG-EAWSANTSG 122 (606)
Q Consensus 46 ~~~~l~s~~g~f~~gf~~~~~-~-~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l~~~~~-~~w~t~~~~ 122 (606)
.+++|+|+++.|++|||.... . ++++|||.+.+ +++||+|||+.|....++|.|+.||+|+|++.++ ++|++++.+
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 489999999999999999764 4 89999999877 8999999999996667899999999999998765 899999865
Q ss_pred -CceeEEEEecCCcEEEEecCCceEEEecCCC
Q 037563 123 -QKVECMELQDSGNLVLLGVNGSILWQSFSHP 153 (606)
Q Consensus 123 -~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~P 153 (606)
....+|+|+|||||||++.++.++|||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 6677899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-27 Score=247.75 Aligned_cols=191 Identities=29% Similarity=0.412 Sum_probs=158.3
Q ss_pred cccCCcCcee-EEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGS-VYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~-Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
+.+|.|+-|+ ||+|.. ++++||||++-.. ......+||..|+.- +|||||+.++.-++...+||..|.| ..+|+
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 4589999876 899999 7889999988432 234557899999888 4999999999999999999999999 55999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---C--CcEEEeeccCCcccCcCcc-
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---N--FTAKVSDFGLAKLMNREES- 559 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~--~~~kl~Dfgla~~~~~~~~- 559 (606)
+++...........-.....++.|+++||++||+. +|+||||||.||||+. + ..++|+|||+++.+.....
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 99976422212222255677899999999999997 9999999999999975 3 4799999999998876544
Q ss_pred -eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhC-CCCC
Q 037563 560 -LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG-RKSF 605 (606)
Q Consensus 560 -~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG-~~pf 605 (606)
.......||-||+|||.+....-+..+|++|+|||+|+.++| .+||
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 224457899999999999998888899999999999999996 9998
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=192.49 Aligned_cols=93 Identities=44% Similarity=0.727 Sum_probs=69.3
Q ss_pred CCeEEEEeCCCCCCCC---CCcEEEeccccEEEEcCCc-eeEee-ccCCC--ceeEEEEecCCcEEEEecCCceEEEecC
Q 037563 79 SAKVVWTANRGLLIRD---SDKFVFEKSGNAYLQRGNG-EAWSA-NTSGQ--KVECMELQDSGNLVLLGVNGSILWQSFS 151 (606)
Q Consensus 79 ~~~~vW~an~~~p~~~---~~~~~~~~~g~l~l~~~~~-~~w~t-~~~~~--~~~~~~l~~~Gnlvl~~~~~~~~WqsFd 151 (606)
++|+||+|||+.|+.. ..+|.|+.||+|+|++.++ .+|++ ++.+. ..+.|.|+|+|||||+|.++.++|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 3699999999999943 4789999999999999885 79999 56544 5889999999999999998999999999
Q ss_pred CCCCccCCCCcccCceEEEe
Q 037563 152 HPTDTLLPGQQFMEGMRLKS 171 (606)
Q Consensus 152 ~PtDtllpg~~l~~~~~l~s 171 (606)
|||||+||+|+|+.+.....
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~ 100 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGK 100 (114)
T ss_dssp SSS-EEEEEET--TSEEEEE
T ss_pred CCccEEEeccCcccCCCccc
Confidence 99999999999987665543
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=186.78 Aligned_cols=107 Identities=36% Similarity=0.627 Sum_probs=96.7
Q ss_pred CCCcEEEeCCCeeEEEEEecCC-CcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEEEcCCc-eeEeeccC-
Q 037563 45 NNGLFLISNNSVFGFGFYTALD-VQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNG-EAWSANTS- 121 (606)
Q Consensus 45 ~~~~~l~s~~g~f~~gf~~~~~-~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l~~~~~-~~w~t~~~- 121 (606)
..++.|+|+++.|++|||.... .++++|||.+.+ +++||+|||+.|+.+++.|.|+.||+|+|++.++ ++|++++.
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~ 83 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTG 83 (114)
T ss_pred CCCCEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccC
Confidence 3589999999999999998654 689999999877 8999999999998887889999999999998866 89999986
Q ss_pred CCceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 122 GQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 122 ~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
+....+++|+|+|||||++.++.++||||||
T Consensus 84 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 84 ANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 6667789999999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=199.52 Aligned_cols=182 Identities=39% Similarity=0.630 Sum_probs=159.0
Q ss_pred cCCcCceeEEEEEeCC-CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhh
Q 037563 410 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 89999999976544 35789999999999999999999999999999999999999999999
Q ss_pred hhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCcCcceeeeec
Q 037563 487 WIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTL 565 (606)
Q Consensus 487 ~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 565 (606)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||++++ ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 986432 3578899999999999999999998 9999999999999999 89999999999987654321 12335
Q ss_pred ccccCccccccccCC-CCCCccchHHHHHHHHHH
Q 037563 566 RGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEI 598 (606)
Q Consensus 566 ~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~el 598 (606)
.+...|++||..... ..+.++|+|++|++++||
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 578899999998876 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=222.47 Aligned_cols=206 Identities=25% Similarity=0.300 Sum_probs=178.3
Q ss_pred ccChHHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcc------cCCcceeecc
Q 037563 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVH------HVHLVKLKGF 465 (606)
Q Consensus 393 ~~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~------h~nIv~l~g~ 465 (606)
++.+.|+....|++....|+|-|++|.+|.+.. |+.||||++.+.+-..+.=+.|+++|++|+ .-+.++|+-.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 466888999999999999999999999999764 889999999887666667788999999995 4589999999
Q ss_pred eeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEE
Q 037563 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAK 544 (606)
Q Consensus 466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~k 544 (606)
|...+++|||+|-+ ..+|.+.|...... -.|....+..++.|+.-||..|... +|+|.||||.|||+++. ..+|
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence 99999999999977 56899999765543 3477888899999999999999997 99999999999999876 4689
Q ss_pred EeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 545 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|||||.|......+ .++...+..|.|||.+.+.+|+...|+||.||.||||.||+..|.
T Consensus 578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 99999998766543 234455678999999999999999999999999999999998773
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-24 Score=198.64 Aligned_cols=191 Identities=19% Similarity=0.347 Sum_probs=154.0
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecc-eeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGF-CIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~-~~~~~~~~lV~E~~ 479 (606)
.+++.+.||+|.||.+-+++++. .+.+++|.+.......++|.+|..---.+ .|.||+.-+.. |+..+..+.++||.
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 36677889999999999999875 67899999887777788999998643333 58999988765 66777778999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc--CCCcEEEeeccCCcccCcC
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgla~~~~~~ 557 (606)
|.|+|.+-+.. ..+.+....+++.|+++||.|+|+. .++|||||.+||||- +..++|++|||+.+..+..
T Consensus 105 P~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 105 PRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999887743 3366777888999999999999998 999999999999993 3458999999998754332
Q ss_pred cceeeeecccccCccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNN-----PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
- ....-+..|.+||..... ...+.+|+|.||++++..+||..||
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 1 112345578899976432 2467899999999999999999997
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=201.97 Aligned_cols=185 Identities=29% Similarity=0.354 Sum_probs=152.1
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceec------cccceeeee
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE------GAHRLLAYE 477 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------~~~~~lV~E 477 (606)
+.+|.|.- .|-.+.+. .+++||+|++... ....+...+|...+..++|+||++++.++.- -.+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34666766 45444432 3789999988532 2344677889999999999999999999863 235689999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+|. .+|...+.. .++-.+...|..|++.|+.|||+. +|+||||||+||++..+...||.|||+++....+
T Consensus 102 ~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 994 578777752 356677888999999999999998 9999999999999999999999999999865443
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..++..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 4567788899999999999988999999999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=206.91 Aligned_cols=161 Identities=22% Similarity=0.209 Sum_probs=125.2
Q ss_pred HhhccccccCCcCceeEEEEEeC--CCcEEEEEEeccc------CCChHHHHHHHHHHHhcccCCcce-eecceeccccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESI------GQGKKEFSAEVTIIGNVHHVHLVK-LKGFCIEGAHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~--~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~nIv~-l~g~~~~~~~~ 472 (606)
..+.+.+.||+|+||+||++++. +++.+|||++... ....+.|.+|++++++++|+|++. ++.. ...
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 44667788999999999999875 4777899987532 112456899999999999999985 4432 457
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeEEcCCCcEEEeeccCC
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI-KPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfgla 551 (606)
++||||+++++|.... .. . ...++.|++++|.|||+. +|+|||| ||+|||++.++.+||+|||++
T Consensus 94 ~LVmE~~~G~~L~~~~----~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 94 GLVRGWTEGVPLHLAR----PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEEEccCCCCHHHhC----cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 9999999999996321 10 0 146788999999999998 9999999 999999999999999999999
Q ss_pred cccCcCcc-ee------eeecccccCccccccccCC
Q 037563 552 KLMNREES-LV------YTTLRGTRGYLAPEWITNN 580 (606)
Q Consensus 552 ~~~~~~~~-~~------~~~~~gt~~y~aPE~~~~~ 580 (606)
+....... .. .+...+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97654321 00 1345678889999988643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=204.14 Aligned_cols=190 Identities=25% Similarity=0.352 Sum_probs=158.8
Q ss_pred ccccccCCcCceeEEEEEeCC----CcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeec
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
...++||+|.|+.||++++.. .+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..+++..+|+||+
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 345789999999999999643 5789999986543 3556899999999995 999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccC---
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN--- 555 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~--- 555 (606)
++.+..+++. .++...+..++..+++||.++|++ +|+||||||+|+|.+. .+.-.|.|||++....
T Consensus 118 ~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 118 EHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999884 366788888999999999999999 9999999999999985 4668899999997210
Q ss_pred --------------c----------------Ccc----------eeeeecccccCccccccccCC-CCCCccchHHHHHH
Q 037563 556 --------------R----------------EES----------LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMV 594 (606)
Q Consensus 556 --------------~----------------~~~----------~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvv 594 (606)
. ... .......||+||.|||++... ..+.++||||-|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000 001234799999999988765 46889999999999
Q ss_pred HHHHHhCCCCC
Q 037563 595 LLEIIGGRKSF 605 (606)
Q Consensus 595 l~elltG~~pf 605 (606)
++-+++++.||
T Consensus 268 ~Lslls~~~PF 278 (418)
T KOG1167|consen 268 LLSLLSRRYPF 278 (418)
T ss_pred eehhhcccccc
Confidence 99999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=200.99 Aligned_cols=140 Identities=31% Similarity=0.408 Sum_probs=118.2
Q ss_pred cChHHHHH-HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcc--------cCCcceee
Q 037563 394 FSYDDLCK-ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVH--------HVHLVKLK 463 (606)
Q Consensus 394 ~~~~el~~-~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--------h~nIv~l~ 463 (606)
..+.|+.. .+|-..++||=|.|++||++.+.. .+-||+|+.+....-.+....||++|.+++ ...||+|+
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 44556555 778888999999999999999754 678999999876666677899999999984 34799999
Q ss_pred cceec----cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 464 GFCIE----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 464 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
+.|.. +.+.++|+|++ |.+|..+|....- +.++...+.+|+.||+.||.|||.+| +|||.||||+|||+-
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 99975 45889999998 7788888876544 45888999999999999999999997 999999999999993
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-23 Score=213.16 Aligned_cols=195 Identities=24% Similarity=0.343 Sum_probs=166.0
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..++....+|.|.+|.|||+++.. ++..|+|+++-. .....-..+|+-+++..+||||+.++|-+......++.|||+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 345566889999999999999764 788999988743 345567788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
.+|+|++.-+-. .++++.+........++||.|||+. +-+|||||-.||++.+.+.+|++|||.+..+...-
T Consensus 95 gggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 95 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred CCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999999876533 4588888889999999999999998 88999999999999999999999999987664321
Q ss_pred eeeeecccccCccccccc---cCCCCCCccchHHHHHHHHHHHhCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWI---TNNPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~---~~~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
.......||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 122346899999999975 345688999999999999999877766
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=225.47 Aligned_cols=146 Identities=20% Similarity=0.229 Sum_probs=112.5
Q ss_pred hccc-CCcceeecce-------eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc
Q 037563 453 NVHH-VHLVKLKGFC-------IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524 (606)
Q Consensus 453 ~l~h-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~ 524 (606)
.++| +||+++++.| .+....+.++||+ +++|.++|... ...+++.+++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5888888887 2334567788987 56999999642 24588999999999999999999998 9
Q ss_pred eeecCCCCCCeEEcC-------------------CCcEEEeeccCCcccCcCcc---------------eeeeecccccC
Q 037563 525 IVHCDIKPENVLLDD-------------------NFTAKVSDFGLAKLMNREES---------------LVYTTLRGTRG 570 (606)
Q Consensus 525 iiH~dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~ 570 (606)
|+||||||+||||+. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44556666666653211000 00112357888
Q ss_pred ccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 571 y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|||||++.+..++.++|||||||+||||++|..||
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCch
Confidence 99999999999999999999999999999999886
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=190.32 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=160.6
Q ss_pred hhccccccCCcCceeEEEEEeCCC--cEEEEEEecccCC-ChHHHHHHHHHHHhccc----CCcceeecce-ecccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDG--IQVAVKKLESIGQ-GKKEFSAEVTIIGNVHH----VHLVKLKGFC-IEGAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~--~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h----~nIv~l~g~~-~~~~~~~l 474 (606)
.+.+.++||+|+||.||++...+. ..+|+|.-..... ....+..|+.++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 466778999999999999997653 4778887654322 22278888988888873 5888888888 47778899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-----CcEEEeecc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-----FTAKVSDFG 549 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg 549 (606)
||+.. |.+|.+...... ...++..+.+.|+.|++.+|++||+. +++||||||.|+++... -.+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99976 889999775544 35689999999999999999999998 99999999999999865 369999999
Q ss_pred CCc--ccCcCcc-------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 550 LAK--LMNREES-------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 550 la~--~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+++ ....... ......+||..|.+++...+.+.+.+.|+||++.++.|++.|..||
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 998 3221111 1012356999999999999999999999999999999999999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=177.13 Aligned_cols=196 Identities=23% Similarity=0.336 Sum_probs=166.0
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
-.+.+.++||+|+||.++.|+. -+++.||||- +....+..++..|....+.|. .++|...+-+-+++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3456789999999999999993 4689999994 444556778889998888885 689999999999999999999987
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-----CCcEEEeeccCCccc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLM 554 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgla~~~ 554 (606)
|-+|++.+.-. +..++.+++..+|.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||||+..
T Consensus 107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77888877432 35689999999999999999999998 9999999999999963 346899999999987
Q ss_pred CcCcc---ee---eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREES---LV---YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... .. .....||.+||+-....+.+.+.+.|+=|+|-++.+.|-|..||
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW 236 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 236 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence 54432 11 12357999999999999999999999999999999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=174.62 Aligned_cols=137 Identities=14% Similarity=0.125 Sum_probs=107.6
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCC---C-------hHHH-----------------HHHHHHHHhcccCCcc
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---G-------KKEF-----------------SAEVTIIGNVHHVHLV 460 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~-------~~~~-----------------~~Ei~~l~~l~h~nIv 460 (606)
..||+|+||.||+|..++|+.||||+++.... . ...| ..|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999998899999999964321 1 1122 3499999999888775
Q ss_pred eeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHH-HhcCCCceeecCCCCCCeEEcC
Q 037563 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL-HEECEVKIVHCDIKPENVLLDD 539 (606)
Q Consensus 461 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~iiH~dlkp~NIll~~ 539 (606)
....+. ....+|||||++++++...... ...++.....+++.|++.+|.|| |+. +|+||||||+||+++
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 433322 2234899999999877654321 13578889999999999999999 687 999999999999998
Q ss_pred CCcEEEeeccCCccc
Q 037563 540 NFTAKVSDFGLAKLM 554 (606)
Q Consensus 540 ~~~~kl~Dfgla~~~ 554 (606)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=184.40 Aligned_cols=195 Identities=36% Similarity=0.525 Sum_probs=165.4
Q ss_pred ccccccCCcCceeEEEEEeCCCcEEEEEEecccCC----ChHHHHHHHHHHHhcccC-Ccceeecceeccccceeeeeec
Q 037563 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHV-HLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~-nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
...+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++...+......++++|++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45577999999999999986 7889999865432 367899999999999988 7999999997777789999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCcCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREE 558 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 558 (606)
.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||.||+++... .++++|||+++......
T Consensus 81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999776443211 2578889999999999999999998 899999999999999988 79999999998654433
Q ss_pred ce-----eeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SL-----VYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. ......++..|++||.+.+ .......|+||+|++++++++|+.||
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~ 211 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 21 2356789999999999987 57888999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=172.66 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=164.7
Q ss_pred HHHHhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhccc-CCcceeecceeccccceeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~ 476 (606)
+....+...++||.|+||.+|.|.. .+|.+||||.-+ ......++.-|.++.+.++| ..|..+..+..++.+..+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3445577889999999999999994 579999999653 33445677889999999975 78888899999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~ 553 (606)
|.. |-+|++.+.-.. ..++.++++-++-|++.-++|+|.+ +++||||||+|.|+.- ...+.++|||+++.
T Consensus 91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 987 779988875433 3578889999999999999999998 9999999999999964 34689999999987
Q ss_pred cCcCcc------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .......||.+|.+-....+...+.+.|+=|+|.+|.++.-|..||
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence 643322 1123467899999988888888889999999999999999999997
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=178.64 Aligned_cols=173 Identities=14% Similarity=0.105 Sum_probs=133.9
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChH----------HHHHHHHHHHhcccCCcceeecce
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK----------EFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~----------~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
+++....+...+.+|.|+||.||.... ++..+|+|.+.......+ .+.+|+..+.+++|++|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 455666777789999999999999666 577899999964432222 268999999999999999998886
Q ss_pred ecc--------ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 467 IEG--------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 467 ~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
... ...+|||||++|.+|.++.. ++. ....+++.+|..+|+. +++|+|++|.||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 533 35789999999999988741 222 2456899999999998 999999999999999
Q ss_pred CCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHH
Q 037563 539 DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ell 599 (606)
+++ ++|+|||........... ..+.....+..++|+|+||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999988755322211 11344555678999999999877653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=170.15 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=110.4
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCC---------------------------hHHHHHHHHHHHhcccCCc
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---------------------------KKEFSAEVTIIGNVHHVHL 459 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~---------------------------~~~~~~Ei~~l~~l~h~nI 459 (606)
...||+|+||.||+|++.+|+.||||+++..... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999888999999998643210 1123578899999999988
Q ss_pred ceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEc
Q 037563 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~ 538 (606)
.....+... ..++||||++++++...... ...++......++.|++.++.+||+ . +|+||||||.||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 655444332 34899999998865443211 1246678889999999999999999 7 999999999999999
Q ss_pred CCCcEEEeeccCCcccCc
Q 037563 539 DNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~ 556 (606)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-21 Score=177.84 Aligned_cols=196 Identities=21% Similarity=0.353 Sum_probs=156.8
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
-...++..+|.+..-|+.|+|++ .|..+++|++... ..-.++|..|.-.|+.+.||||+.++|.|....++.++..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 34457778899999999999999 4556777888643 2345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
||+-|+|+..|+.... -..+..++.+++..|++|++|||+.. +-|.--.|.++.++||++.+++|+- +-.++.-.
T Consensus 268 ~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfq- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ- 342 (448)
T ss_pred eccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeee-
Confidence 9999999999976443 46778899999999999999999973 2344447899999999999988852 11221111
Q ss_pred cceeeeecccccCccccccccCCCCC---CccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPIS---EKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t---~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....-.+.||+||.+...+-+ ..+|+|||++++|||.|...||+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 1112346789999999876543 57899999999999999999996
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=167.87 Aligned_cols=105 Identities=27% Similarity=0.323 Sum_probs=92.7
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|.+++... +..+++..+..|+.||++||.|||++ + ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888988643 24589999999999999999999997 4 999999999999999 99998754432
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..|++.|||||++.+..++.++||||||+++|||++|+.||.
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 268899999999999999999999999999999999999984
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=164.26 Aligned_cols=180 Identities=17% Similarity=0.095 Sum_probs=136.0
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCCh-----HHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeecc
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-----KEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~-----~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
...|++|+||+||.... ++++++.+.+.....-. +.+.+|+++|++++ |+++.+++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35699999999997776 67888888886554322 25889999999995 5889999886 34699999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI-KPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
|.+|...+.. ....++.|+..+|.++|++ +|+|||| ||.|||+++++.++|+|||++........
T Consensus 82 G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998654310 1135778999999999998 9999999 79999999999999999999985443221
Q ss_pred e----e--------eeecccccCccccccccCC-CCC-CccchHHHHHHHHHHHhCCCCC
Q 037563 560 L----V--------YTTLRGTRGYLAPEWITNN-PIS-EKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. . ..-...++.|++|+...-. ..+ ...+.++-|.-+|+++|++.|+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 0012357778888743321 222 4568899999999999998875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-18 Score=189.68 Aligned_cols=199 Identities=20% Similarity=0.237 Sum_probs=161.1
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcc---cCCcceeecceeccccc
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~ 472 (606)
.-++...++.+...||+|+||+||+|...+|+.||+|+=+... ..+|---.+++.||+ -+.|..+.....-.+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3345555667778999999999999999899999999865432 334444444555555 23455555555556667
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-------CCCcEEE
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-------DNFTAKV 545 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-------~~~~~kl 545 (606)
+||+||.+.|+|.+++. ..+.++|...+.++.|+++.++.||.. +|||+||||+|.||. +...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 89999999999999995 446799999999999999999999998 999999999999994 2346999
Q ss_pred eeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCC
Q 037563 546 SDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603 (606)
Q Consensus 546 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~ 603 (606)
+|||.+..+..-.. ......++|-.+-.+|...+++++..+|.|.++-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987765433 45677889999999999999999999999999999999999863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=156.83 Aligned_cols=134 Identities=19% Similarity=0.273 Sum_probs=103.6
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEeccc-CCChHHHHHHHHHHHhc-----ccCCcceeecceeccc---cce-eeee
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNV-----HHVHLVKLKGFCIEGA---HRL-LAYE 477 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l-----~h~nIv~l~g~~~~~~---~~~-lV~E 477 (606)
+.||+|+||.||. +++....+||++... ....+++.+|+++++.+ .||||++++|++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5699999999996 444333478987643 33457899999999999 5799999999998864 333 7899
Q ss_pred e--ccCCChhhhhhhccccccccChhhHHHHHHHHHHHH-HHHHhcCCCceeecCCCCCCeEEcC----CCcEEEee-cc
Q 037563 478 Y--LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGL-AYLHEECEVKIVHCDIKPENVLLDD----NFTAKVSD-FG 549 (606)
Q Consensus 478 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~~iiH~dlkp~NIll~~----~~~~kl~D-fg 549 (606)
| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+| ||
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 6689999999542 23433 35677888777 999998 9999999999999974 34799999 55
Q ss_pred CCcc
Q 037563 550 LAKL 553 (606)
Q Consensus 550 la~~ 553 (606)
....
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 5444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=182.72 Aligned_cols=183 Identities=30% Similarity=0.333 Sum_probs=152.2
Q ss_pred cCCcCceeEEEEEe----CCCcEEEEEEecccC---CChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccC
Q 037563 410 LGQGGFGSVYLGML----PDGIQVAVKKLESIG---QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 410 lG~G~fG~Vy~g~~----~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+|+|.||.|+..+- +.+..+|.|.+.+.. ..+.....|-.++...+ ||.+|++...++.+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999997652 246778888876432 12225566778888887 99999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|...+... ....+.....+...++-+++++|+. +++|||+|++||+++.+|.+|+.|||+++..-..+.
T Consensus 82 g~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 82 GDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred chhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9998887543 3355566666778899999999998 999999999999999999999999999987654432
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.+||..|||||++. .....+|.||||++++||+||..||.
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 27899999999988 46788999999999999999999983
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7e-17 Score=158.09 Aligned_cols=141 Identities=15% Similarity=0.127 Sum_probs=109.1
Q ss_pred hccccccCCcCceeEEEEE--eCCCcEEEEEEecccCCC-------------------------hHHHHHHHHHHHhccc
Q 037563 404 KNFSTKLGQGGFGSVYLGM--LPDGIQVAVKKLESIGQG-------------------------KKEFSAEVTIIGNVHH 456 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~Ei~~l~~l~h 456 (606)
+.+.+.||+|+||.||+|+ ..+|+.||+|+++..... ...+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4566889999999999998 567999999998643210 1235689999999976
Q ss_pred CC--cceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc-eeecCCCCC
Q 037563 457 VH--LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK-IVHCDIKPE 533 (606)
Q Consensus 457 ~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~-iiH~dlkp~ 533 (606)
.. +.++++. ...++||||+++.+|..+.... ..+.......++.||+.+|.+||+. + ++|+||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 43 3344432 2358999999998887664221 2344556778999999999999998 8 999999999
Q ss_pred CeEEcCCCcEEEeeccCCcccCc
Q 037563 534 NVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 534 NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999986544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=154.30 Aligned_cols=134 Identities=19% Similarity=0.302 Sum_probs=113.7
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCC---------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+.||+|++|.||+|.. ++..+++|+...... ....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999998 677899998653221 124578899999999999998888887777888999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
++|++|.+++... .. .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988431 12 7788999999999999998 999999999999999 789999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=151.89 Aligned_cols=135 Identities=18% Similarity=0.181 Sum_probs=107.2
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccCC-----------------------ChHHHHHHHHHHHhcccCC--
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-----------------------GKKEFSAEVTIIGNVHHVH-- 458 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~-----------------------~~~~~~~Ei~~l~~l~h~n-- 458 (606)
+.+.+.||+|+||.||++..++|+.||||+++.... ....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 455688999999999999998899999998753221 0123577888999998874
Q ss_pred cceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 459 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
+...++ ....++||||+++++|.+.... .....++.+|+.++.++|+. +++|+||+|.||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 444443 2455899999999999765421 23457889999999999998 999999999999999
Q ss_pred CCCcEEEeeccCCcccC
Q 037563 539 DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~ 555 (606)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=152.14 Aligned_cols=131 Identities=18% Similarity=0.309 Sum_probs=108.3
Q ss_pred ccCCcCceeEEEEEeCCCcEEEEEEecccC--C-------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIG--Q-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~--~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.||+|+||.||+|.+ ++..+++|+..... . ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 67889999864321 1 1255778999999999988776666666777789999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
++++|.+++.... . .++.|++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998874311 0 7899999999999998 999999999999999 8899999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=172.21 Aligned_cols=134 Identities=16% Similarity=0.203 Sum_probs=110.3
Q ss_pred cccccCCcCceeEEEEEeCCCcEEEEEEe-ccc-C-------CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKL-ESI-G-------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~~~~vavK~l-~~~-~-------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.||+|+||.||+|.+.+.. +++|+. .+. . ...+++.+|++++.+++|++++....++.+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999985543 444432 221 1 11246889999999999999999888888777889999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++. ...+++.|++++|.|||+. +++||||||+||++ +++.++|+|||+++....
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence 9999999999873 3467899999999999998 99999999999999 677999999999987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-17 Score=181.72 Aligned_cols=193 Identities=24% Similarity=0.307 Sum_probs=151.3
Q ss_pred cccccCCcCceeEEEEEeCC-CcEEEEEEec----ccCCCh---HHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 406 FSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE----SIGQGK---KEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~----~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
..+.+|.|++|.|+...... ....+.|... ...... ..+..|+-+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34679999999777766432 2223333222 111111 125556667778899999999888888777777799
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++ +|..++... ..+....+..++.|+..|+.|+|+. ++.|||+|++|+++..++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999998543 2467778888999999999999998 9999999999999999999999999999876544
Q ss_pred cc---eeeeecccccCccccccccCCCCCC-ccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES---LVYTTLRGTRGYLAPEWITNNPISE-KSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~-~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......|+..|+|||.+....|.+ -.||||.|+++..|++|+.||.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 33 3345578999999999999988875 5799999999999999999983
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=175.45 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=151.9
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccC--CChHHHHHHHHH--HHhcccCCcceeecceeccccceeeeeec
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTI--IGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~--l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.||++.|=+|.++++++|. |+||++.+.. ...+.|.++++- ...++|||.+.+.-.-.....-|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 456678999999999999998887 9999986543 344556554443 44568999999988877777788999998
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
.+ +|++.|. .++.+...+..=|+.|++.||..+|.. +|+|||||.+||||..=..+.|+||..-+...-.+.
T Consensus 104 kh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 KH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 55 7888773 345677778888999999999999998 999999999999999999999999987764321111
Q ss_pred ------eeeeecccccCccccccccCC----------C-CCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 ------LVYTTLRGTRGYLAPEWITNN----------P-ISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ------~~~~~~~gt~~y~aPE~~~~~----------~-~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.-+.+.+....|+|||.+... + .+++-||||.||++.||++ |++||.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 223345556689999976431 1 4678899999999999987 798884
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-16 Score=155.38 Aligned_cols=194 Identities=23% Similarity=0.329 Sum_probs=128.0
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcc----------cCCcceeeccee--
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVH----------HVHLVKLKGFCI-- 467 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~----------h~nIv~l~g~~~-- 467 (606)
...+.||.|+++.||.+++.. ++++|+|++... ....+++++|.-.+..+. |-.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 345679999999999999876 899999988432 233466777765554421 323332222221
Q ss_pred -------ccc--------cceeeeeeccCCChhhhhh---hccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecC
Q 037563 468 -------EGA--------HRLLAYEYLVNGSLDKWIF---NSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529 (606)
Q Consensus 468 -------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~d 529 (606)
... ..+++|+-+ .++|.+++. ........+....++.+..|+.+.+++||+. +++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 235667766 568877753 2222233455667788889999999999999 999999
Q ss_pred CCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccC--------CCCCCccchHHHHHHHHHHHhC
Q 037563 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--------NPISEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 530 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~Dv~s~Gvvl~elltG 601 (606)
|+|+|++++++|.++|+||+.....+.. ......+..|.+||.... ..++.+.|.|++|+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999877654321 122345678999996643 2468899999999999999999
Q ss_pred CCCCC
Q 037563 602 RKSFS 606 (606)
Q Consensus 602 ~~pfs 606 (606)
+.||.
T Consensus 247 ~lPf~ 251 (288)
T PF14531_consen 247 RLPFG 251 (288)
T ss_dssp S-STC
T ss_pred cCCCC
Confidence 99984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=143.58 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=97.5
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCCh---HHH----------------------HHHHHHHHhcccCC--c
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK---KEF----------------------SAEVTIIGNVHHVH--L 459 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~---~~~----------------------~~Ei~~l~~l~h~n--I 459 (606)
.+.||+|+||.||++...+++.||||++....... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999999889999999886432111 111 34555555554433 3
Q ss_pred ceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEc
Q 037563 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~ 538 (606)
.+.++. ...++||||++++++......... . ......++.+++.++.++|. . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 334432 245899999999654322111000 1 15567899999999999999 6 999999999999999
Q ss_pred CCCcEEEeeccCCcccC
Q 037563 539 DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~ 555 (606)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-14 Score=131.89 Aligned_cols=135 Identities=24% Similarity=0.202 Sum_probs=114.6
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhccc--CCcceeecceeccccceeeeeeccCCCh
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH--VHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
.+.||+|.++.||++...+ ..+++|....... ..++..|+..++.++| .++.+++++....+..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3579999999999999855 7899998865433 5689999999999987 5899999988888889999999999877
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++||+.+...
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 653 34566778999999999999864447999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=159.69 Aligned_cols=151 Identities=28% Similarity=0.473 Sum_probs=125.3
Q ss_pred HHhcccCCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 037563 451 IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDI 530 (606)
Q Consensus 451 l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dl 530 (606)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.... ..+++.-...++..|++||+|||.. +...|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 356889999999999999999999999999999999997633 3588888899999999999999997 22399999
Q ss_pred CCCCeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCC-------CCCCccchHHHHHHHHHHHhCC
Q 037563 531 KPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNN-------PISEKSDVYSYGMVLLEIIGGR 602 (606)
Q Consensus 531 kp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~t~~~Dv~s~Gvvl~elltG~ 602 (606)
+++|.++|..+.+|++|||+......... .......-..-|.|||.+... ..+.+.|+||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999887642111 111223345679999988763 1467899999999999999999
Q ss_pred CCCC
Q 037563 603 KSFS 606 (606)
Q Consensus 603 ~pfs 606 (606)
.||.
T Consensus 156 ~~~~ 159 (484)
T KOG1023|consen 156 GPFD 159 (484)
T ss_pred Cccc
Confidence 9984
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-14 Score=138.47 Aligned_cols=135 Identities=17% Similarity=0.211 Sum_probs=104.9
Q ss_pred cccC-CcCceeEEEEEeCCCcEEEEEEecccC--------------CChHHHHHHHHHHHhcccCCc--ceeecceeccc
Q 037563 408 TKLG-QGGFGSVYLGMLPDGIQVAVKKLESIG--------------QGKKEFSAEVTIIGNVHHVHL--VKLKGFCIEGA 470 (606)
Q Consensus 408 ~~lG-~G~fG~Vy~g~~~~~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~h~nI--v~l~g~~~~~~ 470 (606)
..|| .||.|+||+.... +..++||+.+... .....+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 8999999999984 6788999774311 123567889999999998875 66777654332
Q ss_pred c----ceeeeeeccC-CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEE
Q 037563 471 H----RLLAYEYLVN-GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 545 (606)
Q Consensus 471 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl 545 (606)
. .++|+|++++ .+|.+++... .++.. .+.||+.+|.+||+. +|+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 2599999997 6998887432 23332 357899999999998 9999999999999999999999
Q ss_pred eeccCCcccC
Q 037563 546 SDFGLAKLMN 555 (606)
Q Consensus 546 ~Dfgla~~~~ 555 (606)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999988643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.5e-15 Score=150.85 Aligned_cols=124 Identities=26% Similarity=0.456 Sum_probs=107.1
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++.|+++...+|.+||..... ....++...++++.|++.++.| + +.+|+|+||.||....+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 357899999999999999965433 2457788899999999999999 4 89999999999999999999999999
Q ss_pred CCcccCcCc-----ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh
Q 037563 550 LAKLMNREE-----SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG 600 (606)
Q Consensus 550 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt 600 (606)
+........ ....+...||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987655443 223455789999999999999999999999999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=6e-13 Score=141.91 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=99.6
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCC-----------------------------------------hHHHHH
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-----------------------------------------KKEFSA 446 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 446 (606)
+.||.|++|+||+|++++|+.||||+.+..... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998532100 002444
Q ss_pred HHHHHHhcc----cCCcceeeccee-ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHH-HHHHHHhc
Q 037563 447 EVTIIGNVH----HVHLVKLKGFCI-EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK-GLAYLHEE 520 (606)
Q Consensus 447 Ei~~l~~l~----h~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-gL~yLH~~ 520 (606)
|...+.+++ |.+-+.+-..+. .....+|||||++|++|.++...... .. .+.+++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555542 222233323332 24557999999999999987643211 11 23456666666 46788887
Q ss_pred CCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 521 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
+++|+|++|.||++++++.++++|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.7e-13 Score=133.38 Aligned_cols=142 Identities=25% Similarity=0.390 Sum_probs=105.3
Q ss_pred ccCCcceeecceecc---------------------------ccceeeeeeccCCChhhhhhhccccccccChhhHHHHH
Q 037563 455 HHVHLVKLKGFCIEG---------------------------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA 507 (606)
Q Consensus 455 ~h~nIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 507 (606)
+|||||++.++|.++ ..+|+||.-.+ .+|.+|+.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 599999999887642 23578877654 488888843 235566677799
Q ss_pred HHHHHHHHHHHhcCCCceeecCCCCCCeEEc--CCC--cEEEeeccCCcccCc-----CcceeeeecccccCcccccccc
Q 037563 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLD--DNF--TAKVSDFGLAKLMNR-----EESLVYTTLRGTRGYLAPEWIT 578 (606)
Q Consensus 508 ~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~--~~~--~~kl~Dfgla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~ 578 (606)
.|+++|+.|||++ ++.|||+|++||||. +|. ...|+|||.+---.. +.........|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 444 468899997632111 1111112345677899999765
Q ss_pred CCC------CCCccchHHHHHHHHHHHhCCCCC
Q 037563 579 NNP------ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 579 ~~~------~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..+ .-.|+|.|+.|-+.||+++...||
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPF 457 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPF 457 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcc
Confidence 432 136899999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.7e-14 Score=153.10 Aligned_cols=159 Identities=27% Similarity=0.354 Sum_probs=112.9
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
++.++.+--|++|.||..+++. .++.|+|+- +... +.+. ++.....|.+| |
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~kiN-kq~l----ilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL----ILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhccc-ccch----hhhc--cccccCCccee---------------------c
Confidence 3456779999999999999865 556777432 2111 0100 22222333332 4
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc---
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES--- 559 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--- 559 (606)
+....+.... .++- +++.+++|||+. +|+|||+||.|.+|..-|++|+.|||+.+.......
T Consensus 137 Dc~tllk~~g----~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 137 DCATLLKNIG----PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred hhhhhcccCC----CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 4444443221 2222 227789999998 999999999999999999999999999986421100
Q ss_pred -----------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 -----------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 -----------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..-...+||+.|+|||++..+.|...+|.|++|+|+||.+.|..||
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpf 258 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 258 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeec
Confidence 1112348999999999999999999999999999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.2e-14 Score=152.73 Aligned_cols=199 Identities=27% Similarity=0.345 Sum_probs=157.2
Q ss_pred hhccccccCCcCceeEEEEEeCC--CcEEEEEEecccCCC---hHHHHHHHHHHHhcc-cCCcceeecceeccccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESIGQG---KKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+++.+.||+|+|+.|-...... ...+++|.+...... ......|..+-..+. |+|++.+++...+....++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34566779999999998887644 345666666443322 234445777777776 999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH-hcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCccc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH-EECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLM 554 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~ 554 (606)
||..++++.+.+... .....+......++.|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||++...
T Consensus 101 ~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998887311 1113455666778999999999999 76 999999999999999999 9999999999877
Q ss_pred Cc--Ccceeeeeccc-ccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NR--EESLVYTTLRG-TRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ..........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 66 22233445677 9999999998874 44678999999999999999999873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.2e-12 Score=116.08 Aligned_cols=131 Identities=19% Similarity=0.071 Sum_probs=98.6
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCChhh
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
+.++.|.++.||+.+.. +..+++|...........+..|++.++.+.+.+++ +++... ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46899999999999974 77899998765433344578899999998766654 344432 334589999999988864
Q ss_pred hhhhccccccccChhhHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 487 WIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC--EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 487 ~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
.. . ....++.+++++|+.||... +..++|+|++|.||+++ ++.++++||+.+...
T Consensus 81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 30 0 11235678999999999972 22369999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-12 Score=137.04 Aligned_cols=139 Identities=15% Similarity=0.204 Sum_probs=90.1
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccCC---------------------------C--------hH------HHH
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---------------------------G--------KK------EFS 445 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---------------------------~--------~~------~~~ 445 (606)
+.||+|++|+||++++++ |+.||||+++..-. . .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999988 99999999863210 0 01 133
Q ss_pred HHHHHHHhcc----cCCcceeecceec-cccceeeeeeccCCChhhhh--hhccccccccChhhHHHHHHHHHHHHHHHH
Q 037563 446 AEVTIIGNVH----HVHLVKLKGFCIE-GAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLH 518 (606)
Q Consensus 446 ~Ei~~l~~l~----h~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 518 (606)
.|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- .........+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 3444443332 3333333333332 44568999999999998752 2111111123333333333333 3
Q ss_pred hcCCCceeecCCCCCCeEEcCCC----cEEEeeccCCcccCc
Q 037563 519 EECEVKIVHCDIKPENVLLDDNF----TAKVSDFGLAKLMNR 556 (606)
Q Consensus 519 ~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfgla~~~~~ 556 (606)
.. +++|+|+||.||+++.++ .++++|||+...+..
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999988 999999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-11 Score=118.95 Aligned_cols=155 Identities=21% Similarity=0.331 Sum_probs=120.6
Q ss_pred HHHHHHHhcccCCcceeecceeccc-----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhc
Q 037563 446 AEVTIIGNVHHVHLVKLKGFCIEGA-----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520 (606)
Q Consensus 446 ~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 520 (606)
.-..-|-++.|.|||+++.|+.+.. ...++.|||..|+|..+|++....+..+......+++.||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 3344556678999999999987543 4578899999999999999887777788888999999999999999999
Q ss_pred CCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc----eeeeecccccCccccccccCCCCCCccchHHHHHHHH
Q 037563 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES----LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLL 596 (606)
Q Consensus 521 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ 596 (606)
|.++|+|+++..+.|++..++-+|+.-- .......... .......+-++|.+||+=.....+..+|||+||+..+
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 5679999999999999999999988531 1111111100 0011234678999999876667778899999999999
Q ss_pred HHHhCC
Q 037563 597 EIIGGR 602 (606)
Q Consensus 597 elltG~ 602 (606)
||..+.
T Consensus 274 emailE 279 (458)
T KOG1266|consen 274 EMAILE 279 (458)
T ss_pred HHHHhe
Confidence 987654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-10 Score=109.33 Aligned_cols=141 Identities=21% Similarity=0.243 Sum_probs=109.3
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCC--ChHHHHHHHHHHHhccc--CCcceeecceeccc---cceeeeeecc
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHH--VHLVKLKGFCIEGA---HRLLAYEYLV 480 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~---~~~lV~E~~~ 480 (606)
+.|+.|..+.||+++..+|+.+++|....... ...++..|+++++.+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778899998765432 45678999999999976 44577777766543 5689999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC--------------------------------------- 521 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------------------- 521 (606)
+.++.+.+.. ..++......++.++++.|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988776521 23556667777888888888887521
Q ss_pred --------------CCceeecCCCCCCeEEcC--CCcEEEeeccCCcc
Q 037563 522 --------------EVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKL 553 (606)
Q Consensus 522 --------------~~~iiH~dlkp~NIll~~--~~~~kl~Dfgla~~ 553 (606)
+..++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.6e-11 Score=90.77 Aligned_cols=59 Identities=20% Similarity=0.477 Sum_probs=47.6
Q ss_pred ccceeeeeccccccCCCccCCCCCCChhhHHHHcccCCCceeEEecC--CCCceee-eeccCc
Q 037563 243 SAKLFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFEN--STKNCFL-FDQIGS 302 (606)
Q Consensus 243 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~-~~~l~~ 302 (606)
.++ |++++++++|+........+.++++|++.||+||||+||+|.+ ++++|++ .+.|.+
T Consensus 4 ~d~-F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 4 GDG-FLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCE-EEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 344 9999999998876554445689999999999999999999986 6789995 455544
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=102.74 Aligned_cols=135 Identities=13% Similarity=0.080 Sum_probs=97.3
Q ss_pred cccCCcCceeEEEEEeCC-------CcEEEEEEecccC-----------CC------------hHHHH----HHHHHHHh
Q 037563 408 TKLGQGGFGSVYLGMLPD-------GIQVAVKKLESIG-----------QG------------KKEFS----AEVTIIGN 453 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-------~~~vavK~l~~~~-----------~~------------~~~~~----~Ei~~l~~ 453 (606)
..||.|--+.||.|...+ +..+|||+.+... .+ .+.+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999774210 00 11233 78999998
Q ss_pred ccc--CCcceeecceeccccceeeeeeccCCChhh-hhhhccccccccChhhHHHHHHHHHHHHHHH-HhcCCCceeecC
Q 037563 454 VHH--VHLVKLKGFCIEGAHRLLAYEYLVNGSLDK-WIFNSTEESRFLCWNTRFNIALGTAKGLAYL-HEECEVKIVHCD 529 (606)
Q Consensus 454 l~h--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~~iiH~d 529 (606)
+.. -++.+++.+ ...+|||||+.+..+.. .+.+ ..++.....++..+++.+|..| |+. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 864 456666654 45689999997754422 1211 1234455677889999999999 777 999999
Q ss_pred CCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 530 IKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 530 lkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|++.||+++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-09 Score=98.14 Aligned_cols=142 Identities=18% Similarity=0.259 Sum_probs=109.7
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEE-ecccC--------CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKK-LESIG--------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~-l~~~~--------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
..+-+|+-+.|+++.+ .|+..+||. +.+.. -..+...+|++.+.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999999 677767774 32221 1346788999999999877777777778788888999999
Q ss_pred ccC-CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cEEEeeccCCccc
Q 037563 479 LVN-GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLM 554 (606)
Q Consensus 479 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgla~~~ 554 (606)
+++ .++.+++...... .........++.+|-+.+.-||.+ .|+|+||..+||+|..++ .+.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 987 5888888654432 122233367889999999999999 999999999999997655 4689999998754
Q ss_pred C
Q 037563 555 N 555 (606)
Q Consensus 555 ~ 555 (606)
.
T Consensus 167 ~ 167 (229)
T KOG3087|consen 167 R 167 (229)
T ss_pred c
Confidence 3
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.1e-10 Score=117.21 Aligned_cols=164 Identities=16% Similarity=0.197 Sum_probs=120.8
Q ss_pred CCCcEEEEEEecccCC-ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhh
Q 037563 424 PDGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNT 502 (606)
Q Consensus 424 ~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~ 502 (606)
.++.+|.|...+.... ......+-++.|+.++||||++++....++...|||+|-+. .|..++.. +....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEE 105 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHH
Confidence 3578888888765433 23456778899999999999999999999999999999763 45666633 22344
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCC
Q 037563 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582 (606)
Q Consensus 503 ~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 582 (606)
..-.+.||+.||.|||+.| +++|++|....|++++.|+.||.+|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 5557899999999999764 899999999999999999999999988754322110 001111122455666443222
Q ss_pred CCccchHHHHHHHHHHHhC
Q 037563 583 SEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 583 t~~~Dv~s~Gvvl~elltG 601 (606)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-09 Score=97.48 Aligned_cols=131 Identities=20% Similarity=0.295 Sum_probs=102.8
Q ss_pred ccCCcCceeEEEEEeCCCcEEEEEEe-cccCC--------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 409 KLGQGGFGSVYLGMLPDGIQVAVKKL-ESIGQ--------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~~~~vavK~l-~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++|+-..+|.+.+. |.++++|.- ++... ....-.+|+.++.+++--.|....=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999874 444666643 32211 1245678999999998777777777777888889999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+|..|.+++... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..-.
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999988433 245677777888889998 999999999999998764 9999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.3e-10 Score=119.47 Aligned_cols=204 Identities=25% Similarity=0.267 Sum_probs=157.2
Q ss_pred cChHHHHHHhhccccccCC--cCceeEEEEEe---CCCcEEEEEEeccc---CCChHHHHHHHHHHHhcc-cCCcceeec
Q 037563 394 FSYDDLCKATKNFSTKLGQ--GGFGSVYLGML---PDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVH-HVHLVKLKG 464 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~--G~fG~Vy~g~~---~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~-h~nIv~l~g 464 (606)
-...+.......+...+|+ |.+|.||.+.. .+++.+|+|+-+.. ......=.+|+...++++ |+|.++...
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 3455666777788899999 99999999997 24778898874321 223334456676767775 999999888
Q ss_pred ceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHH----HHHHHHhcCCCceeecCCCCCCeEEcCC
Q 037563 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK----GLAYLHEECEVKIVHCDIKPENVLLDDN 540 (606)
Q Consensus 465 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~~iiH~dlkp~NIll~~~ 540 (606)
.+..++..++-.|++. .+|.++..... ..++......+..+... ||..+|+. .++|-|+||.||++..+
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD 258 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence 8889999999999875 67777765432 23556666777777777 99999998 99999999999999999
Q ss_pred -CcEEEeeccCCcccCcCcc-ee---eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 541 -FTAKVSDFGLAKLMNREES-LV---YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 541 -~~~kl~Dfgla~~~~~~~~-~~---~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...++.|||+...+....- .. .-...+...|++||.+.+. ++...|+|++|.+..|...+..++
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccc
Confidence 8899999999988765432 11 1223677889999987654 788999999999999998887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.5e-08 Score=97.30 Aligned_cols=133 Identities=17% Similarity=0.041 Sum_probs=97.7
Q ss_pred ceeEEEEEeCCCcEEEEEEecccC------------CChHHHHHHHHHHHhcccCCcc--eeecceec-----cccceee
Q 037563 415 FGSVYLGMLPDGIQVAVKKLESIG------------QGKKEFSAEVTIIGNVHHVHLV--KLKGFCIE-----GAHRLLA 475 (606)
Q Consensus 415 fG~Vy~g~~~~~~~vavK~l~~~~------------~~~~~~~~Ei~~l~~l~h~nIv--~l~g~~~~-----~~~~~lV 475 (606)
...|++..+ +|+.+.||+..... .....+.+|...+.++...+|. +++++... ...-+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667777 67889999764322 1112478999999988655444 44555543 2245799
Q ss_pred eeeccCC-ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-------CCcEEEee
Q 037563 476 YEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-------NFTAKVSD 547 (606)
Q Consensus 476 ~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-------~~~~kl~D 547 (606)
+|++++. +|.+++..... ...+...+..++.+++..+.-||.. +|+|+|++++|||++. +..+.++|
T Consensus 114 te~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 114 TEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 9999986 89998743211 2344566778999999999999998 9999999999999985 56899999
Q ss_pred ccCCcc
Q 037563 548 FGLAKL 553 (606)
Q Consensus 548 fgla~~ 553 (606)
|+.++.
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998864
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=98.82 E-value=5e-09 Score=89.63 Aligned_cols=44 Identities=23% Similarity=0.568 Sum_probs=37.9
Q ss_pred CCCcccceeeeccCCCCCCCCCCCCCccccCC--CcccCCCCCCCC
Q 037563 183 NGRAATSEVIKIPQNSCSVPEPCNPYFVCYFD--NRCQCPPSLGSQ 226 (606)
Q Consensus 183 ~~~~~~~~~~~~~~~~C~~~~~CG~~~~C~~~--~~C~C~~g~~~~ 226 (606)
+....|..+|..|.+.||+|+.||+||+|+.+ +.|+|++||+++
T Consensus 64 ~~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~ 109 (110)
T PF00954_consen 64 ESTQSWSVFWSAPKDQCDVYGFCGPNGICNSNNSPKCSCLPGFEPK 109 (110)
T ss_pred cCCCcEEEEEEecccCCCCccccCCccEeCCCCCCceECCCCcCCC
Confidence 34456778899999999999999999999876 679999999875
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.6e-08 Score=82.04 Aligned_cols=52 Identities=25% Similarity=0.556 Sum_probs=42.5
Q ss_pred eeeeeccccccCCCccCCCCCCChhhHHHHcccCCCceeEEecCCCCceeeeec
Q 037563 246 LFYLGERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQ 299 (606)
Q Consensus 246 ~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~ 299 (606)
.|+.++.+++++..... ...++++|++.|++||+|.||+|.+++++|+++..
T Consensus 13 ~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~ 64 (84)
T cd01098 13 GFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG 64 (84)
T ss_pred EEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEec
Confidence 38888888887654332 56789999999999999999999987889996643
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.2e-08 Score=89.64 Aligned_cols=125 Identities=23% Similarity=0.281 Sum_probs=82.8
Q ss_pred eEEEEEeCCCcEEEEEEecccC--------------C-------------ChHHHHHHHHHHHhcccC--Ccceeeccee
Q 037563 417 SVYLGMLPDGIQVAVKKLESIG--------------Q-------------GKKEFSAEVTIIGNVHHV--HLVKLKGFCI 467 (606)
Q Consensus 417 ~Vy~g~~~~~~~vavK~l~~~~--------------~-------------~~~~~~~Ei~~l~~l~h~--nIv~l~g~~~ 467 (606)
.||.|...++..+|||..+... . ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999764210 0 013457799999999866 45556544
Q ss_pred ccccceeeeeecc--CCChhhhhhhccccccccChhhHHHHHHHHHHHHHH-HHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 468 EGAHRLLAYEYLV--NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY-LHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 468 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
....|||||++ +..+.... ... ++......++.+++..+.. +|+. +++|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24589999998 55554432 211 1134556677888886665 4676 99999999999999988 999
Q ss_pred EeeccCCcccC
Q 037563 545 VSDFGLAKLMN 555 (606)
Q Consensus 545 l~Dfgla~~~~ 555 (606)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.1e-08 Score=99.10 Aligned_cols=166 Identities=15% Similarity=0.255 Sum_probs=128.1
Q ss_pred eeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceec----cccceeeeeeccC-CChhhhh
Q 037563 416 GSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLAYEYLVN-GSLDKWI 488 (606)
Q Consensus 416 G~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~l 488 (606)
.+.||+... ||..+++|++.... +.......-+++++++.|+|+|++..++.. +..+++||+|.|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467888854 79999999994322 222233456788999999999999999873 4567899999986 6888887
Q ss_pred hhcccc-----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 489 FNSTEE-----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 489 ~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+..... +...++.....++.|+..||.++|+. |+.-+-|.+++|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 654332 23466788999999999999999998 9999999999999999999999998888776554
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~ 602 (606)
.. |-+.+ -.+-|.=.||.+++.|.||.
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 31 11222 23568889999999999984
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-08 Score=108.07 Aligned_cols=189 Identities=22% Similarity=0.269 Sum_probs=140.4
Q ss_pred hccccccCCcCceeEEEEEeC--CCcEEEEEEecccCCC---hHHHHHHHHHHHhc-ccCCcceeecceeccccceeeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIGQG---KKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~--~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
+....+||.|.|+.|++...+ ++..+++|.+.+.-.. ...-..|+.+...+ .|.++++....+....+.++=-|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 344578999999999997744 4677888877543221 11224455555555 48899998888888888889999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~ 556 (606)
|++++++...+. ....+....++++..|++.++.++|+. .++|+|++|+||++..+ +.-++.||+.+..+.-
T Consensus 347 ~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 347 FCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred hhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 999998877662 223467778889999999999999987 99999999999999886 8889999998864221
Q ss_pred CcceeeeecccccCcc--ccccccCCCCCCccchHHHHHHHHHHHhCCC
Q 037563 557 EESLVYTTLRGTRGYL--APEWITNNPISEKSDVYSYGMVLLEIIGGRK 603 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~--aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~ 603 (606)
.. .......+++ +|+......+-.+.|++|||+-+.|.+++..
T Consensus 420 ~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 420 SS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11 1122233444 5566667788899999999999999888753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.5e-07 Score=88.27 Aligned_cols=135 Identities=21% Similarity=0.210 Sum_probs=95.9
Q ss_pred ccccccCCcCceeEEEEEeCCCcEEEEEEecc-------c----------C------CChHHHHHHHHHHHhcccC--Cc
Q 037563 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLES-------I----------G------QGKKEFSAEVTIIGNVHHV--HL 459 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~-------~----------~------~~~~~~~~Ei~~l~~l~h~--nI 459 (606)
.++.+||-|--+.||.|..++|.++|||--+. . . -.+...++|.+.|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45678999999999999999999999994321 0 0 0123457788899888654 66
Q ss_pred ceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC
Q 037563 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539 (606)
Q Consensus 460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~ 539 (606)
.+.+++ +...+||||+++-.|...- ++....-.|+..|+.-+.-+-.. +++|+|+++=||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 666655 4458999999997665432 11223333444444444444454 9999999999999999
Q ss_pred CCcEEEeeccCCcccC
Q 037563 540 NFTAKVSDFGLAKLMN 555 (606)
Q Consensus 540 ~~~~kl~Dfgla~~~~ 555 (606)
+|.+.++||--+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.2e-08 Score=110.11 Aligned_cols=193 Identities=22% Similarity=0.240 Sum_probs=130.7
Q ss_pred ccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 407 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+-+-+|.++.++...-.. |...++|..... ....+....+-.++-..+||-+++..--+.-....+|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 3457778888888766432 322233322111 11122222222222223455555555445556778999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC------
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN------ 555 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~------ 555 (606)
++|...|++... .+.....-.+..+..+++|||.. .+.|+|++|.|+++..++..+++||+......
T Consensus 889 ~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999999876542 33333344556678899999997 69999999999999999999999998332210
Q ss_pred ---------------cCc---------ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 ---------------REE---------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ---------------~~~---------~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ........+|+.|.+||.+.+......+|.|+.|++++|.++|..||.
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 000 011223568999999999999999999999999999999999999984
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.3e-07 Score=83.77 Aligned_cols=137 Identities=16% Similarity=0.160 Sum_probs=103.4
Q ss_pred cCCcCceeEEEEEeCCCcEEEEEEeccc-------CCChHHHHHHHHHHHhcccCC--cceeeccee-ccc----cceee
Q 037563 410 LGQGGFGSVYLGMLPDGIQVAVKKLESI-------GQGKKEFSAEVTIIGNVHHVH--LVKLKGFCI-EGA----HRLLA 475 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~~~~vavK~l~~~-------~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~-~~~----~~~lV 475 (606)
-|+||-+.|++-.+ +|+.+-+|+-+.. ..+...|.+|+..|.++...+ +.++. ++. ... .-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46799999999888 4557999987521 235678999999999996433 44444 332 111 24699
Q ss_pred eeeccC-CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc--EEEeeccCCc
Q 037563 476 YEYLVN-GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfgla~ 552 (606)
+|-+++ .+|.+++..... ...+...+..++.+++..+.-||+. ++.|+|+.++||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 589888854322 2356677788999999999999998 9999999999999986666 9999998776
Q ss_pred c
Q 037563 553 L 553 (606)
Q Consensus 553 ~ 553 (606)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-07 Score=100.67 Aligned_cols=144 Identities=17% Similarity=0.195 Sum_probs=92.4
Q ss_pred ccc-cccCCcCceeEEEEEeCCCcEEEEEEecccCC---------------------------Ch----H----------
Q 037563 405 NFS-TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------------------------GK----K---------- 442 (606)
Q Consensus 405 ~~~-~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---------------------------~~----~---------- 442 (606)
+|. +.|+.++-|+||+|++++|+.||||+.+..-. .. +
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 444 56899999999999999999999998743100 00 1
Q ss_pred HHHHHHHHHHhcc----cCCcceeeccee-ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHH-HHH
Q 037563 443 EFSAEVTIIGNVH----HVHLVKLKGFCI-EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKG-LAY 516 (606)
Q Consensus 443 ~~~~Ei~~l~~l~----h~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~g-L~y 516 (606)
++..|..-+.+++ +..-+++=.++. -.+...|+|||++|-.+.+....... ..+ +..++..++++ +..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q 280 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQ 280 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHH
Confidence 1233444444432 222222223333 35677999999999999888532221 122 22333333332 122
Q ss_pred HHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 517 LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+-.. +++|.|.+|.||+++.++++.+.|||+...+.+.
T Consensus 281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2222 9999999999999999999999999999876543
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.5e-07 Score=74.67 Aligned_cols=54 Identities=15% Similarity=0.341 Sum_probs=40.7
Q ss_pred eeeeccccccCCCccCCCCCCChhhHHHHccc---CCCceeEEecCCCCcee-eeecc-Cccccc
Q 037563 247 FYLGERLDYFALGFVSPFPKYDINTCKEACLH---NCSCSVLFFENSTKNCF-LFDQI-GSLQRS 306 (606)
Q Consensus 247 f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~C~-~~~~l-~~~~~~ 306 (606)
|..+.+++.++.. ..++++|++.|++ ||||+||+|.+.+.+|. |.+.+ .+.++.
T Consensus 11 fl~~~~~klpd~~------~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~ 69 (80)
T cd00129 11 TLIKIALKIKTTK------ANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKE 69 (80)
T ss_pred EEEeecccCCccc------ccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhc
Confidence 6666666665543 2678999999999 99999999986667899 55556 565544
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=83.37 Aligned_cols=109 Identities=17% Similarity=0.175 Sum_probs=84.9
Q ss_pred ChHHHHHHHHHHHhcccC--Ccceeecceeccc----cceeeeeeccCC-ChhhhhhhccccccccChhhHHHHHHHHHH
Q 037563 440 GKKEFSAEVTIIGNVHHV--HLVKLKGFCIEGA----HRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAK 512 (606)
Q Consensus 440 ~~~~~~~Ei~~l~~l~h~--nIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 512 (606)
......+|...+.++... ...+.+++..... .-++|+|++++. +|.+++..... .+......++.+++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHH
Confidence 345678888888888644 4455666655432 347999999984 89999854222 455667889999999
Q ss_pred HHHHHHhcCCCceeecCCCCCCeEEcCCC---cEEEeeccCCcccC
Q 037563 513 GLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLMN 555 (606)
Q Consensus 513 gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgla~~~~ 555 (606)
.+.-||.. +|+|+|++++|||++.+. .+.++||+.++...
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 999999999999999887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.2e-06 Score=73.61 Aligned_cols=104 Identities=19% Similarity=0.307 Sum_probs=70.6
Q ss_pred eecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEe-CCCCCCCCCCcEEEeccccEEEEcCCc-eeEeec
Q 037563 42 WINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTA-NRGLLIRDSDKFVFEKSGNAYLQRGNG-EAWSAN 119 (606)
Q Consensus 42 ~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~a-n~~~p~~~~~~~~~~~~g~l~l~~~~~-~~w~t~ 119 (606)
|+.|.++.+.+.+|.+.|-|...|+. +.|. ...+++|.+ +...+....+.+.|+.||||||++..+ .+|++
T Consensus 6 W~an~~~p~~~~s~~~~L~l~~dGnL----vl~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S- 78 (114)
T PF01453_consen 6 WVANRNSPLTSSSGNYTLILQSDGNL----VLYD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS- 78 (114)
T ss_dssp ----TTEEEEECETTEEEEEETTSEE----EEEE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES-
T ss_pred cccccccccccccccccceECCCCeE----EEEc--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee-
Confidence 67777888877669999999887762 2232 346789999 444443356789999999999999665 79999
Q ss_pred cCCCceeEEEEec--CCcEEEEecCCceEEEecCCC
Q 037563 120 TSGQKVECMELQD--SGNLVLLGVNGSILWQSFSHP 153 (606)
Q Consensus 120 ~~~~~~~~~~l~~--~Gnlvl~~~~~~~~WqsFd~P 153 (606)
......+.+..|+ +||++ +.....+.|.|=+.|
T Consensus 79 f~~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDP 113 (114)
T ss_dssp TTSSS-EEEEEET--TSEEE-EESTSSEEEESS---
T ss_pred cCCCccEEEeccCcccCCCc-cccceEEeECCCCCC
Confidence 3344667778888 99999 765667899987766
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.3e-07 Score=89.54 Aligned_cols=191 Identities=16% Similarity=0.167 Sum_probs=124.1
Q ss_pred cccccCCcCceeEEEEEeCCCcEEEEEEecccC-CChHHHHHHHHHHHhc-ccCCcceeecc----e--ecccc-ceeee
Q 037563 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNV-HHVHLVKLKGF----C--IEGAH-RLLAY 476 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~----~--~~~~~-~~lV~ 476 (606)
.++.||+|+.+-+|-.--- +. .+-|+..... ....+. +..|... .||-+-.-+.+ . -+... .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3567999999999954321 12 2336553321 111221 2223332 45533221111 1 01122 34667
Q ss_pred eeccCCChhhhhhh---ccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFN---STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
..+++..=-..+.+ .+..-...+|.-.++.+..++.+.+-||.. +.+-+|+.++|+|+.+++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 76665422222221 122234578999999999999999999998 999999999999999999999998544433
Q ss_pred cCcCcceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhC-CCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGG-RKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG-~~pfs 606 (606)
. .......+.+|...|.+||... +..-+..+|-|.+||++++++.| ++|||
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 2 2234456788999999999754 34457789999999999999886 99997
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-05 Score=78.01 Aligned_cols=141 Identities=18% Similarity=0.178 Sum_probs=86.2
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCc--ceeecceeccccceeeeeeccCCC-h
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL--VKLKGFCIEGAHRLLAYEYLVNGS-L 484 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI--v~l~g~~~~~~~~~lV~E~~~~gs-L 484 (606)
..||+|..+.||+. .+...++|..+. ........+|.+.++.+..-.+ .+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999983 244677787754 2345667999999999875444 667777777777789999999974 2
Q ss_pred hhhh---------------------hhccccccccChhhHHHHHHH----------HHH-HHHHHHhc-CCCceeecCCC
Q 037563 485 DKWI---------------------FNSTEESRFLCWNTRFNIALG----------TAK-GLAYLHEE-CEVKIVHCDIK 531 (606)
Q Consensus 485 ~~~l---------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-gL~yLH~~-~~~~iiH~dlk 531 (606)
...+ +........+.. ...++-.+ +.. ...+|... ....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 100000000000 00000000 001 12222211 13467999999
Q ss_pred CCCeEEcCCCcEEEeeccCCccc
Q 037563 532 PENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 532 p~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|.||++++++ +.|+||+.+..-
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcC
Confidence 9999999888 999999988754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.8e-06 Score=74.61 Aligned_cols=56 Identities=29% Similarity=0.541 Sum_probs=45.5
Q ss_pred cEEEec-cccEEEEcCC--ceeEeeccCC--CceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 97 KFVFEK-SGNAYLQRGN--GEAWSANTSG--QKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 97 ~~~~~~-~g~l~l~~~~--~~~w~t~~~~--~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
++.++. ||++|++... ..+|++++.. ...+.+.|+++|||||++.++.++|+|=-.
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~ 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc
Confidence 345666 9999999765 4799999753 466789999999999999999999997543
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.3e-06 Score=73.74 Aligned_cols=53 Identities=28% Similarity=0.522 Sum_probs=44.0
Q ss_pred cEEEeccccEEEEcCC--ceeEeeccC--CCceeEEEEecCCcEEEEecCCceEEEe
Q 037563 97 KFVFEKSGNAYLQRGN--GEAWSANTS--GQKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 97 ~~~~~~~g~l~l~~~~--~~~w~t~~~--~~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
++.++.||++|++... ..||++++. ....+.+.|+++|||||++.++.++|+|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 4556789999999875 589999974 2334789999999999999989999998
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.8e-06 Score=87.08 Aligned_cols=145 Identities=19% Similarity=0.252 Sum_probs=91.0
Q ss_pred ccc-cccCCcCceeEEEEEeCCCcEEEEEEecccCC--------------------------------------ChHHHH
Q 037563 405 NFS-TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--------------------------------------GKKEFS 445 (606)
Q Consensus 405 ~~~-~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~--------------------------------------~~~~~~ 445 (606)
+|. +.||.-+.|+||++++++|+.||||+-+..-. .+=+|.
T Consensus 163 ~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred hcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 344 56999999999999999999999997643100 001244
Q ss_pred HHHHHHHhc----ccCCcc---eeecceec-cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHH
Q 037563 446 AEVTIIGNV----HHVHLV---KLKGFCIE-GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517 (606)
Q Consensus 446 ~Ei~~l~~l----~h~nIv---~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yL 517 (606)
.|.+-.++. .|-++. .+=.++.+ ...+.|+||||+|..+.+.-.-.. ..++.. +|+..+.++ |+
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~---~i~~~l~~~--~~ 314 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPH---DILNKLVEA--YL 314 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHH---HHHHHHHHH--HH
Confidence 455444433 455511 12222322 357799999999998777643211 123333 333333332 22
Q ss_pred HhcCCCceeecCCCCCCeEEcC----CCcEEEeeccCCcccCcC
Q 037563 518 HEECEVKIVHCDIKPENVLLDD----NFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 518 H~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfgla~~~~~~ 557 (606)
+.--..|++|+|-+|.||+++. ++.+.+.|||+...+...
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2212238999999999999984 678999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.4e-05 Score=74.25 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=87.2
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCC-h---------HHHHHHHHHHHhcccC---Ccceeecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-K---------KEFSAEVTIIGNVHHV---HLVKLKGF 465 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~-~---------~~~~~Ei~~l~~l~h~---nIv~l~g~ 465 (606)
+....++..+.+-......|.+-.. +|...++|..+....- . .+..+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3344444455566666666777666 6678888977543211 1 1223344444444322 22232222
Q ss_pred ee-----ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC
Q 037563 466 CI-----EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN 540 (606)
Q Consensus 466 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~ 540 (606)
.. -....+++|||++|..|.++.. ++. .++..+...+.-||+. |++|+|.+|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 22 1234468999999988876541 221 2556677889999998 99999999999999865
Q ss_pred CcEEEeeccCCcc
Q 037563 541 FTAKVSDFGLAKL 553 (606)
Q Consensus 541 ~~~kl~Dfgla~~ 553 (606)
.++++|++..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.2e-05 Score=75.72 Aligned_cols=105 Identities=23% Similarity=0.220 Sum_probs=83.0
Q ss_pred HHHHHHHHhccc-CCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCC
Q 037563 445 SAEVTIIGNVHH-VHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523 (606)
Q Consensus 445 ~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ 523 (606)
.+|.-++..+++ +++.+++|+|-+ ++|.||...+++...-. .-.+--..+|..+.+||.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357788888876 699999999954 88999998776542100 000112368999999999999999999997655
Q ss_pred ceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 524 ~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
.+..+|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7889999999999999999999998877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.2e-05 Score=74.31 Aligned_cols=143 Identities=12% Similarity=0.036 Sum_probs=87.0
Q ss_pred cCCcCc-eeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccCCChhhh
Q 037563 410 LGQGGF-GSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKW 487 (606)
Q Consensus 410 lG~G~f-G~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 487 (606)
|-.|.. ..||+...+ +..+++|+..... ..+...|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 789999874 4778888876443 446778998888874 34456777777666667999999999887644
Q ss_pred hh-------------------hccccccccCh--hhHHHH-HH-------------------HHHHHHHHHHhc----CC
Q 037563 488 IF-------------------NSTEESRFLCW--NTRFNI-AL-------------------GTAKGLAYLHEE----CE 522 (606)
Q Consensus 488 l~-------------------~~~~~~~~l~~--~~~~~i-~~-------------------qi~~gL~yLH~~----~~ 522 (606)
.. ........... .....- .. .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 00000000000 000000 00 011112222111 13
Q ss_pred CceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 523 ~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+.++|+|+.|.||+++++....|+||+.+....
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 468999999999999998778999999887543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.6e-05 Score=71.64 Aligned_cols=135 Identities=19% Similarity=0.170 Sum_probs=89.5
Q ss_pred ccCCcCceeEEEEEeCCCcEEEEEEecccCCC----------hHH---------------HHHHHHHHHhcc--cCCcce
Q 037563 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG----------KKE---------------FSAEVTIIGNVH--HVHLVK 461 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~----------~~~---------------~~~Ei~~l~~l~--h~nIv~ 461 (606)
.|..|--..||+|...++..+|||+.+..... ... ...|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 57788899999999888999999988543111 011 133555555553 333444
Q ss_pred eecceeccccceeeeeeccCCC-hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC
Q 037563 462 LKGFCIEGAHRLLAYEYLVNGS-LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN 540 (606)
Q Consensus 462 l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~ 540 (606)
.+++.. -.|||||+.... -.-.|.+ ..+.......+..++++.+.-|-.. .+++|+||+.=|||+. +
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 444432 379999996541 1111111 1122225666777888888877763 3999999999999999 8
Q ss_pred CcEEEeeccCCcccC
Q 037563 541 FTAKVSDFGLAKLMN 555 (606)
Q Consensus 541 ~~~kl~Dfgla~~~~ 555 (606)
+.+.|+|++-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.8e-07 Score=94.90 Aligned_cols=95 Identities=31% Similarity=0.504 Sum_probs=75.3
Q ss_pred HHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce--------eeeecccccCcccccccc
Q 037563 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL--------VYTTLRGTRGYLAPEWIT 578 (606)
Q Consensus 507 ~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~ 578 (606)
+.+.+.||.|+|.. .+++|++|.|++|.++.++..||+.|+.+......... ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44566999999987 69999999999999999999999999987654432111 011124466899999999
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCC
Q 037563 579 NNPISEKSDVYSYGMVLLEIIGGRK 603 (606)
Q Consensus 579 ~~~~t~~~Dv~s~Gvvl~elltG~~ 603 (606)
+...+.++|+||+|++++-+..|.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk 207 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGK 207 (700)
T ss_pred cccccccccceeeeeEEEEEecCCc
Confidence 9888999999999999988874443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.4e-05 Score=75.24 Aligned_cols=144 Identities=17% Similarity=0.134 Sum_probs=85.6
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecceecc---ccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGFCIEG---AHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~~~---~~~~lV~E~~~~g 482 (606)
+.++.|..+.||+....+ ..+++|..... ....++..|..++..+.... +.+++...... ...+++||++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 458889999999999977 68999987654 44577888999998886443 45666644322 2457999999999
Q ss_pred Chhh----------------hh---hhccccccccChh---------hHHH------------HHHHHHH-HHHHHHhc-
Q 037563 483 SLDK----------------WI---FNSTEESRFLCWN---------TRFN------------IALGTAK-GLAYLHEE- 520 (606)
Q Consensus 483 sL~~----------------~l---~~~~~~~~~l~~~---------~~~~------------i~~qi~~-gL~yLH~~- 520 (606)
.+.. .+ +..........+. .... ....+.+ .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8887 11 1110000000000 0000 0112222 33333332
Q ss_pred ---CCCceeecCCCCCCeEEc-CCCcEEEeeccCCcc
Q 037563 521 ---CEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKL 553 (606)
Q Consensus 521 ---~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~ 553 (606)
.+..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 345799999999999999 666678999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.1e-06 Score=91.40 Aligned_cols=182 Identities=18% Similarity=0.080 Sum_probs=129.2
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC-cceeecceeccccceeeeeeccCC-Ch
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH-LVKLKGFCIEGAHRLLAYEYLVNG-SL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~E~~~~g-sL 484 (606)
-..++++++++++|.+....+....+.+.. ..+..-++++|.+++||| .+.-++-++.+....++++++..+ +-
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 355788999999998864444444444322 245567889999999999 666677777777888999998776 21
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
..-.- .....+...+...+...-.++++|||+. .-+|+| ||+..+ +..|..||+....+.+.. ..+.
T Consensus 323 ~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 11110 0111233334445556667889999986 457888 777665 688999999988776543 3355
Q ss_pred cccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..+++.++|||+.....+..+.|+|+.|+=..++--|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 77899999999999999999999999998767776666664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=71.62 Aligned_cols=144 Identities=15% Similarity=0.111 Sum_probs=83.9
Q ss_pred cccCCcCceeEEEEEeCC--CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCCh
Q 037563 408 TKLGQGGFGSVYLGMLPD--GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
+.|..|-...+|+....+ +..+++|+........-+..+|+.++..+...+++ ++++... ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998764 67888897654322223445788888888654444 3433322 2489999999876
Q ss_pred hhh-------h----------hhccccc-------cccC-hhhHHHHHH----------------------HHHHHHHHH
Q 037563 485 DKW-------I----------FNSTEES-------RFLC-WNTRFNIAL----------------------GTAKGLAYL 517 (606)
Q Consensus 485 ~~~-------l----------~~~~~~~-------~~l~-~~~~~~i~~----------------------qi~~gL~yL 517 (606)
... + +...... .... +.....+.. .+..-+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 422 0 1111100 0011 111111111 111111122
Q ss_pred ----Hhc-CCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccC
Q 037563 518 ----HEE-CEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 555 (606)
Q Consensus 518 ----H~~-~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~ 555 (606)
... .+..++|+|+.+.||++++ +..+.++||..+....
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 111 2347999999999999998 5789999999887543
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=66.17 Aligned_cols=129 Identities=19% Similarity=0.267 Sum_probs=88.0
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcce-eecceeccccceeeeeeccCCChh
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVK-LKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~-l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.+.|++|.+|.||+|.+. +..+|+|+-+. ...+..+..|++++..+.-.++-+ ++.|- ...+.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 456999999999999994 45888887643 345778999999999988766654 33332 234569999998887
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCC-CCCeEEcCCCcEEEeeccCCcccC
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIK-PENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlk-p~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+.-.. .+-++...+ +.. +|.-+. .+|-|+.|+ |..++|-.+..+-|+||..|..-.
T Consensus 101 ~~~~~-------~~rk~l~~v----lE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIG-------GDRKHLLRV----LEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhc-------ccHHHHHHH----HHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 76421 122333333 333 233222 389999985 666666666699999999998543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00032 Score=71.30 Aligned_cols=75 Identities=12% Similarity=0.037 Sum_probs=57.0
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhccc---CCcceeecceecc---ccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH---VHLVKLKGFCIEG---AHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h---~nIv~l~g~~~~~---~~~~lV~E~~~~ 481 (606)
+.||+|..+.||+....+++ +++|..+. ......+..|...++.+.. ..+.++++++... +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 56999999999999876664 66676432 2244689999999998853 4678888877543 567999999998
Q ss_pred CCh
Q 037563 482 GSL 484 (606)
Q Consensus 482 gsL 484 (606)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00025 Score=69.57 Aligned_cols=74 Identities=12% Similarity=0.121 Sum_probs=46.9
Q ss_pred cccCCcCce-eEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccC---Ccceeecceecc---ccceeeeeecc
Q 037563 408 TKLGQGGFG-SVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV---HLVKLKGFCIEG---AHRLLAYEYLV 480 (606)
Q Consensus 408 ~~lG~G~fG-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~---nIv~l~g~~~~~---~~~~lV~E~~~ 480 (606)
+.|+.|+.. .||+. +..+++|..+. .....++..|.+.+..+... .+.+.++..... ...+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 346766666 58875 23567776543 33456889999999888632 344444443332 23478999999
Q ss_pred CCChhh
Q 037563 481 NGSLDK 486 (606)
Q Consensus 481 ~gsL~~ 486 (606)
|.++.+
T Consensus 78 G~~l~~ 83 (235)
T cd05155 78 GETATA 83 (235)
T ss_pred CCCCCc
Confidence 987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00029 Score=81.92 Aligned_cols=148 Identities=18% Similarity=0.256 Sum_probs=94.0
Q ss_pred cccCCcCceeEEEEEeCCC---cEEEEEEecccC--CChHHHHHHHHHHHhcc-cCCc--ceeecceecc---ccceeee
Q 037563 408 TKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKKEFSAEVTIIGNVH-HVHL--VKLKGFCIEG---AHRLLAY 476 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~nI--v~l~g~~~~~---~~~~lV~ 476 (606)
+.++.|....+|+....++ ..+++|+.+... .....+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5689999999999887654 467788765432 23467899999999996 6655 7788888764 4578999
Q ss_pred eeccCCChhhh-----------------------hhhcccc-------ccccCh--hhHHHHH---------------HH
Q 037563 477 EYLVNGSLDKW-----------------------IFNSTEE-------SRFLCW--NTRFNIA---------------LG 509 (606)
Q Consensus 477 E~~~~gsL~~~-----------------------l~~~~~~-------~~~l~~--~~~~~i~---------------~q 509 (606)
||+++..+.+- |+..... +.+..+ .++..+. ..
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99998754321 1110000 000011 1111111 12
Q ss_pred HHHHHHHHHhcCC--------CceeecCCCCCCeEEcCC-Cc-EEEeeccCCcccC
Q 037563 510 TAKGLAYLHEECE--------VKIVHCDIKPENVLLDDN-FT-AKVSDFGLAKLMN 555 (606)
Q Consensus 510 i~~gL~yLH~~~~--------~~iiH~dlkp~NIll~~~-~~-~kl~Dfgla~~~~ 555 (606)
+.+.+.+|..+.+ ..++|+|+++.||+++.+ .. .-|.||+++..-.
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 3344667755433 359999999999999853 33 5789999887643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00022 Score=66.93 Aligned_cols=124 Identities=24% Similarity=0.347 Sum_probs=90.4
Q ss_pred HhhccccccCCcCc-eeEEEEEeCCCcEEEEEEecc------------cC----------CChHHHHHHHHHHHhcc---
Q 037563 402 ATKNFSTKLGQGGF-GSVYLGMLPDGIQVAVKKLES------------IG----------QGKKEFSAEVTIIGNVH--- 455 (606)
Q Consensus 402 ~~~~~~~~lG~G~f-G~Vy~g~~~~~~~vavK~l~~------------~~----------~~~~~~~~Ei~~l~~l~--- 455 (606)
+..+|.+.||.|.- |.|||.+. +|+.+|+|.++. .. .....|..|.....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788999999999 99999999 778999999421 00 11245888999888885
Q ss_pred cCCc--ceeecceecc------------------ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHH
Q 037563 456 HVHL--VKLKGFCIEG------------------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515 (606)
Q Consensus 456 h~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~ 515 (606)
+.++ |+.+|+..-. ....||.||.+... ....+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4566 8899986321 01246777765532 111234566778888
Q ss_pred HHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 516 yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.+|+. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999987 5689999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00084 Score=63.54 Aligned_cols=130 Identities=18% Similarity=0.260 Sum_probs=91.4
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccC-----------------CChHHHHHHHHHHHhcc------cCCcceeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----------------QGKKEFSAEVTIIGNVH------HVHLVKLKG 464 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-----------------~~~~~~~~Ei~~l~~l~------h~nIv~l~g 464 (606)
..||+|+.-.||. +++.....||+..... ...++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999995 4455567888875443 23467777877666665 889999999
Q ss_pred ceeccccceeeeeeccC------CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 465 FCIEGAHRLLAYEYLVN------GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 465 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
+.+++.-.-+|+|.+.+ -+|.+++... .++. . +...+-+-..||-+. .|+.+|++|.||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999888999998753 3677877432 2333 2 233333445677776 999999999999996
Q ss_pred CCC----cEEEee-ccCC
Q 037563 539 DNF----TAKVSD-FGLA 551 (606)
Q Consensus 539 ~~~----~~kl~D-fgla 551 (606)
.+. .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 577887 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00059 Score=69.65 Aligned_cols=144 Identities=22% Similarity=0.205 Sum_probs=86.9
Q ss_pred ccCCcCceeEEEEEeCC-------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeecc
Q 037563 409 KLGQGGFGSVYLGMLPD-------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+..|--..+|+....+ ++.+++|+.........+..+|.+++..+....+. ++++.+.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899888755 47889998765433445678888888888644443 45554432 36899999
Q ss_pred CCChhhhh-----------------hhcccc--cc---ccC--hhhHHH--------------------------HHHHH
Q 037563 481 NGSLDKWI-----------------FNSTEE--SR---FLC--WNTRFN--------------------------IALGT 510 (606)
Q Consensus 481 ~gsL~~~l-----------------~~~~~~--~~---~l~--~~~~~~--------------------------i~~qi 510 (606)
|..+.... +..... .. ..+ |....+ +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 88775421 111110 00 000 111100 11222
Q ss_pred HHHHHHHHh------cCCCceeecCCCCCCeEEcCC----CcEEEeeccCCcccCc
Q 037563 511 AKGLAYLHE------ECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLMNR 556 (606)
Q Consensus 511 ~~gL~yLH~------~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgla~~~~~ 556 (606)
..-+..|.. ..+..++|+|+.+.||+++++ +.++++||..+....+
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 233344432 245689999999999999985 8899999999876443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00061 Score=67.75 Aligned_cols=141 Identities=14% Similarity=0.078 Sum_probs=81.9
Q ss_pred ccCCcCceeEEEEEeCCCcEEEEEEecccCCCh-HHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCChhh
Q 037563 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-KEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~-~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
.+..|-...+|+... +++.+++|......... -+..+|..+++.+....++ ++++... ..+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356677889999884 56778888764332221 2467888899888754443 3444332 379999999877643
Q ss_pred h-----------------hhhccccccccChhhH-HHHHHHH---------HHHHHHHHhc-----CCCceeecCCCCCC
Q 037563 487 W-----------------IFNSTEESRFLCWNTR-FNIALGT---------AKGLAYLHEE-----CEVKIVHCDIKPEN 534 (606)
Q Consensus 487 ~-----------------l~~~~~~~~~l~~~~~-~~i~~qi---------~~gL~yLH~~-----~~~~iiH~dlkp~N 534 (606)
- |+........++.... .++..++ .+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1111111111111111 1111111 1112222221 13468999999999
Q ss_pred eEEcCCCcEEEeeccCCcccC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~ 555 (606)
|++++++ +.|+||..+..-.
T Consensus 158 il~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred EEEeCCC-CEEEeccccCcCC
Confidence 9999877 7899999887644
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=67.66 Aligned_cols=74 Identities=15% Similarity=0.119 Sum_probs=53.2
Q ss_pred cccCCcCceeEEEEEeCCC-cEEEEEEeccc--------CCChHHHHHHHHHHHhcc---cCCcceeecceeccccceee
Q 037563 408 TKLGQGGFGSVYLGMLPDG-IQVAVKKLESI--------GQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~-~~vavK~l~~~--------~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV 475 (606)
+.||.|.+..||+....+| +.++||.-... ....+.+..|.+.|..+. -.++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999999877 58999975321 123456777888887763 2356667666 34556899
Q ss_pred eeeccCCC
Q 037563 476 YEYLVNGS 483 (606)
Q Consensus 476 ~E~~~~gs 483 (606)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0016 Score=66.24 Aligned_cols=144 Identities=16% Similarity=0.143 Sum_probs=88.1
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecce------eccccceeeeeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGFC------IEGAHRLLAYEYL 479 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~------~~~~~~~lV~E~~ 479 (606)
+.+..|.-..+|+....+ ..+++|+... ....+...|+.++..+++.+ +.+++... ...+..++|+||+
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 457778788999988744 4688888764 34566777888888885433 44544421 2234567999999
Q ss_pred cCCChhh----hh----------hhcccc-------ccccChhhHH----------HHHHHHHHHHHHHHh----cCCCc
Q 037563 480 VNGSLDK----WI----------FNSTEE-------SRFLCWNTRF----------NIALGTAKGLAYLHE----ECEVK 524 (606)
Q Consensus 480 ~~gsL~~----~l----------~~~~~~-------~~~l~~~~~~----------~i~~qi~~gL~yLH~----~~~~~ 524 (606)
+|..+.. .+ +..... .....|.... .....+...+.++.. ..+..
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9987643 10 110000 0011121110 111223344555553 22457
Q ss_pred eeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 525 iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
++|+|+.|.||+++++..+.|+||+.+..-
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 999999999999999877899999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00042 Score=54.81 Aligned_cols=51 Identities=25% Similarity=0.590 Sum_probs=38.5
Q ss_pred eeeeccccccCCCccCCCCCCChhhHHHHccc-CCCceeEEecCCCCceeeee
Q 037563 247 FYLGERLDYFALGFVSPFPKYDINTCKEACLH-NCSCSVLFFENSTKNCFLFD 298 (606)
Q Consensus 247 f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~C~~~~ 298 (606)
|..+++..+++.... .....++++|++.|+. +|+|.|+.|..+++.|+++.
T Consensus 6 f~~~~~~~l~~~~~~-~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~ 57 (78)
T smart00473 6 FVRLPNTKLPGFSRI-VISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWS 57 (78)
T ss_pred eEEecCccCCCCcce-eEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEee
Confidence 666666666533321 1345688999999999 99999999987678999775
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00041 Score=54.35 Aligned_cols=50 Identities=20% Similarity=0.479 Sum_probs=37.1
Q ss_pred ccccccCCCccCCCCCCChhhHHHHcccCCCceeEEecCCCCceeeeeccC
Q 037563 251 ERLDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQIG 301 (606)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~l~ 301 (606)
+++++++.+... ....+.++|+..|+.+|+|.||.|..+.+.|+++...+
T Consensus 10 ~~~~~~g~d~~~-~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~~ 59 (73)
T cd01100 10 SNVDFRGGDLST-VFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSEG 59 (73)
T ss_pred CCCccccCCcce-eecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCCC
Confidence 344555444322 22557899999999999999999998789999886643
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.007 Score=62.27 Aligned_cols=143 Identities=14% Similarity=0.131 Sum_probs=79.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecc------eeccccceeeeeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGF------CIEGAHRLLAYEYL 479 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~------~~~~~~~~lV~E~~ 479 (606)
+.+..|....+|+....+| .+++|+.+ ....++...|+.++..+...+ +.+.+.. ....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3467777789999987655 68889876 223445555666666664222 3333321 12244568999999
Q ss_pred cCCChhh-----h------h---hhcccc-------cccc-ChhhHHH------------HH-HHHHHHHHHHHhc----
Q 037563 480 VNGSLDK-----W------I---FNSTEE-------SRFL-CWNTRFN------------IA-LGTAKGLAYLHEE---- 520 (606)
Q Consensus 480 ~~gsL~~-----~------l---~~~~~~-------~~~l-~~~~~~~------------i~-~qi~~gL~yLH~~---- 520 (606)
+|..+.. . | +..... ...+ .|....+ .+ ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9975421 1 1 111000 0011 1111111 11 1111222333211
Q ss_pred CCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 521 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
.+.+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 345899999999999999775568999998864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0075 Score=62.67 Aligned_cols=142 Identities=16% Similarity=0.171 Sum_probs=82.0
Q ss_pred cCCcCceeEEEEEeCC-----CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCC
Q 037563 410 LGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
+-.|-.-.+|+....+ ++.+++|+........-+..+|..++..+...++. ++++.+..+ .|.||+++.+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~ 119 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART 119 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence 4446677888877532 36788887754332222347788888888755554 455555332 5899998877
Q ss_pred hhhh-----------------hhhcccccc--ccChhhHHHHHHHH-----------------HHHHHHHH----h-cCC
Q 037563 484 LDKW-----------------IFNSTEESR--FLCWNTRFNIALGT-----------------AKGLAYLH----E-ECE 522 (606)
Q Consensus 484 L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~gL~yLH----~-~~~ 522 (606)
|..- ++....... ...+....++..++ ...+..|. . ..+
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6532 111110000 11122222222111 11122222 1 223
Q ss_pred CceeecCCCCCCeEEcC-CCcEEEeeccCCcccC
Q 037563 523 VKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 555 (606)
Q Consensus 523 ~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~ 555 (606)
..++|+|+++.||++++ ++.+.++||..+....
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 47899999999999986 4689999999887644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.015 Score=59.45 Aligned_cols=144 Identities=19% Similarity=0.216 Sum_probs=84.3
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecce------eccccceeeeeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGFC------IEGAHRLLAYEYL 479 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~------~~~~~~~lV~E~~ 479 (606)
+.++.|.-..+|+....++ .+++|+.... ...++...|++++..+.... +.+++... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4577777789999886555 5777876442 23455667777777774322 44444422 1234568999999
Q ss_pred cCCChhhh--------------hhhcccc---c-----cccChhhHH------------HHHHHHHHHHHHHHh----cC
Q 037563 480 VNGSLDKW--------------IFNSTEE---S-----RFLCWNTRF------------NIALGTAKGLAYLHE----EC 521 (606)
Q Consensus 480 ~~gsL~~~--------------l~~~~~~---~-----~~l~~~~~~------------~i~~qi~~gL~yLH~----~~ 521 (606)
+|..+... ++..... . ....|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 98654311 1110000 0 001121110 011223344555543 23
Q ss_pred CCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 522 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+.+++|+|+++.||++++++...|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 46899999999999999987778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.012 Score=59.02 Aligned_cols=34 Identities=26% Similarity=0.498 Sum_probs=27.8
Q ss_pred CceeecCCCCCCeEEcCCCc-EEEeeccCCcccCc
Q 037563 523 VKIVHCDIKPENVLLDDNFT-AKVSDFGLAKLMNR 556 (606)
Q Consensus 523 ~~iiH~dlkp~NIll~~~~~-~kl~Dfgla~~~~~ 556 (606)
..++|+|++|.||++++++. .-|+||+.+....+
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 35899999999999997555 46999999876543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0031 Score=62.89 Aligned_cols=132 Identities=14% Similarity=0.156 Sum_probs=88.6
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEec-------c----------cCCC------hHHHHHHHHHHHhccc--CC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLE-------S----------IGQG------KKEFSAEVTIIGNVHH--VH 458 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~-------~----------~~~~------~~~~~~Ei~~l~~l~h--~n 458 (606)
..+.++||-|--+-||.+-..+|++.++|.-+ . .... +-....|...|+.+.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 34568899999999999999999999988321 0 0011 1223557777777753 33
Q ss_pred cceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 459 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
+.+.+.+ +..++|||++.+-.|...-+ ..+..++.. .+..-+--|-.+ |+||+|..-=||+++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee-------cCChHHHHH---HHHHHHHHHHHc---CceecccchheeEEe
Confidence 4445544 34589999999888765431 122223332 222333445555 999999999999999
Q ss_pred CCCcEEEeeccCCc
Q 037563 539 DNFTAKVSDFGLAK 552 (606)
Q Consensus 539 ~~~~~kl~Dfgla~ 552 (606)
++..++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0053 Score=59.05 Aligned_cols=124 Identities=15% Similarity=0.126 Sum_probs=63.1
Q ss_pred CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCChhhh-------h---------
Q 037563 426 GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGSLDKW-------I--------- 488 (606)
Q Consensus 426 ~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~~-------l--------- 488 (606)
.+.|+||+........-+...|..+++.+...++. ++++.+.. -+|+||+++.+|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 35688888765555566778899999988766664 45554433 257799977665331 1
Q ss_pred -hhccc---cccccChhhHHHH----------------------HHHHHHHHHHHHh-----cCCCceeecCCCCCCeEE
Q 037563 489 -FNSTE---ESRFLCWNTRFNI----------------------ALGTAKGLAYLHE-----ECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 489 -~~~~~---~~~~l~~~~~~~i----------------------~~qi~~gL~yLH~-----~~~~~iiH~dlkp~NIll 537 (606)
+.... .....-|....++ ...+..-+..+.+ ..+..++|+|+.|.||++
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 00000 0000011111111 1111222222221 112468999999999999
Q ss_pred -cCCCcEEEeeccCCcc
Q 037563 538 -DDNFTAKVSDFGLAKL 553 (606)
Q Consensus 538 -~~~~~~kl~Dfgla~~ 553 (606)
+.++.++++||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.027 Score=58.27 Aligned_cols=144 Identities=15% Similarity=0.173 Sum_probs=81.0
Q ss_pred ccCCcCceeEEEEEeCC----CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeeccCCC
Q 037563 409 KLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
.|..|=--.+|+....+ +..+++|+........-+..+|..+++.+...++- ++++++.. . +|.+|+++.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCCC
Confidence 34446667788887543 23788887754332233447788888888766664 45555532 2 5899998776
Q ss_pred hhhh-------h----------hhccccc-c-ccChhhHHHHHHHH----------------------HHHHHHHHh---
Q 037563 484 LDKW-------I----------FNSTEES-R-FLCWNTRFNIALGT----------------------AKGLAYLHE--- 519 (606)
Q Consensus 484 L~~~-------l----------~~~~~~~-~-~l~~~~~~~i~~qi----------------------~~gL~yLH~--- 519 (606)
|..- + +...... . +.-|....++..++ ..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 6321 1 1111000 0 11122222222111 111222211
Q ss_pred --cCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCc
Q 037563 520 --ECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 520 --~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 556 (606)
..+.-++|+|+.+.||++++ ++.++++||..+....+
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~ 216 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR 216 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence 12335899999999999975 57899999998876443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0098 Score=59.90 Aligned_cols=72 Identities=19% Similarity=0.238 Sum_probs=48.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcc---cCCcceeecceeccccceeeeeeccCC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.++.|....+|+.. .+++.+.||.-. ......|..|..-|+.|. -..+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 568999999999988 477889999876 334567899999888884 345778888877777779999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.055 Score=55.54 Aligned_cols=138 Identities=22% Similarity=0.263 Sum_probs=84.3
Q ss_pred CceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCc------ceeecc----eeccccceeeeeeccCCC
Q 037563 414 GFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL------VKLKGF----CIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 414 ~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI------v~l~g~----~~~~~~~~lV~E~~~~gs 483 (606)
.-..+|+....+|+. ++|..+.. ....+...|+..+.-+.-..| ..+-|- .......+-++||++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 456789999877776 88887765 567777888888877742222 222221 112236678999999988
Q ss_pred hhh-hh--------------hhc--------cccccccChh-------------hHHHHHHHHHHHHHHHHhc----CCC
Q 037563 484 LDK-WI--------------FNS--------TEESRFLCWN-------------TRFNIALGTAKGLAYLHEE----CEV 523 (606)
Q Consensus 484 L~~-~l--------------~~~--------~~~~~~l~~~-------------~~~~i~~qi~~gL~yLH~~----~~~ 523 (606)
+.. .- +.. ........|. .......++...+..+.+. .+.
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 873 10 100 0001123332 0111233344444444443 233
Q ss_pred c---eeecCCCCCCeEEcCCCc-EEEeeccCCcc
Q 037563 524 K---IVHCDIKPENVLLDDNFT-AKVSDFGLAKL 553 (606)
Q Consensus 524 ~---iiH~dlkp~NIll~~~~~-~kl~Dfgla~~ 553 (606)
. +||+|+.|.||+++.+.. +.++||+-+..
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 4 999999999999999885 89999998763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.075 Score=54.02 Aligned_cols=140 Identities=17% Similarity=0.233 Sum_probs=82.5
Q ss_pred eEEEEEeCCCcEEEEEEecc---cCCChHHHHHHHHHHHhccc--CCcceeecceeccc--cceeeeeeccCCChhhhhh
Q 037563 417 SVYLGMLPDGIQVAVKKLES---IGQGKKEFSAEVTIIGNVHH--VHLVKLKGFCIEGA--HRLLAYEYLVNGSLDKWIF 489 (606)
Q Consensus 417 ~Vy~g~~~~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~ 489 (606)
.+|..... +++.+++ .+. .........+|...|+.+.- .-..+.++.|.++. ..+.||+|.+|..+.+.+.
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34444443 6777877 332 12334566778888887753 34455677777766 6799999999843333221
Q ss_pred hcccc----------------------------------ccccChhhHHHHH--------HHHHHHHHHHHhcC-----C
Q 037563 490 NSTEE----------------------------------SRFLCWNTRFNIA--------LGTAKGLAYLHEEC-----E 522 (606)
Q Consensus 490 ~~~~~----------------------------------~~~l~~~~~~~i~--------~qi~~gL~yLH~~~-----~ 522 (606)
..... ++...|...++.+ -....-..+|+.+. +
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 10000 0001111111100 11122345555543 3
Q ss_pred CceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 523 ~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
..++|+|+++.||+++++.-.-|.||+++..-.+..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLE 233 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHH
Confidence 579999999999999999889999999998765443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0011 Score=77.68 Aligned_cols=161 Identities=16% Similarity=0.053 Sum_probs=115.5
Q ss_pred HHHHHHHHHhcccCCcceeeccee--ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC
Q 037563 444 FSAEVTIIGNVHHVHLVKLKGFCI--EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521 (606)
Q Consensus 444 ~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 521 (606)
...|...++...|+++.....-.. ++.+.+.+++|+..|.+.+.|.+...+.+.+...-+...-.+......-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678888776544332 345678999999999999999877666555555444433333244444545432
Q ss_pred --CCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHH
Q 037563 522 --EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599 (606)
Q Consensus 522 --~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ell 599 (606)
..--+|+++|+-|.+|..+..+|+.++|+.+...+... ......+++.|+.|+....-.++.++|+|..+.-+++.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22358999999999999999999999999994433322 223456788899999888888899999999999999887
Q ss_pred hCCCCC
Q 037563 600 GGRKSF 605 (606)
Q Consensus 600 tG~~pf 605 (606)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 777665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.023 Score=65.58 Aligned_cols=152 Identities=19% Similarity=0.189 Sum_probs=107.9
Q ss_pred HHHHHHHHHHhcccCCcceeecceeccccc----eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH
Q 037563 443 EFSAEVTIIGNVHHVHLVKLKGFCIEGAHR----LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518 (606)
Q Consensus 443 ~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH 518 (606)
...-|++.+.++.|+|++...++-.++... .+..|++..-++...++.. ..++..+.+.+..+...||.|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence 345577788889999999999887654433 3456888888888877543 34777888889999999999999
Q ss_pred hcCCCceeecCCCCC---CeEEcCCCcEEEe--eccCCcccCcCcceeeeecccccCccccccccCCCCCC--ccchHHH
Q 037563 519 EECEVKIVHCDIKPE---NVLLDDNFTAKVS--DFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE--KSDVYSY 591 (606)
Q Consensus 519 ~~~~~~iiH~dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--~~Dv~s~ 591 (606)
+. ...|.-+..+ +-..+.++...+. ||+..+.+...... ....-+..+.+||.......+. ..|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence 98 5555444444 5555666777777 88888765443221 1123345677888777665544 4699999
Q ss_pred HHHHHHHHhCCC
Q 037563 592 GMVLLEIIGGRK 603 (606)
Q Consensus 592 Gvvl~elltG~~ 603 (606)
|..+..+..|..
T Consensus 379 gll~~~~~~~~~ 390 (1351)
T KOG1035|consen 379 GLLLLQLSQGED 390 (1351)
T ss_pred HHHHhhhhhcCc
Confidence 999999988765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.067 Score=54.57 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=92.7
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccC----------CC-------------hH----HHHHHHHHHHhcccCCc
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIG----------QG-------------KK----EFSAEVTIIGNVHHVHL 459 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~----------~~-------------~~----~~~~Ei~~l~~l~h~nI 459 (606)
...|..|--..||.+.-.+|..+|||+.+.+- .+ ++ -...|+.-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34588899999999999999999999875320 00 01 12346666777765554
Q ss_pred ceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC
Q 037563 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539 (606)
Q Consensus 460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~ 539 (606)
...--... ....|||+|+....... .......++...+..+-.|++.-|.-|-..| +++|.||.-=|+|+.+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 33222222 13479999985321110 0011234666677788888888888888876 8999999999999854
Q ss_pred CCcEEEeeccCCccc
Q 037563 540 NFTAKVSDFGLAKLM 554 (606)
Q Consensus 540 ~~~~kl~Dfgla~~~ 554 (606)
|.+.|+|.+-+...
T Consensus 301 -G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEH 314 (520)
T ss_pred -CEEEEEEccccccC
Confidence 58999998766543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.17 Score=52.24 Aligned_cols=72 Identities=14% Similarity=0.014 Sum_probs=47.6
Q ss_pred cCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccC--Ccceee---c--ceeccccceeeeeeccCCCh
Q 037563 413 GGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV--HLVKLK---G--FCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 413 G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~---g--~~~~~~~~~lV~E~~~~gsL 484 (606)
+.-..||+...+++..+++|..+.......+...|+..+..+... .++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 345679999988888899998765444667778888888777422 223322 2 12223456789999988654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 606 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-123
Identities = 110/237 (46%), Positives = 151/237 (63%), Gaps = 6/237 (2%)
Query: 373 FSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFST--KLGQGGFGSVYLGMLPDGIQVA 430
F EED E G RFS +L A+ NFS LG+GGFG VY G L DG VA
Sbjct: 1 FFDVPAEED--PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVA 58
Query: 431 VKKL-ESIGQG-KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWI 488
VK+L E QG + +F EV +I H +L++L+GFC+ RLL Y Y+ NGS+ +
Sbjct: 59 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 489 FNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 548
E L W R IALG+A+GLAYLH+ C+ KI+H D+K N+LLD+ F A V DF
Sbjct: 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
GLAKLM+ +++ V T +RGT G++APE+++ SEK+DV+ YG++LLE+I G+++F
Sbjct: 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-103
Identities = 90/240 (37%), Positives = 133/240 (55%), Gaps = 20/240 (8%)
Query: 380 EDYFLESFSGMPTRFSYDDLCKATKNFST--------KLGQGGFGSVYLGMLPDGIQVAV 431
E+ LE FS+ +L T NF K+G+GGFG VY G + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 432 KKLESI-----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDK 486
KKL ++ + K++F E+ ++ H +LV+L GF +G L Y Y+ NGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 487 WIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546
+ + + L W+ R IA G A G+ +LHE +H DIK N+LLD+ FTAK+S
Sbjct: 120 RLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 547 DFGLAKLM-NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
DFGLA+ ++++ + + GT Y+APE + I+ KSD+YS+G+VLLEII G +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-101
Identities = 86/215 (40%), Positives = 128/215 (59%), Gaps = 7/215 (3%)
Query: 393 RFSYDDLCKATKNFSTK--LGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVT 449
R DL +AT NF K +G G FG VY G+L DG +VA+K+ QG +EF E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 450 IIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALG 509
+ H HLV L GFC E +L Y+Y+ NG+L + ++ S + + W R I +G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-NREESLVYTTLRGT 568
A+GL YLH I+H D+K N+LLD+NF K++DFG++K +++ + T ++GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 569 RGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603
GY+ PE+ ++EKSDVYS+G+VL E++ R
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 25/232 (10%)
Query: 394 FSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTII 451
++L + +G FG V+ VAVK + + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 452 GNVHHVHLVKLKGFCIEGAH----RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA 507
+ H ++++ G G L + GSL ++ + + WN +IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIA 127
Query: 508 LGTAKGLAYLHEE-------CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560
A+GLAYLHE+ + I H DIK +NVLL +N TA ++DFGLA +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 561 VYTTLR-GTRGYLAPEWI-----TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
T + GTR Y+APE + + D+Y+ G+VL E+ +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-61
Identities = 76/247 (30%), Positives = 119/247 (48%), Gaps = 12/247 (4%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM 422
HH+ ++ + E YF + G + DL N K+G G FG+V+
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAE 57
Query: 423 LPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479
G VAVK L + + EF EV I+ + H ++V G + + + EYL
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539
GSL + + S L R ++A AKG+ YLH IVH ++K N+L+D
Sbjct: 117 SRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174
Query: 540 NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
+T KV DFGL++L + GT ++APE + + P +EKSDVYS+G++L E+
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 600 GGRKSFS 606
++ +
Sbjct: 234 TLQQPWG 240
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G FG V VA+K++ES +K F E+ + V+H ++VKL G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C+ L EY GSL + + E + + L ++G+AYLH +
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 526 VHCDIKPENVLLDDNFT-AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+H D+KP N+LL T K+ DFG A + T +G+ ++APE + SE
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 585 KSDVYSYGMVLLEIIGGRKSFS 606
K DV+S+G++L E+I RK F
Sbjct: 183 KCDVFSWGIILWEVITRRKPFD 204
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKL-----ESIGQGKKEFSAEVTIIGNVHHVHLV 460
+G GGFG VY G +VAVK E I Q + E + + H +++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
L+G C++ + L E+ G L++ + + + + N A+ A+G+ YLH+E
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 521 CEVKIVHCDIKPENVLLD--------DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
V I+H D+K N+L+ N K++DFGLA+ +R + G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWM 181
Query: 573 APEWITNNPISEKSDVYSYGMVLLEIIGGR 602
APE I + S+ SDV+SYG++L E++ G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 37/235 (15%)
Query: 394 FSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTI- 450
+ + N +G+G +G+VY G L D VAVK ++ F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF--ANRQNFINEKNIY 59
Query: 451 -IGNVHHVHLVKLKGFCIEG-----AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF 504
+ + H ++ + LL EY NGSL K++ T W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSC 114
Query: 505 NIALGTAKGLAYLHEE------CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-- 556
+A +GLAYLH E + I H D+ NVL+ ++ T +SDFGL+ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 557 -----EESLVYTTLRGTRGYLAPEWITN-------NPISEKSDVYSYGMVLLEII 599
EE + GT Y+APE + ++ D+Y+ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-52
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 406 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKL--------ESIGQGKKEFSAEVTIIGNVHH 456
+ ++G+GGFG V+ G + D VA+K L + + +EF EV I+ N++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
++VKL G + E++ G L + + ++ + W+ + + L A G+ Y
Sbjct: 83 PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 517 LHEECEVKIVHCDIKPENVLLD-----DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+ IVH D++ N+ L AKV+DFGL+ ++ + L G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQW 192
Query: 572 LAPEWIT--NNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+APE I +EK+D YS+ M+L I+ G F
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQ-GKKEFSAEVTIIGNVHHVHLVKLKGFC 466
LG+G FG G + +K+L + ++ F EV ++ + H +++K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ EY+ G+L I + W+ R + A A G+AYLH I+
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-------------TTLRGTRGYLA 573
H D+ N L+ +N V+DFGLA+LM E++ T+ G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 574 PEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
PE I EK DV+S+G+VL EIIG +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 45/219 (20%), Positives = 90/219 (41%), Gaps = 23/219 (10%)
Query: 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTIIG 452
+ L NF TKL + G ++ G G + VK L + + ++F+ E +
Sbjct: 9 FKQL-----NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 453 NVHHVHLVKLKGFCIEGAHRLLAY--EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT 510
H +++ + G C ++ GSL + T + + + AL
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDM 120
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
A+G+A+LH E I + +V++D++ TA++S + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 571 YLAPEWITNNP---ISEKSDVYSYGMVLLEIIGGRKSFS 606
++APE + P +D++S+ ++L E++ F+
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-50
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G G FG+VY G VAVK L Q + F EV ++ HV+++ G+
Sbjct: 31 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+ ++ SL + +IA TA+G+ YLH + I
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-EESLVYTTLRGTRGYLAPEWITN---NP 581
+H D+K N+ L ++ T K+ DFGLA +R S + L G+ ++APE I NP
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 582 ISEKSDVYSYGMVLLEIIGGR 602
S +SDVY++G+VL E++ G+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 58/246 (23%), Positives = 106/246 (43%), Gaps = 32/246 (13%)
Query: 375 QENLEEDYFLESFSGMPT---RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAV 431
++ +E+ S SG+P R + ++G+G +G V++G G +VAV
Sbjct: 12 RDLIEQSQSSGSGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKW-RGEKVAV 65
Query: 432 KKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY----EYLVNGSLDKW 487
K + + E+ + H +++ I+G +Y NGSL +
Sbjct: 66 KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125
Query: 488 IFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE-----CEVKIVHCDIKPENVLLDDNFT 542
+ ++T L + +A + GL +LH E + I H D+K +N+L+ N T
Sbjct: 126 LKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
Query: 543 AKVSDFGLAKLMNREESLVY---TTLRGTRGYLAPE------WITNNPISEKSDVYSYGM 593
++D GLA + + V T GT+ Y+ PE + +D+YS+G+
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240
Query: 594 VLLEII 599
+L E+
Sbjct: 241 ILWEVA 246
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 53/217 (24%), Positives = 81/217 (37%), Gaps = 25/217 (11%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G+G FG VY G +VA++ + K F EV H ++V
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C+ H + +L + + L N IA KG+ YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR----EESLVYTTLRGTRGYLAPEWIT 578
I+H D+K +NV D+ ++DFGL + G +LAPE I
Sbjct: 150 -GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 579 N---------NPISEKSDVYSYGMVLLEIIGGRKSFS 606
P S+ SDV++ G + E+ F
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTI--IGNVHHVHLVKLK 463
+G+G +G V+ G G VAVK S + +K + E + + H +++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 464 GFCIEGAHRLLAY----EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
+ H Y GSL ++ +T L + I L A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 520 E-----CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---TTLRGTRGY 571
E + I H D+K +N+L+ N ++D GLA + ++ + + GT+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 572 LAPEWITNNPI------SEKSDVYSYGMVLLEII 599
+APE + ++ D++++G+VL E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-45
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 32/249 (12%)
Query: 372 KFSQENLEEDYFLESFSGMPT---RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQ 428
++ + + S SG+P R + +G+G FG V+ G G +
Sbjct: 14 TTLKDLIYDMTTSGSGSGLPLLVQRTIARTIV-----LQESIGKGRFGEVWRGKW-RGEE 67
Query: 429 VAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY----EYLVNGSL 484
VAVK S + AE+ + H +++ + +Y +GSL
Sbjct: 68 VAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
Query: 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE-----CEVKIVHCDIKPENVLLDD 539
++ + +AL TA GLA+LH E + I H D+K +N+L+
Sbjct: 128 FDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182
Query: 540 NFTAKVSDFGLAKLMNREES---LVYTTLRGTRGYLAPE------WITNNPISEKSDVYS 590
N T ++D GLA + + GT+ Y+APE + + +++D+Y+
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 591 YGMVLLEII 599
G+V EI
Sbjct: 243 MGLVFWEIA 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 16/198 (8%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
++G+G FG V+ G L D VAVK K +F E I+ H ++V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
C + + E + G ++ E L T + A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY----LAPEWITNNP 581
+H D+ N L+ + K+SDFG+++ Y G R APE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291
Query: 582 ISEKSDVYSYGMVLLEII 599
S +SDV+S+G++L E
Sbjct: 292 YSSESDVWSFGILLWETF 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-38
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLGQG FG V++G +VA+K L+ + F E ++ + H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
E + EY+ GSL F E ++L ++A A G+AY+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 358
Query: 583 SEKSDVYSYGMVLLEII 599
+ KSDV+S+G++L E+
Sbjct: 359 TIKSDVWSFGILLTELT 375
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-38
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 406 FSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
KLG G +G VY G+ + VAVK L+ +EF E ++ + H +LV+L G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
C + E++ G+L + + + +A + + YL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNP 581
+H ++ N L+ +N KV+DFGL++LM + YT G + + APE + N
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNK 395
Query: 582 ISEKSDVYSYGMVLLEII 599
S KSDV+++G++L EI
Sbjct: 396 FSIKSDVWAFGVLLWEIA 413
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-38
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLG G FG V++ +VAVK ++ + F AE ++ + H LVKL
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+ + E++ GSL F ++E + + A+G+A++ +
Sbjct: 252 VTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWITNNPI 582
+H D++ N+L+ + K++DFGLA+++ E YT G + + APE I
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 362
Query: 583 SEKSDVYSYGMVLLEII 599
+ KSDV+S+G++L+EI+
Sbjct: 363 TIKSDVWSFGILLMEIV 379
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-37
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
KLGQG FG V++G +VA+K L+ + F E ++ + H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
E + EY+ GSL F E ++L ++A A G+AY+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 582
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 441
Query: 583 SEKSDVYSYGMVLLEII 599
+ KSDV+S+G++L E+
Sbjct: 442 TIKSDVWSFGILLTELT 458
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 409 KLGQGGFGSVYLGMLP-----DGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG+G FG V L G QVAVK L ES G + E+ I+ N++H ++VK
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 462 LKGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
KG C E L E+L +GSL +++ + + + + A+ KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGS 144
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 576
+ VH D+ NVL++ K+ DFGL K + ++ YT + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPEC 200
Query: 577 ITNNPISEKSDVYSYGMVLLEII 599
+ + SDV+S+G+ L E++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+LG G FG V LG VAVK ++ + EF E + + H LVK G C +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ NG L ++ + L + + +G+A+L + +H
Sbjct: 75 EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D+ N L+D + KVSDFG+ + + ++ Y + GT+ + APE S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 586 SDVYSYGMVLLEII 599
SDV+++G+++ E+
Sbjct: 186 SDVWAFGILMWEVF 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 409 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG+G FGSV + G VAVKKL S + ++F E+ I+ ++ H ++VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 463 KGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
KG C R L EYL GSL ++ E + KG+ YL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 577
+ +H D+ N+L+++ K+ DFGL K++ +++ + + APE +
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESL 189
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
T + S SDV+S+G+VL E+
Sbjct: 190 TESKFSVASDVWSFGVVLYELF 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
++G G FG V+LG + +VA+K + +++F E ++ + H LV+L G C+E
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
A L E++ +G L ++ T + L +G+AYL E ++H
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CVIHR 128
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D+ N L+ +N KVSDFG+ + + ++ YT+ GT+ + +PE + + S K
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 586 SDVYSYGMVLLEII 599
SDV+S+G+++ E+
Sbjct: 186 SDVWSFGVLMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 409 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG+G FGSV + G VAVKKL S + ++F E+ I+ ++ H ++VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 463 KGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
KG C R L EYL GSL ++ E + KG+ YL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 577
+ +H D+ N+L+++ K+ DFGL K++ +++ Y + APE +
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPESL 220
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
T + S SDV+S+G+VL E+
Sbjct: 221 TESKFSVASDVWSFGVVLYELF 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 409 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG+G FGSV L G VAVK+L S +++F E+ I+ +H +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 463 KGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+G + L EYL +G L ++ L + + KG+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSR 146
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 577
+ VH D+ N+L++ K++DFGLAKL+ ++ Y + + APE +
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESL 202
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
++N S +SDV+S+G+VL E+
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELF 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
+G GGFG V+ DG +K+ + ++ EV + + HV++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 468 EGAHRLLAY----------------EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA 511
+ E+ G+L++WI L +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
KG+ Y+H + K+++ D+KP N+ L D K+ DFGL + + T +GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 187
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
++PE I++ ++ D+Y+ G++L E++ +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+LG G FG V++G +VAVK L+ F AE ++ + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ NGSL F T L N ++A A+G+A++ E +H
Sbjct: 80 E-PIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-----APEWITNNPIS 583
D++ N+L+ D + K++DFGLA+L+ E YT G + APE I +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK--FPIKWTAPEAINYGTFT 188
Query: 584 EKSDVYSYGMVLLEII 599
KSDV+S+G++L EI+
Sbjct: 189 IKSDVWSFGILLTEIV 204
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 408 TKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG G FGSV G+ I VA+K L + +E E I+ + + ++V+L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C A L+ E G L K++ + + + + + G+ YL E
Sbjct: 76 IGVCQAEALMLVM-EMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
VH D+ NVLL + AK+SDFGL+K + ++S YT + + APE I
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINF 187
Query: 580 NPISEKSDVYSYGMVLLEII 599
S +SDV+SYG+ + E +
Sbjct: 188 RKFSSRSDVWSYGVTMWEAL 207
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 9/202 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQG----KKEFSAEVTIIGNVHHVHLVKLK 463
K+G+G F VY L DG+ VA+KK++ + + E+ ++ ++H +++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
IE + E G L + I + ++ R + T + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--- 155
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+++H DIKP NV + K+ D GL + + + + ++ + GT Y++PE I N +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
KSD++S G +L E+ + F
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPF 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+LG G FG V G VA+K ++ + EF E ++ N+ H LV+L G C +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ NG L ++ + + + YL + + +H
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 585
D+ N L++D KVSDFGL++ + +E YT+ G++ + PE + + S K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 586 SDVYSYGMVLLEII 599
SD++++G+++ EI
Sbjct: 202 SDIWAFGVLMWEIY 215
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G G G V G L + VA+K L + +++F +E +I+G H ++++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+G G ++ EY+ NGSLD ++ + + G G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPEW 576
VH D+ NVL+D N KVSDFGL++++ + YTT G T APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 577 ITNNPISEKSDVYSYGMVLLEII 599
I S SDV+S+G+V+ E++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVL 248
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 15/203 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTIIGNV-HHVHLVKLK 463
+LG G +G V+ DG AVK+ S +G K+ + AEV V H V+L+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
EG L E SL + L + T LA+LH +
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ--- 176
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+VH D+KP N+ L K+ DFGL + + G Y+APE +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPE-LLQGSYG 233
Query: 584 EKSDVYSYGMVLLEIIGGRKSFS 606
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMELPH 256
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 409 KLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG+G FG V L G VAVK L ++ Q + + E+ I+ ++H H++K
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 462 LKGFCIEGAHR--LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
KG C + L EY+ GSL ++ + A +G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 576
+ +H D+ NVLLD++ K+ DFGLAK + Y + APE
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPEC 208
Query: 577 ITNNPISEKSDVYSYGMVLLEII 599
+ SDV+S+G+ L E++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELL 231
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 409 KLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
+G G FG VY GML + VA+K L + + +F E I+G H ++++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L+G + ++ EY+ NG+LDK++ E + G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANM- 166
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPE 575
VH D+ N+L++ N KVSDFGL++++ + YTT G T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 576 WITNNPISEKSDVYSYGMVLLEII 599
I+ + SDV+S+G+V+ E++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVM 244
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LG+GGFG V+ D A+K+ L + +++ EV + + H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 466 CIEGAHRLLAY------------EYLVNGSLDKWIFN---STEESRFLCWNTRFNIALGT 510
+E + +L W+ E R +C + I L
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH----IFLQI 127
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---------- 560
A+ + +LH + ++H D+KP N+ + KV DFGL M+++E
Sbjct: 128 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 561 -VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEII 599
+T GT+ Y++PE I N S K D++S G++L E++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 409 KLGQGGFGSVYLGML-PDG----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG G FG+VY G+ P+G I VA+K+L + + KE E ++ +V + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L G C+ L + + G L ++ + + N + AKG+ YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 578
++VH D+ NVL+ K++DFGLAKL+ EE G + ++A E I
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 579 NNPISEKSDVYSYGMVLLEII 599
+ + +SDV+SYG+ + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 65/250 (26%), Positives = 110/250 (44%), Gaps = 39/250 (15%)
Query: 379 EEDYFLESFSGMPTR------FSYDDLCKATKNFS-----------TKLGQGGFGSVYLG 421
+ +F +P +++D + F+ +G G FG V G
Sbjct: 5 KRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 422 MLP----DGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475
L I VA+K L + +++F E +I+G H ++++L+G + ++
Sbjct: 65 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535
EY+ NGSLD ++ + + G A G+ YL + VH D+ N+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNI 178
Query: 536 LLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPEWITNNPISEKSDVY 589
L++ N KVSDFGL +++ + YTT G T +PE I + SDV+
Sbjct: 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVW 234
Query: 590 SYGMVLLEII 599
SYG+VL E++
Sbjct: 235 SYGIVLWEVM 244
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 34/267 (12%)
Query: 360 GLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDD---LCKATKNFSTKLGQGGFG 416
G+ + K+K + + +E PT+ Y++ + F LG G FG
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFG 60
Query: 417 SVYLGMLPD------GIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467
V ++VAVK L + K+ +E+ I+ ++ H ++V L G C
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 468 EGAHRLLAYEYLVNGSL----------DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
G L+ EY G L + + + + A+G+A+L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL----- 572
+ +H D+ NVLL + AK+ DFGLA+ + + Y L
Sbjct: 181 ASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--NYI--VKGNARLPVKWM 233
Query: 573 APEWITNNPISEKSDVYSYGMVLLEII 599
APE I + + +SDV+SYG++L EI
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 409 KLGQGGFGSVYLGMLPDG-IQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
KLG G +G VY G+ + VAVK L+ +EF E ++ + H +LV+L G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
+ E++ G+L + + + +A + + YL ++ +H
Sbjct: 80 REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISE 584
D+ N L+ +N KV+DFGL++LM + YT G + + APE + N S
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 585 KSDVYSYGMVLLEII 599
KSDV+++G++L EI
Sbjct: 192 KSDVWAFGVLLWEIA 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG-----IQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVH 458
LG G FG+V+ G+ I V +K + +S Q + + + IG++ H H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+V+L G C + +L+ +YL GSL + L N + AKG+ YL
Sbjct: 77 IVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE 132
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPE 575
E +VH ++ NVLL +V+DFG+A L+ ++ + ++A E
Sbjct: 133 EH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALE 187
Query: 576 WITNNPISEKSDVYSYGMVLLEII 599
I + +SDV+SYG+ + E++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELM 211
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKG 464
+G G +G DG + K+L+ + E EV ++ + H ++V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 465 -FCIEGAHRLLAY-EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
L EY G L I T+E ++L + L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 523 V--KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
++H D+KP NV LD K+ DFGLA+++N + S T GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSPEQMNRM 191
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
+EKSD++S G +L E+ F
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 409 KLGQGGFGSVYLGMLPDG---IQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG G FG+V G VAVK L + K E AE ++ + + ++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C + L+ E G L+K++ +++R + + + G+ YL E
Sbjct: 84 IGICEAESWMLVM-EMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
VH D+ NVLL AK+SDFGL+K + +E+ Y + + APE I
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINY 194
Query: 580 NPISEKSDVYSYGMVLLEII 599
S KSDV+S+G+++ E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 408 TKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG G FGSV G+ I VA+K L + +E E I+ + + ++V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C A L+ E G L K++ EE + + + + G+ YL E+
Sbjct: 402 IGVCQAEALMLVM-EMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK-- 455
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
VH ++ NVLL + AK+SDFGL+K + ++S YT + + APE I
Sbjct: 456 -NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINF 513
Query: 580 NPISEKSDVYSYGMVLLEII 599
S +SDV+SYG+ + E +
Sbjct: 514 RKFSSRSDVWSYGVTMWEAL 533
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHL 459
+G+G FG VY G D IQ A+K + Q + F E ++ ++H ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 460 VKLKGFCIEGA-HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+ L G + + Y+ +G L ++I R + L A+G+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL------ 572
E+ K VH D+ N +LD++FT KV+DFGLA+ + E Y +++ R
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE---YYSVQQHRHARLPVKWT 195
Query: 573 APEWITNNPISEKSDVYSYGMVLLEII 599
A E + + KSDV+S+G++L E++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVH 458
+F+ +G+G FG VY G L D I AVK L + +F E I+ + H +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 459 LVKLKGFCIEGAH-RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
++ L G C+ L+ Y+ +G L +I N T L AKG+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYL 144
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL----- 572
+ K VH D+ N +LD+ FT KV+DFGLA+ M +E Y+ T L
Sbjct: 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY--YSVHNKTGAKLPVKWM 199
Query: 573 APEWITNNPISEKSDVYSYGMVLLEII 599
A E + + KSDV+S+G++L E++
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 346 VVATILVIASLLYAGLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYD-DLCKATK 404
V A ILV + + + + E YF + + + + +L +A +
Sbjct: 21 VAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQ 80
Query: 405 NF-----------STKLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAE 447
+ + +G+G FG VY G L D I AVK L + +F E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 448 VTIIGNVHHVHLVKLKGFCIEGAH-RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNI 506
I+ + H +++ L G C+ L+ Y+ +G L +I N T
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGF 197
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 566
L AKG+ +L K VH D+ N +LD+ FT KV+DFGLA+ M +E
Sbjct: 198 GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN-- 252
Query: 567 GTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
T L A E + + KSDV+S+G++L E++
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNVHHVHLVKLKG 464
K+G+G FG L DG Q +K++ KE EV ++ N+ H ++V+ +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
E + +Y G L K I + ++ + + + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
I+H DIK +N+ L + T ++ DFG+A+++N L + GT YL+PE N P +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSD+++ G VL E+ + +F
Sbjct: 205 KSDIWALGCVLYELCTLKHAF 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-34
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G FG V LG G +VAVK +++ + F AE +++ + H +LV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 466 CIEGAHRLLAY---EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+E L Y EY+ GSL + + L + +L + + YL
Sbjct: 255 IVEEKGGL--YIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
VH D+ NVL+ ++ AKVSDFGL +E +T + + APE +
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLT----KEA---SSTQDTGKLPVKWTAPEALRE 360
Query: 580 NPISEKSDVYSYGMVLLEII 599
S KSDV+S+G++L EI
Sbjct: 361 KKFSTKSDVWSFGILLWEIY 380
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 409 KLGQGGFGSVYLGMLPDG-----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG G FG+VY G+ I VA+K+L + + KE E ++ +V + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L G C+ L + + G L ++ + + N + AKG+ YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 578
++VH D+ NVL+ K++DFGLAKL+ EE G + ++A E I
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 579 NNPISEKSDVYSYGMVLLEII 599
+ + +SDV+SYG+ + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 406 FSTKLGQGGFGSVYLGML----PDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHL 459
+ LG+G FG VY G+ + I VAVK K + K++F +E I+ N+ H H+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
VKL G E + E G L ++ + L T +L K +AYL
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES 131
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 576
VH DI N+L+ K+ DFGL++ + E+ Y TR +++PE
Sbjct: 132 I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPES 185
Query: 577 ITNNPISEKSDVYSYGMVLLEII 599
I + SDV+ + + + EI+
Sbjct: 186 INFRRFTTASDVWMFAVCMWEIL 208
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVK 461
LG+G FGSV G L ++VAVK ++ + +EF +E + + H ++++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 462 LKGFCIEGAHRLLAY-----EYLVNGSLDKWIFNS--TEESRFLCWNTRFNIALGTAKGL 514
L G CIE + + + ++ G L ++ S + + T + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-- 572
YL +H D+ N +L D+ T V+DFGL+K + + Y +G +
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--YYR--QGRIAKMPV 213
Query: 573 ---APEWITNNPISEKSDVYSYGMVLLEII 599
A E + + + KSDV+++G+ + EI
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
LGQG FG V D A+KK+ + +EV ++ +++H ++V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 468 EGAHRLLAY-------------EYLVNGSLDKWI-----FNSTEESRFLCWNTRFNIALG 509
E + + EY NG+L I +E L
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI------- 125
Query: 510 TAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY------- 562
+ L+Y+H + I+H D+KP N+ +D++ K+ DFGLAK ++R ++
Sbjct: 126 -LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 563 ------TTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLE 597
T+ GT Y+A E + +EK D+YS G++ E
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G FG V LG G +VAVK +++ + F AE +++ + H +LV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 466 CIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+E L + EY+ GSL + + L + +L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-----APEWITN 579
VH D+ NVL+ ++ AKVSDFGL +E +T + L APE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT----KEA---SSTQDTGK--LPVKWTAPEALRE 188
Query: 580 NPISEKSDVYSYGMVLLEII 599
S KSDV+S+G++L EI
Sbjct: 189 KKFSTKSDVWSFGILLWEIY 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 22/246 (8%)
Query: 365 NKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-L 423
+ +L + E + + L + P + Y + + ++G+G FG V+
Sbjct: 22 SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP-RVGRGSFGEVHRMKDK 80
Query: 424 PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483
G Q AVKK+ + + E E+ + +V L G EG + E L GS
Sbjct: 81 QTGFQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 484 LDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN- 540
L + I E R L +GL YLH +I+H D+K +NVLL +
Sbjct: 137 LGQLIKQMGCLPEDRAL------YYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDG 187
Query: 541 FTAKVSDFGLAKLMNREESLVYT----TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLL 596
A + DFG A + + + GT ++APE + P K D++S ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 597 EIIGGR 602
++ G
Sbjct: 248 HMLNGC 253
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 409 KLGQGGFGSVYLGML--PDG--IQVAVKKL----ESIGQGKKEFSAEVTIIGNVHHVHLV 460
KLG G FG V G P G + VAVK L S + +F EV + ++ H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+L G + +++ E GSL + T A+ A+G+ YL +
Sbjct: 85 RLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESK 140
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 577
+ +H D+ N+LL K+ DFGL + + + + Y + + APE +
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESL 196
Query: 578 TNNPISEKSDVYSYGMVLLEII 599
S SD + +G+ L E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMF 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSAEVTIIGNVHHVHLVKLKG 464
++G+G F +VY G+ ++VA +L+ K E F E ++ + H ++V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 465 FCI---EGAHRLLAY-EYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+G ++ E + +G+L ++ F + W + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKGLQFLH 146
Query: 519 EECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
I+H D+K +N+ + + K+ D GLA L + + GT ++APE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 202
Query: 578 TNNPISEKSDVYSYGMVLLEIIGGR 602
E DVY++GM +LE+
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 19/200 (9%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G+G FG V+ G+ + VA+K K + +++F E + H H+VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G E + E G L ++ L + A + LAYL +
Sbjct: 82 IGVITENPV-WIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK-- 135
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
+ VH DI NVL+ N K+ DFGL++ M Y + ++APE I
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINF 191
Query: 580 NPISEKSDVYSYGMVLLEII 599
+ SDV+ +G+ + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVH 458
+LG+G FG V+L + + VAVK L E+ +++F E ++ + H H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSL-----------DKWIFNSTEESRFLCWNTRFNIA 507
+V+ G C EG L+ +EY+ +G L L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
A G+ YL + VH D+ N L+ K+ DFG+++ + + Y G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYR-VG 217
Query: 568 TRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
R L PE I + +SDV+S+G+VL EI
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 406 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHV 457
LG G FG VY G + P +QVAVK L Q + +F E II +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGL 514
++V+ G ++ R + E + G L ++ + + L ++A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 515 AYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
YL E +H DI N LL AK+ DFG+A+ + R Y +G
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYR-KGGCAM 206
Query: 572 L-----APEWITNNPISEKSDVYSYGMVLLEII 599
L PE + K+D +S+G++L EI
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG+G FGSV L ++VAVK L +EF E + H H+ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 462 LKGFCIEGAHRLLAY------EYLVNGSLDKWIFNS--TEESRFLCWNTRFNIALGTAKG 513
L G + + ++ +G L ++ S E L T + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL- 572
+ YL +H D+ N +L ++ T V+DFGL++ + + Y +G L
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD--YYR--QGCASKLP 202
Query: 573 ----APEWITNNPISEKSDVYSYGMVLLEII 599
A E + +N + SDV+++G+ + EI+
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 409 KLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLV 460
LG G FG VY G + +QVAVK L Q + +F E II +H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGLAYL 517
+ G ++ R + E + G L ++ + + L ++A A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 518 HEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-- 572
E +H DI N LL AK+ DFG+A+ + R Y +G L
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYR-KGGCAMLPV 250
Query: 573 ---APEWITNNPISEKSDVYSYGMVLLEII 599
PE + K+D +S+G++L EI
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVH 458
+LG+G FG V+L + + VAVK L + +K+F E ++ N+ H H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNTRFNI 506
+VK G C +G ++ +EY+ +G L + L + +I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 566
A A G+ YL + VH D+ N L+ N K+ DFG+++ + + Y
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYR-V 191
Query: 567 GTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
G L PE I + +SDV+S+G++L EI
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 406 FSTKLGQGGFGSVYLGMLPD--------GIQVAVKKL--ESIGQGKKEFSAEVTIIGNV- 454
LG+G FG V + + VAVK L ++ + + +E+ ++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNT 502
H +++ L G C + + EY G+L + + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+ A+G+ YL + K +H D+ NVL+ +N K++DFGLA+ +N + Y
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YY 213
Query: 563 TTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
+ T G L APE + + + +SDV+S+G+++ EI
Sbjct: 214 K--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHV 457
F +LG+ FG VY G L VA+K L ++ G ++EF E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDK------------WIFNSTEESRFLCWNTRFN 505
++V L G + + + Y +G L + + L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
+ A G+ YL +VH D+ NVL+ D K+SD GL + + + Y
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD--YYKL- 186
Query: 566 RGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
L APE I S SD++SYG+VL E+
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HHVHL 459
F +G+G FG V + + A+K++ + ++F+ E+ ++ + HH ++
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNTRFNIA 507
+ L G C + LA EY +G+L D + + L + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL+ R + VY +
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS----RGQE-VYV--KK 198
Query: 568 TRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
T G L A E + + + SDV+SYG++L EI+
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 43/242 (17%)
Query: 388 SGMPTRFS--YDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEF 444
GM +R++ + +L K +G G FGSV+ + DG A+K+ + G +
Sbjct: 3 MGMKSRYTTEFHELEK--------IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE 54
Query: 445 SA---EVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCW 500
EV + H H+V+ E H L+ EY GSL I + +
Sbjct: 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 501 NTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-------------------F 541
++ L +GL Y+H +VH DIKP N+ +
Sbjct: 115 AELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 542 TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPISEKSDVYSYGMVLLEIIG 600
K+ D G ++ + G +LA E N K+D+++ + ++ G
Sbjct: 172 MFKIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 601 GR 602
Sbjct: 227 AE 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHV 457
S +LGQG FG VY G+ +VA+K + + + + EF E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRF------NIALGTA 511
H+V+L G +G L+ E + G L ++ + +A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
G+AYL+ K VH D+ N ++ ++FT K+ DFG+ + + + Y +G +G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--YYR--KGGKGL 201
Query: 572 L-----APEWITNNPISEKSDVYSYGMVLLEII 599
L +PE + + + SDV+S+G+VL EI
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 409 KLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLV 460
LG+G FG V VAVK L + ++ +E ++ V+H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSL--------------------DKWIFNSTEESRFLCW 500
KL G C + LL EY GSL + R L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 501 NTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560
+ A ++G+ YL E +K+VH D+ N+L+ + K+SDFGL++ + E+
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-- 204
Query: 561 VYTTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
Y + ++G + A E + ++ + +SDV+S+G++L EI+
Sbjct: 205 SYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 406 FSTKLGQGGFGSVYLGML--------PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNV- 454
LG+G FG V + + + VAVK L ++ + + +E+ ++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNT 502
H +++ L G C + + EY G+L + + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+ A+G+ YL + K +H D+ NVL+ +N K++DFGLA+ +N + Y
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YY 259
Query: 563 TTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
+ T G L APE + + + +SDV+S+G+++ EI
Sbjct: 260 K--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 65/274 (23%), Positives = 103/274 (37%), Gaps = 51/274 (18%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTR----FSYDDLCKATKNFSTKLGQGGFGSV 418
+ ++ + + + E YF F F ++L F LG G FG V
Sbjct: 9 YESQLQMVQVTGSSDNE--YFYVDFREYEYDLKWEFPRENL-----EFGKVLGSGAFGKV 61
Query: 419 YLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469
IQVAVK L ++ ++ +E+ ++ + H ++V L G C
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121
Query: 470 AHRLLAYEYLVNGSL-------------------DKWIFNSTEESRFLCWNTRFNIALGT 510
L +EY G L ++ E+ L + A
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
AKG+ +L + VH D+ NVL+ K+ DFGLA+ + + Y
Sbjct: 182 AKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--NYV--VRGNA 234
Query: 571 YL-----APEWITNNPISEKSDVYSYGMVLLEII 599
L APE + + KSDV+SYG++L EI
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 409 KLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G+G FG V+ G+ + VA+K K + +++F E + H H+VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G E + E G L ++ L + A + LAYL
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES--- 509
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 579
+ VH DI NVL+ N K+ DFGL++ M Y + ++APE I
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINF 566
Query: 580 NPISEKSDVYSYGMVLLEII 599
+ SDV+ +G+ + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 406 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HH 456
LG+G FG V VAVK L + + +E+ I+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 457 VHLVKLKGFC-IEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNTR 503
+++V L G C G ++ E+ G+L + FL
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 504 FNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563
+ AKG+ +L K +H D+ N+LL + K+ DFGLA+ + ++ Y
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYV 205
Query: 564 TLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
R L APE I + + +SDV+S+G++L EI
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 406 FSTKLGQGGFGSVYLGMLPD------GIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HH 456
F LG G FG V + VAVK L + ++ +E+ ++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLVNGSL--------------DKWIFNSTEESRFLCWNT 502
+++V L G C G L+ EY G L ++ L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+ + AKG+A+L + +H D+ N+LL K+ DFGLA+ + + Y
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--NY 201
Query: 563 TTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
L APE I N + +SDV+SYG+ L E+
Sbjct: 202 V--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 40/227 (17%)
Query: 406 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHV 457
+ +G+G FG V+ P VAVK L E+ + +F E ++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSL--------------------DKWIFNSTEESRF 497
++VKL G C G L +EY+ G L S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 498 LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557
L + IA A G+AYL E K VH D+ N L+ +N K++DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 558 ESLVYTTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
+ Y + PE I N + +SDV++YG+VL EI
Sbjct: 228 D--YYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 409 KLGQGGFGSVYLGMLPD--------GIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HHV 457
LG+G FG V L +VAVK L ++ + + +E+ ++ + H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSL------------DKWIFNSTEESRFLCWNTRFN 505
+++ L G C + + EY G+L + S L +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 565
A A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + Y
Sbjct: 196 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--YYK-- 248
Query: 566 RGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
+ T G L APE + + + +SDV+S+G++L EI
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNV--HHVHLVKLK 463
++G GG V+ + A+K E+ Q + E+ + + H +++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ I + + E N L+ W+ ++ + + R + + + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-TTLRGTRGYLAPEWITNNP- 581
IVH D+KP N L+ D K+ DFG+A M + + V + GT Y+ PE I +
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 582 ----------ISEKSDVYSYGMVLLEIIGGR 602
IS KSDV+S G +L + G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 46/214 (21%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 406 FSTKLGQGGFGSVYLGML--------PDGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHH 456
F+ LGQG F ++ G+ +V +K L ++ + F +++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
HLV G C+ G +L E++ GSLD ++ + + + +A A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHF 128
Query: 517 LHEECEVKIVHCDIKPENVLLD--------DNFTAKVSDFGLAKLMNREESLVYTT--LR 566
L E ++H ++ +N+LL + K+SD G++ + ++ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIP 182
Query: 567 GTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEII 599
PE I N + +D +S+G L EI
Sbjct: 183 WV----PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVK 461
KLG GG +VYL D I +VA+K + + K+E EV + H ++V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 462 LKGFCIEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ E L EY + G +L ++I E L +T N G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEY-IEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITN 579
+IVH DIKP+N+L+D N T K+ DFG+AK ++ E SL T + GT Y +PE
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
E +D+YS G+VL E++ G F+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNV--HHVHLVKLK 463
++G GG V+ + A+K E+ Q + E+ + + H +++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ I + + E N L+ W+ ++ + + R + + + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWITNNP- 581
IVH D+KP N L+ D K+ DFG+A M + S+V + GT Y+ PE I +
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 582 ----------ISEKSDVYSYGMVLLEIIGGR 602
IS KSDV+S G +L + G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-30
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 25/207 (12%)
Query: 409 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKG 464
+ GG G +YL +G V +K L G + + AE + V H +V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 465 FCIEGAHRLLAYEYLV----NG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
F Y+V G SL + + L L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
+ +V+ D+KPEN++L + K+ D G +N L GT G+ APE +
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIVRT 251
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
P + +D+Y+ G L + + +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLPTRN 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK-KEFSAEVTIIGNVHHVHLVKLKGFCI 467
LG+G +G VY G L + +++A+K++ + E+ + ++ H ++V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 468 EGAHRLLAYEYLVNGSLD---KWIFNSTEESRFLCWNTRFNIALGTA---KGLAYLHEEC 521
E + E + GSL + + +++ I T +GL YLH+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-------IGFYTKQILEGLKYLHDN- 141
Query: 522 EVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
+IVH DIK +NVL++ + K+SDFG +K + T GT Y+APE I
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEIIDKG 198
Query: 581 PI--SEKSDVYSYGMVLLEIIGGRKSFS 606
P + +D++S G ++E+ G+ F
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFY 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 26/215 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKE---FSAEVTIIGNVHH--VHLVKLK 463
++G GG V+ + A+K + + + E+ + + +++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ I + + E N L+ W+ ++ + + R + + + +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWITNNP- 581
IVH D+KP N L+ D K+ DFG+A M + S+V + G Y+ PE I +
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 582 ----------ISEKSDVYSYGMVLLEIIGGRKSFS 606
IS KSDV+S G +L + G+ F
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G F VY + G++VA+K + G ++ EV I + H +++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWI------FNSTEESRFLCWNTRFNIALGTAKGLAY 516
E ++ + L E NG +++++ F+ E F+ G+ Y
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM---------HQIITGMLY 127
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
LH I+H D+ N+LL N K++DFGLA + YT GT Y++PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEI 183
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGR 602
T + +SDV+S G + ++ GR
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 39/227 (17%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA---EVTI-IGNVHHVHLV 460
LG G G+V G VAVK++ E+ + + H +++
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVI 72
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWI---FNSTEESRFLCWNTRFNIALGTAKGLAYL 517
+ +A E N +L + S E + ++ A G+A+L
Sbjct: 73 RYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 518 HEECEVKIVHCDIKPENVLLD-------------DNFTAKVSDFGLAKLMNREESLVYTT 564
H KI+H D+KP+N+L+ +N +SDFGL K ++ +S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 565 LR---GTRGYLAPEWITNN-------PISEKSDVYSYGMVLLEIIGG 601
L GT G+ APE + + ++ D++S G V I+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+GGF + A K L Q +K S E++I ++ H H+V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G E + + E SL + R+ G YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+++H D+K N+ L+++ K+ DFGLA + + GT Y+APE ++
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH 218
Query: 583 SEKSDVYSYGMVLLEIIGGR 602
S + DV+S G ++ ++ G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 32/238 (13%), Positives = 69/238 (28%), Gaps = 53/238 (22%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK--------KLESIGQGKKE----------------- 443
LGQ + G V +I Q K+E
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 444 ----FSAEVTIIGNVHHVHLVKLKG-FCIEGAHRLLAYEYLVNGSLD---KWIFNSTEES 495
F ++ + +++++ + +L + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555
+ L + R + L + LA LH +VH ++P +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 556 REESLVYTTLRGTRGYLAPEWITNN-----------PISEKSDVYSYGMVLLEIIGGR 602
+RG+ PE ++ D ++ G+V+ I
Sbjct: 258 A-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 20/211 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
KLG+GGF V L L DG A+K++ Q ++E E + +H ++++L +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 467 IE----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ L + G+L I ++ FL + + LG +GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT--------TLRGTRGYLAP 574
H D+KP N+LL D + D G R T Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 575 EWI---TNNPISEKSDVYSYGMVLLEIIGGR 602
E ++ I E++DV+S G VL ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+GGF + A K L Q +K S E++I ++ H H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGLAYLH 518
G E + + E SL + + E+R+ G YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--------YLRQIVLGCQYLH 132
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
+++H D+K N+ L+++ K+ DFGLA + + GT Y+APE ++
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 579 NNPISEKSDVYSYGMVLLEIIGGR 602
S + DV+S G ++ ++ G+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G FG+VYL +A+K +LE G + EV I ++ H ++++L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G+ A R+ L EY G++ + + + S+F T I A L+Y H +
Sbjct: 76 GY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITE-LANALSYCHSK-- 128
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+++H DIKPEN+LL K++DFG + S T L GT YL PE I
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
EK D++S G++ E + G+ F
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPF 207
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 26/207 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA---EVTIIGNV-HHVHLVKLKG 464
LG G G++ + D VAVK++ + FS EV ++ H ++++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ + +A E L +L +++ ++ + T GLA+LH
Sbjct: 86 TEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSL---N 138
Query: 525 IVHCDIKPENVLL-----DDNFTAKVSDFGLAKLMNREESLVY--TTLRGTRGYLAPEWI 577
IVH D+KP N+L+ A +SDFGL K + + + GT G++APE +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 578 ---TNNPISEKSDVYSYGMVLLEIIGG 601
+ D++S G V +I
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 410 LGQGGFGSVYLG-MLPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G FG+VYL + +A+K +LE G + E+ I ++ H +++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ R+ L E+ G L K + + RF + + A L Y HE
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEE-LADALHYCHER-- 133
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
K++H DIKPEN+L+ K++DFG + SL T+ GT YL PE I
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 583 SEKSDVYSYGMVLLEIIGGR 602
EK D++ G++ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKL--- 462
+LG GGFG V + G QVA+K + E + ++ + E+ I+ ++H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 463 ---KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
LLA EY G L K++ N E L + + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 520 ECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
+I+H D+KPEN++L K+ D G AK +++ E T GT YLAPE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAPEL 194
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGR 602
+ + D +S+G + E I G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 28/232 (12%), Positives = 61/232 (26%), Gaps = 42/232 (18%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKL--------ESIGQGKKEFSAEVTIIGNVHHVHLV 460
LGQ + G V +I Q K+E + G +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 461 KLKGFCI------------------EGAHRLLAYEYLV-------NGSLDKWIFNSTEES 495
F + + + + + + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555
+ L + R + L + LA LH +VH ++P +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 556 REESLVYTTLRGTRGYLAPEWITNNP-----ISEKSDVYSYGMVLLEIIGGR 602
A + ++ D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 36/219 (16%), Positives = 75/219 (34%), Gaps = 27/219 (12%)
Query: 409 KLGQGGFGSVYLGM------LPDGIQVAVKKLESIGQGKKEF---SAEVTIIGNVHHVHL 459
LG+G F VY + + +K + EF + + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMF 129
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSL-DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+K + +L E G+L + + + + A+ + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 519 EECEVKIVHCDIKPENVLL-----------DDNFTAKVSDFGLAKLMNR-EESLVYTTLR 566
+ +I+H DIKP+N +L D + + D G + M + ++T
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 567 GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
T G+ E ++N P + + D + + ++ G
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 23/211 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LGQG +V+ G G A+K S + E ++ ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 466 --CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
H++L E+ GSL + + L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 524 KIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
IVH +IKP N++ D K++DFG A+ + +E +L GT YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYER 189
Query: 580 NPI--------SEKSDVYSYGMVLLEIIGGR 602
+ D++S G+ G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVK 461
LG GG V+L D VAVK L + F E ++H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 462 L--KGFCIEGAHRLLAY---EYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
+ G E L Y EY V+G +L + + + + L
Sbjct: 77 VYDTG-EAETPAGPLPYIVMEY-VDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRGYLA 573
+ H+ I+H D+KP N+++ KV DFG+A+ + + V T + GT YL+
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 574 PEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
PE + + +SDVYS G VL E++ G F+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 20/207 (9%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTIIGNVHHVHLVK 461
+G+GG G VY D + VA+K + F E G + H+V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 462 LKGFCIEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ F + +NG L + L I L H
Sbjct: 99 IHDFGEIDGQLYVDMRL-INGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITN 579
H D+KPEN+L+ + A + DFG+A +E L GT Y+APE +
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + ++D+Y+ VL E + G +
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLE-SIGQGKKEFSA-----------------EVTI 450
L QG F + L D A+KK E S+ + K++F+ E+ I
Sbjct: 38 TLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 451 IGNVHHVHLVKLKGFCIEGAHRL-LAYEYLVNGSLDKWI-----FNSTEESRFLCWNTRF 504
I ++ + + + +G I + + YEY+ N S+ K+ + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564
I +Y+H E I H D+KP N+L+D N K+SDFG ++ M
Sbjct: 156 -IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 565 LRGTRGYLAPEWITNNPI--SEKSDVYSYGMVLLEIIGGR 602
RGT ++ PE+ +N K D++S G+ L +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 25/212 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LGQG +V+ G G A+K S + E ++ ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 466 CIEGAHRLLAY---EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
E E+ GSL + + L + + G+ +L E
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 523 VKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
IVH +IKP N++ D K++DFG A+ + +E +L GT YL P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYE 188
Query: 579 NNPI--------SEKSDVYSYGMVLLEIIGGR 602
+ D++S G+ G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKK--LESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+LG G G V+ P G+ +A K LE + + E+ ++ + ++V G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHE 519
+ E++ GSLD+ L R +++ KGL YL E
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ----------VLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
+ KI+H D+KP N+L++ K+ DFG++ + +S+ + + GTR Y++PE +
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQG 204
Query: 580 NPISEKSDVYSYGMVLLEIIGGR 602
S +SD++S G+ L+E+ GR
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNV-HHVHLVKLKGF 465
L +GGF VY + G + A+K+L S + + EV + + H ++V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 466 CIEGAHRLLA--YEYLV-----NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
G E+L+ G L +++ C I T + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----------TLRG 567
+ I+H D+K EN+LL + T K+ DFG A ++ ++ T
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 568 TRGYLAPEWI---TNNPISEKSDVYSYGMVLLEIIGGRKSF 605
T Y PE I +N PI EK D+++ G +L + + F
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 21/228 (9%), Positives = 51/228 (22%), Gaps = 42/228 (18%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
L G V+L + A+K E+ + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 465 FC----------IEG----------------AHRLLAYEYLV--NGSLDKWIFNSTEESR 496
++ A+ LL L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 497 FLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556
+ + A L + +VH P+N+ + + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL----W 242
Query: 557 EESLVYTTLRGTRGYLAPEWIT--NNPISEKSDVYSYGMVLLEIIGGR 602
+ Y E++ + + + G+ + +
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKGFC 466
K+G+G G V L G QVAVK ++ Q ++E EV I+ + H ++V++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHEE 520
+ G + E+L G+L + R N + + LAYLH +
Sbjct: 112 LVGEELWVLMEFLQGGALTD-----------IVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 576
++H DIK +++LL + K+SDFG ++K + + +SLV GT ++APE
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEV 212
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGG 601
I+ + + + D++S G++++E++ G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKGFC 466
K+GQG G+VY M + G +VA++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLHEE 520
+ G + EYL GSL + T + + + L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 576
+++H DIK +N+LL + + K++DFG + ++ ++V GT ++APE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEV 187
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGG 601
+T K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 23/196 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKGFC 466
LG G F V+L G A+K ++ + E+ ++ + H ++V L+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKGLAYLHEECE 522
H L + + G L I TE ++ + + YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV--------LSAVKYLHEN-- 125
Query: 523 VKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
IVH D+KPEN+L ++N ++DFGL+K+ + +T GT GY+APE +
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQ 181
Query: 580 NPISEKSDVYSYGMVL 595
P S+ D +S G++
Sbjct: 182 KPYSKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTII-GNVHHVHLVKLKG 464
+LG+G +G V +P G +AVK+ Q +K ++ I V V G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ E + + SLDK+ ++ + + + IA+ K L +LH + +
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPEWITNNPI- 582
++H D+KP NVL++ K+ DFG+ L++ + G + Y+APE I
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQ 187
Query: 583 ---SEKSDVYSYGMVLLEIIGGR 602
S KSD++S G+ ++E+ R
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTIIGNV 454
S LG G G V L +VA++ K + + + E+ I+ +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGT 510
+H ++K+K F + + E + G L + + E + +
Sbjct: 198 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-------- 248
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
+ YLHE I+H D+KPENVLL +++ K++DFG +K++ E+ + TL G
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 568 TRGYLAPEWITNN---PISEKSDVYSYGMVL 595
T YLAPE + + + D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTII-GNVHHVHLVKLKG 464
++G+G +GSV + P G +AVK+ + +K+ ++ ++ + ++V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLH 518
+ E + + S DK+ + + + I L T K L +L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFY-----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPEWI 577
E +KI+H DIKP N+LLD + K+ DFG+ +L++ S+ T G R Y+APE I
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERI 197
Query: 578 TNNPI----SEKSDVYSYGMVLLEIIGGR 602
+ +SDV+S G+ L E+ GR
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 31/208 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-----KLESI-GQGKKEFSAEVTIIGNVHHVHLVK 461
+G+G F V + G Q AVK K S G ++ E +I + H H+V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 462 LKGFCIEGAHRLLAYEYLVNGSL-------DKWIFNSTE-ESRFLCWNTRFNIALGTAKG 513
L + +E++ L F +E + +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI--------LEA 142
Query: 514 LAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
L Y H+ I+H D+KP VLL +++ K+ FG+A + E LV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPH 198
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLLEI 598
++APE + P + DV+ G V+L I
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCG-VILFI 225
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+LG+G F V + G++ A K + + ++ E I + H ++V+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGLAYLHEE 520
E + L ++ + G L + I S ++ + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--------LESIAYCHSN 124
Query: 521 CEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
IVH ++KPEN+LL K++DFGLA + +S + GT GYL+PE +
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVL 179
Query: 578 TNNPISEKSDVYSYGMVL 595
+P S+ D+++ G++L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 401 KATKNFSTK------LGQGGFGSVYLGM-LPDGIQVAVK----------KLESIGQGKKE 443
+T F LG+G V + P + AVK E + + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 444 FSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFL 498
EV I+ V H ++++LK L ++ + G L ++ S +E+R +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 499 CWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558
+ + LH+ IVH D+KPEN+LLDD+ K++DFG + ++ E
Sbjct: 130 MRAL--------LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 559 SLVYTTLRGTRGYLAPE------WITNNPISEKSDVYSYGMVL 595
+ GT YLAPE + ++ D++S G+++
Sbjct: 179 --KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 47/244 (19%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 421
HH+ R + Q E Y N LG+G FG V
Sbjct: 5 HHHSSGRENLYFQGTFAERY----------------------NIVCMLGKGSFGEVLKCK 42
Query: 422 MLPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478
+ AVK K + + EV ++ + H +++KL + + + E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 479 LVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534
G L I S ++ + G+ Y+H+ IVH D+KPEN
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQV--------FSGITYMHKH---NIVHRDLKPEN 151
Query: 535 VLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 591
+LL + + K+ DFGL+ +++ GT Y+APE + EK DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSA 208
Query: 592 GMVL 595
G++L
Sbjct: 209 GVIL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTIIGNV 454
S LG G G V L +VA+K K + + + E+ I+ +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGT 510
+H ++K+K F + + E + G L + + E + + +
Sbjct: 73 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQML--- 124
Query: 511 AKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
+ YLHE I+H D+KPENVLL +++ K++DFG +K++ E+ + TL G
Sbjct: 125 -LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 568 TRGYLAPEWITNN---PISEKSDVYSYGMVL 595
T YLAPE + + + D +S G++L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 60/242 (24%), Positives = 93/242 (38%), Gaps = 43/242 (17%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 421
HH+ R + Q E Y N LG+G FG V
Sbjct: 5 HHHSSGRENLYFQGTFAERY----------------------NIVCMLGKGSFGEVLKCK 42
Query: 422 MLPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478
+ AVK K + + EV ++ + H +++KL + + + E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 479 LVNGSLDKWIFNSTEESRFLCWNTR--FNIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536
G L I + RF + I G+ Y+H+ IVH D+KPEN+L
Sbjct: 103 YTGGELFDEI---IKRKRF---SEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENIL 153
Query: 537 L---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGM 593
L + + K+ DFGL+ + + GT Y+APE + EK DV+S G+
Sbjct: 154 LESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
Query: 594 VL 595
+L
Sbjct: 211 IL 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 406 FSTKLGQGGFGSVYLG-MLPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVK 461
KLG G +G V L ++ A+K K + EV ++ + H +++K
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L F + + L E G L I +F + I G+ YLH+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAA-VIIKQVLSGVTYLHKH- 155
Query: 522 EVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
IVH D+KPEN+LL + + K+ DFGL+ + ++ + GT Y+APE +
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VL 210
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSF 605
EK DV+S G++L ++ G F
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTIIGNVHHVHLV 460
+LG G F V G++ A K + G ++E EV+I+ V H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L +L E + G L K + E + F+ I G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI----LDGVN 129
Query: 516 YLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
YLH + KI H D+KPEN++L K+ DFGLA + + + GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEF 184
Query: 572 LAPEWITNNPISEKSDVYSYGMVL 595
+APE + P+ ++D++S G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+LG+G F V + G++ A K + + ++ E I + H ++V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKGLAYLHEE 520
E + L ++ + G L + I +E ++ + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--------LESIAYCHSN 147
Query: 521 CEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
IVH ++KPEN+LL K++DFGLA + +S + GT GYL+PE +
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVL 202
Query: 578 TNNPISEKSDVYSYGMVL 595
+P S+ D+++ G++L
Sbjct: 203 KKDPYSKPVDIWACGVIL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTIIGNVHHVHLV 460
+LG G F V G++ A K + G ++E EV+I+ V H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L +L E + G L K + E + F+ I G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI----LDGVN 129
Query: 516 YLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
YLH + KI H D+KPEN++L K+ DFGLA + + + GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEF 184
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
+APE + P+ ++D++S G V+ I
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VITYI 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 35/137 (25%), Positives = 65/137 (47%), Gaps = 21/137 (15%)
Query: 477 EYLVNGSLDKWI---FNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPE 533
+ +L W+ + + +C + I + A+ + +LH + ++H D+KP
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLH----IFIQIAEAVEFLHSK---GLMHRDLKPS 193
Query: 534 NVLLDDNFTAKVSDFGLAKLMNREESL-----------VYTTLRGTRGYLAPEWITNNPI 582
N+ + KV DFGL M+++E +T GT+ Y++PE I N
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 583 SEKSDVYSYGMVLLEII 599
S K D++S G++L E++
Sbjct: 254 SHKVDIFSLGLILFELL 270
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 55/255 (21%), Positives = 102/255 (40%), Gaps = 36/255 (14%)
Query: 360 GLWHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFST------KLGQG 413
G HH+ + + + + + + + + ++ + + +LG G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 414 GFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471
FG V+ + G K + K E++I+ +HH L+ L +
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122
Query: 472 RLLAYEYLVNGSL-DKWI---FNSTEES-----RFLCWNTRFNIALGTAKGLAYLHEECE 522
+L E+L G L D+ + +E R C GL ++HE
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE------------GLKHMHEH-- 168
Query: 523 VKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
IVH DIKPEN++ + + K+ DFGLA +N +E + T + APE +
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDRE 225
Query: 581 PISEKSDVYSYGMVL 595
P+ +D+++ G++
Sbjct: 226 PVGFYTDMWAIGVLG 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 48/246 (19%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 421
HH+ R + Q +++ + F KLG G FG V+L
Sbjct: 5 HHHSSGRENLYFQGTIDDLF----------------------IFKRKLGSGAFGDVHLVE 42
Query: 422 MLPDGIQVAVKKLE--SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479
G++ +K + ++ AE+ ++ ++ H +++K+ + + + E
Sbjct: 43 ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102
Query: 480 VNGSL-DKWIFNSTEESRF------LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532
G L ++ + N LAY H + +VH D+KP
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMN-------ALAYFHSQ---HVVHKDLKP 152
Query: 533 ENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 589
EN+L + K+ DFGLA+L + T GT Y+APE + ++ K D++
Sbjct: 153 ENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIW 209
Query: 590 SYGMVL 595
S G+V+
Sbjct: 210 SAGVVM 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 46/198 (23%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+LG+G F V + + G + A + + ++ E I + H ++V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKGLAYLHEE 520
E H L ++ + G L + I +E ++ + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI--------LEAVLHCHQM 129
Query: 521 CEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
+VH ++KPEN+LL K++DFGLA + E+ + GT GYL+PE +
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVL 185
Query: 578 TNNPISEKSDVYSYGMVL 595
+P + D+++ G++L
Sbjct: 186 RKDPYGKPVDLWACGVIL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 32/207 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTIIGNVHHVHLV 460
+LG G F V G + A K G ++E EV I+ + H +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L +L E + G L +K E ++FL I G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QIL----DGVH 122
Query: 516 YLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
YLH + +I H D+KPEN++L N K+ DFG+A + + GT +
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEF 177
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
+APE + P+ ++D++S G V+ I
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG-VITYI 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 405 NFSTKLGQGGFGSVYLG-MLPDGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHL 459
LG+G FG V L G + AVK + K+ EV ++ + H ++
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
+KL F + + L E G L F+ + I G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 520 ECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
KIVH D+KPEN+LL + ++ DFGL+ + + GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE- 198
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ + EK DV+S G++L ++ G F
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPF 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 36/206 (17%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTIIGNV-HHVHLVKLK 463
+LG+G F V + G + A K K + E E+ ++ ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 464 GFCIEGAHRLLAYEYLVNGSL-----DKWIFNSTEES-----RFLCWNTRFNIALGTAKG 513
+ +L EY G + + +E + + +G
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL------------EG 143
Query: 514 LAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
+ YLH+ IVH D+KP+N+LL K+ DFG+++ + + + GT
Sbjct: 144 VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPE 198
Query: 571 YLAPEWITNNPISEKSDVYSYGMVLL 596
YLAPE + +PI+ +D+++ G ++
Sbjct: 199 YLAPEILNYDPITTATDMWNIG-IIA 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 50/237 (21%)
Query: 369 RLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGI 427
R+ Q + Y + + LG G FG V+ G+
Sbjct: 76 RIVTAKQGAVNSFYTVSK--------------------TEILGGGRFGQVHKCEETATGL 115
Query: 428 QVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL-D 485
++A K +++ G + K+E E++++ + H +L++L +L EY+ G L D
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 486 KWI---FNSTEES-----RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537
+ I +N TE + +C G+ ++H+ I+H D+KPEN+L
Sbjct: 176 RIIDESYNLTELDTILFMKQICE------------GIRHMHQM---YILHLDLKPENILC 220
Query: 538 DDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYG 592
+ K+ DFGLA+ E L GT +LAPE + + +S +D++S G
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIG-NVHHVHLVKL 462
+G G + + ++ AVK I + K++ + E+ I+ H +++ L
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTEEIEILLRYGQHPNIITL 81
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKGLAYLH 518
K +G + + E + G L I +E E+ + + K + YLH
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI--------TKTVEYLH 133
Query: 519 EECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 574
+ +VH D+KP N+L + + ++ DFG AK + E L+ T T ++AP
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAP 189
Query: 575 EWITNNPISEKSDVYSYGMVL 595
E + D++S G++L
Sbjct: 190 EVLERQGYDAACDIWSLGVLL 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK---------KLESIGQGKKEFSAEVTIIGNVH-HV 457
+G+G V + G + AVK E + + ++ E I+ V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKG 513
H++ L + L ++ + G L ++ +E E+R + ++ +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM----RSLL----EA 212
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
+++LH IVH D+KPEN+LLDDN ++SDFG + + E L GT GYLA
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLA 267
Query: 574 PE------WITNNPISEKSDVYSYGMVL 595
PE T+ ++ D+++ G++L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 30/202 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
LG+G FG V+ + K ++ G + E++I+ H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 468 EGAHRLLAYEYLVNGSL-DKWI---FNSTEES-----RFLCWNTRFNIALGTAKGLAYLH 518
++ +E++ + ++ F E +C L +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------------ALQFLH 119
Query: 519 EECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
I H DI+PEN++ ++ K+ +FG A+ + + + L Y APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEV 174
Query: 577 ITNNPISEKSDVYSYGMVLLEI 598
++ +S +D++S G L+ +
Sbjct: 175 HQHDVVSTATDMWSLG-TLVYV 195
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
K+G+G FG V+ G+ VA+K LE ++ E+T++ ++ K G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNST-EESRFLCWNTRFNIAL---GTAKGLAYLHEEC 521
++ + EYL GS + +E++ IA KGL YLH E
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREILKGLDYLHSE- 138
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
K +H DIK NVLL ++ K++DFG+A + + T GT ++APE I +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA 195
Query: 582 ISEKSDVYSYGMVLLEIIGG 601
K+D++S G+ +E+ G
Sbjct: 196 YDSKADIWSLGITAIELARG 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 408 TKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
KLG+G +GSVY + G VA+K++ + +E E++I+ H+VK G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 467 IEGAHRLLAYEYLVNGSLD---KWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLHEE 520
+ + EY GS+ + + E IA T KGL YLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLHFM 144
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 576
+ +H DIK N+LL+ AK++DFG L M + +++ GT ++APE
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEV 196
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGG 601
I + +D++S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTIIGNVHHVHLV 460
+LG G F V G+Q A K K G +++ EV+I+ + H +++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
L +L E + G L +K E + FL I G+
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QIL----NGVY 128
Query: 516 YLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
YLH +I H D+KPEN++L K+ DFGLA ++ + + GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEF 183
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
+APE + P+ ++D++S G V+ I
Sbjct: 184 VAPEIVNYEPLGLEADMWSIG-VITYI 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G +G V + + AVK KL I G+ E+ ++ + H ++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 464 GFCIEGAHRLLAY---EYLVNGSLDKWIFNSTEESRFLCWNTR--FN--IALGTAKGLAY 516
+ + Y EY V G + + +S E RF F I GL Y
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID-----GLEY 124
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN--REESLVYTTLRGTRGYLAP 574
LH + IVH DIKP N+LL T K+S G+A+ ++ + T+ +G+ + P
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180
Query: 575 EWITNNPISE--KSDVYSYGMVLLEIIGGRKSF 605
E K D++S G+ L I G F
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 45/209 (21%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTIIGN-VHHVHLVKLKG 464
++G G G V+ G +AVK+ + K ++ ++ ++V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN------IALGTAKGLAYLH 518
I +A E + +K + + K L YL
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLK---------KRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
E+ ++H D+KP N+LLD+ K+ DFG++ + + G Y+APE I
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERID 197
Query: 579 NNPISE-----KSDVYSYGMVLLEIIGGR 602
++ ++DV+S G+ L+E+ G+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 31/204 (15%)
Query: 405 NFSTKLGQGGFGSVYLG-MLPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVH 458
+G+G +G V + I+ A K +E F E+ I+ ++ H +
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPN 67
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGL 514
+++L + L E G L + + + ++ + + +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV--------LSAV 119
Query: 515 AYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
AY H+ + H D+KPEN L + K+ DFGLA + + T GT Y
Sbjct: 120 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYY 174
Query: 572 LAPEWITNNPISEKSDVYSYGMVL 595
++P+ + + D +S G+++
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 33/212 (15%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----------KLESIGQGKKEFSAEVTIIGNVHHV 457
LG+GGFG+V+ G L D +QVA+K L E + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGS--LDKWIFN---STEESRFLCWNTRFNIALGTAK 512
+++L + +L E + D SR
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV--------VA 150
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+ + H +VH DIK EN+L+D AK+ DFG L++ E YT GTR Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVY 204
Query: 572 LAPEWITNNP-ISEKSDVYSYGMVLLEIIGGR 602
PEWI+ + + + V+S G++L +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
+LG+G VY A+K L KK E+ ++ + H +++KLK
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNS---TE-ESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
L E + G L I +E ++ + +AYLHE
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI--------LEAVAYLHEN--- 167
Query: 524 KIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
IVH D+KPEN+L + K++DFGL+K++ E ++ T+ GT GY APE +
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGC 225
Query: 581 PISEKSDVYSYGMVL 595
+ D++S G++
Sbjct: 226 AYGPEVDMWSVGIIT 240
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/198 (27%), Positives = 83/198 (41%), Gaps = 27/198 (13%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNV-HHVHLVKLKGF 465
LG+G F + AVK I + + E+T + H ++VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 466 CIEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ H L E L G L K F+ TE S I ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------IMRKLVSAVSHMHDV 125
Query: 521 CEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
+VH D+KPEN+L +DN K+ DFG A+L ++ T T Y APE +
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPELL 181
Query: 578 TNNPISEKSDVYSYGMVL 595
N E D++S G++L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 43/254 (16%)
Query: 363 HHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 421
HH+ + F + ++ G SY KLG G +G V L
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEG-KIGESYF--------KVRKLGSGAYGEVLLCK 56
Query: 422 MLPDGIQVAVK-----KLESIGQGKKEFSA---------EVTIIGNVHHVHLVKLKGFCI 467
+ A+K + + + E++++ ++ H +++KL
Sbjct: 57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT---AKGLAYLHEECEVK 524
+ + L E+ G L + I +F + A G+ YLH+
Sbjct: 117 DKKYFYLVTEFYEGGELFEQI---INRHKF----DECDAANIMKQILSGICYLHKH---N 166
Query: 525 IVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
IVH DIKPEN+LL + K+ DFGL+ +++ L GT Y+APE +
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKK 223
Query: 582 ISEKSDVYSYGMVL 595
+EK DV+S G+++
Sbjct: 224 YNEKCDVWSCGVIM 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 405 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+ +LG G FG V+ G A K + K+ E+ + + H LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 463 KGFCIEGAHRLLAYEYLVNGSL-DKWI---FNSTEES-----RFLCWNTRFNIALGTAKG 513
+ ++ YE++ G L +K +E+ R +C G
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK------------G 267
Query: 514 LAYLHEECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGY 571
L ++HE VH D+KPEN++ + K+ DFGL ++ ++S+ GT +
Sbjct: 268 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEF 322
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEI 598
APE P+ +D++S G VL I
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVG-VLSYI 348
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKGFC 466
+LG G FG VY G A K +E+ + + E + E+ I+ H ++VKL G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 467 IEGAHRLLAYEYLVNGSLD---KWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLHEE 520
+ E+ G++D + E + I + + L +LH +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVVCRQMLEALNFLHSK 136
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 576
+I+H D+K NVL+ +++DFG K + + +S + GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188
Query: 577 ITNNPISE-----KSDVYSYGMVLLEIIGG 601
+ + + K+D++S G+ L+E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 34/212 (16%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK------KLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG+G +G V L + VAVK ++ KKE + I ++H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 463 KGFCIEGAHRLLAYEYLVNGSL-DKWIFN---STEESRFLCWNTRFN--IALGTAKGLAY 516
G EG + L EY G L D+ + +++ F+ +A G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF-----FHQLMA-----GVVY 120
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 574
LH I H DIKPEN+LLD+ K+SDFGLA + N E L+ GT Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 575 EWITNNP-ISEKSDVYSYGMVLLEIIGGRKSF 605
E + +E DV+S G+VL ++ G +
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 56/237 (23%), Positives = 86/237 (36%), Gaps = 53/237 (22%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKE-FSAEVTIIGNVHHVHLVK 461
+GQG +G V + + A+K K+ I E EV ++ +HH ++ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 462 LKGFCIEGAHRLLAYEYLVNGSL-DKWIFNSTEESRFLCWNTRFNIALGTAK-------- 512
L + + L E G L DK + + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 513 ---------------------------GLAYLHEECEVKIVHCDIKPENVLL--DDNFTA 543
L YLH + I H DIKPEN L + +F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 544 KVSDFGLAKLMNR---EESLVYTTLRGTRGYLAPEWI--TNNPISEKSDVYSYGMVL 595
K+ DFGL+K + E TT GT ++APE + TN K D +S G++L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V+ + ++ A KKL + + + K A E I+ VH +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTE-ESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ E L L + G + I+N E F F A GL +LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQR-- 308
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I++ D+KPENVLLDD+ ++SD GLA + ++ GT G++APE +
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-KGYAGTPGFMAPELLLGEEY 366
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D ++ G+ L E+I R F
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 410 LGQGGFGSVYLG-MLPDGIQVAVKKL--ESIGQGKKE--FSAEVTIIGNVHHVHLVKLKG 464
LG+G F +V L L + A+K L I + K + E ++ + H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEECE 522
F + +L Y NG L K+I + F TRF A + +A L YLH +
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSA--LEYLHGK-- 149
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNP 581
I+H D+KPEN+LL+++ +++DFG AK+++ E + GT Y++PE +T
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 582 ISEKSDVYSYGMVLLEIIGGR 602
+ SD+++ G ++ +++ G
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+G G V P +VA+K LE E E+ + HH ++V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFN---IAL---GTAKGLAYLHE 519
+ L + L GS+ I ++ + + IA +GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPE 575
+H D+K N+LL ++ + +++DFG LA + + V T GT ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 576 WIT-NNPISEKSDVYSYGMVLLEIIGGR 602
+ K+D++S+G+ +E+ G
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVK----- 461
+G G +G VY G + G A+K ++ G ++E E+ ++ HH ++
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 462 LKGFCIEGAHRL-LAYEYLVNGSL-DKWIFNSTEESRFLCWNTRFNIAL---GTAKGLAY 516
+K +L L E+ GS+ D + +T+ + IA +GL++
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTL----KEEWIAYICREILRGLSH 144
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
LH+ K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEV 200
Query: 577 ITNNPISE-----KSDVYSYGMVLLEIIGG 601
I + + KSD++S G+ +E+ G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLK 463
++G G FG+VY + + VA+KK+ G+ E EV + + H + ++ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 464 GFCIEGAHRLLAYEYLVNGSLD--KWIFNSTEESRFLCWNTRFNIAL---GTAKGLAYLH 518
G + L EY + + D + +E IA G +GLAYLH
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYLH 171
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
++H D+K N+LL + K+ DFG A +M S V GT ++APE I
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 579 N---NPISEKSDVYSYGMVLLEIIGG 601
K DV+S G+ +E+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTIIGNVHHVHL 459
LG G FG V+ + +V VK K+ + E+ I+ V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 460 VKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK------ 512
+K+ E L E +G LD +F F+ + R + L +
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-LD--LFA------FIDRHPRLDEPLASYIFRQLVS 141
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 572
+ YL + I+H DIK EN+++ ++FT K+ DFG A + R + T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYC 196
Query: 573 APEWITNNP-ISEKSDVYSYGMVL 595
APE + NP + +++S G+ L
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTL 220
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 37/206 (17%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA--EVTIIGNVHHV--HL 459
LG GGFGSVY G+ + D + VA+K ++ G+ EV ++ V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 460 VKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN--------STEESRFLCWNTRFNIALGTA 511
++L + +L E D +F+ E +R W
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQV--------L 159
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYTTLRGTRG 570
+ + + H ++H DIK EN+L+D N K+ DFG L+ VYT GTR
Sbjct: 160 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 213
Query: 571 YLAPEWITNNP-ISEKSDVYSYGMVL 595
Y PEWI + + V+S G++L
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 34/202 (16%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK------KLESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
LG+G +G V L + VAVK ++ KKE + I ++H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 463 KGFCIEGAHRLLAYEYLVNGSL-DKWIFN---STEESRFLCWNTRFN--IALGTAKGLAY 516
G EG + L EY G L D+ + +++ F+ +A G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF-----FHQLMA-----GVVY 120
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 574
LH I H DIKPEN+LLD+ K+SDFGLA + N E L+ GT Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 575 EWITNNP-ISEKSDVYSYGMVL 595
E + +E DV+S G+VL
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFSA--EVTIIGNVHHVHLVKLKG 464
LG+GGFG V + ++ A KKL + I + K E A E I+ V+ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTE----ESRFLCWNTRFNIALGTAKGLAYLHE 519
+ E L L + G L I++ + E+R F A GL LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-----AVFYAA-EICCGLEDLHR 304
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
E +IV+ D+KPEN+LLDD+ ++SD GLA + +++ GT GY+APE + N
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKN 359
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
+ D ++ G +L E+I G+ F
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPF 385
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 30/199 (15%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
+G+G F V L + G +VA+K +L K EV I+ ++H ++VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKL- 79
Query: 464 GF-CIEGAHRL-LAYEYLVNGSL-DKWIFN---STEESRFLCWNTRFNIALGTAKGLAYL 517
F IE L L EY G + D + + +E+R + Y
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI--------VSAVQYC 130
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
H++ IVH D+K EN+LLD + K++DFG + L G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELF 185
Query: 578 TNNP-ISEKSDVYSYGMVL 595
+ DV+S G++L
Sbjct: 186 QGKKYDGPEVDVWSLGVIL 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 50/223 (22%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----------------- 446
+G+G +G V L D A+K KL +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 447 -----EVTIIGNVHHVHLVKLKGFCIEGAHRLLAY---EYLVNGSLDKWIFN---STEES 495
E+ I+ + H ++VKL ++ + Y E + G + + S +++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 496 RFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555
RF ++ G+ YLH + KI+H DIKP N+L+ ++ K++DFG++
Sbjct: 140 RFYFQ----DLIK----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 556 REESLVYTTLRGTRGYLAPEWITNNPIS---EKSDVYSYGMVL 595
++L+ T GT ++APE ++ + DV++ G+ L
Sbjct: 189 GSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+G G FG L VAVK +E + E+ ++ H ++V+ K +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 469 GAHRLLAYEYLVNGSLDKWIFN----STEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
H + EY G L + I N S +E+RF ++ G++Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---LS-----GVSYCHSM---Q 136
Query: 525 IVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP- 581
I H D+K EN LLD + K+ DFG +K S +T+ GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVLLRQEY 194
Query: 582 ISEKSDVYSYGMVL 595
+ +DV+S G+ L
Sbjct: 195 DGKIADVWSCGVTL 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-20
Identities = 42/219 (19%), Positives = 75/219 (34%), Gaps = 33/219 (15%)
Query: 409 KLGQG--GFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTIIGNVHHVHLVKL 462
+G+G +V L P G V V+++ + + E+ + +H ++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 463 KGFCIEGAHRLLAYEYLVNGSLD---KWIFNST-EESRFLCWNTRFNIAL---GTAKGLA 515
+ I + ++ GS F E IA G K L
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKALD 142
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLR--GTR 569
Y+H VH +K ++L+ + +S + R+ +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 570 GYLAPEWITNNPI--SEKSDVYSYGMVLLEIIGGRKSFS 606
+L+PE + N KSD+YS G+ E+ G F
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 4e-20
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKLE--SIGQGKKEFSA--EVTIIGNVHHVH---LVK 461
+G+GGFG VY D ++ A+K L+ I + E A E ++ V +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 462 LKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ + +L + + G L + F + RF A GL ++H
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAA-EIILGLEHMHNR 311
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
+V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+APE +
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 365
Query: 581 PISEKS-DVYSYGMVLLEIIGGRKSF 605
+ S D +S G +L +++ G F
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG G FG V +G G +VAVK K+ S+ K E+ + H H++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 464 GFCIEGAHRL-LAYEYLVNGSL-DKWIFN---STEESRFLCWNTRFNIALGTAKGLAYLH 518
I + EY+ G L D + E+R L ++ + Y H
Sbjct: 78 Q-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LS-----AVDYCH 128
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
+VH D+KPENVLLD + AK++DFGL+ +M+ E L T G+ Y APE I+
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 183
Query: 579 NNP-ISEKSDVYSYGMVLLEIIGGR 602
+ D++S G++L ++ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 46/202 (22%), Positives = 74/202 (36%), Gaps = 33/202 (16%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466
LG G G V G + A+K L + EV H+V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 467 IEGAHRLLAY----EYLVNGSL-----DKWIFNSTE-ESRFLCWNTRFNIALGTAKGLAY 516
H E + G L ++ TE E+ + +I + +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM----RDIG----TAIQF 143
Query: 517 LHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 573
LH I H D+KPEN+L + + K++DFG AK + T T Y+A
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVA 197
Query: 574 PEWITNNPISEKSDVYSYGMVL 595
PE + + D++S G+++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 54/209 (25%), Positives = 81/209 (38%), Gaps = 35/209 (16%)
Query: 406 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLK 463
S LG G G V + A+K L+ + EV + H+V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 121
Query: 464 GFCIEGAHRLLAYEYLV-----NGSL-----DKWIFNSTE-ESRFLCWNTRFNIALGTAK 512
E + +V G L D+ TE E+ + +I +
Sbjct: 122 DVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM----KSIG----E 172
Query: 513 GLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 569
+ YLH I H D+KPEN+L N K++DFG AK SL TT T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTP 227
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEI 598
Y+APE + + D++S G V++ I
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLG-VIMYI 255
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G FG V L +VA+K L+ + E++ + + H H++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK------GLAY 516
I + + EY G L F+ ++ R G + Y
Sbjct: 76 DV-ITTPTDIVMVIEY-AGGEL----FD------YIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
H KIVH D+KPEN+LLDDN K++DFGL+ +M L T G+ Y APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEV 178
Query: 577 ITNNP-ISEKSDVYSYGMVLLEIIGGR 602
I + DV+S G+VL ++ GR
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKE---FSAEVTIIGNVHHVHLVKLK 463
+G+G FG V + L + +V A+K L + + + E F E ++ N + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLH 140
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEEC 521
+ + + L L +Y V G L + S E R RF +A + A + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIA--IDSVHQ-- 193
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+ VH DIKP+N+L+D N +++DFG + + ++ + GT Y++PE +
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 582 ISEKS-----DVYSYGMVLLEIIGGRKSF 605
+ D +S G+ + E++ G F
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLVKLK 463
+G+G FG V + D ++ A+K + + + + E E+ I+ + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEEC 521
+ + + + + L+ G L ++ + F + I L A L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEETVKLFICELVMA--LDYLQNQ- 134
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+I+H D+KP+N+LLD++ ++DF +A ++ RE + TT+ GT+ Y+APE ++
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRK 190
Query: 582 ISEKS---DVYSYGMVLLEIIGGRKSF 605
+ S D +S G+ E++ GR+ +
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPY 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKE---FSAEVTIIGNVHHVHLVKLK 463
+G+G F V + + QV A+K + + + + E F E ++ N + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLH 127
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
F + + L L EY V G L + S R RF +A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLA-EIVMAIDSVHR--- 180
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+ VH DIKP+N+LLD +++DFG + + ++ GT YL+PE +
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 583 SEKSDVY-------SYGMVLLEIIGGRKSF 605
+ Y + G+ E+ G+ F
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 6e-19
Identities = 65/198 (32%), Positives = 95/198 (47%), Gaps = 27/198 (13%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG G FG V +G G +VAVK K+ S+ K E+ + H H++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 464 GFCIEGAHRL-LAYEYLVNGSL-DKWIFN---STEESRFLCWNTRFNIALGTAKGLAYLH 518
I + + EY+ G L D N +ESR L ++ G+ Y H
Sbjct: 83 QV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LS-----GVDYCH 133
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
+VH D+KPENVLLD + AK++DFGL+ +M+ E L T G+ Y APE I+
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 188
Query: 579 NNP-ISEKSDVYSYGMVL 595
+ D++S G++L
Sbjct: 189 GRLYAGPEVDIWSSGVIL 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+G G FG V+ L + +VA+KK + Q K+ + E+ I+ V H ++V LK F
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 469 GAHRL------LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT---AKGLAYLHE 519
+ L EY V ++ + + + + + I L + LAY+H
Sbjct: 104 NGDKKDEVFLNLVLEY-VPETVYRASRHYAKLKQTM---PMLLIKLYMYQLLRSLAYIHS 159
Query: 520 ECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
+ I H DIKP+N+LLD + K+ DFG AK++ E + +R Y APE I
Sbjct: 160 ---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIF 214
Query: 579 NNPI-SEKSDVYSYGMVLLEIIGGR 602
+ D++S G V+ E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLVKLK 463
LG+G FG V L + A+K L E I K E + E ++ N H L LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ + RL EY G L F+ + E F RF A L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN 269
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+V+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPF 349
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 34/208 (16%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466
LG+G V + L + AVK +E G + EV ++ H ++++L F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 467 IEGAHRLLAYEYLVNGSL-----DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
E L +E + GS+ + FN E S + A L +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---------VVQDVASALDFLHNK- 130
Query: 522 EVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESL------VYTTLRGTRGYL 572
I H D+KPEN+L + K+ DF L + T G+ Y+
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 573 APE-----WITNNPISEKSDVYSYGMVL 595
APE + ++ D++S G++L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKE--FSAEVTIIGNVHHVHLVKLKG 464
+G+G FG V L +V A+K L + + F E I+ + +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 465 FCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ + L + EY+ G L N RF A L +H +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVL-ALDAIHS---M 187
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+H D+KP+N+LLD + K++DFG MN+E + T GT Y++PE + +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 584 EK----SDVYSYGMVLLEIIGGRKSF 605
D +S G+ L E++ G F
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG-FC 466
+G G FG VY L G VA+KK + Q K+ + E+ I+ + H ++V+L+ F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 467 IEGAHRLLAYEYLV----NGSLDKWIFNSTEESRFLCWNTRFNIALGT---AKGLAYLHE 519
G + Y LV ++ + + + + L + L + LAY+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYIHS 174
Query: 520 ECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWI 577
I H DIKP+N+LLD D K+ DFG AK + R E V Y +R Y APE I
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 228
Query: 578 TNNPI-SEKSDVYSYGMVLLEIIGGR 602
+ DV+S G VL E++ G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 31/220 (14%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV---------- 457
KLG G F +V+L + + VA+K + + E+ ++ V+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 458 -HLVKLKGF----CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAK 512
H++KL G H ++ +E L +L I E + I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVK-QISKQLLL 142
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDD------NFTAKVSDFGLAKLMNREESLVYTTLR 566
GL Y+H C I+H DIKPENVL++ K++D G A + +++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQ 197
Query: 567 GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
TR Y +PE + P +D++S ++ E+I G F
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 66/203 (32%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLVKLK 463
LG+G FG V L + A+K L E I K E + E ++ N H L LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ + RL EY G L F+ + E F RF A L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSR-- 124
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+V+ DIK EN++LD + K++DFGL K + T GT YLAPE + +N
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 12/116 (10%)
Query: 489 FNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 548
FL + AKG+ +L K +H D+ N+LL + K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF 237
Query: 549 GLAKLMNREESLVYTTLRGTRGYL-----APEWITNNPISEKSDVYSYGMVLLEII 599
GLA+ + ++ Y R L APE I + + +SDV+S+G++L EI
Sbjct: 238 GLARDIYKDP--DYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 33/164 (20%), Positives = 61/164 (37%), Gaps = 21/164 (12%)
Query: 406 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HH 456
LG+G FG V VAVK L + + +E+ I+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 457 VHLVKLKGFCIEGAHRLLA-YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA 515
+++V L G C + L+ E+ G+L ++ + R KG
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGAR 134
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559
+ + V + D+K + + ++ S F K ++ E
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 410 LGQGGFGSVYL---GMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLV 460
LG+GG+G V+ + ++ A+K L I + K+ + AE I+ V H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 461 KLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLH 518
L + + +L L EYL G L E F+ F +A + A L +LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMA--LGHLH 138
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
++ I++ D+KPEN++L+ K++DFGL K + ++ +T GT Y+APE +
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILM 194
Query: 579 NNPISEKSDVYSYGMVLLEIIGGR 602
+ + D +S G ++ +++ G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLVKLK 463
LG G FG V+L + A+K L E + + K+ E ++ V H ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 464 GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLHE 519
+ A ++ + +Y+ G L + RF +F + L L YLH
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGEL---FSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHS 124
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 579
+ I++ D+KPEN+LLD N K++DFG AK V TL GT Y+APE ++
Sbjct: 125 K---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVST 177
Query: 580 NPISEKSDVYSYGMVLLEIIGGR 602
P ++ D +S+G+++ E++ G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGY 200
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 410 LGQGGFGSVYL---GMLPDGIQV-AVKKL--ESIGQGKKEFS-AEVTIIGNVHHVHLVKL 462
LGQG FG V+L D Q+ A+K L ++ + + E I+ V+H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYLHEE 520
+ + +L L ++L G L ++E F + +F +A L A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALA--LDHLHSL 145
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
I++ D+KPEN+LLD+ K++DFGL+K E Y+ GT Y+APE +
Sbjct: 146 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRR 201
Query: 581 PISEKSDVYSYGMVLLEIIGGR 602
++ +D +S+G+++ E++ G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 31/249 (12%)
Query: 367 RKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDG 426
+ K +ED+ + + D + LG G FG V L +
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF-----DRIKTLGTGSFGRVMLVKHKES 65
Query: 427 IQV-AVKKL--ESIGQGKKEFS---AEVTIIGNVHHVHLVKLKGFCIEGAHRL-LAYEYL 479
A+K L + + + K+ E I+ V+ LVKL+ F + L + EY+
Sbjct: 66 GNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYV 123
Query: 480 VNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536
G + + RF + RF I L YLH +++ D+KPEN+L
Sbjct: 124 AGGEM---FSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSL---DLIYRDLKPENLL 173
Query: 537 LDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLL 596
+D +V+DFG AK TL GT LAPE I + ++ D ++ G+++
Sbjct: 174 IDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 597 EIIGGRKSF 605
E+ G F
Sbjct: 230 EMAAGYPPF 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 73/261 (27%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTII-----GNVHHV---HL 459
KLG G F +V+L + VA+K ++S + E+ ++ + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 460 VKLKG-FCIEGA---HRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGL 514
V+L F I G H + +E L G L KWI S + I +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKS-NYQGLPLPCVKK-IIQQVLQGL 159
Query: 515 AYLHEECEVKIVHCDIKPENVLL------------------------------------- 537
YLH +C +I+H DIKPEN+LL
Sbjct: 160 DYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 538 ------------DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
+ K++D G A +++ +T TR Y + E + + +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 586 SDVYSYGMVLLEIIGGRKSFS 606
+D++S + E+ G F
Sbjct: 274 ADIWSTACMAFELATGDYLFE 294
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 21/205 (10%), Positives = 50/205 (24%), Gaps = 46/205 (22%)
Query: 409 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVK 461
G + + D QVA+ ++ G +E + + + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ A L+ E++ GSL + ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTS-PSPVGAIRAMQSLAAAADAAHRA- 148
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
+ P V + + ++ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------ 179
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + D+ G L ++ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLP 203
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 70/204 (34%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIG-NVHHVHLVKL 462
+G+G FG V L AVK L ++I + KKE +E ++ NV H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLH 518
F + A +L +Y+ G L ++ E FL RF IA L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASA----LGYLH 156
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
IV+ D+KPEN+LLD ++DFGL K N E + +T GT YLAPE +
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 579 NNPISEKSDVYSYGMVLLEIIGGR 602
P D + G VL E++ G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 410 LGQGGFGSVYL---GMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNV-HHVHL 459
LG G +G V+L D ++ A+K L +I Q K E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 460 VKLKGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA-LGTAKGLAYL 517
V L + + +L L +Y+ G L + ++ RF + + + A L +L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLA--LEHL 175
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
H+ I++ DIK EN+LLD N ++DFGL+K +E+ GT Y+AP+ +
Sbjct: 176 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 578 TNNPISEKSDV--YSYGMVLLEIIGGRKSF 605
V +S G+++ E++ G F
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPF 262
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 33/257 (12%)
Query: 362 WHHNKRKRLTKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG 421
+ K + TK +E +G R D NF LG+G FG V L
Sbjct: 306 FERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDF-----NFLMVLGKGSFGKVMLS 360
Query: 422 MLPDGIQV-AVKKLESIGQGKKEF----------SAEVTIIGNV-HHVHLVKLKGFCIEG 469
++ AVK L KK+ E ++ L +L C +
Sbjct: 361 ERKGTDELYAVKIL------KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQT 413
Query: 470 AHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
RL EY+ G L +++ + RF + F A A GL +L + I++
Sbjct: 414 MDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSK---GIIYR 466
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 588
D+K +NV+LD K++DFG+ K N + + T GT Y+APE I P + D
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 589 YSYGMVLLEIIGGRKSF 605
+++G++L E++ G+ F
Sbjct: 526 WAFGVLLYEMLAGQAPF 542
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 409 KLGQGGFGSVYLGML-PDGIQVAVKK-LESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
GQG FG+V LG G+ VA+KK ++ +E + + +HH ++V+L+ +
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 467 IEGAHRLLA--YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALG----------TAKGL 514
R Y +V + R R +A + +
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP------DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 515 AYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYL 572
LH V + H DIKP NVL++ + T K+ DFG AK ++ E V Y +R Y
Sbjct: 143 GCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC---SRYYR 198
Query: 573 APEWITNNPI-SEKSDVYSYGMVLLEIIGGR 602
APE I N + D++S G + E++ G
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNV-HHVHLVKL 462
+G+G + V L L ++ A+K + E + ++ E + +H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLH 518
C + RL EY+ G L +F+ + + + RF I+L L YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA----LNYLH 127
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
E I++ D+K +NVLLD K++D+G+ K +T GT Y+APE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILR 183
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSFS 606
D ++ G+++ E++ GR F
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFD 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNV-HHVHLVKL 462
LG+G FG V L ++ AVK L + + Q + E ++ L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
C + RL EY+ G L +++ + RF + F A A GL +L +
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSK- 140
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
I++ D+K +NV+LD K++DFG+ K N + + T GT Y+APE I P
Sbjct: 141 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQP 197
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D +++G++L E++ G+ F
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPF 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIG-NVHHVHLVKL 462
LG+G FG V+L Q A+K L + + + E ++ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
+ L EYL G L +++ +F F A GL +LH +
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA-EIILGLQFLHSK- 137
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
IV+ D+K +N+LLD + K++DFG+ K N T GT Y+APE +
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAPEILLGQK 194
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D +S+G++L E++ G+ F
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPF 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNV-HHVHLVKL 462
LG+G FG V L + + + AVK L + I Q + E I+ +H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQL 89
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
C + RL E++ G L +F+ + RF RF A L +LH++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAA-EIISALMFLHDK- 143
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
I++ D+K +NVLLD K++DFG+ K + T GT Y+APE +
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPEILQEML 200
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
D ++ G++L E++ G F
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPF 224
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 410 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTIIGNV-HHVHLVKL 462
+G+G + V L L ++ A++ + E + ++ E + +H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 463 KGFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRF---NIALGTAKGLAYLH 518
C + RL EY+ G L +F+ + + + RF I+L L YLH
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
E I++ D+K +NVLLD K++D+G+ K +T GT Y+APE +
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILR 226
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSFS 606
D ++ G+++ E++ GR F
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ + T TR Y
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 192
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE I E D++S G ++ E+I G F
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 50/238 (21%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
LG G FG V + G + A+KK + Q + + E+ I+ + HV+++KL +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEES---------------------------RFLCW 500
+ N+ + + L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 501 NTRFNIALG----------TAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFG 549
R ++ + + ++H + I H DIKP+N+L++ + T K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 550 LAKLMNREESLV-YTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
AK + E V Y +R Y APE + + D++S G V E+I G+ F
Sbjct: 188 SAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEF--SA--EVTIIGNVHHVHLVK 461
LG+G F +VY VA+KK L + K +A E+ ++ + H +++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA------LGTAKGLA 515
L ++ L ++++ L+ I ++ + + L T +GL
Sbjct: 77 LLDAFGHKSNISLVFDFM-ETDLEVIIKDN---------SLVLTPSHIKAYMLMTLQGLE 126
Query: 516 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
YLH+ I+H D+KP N+LLD+N K++DFGLAK + YT TR Y APE
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPE 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466
KLG+G + V+ + + + +V VK L+ + KK+ E+ I+ N+ +++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIV 100
Query: 467 IEGAHRLLAY--EYLVNGSLDKWIFN-STEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ R A E++ N + + + RF + K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI--------LKALDYCHSM--- 149
Query: 524 KIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
I+H D+KP NV++D ++ ++ D+GLA+ + + Y +R + PE + + +
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQM 207
Query: 583 SEKS-DVYSYGMVLLEIIGGRKSF 605
+ S D++S G +L +I ++ F
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 40/163 (24%), Positives = 60/163 (36%), Gaps = 32/163 (19%)
Query: 406 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLK 463
S LG G G V + A+K L+ + EV + H+V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 77
Query: 464 GFCIEGAHRLLAYEYLV-----NGSL-----DKWIFNSTE-ESRFLCWNTRFNIALGTAK 512
E + +V G L D+ TE E+ + +I +
Sbjct: 78 DVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM----KSIG----E 128
Query: 513 GLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAK 552
+ YLH I H D+KPEN+L N K++DFG AK
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 55/197 (27%), Positives = 79/197 (40%), Gaps = 52/197 (26%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLV 460
K+GQG FG V+ G +VA+KK +E+ +KE +A E+ I+ + H ++V
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQLLKHENVV 79
Query: 461 KLKGFCIEGAHRLLAYE---YLV--------NGSLDKWIFNSTEESRFLCWNTRFNIALG 509
L C A + YLV G L N L
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---------------NVLVKFTLS 124
Query: 510 TAK--------GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REE 558
K GL Y+H KI+H D+K NVL+ + K++DFGLA+ + +
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 559 SLVYTTLRGTRGYLAPE 575
YT T Y PE
Sbjct: 182 PNRYTNRVVTLWYRPPE 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 14/172 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA--EVTIIGNVHHVHLVKLK 463
K+G+G +G V+ G VA+KK K A E+ ++ + H +LV L
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHPNLVNLL 68
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
L +EY + ++ + R + + +I T + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH--- 121
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+H D+KPEN+L+ + K+ DFG A+L+ Y TR Y +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPE 172
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTII--------GNVHHVHLV 460
+G+G FG V VA+K + + + ++ + E+ I+ N +V +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV--I 162
Query: 461 KLKGF-------CI--EGAHRLLA---YEYLVNGSLDKWIFN--STEESRFLCWNTRFNI 506
+ C+ E LL+ YE + F S R
Sbjct: 163 HMLENFTFRNHICMTFE----LLSMNLYELIKKNK-----FQGFSLPLVR--------KF 205
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTT 564
A + L LH+ +I+HCD+KPEN+LL + KV DFG + ++ VYT
Sbjct: 206 AHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTY 259
Query: 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
++ +R Y APE I D++S G +L E++ G
Sbjct: 260 IQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA------------EVTIIGNVHH 456
+ G +G+V G+ +GI VA+K++ + + + E+ ++ + HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLV----NGSLDKWIFN-----STEESRFLCWNTRFNIA 507
+++ L+ + + YLV L + I + S + ++ ++
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI----- 143
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
GL LHE +VH D+ P N+LL DN + DF LA+ + + T
Sbjct: 144 ---LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVT 195
Query: 568 TRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
R Y APE + ++ D++S G V+ E+ + F
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLV 460
K+G+G +G VY G VA+KK L++ + E +A E++++ ++H ++V
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIV 65
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLD-KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
KL L +E+L D K +++ + + + +GLA+ H
Sbjct: 66 KLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLAFCHS 121
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+++H D+KP+N+L++ K++DFGLA+ YT T Y APE
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPE 173
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ + T TR Y
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 229
Query: 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
APE I E D++S G ++ E++ + F
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 19/174 (10%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLVK 461
K+G+G +G VY G VA+K+ L++ + E +A E++++ +HH ++V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L L +E++ L K + ++ + +G+A+ H+
Sbjct: 84 LIDVIHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIK-IYLYQLLRGVAHCHQH- 138
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+I+H D+KP+N+L++ + K++DFGLA+ YT T Y AP+
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPD 189
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 21/191 (10%)
Query: 400 CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEF--SA--EVTI 450
AT + ++G G +G+VY G VA+K + + G G S EV +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 451 ---IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD---KWIFNSTEESRFLCWNTRF 504
+ H ++V+L C LV +D + + +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK- 123
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 564
++ +GL +LH IVH D+KPEN+L+ T K++DFGLA++ + + + T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTP 178
Query: 565 LRGTRGYLAPE 575
+ T Y APE
Sbjct: 179 VVVTLWYRAPE 189
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTR 569
L +L E+ I+HCD+KPEN+LL + + K+ DFG + + + +Y ++ +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQ-SR 222
Query: 570 GYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
Y +PE + P D++S G +L+E+ G F
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 16/175 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSA--EVTIIGNVHHVHLVKL 462
KLG G + +VY G+ G+ VA+K+ + +E +A E++++ + H ++V+L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKE---VKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
L +E++ + L K++ R L N +GLA+ HE
Sbjct: 69 YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
KI+H D+KP+N+L++ K+ DFGLA+ + +++ T Y AP+
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPD 178
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
KGL Y+H I+H D+KP N+ ++++ K+ DFGLA R+ T TR Y
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYVVTRWY 191
Query: 572 LAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
APE I N ++ D++S G ++ E+I G+ F
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 2e-12
Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLV 460
K+G+G +G+V+ VA+K+ L+ E SA E+ ++ + H ++V
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICLLKELKHKNIV 64
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+L L +E+ + L K+ + + + KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFC-DQDLKKYF--DSCNGDLDPEIVK-SFLFQLLKGLGFCHSR 120
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
++H D+KP+N+L++ N K+++FGLA+ Y+ T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPD 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
KGL Y+H +VH D+KP N+ ++++ K+ DFGLA R T TR Y
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTRWY 189
Query: 572 LAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
APE I + ++ D++S G ++ E++ G+ F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA--EVTIIGNVHHVHLVKLK 463
+G+G +G V G VA+KK + K A E+ ++ + H +LV L
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNLL 90
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
C + L +E++ + ++ + + + G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQ-KYLFQIINGIGFCHSH--- 143
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
I+H DIKPEN+L+ + K+ DFG A+ + VY TR Y APE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPE 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 374 SQENLEEDYFLESFSGMPTRFSYDDL--CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQ 428
+ + LE+ + P S + + TKLG+G +G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 429 VAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL-- 479
VA+K+ LE ++E +A EV+++ + H ++++LK L +EY
Sbjct: 62 VAIKRIRLEH----EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 480 -VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538
+ +DK S + + G+ + H + +H D+KP+N+LL
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHSR---RCLHRDLKPQNLLLS 166
Query: 539 DNFTA-----KVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+ + K+ DFGLA+ +T T Y PE
Sbjct: 167 VSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPE 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLV 460
KLG+G + +VY G VA+K+ LE +E +A EV+++ ++ H ++V
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLE-----HEEGAPCTAIREVSLLKDLKHANIV 63
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
L L +EYL + L +++ + N + +GLAY H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVK-LFLFQLLRGLAYCHRQ 119
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
K++H D+KP+N+L+++ K++DFGLA+ + + Y T Y P+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPD 170
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKK--LESIGQGKKE---FSA--EVTIIGNVHHVHLVK 461
K+G+G +G VY G A+KK LE + E + E++I+ + H ++VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK----EDEGIPSTTIREISILKELKHSNIVK 64
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L +L +E+L + L K + E + + L G+AY H+
Sbjct: 65 LYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAK-SFLLQLLNGIAYCHDR- 119
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 575
+++H D+KP+N+L++ K++DFGLA+ YT T Y AP+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPD 170
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 571
+GL Y+H I+H D+KP N+ ++++ K+ DFGLA R + T TR Y
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTGYVATRWY 195
Query: 572 LAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
APE + N ++ D++S G ++ E++ GR F
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 3e-12
Identities = 76/499 (15%), Positives = 149/499 (29%), Gaps = 141/499 (28%)
Query: 128 MELQDSGNLVLLGVNG---SILWQS--FSHPTDTLLPGQQFMEGMRLKSSNGEITFSNLR 182
+EL+ + N+++ GV G + + S+ + + F + N
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW-----------LNLKNCN 193
Query: 183 NGRAATSEVIKIPQNSCSVPEPCNPYFVCYFDNRCQCPPSLGSQFNCRPPVASTCNESMN 242
+ V+++ Q +P N S + + S+
Sbjct: 194 S----PETVLEMLQKLLYQIDP----------NWTS-----RSDHSSNIKLRI---HSIQ 231
Query: 243 SAKLFYLGER--------LDYFALGFVSPFPKYDINTCKEACLHNCSCSVLFFENSTKNC 294
+ L + L ++ K N SC +L +T+
Sbjct: 232 AELRRLLKSKPYENCLLVLL-------------NVQNAKAWNAFNLSCKILL---TTRFK 275
Query: 295 FLFDQIGSLQRSQQGSTGYVSYMKISRG---NEVLN--SK---IRESDGGKTVVLIVVIV 346
+ D + + + ++S S +EV + K R D + V+
Sbjct: 276 QVTDFLSAATTT------HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 347 VATILVIASLLYAGL-----WHHNKRKRLTKF---SQENLEED----YFLESFSGMPTRF 394
++ +IA + GL W H +LT S LE F + S P
Sbjct: 330 LS---IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFP--- 382
Query: 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLES---IGQGKKEFSAEVTII 451
+ T L ++ ++ + V V KL + + KE + ++I
Sbjct: 383 --PSA-----HIPTIL----LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST--ISI- 428
Query: 452 GNVHHVHLVKLKGFCIEGA-HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGT 510
++L E A HR + Y + + D ++ +
Sbjct: 429 ---PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH--------- 476
Query: 511 AKGLAYLH-EECEVKIVHCDIKPE--NVLLDDNF-TAKVSDFGLAKLMNREESLVYTTLR 566
+ + H + E H + V LD F K+ A + L+
Sbjct: 477 ---IGH-HLKNIE----HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528
Query: 567 GTRGYLAPEWITNNPISEK 585
+ Y+ N+P E+
Sbjct: 529 FYKPYICD----NDPKYER 543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 31/188 (16%)
Query: 409 KLGQGGFGSVYLGM---LPDGIQVAVKKLESIGQGKKEFSA--EVTIIGNVHHVHLVKLK 463
K+G+G +G VY D A+K++E G SA E+ ++ + H +++ L+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQ 84
Query: 464 GFCIEGAHRL--LAYEYLVNGSLD-KWIFNSTEESRFLCWNTRFNIALG------TAKGL 514
+ A R L ++Y D I S+ + + G+
Sbjct: 85 KVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 515 AYLHEECEVKIVHCDIKPENVLLDDNFTA----KVSDFGLAKLMNREESLVYTTLRG--- 567
YLH ++H D+KP N+L+ K++D G A+L N L
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVV 197
Query: 568 TRGYLAPE 575
T Y APE
Sbjct: 198 TFWYRAPE 205
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTR 569
+GL Y+H ++H D+KP N+LL+ K+ DFGLA++ + + + T TR
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 570 GYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
Y APE + N+ ++ D++S G +L E++ R F
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 51/225 (22%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 397 DDLCKATKNFS--TKLGQGGFGSVYLG--MLPDGIQVAVKK--LESIGQGKKE---FSA- 446
D LC+A + + ++G+G +G V+ + G VA+K+ +++ +E S
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT----GEEGMPLSTI 59
Query: 447 -EVTI---IGNVHHVHLVKLK----GFCIEGAHRL-LAYEYLVNGSLDKWIFNSTEESRF 497
EV + + H ++V+L + +L L +E++ + L ++
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPG 116
Query: 498 LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557
+ T ++ +GL +LH ++VH D+KP+N+L+ + K++DFGLA++ + +
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
Query: 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602
+ T++ T Y APE + + + D++S G + E+ +
Sbjct: 174 --MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 17/152 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFC 466
++G+G FG ++ G L + QVA+K E + E + + + F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 467 IEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
EG H +L + L G SL+ + + R T A + +HE+ +
Sbjct: 76 QEGLHNVLVIDLL--GPSLED-LLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 526 VHCDIKPENVLLDDNFTAK-----VSDFGLAK 552
V+ DIKP+N L+ + V DFG+ K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG---- 567
+ + LH ++H D+KP N+L++ N KV DFGLA++++ +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 568 -----TRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
TR Y APE + + S DV+S G +L E+ R F
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 17/152 (11%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFC 466
K+G G FG + LG L VA+K LE + + E + + ++ F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 467 IEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
G + + E L G SL+ +F+ R T IA+ + Y+H + +
Sbjct: 75 PCGKYNAMVLELL--GPSLED-LFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 526 VHCDIKPENVLLDDNFTAKVS-----DFGLAK 552
++ D+KPEN L+ DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 24/98 (24%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNRE--ESLVYTTLRGT 568
+GL Y+H ++H D+KP N+ ++ ++ K+ DFGLA++M+ + T
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 569 RGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSF 605
+ Y +P + + ++ D+++ G + E++ G+ F
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 53/234 (22%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-----EVTIIGNVHHVHLVKL 462
+G+G +G VYL VA+KK+ + + E+TI+ + ++++L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--DLIDCKRILREITILNRLKSDYIIRL 90
Query: 463 KGFCIEGAHRLLAYE--YLVNGSLD---KWIFNS----TEE-SRFLCWNTRFNIALGTAK 512
+ LL ++ Y+V D K +F + TEE + + +N L
Sbjct: 91 YD--LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL-----L---L 140
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG----- 567
G ++HE I+H D+KP N LL+ + + KV DFGLA+ +N E+
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 568 ----------------TRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKS 604
TR Y APE I ++ D++S G + E++ +S
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFC 466
K+G G FG +YLG + G +VA+K E + + E I + V + ++
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 467 IEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
EG + ++ E L G SL+ +FN SR T +A + Y+H +
Sbjct: 75 AEGDYNVMVMELL--GPSLED-LFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 526 VHCDIKPENVLL---DDNFTAKVSDFGLAK 552
+H D+KP+N L+ + DFGLAK
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 26/109 (23%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------KVSDFGLAK 552
L +LHE ++ H D+KPEN+L ++ +V+DFG A
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG 601
+ T + TR Y PE I ++ DV+S G +L E G
Sbjct: 191 FDHEH---HTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 5e-10
Identities = 37/221 (16%), Positives = 63/221 (28%), Gaps = 51/221 (23%)
Query: 391 PTRFSYDDLCKATKNFST--KLGQGGFGSVYLGMLPDGIQVAVKKL---------ESIGQ 439
P FS+ C T+ K+G+G FG V+ + D VA+K + S +
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 440 GKKEFSAEVTI---------IGNVHHVHLVKLKGFCI----EGAHRLLAYEYL--VNGSL 484
+E E+ I + L L A+++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 485 DKWIFNSTEESRFLC-------------------WNTRFNIALGTAKGLAYLHEECEVKI 525
+ ++ F+ T +I LA +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 566
H D+ NVLL K+ K + ++
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 27/169 (15%), Positives = 56/169 (33%), Gaps = 33/169 (19%)
Query: 409 KLGQGGFGSVYLGM---------LPDGIQVAVKKLES------------IGQGKKEFSAE 447
+ G +Y P + ++ KL++ K +
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 448 VTIIGNVHHVHLVKLKGF-CIEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFN 505
+ + + + GF + +R L L G SL + + + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVL-SERSVLQ 163
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 552
+A L +LH E + VH ++ EN+ +D ++V + +G A
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFC 466
K+G G FG +YLG + +VA+K E++ + E I + + ++ F
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 467 IEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+EG + +L + L G SL+ +FN SR L T +A + ++H +
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 526 VHCDIKPENVLLDDNFTAK---VSDFGLAK 552
+H DIKP+N L+ A + DFGLAK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 26/105 (24%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------KVSDFGLAK 552
K + +LH K+ H D+KPEN+L + KV DFG A
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLE 597
+ T + TR Y APE I S+ DV+S G +L+E
Sbjct: 186 YDDEH---HSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 34/111 (30%), Positives = 47/111 (42%), Gaps = 32/111 (28%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------------KVS 546
K L YL + + + H D+KPEN+LLDD + K+
Sbjct: 148 KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLE 597
DFG A + + + TR Y APE I N SD++S+G VL E
Sbjct: 205 DFGCATFKSDY---HGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 30/112 (26%), Positives = 49/112 (43%), Gaps = 24/112 (21%)
Query: 512 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG---- 567
K + YLH ++H D+KP N+LL+ KV+DFGL++ +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 568 ----------------TRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGR 602
TR Y APE + + ++ D++S G +L EI+ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 39/167 (23%), Positives = 63/167 (37%), Gaps = 32/167 (19%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQG-------------KKEFSAEVTIIG 452
K+G GGFG +YL + A K+E G KK+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 453 NVHHVHLVKLKGF----CIEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIA 507
+ ++ + G ++R + E L G L K I ++ +T +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISG---QNGTFKKSTVLQLG 157
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 552
+ L Y+HE VH DIK N+LL +V +D+GL+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 3e-09
Identities = 19/75 (25%), Positives = 36/75 (48%), Gaps = 2/75 (2%)
Query: 76 HISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEAWSANTSGQKVECME-LQDSG 134
+SS ++T + L + S + + + N L W++NT G C L ++G
Sbjct: 3 SLSSPNSLFTGHS-LEVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNG 61
Query: 135 NLVLLGVNGSILWQS 149
NLV+ + ++WQ+
Sbjct: 62 NLVIYDQSNRVIWQT 76
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-06
Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 6/79 (7%)
Query: 78 SSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGN 135
S K VW +N G L + +GN + + W T+G++ + LQ N
Sbjct: 36 DSGKPVWASNTGGLGSGC-RLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRN 94
Query: 136 LVLLGVNGSILWQSFSHPT 154
+V+ G ++W + S P
Sbjct: 95 VVI---YGPVVWATGSGPA 110
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 58/239 (24%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-----EVTIIGNVHHVHLVKL 462
+G G +G V + VA+KK+ + + E+ I+ ++H H+VK+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRLNHDHVVKV 117
Query: 463 KGFCIEGAHRLLAYE--YLVNGSLD---KWIFNS----TEE-SRFLCWNTRFNIALGTAK 512
I + ++ Y+V D K +F + TE + L +N L
Sbjct: 118 LD--IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL-----L---V 167
Query: 513 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG----- 567
G+ Y+H I+H D+KP N L++ + + KV DFGLA+ ++ E+
Sbjct: 168 GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 568 ---------------------TRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKS 604
TR Y APE I +E DV+S G + E++ K
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 33/169 (19%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFS------------AEVTIIGNVHH 456
+GQGGFG +YL + V + + A+ I
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 457 VHLVKLKGFC----------IEGAHRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFN 505
+K G ++R + + G L K I+ + ++ T
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEAN--AKRFSRKTVLQ 156
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 552
++L L Y+HE VH DIK N+LL+ +V D+GLA
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 7e-09
Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 11/107 (10%)
Query: 47 GLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNA 106
G L +F +LV+ + + VW + + GN
Sbjct: 13 GGSLAEGGYLFIIQND-------CNLVLYD--NNRAVWASGTNGKASGC-VLKMQNDGNL 62
Query: 107 YLQRGNGEAWSANTSGQKVECM-ELQDSGNLVLLGVNGSILWQSFSH 152
+ G+ W++NT+ Q LQ N+V+ + + +W + ++
Sbjct: 63 VIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTN 109
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 4e-04
Identities = 14/59 (23%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPT 154
F+ + N L N W++ T+G+ C +++Q+ GNLV+ + +I + +
Sbjct: 22 LFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQN 80
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 17/54 (31%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
+F+ + N L N W+ NT G C LQ G LV++ +WQS
Sbjct: 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS 86
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-06
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGNLVL 138
+W N G L + V + G + W + +G+ + LQ N+V+
Sbjct: 49 NPIWATNTGGLGNGC-RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 139 LGVNGSILWQS 149
G LW +
Sbjct: 108 ---YGDALWAT 115
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 5e-08
Identities = 17/64 (26%), Positives = 26/64 (40%), Gaps = 2/64 (3%)
Query: 91 LIRDSDKFVFEKSGNAYLQRGNGEAWSANTSGQKVE--CMELQDSGNLVLLGVNGSILWQ 148
L + F+ ++ N L + W++NT + LQ GN V+ G LW
Sbjct: 16 LDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWA 75
Query: 149 SFSH 152
S S
Sbjct: 76 SHSV 79
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 19/77 (24%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 78 SSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGN 135
+ VW +N G+L + K V + GN + G + W++++ + LQ+ GN
Sbjct: 35 DHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGN 94
Query: 136 LVLLGVNGSILWQSFSH 152
+V+ GS +W + ++
Sbjct: 95 VVIY---GSDIWSTGTY 108
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-07
Identities = 15/57 (26%), Positives = 26/57 (45%), Gaps = 1/57 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
F+ ++ N L + W+ NT G C + +Q GNLV+ + +W S +
Sbjct: 22 VFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTG 78
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 9e-05
Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 6/74 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVECM-ELQDSGNLVL 138
K +W N G L R + GN + W++NT G+ + LQ N+V+
Sbjct: 38 KPIWATNTGGLDRRC-HLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI 96
Query: 139 LGVNGSILWQSFSH 152
G+ W + ++
Sbjct: 97 Y---GTARWATGTN 107
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 5e-07
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 2/63 (3%)
Query: 91 LIRDSDKFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
L + + V + N L G W +NT G C + L G L++ + +W S
Sbjct: 21 LTAKNHQLVMQGDCNLVL-YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSS 79
Query: 150 FSH 152
S
Sbjct: 80 RSS 82
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-07
Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 1/57 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
+ N + + W++NT + C + L GNLV+ N + +W S
Sbjct: 23 TLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW 79
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.9 bits (115), Expect = 2e-06
Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 5/90 (5%)
Query: 65 LDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQ 123
L Q +V + + W A + + + VF+ GN + W ++T G
Sbjct: 168 LVFQGDGNLVAYGPNGAATWNAGTQ--GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGH 225
Query: 124 KVECMELQDSGNLVLLGVNGSILWQSFSHP 153
+ LQ +G++ + ++ +W F
Sbjct: 226 ASAVLRLQANGSIAI--LDEKPVWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 2e-04
Identities = 21/59 (35%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 95 SDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSH 152
+ K VF+ GN NG A W+A T G+ Q GNLV+ G ++LW S +
Sbjct: 165 ASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG 223
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 4/60 (6%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPTD 155
V + N L GN W +NT+ +C + L D G LV+ +GS +W+S +
Sbjct: 24 DLVMQDDCNLVLYNGN---WQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVK 80
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 2e-06
Identities = 15/60 (25%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPTD 155
+ E N L + WS NT+G+ C LQ +G + +L +W S + +
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 3e-06
Identities = 16/59 (27%), Positives = 26/59 (44%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155
+F + N L + W++NT+G LQ G LV+L +I W S + +
Sbjct: 29 RFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSI 87
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 13/56 (23%), Positives = 19/56 (33%), Gaps = 3/56 (5%)
Query: 97 KFVFEKSGN--AYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
V N W + TSG+ C M L SG L + + ++ S
Sbjct: 27 SLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVS 82
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 17/80 (21%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 72 LVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-ME 129
LV+ S +VW + + SG + + +NT GQ+ + +
Sbjct: 36 LVLTKGSKTNIVWESGTSGRGQHC-FMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLI 94
Query: 130 LQDSGNLVLLGVNGSILWQS 149
LQ +G V+ G +W +
Sbjct: 95 LQINGQAVVY---GPAVWST 111
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 6e-04
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 3/58 (5%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNG-SILWQSFSH 152
FV + N L + +NT G+ V+C + L + G L + N + +W
Sbjct: 23 AFVMQGDCNLVL-YNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS 79
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.79 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.73 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.64 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.6 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.51 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.31 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.18 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.17 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.96 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.91 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.9 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.83 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.01 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.53 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 88.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.35 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.34 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=392.19 Aligned_cols=210 Identities=26% Similarity=0.413 Sum_probs=182.2
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecc
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGF 465 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~ 465 (606)
.++.|+..++.+|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 4455666778899999999999999999973 46889999997542 345789999999999999999999999
Q ss_pred eeccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 037563 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPE 533 (606)
Q Consensus 466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~ 533 (606)
|.++...+||||||++|+|.++|..... ....++|..+++|+.||++||+|||++ +|+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCcccc
Confidence 9999999999999999999999965432 124689999999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 534 NVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 534 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||||++++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987654332 22345679999999999999999999999999999999999 899984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=386.73 Aligned_cols=203 Identities=30% Similarity=0.545 Sum_probs=175.4
Q ss_pred HHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+..+.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.++...+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345567789999999999999864 36789999997543 34578999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhcc---------ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 474 LAYEYLVNGSLDKWIFNST---------EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
||||||++|+|.++|.... .....++|.++++|+.||++||+|||++ +|+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997643 1234699999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcceee-eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 545 VSDFGLAKLMNREESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+|||+++.......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999987655433222 23468999999999999999999999999999999999 999994
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.12 Aligned_cols=200 Identities=33% Similarity=0.538 Sum_probs=168.1
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
|+......+.++||+|+||+||+|++++ .||||+++.... ..++|.+|++++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4444556788999999999999999854 599999875432 34679999999999999999999998865 56899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++|+|.++|.... ..+++.++..|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999999999996533 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcc-eeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES-LVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .......||+.|||||++.+ .+++.++|||||||++|||+||+.||.
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 54322 23345789999999999864 468999999999999999999999994
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=385.21 Aligned_cols=202 Identities=28% Similarity=0.509 Sum_probs=169.3
Q ss_pred HhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34566789999999999999864 37889999997543 345789999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhcccc-----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 475 AYEYLVNGSLDKWIFNSTEE-----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
|||||++|+|.++|...... ...++|.++++|+.||++||+|||+. +|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999999764321 24689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 544 KVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 9999999997654432 22344679999999999999999999999999999999999 999984
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=370.77 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=178.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+++.. +++.||||++++. ....+.+.+|++++++++|||||++++++.++...|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788899999999999999975 4899999999642 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.+...
T Consensus 113 y~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 113 YAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999643 3589999999999999999999998 9999999999999999999999999999987543
Q ss_pred cc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ....+.+||+.|||||++.+..++.++||||+||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 32 23456789999999999999999999999999999999999999994
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=374.91 Aligned_cols=195 Identities=26% Similarity=0.444 Sum_probs=176.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.++||+|+||+||+++.. +|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+++..||||||++
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3667789999999999999986 4899999999644 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 155 gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 155 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 9999999854 3489999999999999999999998 999999999999999999999999999997654432
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2345789999999999999999999999999999999999999994
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=375.82 Aligned_cols=198 Identities=27% Similarity=0.426 Sum_probs=170.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.|++.++||+|+||+||+++.. +++.||||++..... ..+.+.+|++++++++|||||++++++.++...||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4677889999999999999975 489999999975432 346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.++|.... ...+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 105 ~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999996533 24578889999999999999999998 99999999999999999999999999999765432
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2 1234679999999999999999999999999999999999999994
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.28 Aligned_cols=193 Identities=25% Similarity=0.449 Sum_probs=166.6
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec----cccceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~ 476 (606)
+|.++||+|+||.||+|++.. ++.||+|++.... ...+.|.+|++++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999764 8899999996543 234679999999999999999999999865 34579999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~ 555 (606)
||+++|+|.+++... ..+++..+..|+.||+.||+|||++. ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999643 45899999999999999999999971 1399999999999998 47999999999998644
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....||+.|||||++.+ .++.++|||||||++|||+||+.||.
T Consensus 184 ~~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 184 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCc---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 322 345789999999998865 59999999999999999999999994
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=367.31 Aligned_cols=192 Identities=28% Similarity=0.379 Sum_probs=167.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+.+.++||+|+||.||++++. .|+.||||+++.... ..+|+.++++++|||||++++++.++...+|||||+++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 456678999999999999976 489999999975432 246999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCcCcc--
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREES-- 559 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~-- 559 (606)
+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++.+.....
T Consensus 136 ~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999643 3589999999999999999999998 999999999999999988 699999999997754322
Q ss_pred --eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 --LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 --~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 11223579999999999999999999999999999999999999994
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=375.89 Aligned_cols=195 Identities=26% Similarity=0.444 Sum_probs=176.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.+|++++|||||++++++.+++..|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3677789999999999999986 4899999999654 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 232 gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 232 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 9999999853 3488999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2345789999999999999999999999999999999999999994
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.60 Aligned_cols=207 Identities=26% Similarity=0.439 Sum_probs=178.7
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhccc-CCcceeeccee
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHH-VHLVKLKGFCI 467 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~ 467 (606)
.|+....+++.++||+|+||+||+|++.. ++.||||+++... ...++|.+|+++|.+++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 45667788899999999999999998642 3689999997543 234679999999999965 89999999997
Q ss_pred cc-ccceeeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 468 EG-AHRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 468 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
+. ...+||||||++|+|.++|+..... ...+++..+..|+.||++||+|||++ +|+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 64 5689999999999999999764321 24589999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+++++.+||+|||+|+.+..... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999997765443 23345678999999999999999999999999999999998 999994
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=366.58 Aligned_cols=197 Identities=28% Similarity=0.360 Sum_probs=162.9
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccc----cceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA----HRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~lV~E~ 478 (606)
++.+.++||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||+++|+|.++. ..+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 345668899999999999998 6899999999755433334456777778899999999999998754 57899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
|++|+|.++|.. ..++|..+.+|+.|+++||+|||+++ .++|+||||||+||||++++++||+|||+++.
T Consensus 83 ~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999964 35889999999999999999999852 35899999999999999999999999999987
Q ss_pred cCcCcce---eeeecccccCccccccccCC------CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESL---VYTTLRGTRGYLAPEWITNN------PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....... ......||+.|||||++.+. .++.++|||||||++|||+||++||
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 6543321 12345799999999998764 3577999999999999999998765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.93 Aligned_cols=197 Identities=27% Similarity=0.365 Sum_probs=167.4
Q ss_pred HhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+++.+.||+|+||+||+++.. .++.||||+++... ....++.+|++++++++|||||++++++.++...++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34788899999999999999863 36889999996432 234578899999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999643 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......||+.|||||++.+..++.++||||+||++|||+||+.||.
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 43322 2345689999999999999999999999999999999999999994
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.20 Aligned_cols=194 Identities=28% Similarity=0.466 Sum_probs=160.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+++.. +++.||||+++.. ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4678899999999999999975 5899999999643 2335679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+ +|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 y~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 67999998643 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......||+.|||||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 2 2345789999999999998876 579999999999999999999994
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=348.07 Aligned_cols=196 Identities=26% Similarity=0.430 Sum_probs=158.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccc---------
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA--------- 470 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--------- 470 (606)
.+++.+.||+|+||+||+++.. +++.||||+++.... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4677889999999999999975 589999999965432 3467899999999999999999999987544
Q ss_pred ---cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEee
Q 037563 471 ---HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 547 (606)
Q Consensus 471 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 547 (606)
..++||||+++|+|.+++...... ....+..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 368999999999999999754322 3356677889999999999999998 999999999999999999999999
Q ss_pred ccCCcccCcCcce-----------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 548 FGLAKLMNREESL-----------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 548 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
||+|+.+...... ..+..+||+.|||||++.+..++.++|||||||++|||++ ||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf 227 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence 9999876543221 1234579999999999999999999999999999999996 66
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=345.67 Aligned_cols=196 Identities=24% Similarity=0.391 Sum_probs=167.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceec------cccc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIE------GAHR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------~~~~ 472 (606)
.+++.++||+|+||+||++++. +|+.||||+++..... .+.+.+|+++|++++|||||++++++.. ....
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4677889999999999999975 5899999999754332 3568899999999999999999998764 3578
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
||||||++ |+|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 135 ~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 99999996 6899998542 4689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCc---ceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREE---SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 764322 1223457899999999998775 46899999999999999999999993
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=340.15 Aligned_cols=192 Identities=27% Similarity=0.376 Sum_probs=165.9
Q ss_pred hhccccccCCcCceeEEEEEeC----CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.|++.++||+|+||+||+++.+ .++.||+|++... ....++.+|++++..+ +|||||++++++.+.++.++|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 4677899999999999999853 3678999998654 3456788999999998 69999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~ 556 (606)
|+++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999982 488899999999999999999998 99999999999999877 7999999999986532
Q ss_pred Ccc---------------------------eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EES---------------------------LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... ...+..+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 210 112345799999999998876 4899999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=358.12 Aligned_cols=194 Identities=25% Similarity=0.361 Sum_probs=168.9
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHH---HHHHHhcccCCcceeecceecccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAE---VTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~E---i~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
.+++.+.||+|+||+||+++... |+.||||++++. ......+.+| +.+++.++|||||++++++++....||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 36778899999999999999864 899999999643 2333444444 566667789999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||++||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+
T Consensus 270 VmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999643 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ..+.+||+.|||||++.. ..++.++|+||+||++|||++|+.||.
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5433 235689999999999964 579999999999999999999999994
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.17 Aligned_cols=196 Identities=24% Similarity=0.403 Sum_probs=175.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.|++.++||+|+||.||+++.+ +|+.||+|++.... ...+.+.+|+++|++++|||||++++++.+....+|||||++
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4678899999999999999986 48999999986543 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC--CcEEEeeccCCcccCcCc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 558 (606)
+|+|.++|.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 238 gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 238 GGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999985432 3588999999999999999999998 99999999999999854 899999999999876543
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||.
T Consensus 312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred c--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2 345689999999999999999999999999999999999999994
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.26 Aligned_cols=216 Identities=47% Similarity=0.827 Sum_probs=190.7
Q ss_pred CCccChHHHHHHhhcc--ccccCCcCceeEEEEEeCCCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecce
Q 037563 391 PTRFSYDDLCKATKNF--STKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 391 ~~~~~~~el~~~~~~~--~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
...+++.++...+.+| .+.||+|+||.||+++.++++.||||++.... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4567888888777666 47899999999999998889999999996542 2345799999999999999999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEe
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 546 (606)
.+....++||||+++++|.+++.........+++..+..++.||+.||+|||+.+..+|+||||||+||++++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998766655679999999999999999999999766699999999999999999999999
Q ss_pred eccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 547 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776555444555679999999999988889999999999999999999999983
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.00 Aligned_cols=199 Identities=22% Similarity=0.305 Sum_probs=175.2
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.++||+|+||+||++++.+ ++.||+|+++.. ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 345667899999999999999875 789999999642 233455899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 154 Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999996532 3589999999999999999999998 999999999999999999999999999987665
Q ss_pred CcceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 5444444568999999999987 5678999999999999999999999994
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.39 Aligned_cols=197 Identities=25% Similarity=0.311 Sum_probs=174.1
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.+.||+|+||.||+++... ++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 345667899999999999999865 789999999642 334566889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 149 E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999854 2478899999999999999999998 999999999999999999999999999987765
Q ss_pred CcceeeeecccccCccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 4433344678999999999998765 7889999999999999999999994
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.16 Aligned_cols=196 Identities=29% Similarity=0.363 Sum_probs=174.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+++.. +++.||+|+++.. ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4567789999999999999986 4899999999643 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 86 YANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999998643 3588999999999999999999998 9999999999999999999999999999864332
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......||+.|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 22 2345679999999999999999999999999999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.49 Aligned_cols=200 Identities=39% Similarity=0.742 Sum_probs=176.3
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
+++.+.||+|+||.||+|++++++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||++++
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 34457899999999999999889999999986543 34578999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-ee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LV 561 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 561 (606)
+|.+++.........+++..+..++.||+.||.|||++ +++||||||+||++++++.+||+|||+++....... ..
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999976554445689999999999999999999998 999999999999999999999999999986543222 22
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 234568999999999998899999999999999999999999983
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.29 Aligned_cols=206 Identities=26% Similarity=0.411 Sum_probs=180.5
Q ss_pred CccChHHHHHHhh------------ccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccC
Q 037563 392 TRFSYDDLCKATK------------NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHV 457 (606)
Q Consensus 392 ~~~~~~el~~~~~------------~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~ 457 (606)
..++++++..++. ++.++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3477888877764 33467999999999999986 6899999999754 34567799999999999999
Q ss_pred CcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 458 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999853 3588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999876543221 234679999999999999999999999999999999999999983
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.03 Aligned_cols=201 Identities=26% Similarity=0.444 Sum_probs=180.4
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
....+.+.+.||+|+||.||+++.+++..||+|+++......+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34566778899999999999999988889999999877777889999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999996532 3589999999999999999999998 999999999999999999999999999987665543
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 33344556778999999998889999999999999999999 999984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.02 Aligned_cols=199 Identities=21% Similarity=0.271 Sum_probs=174.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.+.||+|+||+||+++.+ +++.||+|++++. ....+.+.+|+.++.+++||||+++++++++....++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34566789999999999999986 5899999999642 223456889999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 141 E~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999996532 3588999999999999999999998 999999999999999999999999999987765
Q ss_pred CcceeeeecccccCcccccccc-------CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWIT-------NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 4433334568999999999987 3568999999999999999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.12 Aligned_cols=196 Identities=26% Similarity=0.431 Sum_probs=174.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.++||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 34566788999999999999964 5899999998644 345677899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999854 2478899999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2344679999999999999999999999999999999999999983
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.66 Aligned_cols=200 Identities=18% Similarity=0.229 Sum_probs=173.7
Q ss_pred HHhhccccccCCcCceeEEEEE------eCCCcEEEEEEecccCCChHHHHHHHHHHHhcc---cCCcceeecceecccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGM------LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAH 471 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~------~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~ 471 (606)
...+.+.+.||+|+||.||+|+ ...++.||||+++.. ..+++..|++++++++ |+||+++++++.....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 3456667889999999999994 345889999998643 5678889999999887 9999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccc-cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-----------
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTE-ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD----------- 539 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~----------- 539 (606)
.++||||+++|+|.+++..... ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999975332 235699999999999999999999998 9999999999999998
Q ss_pred CCcEEEeeccCCcccCcC-cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 540 NFTAKVSDFGLAKLMNRE-ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 540 ~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999999765422 223445678999999999999999999999999999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.18 Aligned_cols=198 Identities=31% Similarity=0.457 Sum_probs=168.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++.. .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 34667789999999999999975 488999999854322 2367899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999643 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 43333344678999999999999999999999999999999999999984
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.70 Aligned_cols=199 Identities=28% Similarity=0.517 Sum_probs=178.5
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+++.+.||+|+||.||+++..+++.||+|++.......+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 45677789999999999999998899999999987777788999999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999996433 3588999999999999999999998 99999999999999999999999999998765443322
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 334566788999999998999999999999999999999 999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.67 Aligned_cols=196 Identities=24% Similarity=0.339 Sum_probs=172.5
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.+.||+|+||.||+++.++ ++.||+|+++... ...+.+..|..++.++ +||||+++++++.+....++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 346778899999999999999865 7889999997542 2345688999999887 899999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998653 3589999999999999999999998 99999999999999999999999999998633
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf 253 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 222 2234578999999999999999999999999999999999999999
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.83 Aligned_cols=200 Identities=28% Similarity=0.348 Sum_probs=170.8
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~ 472 (606)
+....+++.+.||+|+||.||+++... ++.||||+++.. ....+.+..|..++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 334556778999999999999999764 889999999643 34556788999999988 699999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999653 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 643322 22345689999999999998889999999999999999999999994
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.64 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=172.5
Q ss_pred hhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+.+.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 356678899999999999997 4689999999965432 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 96 ASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999653 3488999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeeecccccCccccccccCCCCC-CccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t-~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....||+.|+|||.+.+..+. .++||||||+++|||++|+.||.
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 2 2446799999999999888765 79999999999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.10 Aligned_cols=193 Identities=28% Similarity=0.429 Sum_probs=173.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4667789999999999999986 5899999999643 2456788999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 87 YIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999653 3488899999999999999999998 9999999999999999999999999999875432
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 234679999999999999999999999999999999999999984
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=329.08 Aligned_cols=203 Identities=26% Similarity=0.469 Sum_probs=178.1
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++....+++.++||+|+||.||+|+++++..||||+++......++|.+|+.++++++||||+++++++. ....++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4455667788999999999999999988899999999876677889999999999999999999999986 567899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999996432 23578889999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........+++.|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 2222233456789999999998899999999999999999999 999984
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.92 Aligned_cols=201 Identities=34% Similarity=0.525 Sum_probs=166.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
....+++.+.||+|+||.||+++. +++.||||++...... .+++.+|++++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 345567788999999999999998 6889999999754332 357899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||+++++|.+++..... ...+++..+..++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999965332 23589999999999999999999998 7 999999999999999999999999999865
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 12234678999999999999999999999999999999999999984
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.30 Aligned_cols=197 Identities=26% Similarity=0.367 Sum_probs=174.2
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+.+.+.||+|+||.||+++.+ +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+....++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45677789999999999999986 4889999999653 34567788999999887 899999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999643 3488999999999999999999998 99999999999999999999999999998643
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ......||+.|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 3222 2345689999999999999999999999999999999999999984
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=311.99 Aligned_cols=203 Identities=23% Similarity=0.361 Sum_probs=177.3
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc------CCChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
....+++.+.||+|+||.||+++.. +++.||||++... ....+++.+|+.++++++||||+++++++.+....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456888899999999999999975 4899999998532 12467899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EEEeecc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFG 549 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg 549 (606)
++||||+++++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999998866544445688999999999999999999998 9999999999999987655 9999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 9987654322 2334679999999999999999999999999999999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.07 Aligned_cols=205 Identities=26% Similarity=0.458 Sum_probs=181.4
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.++....+.+.++||+|+||.||+|++.+ ++.||||+++......++|.+|+.++++++||||++++++|.+....++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34555667888999999999999999875 88999999987766788999999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999975432 4588999999999999999999998 99999999999999999999999999998765
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 443222233456789999999998899999999999999999999 999983
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=304.72 Aligned_cols=198 Identities=31% Similarity=0.476 Sum_probs=172.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.+.||+|+||.||++++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 34567788999999999999986 48899999886543 34578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999996532 3589999999999999999999998 999999999999999999999999999987643322
Q ss_pred ee-------------eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 560 LV-------------YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 560 ~~-------------~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~ 222 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCC
Confidence 11 11457899999999999999999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.27 Aligned_cols=203 Identities=25% Similarity=0.444 Sum_probs=177.6
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++....+.+.+.||+|+||.||++.+.+++.||+|+++......+++.+|++++++++||||+++++++.+....++|||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34455677889999999999999999888899999998777778899999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+||++++++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999996532 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 3222233456788999999998889999999999999999999 999984
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.85 Aligned_cols=196 Identities=21% Similarity=0.335 Sum_probs=175.2
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.+.+.+.||+|+||.||+++... ++.+|+|.+.........+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 45677889999999999999864 78999999976555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC--CCcEEEeeccCCcccCcCcc
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~ 559 (606)
++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 86 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 86 LDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999995432 3588999999999999999999998 9999999999999987 78999999999987754432
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 345678999999999998888999999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.97 Aligned_cols=203 Identities=25% Similarity=0.463 Sum_probs=174.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
...+.+.+.||+|+||.||++++. ++..||||+++... ...+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 455677889999999999999852 35679999997543 2346799999999999 899999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
...++||||+++|+|.+++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999764321 23578999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999986654322 11233456889999999999999999999999999999999 999984
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.97 Aligned_cols=196 Identities=26% Similarity=0.436 Sum_probs=174.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-------ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+++.+.||+|+||.||+++.. +++.||+|+++.... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 34677889999999999999986 489999999965421 3578999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC----cEEEeecc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDFG 549 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg 549 (606)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++ .+||+|||
T Consensus 92 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999542 4588999999999999999999998 999999999999998877 79999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9987654322 244679999999999999999999999999999999999999983
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.55 Aligned_cols=196 Identities=26% Similarity=0.407 Sum_probs=173.8
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++..+ ++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 456778899999999999999765 789999998643 345678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999643 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 32 2345689999999999864 458899999999999999999999983
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.21 Aligned_cols=195 Identities=25% Similarity=0.344 Sum_probs=172.1
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC----ChHHHHHHHHHHHhc-ccCCcceeecceeccccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ----GKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+++.+.||+|+||.||+++.+. ++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+....++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 45677899999999999999864 88999999975421 235688899999988 8999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999643 3588999999999999999999998 999999999999999999999999999986433
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... ......||+.|+|||.+.+..++.++|+||||+++|||++|+.||
T Consensus 163 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 210 (345)
T 3a8x_A 163 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCc
Confidence 221 234568999999999999999999999999999999999999999
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.87 Aligned_cols=203 Identities=30% Similarity=0.499 Sum_probs=172.1
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++....+.+.++||+|+||.||+|+++++..||||+++......++|.+|++++++++||||+++++++.+ ...++|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34455677888999999999999999888889999998766667899999999999999999999999876 67899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999996432 23588999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 3222234456889999999998899999999999999999999 999984
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.11 Aligned_cols=197 Identities=25% Similarity=0.429 Sum_probs=174.9
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-------CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+.+.+.||+|+||.||+++.. +++.||+|++.... ...+++.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456788899999999999999986 48999999986432 1357899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC----cEEEeec
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDF 548 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 548 (606)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999542 4588999999999999999999998 999999999999999887 8999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 99987654322 234679999999999999999999999999999999999999983
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.64 Aligned_cols=202 Identities=29% Similarity=0.511 Sum_probs=172.2
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
+....+.+.+.||+|+||.||+|++. .+..||||+++... ...+++.+|+.++++++||||+++++++.++...
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44456677789999999999999985 35579999997542 2346799999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999996432 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 553 LMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 76544322 2223456778999999998899999999999999999999 999983
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=309.19 Aligned_cols=194 Identities=27% Similarity=0.330 Sum_probs=174.2
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34677789999999999999986 4899999999643 345678899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999653 3488999999999999999999998 999999999999999999999999999987644
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 194 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred Cc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 32 34578999999999999999999999999999999999999984
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=310.03 Aligned_cols=198 Identities=27% Similarity=0.353 Sum_probs=174.8
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceecccccee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l 474 (606)
...+++.+.||+|+||.||+++... ++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+....++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3456778899999999999999875 788999999643 34567788999999887 79999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999643 3488999999999999999999998 9999999999999999999999999999864
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence 3222 12345679999999999999999999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=300.01 Aligned_cols=210 Identities=41% Similarity=0.706 Sum_probs=182.5
Q ss_pred CCccChHHHHHHhhcccc--------ccCCcCceeEEEEEeCCCcEEEEEEecccC-----CChHHHHHHHHHHHhcccC
Q 037563 391 PTRFSYDDLCKATKNFST--------KLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----QGKKEFSAEVTIIGNVHHV 457 (606)
Q Consensus 391 ~~~~~~~el~~~~~~~~~--------~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~ 457 (606)
...|++.++..++.+|.+ .||+|+||.||+|+. +++.||||++.... ...+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 356899999999998864 499999999999998 67899999986432 2356799999999999999
Q ss_pred CcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 458 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
||+++++++.+....++||||+++++|.+++..... ...+++..+..++.||+.||.|||+. +++|+||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999965332 24689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 9999999999999987654332 22234578999999998765 47899999999999999999999984
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=307.52 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=164.9
Q ss_pred HHhhccccccCCcCceeEEEEEe----CCCcEEEEEEecccC-----CChHHHHHHHHHHHhcccCCcceeecceecccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESIG-----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~ 471 (606)
...+++.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34577889999999999999997 468999999997532 234568899999999999999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999643 3478899999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 86433221 2234678999999999999899999999999999999999999984
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.84 Aligned_cols=200 Identities=29% Similarity=0.395 Sum_probs=177.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 3455678999999999999986 4899999999643 2456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999999976554445689999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 343 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 343 QTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp CCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred Ccc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 322 234589999999999999999999999999999999999999994
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.34 Aligned_cols=197 Identities=30% Similarity=0.430 Sum_probs=170.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4567789999999999999976 58899999986432 23467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 88 SGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp TTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999998532 3589999999999999999999998 999999999999999999999999999986543322
Q ss_pred -eeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 -LVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 -~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 22234679999999999987765 778999999999999999999984
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=306.37 Aligned_cols=198 Identities=27% Similarity=0.455 Sum_probs=174.4
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
....+.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3566888899999999999999976 489999999975432 335788999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cEEEeeccCCc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgla~ 552 (606)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999998543 4588999999999999999999998 999999999999998654 59999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 7654322 234679999999999999899999999999999999999999983
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.72 Aligned_cols=197 Identities=25% Similarity=0.367 Sum_probs=169.0
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
..+.+.++||+|+||.||+++..+++.||+|++..... ..+.+.+|++++++++||||+++++++.++...++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 34567789999999999999998899999999964422 246789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++ +|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 101 MEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 985 7888875432 3588999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 2 2334578999999999876 568999999999999999999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=301.26 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=183.3
Q ss_pred ChHHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 395 ~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
.-.++....+.+.+.||+|+||.||++++.+ ++.||+|++.......+++.+|++++++++||||+++++++.+....+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3344556677888999999999999999865 789999999876666788999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++..... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999965432 4588999999999999999999999 999999999999999999999999999987
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~ 214 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76554444444567889999999998899999999999999999999 999984
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.17 Aligned_cols=200 Identities=24% Similarity=0.399 Sum_probs=169.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccc--------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-------- 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-------- 470 (606)
..+++.+.||+|+||.||++++. +++.||||+++... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677889999999999999986 68999999997432 34578999999999999999999999986543
Q ss_pred -------------------------------------------------cceeeeeeccCCChhhhhhhccccccccChh
Q 037563 471 -------------------------------------------------HRLLAYEYLVNGSLDKWIFNSTEESRFLCWN 501 (606)
Q Consensus 471 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 501 (606)
..++||||+++++|.+++...... ...++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhhH
Confidence 278999999999999999765432 345677
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-----------eeeeecccccC
Q 037563 502 TRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-----------LVYTTLRGTRG 570 (606)
Q Consensus 502 ~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 570 (606)
.+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999998 999999999999999999999999999987655421 11233568999
Q ss_pred ccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 571 YLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 571 y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999998875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.17 Aligned_cols=201 Identities=28% Similarity=0.508 Sum_probs=161.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
....+.+.+.||+|+||.||+|++. ++..||||+++... ...++|.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3445677789999999999999975 46789999997542 23467999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999996432 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCccee--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 65433211 122345778999999999999999999999999999998 999983
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.23 Aligned_cols=201 Identities=30% Similarity=0.522 Sum_probs=176.5
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
....+++.+.||+|+||.||+++..+++.||+|++.......+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 345677889999999999999999888899999998776678899999999999999999999999864 5689999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ...+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999995432 13588999999999999999999998 999999999999999999999999999987655433
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 22233456789999999988889999999999999999999 999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.49 Aligned_cols=198 Identities=31% Similarity=0.393 Sum_probs=176.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34566788999999999999986 5899999999643 345677899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 264 Ey~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999965432 3488999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~ 386 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence 332 344689999999999999899999999999999999999999994
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=297.15 Aligned_cols=195 Identities=25% Similarity=0.398 Sum_probs=165.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---------------------------ChHHHHHHHHHHHhc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------------------------GKKEFSAEVTIIGNV 454 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~Ei~~l~~l 454 (606)
.+.+.+.||+|+||.||+++.. +++.||||++..... ..+++.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4567788999999999999975 488999999864321 135689999999999
Q ss_pred ccCCcceeecceec--cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 037563 455 HHVHLVKLKGFCIE--GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532 (606)
Q Consensus 455 ~h~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp 532 (606)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||+.||+|||++ +|+||||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 99999999999986 567899999999999988753 24589999999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 533 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP---ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 533 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999987654432 234567999999999987765 3778999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.10 Aligned_cols=199 Identities=28% Similarity=0.506 Sum_probs=177.4
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+.+.+.||+|+||.||+++..+++.||+|++.......+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 45667789999999999999998889999999987766778999999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 88 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999996532 3578999999999999999999998 99999999999999999999999999998764432222
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence 233456788999999998889999999999999999999 899984
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.04 Aligned_cols=195 Identities=31% Similarity=0.507 Sum_probs=169.7
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccc-cceeeeeec
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA-HRLLAYEYL 479 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-~~~lV~E~~ 479 (606)
...+.+.+.||+|+||.||+|.+ .++.||||+++... ..++|.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 34566778999999999999998 47899999997643 5678999999999999999999999987655 789999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp TTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999975432 3478899999999999999999998 99999999999999999999999999998543321
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22467889999999999999999999999999999999 999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.22 Aligned_cols=197 Identities=31% Similarity=0.413 Sum_probs=164.5
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHH-HHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTI-IGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~-l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.+.||+|+||.||+++.+. ++.||+|+++... ...+.+..|..+ ++.++||||+++++++.+....++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 456788999999999999999864 7889999996542 233456667666 5678999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999653 3478889999999999999999998 99999999999999999999999999998643
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... ......||+.|+|||++.+..++.++|+||||+++|||++|+.||.
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 3221 2345689999999999999999999999999999999999999984
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.91 Aligned_cols=194 Identities=30% Similarity=0.463 Sum_probs=170.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||++++. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 3566788999999999999974 5889999998643 3345689999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+ +|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 90 ~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 90 YA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99 78999988643 3588999999999999999999999 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred cc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 32 234679999999999988776 789999999999999999999984
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=299.80 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=171.2
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccc--cceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA--HRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++... ++.||||+++.. ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 35667889999999999999865 899999999754 245678899999999999999999999988655 6789999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE----cCCCcEEEeeccCCcc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKL 553 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgla~~ 553 (606)
|+++++|.+++...... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp CCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999754322 2389999999999999999999998 99999999999999 7888899999999987
Q ss_pred cCcCcceeeeecccccCcccccccc--------CCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWIT--------NNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 223 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 654432 23457899999999876 567899999999999999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.41 Aligned_cols=198 Identities=24% Similarity=0.398 Sum_probs=173.0
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
...+.+.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456788899999999999999875 58999999986543 23457899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc---CCCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgla~~ 553 (606)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998653 3588999999999999999999998 999999999999998 567899999999987
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 654332 2244679999999999999899999999999999999999999983
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=307.15 Aligned_cols=199 Identities=31% Similarity=0.421 Sum_probs=169.2
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecccc----ceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH----RLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~----~~lV~E 477 (606)
..+++.+.||+|+||.||+|++. ++.||||+++........+..|+.++++++||||+++++++.+... .++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 45677789999999999999984 7899999997665555667789999999999999999999987553 599999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-------CCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC-------EVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-------~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999954 34889999999999999999999851 23899999999999999999999999999
Q ss_pred CcccCcCcce-eeeecccccCccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREESL-VYTTLRGTRGYLAPEWITNN-----PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9876543321 22335789999999998863 45668899999999999999999983
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.63 Aligned_cols=196 Identities=22% Similarity=0.279 Sum_probs=171.4
Q ss_pred hhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+.+.||+|+||.||+++. .+++.||||++.... ..+++.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 456678899999999999996 468999999986542 345689999999999 9999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc-----EEEeeccCCcccC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-----AKVSDFGLAKLMN 555 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfgla~~~~ 555 (606)
+++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999654 24689999999999999999999998 9999999999999999887 9999999998764
Q ss_pred cCcce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 43221 1234679999999999999999999999999999999999999994
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=298.48 Aligned_cols=199 Identities=28% Similarity=0.428 Sum_probs=160.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.++||+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4566788999999999999975 48999999986432 34578899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccc--cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 480 VNGSLDKWIFNSTE--ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 480 ~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+ ++|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 599999865322 223588999999999999999999998 9999999999999999999999999999876533
Q ss_pred cceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22 2234578999999999876 468999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.32 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=173.2
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
+....+.+.+.||+|+||.||+|++. +++.||||+++.... ..++|.+|++++++++||||+++++++.+....++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 33456677899999999999999986 589999999875422 235688999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999996432 3588999999999999999999998 99999999999999999999999999998654
Q ss_pred cCcceee-eecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~ 317 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221111 11235778999999998889999999999999999999 999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.50 Aligned_cols=196 Identities=27% Similarity=0.360 Sum_probs=165.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
..+.+.+.||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 34677889999999999999986 58899999998766667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc--EEEeeccCCcccCcCc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGLAKLMNREE 558 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfgla~~~~~~~ 558 (606)
+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 100 GGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp SCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999998643 3488999999999999999999998 9999999999999987765 9999999997543222
Q ss_pred ceeeeecccccCccccccccCCCCCCc-cchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEK-SDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~-~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 2234579999999999988877655 899999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=328.06 Aligned_cols=203 Identities=30% Similarity=0.499 Sum_probs=177.7
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
++....+.+.++||+|+||.||+|++.++..||||+++......++|.+|++++++++|+||+++++++.+ ...++|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 44556677889999999999999999888899999998766667899999999999999999999999876 67899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.++|.... ...+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999996432 23588999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2222223456789999999998899999999999999999999 999984
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.53 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=174.3
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~ 469 (606)
++....+.+.+.||+|+||.||+|++. .++.||||+++... ....++.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344566778899999999999999953 36789999996532 3345789999999999999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccc---cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cE
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TA 543 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~ 543 (606)
...++||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999976542 224588999999999999999999998 999999999999999555 59
Q ss_pred EEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 544 KVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999985532211 12234567899999999999999999999999999999998 999984
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.74 Aligned_cols=195 Identities=27% Similarity=0.372 Sum_probs=166.8
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
+.+.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 56678999999999999999779999999986432 234778999999999999999999999999999999999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 84 Q-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp E-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred C-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 6 8998886432 3588899999999999999999998 999999999999999999999999999986543221
Q ss_pred eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2234578999999999876 458999999999999999999999984
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.43 Aligned_cols=198 Identities=25% Similarity=0.380 Sum_probs=164.2
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccc----
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR---- 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~---- 472 (606)
..+.+.+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3467778999999999999997 4589999999975422 235688999999999999999999998876654
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999643 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 7654322 12233568999999999999999999999999999999999999984
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=306.26 Aligned_cols=192 Identities=28% Similarity=0.431 Sum_probs=165.4
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCCh
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
.+.||+|+||.||+++.. +++.||+|+++... ...+++.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999975 58999999997543 3457899999999999999999999999999999999999999999
Q ss_pred hhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE--cCCCcEEEeeccCCcccCcCcceee
Q 037563 485 DKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL--DDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 485 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 99986432 3588999999999999999999998 99999999999999 6778999999999987654432 2
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 34579999999999999999999999999999999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=317.64 Aligned_cols=197 Identities=28% Similarity=0.357 Sum_probs=163.9
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+++.+.||+|+||.||+++.. +++.||||+++.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34677789999999999999975 4889999999642 234467888999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++...
T Consensus 228 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 228 EYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998643 358899999999999999999998 6 99999999999999999999999999998643
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 322 22345789999999999999999999999999999999999999984
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.07 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=174.6
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccCC--ChHHHHHHHHHHHhc-ccCCcceeeccee
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~ 467 (606)
.++....+.+.+.||+|+||.||++++ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 344556677889999999999999973 2468899999975432 345799999999999 7999999999988
Q ss_pred ccc-cceeeeeeccCCChhhhhhhcccc----------------------------------------------------
Q 037563 468 EGA-HRLLAYEYLVNGSLDKWIFNSTEE---------------------------------------------------- 494 (606)
Q Consensus 468 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------- 494 (606)
+.. ..++||||+++|+|.+++......
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 489999999999999999764321
Q ss_pred ----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc-eeee
Q 037563 495 ----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYT 563 (606)
Q Consensus 495 ----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 563 (606)
...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 12288999999999999999999998 999999999999999999999999999987654333 2334
Q ss_pred ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 297 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence 4678999999999999999999999999999999999 999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.36 Aligned_cols=206 Identities=27% Similarity=0.438 Sum_probs=177.2
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEecccCC--ChHHHHHHHHHHHhc-ccCCcceeecce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHLVKLKGFC 466 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~g~~ 466 (606)
++....+.+.++||+|+||.||+++.. ++..||||+++.... ..+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 455567788899999999999999852 246799999975432 346789999999999 899999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
.+....++||||+++++|.+++...... ...+++..+..|+.||+.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 9999999999999999999999764421 24589999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999987654322 22233567889999999999999999999999999999999 999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.22 Aligned_cols=189 Identities=27% Similarity=0.389 Sum_probs=151.0
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
+.||+|+||.||+++.. +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999986 4899999998643 4567889999999997 999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cEEEeeccCCcccCcCcceee
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 95 ~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 95 ERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 999653 3589999999999999999999998 999999999999998765 899999999986544322 23
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 44678999999999999999999999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.75 Aligned_cols=201 Identities=29% Similarity=0.472 Sum_probs=168.3
Q ss_pred HHHHhhccccccCCcCceeEEEEEe-----CCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceecc--c
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--A 470 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~ 470 (606)
+....+++.++||+|+||.||++++ .+++.||||++.... ...+++.+|++++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3445677889999999999999984 258899999997543 2346789999999999999999999998654 4
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5799999999999999996543 3588999999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 551 AKLMNREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 551 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
++....... .......++..|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 987654332 1223345778899999999999999999999999999999999887
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.10 Aligned_cols=195 Identities=27% Similarity=0.411 Sum_probs=156.9
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
..+++.+.||+|+||.||+++... ++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 346677899999999999999874 7899999997543 45678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcccCcC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~~~~~ 557 (606)
+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 132 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 132 GGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp SCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999998543 3588999999999999999999998 9999999999999975 889999999999865433
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 2 2234678999999999999999999999999999999999999983
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.26 Aligned_cols=203 Identities=29% Similarity=0.502 Sum_probs=173.7
Q ss_pred HHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+.+.+.||+|+||.||+++.. +++.||||+++... ...+++.+|+.++++++||||+++++++.+....
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345677789999999999999974 34889999997543 2346799999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhcccc--------------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEE--------------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp 532 (606)
++||||+++++|.+++...... ...+++..+..++.||++||.|||+. +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 9999999999999999764321 14689999999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 533 ENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 533 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+||++++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999986644322 22234567899999999998899999999999999999999 999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=300.00 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=175.0
Q ss_pred HHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~ 471 (606)
....+.+.+.||+|+||.||+++. .+++.||||++.... ...+++.+|++++++++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 345567778999999999999986 235889999997543 234678999999999999999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccc--------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTE--------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIK 531 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlk 531 (606)
.++||||+++++|.+++..... ....+++..+..++.||+.||.|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976433 123588999999999999999999998 99999999
Q ss_pred CCCeEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 532 PENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 532 p~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999876544332 2233466889999999998889999999999999999999 999984
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.65 Aligned_cols=206 Identities=29% Similarity=0.474 Sum_probs=174.9
Q ss_pred HHHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceec
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE 468 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~ 468 (606)
++....+.+.+.||+|+||.||++++ ..++.||||++... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34456678889999999999999996 23578999999743 23457899999999999 89999999999999
Q ss_pred cccceeeeeeccCCChhhhhhhcccc-------------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecC
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTEE-------------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~d 529 (606)
....++||||+++++|.+++...... ...+++..+..++.||+.||+|||+. +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999754321 13478999999999999999999998 999999
Q ss_pred CCCCCeEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 530 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999876544332 2234567889999999998899999999999999999998 999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.90 Aligned_cols=198 Identities=24% Similarity=0.325 Sum_probs=171.0
Q ss_pred HhhccccccCCcCceeEEEEEe----CCCcEEEEEEeccc-----CCChHHHHHHHHHHHhc-ccCCcceeecceecccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESI-----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~ 471 (606)
..+++.+.||+|+||.||+++. .+++.||||+++.. ....+.+.+|+++++++ +||||+++++++.+...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3567788999999999999997 36899999998643 23456788899999999 69999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999643 3588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+..............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 8765443333344679999999999885 347899999999999999999999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.24 Aligned_cols=198 Identities=27% Similarity=0.353 Sum_probs=174.9
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhc-ccCCcceeecceecccccee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l 474 (606)
...+++.+.||+|+||.||+++... ++.||||+++.. ....+.+..|..++..+ +||+|+++++++.+....++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 3456778899999999999999764 788999999642 34567788999999887 79999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 420 V~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999653 3488999999999999999999998 9999999999999999999999999999864
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 3322 22345789999999999999999999999999999999999999994
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.36 Aligned_cols=200 Identities=27% Similarity=0.428 Sum_probs=171.0
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+.+.++||+|+||.||+++.. +++.+|+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356788899999999999999975 4889999998654 3356889999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCccc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~ 554 (606)
|+++++|.+++.........+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999976544446789999999999999999999998 99999999999999 45678999999999876
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||.+. ..++.++||||||+++|||++|+.||.
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 54322 23467899999999876 468899999999999999999999984
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.05 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=173.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+++.+.||+|+||.||+++.. +++.+|+|++.... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 35677889999999999999986 48899999986543 23467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC--CCcEEEeeccCCcccCcC
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 557 (606)
++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999986432 3588999999999999999999998 9999999999999974 578999999999876554
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 32 234579999999999999999999999999999999999999984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=301.65 Aligned_cols=203 Identities=26% Similarity=0.333 Sum_probs=168.9
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc------CCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
...+++.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 456788899999999999999975 4789999998542 234578999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccc------------------------------------cccccChhhHHHHHHHHHHHHHHH
Q 037563 474 LAYEYLVNGSLDKWIFNSTE------------------------------------ESRFLCWNTRFNIALGTAKGLAYL 517 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~qi~~gL~yL 517 (606)
+||||+++++|.+++..... ....+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852110 012346677889999999999999
Q ss_pred HhcCCCceeecCCCCCCeEEcCCC--cEEEeeccCCcccCcCcc---eeeeecccccCccccccccC--CCCCCccchHH
Q 037563 518 HEECEVKIVHCDIKPENVLLDDNF--TAKVSDFGLAKLMNREES---LVYTTLRGTRGYLAPEWITN--NPISEKSDVYS 590 (606)
Q Consensus 518 H~~~~~~iiH~dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s 590 (606)
|+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 998 999999999999998776 899999999986543221 22345679999999999865 67889999999
Q ss_pred HHHHHHHHHhCCCCCC
Q 037563 591 YGMVLLEIIGGRKSFS 606 (606)
Q Consensus 591 ~Gvvl~elltG~~pfs 606 (606)
||+++|||++|+.||.
T Consensus 262 lG~il~el~~g~~pf~ 277 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHCCCCCC
Confidence 9999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.53 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=168.6
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC------CChHHHHHHHHHHHhcc---cCCcceeeccee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTIIGNVH---HVHLVKLKGFCI 467 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~ 467 (606)
++....+++.++||+|+||.||+++.. +++.||||++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 344566788899999999999999974 58899999986432 12356788888887775 999999999998
Q ss_pred ccc-----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc
Q 037563 468 EGA-----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 542 (606)
Q Consensus 468 ~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~ 542 (606)
... ..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 755 4789999997 599999865432 3489999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 543 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999987654322 244678999999999999999999999999999999999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.15 Aligned_cols=201 Identities=27% Similarity=0.314 Sum_probs=168.6
Q ss_pred ChHHHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 395 SYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 395 ~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
...++....+++.++||+|+||+||+|++. +++.||||++...... ..++..|+..+.++ +||||+++++++.++
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345667778888999999999999999986 5899999998654332 23455566655555 899999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999 779999886543 3589999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+++...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||
T Consensus 203 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 203 LLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred eeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 998765432 2234568999999998876 6899999999999999999997665
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.61 Aligned_cols=199 Identities=30% Similarity=0.367 Sum_probs=175.2
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-----cCCcceeecceecccc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-----HVHLVKLKGFCIEGAH 471 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----h~nIv~l~g~~~~~~~ 471 (606)
++....+.+.++||+|+||.||+++.. +++.||||+++......+.+..|+.++++++ ||||+++++++.....
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 344456777899999999999999985 5889999999765555677888999999996 9999999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC------------
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD------------ 539 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~------------ 539 (606)
.++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence 99999999 9999999975432 3488999999999999999999998 9999999999999976
Q ss_pred -------------CCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 540 -------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 540 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 7899999999998654332 34578999999999999999999999999999999999999984
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.91 Aligned_cols=199 Identities=29% Similarity=0.477 Sum_probs=166.0
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-Cc----EEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
...+++.+.||+|+||.||+|++.. ++ .||+|.+... ....+++.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3456777899999999999999643 43 4688887543 345678999999999999999999999998754 78
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+||+++|+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999997543 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 654433 22234566889999999999999999999999999999999 999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=296.94 Aligned_cols=196 Identities=32% Similarity=0.510 Sum_probs=162.5
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
..+++.+.||+|+||.||+++. .++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 3456778899999999999998 4788999998643 346789999999999999999999999874 47999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc-EEEeeccCCcccCcCcce
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-AKVSDFGLAKLMNREESL 560 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 560 (606)
++|.+++..... ...+++..+..++.||++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999975432 234788899999999999999999932238999999999999998886 7999999997654322
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 23468999999999999999999999999999999999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.69 Aligned_cols=193 Identities=26% Similarity=0.424 Sum_probs=163.0
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHh--cccCCcceeecceecc----ccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGN--VHHVHLVKLKGFCIEG----AHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~~~----~~~~lV 475 (606)
..+.+.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 4567788999999999999998 7899999998653 34556667777666 7999999999987543 457899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCCeEEcCCCcEEEee
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH--------EECEVKIVHCDIKPENVLLDDNFTAKVSD 547 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~iiH~dlkp~NIll~~~~~~kl~D 547 (606)
|||+++|+|.+++.. ..+++..+..++.||+.||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 85 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp ECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred hhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999943 35889999999999999999999 66 999999999999999999999999
Q ss_pred ccCCcccCcCccee---eeecccccCccccccccCC------CCCCccchHHHHHHHHHHHhC----------CCCC
Q 037563 548 FGLAKLMNREESLV---YTTLRGTRGYLAPEWITNN------PISEKSDVYSYGMVLLEIIGG----------RKSF 605 (606)
Q Consensus 548 fgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~~Dv~s~Gvvl~elltG----------~~pf 605 (606)
||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99998665443321 2234789999999998876 445799999999999999999 8887
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.13 Aligned_cols=196 Identities=23% Similarity=0.385 Sum_probs=173.4
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
...+.+.+.||+|+||.||+++... +..+|+|++... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3457778899999999999999865 678999998654 45578899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCcccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~~ 555 (606)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998643 3488999999999999999999998 99999999999999 788999999999998765
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||.
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred Cccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCC
Confidence 4332 2345789999999988765 8999999999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.94 Aligned_cols=195 Identities=22% Similarity=0.334 Sum_probs=167.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.++||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3566789999999999999986 488999999964432 236788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 83 CDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 986 555555432 24589999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeeecccccCccccccccCCC-CCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
. ......+|+.|+|||.+.+.. ++.++||||||+++|||++|+.||
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 2 223457899999999987765 799999999999999999998885
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.19 Aligned_cols=197 Identities=26% Similarity=0.438 Sum_probs=175.0
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-------ChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+.+.+.||+|+||.||+++.. +++.||+|++..... ..+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456788899999999999999986 488999999864321 357899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC----cEEEeec
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDF 548 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 548 (606)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999642 3588999999999999999999998 999999999999999888 7999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 99987654322 234578999999999999999999999999999999999999983
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.41 Aligned_cols=206 Identities=29% Similarity=0.483 Sum_probs=175.5
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceec
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE 468 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~ 468 (606)
++....+.+.+.||+|+||.||+++... ...||+|++.... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4445667778999999999999999743 2479999997543 2346789999999999 89999999999999
Q ss_pred cccceeeeeeccCCChhhhhhhcccc----------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTEE----------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
....++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 99999999999999999999754211 23578999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 539 DNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999876544332 2233567889999999998899999999999999999999 999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.41 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=160.1
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
....+++.+.||+|+||.||+|++.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++. ....+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567788999999999999999753 45799999865432 3467899999999999999999999985 46689
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999996532 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 65443333334567889999999998899999999999999999997 999984
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.50 Aligned_cols=200 Identities=20% Similarity=0.226 Sum_probs=172.4
Q ss_pred HhhccccccCCc--CceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G--~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.++||+| +||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 356778899999 99999999986 589999999975432 235688899999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 105 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999975432 3588999999999999999999998 99999999999999999999999999986543
Q ss_pred cCcc------eeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES------LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 2211 11122468899999999987 578999999999999999999999984
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.93 Aligned_cols=197 Identities=26% Similarity=0.370 Sum_probs=172.4
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---------ChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
...+.+.+.||+|+||.||+++.. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456777889999999999999964 588999999965421 3346788999999999999999999999999
Q ss_pred cceeeeeeccCC-ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 471 HRLLAYEYLVNG-SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 471 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
..++||||+.+| +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 999998543 3588999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 9987654432 234578999999999988776 789999999999999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=297.18 Aligned_cols=205 Identities=28% Similarity=0.483 Sum_probs=176.7
Q ss_pred HHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccCC--ChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||++++ .+++.||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3445677889999999999999985 2468899999975432 346799999999999 999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhcccc--------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEE--------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
...++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 9999999999999999999764321 23589999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++++++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999998776544322 233557889999999999999999999999999999999 999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=287.15 Aligned_cols=197 Identities=24% Similarity=0.439 Sum_probs=171.8
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-------CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+++.+.||+|+||.||+++.. +++.||+|+++... ...+++.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456788899999999999999986 48999999986432 1367899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC----cEEEeec
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDF 548 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Df 548 (606)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999999643 3588999999999999999999998 999999999999999877 8999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 99987654322 234568999999999999999999999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.40 Aligned_cols=200 Identities=22% Similarity=0.286 Sum_probs=165.0
Q ss_pred HHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEecccCC------------ChHHHHHHHHHHHhcccCCcce
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ------------GKKEFSAEVTIIGNVHHVHLVK 461 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~h~nIv~ 461 (606)
....+.+.+.||+|+||.||++++.. ++.||||++..... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 33467778999999999999999865 37899999865421 1123344555666778999999
Q ss_pred eecceecc----ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE
Q 037563 462 LKGFCIEG----AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 462 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll 537 (606)
+++++... ...++||||+ +++|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998875 4579999999 999999996532 4589999999999999999999998 99999999999999
Q ss_pred c--CCCcEEEeeccCCcccCcCcce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 538 D--DNFTAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 538 ~--~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+ .++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9 8899999999999876543221 1123459999999999999999999999999999999999999994
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=290.97 Aligned_cols=196 Identities=32% Similarity=0.535 Sum_probs=160.1
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccC-----CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||++++ .++.||||+++... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3456778999999999999998 48899999986432 33478999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC--------CCcEEEeec
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD--------NFTAKVSDF 548 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~--------~~~~kl~Df 548 (606)
||+++++|.+++.. ..+++..+..++.|++.||.|||++...+++||||||+||++++ ++.+||+||
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999842 35889999999999999999999982222999999999999986 778999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99986544322 24578999999999999899999999999999999999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=310.62 Aligned_cols=195 Identities=30% Similarity=0.456 Sum_probs=172.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3566788999999999999986 5899999999643 2345689999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 97 YVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp CCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999542 4589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 170 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp CC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 22 234679999999999988765 689999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.42 Aligned_cols=197 Identities=27% Similarity=0.438 Sum_probs=153.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 3566788999999999999974 6899999999643 2345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 92 MCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp CCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred cCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999996432 4588999999999999999999998 9999999999999999999999999999876533
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 221 223568999999999998889999999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.50 Aligned_cols=198 Identities=22% Similarity=0.306 Sum_probs=162.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++.. +++.||+|++..... ..+++.+|+.++++++||||+++++++.++...++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34677789999999999999976 588999999965422 2367899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999643 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 43333345678999999999999999999999999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.19 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=158.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcc-cCCcceeecceeccc--cc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGA--HR 472 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~--~~ 472 (606)
....+.+.+.||+|+||.||++++. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3456778899999999999999975 48999999986432 23456788999999997 999999999997544 67
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 589988854 3578889999999999999999998 99999999999999999999999999998
Q ss_pred ccCcC--------------------cceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNRE--------------------ESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 65321 1112344679999999999876 678999999999999999999999993
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.38 Aligned_cols=206 Identities=30% Similarity=0.446 Sum_probs=174.7
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEe-----CCCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecce
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
....++....+++.+.||+|+||.||++++ .+++.||+|++... ....+.+.+|++++++++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 333444455677889999999999999983 35899999999644 34557899999999999999999999999
Q ss_pred ecc--ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 467 IEG--AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 467 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
.+. ...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence 876 56789999999999999996533 3488999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 545 VSDFGLAKLMNREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 545 l~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 999999987765433 1223456788899999999988999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.16 Aligned_cols=195 Identities=24% Similarity=0.367 Sum_probs=163.7
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhccc--CCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHH--VHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||++...+++.||||++..... ..+.+.+|+.++.+++| +||+++++++.+....++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 4567789999999999999998899999999865433 23678999999999986 999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+.+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 90 -~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 90 -CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp -CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred -CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 5688999999653 3588999999999999999999998 999999999999997 578999999999876544
Q ss_pred cce-eeeecccccCccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESL-VYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 322 2335679999999999864 678899999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.55 Aligned_cols=197 Identities=30% Similarity=0.488 Sum_probs=166.4
Q ss_pred hhccccccCCcCceeEEEEEeCC-Cc----EEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.+.+.+.||+|+||.||+|++.. ++ .|++|.+... ....+++.+|+.++++++||||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 45667889999999999999753 43 3888887543 234467889999999999999999999886 5668899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999653 24688999999999999999999998 99999999999999999999999999998775
Q ss_pred cCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 4433 22344567889999999998999999999999999999999 999984
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.40 Aligned_cols=188 Identities=26% Similarity=0.326 Sum_probs=157.1
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHH-hcccCCcceeecceec----cccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIG-NVHHVHLVKLKGFCIE----GAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~-~l~h~nIv~l~g~~~~----~~~~~lV~E~~~~ 481 (606)
+.||+|+||.||+++.. +++.||||+++. ...+.+|+.++. ..+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 67999999999999986 488999999863 356778888874 4589999999998875 6678999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcccCcCc
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~~~~~~ 558 (606)
|+|.+++..... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 144 g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 144 GELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp EEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999999965322 3589999999999999999999998 9999999999999997 7899999999998755332
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 2345678999999999999999999999999999999999999983
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=298.83 Aligned_cols=204 Identities=25% Similarity=0.421 Sum_probs=159.4
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCC----cEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDG----IQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~----~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
....+.+.+.||+|+||.||++++... ..||||+++.. ....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345677788999999999999997653 27999999653 23457899999999999999999999999877655
Q ss_pred ------eeeeeeccCCChhhhhhhcccc--ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 473 ------LLAYEYLVNGSLDKWIFNSTEE--SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 473 ------~lV~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
++||||+++++|.+++...... ...+++..+..++.||+.||.|||++ +|+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 8999999999999999654322 22588999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 545 VSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 241 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999999987644332 12223456789999999999999999999999999999999 999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.07 Aligned_cols=194 Identities=27% Similarity=0.431 Sum_probs=168.9
Q ss_pred HHhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
...+...+.||+|+||.||+++. .+++.||||++..... ..+++.+|++++++++||||+++++++.++...++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34466778899999999999996 4689999999965432 235789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||++ |+|.+++.... ..+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 68888875432 4588999999999999999999998 99999999999999999999999999998765
Q ss_pred cCcceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ....||+.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 33 2357899999999884 5678999999999999999999999983
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.22 Aligned_cols=206 Identities=25% Similarity=0.466 Sum_probs=175.3
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC--------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecce
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~ 466 (606)
++....+.+.+.||+|+||.||++++. +++.||+|+++... ...+++.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 444567788899999999999999863 46789999997543 2346789999999999 899999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
.+....++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999764321 23488999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999876544322 1233456889999999988889999999999999999999 999984
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=287.36 Aligned_cols=194 Identities=28% Similarity=0.432 Sum_probs=168.6
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++... ++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 35667889999999999999765 678999998543 2345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 90 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999643 3488999999999999999999998 9999999999999999999999999998654332
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence 2 234578999999999999999999999999999999999999984
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.50 Aligned_cols=199 Identities=28% Similarity=0.418 Sum_probs=161.6
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---------CChHHHHHHHHHHHhcccCCcceeeccee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---------QGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~ 467 (606)
+.....+.+.+.||+|+||.||+++... ++.||||++.... .....+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445677888999999999999999764 7899999986431 12235889999999999999999999975
Q ss_pred ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---CcEE
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAK 544 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~---~~~k 544 (606)
. ...++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ ..+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 4 4578999999999999988543 4589999999999999999999998 99999999999999754 4599
Q ss_pred EeeccCCcccCcCcceeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 545 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999998765432 2345679999999999853 567889999999999999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=285.36 Aligned_cols=198 Identities=30% Similarity=0.428 Sum_probs=172.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
..+++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677889999999999999986 58899999986432 3357899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998532 3588999999999999999999998 99999999999999999999999999998654332
Q ss_pred c-eeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 S-LVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 2 12234578999999999987665 778999999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=291.19 Aligned_cols=196 Identities=26% Similarity=0.381 Sum_probs=165.5
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.++||+|+||.||+++... ++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 35667899999999999999865 899999998654432 45688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 84 CDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999987533 3488999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 2 2234578999999999876 567999999999999999999999984
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=286.89 Aligned_cols=200 Identities=25% Similarity=0.449 Sum_probs=174.2
Q ss_pred hHHHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec------
Q 037563 396 YDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE------ 468 (606)
Q Consensus 396 ~~el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------ 468 (606)
..+.....+++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34555677888899999999999999986 68999999986542 467889999999999999999998854
Q ss_pred ----------cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc
Q 037563 469 ----------GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 469 ----------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~ 538 (606)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+. +|+|+||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 445789999999999999997543 24688999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 539 DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 999999999999987654332 23456899999999999999999999999999999999999886
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=285.28 Aligned_cols=195 Identities=27% Similarity=0.463 Sum_probs=171.5
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.+.||+|+||.||++.... ++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 45677889999999999999764 88999999965432 236788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EEEeeccCCcccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFGLAKLMN 555 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfgla~~~~ 555 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++||||||+||+++.++. +||+|||++....
T Consensus 87 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 87 VTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999988643 3588999999999999999999998 9999999999999987655 9999999998765
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 4332 234678999999999999999999999999999999999999983
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.52 Aligned_cols=192 Identities=26% Similarity=0.292 Sum_probs=160.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccc------cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~ 472 (606)
.+++.+.||+|+||.||+++.. +++.||||++.... ...+++.+|+.+++.++||||+++++++.... ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3566788999999999999975 48899999997542 23467889999999999999999999987553 46
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||++++ |.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 143 ~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred EEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 9999999865 555552 2378899999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 765432 2345689999999999999999999999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=288.46 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=171.8
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+.+.+.||+|+||.||+++. .+++.||||++... ...+++.+|+.+++++ +|+|++++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 3466778899999999999996 46899999998643 3345688999999999 7999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc-----EEEeeccCCccc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-----AKVSDFGLAKLM 554 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfgla~~~ 554 (606)
+++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 89 -~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 89 -GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999996532 3589999999999999999999998 9999999999999987776 999999999876
Q ss_pred CcCcce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 543221 1234578999999999999999999999999999999999999984
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.41 Aligned_cols=195 Identities=25% Similarity=0.441 Sum_probs=168.6
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-C-------cEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-G-------IQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~-------~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||+++... + ..||+|++.... ...+.+.+|++++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 334566778899999999999999754 2 579999996543 4457899999999999999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc-------
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT------- 542 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~------- 542 (606)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999996532 3488999999999999999999998 9999999999999998887
Q ss_pred -EEEeeccCCcccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCC
Q 037563 543 -AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 543 -~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
+||+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 999999999765432 22457889999999987 6789999999999999999995444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.66 Aligned_cols=195 Identities=24% Similarity=0.368 Sum_probs=164.9
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcc--cCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVH--HVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||++...+++.||||++..... ..+++.+|+.++.+++ ||||+++++++......++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 4677789999999999999998899999999865432 3467899999999996 5999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+.+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 137 -~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 137 -CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp -CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred -cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 5788999999653 3578889999999999999999998 999999999999995 579999999999876543
Q ss_pred cc-eeeeecccccCccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES-LVYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~-~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 32 22345679999999999865 368899999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.25 Aligned_cols=193 Identities=32% Similarity=0.549 Sum_probs=166.0
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--------ChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
..+++.+.||+|+||.||++++. +++.||+|++..... ..+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 45677789999999999999985 588999999854321 1267899999999999999999999987655
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEcCCCc-----EEE
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFT-----AKV 545 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~~~~~-----~kl 545 (606)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. + ++||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999886533 3589999999999999999999998 7 999999999999988776 999
Q ss_pred eeccCCcccCcCcceeeeecccccCccccccc--cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 546 SDFGLAKLMNREESLVYTTLRGTRGYLAPEWI--TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 546 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|||+++..... .....+|+.|+|||.+ ....++.++||||||+++|||++|+.||.
T Consensus 171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999854332 3446789999999998 44567899999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=296.39 Aligned_cols=195 Identities=23% Similarity=0.411 Sum_probs=168.5
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
...+++.+.||+|+||.||+++.+ +++.||||+++.... ...+|++++.++ +||||+++++++.++...++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 356778899999999999999986 488999999975432 345688888888 799999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC----CcEEEeeccCCccc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLM 554 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgla~~~ 554 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998643 3588999999999999999999998 99999999999998543 35999999999876
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 54332 2234678999999999988888999999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.47 Aligned_cols=197 Identities=27% Similarity=0.442 Sum_probs=171.7
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---------hHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---------KKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---------~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
...+++.+.||+|+||.||++++. +|+.||||+++..... .+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 345677789999999999999986 5899999998654311 35678899999999 799999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999643 3588999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccC------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9987654332 234678999999998863 357889999999999999999999983
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.28 Aligned_cols=204 Identities=30% Similarity=0.516 Sum_probs=161.6
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccc
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~ 470 (606)
+...|+....+.+.++||+|+||.||++++.+ .||+|+++.... ..+.+.+|++++++++||||+++++++ ...
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34446666778888999999999999999743 599999975433 246789999999999999999999965 456
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence 6899999999999999996432 4588999999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCcc-eeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREES-LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++....... .......||+.|+|||.+. +..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 986543222 2234467899999999886 5678889999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.80 Aligned_cols=195 Identities=27% Similarity=0.394 Sum_probs=172.9
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++... ++.||+|++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 346777899999999999999864 788999998543 334578999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999653 3488999999999999999999998 999999999999999999999999999976543
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 22 234578999999999999999999999999999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=285.16 Aligned_cols=193 Identities=23% Similarity=0.383 Sum_probs=167.2
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc--ccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+|++ +++.||||+++.... ..+++.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4567778999999999999998 488999999975432 346799999999999999999999999877 7789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||+++++|.+++..... ..+++..+..++.||+.||.|||+. + ++|+||||+||++++++.+||.|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999975332 3589999999999999999999997 7 999999999999999999999999887643
Q ss_pred CcCcceeeeecccccCccccccccCCCCCC---ccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISE---KSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ...+|+.|+|||.+.+...+. ++||||||+++|||++|+.||.
T Consensus 164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 246789999999998765544 7999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=289.86 Aligned_cols=197 Identities=30% Similarity=0.482 Sum_probs=169.1
Q ss_pred hhcccc-ccCCcCceeEEEEEeC---CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 403 TKNFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~-~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+.+.+ .||+|+||.||+|++. +++.||||+++... ...+++.+|++++++++||||+++++++ +....++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999864 57889999997643 2356799999999999999999999999 556689999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999643 24588999999999999999999998 999999999999999999999999999987754
Q ss_pred Cccee--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 557 EESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 557 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 43321 123456889999999988889999999999999999999 999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.22 Aligned_cols=196 Identities=25% Similarity=0.363 Sum_probs=172.4
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++..+ ++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 45667889999999999999864 7889999986542 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 96 LCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp CCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999988543 3588999999999999999999998 9999999999999999999999999999876433
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 2234578999999999998889999999999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.45 Aligned_cols=207 Identities=23% Similarity=0.389 Sum_probs=175.7
Q ss_pred ccChHHHHHHhhccc-cccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcc-cCCcceeecce
Q 037563 393 RFSYDDLCKATKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVH-HVHLVKLKGFC 466 (606)
Q Consensus 393 ~~~~~el~~~~~~~~-~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~ 466 (606)
.|...+.....+.+. +.||+|+||.||+++.. +++.||+|+++... ....++.+|+.++.+++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455556666667776 78999999999999976 48999999986542 34578999999999995 69999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcE
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTA 543 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~ 543 (606)
.+....++||||+++++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999985432 24689999999999999999999998 9999999999999998 7899
Q ss_pred EEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 544 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999987654322 234578999999999999999999999999999999999999983
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.96 Aligned_cols=195 Identities=18% Similarity=0.200 Sum_probs=159.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHH---HHHHhcccCCcceeec-------cee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEV---TIIGNVHHVHLVKLKG-------FCI 467 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei---~~l~~l~h~nIv~l~g-------~~~ 467 (606)
.+.+.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+ +++++++||||+++++ ++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 3456688999999999999974 5899999999632 23457889999 5555668999999984 444
Q ss_pred ccc-----------------cceeeeeeccCCChhhhhhhccc---cccccChhhHHHHHHHHHHHHHHHHhcCCCceee
Q 037563 468 EGA-----------------HRLLAYEYLVNGSLDKWIFNSTE---ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527 (606)
Q Consensus 468 ~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH 527 (606)
+.+ ..++||||+ +|+|.+++..... ....+++..+..|+.||+.||+|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 332 378999999 6899999975321 123455688899999999999999998 9999
Q ss_pred cCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCC-----------CCCCccchHHHHHHHH
Q 037563 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-----------PISEKSDVYSYGMVLL 596 (606)
Q Consensus 528 ~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~Dv~s~Gvvl~ 596 (606)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++||||||+++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986432 2344567 999999999887 8999999999999999
Q ss_pred HHHhCCCCCC
Q 037563 597 EIIGGRKSFS 606 (606)
Q Consensus 597 elltG~~pfs 606 (606)
||++|+.||.
T Consensus 305 elltg~~Pf~ 314 (377)
T 3byv_A 305 WIWCADLPIT 314 (377)
T ss_dssp HHHHSSCCC-
T ss_pred HHHHCCCCCc
Confidence 9999999983
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=288.46 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=170.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeeccee--ccccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCI--EGAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~lV~ 476 (606)
.+++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4566788999999999999986 58999999997543 23467899999999999999999999875 356789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc-----eeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK-----IVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
||+++++|.+++.........+++..+..++.||+.||+|||+. + ++|+||||+||++++++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999976544445689999999999999999999998 7 999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 876543221 123568999999999999899999999999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.60 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=173.1
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||+++..+ ++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 345667889999999999999865 7889999986542 23467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988543 3588999999999999999999998 999999999999999999999999999987643
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 322 2234578999999999999889999999999999999999999984
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.77 Aligned_cols=191 Identities=28% Similarity=0.405 Sum_probs=160.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccc------cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~ 472 (606)
.+.+.+.||+|+||.||+++.. +++.||||++...... .+++.+|++++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4566788999999999999975 5899999999654322 457889999999999999999999987653 45
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 9999999 8899999854 3488899999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||.+.+ ..++.++||||+|++++||++|+.||.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 75432 234578999999999877 678999999999999999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.75 Aligned_cols=201 Identities=22% Similarity=0.278 Sum_probs=165.2
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeC----CCcEEEEEEecccCC------------ChHHHHHHHHHHHhcccCCcc
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIGQ------------GKKEFSAEVTIIGNVHHVHLV 460 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~h~nIv 460 (606)
.++....+.+.+.||+|+||.||+++.. .+..+|+|++..... ..+.+.+|+..+..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3444556778899999999999999986 467899999865422 123467788889999999999
Q ss_pred eeecceec----cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 037563 461 KLKGFCIE----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536 (606)
Q Consensus 461 ~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIl 536 (606)
++++++.+ ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 183 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL 183 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence 99999987 67889999999 99999998543 2689999999999999999999998 9999999999999
Q ss_pred EcCCC--cEEEeeccCCcccCcCcce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 537 LDDNF--TAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 537 l~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99887 9999999999876533211 113457899999999999999999999999999999999999999
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=289.81 Aligned_cols=196 Identities=24% Similarity=0.354 Sum_probs=163.6
Q ss_pred hccc-cccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeec
Q 037563 404 KNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 404 ~~~~-~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
+.+. +.||+|+||.||+++.. +++.||||+++... ...+.+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 4443 57999999999999965 58999999997543 4467899999999985 7999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EEEeeccCCcccCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFGLAKLMNR 556 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfgla~~~~~ 556 (606)
++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 94 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 94 RGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred CCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999653 3588999999999999999999998 9999999999999998776 99999999986542
Q ss_pred Ccc------eeeeecccccCccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EES------LVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 211 11223468999999999875 457899999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=286.04 Aligned_cols=197 Identities=24% Similarity=0.356 Sum_probs=170.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
...+++.+.||+|+||.||+++.. +++.||+|++.... ....++.+|+..+.++ +||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456777899999999999999986 58999999997542 2356788999999999 899999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---------------
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN--------------- 540 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~--------------- 540 (606)
|||+++++|.+++.........+++..+..++.||+.||.|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976544335689999999999999999999998 99999999999999844
Q ss_pred ----CcEEEeeccCCcccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCC
Q 037563 541 ----FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 541 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..+||+|||++....... ...+|+.|+|||.+.+. .++.++||||||+++|||++|++|+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998765432 24589999999998766 5668999999999999999998875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.79 Aligned_cols=196 Identities=28% Similarity=0.447 Sum_probs=171.4
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
...+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999976 58999999997543 3446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCcccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~~ 555 (606)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998543 3588999999999999999999998 99999999999999 788999999999997654
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 321 223568999999999999999999999999999999999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.76 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=170.0
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccc--cceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA--HRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~E 477 (606)
.+.+.+.||+|+||.||++++.. ++.||||+++.. ....+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 35667889999999999999865 899999999754 244678899999999999999999999988755 6799999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE----cCCCcEEEeeccCCcc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKL 553 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfgla~~ 553 (606)
|+++++|.+++...... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 90 ~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred cCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999654322 2389999999999999999999998 99999999999999 7888899999999987
Q ss_pred cCcCcceeeeecccccCccccccccC--------CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITN--------NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 654432 234678999999998865 45678999999999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.88 Aligned_cols=192 Identities=27% Similarity=0.388 Sum_probs=151.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc-----ccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~ 472 (606)
..+++.+.||+|+||.||++++. +++.||||++..... ..+++.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 35677889999999999999976 588999999965432 346788999999999999999999998543 568
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+ +++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 56899888532 4589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcc--------------------------eeeeecccccCccccccc-cCCCCCCccchHHHHHHHHHHHhC
Q 037563 553 LMNREES--------------------------LVYTTLRGTRGYLAPEWI-TNNPISEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 553 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~s~Gvvl~elltG 601 (606)
....... ...+...||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 123445789999999976 556799999999999999999994
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.05 Aligned_cols=205 Identities=27% Similarity=0.465 Sum_probs=173.9
Q ss_pred HHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccCC--ChHHHHHHHHHHHhc-ccCCcceeecceecc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHLVKLKGFCIEG 469 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~ 469 (606)
+....+.+.+.||+|+||.||++++ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3456677889999999999999984 3468899999975432 345789999999999 799999999998765
Q ss_pred c-cceeeeeeccCCChhhhhhhcccc------------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeE
Q 037563 470 A-HRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVL 536 (606)
Q Consensus 470 ~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIl 536 (606)
. ..++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 4 589999999999999999765432 12378899999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 537 LDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 537 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999987654433 22234567889999999999999999999999999999998 999984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.64 Aligned_cols=195 Identities=29% Similarity=0.402 Sum_probs=173.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3566788999999999999975 5889999999644 345688999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.. ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 103 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp TTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999853 3588999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 2234578999999999999999999999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=289.87 Aligned_cols=201 Identities=26% Similarity=0.445 Sum_probs=164.1
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
..+.+.+.||+|+||.||++... +++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 35677889999999999999974 68999999997532 23467899999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999976444445688999999999999999999998 999999999999999999999999999986644
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 322 1234568999999999999999999999999999999999999983
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=302.44 Aligned_cols=195 Identities=24% Similarity=0.325 Sum_probs=170.8
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhc------ccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNV------HHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l------~h~nIv~l~g~~~~~~~~~l 474 (606)
..+++.+.||+|+||.||+++... ++.||||+++......+++.+|+.+++.+ +|+||+++++++......++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 346778899999999999998764 88999999976554557788899999888 56799999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc--EEEeeccCCc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGLAK 552 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfgla~ 552 (606)
||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 177 v~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999996 699999865432 3488999999999999999999998 9999999999999999987 9999999997
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 65432 234578999999999999999999999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=282.77 Aligned_cols=192 Identities=25% Similarity=0.449 Sum_probs=165.7
Q ss_pred hccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceec----cccceee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLA 475 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV 475 (606)
+.+.+.||+|+||.||+|.... +..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 4566789999999999999754 78899999865432 34678999999999999999999998865 3567999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEc-CCCcEEEeeccCCc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLD-DNFTAKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfgla~ 552 (606)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. + ++|+||||+||+++ +++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999643 3588999999999999999999998 7 99999999999998 88999999999997
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 654432 234578999999998774 58999999999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.05 Aligned_cols=199 Identities=29% Similarity=0.505 Sum_probs=164.3
Q ss_pred HhhccccccCCcCceeEEEEEeCC-----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.+.||+|+||.||+|++.. +..||||+++.... ...++.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 445566889999999999998753 24699999975432 34578999999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999996532 3588999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 555 NREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 555 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 543321 1223346788999999999999999999999999999999 999983
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.52 Aligned_cols=197 Identities=27% Similarity=0.422 Sum_probs=166.4
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
..+.+.+.||+|+||.||+++... ++.||+|++...... .+.+.+|++++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 346677899999999999999865 899999998654332 3567899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999998886432 3488999999999999999999998 9999999999999999999999999999865443
Q ss_pred cceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 22 22345789999999998775 68999999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=317.00 Aligned_cols=191 Identities=30% Similarity=0.490 Sum_probs=162.9
Q ss_pred ccCCcCceeEEEEEeC---CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 409 KLGQGGFGSVYLGMLP---DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
+||+|+||.||+|.+. ++..||||+++.. ....+++.+|++++++++||||+++++++.+ ...++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 4678999999754 3456889999999999999999999999976 56899999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee--
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-- 561 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 561 (606)
|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999643 24589999999999999999999998 99999999999999999999999999998765433211
Q ss_pred eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122345689999999998999999999999999999998 999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.87 Aligned_cols=201 Identities=29% Similarity=0.423 Sum_probs=170.4
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
+.....+++.+.||+|+||.||+++... ++.||+|++... ...+++.+|+.++.+++||||+++++++.+....++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3345567778899999999999999864 899999999754 34678999999999999999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998632 24588999999999999999999998 999999999999999999999999999987644
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 322 1234578999999999999889999999999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=290.78 Aligned_cols=210 Identities=25% Similarity=0.432 Sum_probs=164.2
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecce
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
+.-..+....+.+.+.||+|+||.||++++.. ++.||+|+++.... ..+++.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 33334445667778899999999999998642 45899999875432 236789999999999999999999999
Q ss_pred ecccc-----ceeeeeeccCCChhhhhhhcc--ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC
Q 037563 467 IEGAH-----RLLAYEYLVNGSLDKWIFNST--EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539 (606)
Q Consensus 467 ~~~~~-----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~ 539 (606)
.+... .++||||+++++|.+++.... .....+++..+..++.||+.||.|||+. +|+||||||+||++++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 87653 489999999999999985432 2235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 540 NFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 540 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 251 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence 99999999999987654322 12233467889999999999999999999999999999999 888884
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.04 Aligned_cols=206 Identities=26% Similarity=0.457 Sum_probs=174.5
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~ 469 (606)
++....+.+.+.||+|+||.||+|+.. .++.||+|++..... ...++.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344456778899999999999999864 267899999975432 345689999999999999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhcccc------ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEE------SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
...++||||+++++|.+++...... ...+++..+.+++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 9999999999999999999653211 13468899999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 544 KVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 999999998664433211 123456889999999998899999999999999999999 899984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.96 Aligned_cols=196 Identities=27% Similarity=0.347 Sum_probs=164.4
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc-----------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG----------- 469 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~----------- 469 (606)
..+.+.+.||+|+||.||+++.. +++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 45677789999999999999974 589999999865422 234799999999999999999998543
Q ss_pred ---------------------------ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCC
Q 037563 470 ---------------------------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522 (606)
Q Consensus 470 ---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~ 522 (606)
...++||||++ ++|.+.+.........+++..+..++.||++||.|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 33789999998 588888865444446789999999999999999999998
Q ss_pred CceeecCCCCCCeEEc-CCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHh
Q 037563 523 VKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIG 600 (606)
Q Consensus 523 ~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~ellt 600 (606)
+|+||||||+||+++ +++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+|+++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999987654332 2345789999999988765 48999999999999999999
Q ss_pred CCCCCC
Q 037563 601 GRKSFS 606 (606)
Q Consensus 601 G~~pfs 606 (606)
|+.||.
T Consensus 238 g~~pf~ 243 (383)
T 3eb0_A 238 GKPLFS 243 (383)
T ss_dssp SSCSSC
T ss_pred CCCCCC
Confidence 999984
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=286.17 Aligned_cols=198 Identities=29% Similarity=0.439 Sum_probs=166.5
Q ss_pred HhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+.+.+.||+|+||.||+|++.+ +..||+|++.... ...+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 456677899999999999998643 3469999987542 235679999999999999999999999865 456899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 91 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999996532 3488999999999999999999998 99999999999999999999999999998765
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 543333344567889999999998899999999999999999998 999983
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.31 Aligned_cols=198 Identities=24% Similarity=0.328 Sum_probs=167.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceecc--------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-------- 469 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-------- 469 (606)
..+.+.++||+|+||.||+++.. +++.||+|++.... .....+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 45677889999999999999984 58999999985432 2346788999999999999999999998873
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||+++ +|.+.+.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467899999986 7777775432 3488999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcc---eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREES---LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 9987643221 22344678999999998876 457999999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.63 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=172.6
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
....+++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567888999999999999999986 5889999998542 34567899999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc---CCCcEEEeeccCCc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgla~ 552 (606)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999988643 3588999999999999999999998 999999999999995 45679999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||.
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 765432 2344679999999999876 48999999999999999999999983
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.38 Aligned_cols=198 Identities=29% Similarity=0.448 Sum_probs=165.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceec------ccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE------GAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~------~~~~~l 474 (606)
.+++.+.||+|+||.||+++.. +++.||||++.......+++.+|+.+++++ +||||+++++++.. ....++
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 3566788999999999999975 588999999987666778999999999999 79999999999976 457899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 999999999999997543 24688999999999999999999998 9999999999999999999999999999865
Q ss_pred CcCcceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......+++.|+|||.+. +..++.++||||||+++|||++|+.||.
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 43321 123457899999999987 5678899999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=290.88 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=168.8
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeeccee----ccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCI----EGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~----~~~~~~lV 475 (606)
..+.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4567788999999999999997 468999999986432 34567899999999999999999999987 34577899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.........+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999976544456789999999999999999999998 99999999999999999999999999987654
Q ss_pred cCcce--------eeeecccccCccccccccCCC---CCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESL--------VYTTLRGTRGYLAPEWITNNP---ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 246 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence 22110 011245699999999987654 688999999999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=300.63 Aligned_cols=195 Identities=28% Similarity=0.413 Sum_probs=163.1
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc-----ccce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRL 473 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~ 473 (606)
.+.+.+.||+|+||.||+++... ++.||||++..... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 46677899999999999999764 78999999975432 246789999999999999999999999766 5689
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||++ ++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 9999986 5999998542 4589999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcc---------------------eeeeecccccCccccccc-cCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES---------------------LVYTTLRGTRGYLAPEWI-TNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... ...+...||+.|+|||.+ ....++.++|||||||++|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 654321 123456889999999986 5567999999999999999999865554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.52 Aligned_cols=194 Identities=30% Similarity=0.386 Sum_probs=161.2
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc------ccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~~lV~ 476 (606)
+.+.+.||+|+||.||++++. +++.||||++.... +...+|++++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 556688999999999999986 48999999986432 2335799999999999999999998542 2367999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-CcEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfgla~~~~ 555 (606)
||+++ +|.+.+.........+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 66666654333345689999999999999999999998 99999999999999965 678999999998765
Q ss_pred cCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 4332 2345789999999998765 78999999999999999999999994
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=287.63 Aligned_cols=190 Identities=24% Similarity=0.379 Sum_probs=167.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceec--cccceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIE--GAHRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~--~~~~~lV~E 477 (606)
..+.+.+.||+|+||.||+++.. +++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 45677789999999999999864 588999999864 34678999999999997 9999999999987 567899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 556 (606)
|+++++|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999883 378889999999999999999998 999999999999999776 899999999987654
Q ss_pred CcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 332 234578999999999877 67899999999999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=293.64 Aligned_cols=196 Identities=26% Similarity=0.408 Sum_probs=162.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
++.+.++||+|+||.||+++.. +++.||+|+++.... ....+.+|++++++++||||+++++++.+....++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3566788999999999999986 588999999864322 2234567999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+ ++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 83 D-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp S-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred c-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 7 58988886532 3588999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2334578999999998876 568999999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.74 Aligned_cols=195 Identities=29% Similarity=0.444 Sum_probs=169.0
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC--------------CChHHHHHHHHHHHhcccCCcceeecce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--------------QGKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
..+.+.++||+|+||.||+++... ++.||+|++.... ...+++.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 456777899999999999999864 7899999986432 3356799999999999999999999999
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC---cE
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TA 543 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~---~~ 543 (606)
.+....++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999998643 3589999999999999999999998 999999999999998776 69
Q ss_pred EEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 544 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
||+|||+++....... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||.
T Consensus 189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999987654432 244679999999998874 58999999999999999999999994
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=294.82 Aligned_cols=198 Identities=30% Similarity=0.476 Sum_probs=171.5
Q ss_pred HhhccccccCCcCceeEEEEEe-----CCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeeccee--ccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCI--EGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~ 473 (606)
..+++.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4567788999999999999984 358899999997543 23467999999999999999999999886 455688
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999996532 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 230 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 6544332 223356788899999999888999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.79 Aligned_cols=194 Identities=31% Similarity=0.463 Sum_probs=168.0
Q ss_pred hccccccCCcCceeEEEEEeC-----CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecc--cccee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG--AHRLL 474 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l 474 (606)
+.+.++||+|+||.||++.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377789999999999988653 57899999997543 2346789999999999999999999999874 56789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999954 2388999999999999999999998 9999999999999999999999999999877
Q ss_pred CcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 555 NREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 555 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 554331 223456788899999999988999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=298.28 Aligned_cols=197 Identities=33% Similarity=0.547 Sum_probs=157.1
Q ss_pred hccccccCCcCceeEEEEEeC--C--CcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceec-cccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP--D--GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~--~--~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV~ 476 (606)
+.+.+.||+|+||.||+|++. + ...||+|.++... ...+++.+|+.++++++||||+++++++.+ +...++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455688999999999999964 2 2468999986543 235789999999999999999999998754 55789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 171 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999996432 3578899999999999999999998 999999999999999999999999999986643
Q ss_pred Ccc---eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 557 EES---LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 557 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 321 11233457789999999999999999999999999999999 677773
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.09 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=172.3
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
+....+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 33455677889999999999999986 48899999987542 2346789999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++....
T Consensus 110 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp ECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999653 3488999999999999999999983 179999999999999999999999999997653
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred ccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 221 234578999999999999999999999999999999999999983
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.63 Aligned_cols=197 Identities=28% Similarity=0.429 Sum_probs=168.7
Q ss_pred HHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
....+.+.++||+|+||.||+++.. .++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456788899999999999999986 4889999999654 23467899999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---CcEEEeeccCCc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfgla~ 552 (606)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999988643 3488999999999999999999998 99999999999999764 459999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .....||+.|+|||++. ..++.++||||+|+++|||++|+.||.
T Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 188 VFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp ECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 7654332 23467999999999886 468999999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.88 Aligned_cols=198 Identities=29% Similarity=0.477 Sum_probs=162.3
Q ss_pred HhhccccccCCcCceeEEEEEeCC-Cc----EEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+++.+.||+|+||.||++++.. ++ .|++|.+... ....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 345677899999999999999643 43 3677877543 345688999999999999999999999998755 789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
|+||+++++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999997543 3588999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 555 NREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 555 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 54332 22233456889999999999999999999999999999999 999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.78 Aligned_cols=191 Identities=31% Similarity=0.483 Sum_probs=161.9
Q ss_pred cccCCcCceeEEEEEeC---CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLP---DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
++||+|+||.||+|.+. .++.||||+++... ...+++.+|++++++++|||||++++++.+ ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 36789999997543 235789999999999999999999999864 557899999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc--
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-- 559 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-- 559 (606)
|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999543 3588999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12233456789999999999999999999999999999999 999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.21 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=163.5
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHh--cccCCcceeecceecc--
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGN--VHHVHLVKLKGFCIEG-- 469 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~~~-- 469 (606)
....+.....+.+.+.||+|+||.||+++.. ++.||||++.... ...+..|.+++.. ++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3445556678889999999999999999984 8999999986543 3344455555544 4899999999999877
Q ss_pred --ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEEcCCCc
Q 037563 470 --AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFT 542 (606)
Q Consensus 470 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiH~dlkp~NIll~~~~~ 542 (606)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.. ..+|+||||||+||+++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999954 34889999999999999999999851 338999999999999999999
Q ss_pred EEEeeccCCcccCcCccee---eeecccccCccccccccCCCCCCc------cchHHHHHHHHHHHhC
Q 037563 543 AKVSDFGLAKLMNREESLV---YTTLRGTRGYLAPEWITNNPISEK------SDVYSYGMVLLEIIGG 601 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~------~Dv~s~Gvvl~elltG 601 (606)
+||+|||+++......... .....||+.|+|||.+.+...+.+ +||||||+++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999998665433211 124578999999999988766665 9999999999999999
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=293.52 Aligned_cols=201 Identities=27% Similarity=0.506 Sum_probs=169.2
Q ss_pred HHhhccccccCCcCceeEEEEEeCC-CcE--EEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceecccccee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD-GIQ--VAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~--vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l 474 (606)
...+++.+.||+|+||.||+++... +.. +++|+++.. ....+.+.+|+++++++ +||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 3567788999999999999999753 554 599988643 33456799999999999 89999999999999999999
Q ss_pred eeeeccCCChhhhhhhcc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc
Q 037563 475 AYEYLVNGSLDKWIFNST------------EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 542 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~ 542 (606)
||||+++++|.+++.... .....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997543 2234689999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 543 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999997543221 1223456889999999998889999999999999999998 999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=299.31 Aligned_cols=192 Identities=11% Similarity=0.067 Sum_probs=149.1
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhc--ccCCcceeec-------ceecc
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNV--HHVHLVKLKG-------FCIEG 469 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l--~h~nIv~l~g-------~~~~~ 469 (606)
+.+.+.||+|+||.||++++. +++.||||++..... ..+.+.+|+.+++.+ +||||++++. ++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 556788999999999999975 589999999976432 345677886555555 5999887553 33222
Q ss_pred -----------------ccceeeeeeccCCChhhhhhhccccccccChhhH------HHHHHHHHHHHHHHHhcCCCcee
Q 037563 470 -----------------AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTR------FNIALGTAKGLAYLHEECEVKIV 526 (606)
Q Consensus 470 -----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~gL~yLH~~~~~~ii 526 (606)
...++||||++ ++|.+++.... ..+.+..+ ..++.||+.||+|||++ +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 34799999999 89999997542 23455666 78889999999999998 999
Q ss_pred ecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCC
Q 037563 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKS 604 (606)
Q Consensus 527 H~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~p 604 (606)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865432 124567799999999987 6789999999999999999999999
Q ss_pred CC
Q 037563 605 FS 606 (606)
Q Consensus 605 fs 606 (606)
|.
T Consensus 293 f~ 294 (371)
T 3q60_A 293 FG 294 (371)
T ss_dssp TT
T ss_pred CC
Confidence 84
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.06 Aligned_cols=198 Identities=29% Similarity=0.432 Sum_probs=174.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+....+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888899999999999999986 5899999998643 345678999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccC
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGL 550 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgl 550 (606)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999998643 3588999999999999999999998 99999999999999 5678999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++....... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||.
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 987654332 234579999999999876 68999999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=292.14 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=160.3
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
..+.+.++||+|+||.||+++.. +++.||||+++.... ..+.+.+|++++++++||||+++++++.++...++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 35677789999999999999965 588999999964432 24567899999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE-----cCCCcEEEeeccCCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL-----DDNFTAKVSDFGLAK 552 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll-----~~~~~~kl~Dfgla~ 552 (606)
|+++ +|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++
T Consensus 114 ~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 114 YAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp CCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred cCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9985 999998643 3488999999999999999999998 99999999999999 455569999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 7643322 22345679999999998874 48999999999999999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=284.59 Aligned_cols=194 Identities=31% Similarity=0.512 Sum_probs=162.3
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc-ccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-AHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~~~lV~E~~~ 480 (606)
..+++.+.||+|+||.||+++. +++.||||+++.. ...+.+.+|++++++++||||+++++++.+. ...++||||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 4567788999999999999998 5889999998754 3567899999999999999999999987554 57899999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 99 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999965321 3478899999999999999999998 99999999999999999999999999998654332
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 23457889999999998899999999999999999998 999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.50 Aligned_cols=198 Identities=22% Similarity=0.375 Sum_probs=153.2
Q ss_pred hcc-ccccCCcCceeEEEEEeC---CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeeccee--ccccceeeee
Q 037563 404 KNF-STKLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI--EGAHRLLAYE 477 (606)
Q Consensus 404 ~~~-~~~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~lV~E 477 (606)
+++ .++||+|+||.||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++. .....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 457999999999999975 47889999997543 3457889999999999999999999995 4667899999
Q ss_pred eccCCChhhhhhhccc-----cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE----cCCCcEEEeec
Q 037563 478 YLVNGSLDKWIFNSTE-----ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDF 548 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Df 548 (606)
|+++ +|.+++..... ....+++..+..|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9975 88887753221 122488999999999999999999998 99999999999999 77899999999
Q ss_pred cCCcccCcCcc--eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREES--LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99987654322 223446789999999998874 58999999999999999999999993
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=280.48 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=164.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4566788999999999999986 5899999998643 2445789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 92 YVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred ccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999643 3488899999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 21 234568999999999987765 689999999999999999999984
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.33 Aligned_cols=197 Identities=27% Similarity=0.358 Sum_probs=166.0
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCC------ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.+.||+|+||.||+++... ++.||||++..... ..+.+.+|++++++++||||+++++++.+....++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 456677899999999999999864 89999999864321 13578899999999999999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999986 8888885432 3588899999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 43322 23446789999999998764 57899999999999999999999983
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.77 Aligned_cols=197 Identities=31% Similarity=0.481 Sum_probs=166.2
Q ss_pred Hhhcccc-ccCCcCceeEEEEEeC---CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 402 ATKNFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~-~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
..+.+.+ .||+|+||.||++.+. .++.||||+++.... ..+++.+|++++++++||||+++++++ +....++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455666 8999999999999642 368899999975432 256899999999999999999999999 5677899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999653 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCccee--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 555 NREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 555 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 5543322 223456789999999988889999999999999999999 999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=291.80 Aligned_cols=200 Identities=26% Similarity=0.335 Sum_probs=158.0
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecccc-------c
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH-------R 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-------~ 472 (606)
...+.+.+.||+|+||.||+++.. +++.||||++.........+.+|++.++.++||||+++++++..... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 345667789999999999999985 48999999997665556677889999999999999999999876443 7
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH--hcCCCceeecCCCCCCeEEcC-CCcEEEeecc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH--EECEVKIVHCDIKPENVLLDD-NFTAKVSDFG 549 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg 549 (606)
++||||+++ +|...+.........+++..+..++.||+.||.||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999986 555555433333456888999999999999999999 77 9999999999999997 8999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 9987654332 2345789999999988665 48999999999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.45 Aligned_cols=207 Identities=27% Similarity=0.448 Sum_probs=171.0
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceec
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~ 468 (606)
.++....+.+.+.||+|+||.||++++. +++.||||++.... ....++.+|+.++++++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3455567788899999999999999842 46789999996432 334678999999999999999999999999
Q ss_pred cccceeeeeeccCCChhhhhhhcccc---ccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCc
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTEE---SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFT 542 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~ 542 (606)
....++||||+++++|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999765321 23588999999999999999999998 9999999999999994 456
Q ss_pred EEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 543 AKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999975533222 12234567889999999988899999999999999999998 999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.15 Aligned_cols=195 Identities=27% Similarity=0.412 Sum_probs=171.2
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCC------------------hHHHHHHHHHHHhcccCCcceeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG------------------KKEFSAEVTIIGNVHHVHLVKLKG 464 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~------------------~~~~~~Ei~~l~~l~h~nIv~l~g 464 (606)
.+.+.+.||+|+||.||+++. +++.||+|++...... .+.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 466778999999999999999 8999999998643111 178999999999999999999999
Q ss_pred ceeccccceeeeeeccCCChhhh------hhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEE
Q 037563 465 FCIEGAHRLLAYEYLVNGSLDKW------IFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLL 537 (606)
Q Consensus 465 ~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll 537 (606)
++.+....++||||+++++|.++ +... ....+++..+..++.||+.||.|||+ . +++|+||||+||++
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 99999999999999999999999 4321 13568999999999999999999999 7 99999999999999
Q ss_pred cCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCC-CCCC-ccchHHHHHHHHHHHhCCCCCC
Q 037563 538 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISE-KSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 538 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999876443 23456789999999999877 5665 9999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.45 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=167.2
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC---------CChHHHHHHHHHHHhcccCCcceeeccee
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---------QGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~ 467 (606)
......+.+.+.||+|+||.||+++... ++.||||++.... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 3445678888999999999999999764 7899999986432 12345889999999999999999999987
Q ss_pred ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EE
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AK 544 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~k 544 (606)
.+. .++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++. +|
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 654 79999999999999998542 4588999999999999999999998 9999999999999987664 99
Q ss_pred EeeccCCcccCcCcceeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 545 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+|||+++....... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 158 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (322)
T 2ycf_A 158 ITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220 (322)
T ss_dssp ECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999999987654321 22356899999999863 5678899999999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=295.91 Aligned_cols=196 Identities=17% Similarity=0.208 Sum_probs=167.2
Q ss_pred HHhhccccccCCcCceeEEEEEeCC---------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcce----------
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPD---------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVK---------- 461 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~---------- 461 (606)
...+.+.+.||+|+||.||+++... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3456778899999999999999864 788999998643 46889999999999999998
Q ss_pred -----eecceec-cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 462 -----LKGFCIE-GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 462 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
+++++.. +...++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 4556554 67789999999 999999997542 24689999999999999999999998 999999999999
Q ss_pred EEcCCC--cEEEeeccCCcccCcCcce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 536 LLDDNF--TAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 536 ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 9999999999876543221 1133578999999999999899999999999999999999999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.55 Aligned_cols=204 Identities=29% Similarity=0.387 Sum_probs=173.2
Q ss_pred cChHHHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc--------cCCcceeec
Q 037563 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH--------HVHLVKLKG 464 (606)
Q Consensus 394 ~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--------h~nIv~l~g 464 (606)
+...++....+.+.++||+|+||.||+++.. +++.||||+++......+.+.+|+.++++++ |+||+++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 4455555667888899999999999999965 4889999999765555678899999999996 788999999
Q ss_pred cee----ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC
Q 037563 465 FCI----EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN 540 (606)
Q Consensus 465 ~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~ 540 (606)
++. +....++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ +|+||||||+|||++.+
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~ 183 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCC
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEecc
Confidence 987 566889999999 6667666654322 35889999999999999999999952 89999999999999977
Q ss_pred C-------------------------------------------------cEEEeeccCCcccCcCcceeeeecccccCc
Q 037563 541 F-------------------------------------------------TAKVSDFGLAKLMNREESLVYTTLRGTRGY 571 (606)
Q Consensus 541 ~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 571 (606)
+ .+||+|||+++...... ....||+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y 259 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcc
Confidence 5 79999999998765432 345789999
Q ss_pred cccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 572 LAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 572 ~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=284.22 Aligned_cols=196 Identities=34% Similarity=0.558 Sum_probs=164.2
Q ss_pred hccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeeccee-ccccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCI-EGAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-~~~~~~lV~ 476 (606)
+++.+.||+|+||.||+|++.+ ...+|+|.++.... ..+++.+|+.++++++||||+++++++. .+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5667889999999999999643 23689999875432 3467899999999999999999999864 556789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 107 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp ECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999996432 4578899999999999999999998 999999999999999999999999999987654
Q ss_pred Ccc---eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 557 EES---LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 557 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 332 12234567889999999999999999999999999999999 55555
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.22 Aligned_cols=191 Identities=27% Similarity=0.422 Sum_probs=149.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceecc------ccc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AHR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~ 472 (606)
.+.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4566788999999999999965 589999999965432 346788999999999999999999998654 567
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 110 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 9999999 7899998853 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 65432 234678999999999877 678999999999999999999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.50 Aligned_cols=196 Identities=29% Similarity=0.391 Sum_probs=171.7
Q ss_pred HHhhccccccCCcCceeEEEEEe--CCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC------cceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGML--PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH------LVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~--~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~l~g~~~~~~~~ 472 (606)
...+++.+.||+|+||.||++.. .+++.||||+++......+.+.+|+++++.++|++ ++++++++.+....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 44677888999999999999986 35889999999765555678899999999998765 99999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-------------
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD------------- 539 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~------------- 539 (606)
++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8999999965432 3578899999999999999999998 9999999999999987
Q ss_pred ------CCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 540 ------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 540 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999998654332 34578999999999999999999999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.32 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=157.5
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
...+++.+.||+|+||.||+++.. +++.||+|+++..... .+.+.++...++.++||||+++++++.++...++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 345677889999999999999974 5899999999654322 233445555678889999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++ +|.+++.........+++..+..++.||+.||.|||++ .+++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 89888865444446799999999999999999999985 3899999999999999999999999999987654
Q ss_pred CcceeeeecccccCccccccc----cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWI----TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....+|+.|+|||.+ .+..++.++||||||+++|||++|+.||.
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 322 2334789999999996 56678999999999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.89 Aligned_cols=200 Identities=29% Similarity=0.469 Sum_probs=171.1
Q ss_pred HHHhhccccccCCcCceeEEEEEe-----CCCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccc--c
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA--H 471 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~ 471 (606)
....+++.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345567789999999999999984 358899999997543 33468999999999999999999999987654 7
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 799999999999999996543 3488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCccee--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 552 KLMNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 552 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 8775543321 12345677899999999888999999999999999999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=289.15 Aligned_cols=198 Identities=27% Similarity=0.398 Sum_probs=169.7
Q ss_pred ccChHHHHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHh--cccCCcceeecceeccc
Q 037563 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGN--VHHVHLVKLKGFCIEGA 470 (606)
Q Consensus 393 ~~~~~el~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~~~~ 470 (606)
.+...+.....+.+.+.||+|+||.||+++. +++.||||++... ..+.+..|++++.. ++||||+++++++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3445666778889999999999999999998 5899999998643 35678888888887 78999999999998776
Q ss_pred ----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCCeEEc
Q 037563 471 ----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH--------EECEVKIVHCDIKPENVLLD 538 (606)
Q Consensus 471 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~~iiH~dlkp~NIll~ 538 (606)
..++||||+++++|.+++.. ..+++..+..++.||+.||.||| +. +|+||||||+||+++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999954 24889999999999999999999 66 999999999999999
Q ss_pred CCCcEEEeeccCCcccCcCcce---eeeecccccCccccccccCCC------CCCccchHHHHHHHHHHHhC
Q 037563 539 DNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLAPEWITNNP------ISEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~s~Gvvl~elltG 601 (606)
.++.+||+|||+++........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999876544322 123457899999999987653 33689999999999999999
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=294.16 Aligned_cols=196 Identities=29% Similarity=0.421 Sum_probs=157.3
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHH--HHHHhcccCCcceeeccee-----cccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEV--TIIGNVHHVHLVKLKGFCI-----EGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei--~~l~~l~h~nIv~l~g~~~-----~~~~~~l 474 (606)
..+.+.+.||+|+||.||+|+. +++.||||++.... .+++..|. ..+..++||||+++++.+. .....++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 3456778999999999999988 68999999997543 33444444 4455689999999998543 3345689
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC------CCceeecCCCCCCeEEcCCCcEEEeec
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC------EVKIVHCDIKPENVLLDDNFTAKVSDF 548 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~~iiH~dlkp~NIll~~~~~~kl~Df 548 (606)
||||+++|+|.+++... ..++..+..++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 99999999999999543 3478889999999999999999863 238999999999999999999999999
Q ss_pred cCCcccCcCcc-------eeeeecccccCccccccccC-------CCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 549 GLAKLMNREES-------LVYTTLRGTRGYLAPEWITN-------NPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 549 gla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
|+++.+..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99987653221 11234579999999999876 35567899999999999999997765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.52 Aligned_cols=195 Identities=28% Similarity=0.358 Sum_probs=161.3
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecccc------ceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH------RLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~------~~lV~ 476 (606)
.+.+.+.||+|+||.||++++.++..+|+|++..... ...+|+++++.++||||+++++++..... .++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4566788999999999999998877899998864322 22469999999999999999999865443 78999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeeccCCcccC
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfgla~~~~ 555 (606)
||++++.+. .+.........+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 999875443 3332222235688999999999999999999998 999999999999999 79999999999998764
Q ss_pred cCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4332 2345789999999998765 58999999999999999999999994
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=291.16 Aligned_cols=192 Identities=27% Similarity=0.301 Sum_probs=157.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceeccc------cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~ 472 (606)
.+.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4566788999999999999975 488999999975432 2357889999999999999999999987654 67
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred EEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 999999975 7887773 2378899999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 654332 2234678999999999999999999999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.20 Aligned_cols=196 Identities=24% Similarity=0.377 Sum_probs=159.5
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCC------------hHHHHHHHHHHHhcccCCcceeecceec-
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG------------KKEFSAEVTIIGNVHHVHLVKLKGFCIE- 468 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~------------~~~~~~Ei~~l~~l~h~nIv~l~g~~~~- 468 (606)
..+.+.+.||+|+||.||+++..+++.||||++...... .+.+.+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 345566899999999999999988999999998643211 2679999999999999999999999854
Q ss_pred ----cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEE
Q 037563 469 ----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544 (606)
Q Consensus 469 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~k 544 (606)
....++||||++ ++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEE
Confidence 335799999998 5888887643 23589999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 545 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 545 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+|||+++....... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999985443322 234578999999998876 678999999999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=280.83 Aligned_cols=196 Identities=27% Similarity=0.407 Sum_probs=170.3
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC----------CChHHHHHHHHHHHhcc-cCCcceeecceecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----------QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEG 469 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~----------~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~ 469 (606)
..+.+.+.||+|+||.||+++.. +++.||||+++... ...+.+.+|+.+++++. ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 34566788999999999999986 48899999996442 12356789999999996 99999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999643 3588999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCcccccccc------CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWIT------NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++........ .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 9987654332 23457899999999875 4567899999999999999999999983
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=282.88 Aligned_cols=195 Identities=30% Similarity=0.450 Sum_probs=165.3
Q ss_pred ccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccc-eeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR-LLAYE 477 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~-~lV~E 477 (606)
...+.||+|+||.||+|++.+ +..+|+|+++.... ..+.+.+|+.++++++||||+++++++.+.... ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345789999999999998533 23799999875432 346789999999999999999999999876655 89999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+.+++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999996532 4578899999999999999999998 9999999999999999999999999999865433
Q ss_pred cc---eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 558 ES---LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 558 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. .......+++.|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 21 1223456789999999999999999999999999999999965553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=281.88 Aligned_cols=193 Identities=28% Similarity=0.428 Sum_probs=164.8
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
..||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999975 57899999997543 34578999999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccCCcccCcCcceeeee
Q 037563 486 KWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTT 564 (606)
Q Consensus 486 ~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 564 (606)
+++..... ...+++..+..++.||+.||.|||+. +++|+||||+||+++. ++.+||+|||+++....... ....
T Consensus 108 ~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 108 ALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 99975432 23467888899999999999999998 9999999999999987 89999999999987643221 1234
Q ss_pred cccccCccccccccCCC--CCCccchHHHHHHHHHHHhCCCCC
Q 037563 565 LRGTRGYLAPEWITNNP--ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 565 ~~gt~~y~aPE~~~~~~--~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..|++.|+|||.+.+.. ++.++||||||+++|||++|+.||
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 57899999999987643 789999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=281.26 Aligned_cols=197 Identities=25% Similarity=0.346 Sum_probs=166.3
Q ss_pred HhhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecce-eccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC-IEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~-~~~~~~~lV~E~~ 479 (606)
..+.+.+.||+|+||.||+++. .+++.||||++.... ..+++.+|++++++++|++++..++.+ .+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4567788999999999999997 458899999875432 234688999999999998888777766 5566779999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCcccCc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 556 (606)
+++|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+||++ ++++.+||+|||+++....
T Consensus 88 -~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 88 -GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999986432 3589999999999999999999998 99999999999999 7899999999999987654
Q ss_pred Ccc------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EES------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 332 11234578999999999999999999999999999999999999994
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=280.26 Aligned_cols=196 Identities=25% Similarity=0.349 Sum_probs=167.7
Q ss_pred hhccccccCCcCceeEEEEEe-CCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecce-eccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC-IEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~-~~~~~~~lV~E~~~ 480 (606)
.+.+.+.||+|+||.||+++. .+++.||||++.... ..+++.+|+.++++++|++++..+..+ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 456678899999999999997 468999999986543 345789999999999998877777666 5566779999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCcccCcC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~~~~ 557 (606)
+++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||++ ++++.+||+|||+++.....
T Consensus 88 ~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999996432 3589999999999999999999998 99999999999999 58899999999999876543
Q ss_pred cce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 321 1234578999999999999999999999999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.37 Aligned_cols=195 Identities=24% Similarity=0.403 Sum_probs=166.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecc-----cccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~l 474 (606)
.+.+.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667789999999999999975 588999999975432 236789999999999999999999998754 36789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999997 489998853 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCccee--eeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLV--YTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
....... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 5433211 234578999999998654 558999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=288.69 Aligned_cols=203 Identities=23% Similarity=0.367 Sum_probs=155.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+.+.+.||+|+||.||+++.. +++.||||++... ....+++.+|+.++++++||||+++++++......++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 345677789999999999999975 5889999998643 2345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccc----cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 478 YLVNGSLDKWIFNSTE----ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
|+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999864211 224588999999999999999999998 999999999999999999999999999876
Q ss_pred cCcCcc----eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREES----LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 543221 11234578999999998875 568999999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=284.51 Aligned_cols=198 Identities=24% Similarity=0.389 Sum_probs=167.2
Q ss_pred HhhccccccCCcCceeEEEEEeCC-CcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
..+++.+.||+|+||.||+++... ++.||+|++... ....+++.+|++++++++||||+++++++.+....++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 446777899999999999999864 889999998654 345678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 99 PGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999986532 3588999999999999999999998 99999999999999999999999999876432211
Q ss_pred eeeeecccccCccccccc-----cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWI-----TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~-----~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......+++.|+|||.+ ....++.++||||||+++|||++|+.||.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 112335689999999988 46678999999999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=281.36 Aligned_cols=198 Identities=26% Similarity=0.358 Sum_probs=166.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-----CCChHHHHHHHHHHHhcccCCcceeeccee--cccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCI--EGAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~l 474 (606)
.+.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4567788999999999999985 4789999999643 234578999999999999999999999984 4567899
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||++++ |.+++..... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999887 7777755332 4588999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcc-eeeeecccccCccccccccCCCC--CCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREES-LVYTTLRGTRGYLAPEWITNNPI--SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .......+++.|+|||.+.+... +.++||||||+++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 53222 22345678999999999876543 779999999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=287.68 Aligned_cols=200 Identities=28% Similarity=0.370 Sum_probs=154.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcc-cCCcceeeccee--------ccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVH-HVHLVKLKGFCI--------EGA 470 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~--------~~~ 470 (606)
..+++.+.||+|+||.||++++. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 45677789999999999999975 58899999985443 33467899999999996 999999999984 344
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEcCCCcEEEeec
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVSDF 548 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Df 548 (606)
..++||||++ |+|.+++..... ...+++..+..++.||+.||.|||+. + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 5789999996 799998865332 23589999999999999999999998 7 999999999999999999999999
Q ss_pred cCCcccCcCccee-----------eeecccccCccccccc---cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLV-----------YTTLRGTRGYLAPEWI---TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++......... .....+|+.|+|||.+ .+..++.++||||||+++|||++|+.||.
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9998765432211 1134589999999998 56678899999999999999999999983
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=283.87 Aligned_cols=196 Identities=24% Similarity=0.393 Sum_probs=167.4
Q ss_pred hhccccccCCcCceeEEEEEe--CCCcEEEEEEecccC---CChHHHHHHHHHHHhc---ccCCcceeeccee-----cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGML--PDGIQVAVKKLESIG---QGKKEFSAEVTIIGNV---HHVHLVKLKGFCI-----EG 469 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~--~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~-----~~ 469 (606)
.+.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 456778999999999999997 358899999986432 2234677788777776 8999999999987 56
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 67899999998 699999865432 3488999999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 166 LARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp SCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCC--ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 9987653322 234578999999999999999999999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=279.99 Aligned_cols=194 Identities=28% Similarity=0.420 Sum_probs=161.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec------------
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE------------ 468 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------------ 468 (606)
..+++.+.||+|+||.||+++.. +++.||||+++......+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 45677889999999999999975 58999999997655556789999999999999999999998764
Q ss_pred -cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEee
Q 037563 469 -GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 547 (606)
Q Consensus 469 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~D 547 (606)
....++||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +++|+||||+||+++.++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 456789999999999999997532 3577889999999999999999998 999999999999999999999999
Q ss_pred ccCCcccCcCc-------------ceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhC
Q 037563 548 FGLAKLMNREE-------------SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGG 601 (606)
Q Consensus 548 fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG 601 (606)
||+++...... ........+++.|+|||.+.+. .++.++||||||+++|||+++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence 99998764321 1122345689999999998764 689999999999999999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.94 Aligned_cols=190 Identities=28% Similarity=0.409 Sum_probs=162.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccc------
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR------ 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~------ 472 (606)
.+.+.+.||+|+||.||+++.. +++.||||++...... .+++.+|+.++++++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3556788999999999999975 4899999999754332 46788999999999999999999999877655
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 123 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp EEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 58888772 2388999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 65432 234678999999999887 678999999999999999999999994
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=288.26 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=170.8
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC--CcEEEEEEecccCCChHHHHHHHHHHHhcccCC------cceeecceeccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH------LVKLKGFCIEGA 470 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~l~g~~~~~~ 470 (606)
.....+++.+.||+|+||.||+++... ++.||+|+++......+.+.+|+.++++++|++ ++.+++++....
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 334567888999999999999999753 478999999765555678899999999998776 899999999999
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE-------------
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL------------- 537 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll------------- 537 (606)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777754332 3588999999999999999999998 99999999999999
Q ss_pred ------cCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 538 ------DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 538 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 668899999999998654332 34578999999999999999999999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=290.53 Aligned_cols=197 Identities=27% Similarity=0.371 Sum_probs=168.5
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-cC-----Ccceeecceecccccee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HV-----HLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~-----nIv~l~g~~~~~~~~~l 474 (606)
..+.+.+.||+|+||.||+++.. +++.||||+++......+++..|+.+++.++ |+ +|+++++++......++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 45677789999999999999976 4789999999765444577888999998885 44 49999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc--CCCcEEEeeccCCc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAK 552 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgla~ 552 (606)
||||++ ++|.+++..... ..+++..+..++.||+.||.|||+. ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 134 v~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999996 599999976432 3488999999999999999999952 13899999999999994 57889999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 76433 234678999999999999999999999999999999999999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=311.67 Aligned_cols=202 Identities=26% Similarity=0.396 Sum_probs=168.7
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecccc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH 471 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~ 471 (606)
++....+.+.+.||+|+||.||+|++.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++. ...
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445667778899999999999999743 46799999865432 2467999999999999999999999985 456
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 899999999999999996432 3588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 8765544333344567889999999998899999999999999999997 999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-33 Score=283.20 Aligned_cols=199 Identities=26% Similarity=0.415 Sum_probs=161.2
Q ss_pred HHhhccccccCCcCceeEEEEEeC--CC--cEEEEEEecccC----CChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP--DG--IQVAVKKLESIG----QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~--~~--~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
...+++.+.||+|+||.||++++. ++ ..||||+++... ...+++.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 345677889999999999999853 23 368999986432 23468899999999999999999999998765 7
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++|+||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999996532 4588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 553 LMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 76544332 1223467888999999988889999999999999999999 999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=275.96 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=173.8
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
.......+++.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4455677888999999999999999986 5889999998643 24567899999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC---CcEEEeecc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFG 549 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg 549 (606)
++|+||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.+ +.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 9999999999999998643 3488999999999999999999998 99999999999999764 469999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++........ .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||.
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCC
Confidence 9987654332 2234688999999988764 8999999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-33 Score=282.75 Aligned_cols=195 Identities=26% Similarity=0.371 Sum_probs=158.3
Q ss_pred hhccccccCCcCceeEEEEEeCC-CcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeeccee-------------
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCI------------- 467 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~------------- 467 (606)
.+.+.+.||+|+||.||+++... ++.||+|++.... ...+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 45667889999999999999875 8999999986543 33567899999999999999999998873
Q ss_pred -ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEE
Q 037563 468 -EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKV 545 (606)
Q Consensus 468 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl 545 (606)
+....++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++ +++.+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467789999998 599999843 3578899999999999999999998 999999999999997 5679999
Q ss_pred eeccCCcccCcCcc--eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 546 SDFGLAKLMNREES--LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 546 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|||+++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 99999987643321 11233567899999998765 678999999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=285.36 Aligned_cols=195 Identities=26% Similarity=0.383 Sum_probs=164.6
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecc-----cccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~l 474 (606)
.+.+.+.||+|+||.||+++.. +++.||||+++.... ...++.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4566788999999999999986 488999999964432 245788999999999999999999987754 67799
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 999997 589998854 3588999999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcce---------eeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESL---------VYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 532211 1123468999999998754 678999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=283.53 Aligned_cols=190 Identities=28% Similarity=0.407 Sum_probs=161.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceecccc------c
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH------R 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~------~ 472 (606)
.+.+.+.||+|+||.||+++.. +++.||||++...... .+++.+|+.++++++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556688999999999999975 4899999999654332 3578899999999999999999999987654 4
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 105 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp EEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 99999997 58888773 2388999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 65432 234578999999998876 678999999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=279.99 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=163.3
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCC---ChHHHHHHHHHHHhcc--cCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVH--HVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~~~~lV 475 (606)
...+.+.+.||+|+||.||+++..+++.||||++..... ..+.+.+|++++.+++ |+||+++++++.+....++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 344667789999999999999998899999999965432 3467899999999997 49999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 107 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred Ee-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99 6788999999653 3578899999999999999999998 9999999999999965 899999999998765
Q ss_pred cCcc-eeeeecccccCccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES-LVYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 4332 12234578999999999875 467889999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=295.64 Aligned_cols=194 Identities=25% Similarity=0.340 Sum_probs=154.0
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccCCChh
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.+.||+|+||+||.....+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998766668999999998643 345678999999887 89999999999999999999999996 6999
Q ss_pred hhhhhccccccc---cChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC-------------CcEEEeecc
Q 037563 486 KWIFNSTEESRF---LCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-------------FTAKVSDFG 549 (606)
Q Consensus 486 ~~l~~~~~~~~~---l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~-------------~~~kl~Dfg 549 (606)
+++......... .++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999764432221 24456678999999999999998 99999999999999754 489999999
Q ss_pred CCcccCcCcce---eeeecccccCccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 550 LAKLMNREESL---VYTTLRGTRGYLAPEWITN-------NPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 99877543321 1234579999999999875 568999999999999999999 999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=291.87 Aligned_cols=196 Identities=25% Similarity=0.356 Sum_probs=166.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhccc-CCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+.+.++||+|+||.||++++. +++.||||++.... ..+++..|+++++.++| +++..+..++.+....++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 4567789999999999999974 58999999876433 34568899999999987 55556666667778889999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEE---cCCCcEEEeeccCCcccCcC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfgla~~~~~~ 557 (606)
+++|.+++.... ..+++..+..|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999996432 3589999999999999999999998 99999999999999 68899999999999876543
Q ss_pred cce------eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 321 1224679999999999999999999999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=282.13 Aligned_cols=196 Identities=28% Similarity=0.424 Sum_probs=168.9
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-------ChHHHHHHHHHHHhcc--cCCcceeecceeccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNVH--HVHLVKLKGFCIEGA 470 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~ 470 (606)
...+.+.+.||+|+||.||+++.. +++.||||+++.... ..+.+.+|+.++++++ |+||+++++++.+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 345677789999999999999964 588999999965421 2356788999999996 599999999999999
Q ss_pred cceeeeeeccC-CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCcEEEeec
Q 037563 471 HRLLAYEYLVN-GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDF 548 (606)
Q Consensus 471 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Df 548 (606)
..++|+|++.+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999986 8999998653 3588999999999999999999998 999999999999999 7899999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 9998765432 234578999999999877665 688999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=280.88 Aligned_cols=200 Identities=29% Similarity=0.431 Sum_probs=162.9
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC-------ChHHHHHHHHHHHhc----ccCCcceeec
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTIIGNV----HHVHLVKLKG 464 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l----~h~nIv~l~g 464 (606)
.+.....+.+.+.||+|+||.||+++.. +++.||||++..... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445567888899999999999999875 588999999965421 234467799999998 8999999999
Q ss_pred ceeccccceeeeee-ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc-CCCc
Q 037563 465 FCIEGAHRLLAYEY-LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFT 542 (606)
Q Consensus 465 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~-~~~~ 542 (606)
++.+....++|+|| +++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++ +++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 7899999999653 3488999999999999999999999 999999999999999 8899
Q ss_pred EEEeeccCCcccCcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 543 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+||+|||+++...... .....++..|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 9999999998765432 234568999999999877665 458999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=286.68 Aligned_cols=197 Identities=27% Similarity=0.369 Sum_probs=169.0
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-----------cCCcceeecceec
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-----------HVHLVKLKGFCIE 468 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~l~g~~~~ 468 (606)
...+.+.+.||+|+||.||+++.. +++.||||++.......+.+.+|++++++++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 356778899999999999999974 5899999999765445677899999999886 8999999999886
Q ss_pred cc----cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc------
Q 037563 469 GA----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD------ 538 (606)
Q Consensus 469 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~------ 538 (606)
.. ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCc
Confidence 54 778999999 8999999975432 3488999999999999999999994 2899999999999994
Q ss_pred CCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 539 DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 539 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..+.+||+|||+++...... ....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 44589999999998765432 34578999999999999999999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-33 Score=287.11 Aligned_cols=190 Identities=18% Similarity=0.189 Sum_probs=159.3
Q ss_pred HHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccC---------CChHHHHHHHHHHHhcc---------------
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---------QGKKEFSAEVTIIGNVH--------------- 455 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~--------------- 455 (606)
....+.+.++||+|+||+||+++. +++.||||+++... ...+.+.+|+.++++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346678889999999999999998 78999999997542 22378999999999986
Q ss_pred -----------cCCcceeecceec-------------cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHH
Q 037563 456 -----------HVHLVKLKGFCIE-------------GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTA 511 (606)
Q Consensus 456 -----------h~nIv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~ 511 (606)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 4555555555554 6788999999999987777632 3578999999999999
Q ss_pred HHHHHHH-hcCCCceeecCCCCCCeEEcCCC--------------------cEEEeeccCCcccCcCcceeeeecccccC
Q 037563 512 KGLAYLH-EECEVKIVHCDIKPENVLLDDNF--------------------TAKVSDFGLAKLMNREESLVYTTLRGTRG 570 (606)
Q Consensus 512 ~gL~yLH-~~~~~~iiH~dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 570 (606)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999875432 2478999
Q ss_pred ccccccccCCCCCCccchHHHHHH-HHHHHhCCCCC
Q 037563 571 YLAPEWITNNPISEKSDVYSYGMV-LLEIIGGRKSF 605 (606)
Q Consensus 571 y~aPE~~~~~~~t~~~Dv~s~Gvv-l~elltG~~pf 605 (606)
|||||.+.+.. +.++||||++.+ .+++++|..||
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 99999998776 889999998766 77889999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=284.22 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=164.1
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
+....+++.+.||+|+||.||+|+..+ .+|+|+++.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 334456778899999999999999854 4999998643 23346788999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||+++ ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999996432 3588999999999999999999998 999999999999998 6799999999987653
Q ss_pred cCcc----eeeeecccccCccccccccC---------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES----LVYTTLRGTRGYLAPEWITN---------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2211 11233568999999998864 457889999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=279.92 Aligned_cols=192 Identities=24% Similarity=0.296 Sum_probs=144.1
Q ss_pred hhccc-cccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec----cccceeee
Q 037563 403 TKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLAY 476 (606)
Q Consensus 403 ~~~~~-~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~ 476 (606)
.+.+. +.||+|+||.||+++.. +++.||||++... .....+....+..++||||+++++++.. +...++||
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 45564 45999999999999986 4899999998653 2222233344667799999999999876 45579999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~ 553 (606)
||+++++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 106 e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp ECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred eccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 99999999999975432 4689999999999999999999998 9999999999999986 45599999999986
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 54332 23457899999999998888999999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=298.43 Aligned_cols=198 Identities=30% Similarity=0.453 Sum_probs=170.6
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceec------cccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE------GAHR 472 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------~~~~ 472 (606)
..+.+.+.||+|+||.||++.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56788899999999999999975 48899999986532 234678999999999999999999998765 6778
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCc---EEEeecc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFG 549 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg 549 (606)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999975432 23588999999999999999999998 9999999999999997765 9999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 9987654332 23467899999999999999999999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=277.72 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=147.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHH-HHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVT-IIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+.+.+.||+|+||.||+++.. +++.||||++..... ...++..|+. +++.++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 3456688999999999999985 589999999975432 2345566665 67778999999999999999999999999
Q ss_pred ccCCChhhhhhhcc-ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 479 LVNGSLDKWIFNST-EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 479 ~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+++ +|.+++.... .....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 986 8888775321 1235688999999999999999999995 38999999999999999999999999999876443
Q ss_pred cceeeeecccccCccccccc----cCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWI----TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 22 2334789999999998 45678999999999999999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=288.71 Aligned_cols=194 Identities=25% Similarity=0.349 Sum_probs=154.8
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.++..+.||+|+||+|+.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+....++||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 345567899999999655555578999999986432 23467899999999 79999999999999999999999996
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-----CCcEEEeeccCCcccCc
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgla~~~~~ 556 (606)
++|.+++..... ...+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 599999965432 344556778999999999999998 9999999999999953 34688999999987654
Q ss_pred Ccc--eeeeecccccCcccccccc---CCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 557 EES--LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 557 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 322 2234467999999999987 4567889999999999999999 99998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=307.37 Aligned_cols=191 Identities=26% Similarity=0.376 Sum_probs=163.8
Q ss_pred HHHhhccccccCCcCceeEEEEEeC--CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceecccc----
Q 037563 400 CKATKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH---- 471 (606)
Q Consensus 400 ~~~~~~~~~~lG~G~fG~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~---- 471 (606)
....+.+.+.||+|+||.||++++. +++.||||++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3356778889999999999999975 58999999986432 234578899999999999999999999987765
Q ss_pred -ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 472 -RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 472 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
.++||||+++++|.+++.. .+++..+..|+.||+.||.|||++ +|+||||||+|||++++ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987732 588999999999999999999998 99999999999999986 999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++..... ....||+.|+|||.+.+.. +.++||||||++++||++|..||.
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 9876543 3357899999999987764 889999999999999999998873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=271.14 Aligned_cols=195 Identities=24% Similarity=0.364 Sum_probs=146.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.+.||+|+||.||++++. +++.||||++...... .+.+.++..+++.++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 4566788999999999999986 5899999999754322 23344555677888999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
+ ++.+..+.... ...+++..+..++.||+.||.|||+ . +++|+||||+||+++.++.+||+|||++......
T Consensus 106 ~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 106 M-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp C-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred c-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9 44555444322 2458899999999999999999998 5 8999999999999999999999999999765443
Q ss_pred cceeeeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 22 23457899999999984 4568899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=262.77 Aligned_cols=171 Identities=12% Similarity=0.063 Sum_probs=148.5
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCC----hHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG----KKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
+....+.+.+.||+|+||.||+++... ++.||||++...... .+++.+|+..+.+++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 334457778899999999999999865 899999999755332 367999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++... .....+.+|+.||+.||+|||++ +|+||||||+||++++++.+||+++
T Consensus 108 lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~----- 173 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP----- 173 (286)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC-----
T ss_pred EEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec-----
Confidence 999999999999998431 24456788999999999999998 9999999999999999999999743
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|++| ++.++||||||+++|||++|+.||.
T Consensus 174 ----------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 174 ----------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp ----------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred ----------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34443 6889999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=279.55 Aligned_cols=193 Identities=18% Similarity=0.170 Sum_probs=150.2
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhccc-CCcceeecc-------------
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHH-VHLVKLKGF------------- 465 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~------------- 465 (606)
...+.||+|+||.||++++. +++.||||++... ....+.+.+|+.+++.++| +|......+
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34578999999999999964 5899999998732 2335789999999999987 322211111
Q ss_pred --------eec-----cccceeeeeeccCCChhhhhhhc---cccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecC
Q 037563 466 --------CIE-----GAHRLLAYEYLVNGSLDKWIFNS---TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529 (606)
Q Consensus 466 --------~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~d 529 (606)
... ....+++|++ .+++|.+++... ......+++..++.++.||++||+|||++ +|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 111 1233556665 468999888422 22345688899999999999999999998 999999
Q ss_pred CCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccc----------cCCCCCCccchHHHHHHHHHHH
Q 037563 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI----------TNNPISEKSDVYSYGMVLLEII 599 (606)
Q Consensus 530 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~~Dv~s~Gvvl~ell 599 (606)
|||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999865433 344567 999999998 5556888999999999999999
Q ss_pred hCCCCCC
Q 037563 600 GGRKSFS 606 (606)
Q Consensus 600 tG~~pfs 606 (606)
+|+.||.
T Consensus 312 tg~~Pf~ 318 (413)
T 3dzo_A 312 CADLPNT 318 (413)
T ss_dssp HSSCCCC
T ss_pred HCCCCCC
Confidence 9999984
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=259.85 Aligned_cols=141 Identities=22% Similarity=0.266 Sum_probs=117.5
Q ss_pred ccccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCC-----CCcEEE
Q 037563 26 QHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRD-----SDKFVF 100 (606)
Q Consensus 26 ~~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~-----~~~~~~ 100 (606)
++.|+|.+|++|+. +++|+|++|+|+||||.++ ..|+ |+ |.+ +||+||||.|+.+ +++|.|
T Consensus 12 ~~~~~l~~g~~l~~-------~~~l~S~~g~F~lgf~~~~-~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l 77 (276)
T 3m7h_A 12 VGTSVLPAYQTLSA-------GQYLLSPNQRFKLLLQGDG-NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPL 77 (276)
T ss_dssp TTSSEECTTEEBCT-------TCEEECTTSSEEEEECTTS-CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred ccCCEecCCCEecC-------CCEEEcCCCcEEEEEECCC-CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEE
Confidence 34799999999987 9999999999999999554 4454 65 777 9999999999987 678999
Q ss_pred eccccEEE--EcCCc-eeEeeccCC------CceeEEEEecCCcEEEEecCCceEEEecCCCCCccCCCCc----ccCce
Q 037563 101 EKSGNAYL--QRGNG-EAWSANTSG------QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQ----FMEGM 167 (606)
Q Consensus 101 ~~~g~l~l--~~~~~-~~w~t~~~~------~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~PtDtllpg~~----l~~~~ 167 (606)
+.||+|+| .+.++ +||+|++.. ..++.|+|+|+|||||+| +.++||| |||||+||||+ |..++
T Consensus 78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCc
Confidence 99999999 66554 899999754 456789999999999998 7899999 99999999999 77788
Q ss_pred EEEec----CCceEEEeccCC
Q 037563 168 RLKSS----NGEITFSNLRNG 184 (606)
Q Consensus 168 ~l~s~----~g~~~~~~~~~~ 184 (606)
+|.+. .|.|++....+|
T Consensus 154 ~L~S~~dps~G~fsl~l~~dG 174 (276)
T 3m7h_A 154 ELVQGVVYGAGASKLVFQGDG 174 (276)
T ss_dssp EECTTCEEEETTEEEEECTTS
T ss_pred ccccCCCCCCceEEEeecCCc
Confidence 87543 466666554444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=256.05 Aligned_cols=171 Identities=25% Similarity=0.336 Sum_probs=147.7
Q ss_pred hccc-cccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHH-HhcccCCcceeecceec----cccceeee
Q 037563 404 KNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTII-GNVHHVHLVKLKGFCIE----GAHRLLAY 476 (606)
Q Consensus 404 ~~~~-~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l-~~l~h~nIv~l~g~~~~----~~~~~lV~ 476 (606)
+.+. +.||+|+||.||++... +++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....++||
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 3444 67999999999999975 588999999864 35677888887 56689999999999876 67789999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~~ 553 (606)
||+++++|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp CCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 99999999999976432 3588999999999999999999998 9999999999999998 78999999999864
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. +..++.++||||||+++|||++|+.||.
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 32 2346788999999999999999999983
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-29 Score=274.35 Aligned_cols=183 Identities=17% Similarity=0.036 Sum_probs=128.2
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC-----------CChHHHHHHHHHHHhc-ccCCcceeecceecccccee
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-----------QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-----------~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l 474 (606)
...+.|++|.+..++.. -|+.+++|++.... ...++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45677777777665532 37889999996431 1236799999999999 69999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||++|++|.++|.... .++. .+|+.||+.||+|||++ +|+||||||.||||++++.+||+|||+++..
T Consensus 320 VMEyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999996532 3443 35899999999999999 9999999999999999999999999999876
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR 602 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~ 602 (606)
..... ......||+.|||||.+.+. +..++|+||+|++++++.++.
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCCCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 54332 23446899999999998764 567899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=251.73 Aligned_cols=182 Identities=17% Similarity=0.217 Sum_probs=147.6
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCC---------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+.||+|+||.||++.. .++.+++|+...... ..+.+.+|++++++++||||+++..++......++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35799999999999965 578899998643221 12458999999999999999977777778888899999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++++|.+++.. +..++.||++||.|||++ +|+||||||+|||+++ .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 457999999999999998 9999999999999999 9999999999987654
Q ss_pred ccee------eeecccccCccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLV------YTTLRGTRGYLAPEWITN--NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~------~~~~~gt~~y~aPE~~~~--~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211 234679999999999876 567788999999999999998888763
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-25 Score=213.67 Aligned_cols=138 Identities=16% Similarity=0.153 Sum_probs=105.0
Q ss_pred ccccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEecccc
Q 037563 26 QHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGN 105 (606)
Q Consensus 26 ~~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~ 105 (606)
+..|+|.+|++|.+ +++| ++|.|+|||+.+++. ++|.. +|+||+|||+.| .++.|.|+.|||
T Consensus 6 ~~~~~i~~g~~L~~-------g~~l--~~g~f~l~f~~~gnl----~ly~~---~~~vW~an~~~~--~~~~l~l~~dGn 67 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA-------AQSL--ELSSFRFTMQSDCNL----VLFDS---DVRVWASNTAGA--TGCRAVLQSDGL 67 (236)
T ss_dssp CSSSSSCSCSCCCT-------TCEE--CSTTEEEEECTTSCE----EEEES---SSEEECCCCCSC--SCCBCCBCSSSC
T ss_pred eccceeCCCCEECC-------CCEE--EcCCEEEEECCCCcE----EEEEC---CEEEEECCCCCC--CCeEEEEcCCCc
Confidence 45799999999997 8888 599999999876652 23443 799999999988 667899999999
Q ss_pred EEEEcCCc-eeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecCCCCCcc----------CCCCcccCc-eEEEec
Q 037563 106 AYLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTL----------LPGQQFMEG-MRLKSS 172 (606)
Q Consensus 106 l~l~~~~~-~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~PtDtl----------lpg~~l~~~-~~l~s~ 172 (606)
|||++.++ +||+|++.. .....|+|+|+|||||++. ++||||||||||+ +|||++..+ .+|.+.
T Consensus 68 Lvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~ 144 (236)
T 1dlp_A 68 LVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHAT 144 (236)
T ss_dssp BCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSS
T ss_pred EEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcC
Confidence 99999876 799999753 3456899999999999953 8999999998665 666644322 133322
Q ss_pred ----CCceEEEeccCC
Q 037563 173 ----NGEITFSNLRNG 184 (606)
Q Consensus 173 ----~g~~~~~~~~~~ 184 (606)
+|.|++....+|
T Consensus 145 ~d~s~G~~~l~l~~dG 160 (236)
T 1dlp_A 145 QSLQLSPYRLSMETDC 160 (236)
T ss_dssp CCCBCSSCEEEEETTT
T ss_pred cEeecCcEEEEECCCC
Confidence 466766554444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=203.42 Aligned_cols=152 Identities=14% Similarity=0.064 Sum_probs=122.2
Q ss_pred cccccCCcCceeEEEEEeCCCcEEEEEEecccCC-------------------ChHHHHHHHHHHHhcccCCcceeecce
Q 037563 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------------------GKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~-------------------~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
+.+.||+|+||.||+++..+++.||+|+++.... ....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4588999999999999997799999999863211 2456899999999999 5 6777755
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEe
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 546 (606)
+.+..++||||+++++|.+ +. ......++.||+.||.|||+. +|+||||||+|||++ ++.+||+
T Consensus 171 -~~~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 171 -AWEGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp -EEETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred -eccceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 3466799999999999988 41 123457999999999999998 999999999999999 9999999
Q ss_pred eccCCcccCcCcceeeeecccccCccccccccC----------CCCCCccchHH
Q 037563 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWITN----------NPISEKSDVYS 590 (606)
Q Consensus 547 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~t~~~Dv~s 590 (606)
|||+++.. ..++|||++.. ..+...+|+|.
T Consensus 235 DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 235 DFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999732 34678998753 34556677765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=156.17 Aligned_cols=102 Identities=20% Similarity=0.330 Sum_probs=87.9
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEE
Q 037563 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYL 108 (606)
Q Consensus 29 ~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l 108 (606)
|+|.+|+.|.+ ++.|.| |.|.|.|+..++ +.+ |. ..++||+|||+.|..+++.|.|+.||||||
T Consensus 2 n~L~~g~~L~~-------g~~L~s--g~y~l~~q~DgN---Lvl-y~---~~~~vW~ant~~~~~~~~~L~l~~dGnLvL 65 (105)
T 4h3o_A 2 NILDNNEGLYA-------GQSLDV--EPYHFIMQDDCN---LVL-YD---HSTSTWASNTEIGGKSGCSAVLQSDGNFVV 65 (105)
T ss_dssp CEECTTEEECT-------TCEEEE--TTEEEEECTTSC---EEE-EE---TTEEEEECCCCCTTCCSCEEEECTTSCEEE
T ss_pred CCcCCCCEEcC-------CCEEEE--CCEEEEECCCCe---EEE-EE---CCEEEEEecCCCCCCccEEEEEeCCccEEE
Confidence 78999999987 999998 779999988877 222 22 579999999999998888999999999999
Q ss_pred EcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEe
Q 037563 109 QRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 109 ~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
++.++ .||+|++. ......|+|+|+|||||++. ++|||
T Consensus 66 ~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99886 79999985 45567899999999999963 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-20 Score=157.25 Aligned_cols=108 Identities=20% Similarity=0.316 Sum_probs=91.4
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
+|+|.+|++|.+ ++.|+ ++|.|+|+|+..|+ .++|. .+++||+||++.|. .++.+.|+.|||||
T Consensus 1 ~d~l~~g~~L~~-------g~~l~-~~~~~~l~~~~dGn----lvl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLV 64 (110)
T 3a0c_A 1 VNSLSSPNSLFT-------GHSLE-VGPSYRLIMQGDCN----FVLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLV 64 (110)
T ss_dssp CCEEETTCEECT-------TCEEE-ETTTEEEEECTTSC----EEEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEE
T ss_pred CCEeCCCCEECC-------CCEEE-ECCCEEEEEcCCCc----EEEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEE
Confidence 489999999987 99999 99999999988877 25665 47999999998763 35689999999999
Q ss_pred EEcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCCCC
Q 037563 108 LQRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (606)
Q Consensus 108 l~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~Pt 154 (606)
|++.++ .+|++.+. ......++|+++|||||++. ++||||+||.
T Consensus 65 l~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 65 IYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred EECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 998765 79999975 33456899999999999974 7999999984
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=156.00 Aligned_cols=106 Identities=17% Similarity=0.250 Sum_probs=90.6
Q ss_pred ccccccCCCccccceeeecCCCcEEE--eCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEecc
Q 037563 26 QHIGKLYPGFEATQMEWINNNGLFLI--SNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKS 103 (606)
Q Consensus 26 ~~~~~l~~g~~~~~~~~~~~~~~~l~--s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~ 103 (606)
+..|+|.+|++|.+ ++.|+ |++|.|+|+|+.+++ . +||.+ +++||+|||+.| ..++.+.|+.|
T Consensus 6 ~~~~~l~~g~~L~~-------g~~l~~~S~~g~~~L~~~~dgn--l--vly~~---~~~vW~sn~~~~-~~~~~l~l~~d 70 (119)
T 1b2p_A 6 SKQPDDNHPQILHA-------TESLEILFGTHVYRFIMQTDCN--L--VLYDN---NNPIWATNTGGL-GNGCRAVLQPD 70 (119)
T ss_dssp CSCSSSCCCCEEET-------TCEEEEEETTEEEEEEECTTSC--E--EEEET---TEEEEECCCTTS-CSSCEEEECTT
T ss_pred ecCcccCCCCEEcC-------CCEEEEeCCCCCEEEEEecCCC--E--EEEEC---CEEEEeCCCccC-CCceEEEEccC
Confidence 34799999999997 99999 999999999998877 2 57764 899999999876 33578999999
Q ss_pred ccEEEEcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEe
Q 037563 104 GNAYLQRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 104 g~l~l~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
|||||++.++ .+|++.+. ......++|+|+|||||++ .++|||
T Consensus 71 GNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 71 GVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp SCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred CEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 9999998765 79999875 3456789999999999997 389998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=152.63 Aligned_cols=109 Identities=17% Similarity=0.311 Sum_probs=90.2
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
+|+|.|||+|.+ ++.| ++|.|+|+|+.+++. ++|.. +++||+||++.+ ..++.+.|+.+||||
T Consensus 1 tdtl~~gq~L~~-------g~~L--~~~~~~L~~~~dgnl----vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLv 63 (112)
T 1xd5_A 1 SDRLNSGHQLDT-------GGSL--AEGGYLFIIQNDCNL----VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECT-------TCEE--EETTEEEEECTTSCE----EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEE
T ss_pred CCCCCCCCEECC-------CCEE--eCCCEEEEEcCCCcE----EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEE
Confidence 589999999987 8999 589999999988872 35654 799999999753 235689999999999
Q ss_pred EEcCCceeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCCC
Q 037563 108 LQRGNGEAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSHP 153 (606)
Q Consensus 108 l~~~~~~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~P 153 (606)
|++.+..+|++.+. ......++|+++|||||++.++.++||||++.
T Consensus 64 l~d~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred EEcCCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99933489999875 34456899999999999987778999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=152.24 Aligned_cols=108 Identities=15% Similarity=0.266 Sum_probs=90.3
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
.|+|.|||+|.+ +++|+ +|.|+|+|+.+++. ++|. ..++||+||++.|. .++.+.|+.|||||
T Consensus 2 ~dtl~~gq~L~~-------g~~L~--~g~~~L~~~~dgnl----vly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLv 64 (115)
T 2dpf_A 2 DNVLLSGQTLHA-------DHSLQ--AGAYTLTIQNKCNL----VKYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLV 64 (115)
T ss_dssp CCEEETTCEEET-------TEEEE--ETTEEEEECTTSCE----EEEE---TTEEEEECSCTTSC-SSCEEEECTTSCEE
T ss_pred CCEeCCCCEECC-------CCEEE--CCCEEEEEcCCCcE----EEEe---CCEEEEeCCCCCCC-CceEEEECCCCcEE
Confidence 489999999987 99998 79999999877762 2354 48999999999884 35789999999999
Q ss_pred EEcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCCCCC
Q 037563 108 LQRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155 (606)
Q Consensus 108 l~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~PtD 155 (606)
|++.++ .+|++.+. +....+++|+++|||||++. ++||||.++..
T Consensus 65 l~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 65 IYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 998765 79999875 34567899999999999963 89999998765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.3e-19 Score=173.38 Aligned_cols=135 Identities=17% Similarity=0.122 Sum_probs=105.7
Q ss_pred ccccccCCcCceeEEEEEe-CCCcE--EEEEEecccCCC-------------------------hHHHHHHHHHHHhccc
Q 037563 405 NFSTKLGQGGFGSVYLGML-PDGIQ--VAVKKLESIGQG-------------------------KKEFSAEVTIIGNVHH 456 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~Ei~~l~~l~h 456 (606)
.+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..+.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 67888 999987532111 1367889999999998
Q ss_pred CCc--ceeecceeccccceeeeeeccC-C----ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHH-hcCCCceeec
Q 037563 457 VHL--VKLKGFCIEGAHRLLAYEYLVN-G----SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH-EECEVKIVHC 528 (606)
Q Consensus 457 ~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~~iiH~ 528 (606)
+++ ..++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +. +|+||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 865 333332 467899999953 4 56555421 234567889999999999999 87 99999
Q ss_pred CCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 529 DIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 529 dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
||||.|||+++ .++|+|||++....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999998653
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=141.40 Aligned_cols=102 Identities=25% Similarity=0.400 Sum_probs=84.1
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEE
Q 037563 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYL 108 (606)
Q Consensus 29 ~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l 108 (606)
++|.|||+|.+ ++.|+ +|.|.|.|+.+++. +.|.. .++||++|++.+ ..++.+.|+.||||||
T Consensus 2 ntL~~gq~L~~-------g~~L~--~g~~~L~~q~dGnL----vly~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl 64 (109)
T 3dzw_A 2 NILYSGETLSP-------GEFLN--NGRYVFIMQEDCNL----VLYDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVV 64 (109)
T ss_dssp CEEETTEEECT-------TCEEE--ETTEEEEECTTSCE----EEEET---TEEEEECCCTTS-SSSCEEEECTTSCEEE
T ss_pred CCcCCCCEeCC-------CCEEE--CCCEEEEEcCCCcE----EEEeC---CEEEEECCcccC-CCCEEEEEeCCCCEEE
Confidence 68999999987 99996 79999999888772 22543 689999999876 3356899999999999
Q ss_pred EcCCc-eeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEec
Q 037563 109 QRGNG-EAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSF 150 (606)
Q Consensus 109 ~~~~~-~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsF 150 (606)
++.++ .+|++++.+. ...+|+|+|||||||+++ ++|||=
T Consensus 65 ~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 65 YSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred ECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 98765 8999998643 356899999999999974 799983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.5e-16 Score=131.31 Aligned_cols=102 Identities=18% Similarity=0.193 Sum_probs=81.1
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccE
Q 037563 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNA 106 (606)
Q Consensus 27 ~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l 106 (606)
++|+|.|||+|.+ ++.|+|+ .|.|-|...|+ +.+ |.. ++||++|++.. ..++.+.|+.||||
T Consensus 5 ~~dtL~~gq~L~~-------g~~L~sg--~~~L~~q~dGn---Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 5 TNNLLFSGQVLYG-------DGRLTAK--NHQLVMQGDCN---LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp BTTEEETTCEEET-------TEEEECS--SCEEEECTTSC---EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred ccCEECCCCEecC-------CCEEEeC--CEEEEEcCCCe---EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 4799999999997 9999985 59987766665 222 433 58999999762 23468999999999
Q ss_pred EEEcCCc-eeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEe
Q 037563 107 YLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 107 ~l~~~~~-~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
||++.++ .+|++++.. .....|+|+|||||||++ .++|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 9998765 799999853 344789999999999997 489997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=163.15 Aligned_cols=138 Identities=10% Similarity=0.050 Sum_probs=98.9
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccC---------------CChHHHHHHHHHHHhcccCCcceeeccee-
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---------------QGKKEFSAEVTIIGNVHHVHLVKLKGFCI- 467 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~---------------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~- 467 (606)
+.+...||+|+||.||+|..++|+.||||+++... ........++++.....|+|+++++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46678899999999999999999999999875321 11122333333333334555544433211
Q ss_pred -----ccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-
Q 037563 468 -----EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF- 541 (606)
Q Consensus 468 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~- 541 (606)
.....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred CCeeeeccCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence 1123479999999988866531 123456889999999999998 999999999999998876
Q ss_pred ---------cEEEeeccCCccc
Q 037563 542 ---------TAKVSDFGLAKLM 554 (606)
Q Consensus 542 ---------~~kl~Dfgla~~~ 554 (606)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999977643
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=130.04 Aligned_cols=105 Identities=16% Similarity=0.213 Sum_probs=84.4
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccE
Q 037563 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNA 106 (606)
Q Consensus 27 ~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l 106 (606)
+.|+|.|||.|.+ ++.|.+ |.|.|.|...|+ +.+ |.. ...++||++|++.+. .++.+.|+.||||
T Consensus 5 ~~~tL~~gq~L~~-------g~~L~~--g~~~L~~q~dGN---LvL-~~~-~~~~~vWssnt~~~~-~~~~l~l~~dGNL 69 (113)
T 3mez_B 5 VRNVLFSSQVMYD-------NAQLAT--RDYSLVMRDDCN---LVL-TKG-SKTNIVWESGTSGRG-QHCFMRLGHSGEL 69 (113)
T ss_dssp CSSEEETTCEEET-------TCEEEE--TTEEEEECTTSC---EEE-EET-TTTEEEEECCCTTSC-SSCEEEECTTSCE
T ss_pred cCCEeCCCCEECC-------CCEeEc--CCEEEEEcCCCE---EEE-EEC-CCCEEEEECCcccCC-cCEEEEEeCCCcE
Confidence 4799999999997 899975 889999977776 222 321 147899999998653 3568999999999
Q ss_pred EEEcCCc-eeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEe
Q 037563 107 YLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 107 ~l~~~~~-~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
||++.++ .+|++++.. ....+|+|+|||||||++ ..+|+|
T Consensus 70 Vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 70 DITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9998765 799999853 345789999999999996 589997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-15 Score=126.39 Aligned_cols=100 Identities=16% Similarity=0.285 Sum_probs=80.9
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccE
Q 037563 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNA 106 (606)
Q Consensus 27 ~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l 106 (606)
+.|||.|||.|.+ ++.| .+|.|.|.|...++.. .|. .+|.+|+..+ ..+..+.|+.||||
T Consensus 2 ~~dtL~~gq~L~~-------g~~L--~~g~~~L~~q~dGNLv----l~~------~~Wssnt~~~-~~~~~l~l~~dGnL 61 (109)
T 3r0e_A 2 GTNYLLSGQTLDT-------EGHL--KNGDFDLVMQDDCNLV----LYN------GNWQSNTANN-GRDCKLTLTDYGEL 61 (109)
T ss_dssp CCSEEETTCEECT-------TCEE--EETTEEEEECTTSCEE----EET------TTEECCCTTS-CSSCEEEECTTSCE
T ss_pred ccCCcCCCCCcCC-------CCEe--ECCCEEEEEecCCeEE----EEe------CeEEcCCCCC-CCcEEEEEcCCCeE
Confidence 3699999999987 8888 4799999998777721 132 1699998765 23578999999999
Q ss_pred EEEcCCc-eeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEe
Q 037563 107 YLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 107 ~l~~~~~-~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
||++.++ .+|++++.+ ....+|+|+|||||||++ .++|+|
T Consensus 62 vl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s 103 (109)
T 3r0e_A 62 VIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI 103 (109)
T ss_dssp EEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred EEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence 9998765 799998853 345689999999999996 689998
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.51 E-value=4.9e-14 Score=119.51 Aligned_cols=101 Identities=13% Similarity=0.134 Sum_probs=80.5
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
.|+|.|||.|.+ ++.|. +|.|.|.|...++. +.|.. .. ||.+|+..+ ..++.+.|+.|||||
T Consensus 2 ~~~l~~gq~L~~-------g~~L~--~g~~~L~~q~dGnL----vl~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLV 63 (111)
T 3mez_A 2 NNVLLTGDVIHT-------DNQLS--YESAAFVMQGDCNL----VLYNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLE 63 (111)
T ss_dssp TTEEETTCEECT-------TCEEE--ETTEEEEECTTSCE----EEECS---SC-CEECCCTTS-CSSCEEEECTTSCEE
T ss_pred cCEeCCCCEeCC-------CCEEe--cCCEEEEEccCCeE----EEECC---CC-EEECCcccC-CcCEEEEEcCCCcEE
Confidence 589999999987 89883 78999999877762 22432 23 999999766 235789999999999
Q ss_pred EEcCCc--eeEeeccC---CCceeEEEEecCCcEEEEecCCceEEEe
Q 037563 108 LQRGNG--EAWSANTS---GQKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 108 l~~~~~--~~w~t~~~---~~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
|++.++ .+|++++. ......++|++||||||++ .++|+|
T Consensus 64 l~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 64 IHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp EECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 998865 49999863 2345789999999999996 689997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.7e-12 Score=109.83 Aligned_cols=60 Identities=23% Similarity=0.464 Sum_probs=51.8
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecCCCC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~Pt 154 (606)
..+|.|+.||||||++.+.+||++++.. ...+.++|+++|||||++.++.++||||..|.
T Consensus 21 ~~~l~~~~dGnlvl~~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~ 81 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGK 81 (110)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCS
T ss_pred CEEEEEcCCCcEEEEECCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCCCCC
Confidence 4679999999999999766899999853 34568999999999999988899999998775
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-11 Score=121.73 Aligned_cols=114 Identities=21% Similarity=0.310 Sum_probs=82.9
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEec---CCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEecc
Q 037563 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTA---LDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKS 103 (606)
Q Consensus 27 ~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~---~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~ 103 (606)
.+|||.||+++.. ....++.|.|+ ..++.|+|.. ..+ .+.+ |++ ..+++|.+++..+- ...+.++.+
T Consensus 135 ptdtlLpg~~~~~---~l~~g~~L~S~-~dps~G~fsl~l~~dG-nlvL-y~~--~~~~yW~Sgt~~~~--~~~l~l~~d 204 (276)
T 3m7h_A 135 PAIPLVPGAIDSL---LLAPGSELVQG-VVYGAGASKLVFQGDG-NLVA-YGP--NGAATWNAGTQGKG--AVRAVFQGD 204 (276)
T ss_dssp TTSCCCCSCTTCE---EECSSEEECTT-CEEEETTEEEEECTTS-CEEE-ECT--TSSEEEECCCTTTT--CCEEEECTT
T ss_pred ccccccccccccc---ccccCcccccC-CCCCCceEEEeecCCc-eEEE-EeC--CCeEEEECCCCCCc--cEEEEEcCC
Confidence 4899999999321 12237778654 4555555542 122 2223 332 36899999998763 267899999
Q ss_pred ccEEEEcCCc-eeEeeccCCCceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 104 GNAYLQRGNG-EAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 104 g~l~l~~~~~-~~w~t~~~~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
|+|++++.++ .+|++.+......+++|+++||||+++. .++||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 9999999876 8999998655568899999999999975 689999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.5e-11 Score=119.96 Aligned_cols=141 Identities=13% Similarity=-0.009 Sum_probs=111.7
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccC-CChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+.+...++.|+.+.||+.... ++.+++|+..... ....++.+|+.+++.+. |..+.+++++..+....++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 455677888899999999864 6889999986432 33456899999999985 67788999999888888999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC---------------------------------------- 521 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---------------------------------------- 521 (606)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 95 VLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred eehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99987631 12234578899999999999810
Q ss_pred ----------------CCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 522 ----------------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 522 ----------------~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+..++|+|++|.||+++++..+.|+||+.+...
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 135899999999999987666679999988643
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.6e-11 Score=103.04 Aligned_cols=59 Identities=27% Similarity=0.395 Sum_probs=50.9
Q ss_pred CcEEEeccccEEEEcCCceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecCCCC
Q 037563 96 DKFVFEKSGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (606)
Q Consensus 96 ~~~~~~~~g~l~l~~~~~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~Pt 154 (606)
.+|.|+.||||++++.+.+||++++.. ...+.++|+++|||||+|.++.++||||..|.
T Consensus 32 ~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~ 91 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGK 91 (119)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCCCC
T ss_pred EEEEEecCCCEEEEECCEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCCCC
Confidence 468899999999998866899999753 33578999999999999988999999998775
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.3e-11 Score=102.42 Aligned_cols=59 Identities=24% Similarity=0.484 Sum_probs=50.8
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecCCCC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~Pt 154 (606)
..+|.|+.||+|+|++.+.+||++++.+ ...+.|+|+++|||||++ ++.++||||+.|.
T Consensus 20 ~~~L~~~~dgnlvl~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~ 79 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQ 79 (112)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCCS
T ss_pred CEEEEEcCCCcEEEEECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccCC
Confidence 4578999999999998866899999753 345789999999999999 7889999998875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=6e-11 Score=101.28 Aligned_cols=60 Identities=20% Similarity=0.312 Sum_probs=51.1
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEecCCCC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~Pt 154 (606)
..+|.|+.||||+|++...+||++++... ..+.++|+++|||||+|.++.++|||||+|.
T Consensus 21 ~~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~ 81 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD 81 (115)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCS
T ss_pred CEEEEEcCCCcEEEEeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCCC
Confidence 34688999999999986568999997533 4578999999999999988899999999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.2e-10 Score=114.40 Aligned_cols=130 Identities=14% Similarity=0.028 Sum_probs=98.9
Q ss_pred CCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecceeccccceeeeeeccCCChhhhh
Q 037563 411 GQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGFCIEGAHRLLAYEYLVNGSLDKWI 488 (606)
Q Consensus 411 G~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l 488 (606)
+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 456669999998877888999987643 3356889999999987555 456888887777889999999999884 2
Q ss_pred hhccccccccChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 037563 489 FNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC----------------------------------------------- 521 (606)
Q Consensus 489 ~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~----------------------------------------------- 521 (606)
.. . ....++.++++.|..||+..
T Consensus 105 ~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 10 1 12356777778888888642
Q ss_pred --------CCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 522 --------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 522 --------~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+..++|+|++|.||+++++..++|+||+.+...
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988766779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-09 Score=113.37 Aligned_cols=140 Identities=15% Similarity=0.183 Sum_probs=106.4
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEec--ccC--CChHHHHHHHHHHHhcc--cCCcceeecceecc---ccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLE--SIG--QGKKEFSAEVTIIGNVH--HVHLVKLKGFCIEG---AHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~--~~~--~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~---~~~~lV~E~ 478 (606)
+.++.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568999999999999854 678888876 322 23457888999999997 45678888888776 347899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC------------------------------------- 521 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------------------------------------- 521 (606)
++|..+.+... ..++...+..++.++++.|..||+..
T Consensus 123 v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99988854221 23567778889999999999999831
Q ss_pred ------------------CCceeecCCCCCCeEEcCCCc--EEEeeccCCccc
Q 037563 522 ------------------EVKIVHCDIKPENVLLDDNFT--AKVSDFGLAKLM 554 (606)
Q Consensus 522 ------------------~~~iiH~dlkp~NIll~~~~~--~kl~Dfgla~~~ 554 (606)
+..++|+|+++.||++++++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999998754
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.96 E-value=6.8e-10 Score=94.21 Aligned_cols=57 Identities=25% Similarity=0.340 Sum_probs=48.2
Q ss_pred CCcEEEeccccEEEEcCC--ceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecC
Q 037563 95 SDKFVFEKSGNAYLQRGN--GEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFS 151 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~--~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd 151 (606)
...|.++.||||||++.+ ..+|++++.. ...+.++|+++|||||++.++.++|||=.
T Consensus 25 ~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t 84 (113)
T 3mez_B 25 DYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNT 84 (113)
T ss_dssp TEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSC
T ss_pred CEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCC
Confidence 447899999999999873 4899999853 34578999999999999988899999854
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.91 E-value=1e-09 Score=92.79 Aligned_cols=56 Identities=25% Similarity=0.391 Sum_probs=47.7
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCc-eEEEecC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGS-ILWQSFS 151 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~-~~WqsFd 151 (606)
...|.|+.||||||++.++ +|++++... ..+.++|+++|||||++.++. ++|||.-
T Consensus 21 ~~~L~~q~dGnLvl~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t 78 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPR 78 (111)
T ss_dssp TEEEEECTTSCEEEECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESS
T ss_pred CEEEEEccCCeEEEECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEecc
Confidence 3478999999999999888 999998643 357899999999999998776 5999984
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.90 E-value=2e-09 Score=89.94 Aligned_cols=54 Identities=30% Similarity=0.544 Sum_probs=48.1
Q ss_pred cEEEeccccEEEEcCCceeEeeccC--CCceeEEEEecCCcEEEEecCCceEEEec
Q 037563 97 KFVFEKSGNAYLQRGNGEAWSANTS--GQKVECMELQDSGNLVLLGVNGSILWQSF 150 (606)
Q Consensus 97 ~~~~~~~g~l~l~~~~~~~w~t~~~--~~~~~~~~l~~~Gnlvl~~~~~~~~WqsF 150 (606)
+|.|+.||||||++.+..||++++. ....+.+.|+++|||||+|.++.++|+|=
T Consensus 22 ~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH 77 (105)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred EEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec
Confidence 6899999999999988899999974 34567899999999999999999999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=90.49 Aligned_cols=58 Identities=24% Similarity=0.433 Sum_probs=49.6
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
...|.|+.||||||++.+.++|++++... ..+.+.|+++|||||+|.++.++|||-..
T Consensus 20 ~~~L~~q~dGnLvly~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~ 78 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTG 78 (109)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCC
T ss_pred CEEEEEcCCCcEEEEeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCC
Confidence 34789999999999998778999998543 45789999999999999888999999754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=109.70 Aligned_cols=185 Identities=16% Similarity=0.184 Sum_probs=119.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCC--cceeecceeccc---cceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVH--LVKLKGFCIEGA---HRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~n--Iv~l~g~~~~~~---~~~lV~E~~~~ 481 (606)
+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 448899999999864 45888876432 23567899999998884 333 344544443333 34789999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE----------------------------------------- 520 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------------------------------------- 520 (606)
.+|.+... ..++..++..++.++++.|..||+.
T Consensus 101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 98875432 2356667777888888888888861
Q ss_pred --------------CCCceeecCCCCCCeEEcC--CCcEEEeeccCCcccCcCcceeeeecccccCcccccccc-----C
Q 037563 521 --------------CEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT-----N 579 (606)
Q Consensus 521 --------------~~~~iiH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~ 579 (606)
.+..++|+|++|.||++++ ...+.|+||+.+....+.......... . .-..|+... .
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~-~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED-D-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT-T-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh-c-cccCHHHHHHHHHHc
Confidence 1246899999999999998 456889999998754332111000000 0 001222110 0
Q ss_pred CCC---------CCccchHHHHHHHHHHHhCCCCC
Q 037563 580 NPI---------SEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 580 ~~~---------t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
... ....+.|+++.++|++.+|+.+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 101 12258899999999999998765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.83 E-value=4.6e-09 Score=88.53 Aligned_cols=56 Identities=25% Similarity=0.442 Sum_probs=48.0
Q ss_pred CcEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 96 DKFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 96 ~~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
..|.++.||||||++. ..+|++++... ..+.++|+++|||||+|.++.++|||-.+
T Consensus 26 ~~L~~q~dGnLvl~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~ 82 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSS 82 (110)
T ss_dssp CEEEECTTSCEEEECS-SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCC
T ss_pred EEEEEcCCCeEEEECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCc
Confidence 4789999999999977 68999998543 34689999999999999888999999753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.4e-08 Score=85.47 Aligned_cols=54 Identities=30% Similarity=0.500 Sum_probs=45.5
Q ss_pred CCcEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEecC
Q 037563 95 SDKFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFS 151 (606)
Q Consensus 95 ~~~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsFd 151 (606)
...|.++.||||||++. +|+|++... ..+.++|+++|||||+|.++.++|+|-.
T Consensus 22 ~~~L~~q~dGNLvl~~~---~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t 76 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG---NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGA 76 (109)
T ss_dssp TEEEEECTTSCEEEETT---TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCC
T ss_pred CEEEEEecCCeEEEEeC---eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCC
Confidence 34789999999999985 899998643 4578999999999999988899998643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=5.1e-06 Score=81.83 Aligned_cols=136 Identities=15% Similarity=0.114 Sum_probs=95.7
Q ss_pred cCCcCce-eEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccCCChhh
Q 037563 410 LGQGGFG-SVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 410 lG~G~fG-~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
+..|.-+ .||+.... ++..+++|+-+.. ...++..|...|+.+. +-.+.++++++.+.+..++|||++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 3444444 68988765 4667899986532 3467888999998885 4457788889888888999999999988876
Q ss_pred hhhhccccccccChhhHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 037563 487 WIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE---------------------------------------------- 520 (606)
Q Consensus 487 ~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------------------------------------------- 520 (606)
..... ......+..+++..|.-||..
T Consensus 110 ~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 54221 122233455555555555531
Q ss_pred ---------CCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 521 ---------CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 521 ---------~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
.+..++|+|+.+.||++++++.+-|+||+.+....
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 01237999999999999988777899999887543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=3.8e-06 Score=84.58 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=91.7
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccC---Ccceeeccee-ccccceeeeeeccCCC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV---HLVKLKGFCI-EGAHRLLAYEYLVNGS 483 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~---nIv~l~g~~~-~~~~~~lV~E~~~~gs 483 (606)
+.++.|....||+. +..+++|+.+. ......+..|+.+++.+.+. .+.+.+.+.. ..+..++||||++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 34788888899987 46688887532 22346789999999999753 3556666663 3455789999999988
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE------------------------------------------- 520 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------------------------------------------- 520 (606)
|.+... ..++......++.++++.|..||+.
T Consensus 100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 876321 0122333333444444444444431
Q ss_pred --------------CCCceeecCCCCCCeEEcC---CCc-EEEeeccCCcccCc
Q 037563 521 --------------CEVKIVHCDIKPENVLLDD---NFT-AKVSDFGLAKLMNR 556 (606)
Q Consensus 521 --------------~~~~iiH~dlkp~NIll~~---~~~-~kl~Dfgla~~~~~ 556 (606)
.+..++|+|++|.||++++ ++. ..|+||+.+....+
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 2346799999999999997 455 48999998876443
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.21 E-value=3e-07 Score=88.86 Aligned_cols=57 Identities=28% Similarity=0.417 Sum_probs=50.1
Q ss_pred CcEEEeccccEEEEcCCceeEeeccCCCceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 96 DKFVFEKSGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 96 ~~~~~~~~g~l~l~~~~~~~w~t~~~~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
.+|.|+.||++++++...+||.+++.+...+.+.|+++|||||+|.++.++|+|+++
T Consensus 28 f~l~f~~~gnl~ly~~~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~ 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK 84 (236)
T ss_dssp EEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC
T ss_pred EEEEECCCCcEEEEECCEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc
Confidence 467788999999998877899999865567789999999999999999999999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=5.3e-06 Score=85.35 Aligned_cols=79 Identities=8% Similarity=0.055 Sum_probs=57.0
Q ss_pred ccc-CCcCceeEEEEEeC-------CCcEEEEEEecccC----CChHHHHHHHHHHHhccc---CCcceeecceecc---
Q 037563 408 TKL-GQGGFGSVYLGMLP-------DGIQVAVKKLESIG----QGKKEFSAEVTIIGNVHH---VHLVKLKGFCIEG--- 469 (606)
Q Consensus 408 ~~l-G~G~fG~Vy~g~~~-------~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h---~nIv~l~g~~~~~--- 469 (606)
+.| +.|....+|+.... +++.+++|+..... .....+..|+.+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88889999998864 26778888765432 123567889998888853 3567788877655
Q ss_pred ccceeeeeeccCCChhh
Q 037563 470 AHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~ 486 (606)
...++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.1e-05 Score=78.83 Aligned_cols=142 Identities=12% Similarity=0.138 Sum_probs=83.0
Q ss_pred ccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhccc--CCcceeecc------eeccccceeeeeecc
Q 037563 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH--VHLVKLKGF------CIEGAHRLLAYEYLV 480 (606)
Q Consensus 409 ~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~------~~~~~~~~lV~E~~~ 480 (606)
.|+.|..+.||+....++ .+++|+... ...++..|+.+++.+.. -.+.+++.. ....+..++++||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677899999988655 488998865 23445556666666542 233444431 124556789999999
Q ss_pred CCChhh-----------h---hhhccc-c--c-------cccChhhH-------------------------------HH
Q 037563 481 NGSLDK-----------W---IFNSTE-E--S-------RFLCWNTR-------------------------------FN 505 (606)
Q Consensus 481 ~gsL~~-----------~---l~~~~~-~--~-------~~l~~~~~-------------------------------~~ 505 (606)
|.++.. . ++.... . . ....|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 876530 0 111100 0 0 01122110 11
Q ss_pred HHHHHHHHHHHHHh----------cCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 506 IALGTAKGLAYLHE----------ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 506 i~~qi~~gL~yLH~----------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+..++.+++.+|+. ..+..++|+|+++.||+++.++.+.|+||+.+...
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 11234446667763 12458999999999999988889999999988643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=5.6e-05 Score=78.89 Aligned_cols=73 Identities=11% Similarity=0.057 Sum_probs=49.3
Q ss_pred cccCCcCceeEEEEEeC-CCcEEEEEEecccC--------CChHHHHHHHHHHHhccc--CC-cceeecceeccccceee
Q 037563 408 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--------QGKKEFSAEVTIIGNVHH--VH-LVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~~~Ei~~l~~l~h--~n-Iv~l~g~~~~~~~~~lV 475 (606)
+.+|.|..+.||++... +++.++||...... ...+.+..|.++++.+.+ +. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999864 46789999764321 123567788888888753 33 3345543 34456899
Q ss_pred eeeccCC
Q 037563 476 YEYLVNG 482 (606)
Q Consensus 476 ~E~~~~g 482 (606)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=6.5e-05 Score=79.04 Aligned_cols=79 Identities=9% Similarity=-0.010 Sum_probs=48.1
Q ss_pred CCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeeeecccccCccccccccCCC---CCCccchHHHHHHHHHH
Q 037563 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP---ISEKSDVYSYGMVLLEI 598 (606)
Q Consensus 522 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~Dv~s~Gvvl~el 598 (606)
+..++|+|++|.||++++++ ++|+||+.+....+..........-...|++|+...... -....+.......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999999876 999999998764432221100000123466666543211 11234455777777777
Q ss_pred HhC
Q 037563 599 IGG 601 (606)
Q Consensus 599 ltG 601 (606)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00018 Score=72.33 Aligned_cols=138 Identities=19% Similarity=0.148 Sum_probs=92.0
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcc---cCCcceeecceeccccceeeeeeccCCCh
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVH---HVHLVKLKGFCIEGAHRLLAYEYLVNGSL 484 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~E~~~~gsL 484 (606)
+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4589999999999987 5678889987543 3567899999998885 35688888888777788999999999865
Q ss_pred hh-----------hhhhccc---cc----------c-----ccChhhHH---HHHH----------------HHHHH-HH
Q 037563 485 DK-----------WIFNSTE---ES----------R-----FLCWNTRF---NIAL----------------GTAKG-LA 515 (606)
Q Consensus 485 ~~-----------~l~~~~~---~~----------~-----~l~~~~~~---~i~~----------------qi~~g-L~ 515 (606)
.. .|+.... .+ . .-+|.... ++.. ++... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 32 1222111 00 0 11343321 1111 11111 22
Q ss_pred HHHh-cCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 516 YLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 516 yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
.|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 2356899999999999999887 8999974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00036 Score=69.23 Aligned_cols=73 Identities=22% Similarity=0.216 Sum_probs=54.5
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccC-CChHHHHHHHHHHHhcccC---CcceeecceeccccceeeeeeccCCC
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHV---HLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~---nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
+.+|.|..+.||+.++.||+.+++|+..... .....|..|+..|+.+... .+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 5689999999999999999999999875433 3345688999999988532 34444443 23489999998765
Q ss_pred h
Q 037563 484 L 484 (606)
Q Consensus 484 L 484 (606)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00043 Score=69.10 Aligned_cols=141 Identities=11% Similarity=0.031 Sum_probs=77.4
Q ss_pred ccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeeec-cCCCh
Q 037563 407 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEYL-VNGSL 484 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~~-~~gsL 484 (606)
.+.|+.|....+|+. +.+++|+.........+..+|+..++.+...++. ++++.. ...-++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 356888999999998 4588887754322222346688888777644443 555443 33457899999 66555
Q ss_pred hhhh------------------hhcccc-ccccC-hhhHHHHHH--------------HHHHHHH----HHHh-cCCCce
Q 037563 485 DKWI------------------FNSTEE-SRFLC-WNTRFNIAL--------------GTAKGLA----YLHE-ECEVKI 525 (606)
Q Consensus 485 ~~~l------------------~~~~~~-~~~l~-~~~~~~i~~--------------qi~~gL~----yLH~-~~~~~i 525 (606)
.... +..... ..... +.....+.. .+.+.+. .|.. ..+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 3210 110000 00000 011111100 0111111 1111 223468
Q ss_pred eecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 526 iH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+|+|+.+.||+ ..++.+.|+||..+....
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 99999999999 666788999999887543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00041 Score=73.06 Aligned_cols=73 Identities=21% Similarity=0.223 Sum_probs=51.2
Q ss_pred cccCCcCceeEEEEEeCC--------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCc-ceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL-VKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~E~ 478 (606)
+.|+.|....+|+...++ ++.+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 478899987432 222567789999988865445 566665543 389999
Q ss_pred ccCCChh
Q 037563 479 LVNGSLD 485 (606)
Q Consensus 479 ~~~gsL~ 485 (606)
++|.+|.
T Consensus 154 l~G~~l~ 160 (429)
T 1nw1_A 154 IPSRPLS 160 (429)
T ss_dssp CCEEECC
T ss_pred eCCcccC
Confidence 9875553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00081 Score=71.24 Aligned_cols=74 Identities=9% Similarity=-0.060 Sum_probs=49.1
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCc-ceeecceeccccceeeeeeccCCChh
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL-VKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
+.|+.|-...+|+....+ +..+++|+........-+...|..++..+...++ .++++.+.. .+|+||++|.+|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l~ 189 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYALS 189 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccCC
Confidence 457888889999999865 4788888774322222223688889998875555 456666632 3599999986653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00084 Score=69.21 Aligned_cols=143 Identities=19% Similarity=0.177 Sum_probs=85.4
Q ss_pred cccCCcCceeEEEEEeCC--------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCc-ceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL-VKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~E~ 478 (606)
+.|..|--..+|+...++ ++.+++|+..........+.+|..+++.+...++ .++++.+.++ +|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 346677788899988752 4789999864433456677899999988864333 4566665542 99999
Q ss_pred ccCCChhhhh-----------------hhccc-cccccC--hhhHHHHHHHHHH-------------------HHHHHHh
Q 037563 479 LVNGSLDKWI-----------------FNSTE-ESRFLC--WNTRFNIALGTAK-------------------GLAYLHE 519 (606)
Q Consensus 479 ~~~gsL~~~l-----------------~~~~~-~~~~l~--~~~~~~i~~qi~~-------------------gL~yLH~ 519 (606)
++|.+|..-- +.... ..+... |.+..++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 9987664210 11100 011111 3444444443321 2333322
Q ss_pred -----cCCCceeecCCCCCCeEEcCC----CcEEEeeccCCccc
Q 037563 520 -----ECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLM 554 (606)
Q Consensus 520 -----~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgla~~~ 554 (606)
..+..++|+|+.+.||+++++ +.+.|+||..+...
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 124579999999999999876 78999999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0013 Score=66.37 Aligned_cols=142 Identities=13% Similarity=0.040 Sum_probs=84.2
Q ss_pred cCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecc-----eeccccceeeeeeccCC
Q 037563 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGF-----CIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~-----~~~~~~~~lV~E~~~~g 482 (606)
++ |....||+....+|+.+++|..........++..|..++..+.... +.+++.. ....+..++++||++|.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 55 7788999988877878999998644345667888888888875333 4445443 11233457899999886
Q ss_pred Chhh-----h---------hhhccc-----cccccChhhH----H---------------HHHHHHHHHHHHHHhc----
Q 037563 483 SLDK-----W---------IFNSTE-----ESRFLCWNTR----F---------------NIALGTAKGLAYLHEE---- 520 (606)
Q Consensus 483 sL~~-----~---------l~~~~~-----~~~~l~~~~~----~---------------~i~~qi~~gL~yLH~~---- 520 (606)
.+.. + ++.... .....++... . .+...+...++.+...
T Consensus 113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 192 (328)
T 1zyl_A 113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 192 (328)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 5431 1 111000 0011111110 0 0111111223333321
Q ss_pred CCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 521 ~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
.+..++|+|+++.||+++ + .+.|+||+.+...
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234789999999999999 4 8999999887654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00095 Score=67.15 Aligned_cols=144 Identities=13% Similarity=0.102 Sum_probs=81.9
Q ss_pred cccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCC--cceeecce------eccccceeeeeec
Q 037563 408 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVH--LVKLKGFC------IEGAHRLLAYEYL 479 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~------~~~~~~~lV~E~~ 479 (606)
+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+...+ +.+++... ...+..++++||+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788899999988666 5788987652 23345677888887775333 33344221 1234568999999
Q ss_pred cCCChhhh--------------hhhcccc---c-----cccChhhHHH------------HHHHHHHHHHHHHhc----C
Q 037563 480 VNGSLDKW--------------IFNSTEE---S-----RFLCWNTRFN------------IALGTAKGLAYLHEE----C 521 (606)
Q Consensus 480 ~~gsL~~~--------------l~~~~~~---~-----~~l~~~~~~~------------i~~qi~~gL~yLH~~----~ 521 (606)
+|..+... ++..... . ....|..... +...+...++.++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 98764320 1111000 0 0011221100 011234455566542 2
Q ss_pred CCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 522 ~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+..++|+|+++.||+++++..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 35799999999999999876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.003 Score=63.86 Aligned_cols=144 Identities=18% Similarity=0.075 Sum_probs=75.4
Q ss_pred ccCCcCcee-EEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccC--CcceeecceeccccceeeeeeccCCChh
Q 037563 409 KLGQGGFGS-VYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHV--HLVKLKGFCIEGAHRLLAYEYLVNGSLD 485 (606)
Q Consensus 409 ~lG~G~fG~-Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 485 (606)
.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+... .+.+++.+..+. -+++||++.+.++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 455554444 677776446777777654332 13345567777666432 345566653333 37899999877776
Q ss_pred hhhhhccc---------------------c-ccccChhhHH-------H-------------HHHHHHHHHHHHHh---c
Q 037563 486 KWIFNSTE---------------------E-SRFLCWNTRF-------N-------------IALGTAKGLAYLHE---E 520 (606)
Q Consensus 486 ~~l~~~~~---------------------~-~~~l~~~~~~-------~-------------i~~qi~~gL~yLH~---~ 520 (606)
+++..... . ....+..... . ....+...+..|.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 54432110 0 0001110000 0 00111122222311 1
Q ss_pred CCCceeecCCCCCCeEEcCC----CcEEEeeccCCcccCc
Q 037563 521 CEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLMNR 556 (606)
Q Consensus 521 ~~~~iiH~dlkp~NIll~~~----~~~kl~Dfgla~~~~~ 556 (606)
.+..++|+|+.+.||+++.+ ..+.|+||+.+.....
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 24589999999999999875 6899999998876443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00081 Score=69.23 Aligned_cols=73 Identities=11% Similarity=0.043 Sum_probs=45.0
Q ss_pred cccCCcCceeEEEEEeCC---------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCc-ceeecceeccccceeeee
Q 037563 408 TKLGQGGFGSVYLGMLPD---------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL-VKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~E 477 (606)
+.++.|....+|+....+ ++.+++|+.........+...|..+++.+...++ .++++.. .-.+|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 457788888999998754 2678888765422222234678888888764444 3566543 2378999
Q ss_pred eccCCCh
Q 037563 478 YLVNGSL 484 (606)
Q Consensus 478 ~~~~gsL 484 (606)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.01 Score=60.08 Aligned_cols=68 Identities=12% Similarity=0.073 Sum_probs=44.3
Q ss_pred CCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhccc---CCcceeecc------eeccccceeeeeeccC
Q 037563 411 GQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH---VHLVKLKGF------CIEGAHRLLAYEYLVN 481 (606)
Q Consensus 411 G~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h---~nIv~l~g~------~~~~~~~~lV~E~~~~ 481 (606)
|.|....||+....+| .+++|+...... ..|+..+..+.. |.+.+.+.. .......++||||++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999998777 899998765432 345556655532 224555532 2234567899999998
Q ss_pred CCh
Q 037563 482 GSL 484 (606)
Q Consensus 482 gsL 484 (606)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.01 E-value=0.012 Score=61.43 Aligned_cols=142 Identities=8% Similarity=0.104 Sum_probs=84.9
Q ss_pred cccCCcCceeEEEEEeCC--------CcEEEEEEecccCCChHHHHHHHHHHHhcccCCc-ceeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHL-VKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~E~ 478 (606)
+.+..|--..+|+...++ ++.+++|+........-+..+|..+++.+...++ .++++.+. -.+|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 456778888999998763 5788988864432222344678888888864444 34554332 3789999
Q ss_pred ccCCChhhh-----------------hhhccc---------cccccChhhHHHHHHHH-------------------HHH
Q 037563 479 LVNGSLDKW-----------------IFNSTE---------ESRFLCWNTRFNIALGT-------------------AKG 513 (606)
Q Consensus 479 ~~~gsL~~~-----------------l~~~~~---------~~~~l~~~~~~~i~~qi-------------------~~g 513 (606)
++|.+|..- |+.... ...+.-|.+..++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 999765321 010000 11111233333333222 122
Q ss_pred HHHHHh---------------------cCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 514 LAYLHE---------------------ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 514 L~yLH~---------------------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
+..|.+ ..+..++|+|+.+.||+ +.++.+.|+||..+...
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 333321 12346899999999999 88889999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.15 E-value=0.12 Score=53.52 Aligned_cols=31 Identities=23% Similarity=0.335 Sum_probs=26.2
Q ss_pred ceeecCCCCCCeEE------cCCCcEEEeeccCCccc
Q 037563 524 KIVHCDIKPENVLL------DDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 524 ~iiH~dlkp~NIll------~~~~~~kl~Dfgla~~~ 554 (606)
.++|+|+.+.||++ +++..++++||..+..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46899999999999 45677999999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.16 E-value=0.76 Score=42.73 Aligned_cols=100 Identities=9% Similarity=0.032 Sum_probs=64.6
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
.-+|.+.|.... .++++.++..++.|.+..|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 347888886533 579999999999999999877622111 1 1333457999999999998875 1111
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG 600 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt 600 (606)
.....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888653 345678899999999998765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.53 E-value=0.82 Score=42.38 Aligned_cols=85 Identities=9% Similarity=0.090 Sum_probs=57.9
Q ss_pred ccCCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 455 ~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
.||+++.. ..-.+.+...+.|+ ...+...|-. -..++...+++++.+|+....+++.+ +|--++|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~--~~~~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYD--INDNHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEEC--CCTTSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEE--cCcccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888766 33344444444444 3333333321 13467788899999999888666654 788999999
Q ss_pred eEEcCCCcEEEeeccCCc
Q 037563 535 VLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~ 552 (606)
|+++.++.|++.-.|+-.
T Consensus 110 L~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp EEECTTSCEEESCCEETT
T ss_pred EEEcCCCCEEEEEccCcc
Confidence 999999999998877644
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=88.37 E-value=0.39 Score=36.98 Aligned_cols=35 Identities=14% Similarity=0.393 Sum_probs=31.3
Q ss_pred CCChhhHHHHcccCCCceeEEecCCCCceeeeecc
Q 037563 266 KYDINTCKEACLHNCSCSVLFFENSTKNCFLFDQI 300 (606)
Q Consensus 266 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~l 300 (606)
..++++|+..|+.+=.|.+|.|+.....|+++...
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~~ 63 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRGK 63 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEESS
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccCC
Confidence 56889999999999999999999888899998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.35 E-value=2 Score=39.98 Aligned_cols=85 Identities=9% Similarity=0.019 Sum_probs=55.3
Q ss_pred ccCCcceeecceeccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHH-HHHhcCCCceeecCCCCC
Q 037563 455 HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLA-YLHEECEVKIVHCDIKPE 533 (606)
Q Consensus 455 ~h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~~~~iiH~dlkp~ 533 (606)
.||++ -...-.+.+...+.++--+++.=...+ ..++...+++++.+|+.... +++. -+|--++|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 222334445444544443222111122 34677888888888888766 5554 478889999
Q ss_pred CeEEcCCCcEEEeeccCCcc
Q 037563 534 NVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 534 NIll~~~~~~kl~Dfgla~~ 553 (606)
||++|.++.++|.-.|+-..
T Consensus 114 NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GEEECTTCCEEESCCEETTT
T ss_pred eEEEeCCCcEEEEEcCCccc
Confidence 99999999999988776543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.34 E-value=0.17 Score=53.45 Aligned_cols=60 Identities=10% Similarity=0.077 Sum_probs=18.3
Q ss_pred ccccccCCcCceeEEEEEeCC-CcEEEE------EEeccc---CCChHHHHHHHHHHHhcccCCcceeeccee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-GIQVAV------KKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~~~vav------K~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~ 467 (606)
.+.++|| ||.||+|.+.. ..+||| |..+.. .+....|.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3446677 99999999864 357888 666432 233456888999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 606 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-11 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-06 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-04 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-58
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
++G G FG+VY G + V + + + Q + F EV ++ HV+++ G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
+ ++ SL + +IA TA+G+ YLH + I+H
Sbjct: 75 AP-QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWIT---NNPIS 583
D+K N+ L ++ T K+ DFGLA + +R S + L G+ ++APE I NP S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 584 EKSDVYSYGMVLLEIIGGRKSFS 606
+SDVY++G+VL E++ G+ +S
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 6/197 (3%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+LG G FG V++G +VAVK L+ F AE ++ + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ NGSL ++ L N ++A A+G+A++ E +H
Sbjct: 80 E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 588
D++ N+L+ D + K++DFGLA+L+ E + + APE I + KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 589 YSYGMVLLEIIGGRKSF 605
+S+G++L EI+ +
Sbjct: 194 WSFGILLTEIVTHGRIP 210
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
+LG G G V+ P G+ +A K + E + + E+ ++ + ++V G
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+ E++ GSLD+ + +++ + +++ KGL YL E+ KI
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 126
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
+H D+KP N+L++ K+ DFG++ + + + GTR Y++PE + S +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQ 183
Query: 586 SDVYSYGMVLLEIIGGRKSF 605
SD++S G+ L+E+ GR
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
F ++G G FG V+LG + +VA+K + +++F E ++ + H LV+L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
C+E A L +E++ +G L ++ + T + L +G+AYL E C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
++H D+ N L+ +N KVSDFG+ + + ++ T + + +PE + + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
KSDV+S+G+++ E+ K
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIP 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 7/203 (3%)
Query: 405 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
F +LG G FG V G VA+K ++ + EF E ++ N+ H LV+L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
C + + EY+ NG L ++ + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
+H D+ N L++D KVSDFGL++ + +E + + PE + + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 585 KSDVYSYGMVLLEII-GGRKSFS 606
KSD++++G+++ EI G+ +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYE 203
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-56
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
KLGQG FG V++G +VA+K L+ + F E ++ + H LV+L E
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHC 528
+ EY+ GSL ++ E ++L ++A A G+AY+ VH
Sbjct: 84 E-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 137
Query: 529 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 588
D++ N+L+ +N KV+DFGLA+L+ E + + APE + KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 589 YSYGMVLLEIIGGRKSF 605
+S+G++L E+ +
Sbjct: 198 WSFGILLTELTTKGRVP 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 1e-53
Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 27/231 (11%)
Query: 394 FSYDDLCKATKNFST-----------KLGQGGFGSVYLGMLP----DGIQVAVKKLES-- 436
F+++D +A + F+ +G G FG V G L I VA+K L+S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 437 IGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESR 496
+ +++F +E +I+G H +++ L+G + ++ E++ NGSLD ++ + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 497 FLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556
+ G A G+ YL + VH D+ N+L++ N KVSDFGL++ +
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 557 EESLVYTT----LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603
+ S T + + APE I + SDV+SYG+V+ E++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 9/206 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
+G G +G DG + K+L K+ +EV ++ + H ++V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 465 FCIEGAHRLL--AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE--E 520
I+ + L EY G L I T+E ++L + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 580
++H D+KP NV LD K+ DFGLA+++N + S GT Y++PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRM 189
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSFS 606
+EKSD++S G +L E+ F+
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFT 215
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 1e-52
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 8/218 (3%)
Query: 391 PTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAE 447
P+ +YD + + KLG G +G VY G+ + VAVK L+ +EF E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 448 VTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA 507
++ + H +LV+L G C + E++ G+L ++ + + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMA 121
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
+ + YL ++ +H D+ N L+ +N KV+DFGL++LM + + +
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 568 TRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ APE + N S KSDV+++G++L EI S
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 5e-52
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 25/226 (11%)
Query: 390 MPTRFSYDDLCKATKNFST--KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKK 442
+ F DD K FS ++G G FG+VY + + VA+KK+ + + +
Sbjct: 4 VAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 443 EFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNT 502
+ EV + + H + ++ +G + L EY + + D + + L
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVE 116
Query: 503 RFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+ G +GLAYLH ++H D+K N+LL + K+ DFG A +M
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168
Query: 563 TTLRGTRGYLAPEWI---TNNPISEKSDVYSYGMVLLEIIGGRKSF 605
+ GT ++APE I K DV+S G+ +E+ +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-51
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
+LG G FG VY + + A K +++ + +++ E+ I+ + H ++VKL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ + E+ G++D + R L + + T L YLH+ KI+
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-----TNNP 581
H D+K N+L + K++DFG++ R + GT ++APE + + P
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSFS 606
K+DV+S G+ L+E+
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-50
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 406 FSTKLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
F ++G+G F +VY G+ + ++VA +L + ++ F E ++ + H ++V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 462 LKGFCIEGA----HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
+L E + +G+L ++ + + + KGL +L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 518 HEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
H I+H D+K +N+ + + K+ D GLA L + + GT ++APE
Sbjct: 129 HTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM 184
Query: 577 ITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
E DVY++GM +LE+ +S
Sbjct: 185 Y-EEKYDESVDVYAFGMCMLEMATSEYPYS 213
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-50
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+G+G FG V LG G +VAVK +++ + F AE +++ + H +LV+L G +E
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 469 GAHRL-LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
L + EY+ GSL ++ + L + +L + + YL VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126
Query: 528 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSD 587
D+ NVL+ ++ AKVSDFGL K + + T + + APE + S KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSD 182
Query: 588 VYSYGMVLLEIIGGRKSF 605
V+S+G++L EI +
Sbjct: 183 VWSFGILLWEIYSFGRVP 200
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTIIGNVHHVHLVKLKGFC 466
K+GQG G+VY M + G +VA++++ Q KKE E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ G + EYL GSL + + + + + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSN---QVI 138
Query: 527 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 586
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 587 DVYSYGMVLLEIIGGRKSFS 606
D++S G++ +E+I G +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYL 217
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-49
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE 468
+G+G FG V+ G G +VAVK S + AE+ + H +++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 469 G----AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC--- 521
L +Y +GSL ++ T + +AL TA GLA+LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 522 --EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE---SLVYTTLRGTRGYLAPEW 576
+ I H D+K +N+L+ N T ++D GLA + + GT+ Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 577 ITNN------PISEKSDVYSYGMVLLEIIGGRKSFS 606
+ ++ +++D+Y+ G+V EI
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-49
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 408 TKLGQGGFGSVYLGML---PDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG G FGSV G+ I VA+K L + +E E I+ + + ++V+L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C + +L E G L K++ EE + + + + G+ YL E+
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY--TTLRGTRGYLAPEWITNN 580
VH D+ NVLL + AK+SDFGL+K + ++S + + + APE I
Sbjct: 129 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 581 PISEKSDVYSYGMVLLEIIGGRK 603
S +SDV+SYG+ + E + +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 7e-49
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 393 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAE 447
+++ +D LG+G FG+VYL +A+K L + + E
Sbjct: 2 QWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 448 VTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIA 507
V I ++ H ++++L G+ + L EY G++ + + ++
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYI 112
Query: 508 LGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 567
A L+Y H + +++H DIKPEN+LL K++DFG + TTL G
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG 166
Query: 568 TRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
T YL PE I EK D++S G++ E + G+ F
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 55/236 (23%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 391 PTRF---SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKK 442
PT + ++D+ F +G+G FG V + + A+K+++ +
Sbjct: 1 PTIYPVLDWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 443 EFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS---------- 491
+F+ E+ ++ + HH +++ L G C + LA EY +G+L ++ S
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 492 --TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549
+ L + A A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 172
Query: 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
L++ T R ++A E + + + SDV+SYG++L EI+ +
Sbjct: 173 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 405 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVH 458
+F+ +G+G FG VY G L D I AVK L I +F E I+ + H +
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 459 LVKLKGFCIEG-AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
++ L G C+ L+ Y+ +G L +I N E+ L AKG+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGM--- 143
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---TTLRGTRGYLAP 574
K VH D+ N +LD+ FT KV+DFGLA+ M +E T + ++A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 575 EWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
E + + KSDV+S+G++L E++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-48
Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LG+G +G V L + VAVK + + + E+ I ++H ++VK G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
EG + L EY G L I E + G+ YLH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-EESLVYTTLRGTRGYLAPEWITNNPI-S 583
H DIKPEN+LLD+ K+SDFGLA + + + GT Y+APE + +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
E DV+S G+VL ++ G +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPW 206
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 8e-48
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 37/241 (15%)
Query: 394 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKL--ESIGQGKKEFS 445
+ +++ + +G+G FG V+ P VAVK L E+ + +F
Sbjct: 10 YPRNNI-----EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 446 AEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN--------------- 490
E ++ + ++VKL G C G L +EY+ G L++++ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 491 -----STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 545
S+ L + IA A G+AYL E K VH D+ N L+ +N K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 546 SDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKS 604
+DFGL++ + + ++ PE I N + +SDV++YG+VL EI
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 605 F 605
Sbjct: 242 P 242
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 30/240 (12%)
Query: 391 PTRFSYDDLCKATKN---FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQ 439
PT+ YD + +N F LG G FG V + VAVK L +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 440 GKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNS------- 491
++ +E+ ++ + +H+++V L G C G L+ EY G L ++
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 492 -------TEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 544
++ L + + AKG+A+L + +H D+ N+LL K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITK 185
Query: 545 VSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK 603
+ DFGLA+ + + + V R ++APE I N + +SDV+SYG+ L E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-47
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 36/249 (14%)
Query: 391 PTRFSYDDLCKATKN---FSTKLGQGGFGSVYLGMLPD------GIQVAVKKL--ESIGQ 439
+ YD + + F LG G FG V IQVAVK L ++
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 440 GKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN-------- 490
++ +E+ ++ + H ++V L G C L +EY G L ++ +
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 491 -----------STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD 539
E+ L + A AKG+ +L + VH D+ NVL+
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH 199
Query: 540 NFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
K+ DFGLA+ +M+ +V R ++APE + + KSDV+SYG++L EI
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 599 I-GGRKSFS 606
G +
Sbjct: 260 FSLGVNPYP 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 409 KLGQGGFGSVYLGMLPD---GIQVAVKKLE---SIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+LG G FG+V G VAVK L+ + K E AE ++ + + ++V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G C E +L E G L+K++ ++R + + + G+ YL E
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES-- 126
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRGYLAPEWITNN 580
VH D+ NVLL AK+SDFGL+K + +E+ + + APE I
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 581 PISEKSDVYSYGMVLLEII-GGRKSFS 606
S KSDV+S+G+++ E G+K +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYR 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (418), Expect = 2e-46
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
+LG G FG V+ G A K + K+ E+ + + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ ++ YE++ G L + + + E + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 527 HCDIKPENVLL--DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
H D+KPEN++ + K+ DFGL ++ ++S GT + APE P+
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGY 204
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
+D++S G++ ++ G F
Sbjct: 205 YTDMWSVGVLSYILLSGLSPF 225
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-46
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 410 LGQGGFGSVYLGMLPDG-----IQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKL 462
+G G FG VY GML + VA+K L + + +F E I+G H ++++L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+G + ++ EY+ NG+LDK++ E+ + G A G+ YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN- 130
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRGYLAPEWITNN 580
VH D+ N+L++ N KVSDFGL++++ + YTT + + APE I+
Sbjct: 131 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
+ SDV+S+G+V+ E++ +
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERP 213
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 409 KLGQGGFGSVYLGMLPD-----GIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG G FG+VY G+ I VA+K+L + + KE E ++ +V + H+ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L G C+ +L+ + + G L ++ E + N + AKG+ YL +
Sbjct: 76 LLGICLTSTVQLI-TQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNN 580
++VH D+ NVL+ K++DFGLAKL+ EE + + ++A E I +
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSF 605
+ +SDV+SYG+ + E++
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKP 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG+G F +V L L + A+K LE + E ++ + H VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ Y NG L K+I L YLH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPI 582
I+H D+KPEN+LL+++ +++DFG AK+++ E + GT Y++PE +T
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
+ SD+++ G ++ +++ G F
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPF 210
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-44
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 409 KLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKL 462
+G+G FG V+ G+ + VA+K ++ +++F E + H H+VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
G E + E G L ++ L + A + LAYL +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
+ VH DI NVL+ N K+ DFGL++ M + + ++APE I
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 583 SEKSDVYSYGMVLLEII 599
+ SDV+ +G+ + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 409 KLGQGGFGSVYLGMLP----DGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHLV 460
KLG G FG V G + VAVK L+ S + +F EV + ++ H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+L G + +++ E GSL + T A+ A+G+ YL +
Sbjct: 75 RLYGVVLTPPMKMV-TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWIT 578
+H D+ N+LL K+ DFGL + + N + ++ + + APE +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 579 NNPISEKSDVYSYGMVLLEII-GGRKSFS 606
S SD + +G+ L E+ G++ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 1e-42
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC 466
+LG G FG V+ + G K + K E++I+ +HH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
+ +L E+L G L I E + N +GL ++HE IV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 527 HCDIKPENVLLD--DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
H DIKPEN++ + + K+ DFGLA +N +E + TT T + APE + P+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
+D+++ G++ ++ G F
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPF 228
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-42
Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 391 PTRFSYDDLCKATK--------NFSTKLGQGGFGSVYLGML------PDGIQVAVKKL-- 434
P FS D+ + S +LGQG FG VY G+ +VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 435 ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN---- 490
+ + + EF E +++ + H+V+L G +G L+ E + G L ++ +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 491 --STEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 548
+ + +A A G+AYL+ K VH D+ N ++ ++FT K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 549 GLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
G+ + + + +++PE + + + SDV+S+G+VL EI +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-42
Identities = 41/201 (20%), Positives = 85/201 (42%), Gaps = 11/201 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
LG+G FG V+ + K ++ G + E++I+ H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
++ +E++ + + I + L + + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 528 CDIKPENVLLD--DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
DI+PEN++ + T K+ +FG A+ + ++ + L Y APE ++ +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 586 SDVYSYGMVLLEIIGGRKSFS 606
+D++S G ++ ++ G F
Sbjct: 184 TDMWSLGTLVYVLLSGINPFL 204
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 5e-41
Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 9/201 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
LG G F V L VA+K + +++ + E+ ++ + H ++V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
G H L + + G L I E F + + YLH+ V
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
LD++ +SDFGL+K+ + V +T GT GY+APE + P S+
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 586 SDVYSYGMVLLEIIGGRKSFS 606
D +S G++ ++ G F
Sbjct: 190 VDCWSIGVIAYILLCGYPPFY 210
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 409 KLGQGGFGSVYLGMLP--------DGIQVAVKKL--ESIGQGKKEFSAEVTIIGNV-HHV 457
LG+G FG V L +VAVK L ++ + + +E+ ++ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFN------------STEESRFLCWNTRFN 505
+++ L G C + + EY G+L +++ S L +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 506 IALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-T 564
A A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + T
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 565 LRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
R ++APE + + + +SDV+S+G++L EI S
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 2e-40
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG G FG V+L +G A+K L+ + + + E ++ V H ++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
G + + +Y+ G L + S + + L L
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
I++ D+KPEN+LLD N K++DFG AK + TL GT Y+APE ++ P +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYN 179
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
+ D +S+G+++ E++ G F
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPF 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 409 KLGQGGFGSVYLGM------LPDGIQVAVKKL--ESIGQGKKEFSAEVTIIG-NVHHVHL 459
LG+G FG V VAVK L + + +E+ I+ HH+++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 460 VKLKGFCIE-GAHRLLAYEYLVNGSLDKWIFNSTEE------------SRFLCWNTRFNI 506
V L G C + G ++ E+ G+L ++ + E FL
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-YTTL 565
+ AKG+ +L K +H D+ N+LL + K+ DFGLA+ + ++ V
Sbjct: 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 566 RGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
R ++APE I + + +SDV+S+G++L EI S
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (367), Expect = 4e-40
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL----------ESIGQGKKEFSAEVTIIGNVH-H 456
LG+G V + P + AVK + E + + ++ EV I+ V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 457 VHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
++++LK L ++ + G L ++ E L I + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 576
LH+ IVH D+KPEN+LLDD+ K++DFG + ++ E + GT YLAPE
Sbjct: 126 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEI 180
Query: 577 IT------NNPISEKSDVYSYGMVLLEIIGGRKSF 605
I + ++ D++S G+++ ++ G F
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-39
Identities = 49/220 (22%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 399 LCKATKNFS--TKLGQGGFGSVYLG--MLPDGIQVAVKKL---ESIGQGKKEFSAEVTI- 450
LC+A + + ++G+G +G V+ + G VA+K++ EV +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 451 --IGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWI--FNSTEESRFLCWNTRFNI 506
+ H ++V+L C LV +D+ + + + T ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 507 ALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 566
+GL +LH ++VH D+KP+N+L+ + K++DFGLA++ + + + T++
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 176
Query: 567 GTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
T Y APE + + + D++S G + E+ + F
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (369), Expect = 2e-39
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 19/206 (9%)
Query: 409 KLGQGGFGSVYLGMLPD-GIQVAVKKLE----SIGQGKKEFSAEVTII---GNVHHVHLV 460
+G+GGFG VY D G A+K L+ + QG+ E ++ +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 461 KLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE 520
+ + + G L + + A GL ++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 521 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TN 579
+V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+APE +
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 580 NPISEKSDVYSYGMVLLEIIGGRKSF 605
+D +S G +L +++ G F
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK--KEFSAEVTIIGNVHHVHLVKLKGF 465
+G+G +G V + ++VA+KK+ + E+ I+ H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+ YLV + ++ + L + +GL Y+H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWITNN-PI 582
+H D+KP N+LL+ K+ DFGLA++ + + + T TR Y APE + N+
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
++ D++S G +L E++ R F
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL------ESIGQGKKEFSAEVTIIGNVHHVHLVK 461
LG+G F +VY VA+KK+ E+ + E+ ++ + H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 462 LKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC 521
L ++ L ++++ NS L + L T +GL YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 522 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TNN 580
I+H D+KP N+LLD+N K++DFGLAK + YT TR Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 581 PISEKSDVYSYGMVLLEIIGGRKSFS 606
D+++ G +L E++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLP 202
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 140 bits (353), Expect = 4e-38
Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 18/209 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG GG V+L L VAVK L F E ++H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 464 GFCIE----GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE 519
G + EY+ +L + + + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 129
Query: 520 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV--YTTLRGTRGYLAPEWI 577
I+H D+KP N+++ KV DFG+A+ + + V + GT YL+PE
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 578 TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + +SDVYS G VL E++ G F+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTIIG-NVHHVHLVKL 462
LG+G FG V+L A+K L+ + + E ++ H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 463 KGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECE 522
+ EYL G L I + + A GL +LH +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK-- 122
Query: 523 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 582
IV+ D+K +N+LLD + K++DFG+ K ++ T GT Y+APE +
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKY 180
Query: 583 SEKSDVYSYGMVLLEIIGGRKSFS 606
+ D +S+G++L E++ G+ F
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFH 204
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 391 PTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVT 449
P SY D +G G FG VY L D G VA+KK+ Q K+ + E+
Sbjct: 17 PQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQ 65
Query: 450 IIGNVHHVHLVKLKGFCIE-GAHRLLAYEYLV----NGSLDKWIFNSTEESRFLCWNTRF 504
I+ + H ++V+L+ F G + Y LV ++ + + + + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 505 NIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYT 563
+ LAY+H I H DIKP+N+LLD D K+ DFG AK + R E
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NV 180
Query: 564 TLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606
+ +R Y APE I + DV+S G VL E++ G+ F
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 21/210 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL-------ESIGQGKKEFSAEVTIIGNVHHVH-- 458
LG GGFGSVY G+ + D + VA+K + EV ++ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 459 LVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
+++L + +L E E L + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHC- 126
Query: 519 EECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 577
++H DIK EN+L+D + K+ DFG L+ YT GTR Y PEWI
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 578 TNNP-ISEKSDVYSYGMVLLEIIGGRKSFS 606
+ + V+S G++L +++ G F
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 43/247 (17%)
Query: 371 TKFSQENLEEDYFLESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQV 429
T F QEN+++ Y +LG G F V G+Q
Sbjct: 1 TVFRQENVDDYYDTGE----------------------ELGSGQFAVVKKCREKSTGLQY 38
Query: 430 AVKKL-------ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482
A K + G +++ EV+I+ + H +++ L +L E + G
Sbjct: 39 AAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG 98
Query: 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN-- 540
L ++ E L G+ YLH I H D+KPEN++L D
Sbjct: 99 ELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNV 151
Query: 541 --FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEI 598
K+ DFGLA ++ + + GT ++APE + P+ ++D++S G++ +
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 599 IGGRKSF 605
+ G F
Sbjct: 210 LSGASPF 216
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 2e-37
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 10/201 (4%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKGF 465
K+G+G +G VY G A+KK+ + E++I+ + H ++VKL
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 466 CIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKI 525
+L +E+L L T + L G+AY H+ ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 526 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 585
+H D+KP+N+L++ K++DFGLA+ + + + S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 586 SDVYSYGMVLLEIIGGRKSFS 606
D++S G + E++ G F
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFP 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 18/204 (8%)
Query: 410 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFC-- 466
LG G G V + A+K L+ + ++E H+V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVYEN 76
Query: 467 --IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
L+ E L G L I + +++ I + + YLH
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI---N 131
Query: 525 IVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 581
I H D+KPEN+L N K++DFG AK S TT T Y+APE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEK 189
Query: 582 ISEKSDVYSYGMVLLEIIGGRKSF 605
+ D++S G+++ ++ G F
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPF 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 8e-37
Identities = 47/208 (22%), Positives = 75/208 (36%), Gaps = 17/208 (8%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
K+G G FG +YLG + G +VA+K + + E I + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 468 EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVH 527
+ L+ SL+ SR T +A + Y+H + +H
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 528 CDIKPENVL---LDDNFTAKVSDFGLAKLMNREESLVY------TTLRGTRGYLAPEWIT 578
D+KP+N L + DFGLAK + + L GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSFS 606
S + D+ S G VL+ G +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 10/201 (4%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
K+G+G +G VY G VA+KK+ E++++ ++H ++VKL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
L +E+L F + + +GLA+ H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
++H D+KP+N+L++ K++DFGLA+ + + S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
D++S G + E++ R F
Sbjct: 183 AVDIWSLGCIFAEMVTRRALF 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (342), Expect = 2e-36
Identities = 44/210 (20%), Positives = 75/210 (35%), Gaps = 21/210 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466
++G+G FG ++ G L + QVA+K + E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIV 526
EG H +L + L D R T A + +HE+ +V
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 527 HCDIKPENVLLDDNFT-----AKVSDFGLAKLMNREES------LVYTTLRGTRGYLAPE 575
+ DIKP+N L+ + V DFG+ K + L GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 576 WITNNPISEKSDVYSYGMVLLEIIGGRKSF 605
S + D+ + G V + + G +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPW 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 13/202 (6%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTIIGNVHHVHLVKLK 463
LG+G FG V L G A+K L K+ E ++ N H L LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
EY G L + T A+ ++ L
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR 124
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+V+ DIK EN++LD + K++DFGL K + + + T GT YLAPE + +N
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 183
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
D + G+V+ E++ GR F
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-33
Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLKG 464
+G G +G+V + G +VA+KKL Q + K E+ ++ ++ H +++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
++ + + L + + KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--- 141
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PIS 583
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE I N +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
+ D++S G ++ E+I G+ F
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLF 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 2e-32
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTIIGNVHHVHLVKLK 463
LG G FG V L G A+K L+ + + E I+ V+ LVKL+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 464 GFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEV 523
+ ++ + EY+ G + + A YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 583
+++ D+KPEN+L+D +V+DFG AK + TL GT LAPE I + +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYN 216
Query: 584 EKSDVYSYGMVLLEIIGGRKSFS 606
+ D ++ G+++ E+ G F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFF 239
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 2e-32
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 23/214 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTIIGNVHHVHLVKLKG 464
K+GQG FG V+ G +VA+KK+ E+ I+ + H ++V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 465 FCIEGAHR--------LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAY 516
C A L +++ + + + + GL Y
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYY 132
Query: 517 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLA 573
+ KI+H D+K NVL+ + K++DFGLA+ + ++ YT T Y
Sbjct: 133 I---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 574 PEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606
PE + D++ G ++ E+
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 36/201 (17%), Positives = 75/201 (37%), Gaps = 11/201 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLKG 464
K+G+G +G+V+ VA+K++ + E+ ++ + H ++V+L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
L +E+ + + L + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 584
++H D+KP+N+L++ N K+++FGLA+ + S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 585 KSDVYSYGMVLLEIIGGRKSF 605
D++S G + E+ +
Sbjct: 182 SIDMWSAGCIFAELANAGRPL 202
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 48/234 (20%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 385 ESFSGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESI--- 437
+ +G + ++ LG G +G V+L G A+K L+
Sbjct: 12 ANLTGHAEKVGIENF-----ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 438 --GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEE 494
+ + E ++ ++ LV L L +Y+ G L +
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--- 123
Query: 495 SRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554
T + + + + L ++ I++ DIK EN+LLD N ++DFGL+K
Sbjct: 124 ----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 555 NREESLVYTTLRGTRGYLAPEWI--TNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
+E+ GT Y+AP+ + ++ + D +S G+++ E++ G F+
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 2e-30
Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 22/207 (10%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTIIGNVHHVHLVKLKG 464
+G G G V VA+KKL Q + K E+ ++ V+H +++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 465 FCI------EGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLH 518
E L E + E + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLLYQMLCGIKHLH 136
Query: 519 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 578
I+H D+KP N+++ + T K+ DFGLA+ + T TR Y APE I
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 191
Query: 579 NNPISEKSDVYSYGMVLLEIIGGRKSF 605
E D++S G ++ E++ + F
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 4e-30
Identities = 46/203 (22%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFC 466
KLG+G + V+ + + + +V VK L+ + KK+ E+ I+ N+ +++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIV 99
Query: 467 IEGAHRLLA--YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ R A +E++ N + + L K L Y H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 525 IVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPI 582
I+H D+KP NV++D ++ ++ D+GLA+ + + Y +R + PE +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMY 207
Query: 583 SEKSDVYSYGMVLLEIIGGRKSF 605
D++S G +L +I ++ F
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKG 464
+G G +GSV G++VAVKKL Q K E+ ++ ++ H +++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 465 FCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK 524
+ + L N+ + + L + + +GL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--- 141
Query: 525 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PIS 583
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE + N +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYN 197
Query: 584 EKSDVYSYGMVLLEIIGGRKSF 605
+ D++S G ++ E++ GR F
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLF 219
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 3e-28
Identities = 50/213 (23%), Positives = 82/213 (38%), Gaps = 17/213 (7%)
Query: 409 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCI 467
KLG G F +V+L + + VA+K + + E+ ++ V+ K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 468 EGAHRLLAYEYLVNGSLDKWI------------FNSTEESRFLCWNTRFNIALGTAKGLA 515
+LL + + + E R + I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 516 YLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN-REESLVYTTLRGTRGYLA 573
Y+H C I+H DIKPENVL++ + + +A L N YT TR Y +
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 574 PEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606
PE + P +D++S ++ E+I G F
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 4e-22
Identities = 26/165 (15%), Positives = 47/165 (28%), Gaps = 22/165 (13%)
Query: 409 KLGQGGFGSVYLGMLPDGIQVAVKKLES-----------IGQGKKEFSAEVTIIGNVHHV 457
+G+G +V+ + VK + G FS
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 458 HLVKLKGFCIEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYL 517
L KL+G + Y G+ +E + + + +A
Sbjct: 67 ALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 518 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562
+ IVH D+ NVL+ + + DF + + E
Sbjct: 120 YHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREI 160
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 60.3 bits (146), Expect = 6e-12
Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 1/70 (1%)
Query: 84 WTANRGLLIRDSD-KFVFEKSGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVN 142
T + + S +F + N L + W++NT+G LQ G LV+L
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQ 74
Query: 143 GSILWQSFSH 152
+I W S +
Sbjct: 75 NTIRWSSGTK 84
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 58.0 bits (140), Expect = 3e-11
Identities = 22/95 (23%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 60 GFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSA 118
Y + + +LV+ + VW +N G+L + K V + GN + G + W++
Sbjct: 19 EPYHFIMQEDCNLVLYD--HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76
Query: 119 NTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
++ + LQ+ GN+V+ GS +W + ++
Sbjct: 77 HSVRGNGNYVLVLQEDGNVVIY---GSDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.0 bits (140), Expect = 5e-11
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 77 ISSAKVVWTANRGLLIRDSD-KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSG 134
+ T + ++ S + E N L + WS NT+G+ C LQ +G
Sbjct: 17 QGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNG 76
Query: 135 NLVLLGVNGSILWQSFS--HPTDTLLPGQ 161
+ +L +W S + + Q
Sbjct: 77 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 54.0 bits (129), Expect = 1e-09
Identities = 16/110 (14%), Positives = 38/110 (34%), Gaps = 11/110 (10%)
Query: 47 GLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNA 106
G L +F Q +V++ + + VW + + GN
Sbjct: 13 GGSLAEGGYLFII--------QNDCNLVLY-DNNRAVWASGTNGKASGC-VLKMQNDGNL 62
Query: 107 YLQRGNGEAWSA-NTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155
+ G+ W++ + LQ N+V+ + + +W + ++ +
Sbjct: 63 VIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 45.4 bits (107), Expect = 1e-06
Identities = 15/73 (20%), Positives = 27/73 (36%), Gaps = 6/73 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGNLVL 138
+W N G L + V + G + W + +G+ + LQ N+V+
Sbjct: 49 NPIWATNTGGLGNGC-RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 139 LGVNGSILWQSFS 151
G LW + +
Sbjct: 108 ---YGDALWATQT 117
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.5 bits (102), Expect = 6e-06
Identities = 17/57 (29%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
+F+ + N L N W+ NT G C LQ G LV++ +WQS
Sbjct: 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA 89
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 39.2 bits (91), Expect = 1e-04
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 6/74 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNGEA-WSANTSGQKVECM-ELQDSGNLVL 138
K +W N G L R + GN + + + W++NT GQ + LQ N+V+
Sbjct: 38 KPIWATNTGGLSRSC-FLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI 96
Query: 139 LGVNGSILWQSFSH 152
G+ W + +H
Sbjct: 97 Y---GTDRWATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.9 bits (85), Expect = 0.001
Identities = 15/59 (25%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 97 KFVFEKSGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPT 154
F+ ++ N L + W+ NT G C + +Q GNLV+ + +W S +
Sbjct: 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQ 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.36 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.32 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.08 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.73 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.71 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.34 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.55 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=362.47 Aligned_cols=201 Identities=29% Similarity=0.491 Sum_probs=178.1
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
+....+++.++||+|+||+||+|++++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 4445677889999999999999999888999999998777778899999999999999999999998765 567999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++.... ...+++..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999885432 24589999999999999999999998 99999999999999999999999999999876554
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
........||+.|||||.+.+..++.++|||||||++|||+||..|+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 44444567899999999999999999999999999999999965554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-44 Score=363.53 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=183.7
Q ss_pred HHHHHHhhccccccCCcCceeEEEEEeCC-CcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 397 DDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 397 ~el~~~~~~~~~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.|+....+++.++||+|+||+||+|++.+ ++.||||+++......++|.+|++++++++|||||+++|+|.++...++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 35666677888999999999999999864 88999999987777788999999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|.+++..... ..+++..+..|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 92 ~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999975433 4689999999999999999999998 99999999999999999999999999999876
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...........|++.|||||++.+..++.++|||||||++|||++|..||
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 65544444556899999999999999999999999999999999977765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=358.57 Aligned_cols=197 Identities=27% Similarity=0.508 Sum_probs=166.9
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNG 482 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~g 482 (606)
.+++.++||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|+|.++...++||||+++|
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 35677899999999999999988999999999877777889999999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceee
Q 037563 483 SLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 562 (606)
Q Consensus 483 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 562 (606)
+|.+++.... ..+++..+..|+.||++||.|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 86 ~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 86 CLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp BHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred cHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 9999986533 4588999999999999999999998 999999999999999999999999999987765544434
Q ss_pred eecccccCccccccccCCCCCCccchHHHHHHHHHHHhC-CCCC
Q 037563 563 TTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGG-RKSF 605 (606)
Q Consensus 563 ~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG-~~pf 605 (606)
....||+.|||||.+.+..++.++|||||||++|||+|+ ++||
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 456789999999999999999999999999999999995 5555
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=350.72 Aligned_cols=194 Identities=29% Similarity=0.435 Sum_probs=175.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+++.+ +++.||+|++... ....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3678899999999999999986 4889999998632 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 y~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 87 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred ecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999643 3589999999999999999999998 9999999999999999999999999999866543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 205 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence 2 245689999999999999999999999999999999999999994
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=354.77 Aligned_cols=197 Identities=30% Similarity=0.426 Sum_probs=171.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.++||+|+||+||+++.. +++.||||++... ....+++.+|++++++++|||||++++++.++...++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3667789999999999999975 5899999998643 233467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 86 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999953 24589999999999999999999998 999999999999999999999999999997654332
Q ss_pred -eeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 -LVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 -~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.......||+.|||||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 22345689999999999988776 578999999999999999999994
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=348.03 Aligned_cols=197 Identities=26% Similarity=0.456 Sum_probs=180.1
Q ss_pred hccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccCCC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVNGS 483 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~gs 483 (606)
++|.++||+|+||+||+|++++++.||||+++......++|.+|++++++++||||++++|+|.++...++||||+++|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46788999999999999999888999999998877778999999999999999999999999999999999999999999
Q ss_pred hhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcceeee
Q 037563 484 LDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 563 (606)
Q Consensus 484 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 563 (606)
|.+++.... ..+++..+.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++...........
T Consensus 86 l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999976543 3588999999999999999999998 9999999999999999999999999999877655444444
Q ss_pred ecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 564 TLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 564 ~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC
Confidence 5678999999999999999999999999999999998 899984
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=356.76 Aligned_cols=197 Identities=31% Similarity=0.539 Sum_probs=165.1
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+.+.++||+|+||+||+|++++ .||||+++.. ....++|.+|++++++++|||||+++|++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 3445677899999999999999743 5999999643 3345789999999999999999999998765 56799999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++.... ..+++..+..|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999996533 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cc-eeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES-LVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 32 23345689999999999864 357899999999999999999999994
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=352.30 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=175.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.++||+|+||+||+++.. +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.++...++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4677789999999999999975 5899999999654 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999998743 3588999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence 2345679999999999999999999999999999999999999994
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=353.39 Aligned_cols=203 Identities=26% Similarity=0.404 Sum_probs=164.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceec--cccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIE--GAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~ 476 (606)
.+++.+.||+|+||+||+++.. +|+.||||++..... ..+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 4677889999999999999975 589999999965432 24568999999999999999999999865 45678999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC--EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||+++|+|.+++.........+++..+..++.||+.||.|||++. ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 999999999999765555567999999999999999999999862 124999999999999999999999999999987
Q ss_pred CcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||.
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 54332 2345689999999999999999999999999999999999999994
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=357.20 Aligned_cols=196 Identities=30% Similarity=0.522 Sum_probs=159.2
Q ss_pred ccccccCCcCceeEEEEEeCC-C---cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~~-~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
++.+.||+|+||+||+|+++. + ..||||++.... ...++|.+|+++|++++|||||+++|++.++...++||||
T Consensus 29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey 108 (299)
T d1jpaa_ 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF 108 (299)
T ss_dssp EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEe
Confidence 344679999999999999753 2 358999886432 3346899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++.... ..+++.++..|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 109 ~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 109 MENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred cCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999886432 3589999999999999999999998 99999999999999999999999999999775443
Q ss_pred cee----eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLV----YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~----~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... .....+|+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 211 122457899999999999999999999999999999998 899984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=350.98 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=173.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4678899999999999999975 5899999998632 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 y~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 89 YAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998643 3589999999999999999999998 9999999999999999999999999999977544
Q ss_pred cc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence 32 22345679999999999999999999999999999999999999994
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=353.03 Aligned_cols=199 Identities=29% Similarity=0.470 Sum_probs=170.4
Q ss_pred HHhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
...+++.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 35678889999999999999999888899999998777778899999999999999999999999865 56799999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|.+++..... ..++|.+++.|+.||+.||+|||++ +|+||||||+||||++++++||+|||+++........
T Consensus 95 ~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999865432 4589999999999999999999998 9999999999999999999999999999877655444
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
......+|+.|+|||++....++.++||||||+++|||++|..||
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 445567899999999999999999999999999999999976664
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=361.32 Aligned_cols=196 Identities=25% Similarity=0.373 Sum_probs=173.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
...+++.++||+|+||+||+|+.. +++.||+|+++... ...+++.+|+.++++++|||||++++++.+..+.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 345677789999999999999975 58999999996542 335679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+ + +|+||||||+||||++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999643 358999999999999999999996 5 799999999999999999999999999987643
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .....||+.|||||++.+.+++.++||||+||++|||++|+.||.
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 234689999999999999999999999999999999999999993
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=342.21 Aligned_cols=191 Identities=25% Similarity=0.454 Sum_probs=165.8
Q ss_pred ccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceec----cccceeee
Q 037563 405 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE----GAHRLLAY 476 (606)
Q Consensus 405 ~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~ 476 (606)
+|.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999986 47899999986543 234678999999999999999999999865 34578999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeEEc-CCCcEEEeeccCCcc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVK--IVHCDIKPENVLLD-DNFTAKVSDFGLAKL 553 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfgla~~ 553 (606)
||+++|+|.+++... ..+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999643 3588999999999999999999997 6 99999999999996 578999999999986
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....||+.|||||++.+ .++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 165 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 54332 245689999999998875 59999999999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=350.14 Aligned_cols=196 Identities=26% Similarity=0.403 Sum_probs=172.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEeccc-CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
+++.++||+|+||+||+|++. +++.||||+++.. ....+.+.+|++++++++|||||++++++.+....++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 567789999999999999975 4889999999654 34557899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 94 g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 94 GAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999986432 3589999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred eeecccccCcccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 562 YTTLRGTRGYLAPEWIT-----NNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 562 ~~~~~gt~~y~aPE~~~-----~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.....||+.|||||++. ...++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 23467999999999884 4567899999999999999999999994
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=345.89 Aligned_cols=191 Identities=31% Similarity=0.485 Sum_probs=163.8
Q ss_pred cccCCcCceeEEEEEeCC---CcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 408 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
++||+|+||+||+|.+++ ++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 4689999996432 224679999999999999999999999865 457899999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCccee
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 561 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 561 (606)
|+|.+++... ..+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999998643 3589999999999999999999998 99999999999999999999999999998765543322
Q ss_pred --eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 562 --YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 562 --~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 234578999999999999999999999999999999998 899984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=347.41 Aligned_cols=195 Identities=30% Similarity=0.483 Sum_probs=168.4
Q ss_pred cccc-ccCCcCceeEEEEEeC---CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 405 NFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 405 ~~~~-~lG~G~fG~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+.+ +||+|+||+||+|+++ ++..||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 5999999999999864 35679999997543 234689999999999999999999999865 467999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 90 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 90 AGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp CTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred CCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999985432 3589999999999999999999998 99999999999999999999999999999876543
Q ss_pred cee--eeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 559 SLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 559 ~~~--~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 321 234568999999999999999999999999999999998 999994
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=348.41 Aligned_cols=196 Identities=28% Similarity=0.460 Sum_probs=158.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
..+++.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|++++++++|||||++++++.++...++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 44778899999999999999986 48899999996442 3346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc---CCCcEEEeeccCCcccC
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgla~~~~ 555 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999643 4589999999999999999999998 999999999999994 57899999999998764
Q ss_pred cCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 432 2345679999999999999999999999999999999999999994
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=353.14 Aligned_cols=206 Identities=29% Similarity=0.479 Sum_probs=175.3
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeCC------CcEEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceec
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE 468 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~~------~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~ 468 (606)
|+....+++.++||+|+||+||+|++.. ...||+|++... ....+.+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4555677888999999999999999643 236999998543 34457899999999998 89999999999999
Q ss_pred cccceeeeeeccCCChhhhhhhccc-------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecC
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTE-------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCD 529 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~d 529 (606)
....++||||+++|+|.++|..... ....+++..++.|+.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975432 123589999999999999999999998 999999
Q ss_pred CCCCCeEEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 530 IKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 530 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|||+||+++.++.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876554432 2334568999999999999999999999999999999998 899984
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=347.54 Aligned_cols=196 Identities=29% Similarity=0.363 Sum_probs=176.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||.||+++.. +++.||||++++. ....+.+.+|+.+|++++||||+++++++.+....++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 3677899999999999999975 5899999999643 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 y~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 86 YANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999998653 3588899999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ......||+.|||||++.+..++.++||||+||++|||++|++||.
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 32 2345689999999999999999999999999999999999999984
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-41 Score=345.38 Aligned_cols=193 Identities=28% Similarity=0.432 Sum_probs=174.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.+.||+|+||+||+++.+ +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3677899999999999999975 4899999999632 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 85 YIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred ecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988643 3477888889999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence 2 34689999999999999999999999999999999999999994
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-42 Score=345.71 Aligned_cols=194 Identities=26% Similarity=0.421 Sum_probs=170.6
Q ss_pred HHhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
...++..++||+|+||.||+|+.. +++.||||+++.... ..+++.+|++++++++|||||++++++.++...++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345777889999999999999975 588999999975432 235689999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 94 ~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 9999999998776432 4589999999999999999999998 99999999999999999999999999998754
Q ss_pred cCcceeeeecccccCccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. ....||+.|||||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 43 23579999999999864 458899999999999999999999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=343.47 Aligned_cols=197 Identities=28% Similarity=0.482 Sum_probs=162.9
Q ss_pred hhccccccCCcCceeEEEEEeCCC-----cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceeccccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDG-----IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~-----~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV 475 (606)
.+++.+.||+|+||.||+|+++.. ..||||+++... ....+|.+|++++++++|||||+++|++.+....++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 345667899999999999997542 479999996543 2345799999999999999999999999999999999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||++++++.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 88 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 88 TEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999876543 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred cCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.... .......||+.|||||.+.+..++.++|||||||++|||++|..||
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 4332 2223456899999999999999999999999999999999976654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-41 Score=347.14 Aligned_cols=196 Identities=24% Similarity=0.403 Sum_probs=174.8
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.+.||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++|||||++++++.++...++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5778899999999999999975 58999999996543 335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc--CCCcEEEeeccCCcccCcCc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 558 (606)
+|+|.+++.... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 107 gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 107 GGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp SCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999985432 3589999999999999999999998 999999999999996 46789999999998776543
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 3 345689999999999999999999999999999999999999994
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=336.84 Aligned_cols=196 Identities=25% Similarity=0.431 Sum_probs=174.2
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-------CChHHHHHHHHHHHhcccCCcceeecceeccccce
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRL 473 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~ 473 (606)
..+++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|||||++++++.+....+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35678899999999999999985 58999999986431 23578999999999999999999999999999999
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC----cEEEeecc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDFG 549 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg 549 (606)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999643 3589999999999999999999998 999999999999998876 49999999
Q ss_pred CCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .....+|+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 9987654332 234678999999999999999999999999999999999999983
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.5e-41 Score=344.77 Aligned_cols=196 Identities=27% Similarity=0.407 Sum_probs=175.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.+.||+|+||.||+++.. +|+.||||+++... ...+.+.+|++++++++|||||++++++.++...++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4778899999999999999975 58999999987543 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc--CCCcEEEeeccCCcccCcCc
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 558 (606)
+|+|.+++... ...+++..+..|+.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++......
T Consensus 110 gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 110 GGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887542 23589999999999999999999998 999999999999998 67899999999999876543
Q ss_pred ceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred c--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 2 345679999999999999999999999999999999999999994
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-40 Score=343.26 Aligned_cols=193 Identities=27% Similarity=0.332 Sum_probs=175.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYE 477 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E 477 (606)
.+++.++||+|+||.||+++++ +|+.||||++... ....+.+.+|++++++++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5778899999999999999975 5899999998632 3456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcC
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 557 (606)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999643 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ....||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 2 34679999999999999999999999999999999999999994
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=333.55 Aligned_cols=194 Identities=31% Similarity=0.512 Sum_probs=162.5
Q ss_pred HhhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceec-cccceeeeeecc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRLLAYEYLV 480 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV~E~~~ 480 (606)
..+++.+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+ ....++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3457788999999999999999 5788999999653 456789999999999999999999999865 456799999999
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcce
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 560 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 560 (606)
+|+|.++|..... ..+++..+++|+.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999965422 3589999999999999999999998 99999999999999999999999999998754432
Q ss_pred eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 561 VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 561 ~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
....+++.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 33567899999999999999999999999999999999 677773
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=336.29 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=161.8
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC----CcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
+....+++.+.||+|+||.||+|++.. +..||||+++.... ..+.|.+|++++++++|||||+++|++. ....
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 344567888999999999999999753 45789999865432 3467999999999999999999999986 4678
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+++|+|.+++.... ..+++..+..++.||++||.|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999999876433 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
..............||+.|+|||.+.+..++.++|||||||++|||++ |++||.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence 776544444455678999999999999999999999999999999998 899984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=336.33 Aligned_cols=196 Identities=26% Similarity=0.369 Sum_probs=173.1
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHHHHHHH-hcccCCcceeecceeccccceeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTIIG-NVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~-~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
.+++.+.||+|+||+||+|+.. +++.||||++++. ....+.+..|+.++. .++|||||++++++.++...++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4677899999999999999986 4899999999642 345567777877765 689999999999999999999999
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999643 3478899999999999999999998 999999999999999999999999999986654
Q ss_pred CcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 332 2344689999999999999999999999999999999999999994
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=336.69 Aligned_cols=203 Identities=29% Similarity=0.484 Sum_probs=173.3
Q ss_pred HHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccccc
Q 037563 401 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 401 ~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~ 472 (606)
+..+++.++||+|+||+||+|+.+ +++.||||+++.... ..++|.+|++++++++||||++++++|.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 445678899999999999999863 357899999975432 346799999999999999999999999999999
Q ss_pred eeeeeeccCCChhhhhhhccc--------------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 037563 473 LLAYEYLVNGSLDKWIFNSTE--------------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKP 532 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp 532 (606)
+++|||+++|+|.+++..... ....+++..++.|+.||+.||+|||+. +++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 999999999999999965321 123488999999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCC-CCCC
Q 037563 533 ENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR-KSFS 606 (606)
Q Consensus 533 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~-~pfs 606 (606)
+||||+.++.+||+|||+++.+..... .......+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999987654433 2234567899999999999999999999999999999999996 5663
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=333.71 Aligned_cols=196 Identities=21% Similarity=0.328 Sum_probs=174.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeeccC
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYLVN 481 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~~~ 481 (606)
.|.+.+.||+|+||+||+|+.. +++.||||+++........+.+|+++|++++|||||++++++.++...++||||+++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 3677889999999999999986 488999999987655566789999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCC--CcEEEeeccCCcccCcCcc
Q 037563 482 GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 482 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~~ 559 (606)
|+|.+++.... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 86 g~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 86 LDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999995432 3589999999999999999999998 99999999999999854 589999999998765433
Q ss_pred eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 2344678999999999999999999999999999999999999994
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=335.46 Aligned_cols=196 Identities=30% Similarity=0.475 Sum_probs=166.2
Q ss_pred hccccccCCcCceeEEEEEeCC-Cc----EEEEEEeccc--CCChHHHHHHHHHHHhcccCCcceeecceeccccceeee
Q 037563 404 KNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESI--GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAY 476 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~~-~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~ 476 (606)
+++.+.||+|+||+||+|++.. |+ .||+|+++.. ....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 5677899999999999999753 33 5899988643 34568899999999999999999999999865 567889
Q ss_pred eeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCc
Q 037563 477 EYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 556 (606)
Q Consensus 477 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 556 (606)
||+.+++|.+++.... ..+++..+.+++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 90 e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 9999999999886543 4689999999999999999999998 999999999999999999999999999998765
Q ss_pred Ccce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 557 EESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 557 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
.... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 4432 2334578999999999999999999999999999999999 788884
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-40 Score=328.05 Aligned_cols=197 Identities=25% Similarity=0.365 Sum_probs=164.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC----ChHHHHHHHHHHHhcccCCcceeecceecccc----ce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAH----RL 473 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~----~~ 473 (606)
.+++.+.||+|+||+||+++.. +++.||||+++.... ..+.+.+|++++++++||||+++++++..... .+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4677889999999999999974 589999999965422 23578999999999999999999999876543 78
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+++++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+..
T Consensus 88 lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 999999999999988543 3589999999999999999999998 999999999999999999999999999876
Q ss_pred cCcCcc--eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 543322 22345679999999999999999999999999999999999999994
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-40 Score=339.72 Aligned_cols=194 Identities=24% Similarity=0.353 Sum_probs=167.4
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc----CCChHHHHHH---HHHHHhcccCCcceeecceecccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAE---VTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E---i~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
.+++.+.||+|+||.||+++.. +|+.||||++... ......+.+| +++++.++|||||++++++.+....++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 3567789999999999999976 4899999998532 2333444454 566667789999999999999999999
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++|+|.++|... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 85 vmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999643 3578899999999999999999998 9999999999999999999999999999876
Q ss_pred CcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .....||+.|||||++.. ..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 5443 234679999999999864 568999999999999999999999994
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-39 Score=324.14 Aligned_cols=195 Identities=27% Similarity=0.419 Sum_probs=171.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC----------hHHHHHHHHHHHhcc-cCCcceeecceeccc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG----------KKEFSAEVTIIGNVH-HVHLVKLKGFCIEGA 470 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~----------~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~ 470 (606)
.+++.+.||+|+||+||+++.. +++.||||+++..... .+.+.+|+.++++++ ||||+++++++.++.
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 4667889999999999999974 5899999999654211 235889999999997 999999999999999
Q ss_pred cceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccC
Q 037563 471 HRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 550 (606)
Q Consensus 471 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgl 550 (606)
..+|||||+++|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999643 3589999999999999999999998 999999999999999999999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccC------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~ 216 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence 987755332 344679999999998853 456889999999999999999999995
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=333.20 Aligned_cols=197 Identities=28% Similarity=0.363 Sum_probs=162.0
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceeccc----cceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA----HRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~lV~E~ 478 (606)
++-+.++||+|+||.||+|++ +|+.||||+++........++.|+..+.+++|||||+++++|.+.. ..++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 345567899999999999998 6889999999754333333455666667889999999999998654 57899999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+++|+|.++|.. ..++|..+.+++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.
T Consensus 83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999964 34889999999999999999999731 24999999999999999999999999999987
Q ss_pred cCcCcc---eeeeecccccCccccccccCCC------CCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREES---LVYTTLRGTRGYLAPEWITNNP------ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
...... .......||+.|||||++.... ++.++|||||||++|||+||..||
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 654332 1234567999999999987643 567899999999999999998876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=327.03 Aligned_cols=197 Identities=25% Similarity=0.408 Sum_probs=161.1
Q ss_pred hhccccccCCcCceeEEEEEeCC----CcEEEEEEeccc----CCChHHHHHHHHHHHhcccCCcceeecceecccccee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESI----GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLL 474 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~----~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l 474 (606)
.+++.++||+|+||.||+|++.. ...||||+++.. ....++|.+|++++++++||||++++|++.+ ...++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 46778899999999999998632 247899998643 2234689999999999999999999999976 46789
Q ss_pred eeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 475 AYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 475 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
||||+++++|.+++.... ..+++..+.+++.||++||.|||++ +|+||||||+||+|+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999886533 4589999999999999999999998 9999999999999999999999999999987
Q ss_pred CcCcce--eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 555 NREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 555 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 554332 2233567889999999999999999999999999999998 899984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-40 Score=330.96 Aligned_cols=197 Identities=32% Similarity=0.516 Sum_probs=168.6
Q ss_pred hhccccccCCcCceeEEEEEeCCC----cEEEEEEecccC--CChHHHHHHHHHHHhcccCCcceeecceec-cccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDG----IQVAVKKLESIG--QGKKEFSAEVTIIGNVHHVHLVKLKGFCIE-GAHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~----~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV 475 (606)
+.+|.++||+|+||+||+|++.++ ..||||+++... ...++|.+|++++++++||||++++|++.+ +...++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 346678899999999999997542 368999997432 234679999999999999999999999875 4578999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
|||+++++|.+++.... ..+++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 108 ~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 99999999999986533 3467888999999999999999998 99999999999999999999999999998765
Q ss_pred cCcce---eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 556 REESL---VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 556 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... ......||+.|+|||.+....++.++||||||+++|||+||+.||
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 43321 122357899999999999999999999999999999999988886
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=332.73 Aligned_cols=206 Identities=26% Similarity=0.433 Sum_probs=164.0
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceec
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE 468 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~ 468 (606)
|+....+++.++||+|+||.||+|++. +++.||||+++... ...+++.+|+..+.++ +|+||+.+++++.+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 344566788899999999999999863 24689999996432 2346788888888877 68999999999876
Q ss_pred c-ccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 469 G-AHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 469 ~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
. ...++||||+++|+|.+++..... ....+++..+..++.||++||.|||++ +|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 4 467899999999999999975432 123588999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCC-CCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR-KSFS 606 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~-~pfs 606 (606)
||++++.+||+|||+++....... .......||+.|||||.+.+..++.++|||||||++|||+||. .||.
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999987654433 2233467999999999999999999999999999999999974 5663
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=332.37 Aligned_cols=192 Identities=26% Similarity=0.335 Sum_probs=166.2
Q ss_pred hhcccc-ccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhc-ccCCcceeecceec----cccceee
Q 037563 403 TKNFST-KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE----GAHRLLA 475 (606)
Q Consensus 403 ~~~~~~-~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~----~~~~~lV 475 (606)
.+.+.. .||+|+||.||+|+.. +++.||||+++. ...+.+|++++.++ +|||||++++++.+ +...++|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 355554 5999999999999974 589999999864 45678899887655 89999999999865 4678999
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC---CCcEEEeeccCCc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAK 552 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfgla~ 552 (606)
|||+++|+|.++|..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++
T Consensus 88 mEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999999999965322 4689999999999999999999998 9999999999999985 5679999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
....... .....||+.|||||++.+..++.++|||||||++|||+||+.||
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 7655432 24568999999999999999999999999999999999999999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=327.21 Aligned_cols=192 Identities=27% Similarity=0.331 Sum_probs=164.0
Q ss_pred ccccCCcCceeEEEEEeC-CCcEEEEEEecccCC------ChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 407 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ------GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 407 ~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+.||+|+||+||+|++. +|+.||||+++.... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 367999999999999975 489999999864321 1356899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
+++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988776653 234588899999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......||+.|+|||.+... .++.++|||||||++|||++|+.||.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 22346789999999988654 57999999999999999999999983
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=330.26 Aligned_cols=205 Identities=28% Similarity=0.491 Sum_probs=176.9
Q ss_pred HHHHHhhccccccCCcCceeEEEEEe------CCCcEEEEEEecccC--CChHHHHHHHHHHHhc-ccCCcceeecceec
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTIIGNV-HHVHLVKLKGFCIE 468 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~ 468 (606)
|+....+++.++||+|+||.||+|++ ..++.||||+++... ....+|.+|+.+++++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 56667888999999999999999985 236789999997543 2345789999999999 69999999999999
Q ss_pred cccceeeeeeccCCChhhhhhhccc--------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCC
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTE--------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPEN 534 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~N 534 (606)
....++||||+++|+|.++++.... ....+++..+.+++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999975432 223588999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeccCCcccCcCcc-eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 037563 535 VLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSF 605 (606)
Q Consensus 535 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pf 605 (606)
|+++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |++||
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 9999999999999999997765443 33344678999999999999999999999999999999999 55554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=326.45 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=171.1
Q ss_pred HHHHhhccccccCCcCceeEEEEEeCC--------CcEEEEEEecccCC--ChHHHHHHHHHHHhc-ccCCcceeeccee
Q 037563 399 LCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQ--GKKEFSAEVTIIGNV-HHVHLVKLKGFCI 467 (606)
Q Consensus 399 l~~~~~~~~~~lG~G~fG~Vy~g~~~~--------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~ 467 (606)
+....+++.+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445567888999999999999998532 35799999965432 347889999999888 7999999999999
Q ss_pred ccccceeeeeeccCCChhhhhhhccc------------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 037563 468 EGAHRLLAYEYLVNGSLDKWIFNSTE------------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENV 535 (606)
Q Consensus 468 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NI 535 (606)
++...++||||+++|+|.++|..... ....+++.+++.++.||+.||+|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999965432 124589999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeccCCcccCcCcce-eeeecccccCccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 037563 536 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIG-GRKSFS 606 (606)
Q Consensus 536 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~ellt-G~~pfs 606 (606)
|++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |++||.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999877554332 2334578999999999999999999999999999999998 688873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=327.40 Aligned_cols=199 Identities=27% Similarity=0.498 Sum_probs=167.8
Q ss_pred HhhccccccCCcCceeEEEEEeCC-Cc--EEEEEEeccc--CCChHHHHHHHHHHHhc-ccCCcceeecceeccccceee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLPD-GI--QVAVKKLESI--GQGKKEFSAEVTIIGNV-HHVHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~~-~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV 475 (606)
..+++.++||+|+||.||+|++++ +. .||||+++.. ....++|.+|++++.++ +|||||+++|+|.++...++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 345677899999999999999864 33 5788888543 34567899999999998 799999999999999999999
Q ss_pred eeeccCCChhhhhhhcc------------ccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 476 YEYLVNGSLDKWIFNST------------EESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
|||+++|+|.++|+... .....+++..+.+++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2235689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCC-CC
Q 037563 544 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRK-SF 605 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~-pf 605 (606)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 9999999986543322 234568999999999999999999999999999999999764 66
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=328.34 Aligned_cols=205 Identities=26% Similarity=0.446 Sum_probs=175.0
Q ss_pred HHHHHhhccccccCCcCceeEEEEEeC------CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceecc
Q 037563 398 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEG 469 (606)
Q Consensus 398 el~~~~~~~~~~lG~G~fG~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~ 469 (606)
|+....+++.++||+|+||.||+|++. +++.||||+++.... ....|.+|++++++++||||++++|+|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344566788899999999999999873 257899999975432 234689999999999999999999999999
Q ss_pred ccceeeeeeccCCChhhhhhhccc------cccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcE
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTE------ESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 543 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~ 543 (606)
...++||||+++|+|.+++..... ....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 999999999999999999865321 113468899999999999999999998 99999999999999999999
Q ss_pred EEeeccCCcccCcCccee-eeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCC-CCC
Q 037563 544 KVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGR-KSF 605 (606)
Q Consensus 544 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~-~pf 605 (606)
||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||+ +||
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCC
Confidence 999999998765543322 23346899999999999999999999999999999999985 666
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=318.97 Aligned_cols=194 Identities=28% Similarity=0.417 Sum_probs=166.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC-------CChHHHHHHHHHHHhcc--cCCcceeecceeccccc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTIIGNVH--HVHLVKLKGFCIEGAHR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~~~ 472 (606)
.+++.+.||+|+||.||+|+.. +++.||||+++... ....++.+|+.++++++ |||||++++++.+....
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677789999999999999975 58999999986432 12245778999999997 89999999999999999
Q ss_pred eeeeeeccC-CChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-CCcEEEeeccC
Q 037563 473 LLAYEYLVN-GSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGL 550 (606)
Q Consensus 473 ~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfgl 550 (606)
++||||+.+ +++.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 999999976 6777777543 4589999999999999999999998 9999999999999985 47999999999
Q ss_pred CcccCcCcceeeeecccccCccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 037563 551 AKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 551 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
++...... .+...||+.|||||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 98754332 345689999999999987765 577899999999999999999994
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=319.91 Aligned_cols=197 Identities=26% Similarity=0.380 Sum_probs=166.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.++||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.++...++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 4566789999999999999974 58999999996432 3457899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+.++ +.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 83 LHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred cCCc-hhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9765 444443322 24589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeeecccccCccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
. ......||+.|+|||.+.... .+.++|+||+||++|||++|+.||.
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 2 233457999999999877665 4789999999999999999999994
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-38 Score=316.43 Aligned_cols=196 Identities=26% Similarity=0.345 Sum_probs=167.8
Q ss_pred hhccccccCCcCceeEEEEEeCCCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceeccccceeeeeec
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEYL 479 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~~ 479 (606)
.+++.++||+|+||+||+|++++++.||||+++.. ....+.+.+|+.++++++||||+++++++.+.+..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 35667899999999999999989999999999643 233578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCcc
Q 037563 480 VNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 559 (606)
Q Consensus 480 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 559 (606)
.++.+..+... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+........
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 83 DQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp SEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred hhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 88777766532 24589999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 560 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 560 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 2234568999999998865 456899999999999999999999994
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=317.07 Aligned_cols=197 Identities=23% Similarity=0.347 Sum_probs=164.7
Q ss_pred HhhccccccCCcCceeEEEEEeC-C-CcEEEEEEecccC---CChHHHHHHHHHHHhc---ccCCcceeecceec-----
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-D-GIQVAVKKLESIG---QGKKEFSAEVTIIGNV---HHVHLVKLKGFCIE----- 468 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~-~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~----- 468 (606)
..+++.++||+|+||+||++++. + ++.||||+++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 34677889999999999999974 3 6779999986432 2334567788777766 79999999999853
Q ss_pred cccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeec
Q 037563 469 GAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 548 (606)
Q Consensus 469 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df 548 (606)
....+++|||++++.+...... ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 3467899999998877654432 224588999999999999999999998 9999999999999999999999999
Q ss_pred cCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 549 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 549 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
|+++....... .....||+.|||||++.+.+++.++||||+||++|||++|+.||.
T Consensus 161 g~~~~~~~~~~--~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 161 GLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CSCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhhhccccc--CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 99986544332 345689999999999999999999999999999999999999994
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=313.09 Aligned_cols=196 Identities=24% Similarity=0.402 Sum_probs=163.2
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC--ChHHHHHHHHHHHhcccCCcceeecceeccc----cceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--GKKEFSAEVTIIGNVHHVHLVKLKGFCIEGA----HRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~lV 475 (606)
.+++.++||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+.+|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3567789999999999999964 689999999975432 2457899999999999999999999987654 23556
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccC
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 555 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 555 (606)
+||+.+++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 677789999999954 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred cCcc--eeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES--LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 4322 12244678999999998854 567899999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=313.29 Aligned_cols=198 Identities=24% Similarity=0.322 Sum_probs=171.3
Q ss_pred HhhccccccCCcCceeEEEEEeC----CCcEEEEEEeccc-----CCChHHHHHHHHHHHhccc-CCcceeecceecccc
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTIIGNVHH-VHLVKLKGFCIEGAH 471 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~----~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~ 471 (606)
..+++.++||+|+||+||+++.. +|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 34788899999999999999852 3789999998542 2345678999999999977 899999999999999
Q ss_pred ceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCC
Q 037563 472 RLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 551 (606)
Q Consensus 472 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla 551 (606)
.+++|||+.+|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999996543 467788889999999999999998 9999999999999999999999999999
Q ss_pred cccCcCcceeeeecccccCccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 552 KLMNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 552 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 87655444434557899999999998764 46789999999999999999999994
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-36 Score=305.63 Aligned_cols=196 Identities=22% Similarity=0.296 Sum_probs=168.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhccc-CCcceeecceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH-VHLVKLKGFCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~E~~~ 480 (606)
.+++.++||+|+||.||+|++. +++.||||+++.. ...+++.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 4677889999999999999975 5899999988543 234567889999999975 89999999999999999999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcC-----CCcEEEeeccCCcccC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLMN 555 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfgla~~~~ 555 (606)
+++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 84 ~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 789999886533 3588999999999999999999998 9999999999999974 5789999999998765
Q ss_pred cCcc------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 556 REES------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 556 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.... .......||+.|||||.+.+..++.++||||||+++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 3321 11234679999999999999999999999999999999999999993
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=314.58 Aligned_cols=195 Identities=30% Similarity=0.378 Sum_probs=161.0
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeecceecc------ccceee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKGFCIEG------AHRLLA 475 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~~lV 475 (606)
+|+..++||+|+||+||+|++. +++.||||+++.... ...+|+++|++++||||+++++++... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 3555678999999999999986 489999999975432 234799999999999999999998543 346899
Q ss_pred eeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCccc
Q 037563 476 YEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLM 554 (606)
Q Consensus 476 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~ 554 (606)
|||++++.+.. +.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998764443 332222335689999999999999999999998 999999999999999775 8999999999876
Q ss_pred CcCcceeeeecccccCccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 555 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 555 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 54332 234679999999998765 568999999999999999999999983
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=308.96 Aligned_cols=198 Identities=23% Similarity=0.295 Sum_probs=164.2
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEeccc---CCChHHHHHHHHHHHhcccCCcceeecceec--------c
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTIIGNVHHVHLVKLKGFCIE--------G 469 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--------~ 469 (606)
.++++.++||+|+||+||+|++. +|+.||||++... ....+++.+|+++|++++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 45677889999999999999975 6899999998543 2345778999999999999999999998865 3
Q ss_pred ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeecc
Q 037563 470 AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 549 (606)
Q Consensus 470 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg 549 (606)
...++||||++++.+..+... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457899999998877655432 24578888999999999999999998 99999999999999999999999999
Q ss_pred CCcccCcCcc---eeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 550 LAKLMNREES---LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 550 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 9986653322 112235789999999998765 68999999999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=311.13 Aligned_cols=191 Identities=28% Similarity=0.400 Sum_probs=159.3
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceeccc------cc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEGA------HR 472 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~ 472 (606)
.+++.++||+|+||+||+|+.. +|+.||||+++..... .+.+.+|+++|++++|||||++++++.... +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4667788999999999999975 4899999999754322 457889999999999999999999997654 46
Q ss_pred eeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCc
Q 037563 473 LLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 552 (606)
Q Consensus 473 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~ 552 (606)
++||||+ +.+|..++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++
T Consensus 99 ~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 8999999 5677776632 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 553 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 553 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
...... +...+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 765432 446799999999988764 56899999999999999999999984
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9e-36 Score=304.64 Aligned_cols=191 Identities=24% Similarity=0.383 Sum_probs=165.8
Q ss_pred HhhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-cCCcceeecceec--cccceeeee
Q 037563 402 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIE--GAHRLLAYE 477 (606)
Q Consensus 402 ~~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~--~~~~~lV~E 477 (606)
..+++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 35778899999999999999975 5899999998643 4678999999999995 9999999999874 456889999
Q ss_pred eccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC-cEEEeeccCCcccCc
Q 037563 478 YLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNR 556 (606)
Q Consensus 478 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 556 (606)
|+++++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999998765 3488999999999999999999998 999999999999998655 699999999987654
Q ss_pred CcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 557 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 557 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
... .....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||.
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 432 2446789999999987765 47999999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-36 Score=301.00 Aligned_cols=196 Identities=24% Similarity=0.312 Sum_probs=161.9
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcceeec-ceeccccceeeeeecc
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVKLKG-FCIEGAHRLLAYEYLV 480 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g-~~~~~~~~~lV~E~~~ 480 (606)
++++.++||+|+||.||+|++. +++.||||++.... ..+++..|++++++++|+|++..++ +..+....++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 4677889999999999999974 58999999886532 3456889999999998777665554 456777888999998
Q ss_pred CCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEc---CCCcEEEeeccCCcccCcC
Q 037563 481 NGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNRE 557 (606)
Q Consensus 481 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfgla~~~~~~ 557 (606)
+++|.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.....
T Consensus 86 ~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 556666654322 4589999999999999999999998 999999999999986 4557999999999976543
Q ss_pred cc------eeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 558 ES------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 558 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 22 12234679999999999999999999999999999999999999994
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=298.61 Aligned_cols=195 Identities=21% Similarity=0.294 Sum_probs=169.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccC---CChHHHHHHHHHHHhcccCCcceeecceeccccceeeeee
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTIIGNVHHVHLVKLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~E~ 478 (606)
.+++.++||+|+||+||+|++. +++.||||+++... ...+.+.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3567789999999999999975 58899999996442 2347889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcccCcCc
Q 037563 479 LVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 558 (606)
Q Consensus 479 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 558 (606)
+.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 83 ~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998877533 4578899999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeeecccccCccccccccCCC-CCCccchHHHHHHHHHHHhCCCCC
Q 037563 559 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 559 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
.. .....+++.|+|||.+.... ++.++|||||||++|||++|+.||
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 22 23346788999999887664 689999999999999999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=302.06 Aligned_cols=190 Identities=25% Similarity=0.276 Sum_probs=154.5
Q ss_pred hccccccCCcCceeEEEEEeC-CCcEEEEEEecccCC---ChHHHHHHHHHHHhcccCCcceeecceec------cccce
Q 037563 404 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTIIGNVHHVHLVKLKGFCIE------GAHRL 473 (606)
Q Consensus 404 ~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------~~~~~ 473 (606)
+++.++||+|+||+||+|++. +|+.||||+++.... ..+++.+|+.++++++||||+++++++.. ..+.+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 566789999999999999976 489999999975432 23568899999999999999999999864 35779
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+||||+.++.+..+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 999999776554432 3478899999999999999999998 999999999999999999999999999886
Q ss_pred cCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSF 605 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pf 605 (606)
..... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence 55433 234567899999999999999999999999999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-35 Score=301.06 Aligned_cols=192 Identities=27% Similarity=0.418 Sum_probs=161.5
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCC---hHHHHHHHHHHHhcccCCcceeecceecc-----ccce
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTIIGNVHHVHLVKLKGFCIEG-----AHRL 473 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~ 473 (606)
+|+..++||+|+||+||+|+.. +|+.||||+++..... .+++.+|++++++++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 3667789999999999999964 5899999999755333 35688999999999999999999998643 3457
Q ss_pred eeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 474 LAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 474 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 99 ~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp EEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 77888899999999843 3589999999999999999999998 999999999999999999999999999976
Q ss_pred cCcCcceeeeecccccCccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 554 MNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 554 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
..... ....|++.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 171 ~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 171 TDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp CTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 54332 346789999999987665 46889999999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.1e-31 Score=273.65 Aligned_cols=197 Identities=26% Similarity=0.307 Sum_probs=158.7
Q ss_pred hhccccccCCcCceeEEEEEeC-CCcEEEEEEecccCCChHHHHHHHHHHHhcc-----------cCCcceeecceecc-
Q 037563 403 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTIIGNVH-----------HVHLVKLKGFCIEG- 469 (606)
Q Consensus 403 ~~~~~~~lG~G~fG~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~l~g~~~~~- 469 (606)
+|.+.++||+|+||+||+|+.. +|+.||||+++......+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 3678899999999999999975 5899999999765444567888999998875 57899999888654
Q ss_pred -ccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCC------c
Q 037563 470 -AHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNF------T 542 (606)
Q Consensus 470 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~------~ 542 (606)
...++++++...+.......... ....+++..+..++.||+.||+|||+. .+|+||||||+||||+.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 34556666665554433332222 234678889999999999999999983 2899999999999998665 3
Q ss_pred EEEeeccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 037563 543 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGMVLLEIIGGRKSFS 606 (606)
Q Consensus 543 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gvvl~elltG~~pfs 606 (606)
+|++|||.+....... ....||+.|+|||.+....++.++|+||+||+++||++|+.||.
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 9999999998654332 34679999999999999999999999999999999999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.6e-23 Score=190.66 Aligned_cols=165 Identities=13% Similarity=0.069 Sum_probs=118.8
Q ss_pred cccccCCcCceeEEEEEeCCCcEEEEEEecccCC-------------------ChHHHHHHHHHHHhcccCCcceeecce
Q 037563 406 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------------------GKKEFSAEVTIIGNVHHVHLVKLKGFC 466 (606)
Q Consensus 406 ~~~~lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~-------------------~~~~~~~Ei~~l~~l~h~nIv~l~g~~ 466 (606)
+.++||+|+||+||+|++.+|++||||+++.... .......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5678999999999999998999999998753110 012345688889999999999887653
Q ss_pred eccccceeeeeeccCCChhhhhhhccccccccChhhHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeEEcCCCcEEEe
Q 037563 467 IEGAHRLLAYEYLVNGSLDKWIFNSTEESRFLCWNTRFNIALGTAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 546 (606)
Q Consensus 467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~~iiH~dlkp~NIll~~~~~~kl~ 546 (606)
..+++|||+++..+.+ ++.....+++.|++.+|+|||+. +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3479999998865432 44556678999999999999998 99999999999999965 59999
Q ss_pred eccCCcccCcCcceeeeecccccCccccccccCCCCCCccchHHHHH
Q 037563 547 DFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSYGM 593 (606)
Q Consensus 547 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~Dv~s~Gv 593 (606)
|||++.....+.....- ...... -.|.+ .+.++.++|+||..-
T Consensus 145 DFG~a~~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHH
Confidence 99999765433211000 000000 01111 245778899999643
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=1.5e-21 Score=164.50 Aligned_cols=111 Identities=17% Similarity=0.303 Sum_probs=94.8
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
+|+|.|||.|.+ ++.|+| |.|.|.|+.+|+ +.++. ..++||.||++.|.. .+.+.|+.||+|+
T Consensus 1 tDtL~~gq~L~~-------g~~l~~--g~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLv 63 (112)
T d1xd5a_ 1 SDRLNSGHQLDT-------GGSLAE--GGYLFIIQNDCN---LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECT-------TCEEEE--TTEEEEECTTSC---EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEE
T ss_pred CCEecCCCEecC-------CCEEEE--CCEEEEEcCCCC---EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEE
Confidence 599999999998 999985 889999998887 23322 478999999987744 4679999999999
Q ss_pred EEcCCceeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCCCCC
Q 037563 108 LQRGNGEAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155 (606)
Q Consensus 108 l~~~~~~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~PtD 155 (606)
|++.++.+|++++. .....+|+|+|+|||||++.++.++|||+.+|+|
T Consensus 64 l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEecCCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 99988889988865 4456689999999999999989999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.80 E-value=1.2e-19 Score=151.25 Aligned_cols=105 Identities=24% Similarity=0.392 Sum_probs=89.2
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEE
Q 037563 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYL 108 (606)
Q Consensus 29 ~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l 108 (606)
|+|.||++|.+ ++.|.+ |.|.|+|+..++. - .|. ..++||+||++.|...++.+.|+.||+|+|
T Consensus 2 ~~L~~g~~L~~-------g~~l~~--g~~~l~~q~dgnL---v-l~~---~~~~vW~ant~~~~~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 2 NLLTNGEGLYA-------GQSLDV--EPYHFIMQEDCNL---V-LYD---HSTSVWASNTGILGKKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CEEETTCEEET-------TCEEEE--TTEEEEECTTSCE---E-EEE---TTEEEEECCCCCTTCCCCEEEECTTSCEEE
T ss_pred CCccCCCEEeC-------CCEEEe--CCEEEEecCCCeE---E-EEe---CCEEEEEeCCCCCCceeEEEEEcCCceEEE
Confidence 78999999987 999975 7899999888772 2 232 578999999999998888999999999999
Q ss_pred EcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 109 QRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 109 ~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
++.++ +||+|++. +.....|+|+|||||||++ ..+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---~~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC---CEEEECCCC
T ss_pred EeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---CCEecCCCc
Confidence 99877 79999975 4566789999999999995 369999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.78 E-value=1.6e-19 Score=150.58 Aligned_cols=105 Identities=27% Similarity=0.369 Sum_probs=86.8
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEE
Q 037563 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAY 107 (606)
Q Consensus 28 ~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~ 107 (606)
.|+|.||+.|.+ ++.|. +|.|.|.|+.+|+ +.|+. ..++||.||++.|.. .+.+.|+.+|+|+
T Consensus 1 ~~~L~~g~~L~~-------G~~l~--ng~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~~Gnlv 63 (108)
T d1jpca_ 1 DNILYSGETLST-------GEFLN--YGSFVFIMQEDCN---LVLYD----VDKPIWATNTGGLSR-SCFLSMQTDGNLV 63 (108)
T ss_dssp CCEEETTEEECT-------TCEEE--ETTEEEEECTTSC---EEEEE----TTEEEEECCCTTSCS-SCEEEECTTSCEE
T ss_pred CCCccCCCEecC-------CCEEE--cCCEEEEECCCCe---EEEEe----CCceeeEeCCCCCCC-ccEEEEeccceEE
Confidence 378999999987 99995 6999999999988 33432 468999999988743 4579999999999
Q ss_pred EEcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecCC
Q 037563 108 LQRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (606)
Q Consensus 108 l~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd~ 152 (606)
|++.++ +||++++. ......|+|+|||||||++. .+||||+|
T Consensus 64 l~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 64 VYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp EECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred EECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 999877 79999975 34455789999999999964 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=7.1e-16 Score=130.24 Aligned_cols=81 Identities=21% Similarity=0.221 Sum_probs=71.6
Q ss_pred EEEEEecCCCeEEEEeCCCCCCCCC-CcEEEeccccEEEEcCCceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEE
Q 037563 71 SLVVIHISSAKVVWTANRGLLIRDS-DKFVFEKSGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQ 148 (606)
Q Consensus 71 ~i~~~~~~~~~~vW~an~~~p~~~~-~~~~~~~~g~l~l~~~~~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~Wq 148 (606)
.|||..+++++++|++|++.|+..+ .+|.++.||||+|++.+..+|++++.+ ...+.+.|+++|||||++.++.++||
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 6889999999999999999999884 489999999999999988999999764 35678999999999999999999999
Q ss_pred ecC
Q 037563 149 SFS 151 (606)
Q Consensus 149 sFd 151 (606)
|+.
T Consensus 91 S~t 93 (120)
T d1dlpa2 91 SGN 93 (120)
T ss_dssp CCC
T ss_pred eCC
Confidence 996
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=4.2e-15 Score=125.00 Aligned_cols=104 Identities=19% Similarity=0.337 Sum_probs=82.6
Q ss_pred ccccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEecccc
Q 037563 26 QHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGN 105 (606)
Q Consensus 26 ~~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~ 105 (606)
.+.++|.+||++. +.+..|+|.|.|+.+|+. +.|. ..++||.||+..+.. .+.+.|+.||+
T Consensus 12 ~~~~~l~~~q~l~-----------~~~~~~~y~l~mQ~DGNL----VLy~---~~~~vWssnt~~~~~-~~~l~l~~dGn 72 (119)
T d1b2pa_ 12 NHPQILHATESLE-----------ILFGTHVYRFIMQTDCNL----VLYD---NNNPIWATNTGGLGN-GCRAVLQPDGV 72 (119)
T ss_dssp CCCCEEETTCEEE-----------EEETTEEEEEEECTTSCE----EEEE---TTEEEEECCCTTSCS-SCEEEECTTSC
T ss_pred CCCCEEeCCCeEE-----------EecCCceEEEEECCCCcE----EEEE---CCeEEEEecCCCCCc-ceEEEEEeCCC
Confidence 4567777777763 466799999999999982 2233 478999999986643 46899999999
Q ss_pred EEEEcCCc-eeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEecC
Q 037563 106 AYLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFS 151 (606)
Q Consensus 106 l~l~~~~~-~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd 151 (606)
|+|.+.++ .||++++.+ ....+|+|+|||||||++ .++|||-.
T Consensus 73 LvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred EEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 99999887 799999853 455679999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.36 E-value=5.3e-13 Score=111.14 Aligned_cols=99 Identities=21% Similarity=0.277 Sum_probs=75.9
Q ss_pred ccccccCCCccccceeeecCCCcEEEeCCCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEecccc
Q 037563 26 QHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGN 105 (606)
Q Consensus 26 ~~~~~l~~g~~~~~~~~~~~~~~~l~s~~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~ 105 (606)
++.++|.+|++|. +|.|.|.|..+|+ +-+ |. ..++||.+|... ...+.+.|+.|||
T Consensus 12 ~~~~tl~~~~~l~---------------~g~~~l~~q~DGN---LvL-~~---~~~~vW~s~t~~--~~~~~l~l~~dGN 67 (115)
T d1dlpa1 12 SHPQTLHAAQSLE---------------LSSFRFTMQSDCN---LVL-FD---SDVRVWASNTAG--ATGCRAVLQSDGL 67 (115)
T ss_dssp CSCSCCCTTCEEC---------------STTEEEEECTTSC---EEE-EE---SSSEEECCCCCS--CSCCBCCBCSSSC
T ss_pred CCcceecCCCcEE---------------cCCEEEEECCCCe---EEE-Ec---CCeeEEEcccCC--CCceEEEEeccCC
Confidence 4456666666653 6889999998888 223 32 467899999753 3467899999999
Q ss_pred EEEEcCCc-eeEeeccC-CCceeEEEEecCCcEEEEecCCceEEEecC
Q 037563 106 AYLQRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFS 151 (606)
Q Consensus 106 l~l~~~~~-~~w~t~~~-~~~~~~~~l~~~Gnlvl~~~~~~~~WqsFd 151 (606)
|||++.++ .||++.+. ......++|++|||||||+ .++|+|-.
T Consensus 68 Lvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 68 LVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp BCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred EEEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 99998876 79999985 4556679999999999994 47999854
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.32 E-value=5.9e-14 Score=116.99 Aligned_cols=81 Identities=22% Similarity=0.256 Sum_probs=71.7
Q ss_pred EEEEecCCCeEEEEeCCCCCCCCC-CcEEEeccccEEEEcCCceeEeeccCCCceeEEEEecCCcEEEEecCCceEEEec
Q 037563 72 LVVIHISSAKVVWTANRGLLIRDS-DKFVFEKSGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSF 150 (606)
Q Consensus 72 i~~~~~~~~~~vW~an~~~p~~~~-~~~~~~~~g~l~l~~~~~~~w~t~~~~~~~~~~~l~~~Gnlvl~~~~~~~~WqsF 150 (606)
|||.-.+..+..|+.+.+.++.++ .+|.|+.||||||++++.++|++++.+..++.+.|+++|||||++.++.++|||+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~ 82 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSG 82 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcC
Confidence 566656677888999999999884 4899999999999998889999998777788999999999999999999999998
Q ss_pred CC
Q 037563 151 SH 152 (606)
Q Consensus 151 d~ 152 (606)
..
T Consensus 83 t~ 84 (115)
T d1dlpa1 83 TK 84 (115)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.08 E-value=9.4e-11 Score=98.29 Aligned_cols=85 Identities=20% Similarity=0.344 Sum_probs=64.2
Q ss_pred CCeeEEEEEecCCCcEEEEEEEecCCCeEEEEeCCCCCCCCCCcEEEeccccEEEEcCCc-eeEeeccC-CCceeEEEEe
Q 037563 54 NSVFGFGFYTALDVQFFSLVVIHISSAKVVWTANRGLLIRDSDKFVFEKSGNAYLQRGNG-EAWSANTS-GQKVECMELQ 131 (606)
Q Consensus 54 ~g~f~~gf~~~~~~~~~~i~~~~~~~~~~vW~an~~~p~~~~~~~~~~~~g~l~l~~~~~-~~w~t~~~-~~~~~~~~l~ 131 (606)
.|.|.|.+...|+ +-+ |. ...+||.+|.... ...+.+.|+.+|||||++.++ .+|++.+. ......++|+
T Consensus 34 ~g~y~L~~q~DGN---LvL-~~---~~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq 105 (120)
T d1dlpa2 34 LSPYRLSMETDCN---LVL-FD---RDDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105 (120)
T ss_dssp CSSCEEEEETTTE---EEE-EB---TTBCCSCCCCCSS-CSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEEC
T ss_pred cCCEEEEEcCCCc---EEE-ec---CCcEEEEEccccC-CCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEEC
Confidence 5778888887776 222 22 3678899985432 234679999999999999877 78999975 4456679999
Q ss_pred cCCcEEEEecCCceEEEe
Q 037563 132 DSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 132 ~~Gnlvl~~~~~~~~Wqs 149 (606)
+|||||||+ .++|.|
T Consensus 106 ~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 106 PDRNLAIYG---GALWTT 120 (120)
T ss_dssp SSSCEEEEC---CCCCBC
T ss_pred CCCcEEEeC---CCcccC
Confidence 999999994 468876
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.79 E-value=3.8e-09 Score=87.99 Aligned_cols=54 Identities=30% Similarity=0.465 Sum_probs=48.2
Q ss_pred cEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEec
Q 037563 97 KFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSF 150 (606)
Q Consensus 97 ~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~WqsF 150 (606)
+|.|+.||||||++++..+|++++.+. ..+.+.|+++|||||+|.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP 87 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS
T ss_pred EEEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC
Confidence 688999999999998889999998643 457899999999999999999999974
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.73 E-value=7.2e-09 Score=84.96 Aligned_cols=53 Identities=26% Similarity=0.516 Sum_probs=47.7
Q ss_pred cEEEeccccEEEEcCCceeEeeccCCC-ceeEEEEecCCcEEEEecCCceEEEe
Q 037563 97 KFVFEKSGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 97 ~~~~~~~g~l~l~~~~~~~w~t~~~~~-~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
+|.|+.||||||++.+..||++++.+. ..+.+.|+++|||||++.++.++|+|
T Consensus 22 ~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS 75 (108)
T d1jpca_ 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS 75 (108)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred EEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc
Confidence 689999999999998889999998644 45689999999999999999999997
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.71 E-value=9.5e-09 Score=84.29 Aligned_cols=53 Identities=32% Similarity=0.565 Sum_probs=47.5
Q ss_pred cEEEeccccEEEEcCCceeEeeccC--CCceeEEEEecCCcEEEEecCCceEEEe
Q 037563 97 KFVFEKSGNAYLQRGNGEAWSANTS--GQKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 97 ~~~~~~~g~l~l~~~~~~~w~t~~~--~~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
+|.|+.|||||++..+..||++++. ....+.+.|+++|||||+++++.++|+|
T Consensus 22 ~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s 76 (109)
T d1kj1a_ 22 HFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76 (109)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC
T ss_pred EEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE
Confidence 6889999999999988899999875 4456789999999999999999999998
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.34 E-value=2.6e-07 Score=76.05 Aligned_cols=53 Identities=26% Similarity=0.521 Sum_probs=44.4
Q ss_pred CcEEEeccccEEEEcCCceeEeeccCC-CceeEEEEecCCcEEEEecCCceEEEe
Q 037563 96 DKFVFEKSGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (606)
Q Consensus 96 ~~~~~~~~g~l~l~~~~~~~w~t~~~~-~~~~~~~l~~~Gnlvl~~~~~~~~Wqs 149 (606)
-+|.|+.||||||+..+.+||++++.+ ...+.++|+++|||||++. +..+|.|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS 74 (112)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC
T ss_pred EEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE
Confidence 478999999999999888999998753 4557899999999999986 4566665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=3.1e-06 Score=80.52 Aligned_cols=135 Identities=13% Similarity=0.027 Sum_probs=92.0
Q ss_pred cCCcCceeEEEEEeCCCcEEEEEEeccc-CCChHHHHHHHHHHHhcc-cCCcceeecceeccccceeeeeeccCCChhhh
Q 037563 410 LGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTIIGNVH-HVHLVKLKGFCIEGAHRLLAYEYLVNGSLDKW 487 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 487 (606)
.+.++...||+... +++.+++|+.... .....++.+|...+..+. +--+.+++.+..+++..++|||++++.++.+.
T Consensus 22 ~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 22 TEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 33444578999876 5566788887543 334456788888888774 44467788888888888999999999887654
Q ss_pred hhhccccccccChhhHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 037563 488 IFNSTEESRFLCWNTRFNIALGTAKGLAYLHEE----------------------------------------------- 520 (606)
Q Consensus 488 l~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------------------------------------------- 520 (606)
... .....+++.++++.|+.||+.
T Consensus 101 ~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 101 YED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred ccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 321 111223344444444445431
Q ss_pred ------C---CCceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 521 ------C---EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 521 ------~---~~~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
. ...++|+|+.|.||+++++..+-|+||+.+...
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 1 123799999999999998766779999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=4.9e-05 Score=71.48 Aligned_cols=143 Identities=15% Similarity=0.063 Sum_probs=87.0
Q ss_pred cCCcC-ceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhccc--CCcceeecceeccccceeeeeeccCCChhh
Q 037563 410 LGQGG-FGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHH--VHLVKLKGFCIEGAHRLLAYEYLVNGSLDK 486 (606)
Q Consensus 410 lG~G~-fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 486 (606)
+..|. -..||+...+++..+++|..+.. ...++..|+..++.+.. ..+.+++.+..+.+..++||||++|.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 34444 46899999878888888976543 23457778888877753 335667887788888899999999877644
Q ss_pred hhh--------------h---ccccccccC--hhhHHHHH--------------------HHHHHHHHHHHhcC----CC
Q 037563 487 WIF--------------N---STEESRFLC--WNTRFNIA--------------------LGTAKGLAYLHEEC----EV 523 (606)
Q Consensus 487 ~l~--------------~---~~~~~~~l~--~~~~~~i~--------------------~qi~~gL~yLH~~~----~~ 523 (606)
... . ......... ......-. ......+..+.... +.
T Consensus 96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (255)
T d1nd4a_ 96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL 175 (255)
T ss_dssp SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred ccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence 210 0 000000000 00000000 00112233333321 23
Q ss_pred ceeecCCCCCCeEEcCCCcEEEeeccCCccc
Q 037563 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 554 (606)
Q Consensus 524 ~iiH~dlkp~NIll~~~~~~kl~Dfgla~~~ 554 (606)
.++|+|+.|.||+++++..+-|+||+.+...
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 4899999999999998767789999988653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.54 E-value=0.00026 Score=71.20 Aligned_cols=74 Identities=11% Similarity=0.046 Sum_probs=48.0
Q ss_pred cccCCcCceeEEEEEeCC-CcEEEEEEeccc--------CCChHHHHHHHHHHHhcc-c--CCcceeecceeccccceee
Q 037563 408 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--------GQGKKEFSAEVTIIGNVH-H--VHLVKLKGFCIEGAHRLLA 475 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~-~~~vavK~l~~~--------~~~~~~~~~Ei~~l~~l~-h--~nIv~l~g~~~~~~~~~lV 475 (606)
+.||.|....||+....+ ++.++||.-... .....+...|.+.++.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999999765 678999965321 122344566887777663 2 334455544 45566899
Q ss_pred eeeccCCC
Q 037563 476 YEYLVNGS 483 (606)
Q Consensus 476 ~E~~~~gs 483 (606)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.29 E-value=0.00044 Score=67.47 Aligned_cols=137 Identities=12% Similarity=0.032 Sum_probs=82.4
Q ss_pred ceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcc--eeec-----ceeccccceeeeeeccCCChhhh
Q 037563 415 FGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV--KLKG-----FCIEGAHRLLAYEYLVNGSLDKW 487 (606)
Q Consensus 415 fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv--~l~g-----~~~~~~~~~lV~E~~~~gsL~~~ 487 (606)
.-.||+.+.++|+.+++|..+......+++..|...+..+...++. ..+. ........+.++++++|..+...
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3479999999999999999876666778899999999888643332 1211 12234456788999887543211
Q ss_pred ----h----------hhc----c-cccc-------------------ccChhhHHHHHHHHHHHHHHHHh----cCCCce
Q 037563 488 ----I----------FNS----T-EESR-------------------FLCWNTRFNIALGTAKGLAYLHE----ECEVKI 525 (606)
Q Consensus 488 ----l----------~~~----~-~~~~-------------------~l~~~~~~~i~~qi~~gL~yLH~----~~~~~i 525 (606)
+ +.. . .... .++......+...+.+.++.+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 000 0 0000 11111112222222333333332 234579
Q ss_pred eecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 526 VHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 526 iH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.92 E-value=0.0013 Score=65.94 Aligned_cols=73 Identities=21% Similarity=0.213 Sum_probs=50.7
Q ss_pred cccCCcCceeEEEEEeCCC--------cEEEEEEecccCCChHHHHHHHHHHHhcccCCcc-eeecceeccccceeeeee
Q 037563 408 TKLGQGGFGSVYLGMLPDG--------IQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLV-KLKGFCIEGAHRLLAYEY 478 (606)
Q Consensus 408 ~~lG~G~fG~Vy~g~~~~~--------~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~E~ 478 (606)
+.|+.|---.+|+...+++ +.|++++.-. .....+..+|..+++.+.-.++. ++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678888889999987542 4566666543 33445677899998888644554 67777643 689999
Q ss_pred ccCCChh
Q 037563 479 LVNGSLD 485 (606)
Q Consensus 479 ~~~gsL~ 485 (606)
+++.+|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9886553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.55 E-value=0.046 Score=52.07 Aligned_cols=142 Identities=14% Similarity=0.001 Sum_probs=73.5
Q ss_pred cCCcCceeEEEEEeCCCcEEEEEEecccCCChHHHHHHHHHHHhcccCCcce--eecc------eeccccceeeeeeccC
Q 037563 410 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTIIGNVHHVHLVK--LKGF------CIEGAHRLLAYEYLVN 481 (606)
Q Consensus 410 lG~G~fG~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~nIv~--l~g~------~~~~~~~~lV~E~~~~ 481 (606)
|..|---+.|+.+.++|+ +++|+.+.. ...+++..|++++..+.+.++.- .+-. .........++++.++
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g 103 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 103 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence 556767888999986664 888988643 23456666777777775433321 1111 1112334555666555
Q ss_pred CChhhhh--------------hhcc---c--------------------cccccChhhHHHHHHHHHHHHHHHHh-cCCC
Q 037563 482 GSLDKWI--------------FNST---E--------------------ESRFLCWNTRFNIALGTAKGLAYLHE-ECEV 523 (606)
Q Consensus 482 gsL~~~l--------------~~~~---~--------------------~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ 523 (606)
......- +... . .............+..+...+.-.+. ..+.
T Consensus 104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~ 183 (316)
T d2ppqa1 104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 183 (316)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence 3332110 0000 0 00001111122222222222222222 2345
Q ss_pred ceeecCCCCCCeEEcCCCcEEEeeccCCcc
Q 037563 524 KIVHCDIKPENVLLDDNFTAKVSDFGLAKL 553 (606)
Q Consensus 524 ~iiH~dlkp~NIll~~~~~~kl~Dfgla~~ 553 (606)
++||+|+.+.||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 899999999999999887778999998864
|